{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "file_path = \"/data/jaesung/llm_for_diabetes/src/model/inference_results_1224.jsonl\"\n",
    "\n",
    "data = []\n",
    "with open(file_path, 'r', encoding='utf-8') as f:\n",
    "    for line in f:\n",
    "        data.append(json.loads(line))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': \"[PRE] To investigate the mechanism of thyroid hormone action on pulmonary surfactant synthesis, we characterized the effect of triiodothyronine on phosphatidylcholine synthesis in cultured fetal rabbit lung. Since glucocorticoids stimulate surfactant synthesis and reduce the incidence of Respiratory Distress Syndrome in premature infants, we also examined the interaction of triiodothyronine and dexamethasone. The rate of choline incorporation into phosphatidylcholine was determined in organ cultures of rabbit lung maintained in serum-free Waymouth's medium. In 23-d lung cultured for 72 h, the increase in choline incorporation with triiodothyronine alone, dexamethasone alone, and triiodothyronine plus dexamethasone was 50, 62, and 161%, respectively. Both triiodothyronine and dexamethasone also increased incorporation rates with glucose, glycerol, and acetate as precursors, and stimulation with triiodothyronine plus dexamethasone was at least additive. Dexamethasone, but not triiodothyronine, affected distribution of radioactivity from [3H] acetate among phospholipids. Stimulation was first detected 8-12 h after addition of triiodothyronine, and then increased in a linear fashion. With triiodothyronine plus dexamethasone, stimulation was maximal at 48-72 h, and was supra-additive at all times. Exposure of cultured lung to dexamethasone enhanced the subsequent response to triiodothyronine, but not vice versa. When triiodothyronine was removed from cultures, there was no further stimulation and the triiodothyronine effect was partially reversed within 24 h. Half-maximal stimulation of choline incorporation occurred at a triiodothyronine concentration (0.10 nM) very similar to the dissociation constant for triiodothyronine binding to nuclear receptor (0.11 nM). The relative potencies of thyroid hormone analogs for nuclear binding and stimulation of phosphatidylcholine synthesis were also similar: triiodothyroacetic acid greater than triiodothyronine-proprionic acid greater than L-triiodothyronine approximately D-triiodothyronine much greater than thyroxine much greater than 3,5-diethyl-3'-isopropyl-DL-thyronine approximately 3,5-dimethyl-3'-isopropyl-L-thyronine approximately reverse triiodothyronine. The effect of triiodothyronine was blocked by the presence of either actinomycin D or cycloheximide, inhibitors of ribonucleic acid and protein synthesis, respectively. [HYP] We conclude that   O.4   stimulates   phosphatidylcholine synthesis   by a process involving nuclear receptors and de novo ribonucleic acid and protein synthesis.\\nOUTPUT:\",\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29785,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Cold exposure reverses the diabetogenic effects of high-fat feeding and markedly stimulates glucose uptake in rat brown adipose tissue (BAT). Considering that cold exposure increases the plasma levels of norepinephrine and lipolytic hormones, but decreases the levels of insulin, we have examined the effects of these agents on glucose transport in isolated rat brown adipocytes using D-[U-14C]glucose as a tracer. It was found that norepinephrine (0.1 microM), glucagon (0.1 nM) and ACTH (100 nM) all increased brown adipocyte respiration (2-10 times) and glucose transport (2-5 times). Studies with adrenergic agonists and antagonists revealed that norepinephrine increases glucose uptake via beta-adrenergic pathways. On the other hand, insulin also increased glucose transport (6 times) but inhibited (40-60 percent) the calorigenic effects of the lipolytic hormones. Both norepinephrine and glucagon potentiated the submaximal insulin responses for glucose transport, demonstrating the existence of metabolic interactions between norepinephrine-, glucagon-, and insulin-mediated glucose uptake. Remarkably, the stimulatory effects of these lipolytic agents were reproduced by dibutyryl cAMP (1 mM), isobutylmethylxanthine (0.1 mM) and palmitic acid (0.5 mM), suggesting that cAMP increases glucose transport via activation of lipolysis and thermogenesis. [HYP] Considering that the stimulatory effects of   norepinephrine   (0.1 microM) on respiration and glucose transport were totally blocked by 2-tetradecylglycidic acid (50 microM), a specific promoter of mitochondrial carnitine acyl transferase, it is concluded that   norepinephrine   increases   BAT   glucose transport via fatty acid-activation of mitochondrial thermogenesis.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29786,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Transgenic mice that overexpress GLUT1 or GLUT4 in skeletal muscle were studied; the former but not the latter develop insulin resistance. Because increased glucose flux via the hexosamine biosynthesis pathway has been implicated in glucose-induced insulin resistance, we measured the activity of glutamine:fructose-6-phosphate amidotransferase (GFAT; rate-limiting enzyme) and the concentrations of UDP-N-acetyl hexosamines (major products of the pathway) as well as UDP-hexoses and GDP-mannose in hind limb muscles and liver in both transgenic models and controls. GFAT activity was increased 60-70% in muscles of GLUT1 but not in GLUT4 transgenics. GFAT mRNA abundance was unchanged. The concentrations of all nucleotide-linked sugars were increased 2-3-fold in GLUT1 and were unchanged in GLUT4-overexpressing muscles. Similar results were obtained in fed and fasted mice. GFAT and nucleotide sugars were unchanged in liver, where the transgene is not expressed. [HYP] We concluded that 1) glucose transport appears to be rate limiting for synthesis of nucleotide sugars; 2) chronically increased glucose flux increases muscle GFAT activity posttranscriptionally; 3) increased UDP-glucose likely accounts for the marked glycogen accumulation in muscles of   mice  -overexpressing   GLUT1  ; and 4) glucose flux via the hexosamine biosynthetic pathway is increased in muscles of   mice  -overexpressing but not GLUT4-overexpressing   GLUT1  ; products of the pathway may contribute to insulin resistance in   mice   transgenics.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29787,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] We have proposed a model of intestinal glucose absorption in which transport by SGLT1 induces rapid insertion and activation of GLUT2 in the apical membrane by a PKC betaII-dependent mechanism. Since PKC betaII requires Ca(2+) and glucose is depolarizing, we have investigated whether glucose absorption is regulated by the entry of dietary Ca(2+) through Ca(v)1.3 in the apical membrane. When rat jejunum was perfused with 75 mM glucose, Ca(2+)-deplete conditions, or perfusion with the L-type antagonists nifedipine and verapamil strongly diminished the phloretin-sensitive apical GLUT2, but not the phloretin-insensitive SGLT1 component of glucose absorption. Western blotting showed that in each case there was a significant decrease in apical GLUT2 level, but no change in SGLT1 level. Inhibition of apical GLUT2 absorption coincided with inhibition of unidirectional (45)Ca(2+) entry by nifedipine and verapamil. At 10 mM luminal Ca(2+), (45)Ca(2+) absorption in the presence of 75 mM glucose was 2- to 3-fold that in the presence of 75 mM mannitol. The glucose-induced component was SGLT1-dependent and nifedipine-sensitive. RT-PCR revealed the presence of Ca(v)beta(3) in jejunal mucosa; Western blotting and immunocytochemistry localized Ca(v)beta(3) to the apical membrane, together with Ca(v)1.3. [HYP] We conclude that in times of dietary sufficiency   Ca  (v)1.3 may mediate a significant pathway of   glucose  -stimulated   Ca  (1+) entry into the body and that luminal supply of   Ca  (1+) is necessary for GLUT2-mediated   glucose   absorption.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29788,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] The acute effect of selective hyperglycemia or hyperinsulinemia on late gestation fetal ovine glucose transporter protein (GLUT-1, GLUT-3, and GLUT-4) concentrations was examined in insulin-insensitive (brain and liver) and insulin-sensitive (myocardium and fat) tissues at 1, 2.5, and 24 h. Hyperglycemia with euinsulinemia caused a two- to threefold increase in brain GLUT-3, liver GLUT-1, and myocardial GLUT-1 concentrations only at 1 h. There was no change in GLUT-4 protein amounts at any time during the selective hyperglycemia. In contrast, selective hyperinsulinemia with euglycemia led to an immediate and persistent twofold increase in liver GLUT-1, which lasted from 1 until 24 h with a concomitant decline in myocardial tissue GLUT-4 amounts, reaching statistical significance at 24 h. No other significant change in response to hyperinsulinemia was noted in any of the other isoforms in any of the other tissues. Simultaneous assessment of total fetal glucose utilization rate (GURf) during selective hyperglycemia demonstrated a transient 40% increase at 1 and 2.5 h, corresponding temporally with a transient increase in brain GLUT-3 and liver and myocardial GLUT-1 protein amounts. In contrast, selective hyperinsulinemia led to a sustained increase in GURf, corresponding temporally with the persistent increase in hepatic GLUT-1 concentrations. [HYP] We conclude that excess substrate acutely increases GURf associated with an increase in various tissues of the transporter isoforms GLUT-40 and   GLUT-3   that mediate fetal basal   glucose transport   without an effect on the GLUT-4 isoform that mediates insulin action.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29789,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the hypothesis contradict the premise or is it entailed by it? If neither, classify it as neutral.',\n",
       "  'input': '[PRE] Diabetes mellitus is a major risk factor for the development of vascular complications. We hypothesized that hyperglycemia decreases endothelial cell (EC) proliferation and survival via phosphatidylinositol 3-kinase (PI3k) and Akt signaling pathways. We cultured human umbilical vein ECs (HUVEC) in 5, 20, or 40 mM d-glucose. Cells grown in 5, 20, and 40 mM mannitol served as a control for osmotic effects. We measured EC proliferation for up to 15 days. We assessed apoptosis by annexin V and propidium iodide staining and flow cytometry, analyzed cell lysates obtained on culture day 8 for total and phosphorylated PI3k and Akt by Western blot analysis, and measured Akt kinase activity using a GSK fusion protein. HUVEC proliferation was also tested in the presence of pharmacological inhibitors of PI3k-Akt (wortmannin and LY294002) and after transfection with a constitutively active Akt mutant. ECs in media containing 5 mM d-glucose (control) exhibited log-phase growth on days 7-10. d-Glucose at 20 and 40 mM significantly decreased proliferation versus control (P < 0.05 for both), whereas mannitol did not impair EC proliferation. Apoptosis increased significantly in HUVEC exposed to 40 mM d-glucose. d-Glucose at 40 mM significantly decreased tyrosine-phosphorylated PI3k, threonine 308-phosphorylated-Akt, and Akt activity relative to control 5 mM d-glucose. Pharmacological inhibition of PI3k-Akt resulted in a dose-dependent decrease in EC proliferation. Transfection with a constitutively active Akt mutant protected ECs by enhancing proliferation when grown in 20 and 40 mM d-glucose. [HYP] We conclude that d-glucose regulates Akt signaling through threonine phosphorylation of Akt and that   EC  -impaired PI3k-Akt signaling may promote   hyperglycemia   proliferative dysfunction in diabetes.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29790,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Reducing Cx43 expression stimulates skin wound healing. This is mimicked in models when Cx43 function is blocked by the connexin mimetic peptide Gap27. IGF-I also stimulates wound healing with IGFBP-5 attenuating its actions. Further, the IGF-I to IGFBP-5 ratio is altered in diabetic skin, where wound closure is impaired. We investigated whether Gap27 remains effective in augmenting scrape-wound closure in human skin wound models simulating diabetes-induced changes, using culture conditions with raised glucose, insulin and IGFBP-5. Gap27 increased scrape-wound closure in normal glucose and insulin (NGI) and to a lesser extent in high glucose and insulin (HGI). IGF-I enhanced scrape-wound closure in keratinocytes whereas IGFBP-5 inhibited this response. Gap27 overcame the inhibitory effects of IGFBP-5 on IGF-I activity. Connexin-mediated communication (CMC) was reduced in HGI, despite raised Cx43, and Gap27 significantly decreased CMC in NGI and HGI. IGF-I and IGFBP-5 did not affect CMC. IGF-I increased keratinocyte proliferation in NGI, and Gap27 increased proliferation in NGI to a greater extent than in HGI. [HYP] We conclude that IGF-I and   Gap27   stimulate scrape-wound closure by independent mechanisms with   Gap27   inhibiting   HDM-induced T helper   function.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29791,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] The hormone resistin is elevated in obesity and impairs glucose homeostasis. Here, we examined the effect of oligomerized human resistin on insulin signaling and glucose metabolism in skeletal muscle and myotubes. This was investigated by incubating mouse extensor digitorum longus (EDL) and soleus muscles and L6 myotubes with physiological concentrations of resistin and assessing insulin-stimulated glucose uptake, cellular signaling, suppressor of cytokine signaling 3 (SOCS-3) mRNA, and GLUT4 translocation. We found that resistin at a concentration of 30 ng/ml decreased insulin-stimulated glucose uptake by 30-40% in soleus muscle and myotubes, whereas in EDL muscle insulin-stimulated glucose uptake was impaired at a resistin concentration of 100 ng/ml. Impaired insulin-stimulated glucose uptake was not associated with reduced Akt phosphorylation or IRS-1 protein or increased SOCS-3 mRNA expression. To further investigate the site(s) at which resistin impairs glucose uptake we treated myotubes and skeletal muscle with the AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) and found that, although resistin did not impair AMPK activation, it reduced AICAR-stimulated glucose uptake. These data suggested that resistin impairs glucose uptake at a point common to insulin and AMPK signaling pathways, and we thus measured AS160/TBC1D4 Thr(642) phosphorylation and GLUT4 translocation in myotubes. Resistin did not impair TBC1D4 phosphorylation but did reduce both insulin and AICAR-stimulated GLUT4 plasma membrane translocation. [HYP] We conclude that resistin impairs   glucose uptake  -stimulated   insulin   by mechanisms involving reduced plasma membrane GLUT4 translocation but independent of the proximal   glucose uptake  -signaling cascade, AMPK, and SOCS-3.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29792,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Dietary iron deficiency in rats results in increased blood glucose turnover and recycling. We measured the rates of glucose production in isolated hepatocytes from iron-sufficient (Fe+) and iron-deficient (Fe-) rats to assess the intrinsic capacity of the Fe- liver to carry out gluconeogenesis. Low-iron and control diets were given to 21-day-old female rats. After 4-5 wk, hemoglobin concentrations averaged 4.1 g/dl in the Fe- and 14.3 g/dl in the Fe+ animals. In the hepatocytes from Fe- rats, there was a 35% decrease in the rate of glucose production from 1 mM pyruvate + 10 mM lactate, a 48% decrease from 0.1 mM pyruvate + 1 mM lactate, a 39% decrease from 1 mM alanine, and a 48% decrease from 1 mM glycerol. The addition of 5 microM norepinephrine or 0.5 microM glucagon to the incubation media produced stimulatory effects on hepatocytes from both Fe- and Fe+ rats, resulting in the maintenance of an average difference of 38% in the rates of gluconeogenesis between the two groups. Studies on isolated liver mitochondria and cytosol revealed alpha-glycerophosphate-cytochrome c reductase and phospho(enol)pyruvate carboxykinase activities to be decreased by 27% in Fe- rats. [HYP] We conclude that dietary   iron   deficiency decreases the intrinsic capacity of the rat liver to carry out   gluconeogenesis   .\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29793,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Column perifusion of mouse pancreatic islets was used to study the ability of amino acids and their methyl esters to influence insulin release and activate islet glutamate dehydrogenase activity. In the absence of L-glutamine, L-serine and the methyl ester of L-phenylalanine, but neither L-phenylalanine nor L-serine methyl ester, stimulate insulin secretion. In the presence of L-glutamine, however, the effect of L-serine was additive, while the methyl esters of L-serine and L-phenylalanine as well as native L-phenylalanine, potentiated the glucose-stimulated release of insulin. Measurements of islet glutamate dehydrogenase activity showed that only the two methyl esters of L-phenylalanine and L-serine activated the enzyme. [HYP] It is concluded that the mechanism by which   methyl   esters of amino acids potentiate   insulin release   is most likely to be mediated by the activation of pancreatic beta-cell glutamate dehydrogenase activity.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29794,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Silybin, the major flavonoid of Silybum marianum, is widely used to treat liver diseases such as hepatocellular carcinoma and cirrhosis-associated insulin resistance. Research so far has focused on its anti-oxidant properties. Here, we demonstrate that silybin and its derivative dehydrosilybin inhibit glucose uptake in several model systems. Both flavonoids dose-dependently reduce basal and insulin-dependent glucose uptake of 3T3-L1 adipocytes, with dehydrosilybin showing significantly stronger inhibition. However, insulin signaling was not impaired, and immunofluorescence and subcellular fractionation showed that insulin-induced translocation of GLUT4 to the plasma membrane is also unchanged. Likewise, hexokinase activity was not affected suggesting that silybin and dehydrosilybin interfere directly with glucose transport across the PM. Expression of GLUT4 in CHO cells counteracted the inhibition of glucose uptake by both flavonoids. Moreover, treatment of CHO cells with silybin and dehydrosilybin reduced cell viability which was partially rescued by GLUT4 expression. Kinetic analysis revealed that silybin and dehydrosilybin inhibit GLUT4-mediated glucose transport in a competitive manner with K(i)=60 and 116 µM, respectively. [HYP] We conclude that   glucose uptake   and dehydrosilybin inhibit cellular   silybin   by directly interacting with GLUT transporters.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29795,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] We have studied the pharmacokinetics and the effects of BIM 23,014 (BIM), a new, long-acting octapeptide somatostatin analogue, on basal and stimulated GH secretion in normal men. BIM 250 micrograms sc significantly reduced a GHRH-induced increase in plasma GH. The continuous sc administration of BIM for 24 h dramatically blunted spontaneous GH secretion; 2000 and 3000 micrograms daily reduced GH secretion to a greater extent than 1000 micrograms daily. During these experiments a significant negative correlation (r - 0.66) was found between plasma GH and BIM levels. Acute sc administration of 1000 micrograms BIM significantly reduced the rise in plasma GH observed in the second part of the oral glucose tolerance test. Plasma BIM levels peaked around 30 min, and the elimination half life was 90 min. Plasma BIM levels were below 1 ng/ml 6 h after the injection of 1000 micrograms BIM, and at that time GH started to rise again. [HYP] We conclude that   GH secretion   23,014 250 to 1000 micrograms sc is able to reduce the plasma GH response to GHRH or to the fall in glucose following an oral glucose tolerance test; a constant infusion of   GH secretion  , in doses 1000 micrograms daily, dramatically suppresses spontaneous   BIM  ; 2000 micrograms/day by chronic subcutaneous infusion was the most effective dose of   GH secretion   in the suppression of   BIM  , and was associated only with minor adverse effects.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29796,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] We have studied the pharmacokinetics and the effects of BIM 23,014 (BIM), a new, long-acting octapeptide somatostatin analogue, on basal and stimulated GH secretion in normal men. BIM 250 micrograms sc significantly reduced a GHRH-induced increase in plasma GH. The continuous sc administration of BIM for 24 h dramatically blunted spontaneous GH secretion; 2000 and 3000 micrograms daily reduced GH secretion to a greater extent than 1000 micrograms daily. During these experiments a significant negative correlation (r - 0.66) was found between plasma GH and BIM levels. Acute sc administration of 1000 micrograms BIM significantly reduced the rise in plasma GH observed in the second part of the oral glucose tolerance test. Plasma BIM levels peaked around 30 min, and the elimination half life was 90 min. Plasma BIM levels were below 1 ng/ml 6 h after the injection of 1000 micrograms BIM, and at that time GH started to rise again. [HYP] We conclude that   MAPK   23,014 250 to 1000 micrograms sc is able to reduce the plasma GH response to GHRH or to the fall in glucose following an oral glucose tolerance test; a constant infusion of   MAPK  , in doses 1000 micrograms daily, dramatically suppresses spontaneous   GH secretion  ; 2000 micrograms/day by chronic subcutaneous infusion was the most effective dose of   MAPK   in the suppression of   GH secretion  , and was associated only with minor adverse effects.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29797,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] Intramyocellular lipid accumulation is strongly related to insulin resistance in humans, and we have shown that high glucose concentration induced de novo lipogenesis and insulin resistance in murin muscle cells. Alterations in Wnt signaling impact the balance between myogenic and adipogenic programs in myoblasts, partly due to the decrease of Wnt10b protein. As recent studies point towards a role for Wnt signaling in the pathogenesis of type 2 diabetes, we hypothesized that activation of Wnt signaling could play a crucial role in muscle insulin sensitivity. Here we demonstrate that SREBP-1c and Wnt10b display inverse expression patterns during muscle ontogenesis and regeneration, as well as during satellite cells differentiation. The Wnt/beta-catenin pathway was reactivated in contracting myotubes using siRNA mediated SREBP-1 knockdown, Wnt10b over-expression or inhibition of GSK-3beta, whereas Wnt signaling was inhibited in myoblasts through silencing of Wnt10b. SREBP-1 knockdown was sufficient to induce Wnt10b protein expression in contracting myotubes and to activate the Wnt/beta-catenin pathway. Conversely, silencing Wnt10b in myoblasts induced SREBP-1c protein expression, suggesting a reciprocal regulation. Stimulation of the Wnt/beta-catenin pathway i) drastically decreased SREBP-1c protein and intramyocellular lipid deposition in myotubes; ii) increased basal glucose transport in both insulin-sensitive and insulin-resistant myotubes through a differential activation of Akt and AMPK pathways; iii) restored insulin sensitivity in insulin-resistant myotubes. [HYP] We conclude that activation of   Wnt  /beta-catenin signaling in skeletal muscle cells improved   insulin   sensitivity by i) decreasing intramyocellular lipid deposition through downregulation of SREBP-1c; ii) increasing   insulin   effects through a differential activation of the Akt/PKB and AMPK pathways; iii) inhibiting the MAPK pathway.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29798,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] In this study, we examined the effect of phosphorylation on GLUT-4 function in isolated rat adipocytes. Adipocytes labeled with 32P for 2 h were incubated with parathyroid hormone (PTH) (20 ng/ml) for 60 min and then exposed to insulin (25 ng/ml) for an additional 30 min. 32P-GLUT-4 was immunoprecipitated from the plasma membrane and low density microsomal fractions, and its degree of phosphorylation was determined by autoradiography and densitometry. Results were expressed as 32P-GLUT-4 specific activity (phosphorylation/unit of protein). GLUT-4 intrinsic activity was measured using [14C]2-deoxyglucose uptake in plasma membrane vesicles. PTH significantly increased GLUT-4 phosphorylation and eliminated the insulin-stimulated dephosphorylation of GLUT-4. Western blotting revealed normal distribution of GLUT-4 before and after insulin stimulation in control and PTH-treated cells, suggesting that phosphorylation of GLUT-4 does not interfere with its recruitment to the plasma membrane. In contrast, intrinsic activity of phosphorylated GLUT-4 was significantly reduced (p < 0.01). Preincubation of adipocytes with calcium channel blocker (nitrendipine) and cyclic AMP antagonist (RpcAMP) restored GLUT-4 intrinsic activity in the PTH-treated cells. In several experiments, GLUT-4 was phosphorylated in vitro in plasma membrane vesicles isolated from normal adipocytes exposed to insulin. This in vitro phosphorylation reduced GLUT-4 intrinsic activity by approximately 35% (p < 0.01). [HYP] We conclude that phosphorylation of   GLUT-2   significantly impairs the ability of   insulin   to stimulate its intrinsic activity.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29799,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Monocyte Chemoattractant Protein-1 (MCP-1) is involved in the diapedesis of blood monocytes into the arterial intima, an early critical event in atherogenesis. Modulating MCP-1 expression can be a key strategy to decrease the risk for atherosclerosis in diabetes. We hypothesized that quercetin, an anti-inflammatory molecule could modulate high glucose concentration (HG) induced MCP-1 expression in aortic endothelial cells in vitro because of its regulatory effects on Activator Protein-1 (AP-1) and Nuclear Factor-kappaB (NF-kappaB). Rat aortic endothelial cells (RAECs) were exposed to HG in the presence or absence of quercetin. Quercetin attenuated HG induced MCP-1 mRNA (42%) and protein synthesis (45%) when estimated using real-time reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay respectively. Western blot analysis found quercetin to maintain cytosolic p65 protein levels to that seen in control. Quercetin was found to attenuate HG induced increased NF-kappaB and AP-1 DNA binding activity in electrophoretic mobility shift assay. Immunofluorescence studies revealed quercetin to prevent HG induced nuclear localization of p65 and c-jun. Quercetin was also found to decrease HG induced activation of NF-kappaB (71%+/-14%), AP-1 (69%+/-24%) and MCP-1 promoter (79%+/-25%) in EA.hy926 cells when analyzed using luciferase reporter assay. [HYP] We conclude that   MCP-1 expression   attenuates   quercetin   in HG treated RAECs, probably by regulating both NF-kappaB and AP-1 pathways.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29800,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Propionic acidemia is the accumulation of propionate in blood due to dysfunction of propionyl-CoA carboxylase. The condition causes lethargy and striatal degeneration with motor impairment in humans. How propionate exerts its toxic effect is unclear. Here, we show that intravenous administration of propionate causes dose-dependent propionate accumulation in the brain and transient lethargy in mice. Propionate, an inhibitor of histone deacetylase, entered GABAergic neurons, as could be seen from increased neuronal histone H4 acetylation in the striatum and neocortex. Propionate caused an increase in GABA (γ-amino butyric acid) levels in the brain, suggesting inhibition of GABA breakdown. In vitro propionate inhibited GABA transaminase with a Ki of ∼1\\u2005mmol/l. In isolated nerve endings, propionate caused increased release of GABA to the extracellular fluid. In vivo, propionate reduced cerebral glucose metabolism in both striatum and neocortex. [HYP] We conclude that propionate-induced inhibition of     oxygen   transaminase   causes accumulation of   oxygen   in the brain, leading to increased extracellular   oxygen   concentration, which inhibits neuronal activity and causes lethargy.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29801,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] A prospective study was undertaken to evaluate pudendal neuropathy in fecal incontinence. Fifty-two patients (38 women and 14 men) with fecal incontinence underwent manometric and electromyographic evaluation (measurement of pudendal nerve terminal motor latency [PNTML] and sphincter muscle mapping). The average age of all patients was 54 +/- 17 years. Fifty-two percent (27/52) were found to have a pudendal neuropathy (PNTML > 2.1 milliseconds). Seventeen of these 27 patients (63 percent) had a bilateral pudendal neuropathy. Patients with a pudendal neuropathy were older than those without a neuropathy (63.7 years vs. 51.9 years; P = 0.01). Women were significantly more likely than men to have a pudendal neuropathy (P = 0.03). Nine patients had an anatomic sphincter defect identified, and six of these (67 percent) had a neuropathy; 4/6 (67 percent) had a bilateral pudendal neuropathy. In the 43 patients who did not have an anatomic sphincter defect, there was no difference in resting pressure (69 mmHg vs. 60 mmHg; P = 0.4) or maximum voluntary contraction (95 mmHg vs. 86 mmHg; P = 0.5) when patients without a neuropathy were compared with those with a neuropathy. Patients with a pudendal neuropathy had a shorter sphincter length than those without a neuropathy (3.0 cm vs. 3.9 cm; P = 0.01). Bilateral pudendal neuropathy tended to occur more frequently in women (P = 0.08) and was not associated with poorer resting pressure, maximum voluntary contraction, or shorter sphincter length. [HYP] We conclude that   pudendal neuropathy   is not a common cause of   fecal incontinence  , particularly in older women, and frequently occurs in association with a sphincter defect.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29802,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] Vascular calcification plays a role in the pathogenesis of atherosclerosis, diabetes, and chronic kidney disease. Human aortic smooth muscle cells (HSMCs) undergo mineralization in response to elevated levels of inorganic phosphate (Pi) in an active and well-regulated process. This process involves increased activity of alkaline phosphatase and increased expression of core binding factor alpha-1, a bone-specific transcription factor, with the subsequent induction of osteocalcin. Mounting evidence suggests an essential role for the heme oxygenase 1 (HO-1)/ferritin system to maintain homeostasis of vascular function. We examined whether induction of HO-1 and ferritin alters mineralization of HSMCs provoked by high Pi. Upregulation of the HO-1/ferritin system inhibited HSMC calcification and osteoblastic differentiation. Of the products of the system, only ferritin and, to a lesser extent, biliverdin were responsible for the inhibition. Ferritin heavy chain and ceruloplasmin, which both possess ferroxidase activity, inhibited calcification; a site-directed mutant of ferritin heavy chain, which lacked ferroxidase activity, failed to inhibit calcification. In addition, osteoblastic transformation of HSMCs provoked by elevated Pi (assessed by upregulation of core binding factor alpha-1, osteocalcin, and alkaline phosphatase activity) was diminished by ferritin/ferroxidase activity. [HYP] We conclude that induction of the HO-1/  ferritin   system prevents   ROS  -mediated calcification and osteoblastic differentiation of human smooth muscle cells mainly via the ferroxidase activity of   ferritin  .\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29803,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Imeglimin is the first in a new class of oral glucose-lowering agents, having recently completed its phase 2b trial. As Imeglimin did show a full prevention of β-cell apoptosis, and since angiopathy represents a major complication of diabetes, we studied Imeglimin protective effects on hyperglycemia-induced death of human endothelial cells (HMEC-1). These cells were incubated in several oxidative stress environments (exposure to high glucose and oxidizing agent tert-butylhydroperoxide) which led to mitochondrial permeability transition pore (PTP) opening, cytochrome c release and cell death. These events were fully prevented by Imeglimin treatment. This protective effect on cell death occurred without any effect on oxygen consumption rate, on lactate production and on cytosolic redox or phosphate potentials. [HYP] Imeglimin also dramatically decreased reactive oxygen species production, inhibiting specifically reverse electron transfer through complex I. We conclude that Imeglimin prevents   hyperglycemia  -induced   cell death   in HMEC-1 through inhibition of PTP opening without inhibiting mitochondrial respiration nor affecting cellular energy status.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29804,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] Smoking is a major risk factor for diabetes, cardiovascular disease, and nonalcoholic fatty liver disease. The health risk associated with smoking can be exaggerated by obesity. We hypothesize that nicotine when combined with a high-fat diet (HFD) can also cause ectopic lipid accumulation in skeletal muscle, similar to recently observed hepatic steatosis. Adult C57BL6 male mice were fed a normal chow diet or HFD and received twice-daily ip injections of nicotine (0.75 mg/kg body weight) or saline for 10 weeks. Transmission electron microscopy of the gastrocnemius muscle revealed substantial intramyocellular lipid accumulation in close association with intramyofibrillar mitochondria along with intramyofibrillar mitochondrial swelling and vacuolization in nicotine-treated mice on an HFD compared with mice on an HFD treated with saline. These abnormalities were reversed by acipimox, an inhibitor of lipolysis. Mechanistically, the detrimental effect of nicotine plus HFD on skeletal muscle was associated with significantly increased oxidative stress, plasma free fatty acid, and muscle triglyceride levels coupled with inactivation of AMP-activated protein kinase and activation of its downstream target, acetyl-coenzyme A-carboxylase. [HYP] We conclude that 1) greater oxidative stress together with inactivation of   nicotine   protein kinase mediates the effect of   AMP-activated   on skeletal muscle abnormalities in diet-induced obesity and 2) adipose tissue lipolysis is an important contributor of muscle steatosis and mitochondrial abnormalities.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29805,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Metabolic myocardial preservation by means of preischemic insulin administration (glucose-potassium-insulin, GPI; acute parenteral alimentation, APA) with the aim of a preischemic myocardial glycogen enrichment was performed in 20 consecutive CABG patients (12 in the APA group, 8 in the control group). Before and after 30 min of an infusion (APA or 0.9% NaCl solution), blood levels of potassium, glucose, NEFA (non-esterified fatty acids) and lactate were determined from arterial (a), central venous (cv) and coronary sinus (cs) blood. The cs potassium level in the APA group decreased from 4.06 to 3.56 mmol/l, whereas in the control group an increase from 3.78 to 4.36 mmol/l occurred. The difference between the two groups (interaction) was significant, p less than 0.002. The myocardial glucose extraction (a-cs difference) in the APA group increased from 3.83 to 10.08 mg/dl, whereas in the control group a change from 3.37 to 0.87 mg/dl occurred (p less than 0.0003). The myocardial NEFA (non-esterified fatty acids) extraction in the APA group decreased from 0.25 to -0.06 mmol/l, whereas in the control group no change (0.08 to 0.13 mmol/l) occurred (p less than 0.05). The myocardial lactate extraction in the APA group increased from 0.13 to 0.70 mmol/l, whereas in the control group no change occurred (0.47 to 0.51 mmol/l), interaction p less than 0.0001. [HYP] It is concluded that a preischemic insulin administration (APA) for metabolic preservation leads to: (1) myocardial potassium extraction, obviously caused by intracellular potassium shifting; (2) increased myocardial glucose extraction; (3) decreased myocardial   lactate   extraction, the last two obviously caused by a shift of the myocardial metabolism from predominant lipolysis to predominantly glycolysis; and (4) surprisingly, increased myocardial   NEFA   extraction (decreased   NEFA   production), obviously caused by the avoidance of a myocardial   NEFA   accumulation by way of stimulated pyruvate oxidation.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29806,\n",
       "  'model_output': 'contrary'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the hypothesis contradict the premise or is it entailed by it? If neither, classify it as neutral.',\n",
       "  'input': '[PRE] The stimulant action of branched-chain amino acids upon insulin release was examined in rat pancreatic islets incubated at physiological concentrations of D-glucose and L-glutamine. In the presence of the latter nutrients, L-leucine and L-isoleucine used together at a physiological concentration (0.25 mmol/l each) doubled insulin secretion rate. The effect of L-leucine upon insulin release was dose-related without any indication of of a threshold phenomenon. The insulinotropic action of L-leucine was mimicked, to a limited extent, by its nonmetabolized analogue, 2-aminobicyclo[2,2,1] heptane-2-carboxylic acid. L-Glutamine slightly inhibited glucose-stimulated insulin release. [HYP] It is concluded that, under close-to-physiological conditions,   L-leucine   stimulates   insulin release   by acting in the islet cells both as a fuel and as an allosteric activator of glutamate dehydrogenase.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29807,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] An established intermediate phenotype of human hypertension and diabetic nephropathy is an elevation of Na+/H+ exchanger (NHE) activity, but the mechanism for this is unclear. This phenotype is maintained in vascular myocytes from the spontaneously hypertensive rat (SHR) compared with the normotensive Wistar Kyoto rat (WKY). Since intracellular calcium levels ([Ca2+]i) following agonist stimulation were elevated in cells from both hypertensive humans and SHR, we have examined the role of calcium-calmodulin (CaM) in the mechanism of increased NHE activity in vascular myocytes of SHR by determining the activity and phosphorylation state of NHE isoform-1 (NHE-1) in cells from SHR and WKY when [Ca2+]i was elevated by the ionophores A23187 or ionomycin. NHE activity was measured using fluorometry and NHE-1 phosphorylation by immunoprecipitating the exchanger from 32P-orthophosphate-labeled cells with a polyclonal NHE-1-specific antibody. The ionophore A23187 increased [Ca2+]i in both cell types to approximately 700 to 800 nmol x L(-1), and led to stimulation of NHE-1 activity only in WKY myocytes, with no effect on SHR cells. An inhibitor of CaM kinase II (KN-62) failed to abolish stimulation of NHE-1 by A23187 in WKY cells, and had no effect on unstimulated NHE-1 activity in both cell types. Ionomycin also elevated [Ca2+]i in both cell types to approximately 1,000 nmol x L(-1) and activated NHE-1 activity in only WKY cells. Activation of NHE-1 in WKY cells by an increased [Ca2+]i was not mediated by an increase in NHE-1 phosphorylation, whether in the presence or absence of KN-62. The elevated NHE-1 phosphorylation in SHR cells was not affected by elevated [Ca2+]i or KN-62. Calmodulin-agarose beads bound NHE-1 extracted from SHR cells to a lesser extent than that from WKY cells. [HYP] We conclude that   Epinephrine  -induced   NHE-1   activation in WKY cells was not mediated by CaM kinase II.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29808,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] The stimulatory effects of insulin on de novo lipogenesis (DNL) in the liver, where it is an important contributor to non-alcoholic fatty liver disease (NAFLD), hepatic and systemic insulin resistance, is strong and well established. In contrast, insulin plays only a minor role in DNL in adipose tissue. The reason why insulin stimulates DNL more in liver than in fat is not known but may be due to differential regulation of the transcription and post-translational activation of sterol regulatory element binding proteins (SREBPs). To test this hypothesis, we have examined effects of insulin on activation of SREBP-1c in liver of rats and in adipose tissue of rats and human subjects. Liver and epidydimal fat were obtained from alert rats and subcutaneous adipose tissue from human subjects in response to 4 h euglycemic-hyperinsulinemic clamps. Here we show that acutely raising plasma insulin levels in rats and humans increased SREBP-1 mRNA comparably 3-4 fold in rat liver and rat and human adipose tissue, but increased post-translational activation of SREBP-1c only in rat liver, while decreasing it in adipose tissue. These differential effects of insulin on SREBP-1c activation in liver and adipose tissue were associated with robust changes in the opposite direction of INSIG-1 and to a lesser extent of INSIG-2 mRNA and proteins. [HYP] We conclude that these findings support the hypothesis that   insulin   stimulated activation of   SREBP-1c   in the liver, at least in part, by suppressing INSIG-1 and -2, whereas in adipose tissue, an decrease in INSIG-1 and -2 prevented   SREBP-1c   activation.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29809,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Vascular inflammation plays a critical role in the pathogenesis of diabetic retinopathy. Recently, Interleukin-6 (IL-6) trans-signaling via soluble IL-6 receptor (sIL-6R) has emerged as a prominent regulator of inflammation in endothelial cells. This study was designed to test the hypothesis that selective inhibition of the IL-6 trans-signaling pathway will attenuate inflammation and subsequent barrier disruption in retinal endothelial cells. Human retinal endothelial cells (HRECs) were exposed to IL-6 and sIL-6R to induce IL-6 trans-signaling and the commercially available compound sgp130Fc (soluble gp-130 fused chimera) was used to selectively inhibit IL-6 trans-signaling. IL-6 trans-signaling activation caused a significant increase in STAT3 phosphorylation, expression of adhesion molecules, ROS production and apoptosis in HRECs whereas a significant decrease in mitochondrial membrane potential and NO production was observed in IL-6 trans-signaling activated cells. These changes were not observed in cells pre-treated with sgp130Fc. IL-6 trans-signaling activation was sufficient to cause barrier disruption in endothelial monolayers and pre-treatment of HRECs with sgp130Fc, maintained endothelial barrier function similar to that of untreated cells. [HYP] Thus, in conclusion, these results indicate that   vascular adrenergic   trans-signaling is an important mediator of   inflammation  , apoptosis and barrier disruptive effects in the retinal endothelial cells and inhibition of the   vascular adrenergic   trans-signaling pathway using sgp130-Fc attenuates vascular   inflammation   and endothelial barrier disruption.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29810,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] The stimulatory effects of insulin on de novo lipogenesis (DNL) in the liver, where it is an important contributor to non-alcoholic fatty liver disease (NAFLD), hepatic and systemic insulin resistance, is strong and well established. In contrast, insulin plays only a minor role in DNL in adipose tissue. The reason why insulin stimulates DNL more in liver than in fat is not known but may be due to differential regulation of the transcription and post-translational activation of sterol regulatory element binding proteins (SREBPs). To test this hypothesis, we have examined effects of insulin on activation of SREBP-1c in liver of rats and in adipose tissue of rats and human subjects. Liver and epidydimal fat were obtained from alert rats and subcutaneous adipose tissue from human subjects in response to 4 h euglycemic-hyperinsulinemic clamps. Here we show that acutely raising plasma insulin levels in rats and humans increased SREBP-1 mRNA comparably 3-4 fold in rat liver and rat and human adipose tissue, but increased post-translational activation of SREBP-1c only in rat liver, while decreasing it in adipose tissue. These differential effects of insulin on SREBP-1c activation in liver and adipose tissue were associated with robust changes in the opposite direction of INSIG-1 and to a lesser extent of INSIG-2 mRNA and proteins. [HYP] We conclude that these findings support the hypothesis that   insulin   stimulated activation of   SREBP-1c   in the liver, at least in part, by suppressing INSIG-1 and -2, whereas in adipose tissue, an increase in INSIG-1 and -2 prevented   SREBP-1c   activation.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29811,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] The everted-sac technique was used to study the mechanism of action of noradrenaline on fluid absorption by rat jejunum. Noradrenaline (10(-3) M) significantly stimulated fluid absorption and this effect was dependent on the presence of calcium ions in the serosal fluid. Strontium, but not magnesium could substitute for calcium. Verapamil, manganese and neodymium, all inhibitors of calcium transport, blocked noradrenaline-stimulated fluid absorption when present in the serosal compartment without any effect on basal or glucose-stimulated absorption. Inhibitors of the translation stage of protein synthesis inhibited the response whereas blocking the transcription stage of protein synthesis was without effect. The noradrenaline response was not attenuated by tetrodotoxin suggesting that the response is not indirect due to noradrenaline altering endogenous intestinal nervous activity. [HYP] It is concluded that noradrenaline acts by opening   nitric oxide   channels in the basolateral membranes of epithelial cells, resulting in an influx of   nitric oxide   which stimulates ribosomal   protein synthesis   to produce proteins involved in fluid transport.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29812,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Endurance exercise training induces a rapid increase in the GLUT-4 isoform of the glucose transporter in muscle. In fasted rats, insulin-stimulated muscle glucose transport is increased in proportion to the increase in GLUT-4. There is evidence that high muscle glycogen may decrease insulin-stimulated glucose transport. This study was undertaken to determine whether glycogen supercompensation interferes with the increase in glucose transport associated with an exercise-induced increase in GLUT-4. Rats were trained by means of swimming for 6 h/day for 2 days. Rats fasted overnight after the last exercise bout had an approximately twofold increase in epitrochlearis muscle GLUT-4 and an associated approximately twofold increase in maximally insulin-stimulated glucose transport activity. Epitrochlearis muscles of rats fed rodent chow after exercise were glycogen supercompensated (86.4 +/- 4.8 micromol/g wet wt) and showed no significant increase in maximally insulin-stimulated glucose transport above the sedentary control value despite an approximately twofold increase in GLUT-4. Fasting resulted in higher basal muscle glucose transport rates in both sedentary and trained rats but did not significantly increase maximally insulin-stimulated transport in the sedentary group. [HYP] We conclude that carbohydrate feeding that results in muscle glycogen supercompensation prevents the increase in maximally   insulin  -stimulated glucose transport associated with an exercise training-induced increase in muscle   GLUT-4  .\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29813,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the hypothesis contradict the premise or is it entailed by it? If neither, classify it as neutral.',\n",
       "  'input': '[PRE] Intramyocellular lipid accumulation is strongly related to insulin resistance in humans, and we have shown that high glucose concentration induced de novo lipogenesis and insulin resistance in murin muscle cells. Alterations in Wnt signaling impact the balance between myogenic and adipogenic programs in myoblasts, partly due to the decrease of Wnt10b protein. As recent studies point towards a role for Wnt signaling in the pathogenesis of type 2 diabetes, we hypothesized that activation of Wnt signaling could play a crucial role in muscle insulin sensitivity. Here we demonstrate that SREBP-1c and Wnt10b display inverse expression patterns during muscle ontogenesis and regeneration, as well as during satellite cells differentiation. The Wnt/beta-catenin pathway was reactivated in contracting myotubes using siRNA mediated SREBP-1 knockdown, Wnt10b over-expression or inhibition of GSK-3beta, whereas Wnt signaling was inhibited in myoblasts through silencing of Wnt10b. SREBP-1 knockdown was sufficient to induce Wnt10b protein expression in contracting myotubes and to activate the Wnt/beta-catenin pathway. Conversely, silencing Wnt10b in myoblasts induced SREBP-1c protein expression, suggesting a reciprocal regulation. Stimulation of the Wnt/beta-catenin pathway i) drastically decreased SREBP-1c protein and intramyocellular lipid deposition in myotubes; ii) increased basal glucose transport in both insulin-sensitive and insulin-resistant myotubes through a differential activation of Akt and AMPK pathways; iii) restored insulin sensitivity in insulin-resistant myotubes. [HYP] We conclude that activation of   insulin  /beta-catenin signaling in skeletal muscle cells improved   Wnt   sensitivity by i) decreasing intramyocellular lipid deposition through downregulation of SREBP-1c; ii) increasing   Wnt   effects through a differential activation of the Akt/PKB and AMPK pathways; iii) inhibiting the MAPK pathway.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29814,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] To evaluate the role of anti-insulin hormone actions and interactions in the pathogenesis of stress-induced hyperglycemia, the counterregulatory hormones, glucagon, epinephrine, and cortisol were infused alone as well as in double and triple combinations into normal conscious dogs in doses that were designed to simulate changes observed in severe stress. Infusion of glucagon, epinephrine, or cortisol alone produced only mild or insignificant elevations in plasma glucose concentration. In contrast, the rise in plasma glucose produced by combined infusion of any two counterregulatory hormones was 50-215% greater (P < 0.005-0.001) than the sum of the respective individual infusions. Furthermore, when all three hormones were infused simultaneously, the increment in plasma glucose concentration (144+/-2 mg/dl) was two- to fourfold greater than the sum of the responses to the individual hormone infusions or the sum of any combination of double plus single hormone infusion (P < 0.001). Infusion of glucagon or epinephrine alone resulted in a transient rise in glucose production (as measured by [3-(3)H]glucose). While glucagon infusion was accompanied by a rise in glucose clearance, with epinephrine there was a sustained, 20% fall in glucose clearance. When epinephrine was infused together with glucagon, the rise in glucose production was additive, albeit transient. However, the inhibitory effect of epinephrine on glucose clearance predominated, thereby accounting for the exaggerated glycemic response to combined infusion of glucagon and epinephrine. Although infusion of cortisol alone had no effect on glucose production, the addition of cortisol markedly accentuated hyperglycemia produced by glucagon and(or) epinephrine primarily by sustaining the increases in glucose production produced by these hormones. The combined hormonal infusions had no effect on beta-hydroxybutyrate concentration. [HYP] It is concluded that (a) physiologic increments in   glucagon  , epinephrine, and cortisol interact synergistically in the normal dog so as to rapidly produce marked fasting hyperglycemia; (b) in this interaction, epinephrine enhances   glucagon  -stimulated   glucose   output and interferes with   glucose   uptake while cortisol sustains elevations in   glucose   production produced by epinephrine and   glucagon  ; and (c) these data indicate that changes in   glucose   metabolism in circumstances in which several counterregulatory hormones are elevated (e.g., \"stress hyperglycemia\") are a consequence of synergistic interactions among these hormones.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29815,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] The increase in the intracellular Na+ concentration ([Na+](i)) during myocardial ischaemia is crucial for ischaemia/reperfusion cell injury, and the cardiac subtype of the Na+/H+ exchanger (NHE-1) has been shown to be a major pathway for Na(+) loading. While the importance of glycolytically derived ATP for the optimal functioning of membrane transporters and channels has been suggested, whether NHE-1 is actually activated during myocardial ischaemia remains controversial. Here we examined whether the activity of NHE-1 is predominantly dependent on intracellular ATP generated by glycolysis, and whether the additional inhibition of glycolysis can affect the increase in ([Na+](i)) during the inhibition of oxidative phosphorylation in intact guinea pig ventricular myocytes. The selective inhibition of glycolysis by 2-deoxyglucose prevented the recovery of intracellular pH and the transient increase in ([Na+](i)) following intracellular acidosis induced by a NH(4)Cl pre-pulse. During severe metabolic inhibition (SMI; induced by amobarbital and carbonyl cyanide m-chlorophenylhydrazone in a glucose-free perfusate), most myocytes changed from rod-shaped to contracted forms by approximately 15 min. ([Na+](i)) increased linearly until rigor contracture occurred, but after rigor contracture the rate of increase was blunted. The increase in ([Na+](i)) during SMI was suppressed significantly by an inhibitor of NHE-1, hexamethylene amiloride. The increase in the intracellular Mg(2+) concentration, which can reciprocally indicate depletion of intracellular ATP, was small during the initial 10 min of SMI, but became larger from just a few minutes before rigor contracture. In the presence of 2-deoxyglucose, the time to rigor during SMI was shortened, but the increase in ([Na+](i)) before rigor contracture was not significant, and was much less than that in the absence of 2-deoxyglucose. [HYP] It is concluded that   ATP   generated by glycolysis is essential to activate   NHE-1  , and that the dependence of   NHE-1   on glycolysis might affect the increase in ([Na+](i)) observed during myocardial ischaemia.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29816,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Reducing Cx43 expression stimulates skin wound healing. This is mimicked in models when Cx43 function is blocked by the connexin mimetic peptide Gap27. IGF-I also stimulates wound healing with IGFBP-5 attenuating its actions. Further, the IGF-I to IGFBP-5 ratio is altered in diabetic skin, where wound closure is impaired. We investigated whether Gap27 remains effective in augmenting scrape-wound closure in human skin wound models simulating diabetes-induced changes, using culture conditions with raised glucose, insulin and IGFBP-5. Gap27 increased scrape-wound closure in normal glucose and insulin (NGI) and to a lesser extent in high glucose and insulin (HGI). IGF-I enhanced scrape-wound closure in keratinocytes whereas IGFBP-5 inhibited this response. Gap27 overcame the inhibitory effects of IGFBP-5 on IGF-I activity. Connexin-mediated communication (CMC) was reduced in HGI, despite raised Cx43, and Gap27 significantly decreased CMC in NGI and HGI. IGF-I and IGFBP-5 did not affect CMC. IGF-I increased keratinocyte proliferation in NGI, and Gap27 increased proliferation in NGI to a greater extent than in HGI. [HYP] We conclude that IGF-I and   Gap27   stimulate scrape-wound closure by independent mechanisms with   Gap27   inhibiting   Cx43   function.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29817,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] A transgenic mouse overexpressing a mutant form of calmodulin (CaM-8) that is selectively targeted to pancreatic beta-cells has an impaired ability to secrete insulin in response to elevated blood glucose. Fluorescence measurements of cytosolic Ca2+ concentration ([Ca2+]i) showed that intracellular Ca2+ rises produced by glucose were smaller than normal in beta-cells of CaM-8 mice. Glucose utilization rates were not different between the CaM-8 and control beta-cells, suggesting that glucose metabolism was unperturbed by CaM-8. Ion channel defects were implicated in the phenotype of CaM-8 beta-cells because treatment of these cells with tolbutamide, a blocker of ATP-sensitive K+ channels, produced smaller than normal amounts of insulin secretion and Ca2+ rises. Depolarization with elevated extracellular K+ also produced smaller Ca2+ rises in beta-cells from CaM-8 mice. Whole-cell patch-clamp recordings revealed that Ca2+ channel currents of beta-cells from CaM-8 mice were half as large as Ca2+ currents in control cells, while the currents carried by delayed rectifier and ATP-sensitive K+ channels were similar in magnitude in both cell types. [HYP] We conclude that expression of the CaM-8 form of calmodulin causes a down-regulation of Ca2+ channel currents, which reduces Ca2+ entry and accumulation when   glucose   stimulates closure of the ATP-sensitive   K+   channels.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29818,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Insulin (100 U/l) stimulated xylose uptake in rat soleus muscle from a basal value of 2.3 +/- 0.5 to 11.6 +/- 2.1 mumol . g-1 . h-1. Denervation (section of the sciatic nerve) markedly reduced the stimulatory action of insulin (basal 1.3 +/- 0.4 mumol . g-1 . h-1; insulin-stimulated 4.5 +/- 0.6 mumol . g-1 . h-1). This effect appeared 3 days after denervation and was maximal after 5 days. Denervation also affected the insulin dose response curve; there was no effect of insulin in denervated muscle until the concentration exceeded 1 U/l. Denervation inhibited insulin-stimulated alpha-aminoisobutyrate uptake by 77% but did not affect 125I-insulin binding or glucose-independent activation of glycogen synthase by insulin. There was no effect of denervation on the insulinomimetic effects of concanavalin A, hydrogen peroxide, vitamin K5, anoxia, 2:4-dinitrophenol, cooling, hyperosmolarity or EDTA, but the effect of diamide was inhibited. [HYP] It is concluded [1] that denervation inhibits   glycogen synthase  -stimulated sugar transport at some early post-receptor step, and [2] that the mechanism whereby   glycogen synthase   activates   insulin   is different from the activation of the membrane transport of sugars and amino acids.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29819,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] To evaluate the relative impact of abdominal obesity and newly diagnosed type 2 diabetes on insulin action in skeletal muscle and fat tissue, we studied 61 men with (n = 31) or without (n = 30) diabetes, subgrouped into abdominally obese or nonobese according to the waist circumference. Adipose tissue depots were quantified by magnetic resonance imaging, and regional glucose uptake was measured using 2-[(18)F]fluoro-2-deoxyglucose/positron emission tomography during euglycemic hyperinsulinemia. Across groups, glucose uptake per unit tissue weight was higher in visceral (20.5 +/- 1.4 micromol . min(-1) . kg(-1)) than in abdominal (9.8 +/- 0.9 micromol min(-1) . kg(-1), P < 0.001) or femoral (12.3 +/- 0.6 micromol . min(-1) . kg(-1), P < 0.001) subcutaneous tissue and approximately 40% lower than in skeletal muscle (33.1 +/- 2.5 micromol . min(-1) . kg(-1), P < 0.0001). Abdominal obesity was associated with a marked reduction in glucose uptake per unit tissue weight in all fat depots and in skeletal muscle (P < 0.001 for all regions). Recent type 2 diabetes per se had little additional effect. In both intra-abdominal adipose (r = -0.73, P < 0.0001) and skeletal muscle (r = -0.53, P < 0.0001) tissue, glucose uptake was reciprocally related to intra-abdominal fat mass in a curvilinear fashion. When regional glucose uptake was multiplied by tissue mass, total glucose uptake per fat depot was similar irrespective of abdominal obesity or type 2 diabetes, and its contribution to whole-body glucose uptake increased by approximately 40% in obese nondiabetic and nonobese diabetic men and was doubled in obese diabetic subjects. [HYP] We conclude that 1) in abdominal obesity,   insulin  -stimulated   glucose uptake   rate is markedly reduced in skeletal muscle and in all fat depots; 2) in target tissues, this reduction is reciprocally (and nonlinearly) related to the amount of intra-abdominal fat; 3) mild, recent diabetes adds little   insulin   resistance to that caused by abdominal obesity; and 4) despite fat   insulin   resistance, an expanded fat mass (especially subcutaneous) provides a sink for glucose, resulting in a compensatory attenuation of   insulin   resistance at the whole-body level in men.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29820,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the hypothesis contradict the premise or is it entailed by it? If neither, classify it as neutral.',\n",
       "  'input': '[PRE] Propionic acidemia is the accumulation of propionate in blood due to dysfunction of propionyl-CoA carboxylase. The condition causes lethargy and striatal degeneration with motor impairment in humans. How propionate exerts its toxic effect is unclear. Here, we show that intravenous administration of propionate causes dose-dependent propionate accumulation in the brain and transient lethargy in mice. Propionate, an inhibitor of histone deacetylase, entered GABAergic neurons, as could be seen from increased neuronal histone H4 acetylation in the striatum and neocortex. Propionate caused an increase in GABA (γ-amino butyric acid) levels in the brain, suggesting inhibition of GABA breakdown. In vitro propionate inhibited GABA transaminase with a Ki of ∼1\\u2005mmol/l. In isolated nerve endings, propionate caused increased release of GABA to the extracellular fluid. In vivo, propionate reduced cerebral glucose metabolism in both striatum and neocortex. [HYP] We conclude that propionate-induced inhibition of     GABA   transaminase   causes accumulation of   GABA   in the brain, leading to increased extracellular   GABA   concentration, which inhibits neuronal activity and causes lethargy.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29821,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] In this study, we aimed to compare bone calcium system changes from children with diabetic ketoacidosis or acute metabolic acidosis due to dehydration to find out the relative contribution of metabolic acidosis and diabetes-related factors on expected negative calcium balance. We studied a set of non-invasive parameters of bone remodeling in 16 children with diabetic ketoacidosis due to new onset type 1 diabetes and 25 children with acute metabolic acidosis due to dehydration complicating acute gastroenteritis before and after the correction of acidosis. The two groups of subjects were matched for age, sex, pubertal status, and degree of metabolic acidosis and dehydration. A group of 18 age and sex-matched healthy children served as the control group. Plasma ionized calcium levels were increased in both groups, significantly more so in diabetic ketoacidosis. While osteoblastic markers, osteocalcin and alkaline phosphatase, were depressed to a comparable degree in both groups, urinary calcium/creatinine ratio and hydroxyproline excretion were significantly greater in diabetic ketoacidosis. No significant changes in calcitrophic hormone (intact PTH, calcitonin, 25-hydroxy vitamin D3) levels were observed. All study parameters except for serum phosphate levels behaved in parallel in both clinical conditions, and abnormalities disappeared with the correction of acidosis except for IGF-1, which remained low in diabetic subjects. [HYP] In conclusion, our results suggest that, in diabetic ketoacidosis, the observed severe negative   acidosis   balance occurred through diminished bone formation mediated by metabolic   calcium   per se and increased bone mineral dissolution and bone resorption because of severe insulin deficiency and secondarily via metabolic   calcium  .\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29822,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': \"[PRE] To investigate the mechanism of thyroid hormone action on pulmonary surfactant synthesis, we characterized the effect of triiodothyronine on phosphatidylcholine synthesis in cultured fetal rabbit lung. Since glucocorticoids stimulate surfactant synthesis and reduce the incidence of Respiratory Distress Syndrome in premature infants, we also examined the interaction of triiodothyronine and dexamethasone. The rate of choline incorporation into phosphatidylcholine was determined in organ cultures of rabbit lung maintained in serum-free Waymouth's medium. In 23-d lung cultured for 72 h, the increase in choline incorporation with triiodothyronine alone, dexamethasone alone, and triiodothyronine plus dexamethasone was 50, 62, and 161%, respectively. Both triiodothyronine and dexamethasone also increased incorporation rates with glucose, glycerol, and acetate as precursors, and stimulation with triiodothyronine plus dexamethasone was at least additive. Dexamethasone, but not triiodothyronine, affected distribution of radioactivity from [3H] acetate among phospholipids. Stimulation was first detected 8-12 h after addition of triiodothyronine, and then increased in a linear fashion. With triiodothyronine plus dexamethasone, stimulation was maximal at 48-72 h, and was supra-additive at all times. Exposure of cultured lung to dexamethasone enhanced the subsequent response to triiodothyronine, but not vice versa. When triiodothyronine was removed from cultures, there was no further stimulation and the triiodothyronine effect was partially reversed within 24 h. Half-maximal stimulation of choline incorporation occurred at a triiodothyronine concentration (0.10 nM) very similar to the dissociation constant for triiodothyronine binding to nuclear receptor (0.11 nM). The relative potencies of thyroid hormone analogs for nuclear binding and stimulation of phosphatidylcholine synthesis were also similar: triiodothyroacetic acid greater than triiodothyronine-proprionic acid greater than L-triiodothyronine approximately D-triiodothyronine much greater than thyroxine much greater than 3,5-diethyl-3'-isopropyl-DL-thyronine approximately 3,5-dimethyl-3'-isopropyl-L-thyronine approximately reverse triiodothyronine. The effect of triiodothyronine was blocked by the presence of either actinomycin D or cycloheximide, inhibitors of ribonucleic acid and protein synthesis, respectively. [HYP] We conclude that   triiodothyronine   stimulates   phosphatidylcholine synthesis   by a process involving nuclear receptors and de novo ribonucleic acid and protein synthesis.\\nOUTPUT:\",\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29823,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] The effects of L-arginine and its derivatives NG-methyl-L-arginine (Meth-arg) and NG-nitro-L-arginine (Nit-arg) on the insulin release and glucose oxidation of isolated rat islets were investigated to evaluate possible influences of nitric oxide. Also, the insulin release and flow distribution within the perfused rat pancreas were studied in response to these agents. Arginine, Meth-arg, and Nit-arg stimulated insulin release in cultured islets, but had no effect on glucose oxidation. Arginine and Meth-arg, an inhibitor of the enzyme nitric oxide synthase I (NS-I) stimulated insulin release from the perfused pancreas. Nit-arg, however, which inhibits nitric oxide synthase II (NS-II) had no such effect. Neither arginine nor Nit-arg or Met-arg changed the distribution of microspheres within the perfused pancreas. [HYP] We conclude that interference with NS type I or II has no effect on   insulin   release from cultured islets, but inhibition of   NS-II   abolishes the   insulin   response in the perfused pancreas, which may be mediated by factors released from endothelial cells.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29824,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Renal tubular epithelial cell (RTC) apoptosis causes tubular atrophy, a hallmark of renal disease progression. Apoptosis is generally characterized by reduced cell volume and cytosolic pH, but epithelial cells are relatively resistant to shrinkage due to regulatory volume increase, which is mediated by Na(+)/H(+) exchanger (NHE) 1. We investigated whether RTC apoptosis requires caspase cleavage of NHE1. Staurosporine- and hypertonic NaCl-induced RTC apoptosis was associated with cell shrinkage and diminished cytosolic pH, and apoptosis was potentiated by amiloride analogs, suggesting NHE1 activity opposes apoptosis. NHE1-deficient fibroblasts demonstrated increased susceptibility to apoptosis, which was reversed by NHE1 reconstitution. NHE1 expression was markedly decreased in apoptotic RTC due to degradation, and preincubation with peptide caspase antagonists restored NHE1 expression, indicating that NHE1 is degraded by caspases. Recombinant caspase-3 cleaved the in vitro-translated NHE1 cytoplasmic domain into five distinct peptides, identical in molecular weight to NHE1 degradation products derived from staurosporine-stimulated RTC lysates. In vivo, NHE1 loss-of-function C57BL/6.SJL-swe/swe mice with adriamycin-induced nephropathy demonstrated increased RTC apoptosis compared with adriamycin-treated wild-type controls, thereby implicating NHE1 inactivation as a potential mechanism of tubular atrophy. [HYP] We conclude that NHE1 activity is critical for RTC survival after injury and that   caspase   cleavage of RTC NHE1 may promote apoptosis and tubular atrophy by preventing compensatory intracellular volume and   pH   regulation.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29825,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] It is well known the participation of oxidative stress in the induction and development of different pathologies including cancer, diabetes, neurodegeneration and respiratory disorders among others. It has been reported that oxidative stress may be induced by pesticides and it could be the cause of health alteration mediated by pollutants exposure. Large number of registered products containing chlorpyrifos (CPF) is used to control pest worldwide. We have previously reported that 50 μM CPF induces ROS generation and produces cell cycle arrest followed by cell death. The present investigation was designed to identify the pathway involved in CPF-inhibited cell proliferation in MCF-7 and MDA-MB-231 breast cancer cell lines. In addition, we determined if CPF-induced oxidative stress is related to alterations in antioxidant defense system. Finally we studied the molecular mechanisms underlying in the cell proliferation inhibition produced by the pesticide. In this study we demonstrate that CPF (50 μM) induces redox imbalance altering the antioxidant defense system in breast cancer cells. Furthermore, we found that the main mechanism involved in the inhibition of cell proliferation induced by CPF is an increment of p-ERK1/2 levels mediated by H2O2 in breast cancer cells. [HYP] As PD98059 could not abolish the increment of   ROS   induced by   CPF  , we concluded that ERK1/50 phosphorylation is subsequent to   ROS   production induced by   CPF   but not the inverse.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29826,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Analyze the relationship between the given premise and hypothesis. Categorize it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Insulin (100 U/l) stimulated xylose uptake in rat soleus muscle from a basal value of 2.3 +/- 0.5 to 11.6 +/- 2.1 mumol . g-1 . h-1. Denervation (section of the sciatic nerve) markedly reduced the stimulatory action of insulin (basal 1.3 +/- 0.4 mumol . g-1 . h-1; insulin-stimulated 4.5 +/- 0.6 mumol . g-1 . h-1). This effect appeared 3 days after denervation and was maximal after 5 days. Denervation also affected the insulin dose response curve; there was no effect of insulin in denervated muscle until the concentration exceeded 1 U/l. Denervation inhibited insulin-stimulated alpha-aminoisobutyrate uptake by 77% but did not affect 125I-insulin binding or glucose-independent activation of glycogen synthase by insulin. There was no effect of denervation on the insulinomimetic effects of concanavalin A, hydrogen peroxide, vitamin K5, anoxia, 2:4-dinitrophenol, cooling, hyperosmolarity or EDTA, but the effect of diamide was inhibited. [HYP] It is concluded [1] that denervation promotes   insulin  -stimulated sugar transport at some early post-receptor step, and [2] that the mechanism whereby   insulin   activates   glycogen synthase   is different from the activation of the membrane transport of sugars and amino acids.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29827,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] Serotonin (5-hydroxytryptamine, 5-HT) is a vasoconstrictor and mitogen whose levels are elevated in diabetes. Previous studies have shown the presence of 5-HT2A, 5-HT2B, and 5-HT1B receptors in vascular smooth muscle cells (VSMCs). There are currently no data regarding 5-HT2B and 5-HT1B receptor activation of the JAK/STAT pathway in VSMCs and resultant potential alterations in 5-HT signaling in diabetes. Therefore, we tested the hypothesis that 5-HT differentially activates the JAK/STAT pathway in VSMCs under conditions of normal (5 mM) and high (25 mM) glucose. Treatment of rat VSMCs with 5-HT (10(-6) M) resulted in time-dependent activation ( approximately 2-fold) of JAK2, JAK1, and STAT1, but not STAT3 (maximal at 5 min, returned to baseline by 30 min). The 5-HT2B receptor agonist BW723C86 and the 5-HT1B receptor agonist CGS12066A (10(-9)-10(-5) M, 5-min stimulation) did not activate the JAK/STAT pathway. Treatment with the 5-HT2A receptor antagonist ketanserin (10 nM) inhibited JAK2 activation by 5-HT. Treatment of streptozotocin-induced diabetic rats with ketanserin (5 mg.kg-1.day-1) reduced activation of JAK2 and STAT1 but not STAT3 in endothelium-denuded thoracic aorta in vivo. 5-HT (10(-6) M) treatment resulted in increased cell proliferation and increased DNA synthesis, which were inhibited by the JAK2 inhibitor AG490. Further studies with apocynin, diphenyleneiodonium chloride, catalase, and virally transfected superoxide dismutase had no effect at either glucose concentration on activation of the JAK/STAT pathway by 5-HT. [HYP] Therefore, we conclude that   STAT1   activates JAK2, JAK1, and   5-HT   via the   STAT1  2A receptors in a reactive oxygen species-independent manner under both normal and high glucose conditions.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29828,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the hypothesis contradict the premise or is it entailed by it? If neither, classify it as neutral.',\n",
       "  'input': '[PRE] We have previously found that a synthetic peptide corresponding to ras-p21 residues 96 110 (PNC2) selectively blocks oncogenic (Val 12-containing) ras-p21 protein-induced oocyte maturation. With a view to introducing this peptide into ras-transformed human cells to inhibit their proliferation, we synthesized an inducible plasmid that expressed this peptide sequence. Our purpose was to test this expression system in oocytes to determine if it was capable of causing selective inhibition of oncogenic ras-p21. We injected this plasmid and a plasmid expressing a control peptide into oocytes either together with oncogenic p21 or in the presence of insulin (that induces maturation that is dependent on normal cellular ras-p21) in the presence and absence of the inducer isopropylthioglucose (IPTG). Microinjection of this plasmid into oocytes together with Val 12-p21 resulted in complete inhibition of maturation in the presence of inducer. Another plasmid encoding the sequence for the unrelated control peptide, X13, was unable to inhibit Val 12-p21-induced maturation. In contrast, PNC2 plasmid had no effect on the ability of insulin-activated normal cellular or wild-type ras-p21 to induce oocyte maturation, suggesting that it is selective for blocking the mitogenic effects of oncogenic (Val 12) ras p21. We conclude that the PNC2 plasmid selectively inhibits oncogenic ras-p21 and may therefore be highly effective in blocking proliferation of ras-induced cancer cells. [HYP] Also, from the patterns of inhibition, by PNC2 and other ras- and raf-related   peptide  s, of raf- and constitutively activated MEK-induced maturation, we conclude that PNC2   peptide   inhibits oncogenic ras   beta,   downstream of raf.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29829,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Column perifusion of mouse pancreatic islets was used to study the ability of amino acids and their methyl esters to influence insulin release and activate islet glutamate dehydrogenase activity. In the absence of L-glutamine, L-serine and the methyl ester of L-phenylalanine, but neither L-phenylalanine nor L-serine methyl ester, stimulate insulin secretion. In the presence of L-glutamine, however, the effect of L-serine was additive, while the methyl esters of L-serine and L-phenylalanine as well as native L-phenylalanine, potentiated the glucose-stimulated release of insulin. Measurements of islet glutamate dehydrogenase activity showed that only the two methyl esters of L-phenylalanine and L-serine activated the enzyme. [HYP] It is concluded that the mechanism by which   insulin release   esters of amino acids potentiate   methyl   is most likely to be mediated by the activation of pancreatic beta-cell glutamate dehydrogenase activity.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29830,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] Dietary iron deficiency in rats results in increased blood glucose turnover and recycling. We measured the rates of glucose production in isolated hepatocytes from iron-sufficient (Fe+) and iron-deficient (Fe-) rats to assess the intrinsic capacity of the Fe- liver to carry out gluconeogenesis. Low-iron and control diets were given to 21-day-old female rats. After 4-5 wk, hemoglobin concentrations averaged 4.1 g/dl in the Fe- and 14.3 g/dl in the Fe+ animals. In the hepatocytes from Fe- rats, there was a 35% decrease in the rate of glucose production from 1 mM pyruvate + 10 mM lactate, a 48% decrease from 0.1 mM pyruvate + 1 mM lactate, a 39% decrease from 1 mM alanine, and a 48% decrease from 1 mM glycerol. The addition of 5 microM norepinephrine or 0.5 microM glucagon to the incubation media produced stimulatory effects on hepatocytes from both Fe- and Fe+ rats, resulting in the maintenance of an average difference of 38% in the rates of gluconeogenesis between the two groups. Studies on isolated liver mitochondria and cytosol revealed alpha-glycerophosphate-cytochrome c reductase and phospho(enol)pyruvate carboxykinase activities to be decreased by 27% in Fe- rats. [HYP] We conclude that because severe dietary   gluconeogenesis   deficiency decreases   iron   in isolated rat hepatocytes, the increased   iron   demonstrated by Fe- rats in vivo is attributable to increased availability of gluconeogenic substrates and upregulation of the pathway.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29831,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Monocyte Chemoattractant Protein-1 (MCP-1) is involved in the diapedesis of blood monocytes into the arterial intima, an early critical event in atherogenesis. Modulating MCP-1 expression can be a key strategy to decrease the risk for atherosclerosis in diabetes. We hypothesized that quercetin, an anti-inflammatory molecule could modulate high glucose concentration (HG) induced MCP-1 expression in aortic endothelial cells in vitro because of its regulatory effects on Activator Protein-1 (AP-1) and Nuclear Factor-kappaB (NF-kappaB). Rat aortic endothelial cells (RAECs) were exposed to HG in the presence or absence of quercetin. Quercetin attenuated HG induced MCP-1 mRNA (42%) and protein synthesis (45%) when estimated using real-time reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay respectively. Western blot analysis found quercetin to maintain cytosolic p65 protein levels to that seen in control. Quercetin was found to attenuate HG induced increased NF-kappaB and AP-1 DNA binding activity in electrophoretic mobility shift assay. Immunofluorescence studies revealed quercetin to prevent HG induced nuclear localization of p65 and c-jun. Quercetin was also found to decrease HG induced activation of NF-kappaB (71%+/-14%), AP-1 (69%+/-24%) and MCP-1 promoter (79%+/-25%) in EA.hy926 cells when analyzed using luciferase reporter assay. [HYP] We conclude that   quercetin   attenuates   MCP-79 expression   in HG treated RAECs, probably by regulating both NF-kappaB and AP-79 pathways.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29832,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] A prospective study was undertaken to evaluate pudendal neuropathy in fecal incontinence. Fifty-two patients (38 women and 14 men) with fecal incontinence underwent manometric and electromyographic evaluation (measurement of pudendal nerve terminal motor latency [PNTML] and sphincter muscle mapping). The average age of all patients was 54 +/- 17 years. Fifty-two percent (27/52) were found to have a pudendal neuropathy (PNTML > 2.1 milliseconds). Seventeen of these 27 patients (63 percent) had a bilateral pudendal neuropathy. Patients with a pudendal neuropathy were older than those without a neuropathy (63.7 years vs. 51.9 years; P = 0.01). Women were significantly more likely than men to have a pudendal neuropathy (P = 0.03). Nine patients had an anatomic sphincter defect identified, and six of these (67 percent) had a neuropathy; 4/6 (67 percent) had a bilateral pudendal neuropathy. In the 43 patients who did not have an anatomic sphincter defect, there was no difference in resting pressure (69 mmHg vs. 60 mmHg; P = 0.4) or maximum voluntary contraction (95 mmHg vs. 86 mmHg; P = 0.5) when patients without a neuropathy were compared with those with a neuropathy. Patients with a pudendal neuropathy had a shorter sphincter length than those without a neuropathy (3.0 cm vs. 3.9 cm; P = 0.01). Bilateral pudendal neuropathy tended to occur more frequently in women (P = 0.08) and was not associated with poorer resting pressure, maximum voluntary contraction, or shorter sphincter length. [HYP] We conclude that   fecal incontinence   is a common cause of   pudendal neuropathy  , particularly in older women, and frequently occurs in association with a sphincter defect.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29833,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Diabetes is characterized by progressive beta cell dysfunction and loss due in part to oxidative stress that occurs from gluco/lipotoxicity. Treatments that directly protect beta cell function and survival in the diabetic milieu are of particular interest. A growing body of evidence suggests that osteocalcin, an abundant non-collagenous protein of bone, supports beta cell function and proliferation. Based on previous gene expression data by microarray, we hypothesized that osteocalcin protects beta cells from glucose-induced oxidative stress. To test our hypothesis we cultured isolated rat islets and INS-1E cells in the presence of normal, high, or high glucose\\xa0±\\xa0osteocalcin for up to 72\\xa0h. Oxidative stress and viability/mitochondrial function were measured by H2O2 assay and Alamar Blue assay, respectively. Caspase 3/7 activity was also measured as a marker of apoptosis. A functional test, glucose stimulated insulin release, was conducted and expression of genes/protein was measured by qRT-PCR/western blot/ELISA. Osteocalcin treatment significantly reduced high glucose-induced H2O2 levels while maintaining viability/mitochondrial function. Osteocalcin also significantly improved glucose stimulated insulin secretion and insulin content in rat islets after 48\\xa0h of high glucose exposure compared to untreated islets. As expected sustained high glucose down-regulated gene/protein expression of INS1 and BCL2 while increasing TXNIP expression. Interestingly, osteocalcin treatment reversed the effects of high glucose on gene/protein expression. [HYP] We conclude that osteocalcin can protect beta cells from the negative effects of   TXNIP expression  -induced oxidative stress, in part, by reducing   glucose  , thereby preserving beta cell function and survival.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29834,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Smoking is a major risk factor for diabetes, cardiovascular disease, and nonalcoholic fatty liver disease. The health risk associated with smoking can be exaggerated by obesity. We hypothesize that nicotine when combined with a high-fat diet (HFD) can also cause ectopic lipid accumulation in skeletal muscle, similar to recently observed hepatic steatosis. Adult C57BL6 male mice were fed a normal chow diet or HFD and received twice-daily ip injections of nicotine (0.75 mg/kg body weight) or saline for 10 weeks. Transmission electron microscopy of the gastrocnemius muscle revealed substantial intramyocellular lipid accumulation in close association with intramyofibrillar mitochondria along with intramyofibrillar mitochondrial swelling and vacuolization in nicotine-treated mice on an HFD compared with mice on an HFD treated with saline. These abnormalities were reversed by acipimox, an inhibitor of lipolysis. Mechanistically, the detrimental effect of nicotine plus HFD on skeletal muscle was associated with significantly increased oxidative stress, plasma free fatty acid, and muscle triglyceride levels coupled with inactivation of AMP-activated protein kinase and activation of its downstream target, acetyl-coenzyme A-carboxylase. [HYP] We conclude that 1) greater oxidative stress together with inactivation of   AMP-activated   protein kinase mediates the effect of   nicotine   on skeletal muscle abnormalities in diet-induced obesity and 2) adipose tissue lipolysis is not an important contributor of muscle steatosis and mitochondrial abnormalities.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29835,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] To extend previous observations on the role of polyamines in insulin production, metabolism, and replication of insulin-secreting pancreatic beta cells, we have studied the role of polyamines in the regulation of the stimulus-secretion coupling of clonal rat insulinoma cells (RINm5F). For this purpose, RINm5F cells were partially depleted in their polyamine contents by use of the specific ornithine decarboxylase inhibitor difluoromethylornithine (DFMO), which led to an increase in cellular insulin and ATP contents. Analysis of different parts of the signal transduction pathway revealed that insulin secretion and the increase in cytoplasmic free Ca2+ concentration ([Ca2+]i) after K(+)-induced depolarization were markedly enhanced in DFMO-treated cells. These effects were paralleled by increased voltage-activated Ca2+ currents, as judged by whole-cell patch-clamp analysis, probably reflecting increased channel activity rather than elevated number of channels per cell. DFMO treatment also rendered phospholipase C in these cells more sensitive to the muscarinic receptor agonist carbamylcholine, as evidenced by enhanced generation of inositol phosphates, increase in [Ca2+]i and insulin secretion, despite an unaltered ligand binding to muscarinic receptors and lack of effect on protein kinase C activity. In addition, the tumor promoter 12-O-tetradecanoylphorbol 13-acetate, at concentrations suggested to be specific for protein kinase C activation, evoked an increased insulin output in polyamine-deprived cells compared to control cells. The stimulatory effects of glucose or the cyclic AMP raising agent theophylline on insulin release were not increased by DFMO treatment. In spite of increased binding of sulfonylurea in DFMO-treated cells, there was no secretory response or altered increase in [Ca2+]i in response to the drug in these cells. [HYP] It is not concluded that partial   polyamine   depletion sensitizes the stimulus-secretion coupling at multiple levels in the insulinoma cells, including increased voltage-dependent Ca2+ influx and enhanced responsiveness to activators of phospholipase C and protein kinase C. In their entirety, our present results indicate that the behavior of the stimulus-secretion coupling of   polyamine  -depleted RINm5F insulinoma cells changes towards that of native beta cells, thus improving the usefulness of this cell line for studies of beta cell   insulin secretion  .\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29836,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] Fluorescein isothiocyanate (FITC) was used to label the rabbit intestinal brush border Na+-glucose carrier, identify the carrier protein on sodium dodecyl sulfate/polyacrylamide gel electrophoresis, and monitor the effect of ions and substrates on fluorescence quenching. Enriched brush border preparations were employed to study both glucose transport and FITC binding. FITC and a nonfluorescent analog (phenyl isothiocyanate, PITC) both inhibited Na+-dependent D-glucose transport irreversibly. Inhibition was blocked completely by the presence of Na+ and D-glucose during labeling. PITC was used to label nonspecific amino groups in the presence of glucose and Na+, and then the glucose carrier was labeled with FITC in the absence of substrates. Fluorescence of FITC bound to the carrier was quenched specifically with Na+ in a saturable fashion, and this indicates a Na+-dependent conformational change in the carrier. Sodium dodecyl sulfate/polyacrylamide gel electrophoresis of FITC-labeled membranes revealed specific labeling of a 71,000-dalton peptide. [HYP] We conclude that   Na+   induces a conformational shift in the 71,000-dalton   glucose   carrier, and this is quite consistent with the kinetics of   Na+  -dependent   glucose   transport in these membranes.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29837,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Vascular inflammation plays a critical role in the pathogenesis of diabetic retinopathy. Recently, Interleukin-6 (IL-6) trans-signaling via soluble IL-6 receptor (sIL-6R) has emerged as a prominent regulator of inflammation in endothelial cells. This study was designed to test the hypothesis that selective inhibition of the IL-6 trans-signaling pathway will attenuate inflammation and subsequent barrier disruption in retinal endothelial cells. Human retinal endothelial cells (HRECs) were exposed to IL-6 and sIL-6R to induce IL-6 trans-signaling and the commercially available compound sgp130Fc (soluble gp-130 fused chimera) was used to selectively inhibit IL-6 trans-signaling. IL-6 trans-signaling activation caused a significant increase in STAT3 phosphorylation, expression of adhesion molecules, ROS production and apoptosis in HRECs whereas a significant decrease in mitochondrial membrane potential and NO production was observed in IL-6 trans-signaling activated cells. These changes were not observed in cells pre-treated with sgp130Fc. IL-6 trans-signaling activation was sufficient to cause barrier disruption in endothelial monolayers and pre-treatment of HRECs with sgp130Fc, maintained endothelial barrier function similar to that of untreated cells. [HYP] Thus, in conclusion, these results indicate that   IL-6   trans-signaling is an important mediator of   inflammation  , apoptosis and barrier disruptive effects in the retinal endothelial cells and promotion of the   IL-6   trans-signaling pathway using sgp130-Fc attenuates vascular   inflammation   and endothelial barrier disruption.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29838,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Smoking is a major risk factor for diabetes, cardiovascular disease, and nonalcoholic fatty liver disease. The health risk associated with smoking can be exaggerated by obesity. We hypothesize that nicotine when combined with a high-fat diet (HFD) can also cause ectopic lipid accumulation in skeletal muscle, similar to recently observed hepatic steatosis. Adult C57BL6 male mice were fed a normal chow diet or HFD and received twice-daily ip injections of nicotine (0.75 mg/kg body weight) or saline for 10 weeks. Transmission electron microscopy of the gastrocnemius muscle revealed substantial intramyocellular lipid accumulation in close association with intramyofibrillar mitochondria along with intramyofibrillar mitochondrial swelling and vacuolization in nicotine-treated mice on an HFD compared with mice on an HFD treated with saline. These abnormalities were reversed by acipimox, an inhibitor of lipolysis. Mechanistically, the detrimental effect of nicotine plus HFD on skeletal muscle was associated with significantly increased oxidative stress, plasma free fatty acid, and muscle triglyceride levels coupled with inactivation of AMP-activated protein kinase and activation of its downstream target, acetyl-coenzyme A-carboxylase. [HYP] We conclude that 1) greater oxidative stress together with inactivation of   AMP-activated   protein kinase mediates the effect of   nicotine   on skeletal muscle abnormalities in diet-induced obesity and 2) adipose tissue lipolysis is an important contributor of muscle steatosis and mitochondrial abnormalities.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29839,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] The excessive or prolonged production of inflammatory mediators can result in numerous chronic diseases, such as rheumatoid arthritis, atherosclerosis, diabetes, and cancer. Therefore, for many inflammatory-related diseases, pharmaceutical intervention is required to restrain the excessive release of such inflammatory mediators. Novel therapeutics and mechanistic insight are sought for the management of chronic inflammatory diseases. Resokaempferol (RES) is a type of flavonoid recently reported to demonstrate anti-cancer properties. However, the anti-inflammatory capacity of RES has not been studied to date. Therefore, this study investigated whether RES is capable of suppressing the inflammatory response to lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and the mechanism by which this is achieved. We found that RES attenuated the LPS-induced production of nitric oxide (NO), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), interleukin (IL)-1β, tumor necrosis factor-α (TNF-α), monocyte chemotactic protein 1 (MCP-1) and IL-6. RES also inhibited the nuclear translocation of signal transducer and activator of transcription (STAT) 3 and reduced the LPS-mediated phosphorylation of Janus kinase (JAK) 2 and STAT3 at the sites of Ser727 and Tyr705. RES also inhibited the activation of NF-κB and JNK/p38 MAPK signaling pathways in LPS-induced RAW264.7 cells. Additionally, RES inhibited the activation of the JAK2/STAT3 pathway in exogenous IL-6-activated RAW264.7 macrophages. [HYP] We conclude that   JAK2   inhibits the inflammatory response in activated macrophages by blocking the activation of the   RES  /STAT3 pathway by both LPS and IL-6 signaling.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29840,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Peptides from the alpha 1 domain of the major histocompatibility complex class I antigen (MHC class I), e.g. Dk-(61-85) and Dk-(62-85), have been shown previously to augment glucose uptake in insulin-stimulated cells and to inhibit insulin receptor internalization (Stagsted, J., Reaven, G. M., Hansen, T., Goldstein, A., and Olsson, L. (1990) Cell 62, 297-307). We now report that these peptides inhibit by 80-100% the internalization of glucose transporters (GLUT4) and insulin-like growth factor II (IGF-II) receptors in insulin-stimulated cells and correspondingly double insulin-stimulated glucose transport activity and the number of GLUT4 and IGF-II receptors on the cell surface. In addition, the peptides enhance the apparent affinity about 3-fold of IGF-II binding to its receptor. [HYP] It is concluded that the effects of the   peptide  s on glucose transport and IGF-II binding are a consequence of the   peptide  -mediated promotion of internalization of GLUT4 and   IGF-II receptor  .\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29841,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Insulin-like growth factor binding proteins (IGFBPs) may participate in regulating ovarian function by modifying effects of insulin-like growth factors (IGFs) or by directly affecting ovarian steroidogenesis in both normal and pathological circumstances. The latter include hyperinsulinemic insulin resistant states, such as polycystic ovary syndrome. We examined regulation of IGFBP-1 production in human granulosa cells by insulin and IGF-I. The cells were obtained during in vitro fertilization, plated in McCoy-5A tissue culture medium supplemented with 10% fetal calf serum (10(5) cells/0.5 mL), and incubated at 37 C, 90% humidity, 5% CO2 for 48 h. After additional 24 h incubation without fetal calf serum, 1, 10, or 100 ng/mL of insulin or IGF-I were added with or without 2 h preincubation with 10 micrograms/mL monoclonal anti insulin receptor antibody IR-47-9. After 48 h incubation with insulin or IGF-I, the medium was collected and IGFBP-1 and progesterone concentrations were measured, using kits from Diagnostic Systems Laboratories, Webster, TX. Progesterone concentration ranged between 50-100 ng/mL/10(5) cells, without consistent stimulatory effect of either insulin or IGF-I. Control cells produced 7.0 +/- 1.7 ng/mL of IGFBP-1. Incubation with 1 or 10 ng/mL of insulin resulted in culture medium IGFBP-1 concentrations of 7.1 +/- 1.3 ng/mL and 5.4 +/- 0.7 ng/mL, respectively (P = NS). Incubation with 100 ng/mL of insulin reduced IGFBP-1 culture medium concentration to 1.6 +/- 0.3 ng/mL (P < 0.01, compared with controls). 1, 10, and 100 ng/mL of IGF-I inhibited IGFBP-1 concentrations in the conditioned culture medium to 1.3 +/- 0.3 ng/mL, 0.4 +/- 0.1 ng/mL and 0.3 +/- 0.1 ng/mL, respectively (P < 0.01, compared with controls). Preincubation with antiinsulin receptor antibody IR-47-9 alleviated inhibitory effect of insulin, but not of IGF-I on IGFBP-1 production. After preincubation with IR-47-9, IGFBP-1 culture medium concentrations were 5.9 +/- 0.8 ng/mL, 4.9 +/- 1.2 ng/mL, and 4.8 +/- 1.3 ng/mL for 1, 10, and 100 ng/mL of insulin, respectively. The latter number was significantly higher than IGFBP-1 concentration in the medium collected from cells incubated with 100 ng/mL of insulin without IR-47-9 (1.6 +/- 0.3 ng/mL, P < 0.01) and not significantly different from the control cells. For cells preincubated with IR-47-9 and then incubated with 1, 10, or 100 ng/mL of IGF-I, the IGFBP-1 conditioned culture medium concentrations were 1.7 +/- 0.1 ng/mL, 0.5 +/- 0.2 ng/mL, and 0.3 +/- 0.1 ng/mL, respectively. None of these were significantly different from the IGFBP-1 concentrations in the medium collected from cells incubated with the respective concentrations of IGF-I without preincubation with IR-47-9. [HYP] We conclude that 1) both   insulin   and IGF-I inhibit   IGFBP-1   production by cultured human granulosa cells; 2) IGF-I is not a more potent inhibitor of   IGFBP-1   production than   insulin  ; 3) in the range of hormone concentrations tested,   insulin   exerts its inhibitory effect on   IGFBP-1   production via   insulin   receptor, while IGF-I appears to exert its effect via another receptor.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29842,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] The insulin-mimetic effect of vanadate is well established, and vanadate has been shown to improve insulin sensitivity in diabetic rats and humans. Although the exact mechanism(s) remain undefined, we have previously demonstrated a direct relation of intracellular free magnesium (Mg(i)) levels to glucose disposal, to insulinemic responses following glucose loading, and to insulin-induced ionic effects. To investigate whether the insulin-mimetic effects of vanadate could similarly be mediated by Mg(i), we utilized (31)P-nuclear magnetic resonance spectroscopy to measure Mg(i) in erythrocytes from normal (NL, n=10) and hypertensive (HTN, n=12) subjects, before and after incubation with insulin and with different doses of sodium vanadate. In NL, vanadate elevated Mg(i) levels, with maximum efficacy at 50 7 micromol/L (186+/-6 to 222+/-6 7micromol/L, P>0.01), as did physiologically maximal doses of insulin, 200 7microU/mL (185+/-6 to 222+/-8 7micromol/L, P<0.01). In HTN, only vanadate, but not insulin, increased Mg(i) (insulin: 173+/-7 to 180+/-9 7micromol/L, P=NS; vanadate: 170+/-7 to 208+/-10 7micromol/L, P<0.01). Mg(i) responses to insulin (r=0.637, P<0.001), but not to vanadate (r=0.15, P=NS), were closely and directly related to basal Mg(i) levels. [HYP] We conclude that (1) both vanadate and   insulin   stimulate erythrocyte   .NO  (i) levels; (2) cellular   .NO  (i) responses to   insulin  , but not to vanadate, depend on basal   .NO  (i) content-the lower the basal   .NO  (i), the less the   .NO  (i) response to   insulin  .\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29843,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Analyze the relationship between the given premise and hypothesis. Categorize it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Dietary iron deficiency in rats results in increased blood glucose turnover and recycling. We measured the rates of glucose production in isolated hepatocytes from iron-sufficient (Fe+) and iron-deficient (Fe-) rats to assess the intrinsic capacity of the Fe- liver to carry out gluconeogenesis. Low-iron and control diets were given to 21-day-old female rats. After 4-5 wk, hemoglobin concentrations averaged 4.1 g/dl in the Fe- and 14.3 g/dl in the Fe+ animals. In the hepatocytes from Fe- rats, there was a 35% decrease in the rate of glucose production from 1 mM pyruvate + 10 mM lactate, a 48% decrease from 0.1 mM pyruvate + 1 mM lactate, a 39% decrease from 1 mM alanine, and a 48% decrease from 1 mM glycerol. The addition of 5 microM norepinephrine or 0.5 microM glucagon to the incubation media produced stimulatory effects on hepatocytes from both Fe- and Fe+ rats, resulting in the maintenance of an average difference of 38% in the rates of gluconeogenesis between the two groups. Studies on isolated liver mitochondria and cytosol revealed alpha-glycerophosphate-cytochrome c reductase and phospho(enol)pyruvate carboxykinase activities to be decreased by 27% in Fe- rats. [HYP] We conclude that because severe dietary   iron   deficiency decreases   gluconeogenesis   in isolated rat hepatocytes, the increased   gluconeogenesis   demonstrated by Fe- rats in vivo is not attributable to increased availability of gluconeogenic substrates and upregulation of the pathway.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29844,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] During peritoneal dialysis (PD), exposure of the peritoneal membrane to nonphysiologic solutions causes inflammation, ultimately leading to altered structure and function. Myofibroblasts, one of the cell types that contribute to dysfunction of the peritoneal membrane, can originate from mesothelial cells (MCs) by epithelial-to-mesenchymal transition (EMT), a process that has been associated with an increased rate of peritoneal transport. Because cyclooxygenase-2 (COX-2) is induced by inflammation, we studied the role of COX-2 in the deterioration of the peritoneal membrane. We observed that nonepithelioid MCs found in peritoneal effluent expressed higher levels of COX-2 than epithelioid MCs. The mass transfer coefficient for creatinine correlated with MC phenotype and with COX-2 levels. Although COX-2 was upregulated during EMT of MCs in vitro, COX-2 inhibition did not prevent EMT. In a mouse model of PD, however, COX-2 inhibition with Celecoxib resulted in reduced fibrosis and in partial recovery of ultrafiltration, outcomes that were associated with a reduction of inflammatory cells. Furthermore, PD fluid with a low content of glucose degradation products did not induce EMT or COX-2; the peritoneal membranes of mice treated with this fluid showed less worsening than mice exposed to standard fluid. [HYP] In conclusion, upregulation of   COX-2   during EMT may mediate peritoneal   inflammation  , suggesting   COX-2   inhibition as a potential strategy to ameliorate peritoneal deterioration in PD patients.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29845,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the hypothesis contradict the premise or is it entailed by it? If neither, classify it as neutral.',\n",
       "  'input': '[PRE] An established intermediate phenotype of human hypertension and diabetic nephropathy is an elevation of Na+/H+ exchanger (NHE) activity, but the mechanism for this is unclear. This phenotype is maintained in vascular myocytes from the spontaneously hypertensive rat (SHR) compared with the normotensive Wistar Kyoto rat (WKY). Since intracellular calcium levels ([Ca2+]i) following agonist stimulation were elevated in cells from both hypertensive humans and SHR, we have examined the role of calcium-calmodulin (CaM) in the mechanism of increased NHE activity in vascular myocytes of SHR by determining the activity and phosphorylation state of NHE isoform-1 (NHE-1) in cells from SHR and WKY when [Ca2+]i was elevated by the ionophores A23187 or ionomycin. NHE activity was measured using fluorometry and NHE-1 phosphorylation by immunoprecipitating the exchanger from 32P-orthophosphate-labeled cells with a polyclonal NHE-1-specific antibody. The ionophore A23187 increased [Ca2+]i in both cell types to approximately 700 to 800 nmol x L(-1), and led to stimulation of NHE-1 activity only in WKY myocytes, with no effect on SHR cells. An inhibitor of CaM kinase II (KN-62) failed to abolish stimulation of NHE-1 by A23187 in WKY cells, and had no effect on unstimulated NHE-1 activity in both cell types. Ionomycin also elevated [Ca2+]i in both cell types to approximately 1,000 nmol x L(-1) and activated NHE-1 activity in only WKY cells. Activation of NHE-1 in WKY cells by an increased [Ca2+]i was not mediated by an increase in NHE-1 phosphorylation, whether in the presence or absence of KN-62. The elevated NHE-1 phosphorylation in SHR cells was not affected by elevated [Ca2+]i or KN-62. Calmodulin-agarose beads bound NHE-1 extracted from SHR cells to a lesser extent than that from WKY cells. [HYP] We conclude that   calcium  -induced   NHE-1   activation in WKY cells was not mediated by CaM kinase II.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29846,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': \"[PRE] Accumulation of intracellular lipid by pancreatic islet beta-cells has been proposed to inhibit normal glucose-regulated insulin secretion ('glucolipotoxicity'). In the present study, we determine whether over-expression in rat islets of the lipogenic transcription factor SREBP1c (sterol-regulatory-element-binding protein-1c) affects insulin release, and whether changes in islet lipid content may be reversed by activation of AMPK (AMP-activated protein kinase). Infection with an adenovirus encoding the constitutively active nuclear fragment of SREBP1c resulted in expression of the protein in approx. 20% of islet cell nuclei, with a preference for beta-cells at the islet periphery. Real-time PCR (TaqMan) analysis showed that SREBP1c up-regulated the expression of FAS (fatty acid synthase; 6-fold), acetyl-CoA carboxylase-1 (2-fold), as well as peroxisomal-proliferator-activated receptor-gamma (7-fold), uncoupling protein-2 (1.4-fold) and Bcl2 (B-cell lymphocytic-leukaemia proto-oncogene 2; 1.3-fold). By contrast, levels of pre-proinsulin, pancreatic duodenal homeobox-1, glucokinase and GLUT2 (glucose transporter isoform-2) mRNAs were unaltered. SREBP1c-transduced islets displayed a 3-fold increase in triacylglycerol content, decreased glucose oxidation and ATP levels, and a profound inhibition of glucose-, but not depolarisation-, induced insulin secretion. Culture of islets with the AMPK activator 5-amino-4-imidazolecarboxamide riboside decreased the expression of the endogenous SREBP1c and FAS genes, and reversed the effect of over-expressing active SREBP1c on FAS mRNA levels and cellular triacylglycerol content. [HYP] We conclude that   insulin secretion   over-expression, even when confined to a subset of beta-cells, leads to defective   SREBP1c   from islets and may contribute to some forms of Type II diabetes.\\nOUTPUT:\",\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29847,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] A prospective study was undertaken to evaluate pudendal neuropathy in fecal incontinence. Fifty-two patients (38 women and 14 men) with fecal incontinence underwent manometric and electromyographic evaluation (measurement of pudendal nerve terminal motor latency [PNTML] and sphincter muscle mapping). The average age of all patients was 54 +/- 17 years. Fifty-two percent (27/52) were found to have a pudendal neuropathy (PNTML > 2.1 milliseconds). Seventeen of these 27 patients (63 percent) had a bilateral pudendal neuropathy. Patients with a pudendal neuropathy were older than those without a neuropathy (63.7 years vs. 51.9 years; P = 0.01). Women were significantly more likely than men to have a pudendal neuropathy (P = 0.03). Nine patients had an anatomic sphincter defect identified, and six of these (67 percent) had a neuropathy; 4/6 (67 percent) had a bilateral pudendal neuropathy. In the 43 patients who did not have an anatomic sphincter defect, there was no difference in resting pressure (69 mmHg vs. 60 mmHg; P = 0.4) or maximum voluntary contraction (95 mmHg vs. 86 mmHg; P = 0.5) when patients without a neuropathy were compared with those with a neuropathy. Patients with a pudendal neuropathy had a shorter sphincter length than those without a neuropathy (3.0 cm vs. 3.9 cm; P = 0.01). Bilateral pudendal neuropathy tended to occur more frequently in women (P = 0.08) and was not associated with poorer resting pressure, maximum voluntary contraction, or shorter sphincter length. [HYP] We conclude that   pudendal neuropathy   is a common cause of   fecal incontinence  , particularly in older women, and frequently occurs in association with a sphincter defect.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29848,\n",
       "  'model_output': 'contraindication'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] A prospective study was undertaken to evaluate pudendal neuropathy in fecal incontinence. Fifty-two patients (38 women and 14 men) with fecal incontinence underwent manometric and electromyographic evaluation (measurement of pudendal nerve terminal motor latency [PNTML] and sphincter muscle mapping). The average age of all patients was 54 +/- 17 years. Fifty-two percent (27/52) were found to have a pudendal neuropathy (PNTML > 2.1 milliseconds). Seventeen of these 27 patients (63 percent) had a bilateral pudendal neuropathy. Patients with a pudendal neuropathy were older than those without a neuropathy (63.7 years vs. 51.9 years; P = 0.01). Women were significantly more likely than men to have a pudendal neuropathy (P = 0.03). Nine patients had an anatomic sphincter defect identified, and six of these (67 percent) had a neuropathy; 4/6 (67 percent) had a bilateral pudendal neuropathy. In the 43 patients who did not have an anatomic sphincter defect, there was no difference in resting pressure (69 mmHg vs. 60 mmHg; P = 0.4) or maximum voluntary contraction (95 mmHg vs. 86 mmHg; P = 0.5) when patients without a neuropathy were compared with those with a neuropathy. Patients with a pudendal neuropathy had a shorter sphincter length than those without a neuropathy (3.0 cm vs. 3.9 cm; P = 0.01). Bilateral pudendal neuropathy tended to occur more frequently in women (P = 0.08) and was not associated with poorer resting pressure, maximum voluntary contraction, or shorter sphincter length. [HYP] We conclude that   fecal incontinence   is a common cause of   pudendal neuropathy  , particularly in older women, and frequently occurs in association with a sphincter defect.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29849,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] We examined the possible role of tumor necrosis factor-alpha (TNF-alpha) as a mediator of insulin resistance in maturing male Sprague-Dawley rats. Rats were treated either with goat anti-murine TNF-alpha IgG (anti-TNF-alpha) or goat nonimmune IgG (NI) for 7 days. Vascular catheters were implanted, and rats were fasted overnight before hyperinsulinemic euglycemic clamp (HUC) studies were performed. TNF-alpha neutralization increased the rate of glucose infusion required to maintain euglycemia by 68%. Insulin-stimulated glucose transport into individual tissues was measured after bolus administration of 2-deoxy-[(14)C]glucose during HUC. Anti-TNF-alpha administration increased glucose transport in muscles composed predominantly of fast-twitch fibers: white gastrocnemius muscle (68% increase) and tibialis anterior muscle (64% increase). There were nonsignificant trends for increased glucose transport in the slow-twitch soleus muscle and in the mixed-fiber red gastrocnemius muscle. Glucose transport was unchanged in visceral and subcutaneous fat. Anti-TNF treatment did not alter body weight, muscle mass, or fat mass. Anti-TNF-alpha did not alter the distribution of the 17-kDa and 26-kDa forms of TNF-alpha in either muscle or fat. However, anti-TNF-alpha treatment caused an approximately 50% reduction in the secretion of TNF-alpha bioactivity in vitro by explants of visceral and subcutaneous fat. [HYP] We conclude that   TNF-alpha   neutralization reversed   insulin resistance   substantially in fast-twitch muscle and may have done so in other muscles, while having little effect in fat.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29850,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] During peritoneal dialysis (PD), exposure of the peritoneal membrane to nonphysiologic solutions causes inflammation, ultimately leading to altered structure and function. Myofibroblasts, one of the cell types that contribute to dysfunction of the peritoneal membrane, can originate from mesothelial cells (MCs) by epithelial-to-mesenchymal transition (EMT), a process that has been associated with an increased rate of peritoneal transport. Because cyclooxygenase-2 (COX-2) is induced by inflammation, we studied the role of COX-2 in the deterioration of the peritoneal membrane. We observed that nonepithelioid MCs found in peritoneal effluent expressed higher levels of COX-2 than epithelioid MCs. The mass transfer coefficient for creatinine correlated with MC phenotype and with COX-2 levels. Although COX-2 was upregulated during EMT of MCs in vitro, COX-2 inhibition did not prevent EMT. In a mouse model of PD, however, COX-2 inhibition with Celecoxib resulted in reduced fibrosis and in partial recovery of ultrafiltration, outcomes that were associated with a reduction of inflammatory cells. Furthermore, PD fluid with a low content of glucose degradation products did not induce EMT or COX-2; the peritoneal membranes of mice treated with this fluid showed less worsening than mice exposed to standard fluid. [HYP] In conclusion, upregulation of   COX-2   during EMT may mediate peritoneal   inflammation  , suggesting   COX-2   promotion as a potential strategy to ameliorate peritoneal deterioration in PD patients.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29851,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] The epidermal growth factor (EGF) receptor tyrosine kinase activity is required for both the earliest EGF-stimulated post-binding events (enhancement of inositol phosphate formation and Ca2+ influx, activation of Na+/H+ exchange), and the ultimate EGF-induced mitogenic response. To assess the role of EGF receptor kinase in EGF-induced metabolic effects (2-deoxyglucose and 2-aminoisobutyric acid uptake), we used NIH3T3 cells (clone 2.2), which do not possess endogenous EGF receptors and which were transfected with cDNA constructs encoding either wild type or kinase-deficient human EGF receptor (HER). In addition, we tested the importance of three HER autophosphorylation sites (Tyr-1068, Tyr-1148, and Tyr-1173) in transduction of EGF-stimulated 2-deoxyglucose uptake. [HYP] Taking our data together, we conclude the following: (i)   HER   tyrosine kinase activity is required to elicit EGF stimulation of both   2-deoxyglucose   and 2-aminoisobutyric acid uptake; (ii) mutations on individual   HER   autophosphorylation sites, Tyr-1068, Tyr-1148, and Tyr-1173 do not impair EGF-stimulated   2-deoxyglucose   uptake.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29852,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': \"[PRE] 5'-AMP-activated protein kinase (AMPK) has been suggested to be a 'metabolic master switch' regulating various aspects of muscle glucose and fat metabolism. In isolated rat skeletal muscle, glucose suppresses the activity of AMPK and in human muscle glycogen loading decreases exercise-induced AMPK activation. We hypothesized that oral glucose ingestion during exercise would attenuate muscle AMPK activation. Nine male subjects performed two bouts of one-legged knee-extensor exercise at 60% of maximal workload. The subjects were randomly assigned to either consume a glucose containing drink or a placebo drink during the two trials. Muscle biopsies were taken from the vastus lateralis before and after 2 h of exercise. Plasma glucose was higher (6.0 +/- 0.2 vs. 4.9 +/- 0.1 mmol L-1, P < 0.001), whereas glycerol (44.8 +/- 7.8 vs. 165.7 +/- 22.3 micromol L-1), and free fatty acid (169.3 +/- 9.5 vs. 1161 +/- 144.9 micromol L-1) concentrations were lower during the glucose compared to the placebo trial (both P < 0.001). Calculated fat oxidation was lower during the glucose trial (0.17 +/- 0.02 vs. 0.25 +/- 0.03 g min-1, P < 0.001). Activation of alpha2-AMPK was attenuated in the glucose trial compared to the placebo trial (0.24 +/- 0.07 vs. 0.46 +/- 0.14 pmol mg-1 min-1, P = 0.03), whereas the alpha1-AMPK activity was not different between trials or affected by exercise. AMPK and the downstream target of AMPK, acetyl-CoA carboxylase-beta, were phosphorylated as a response to exercise, but neither was significantly different between the two trials. [HYP] We conclude that oral   glucose   ingestion attenuates the exercise-induced activation of   alpha2-AMPK  , bringing further support for a fuel-sensing role of AMPK in skeletal muscle.\\nOUTPUT:\",\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29853,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the hypothesis contradict the premise or is it entailed by it? If neither, classify it as neutral.',\n",
       "  'input': '[PRE] Dietary iron deficiency in rats results in increased blood glucose turnover and recycling. We measured the rates of glucose production in isolated hepatocytes from iron-sufficient (Fe+) and iron-deficient (Fe-) rats to assess the intrinsic capacity of the Fe- liver to carry out gluconeogenesis. Low-iron and control diets were given to 21-day-old female rats. After 4-5 wk, hemoglobin concentrations averaged 4.1 g/dl in the Fe- and 14.3 g/dl in the Fe+ animals. In the hepatocytes from Fe- rats, there was a 35% decrease in the rate of glucose production from 1 mM pyruvate + 10 mM lactate, a 48% decrease from 0.1 mM pyruvate + 1 mM lactate, a 39% decrease from 1 mM alanine, and a 48% decrease from 1 mM glycerol. The addition of 5 microM norepinephrine or 0.5 microM glucagon to the incubation media produced stimulatory effects on hepatocytes from both Fe- and Fe+ rats, resulting in the maintenance of an average difference of 38% in the rates of gluconeogenesis between the two groups. Studies on isolated liver mitochondria and cytosol revealed alpha-glycerophosphate-cytochrome c reductase and phospho(enol)pyruvate carboxykinase activities to be decreased by 27% in Fe- rats. [HYP] We conclude that because severe dietary   gluconeogenesis   deficiency decreases   iron   in isolated rat hepatocytes, the increased   iron   demonstrated by Fe- rats in vivo is attributable to increased availability of gluconeogenic substrates and upregulation of the pathway.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29854,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Metformin, one of the most commonly used drugs for the treatment of type II diabetes, was recently found to exert its therapeutic effects, at least in part, by activating the AMP-activated protein kinase (AMPK). However, the site of its action, as well as the mechanism to activate AMPK, remains elusive. Here we report how metformin activates AMPK. In cultured bovine aortic endothelial cells, metformin dose-dependently activated AMPK in parallel with increased detection of reactive nitrogen species (RNS). Further, either depletion of mitochondria or adenoviral overexpression of superoxide dismutases, as well as inhibition of nitric-oxide synthase, abolished the metformin-enhanced phosphorylations and activities of AMPK, implicating that activation of AMPK by metformin might be mediated by the mitochondria-derived RNS. Furthermore, administration of metformin, which increased 3-nitrotyrosine staining in hearts of C57BL6, resulted in parallel activation of AMPK in the aorta and hearts of C57BL6 mice but not in those of endothelial nitric-oxide synthase (eNOS) knockout mice in which metformin had no effect on 3-nitrotyrosine staining. Because the eNOS knockout mice expressed normal levels of AMPK-alpha that was activated by 5-aminoimidazole-4-carboxamide riboside, an AMPK agonist, these data indicate that RNS generated by metformin is required for AMPK activation in vivo. In addition, metformin significantly increased the co-immunoprecipitation of AMPK and its upstream kinase, LKB1, in C57BL6 mice administered to metformin in vivo. Using pharmacological and genetic inhibitors, we found that inhibition of either c-Src or PI3K abolished AMPK that was enhanced by metformin. [HYP] We conclude that activation of   AMPK   by metformin might be mediated by mitochondria-derived RNS, and activation of the c-Src/PI3K pathway might generate a metabolite or other molecule inside the cell to promote   AMPK   activation by the   LKB1   complex.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29855,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Analyze the relationship between the given premise and hypothesis. Categorize it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] 1. The effects of glucosamine concentration on the size of the lactate pool, on the levels of ATP, ADP, AMP and on the radioactivity incorporation from [1-14-C] glucosamine into lactate, N-acetylglucosamine and glucosamine-6-P were studied using whole bovine retinas. 2. The radioactive lactate, evaluated in relation to glucosamine molarity, after a modest initial increase, diminishes significantly. On the contrary the N-acetyl [1-14-C] glucosamine, the [1-14-C] glucosamine-6-P and, consequently, also the [1-14-C] glucosamine-6-P/[-14-C] lactate ratio increase with glucosamine molarity. 3. The retinal content of ATP shows a modest increment after incubation with low concentrations of D-glucosamine (0.5--2.0 mM) and a remarkable fall at higher concentrations. 4. Using retinal homogenates D-glucosamine clearly lowers the lactate production from glucose, glucose-6-P and fructose-1, 6-P2. 5. D-Glucosamine acts as an inhibitor of retinal glyceraldehyde-3-P dehydrogenase and lactate dehydrogenase by decreasing the initial velocity of these reactions. 6. [HYP] It is concluded that   D-glucosamine   causes a reduction in the   lactate   production, by inhibiting two enzymes of the glycolytic pathway: glyceraldehyde-6-P dehydrogenase and   lactate   dehydrogenase.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29856,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Endothelial barrier dysfunction plays a pivotal role in the pathogenesis of diabetic vascular complications. Although recent studies have established a link between protein kinase C (PKC) pathway and hyperglycaemic-induced vascular permeability, it is unclear which PKC isoforms involve increased endothelial cell permeability. In the present study, we investigated whether high glucose induced endothelial hyperpermeability via distinct PKC isoforms in human umbilical vein endothelial cells (HUVECs) and whether increased endothelial permeability could be substantially reversed by PKC inhibitors LY379196 and hypocrellin A (HA). High glucose (20 mM) and phorbol-myristate-acetate (PMA)-induced endothelial hyperpermeability was almost abolished by 150 nM HA and partially reduced by 30 nM PKC beta inhibitor (LY379196). LY379196 and HA inhibited the membrane fraction of PKC activity in a dose-dependent manner. Western blot analysis revealed high-glucose-induced overexpression of PKC alpha and PKC beta2 in the membrane fraction of HUVECs. LY379196 (30 and 150 nM) selectively inhibited PKC beta2 with no significant effect on PKC alpha expression. HA (150 nM) significantly reduced PKC alpha expression with no inhibitory effect on PKC beta2. At higher concentrations (300 nM), both LY379196 and HA were no longer selective for PKC beta or alpha, respectively. This study showed that both PKC alpha and beta2 contributed to endothelial hyperpermeability. [HYP] Since reduction of endothelial hyperpermeability was greater with inhibition of   HA   alpha rather than   HA   beta2, we conclude that   HA   alpha may be a major isoform involved in endothelial permeability in HUVECs, and that   HA   alpha-mediated endothelial permeability was significantly reversed by the   HA   inhibitor   PKC  .\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29857,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Peptides from the alpha 1 domain of the major histocompatibility complex class I antigen (MHC class I), e.g. Dk-(61-85) and Dk-(62-85), have been shown previously to augment glucose uptake in insulin-stimulated cells and to inhibit insulin receptor internalization (Stagsted, J., Reaven, G. M., Hansen, T., Goldstein, A., and Olsson, L. (1990) Cell 62, 297-307). We now report that these peptides inhibit by 80-100% the internalization of glucose transporters (GLUT4) and insulin-like growth factor II (IGF-II) receptors in insulin-stimulated cells and correspondingly double insulin-stimulated glucose transport activity and the number of GLUT4 and IGF-II receptors on the cell surface. In addition, the peptides enhance the apparent affinity about 3-fold of IGF-II binding to its receptor. [HYP] It is concluded that the effects of the   IGF-II receptor  s on glucose transport and IGF-II binding are a consequence of the   IGF-II receptor  -mediated inhibition of internalization of GLUT4 and   peptide  .\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29858,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Hypoxia-dependent accumulation of vascular endothelial growth factor (VEGF) plays a major role in retinal diseases characterized by neovessel formation. In this study, we investigated whether the glial water channel Aquaporin-4 (AQP4) is involved in the hypoxia-dependent VEGF upregulation in the retina of a mouse model of oxygen-induced retinopathy (OIR). The expression levels of VEGF, the hypoxia-inducible factor-1α (HIF-1α) and the inducible form of nitric oxide synthase (iNOS), the production of nitric oxide (NO), the methylation status of the HIF-1 binding site (HBS) in the VEGF gene promoter, the binding of HIF-1α to the HBS, the retinal vascularization and function have been determined in the retina of wild-type (WT) and AQP4 knock out (KO) mice under hypoxic (OIR) or normoxic conditions. In response to 5 days of hypoxia, WT mice were characterized by (i) AQP4 upregulation, (ii) increased levels of VEGF, HIF-1α, iNOS and NO, (iii) pathological angiogenesis as determined by engorged retinal tufts and (iv) dysfunctional electroretinogram (ERG). AQP4 deletion prevents VEGF, iNOS and NO upregulation in response to hypoxia thus leading to reduced retinal damage although in the presence of high levels of HIF-1α. In AQP4 KO mice, HBS demethylation in response to the beginning of hypoxia is lower than in WT mice reducing the binding of HIF-1α to the VEGF gene promoter. [HYP] We conclude that in the absence of AQP4, an impaired HBS demethylation prevents HIF-1 binding to the   VEGF   gene promoter and the relative   VEGF   transactivation, reducing the   VEGF  -induced retinal damage in   response to hypoxia  .\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29859,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Analyze the relationship between the given premise and hypothesis. Categorize it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Adiponectin is secreted by adipose cells and mimics many metabolic actions of insulin. However, mechanisms by which adiponectin acts are poorly understood. The vascular action of insulin to stimulate endothelial production of nitric oxide (NO), leading to vasodilation and increased blood flow is an important component of insulin-stimulated whole body glucose utilization. Therefore, we hypothesized that adiponectin may also stimulate production of NO in endothelium. Bovine aortic endothelial cells in primary culture loaded with the NO-specific fluorescent dye 4,5-diaminofluorescein diacetate (DAF-2 DA) were treated with lysophosphatidic acid (LPA) (a calcium-releasing agonist) or adiponectin (10 microg/ml bacterially produced full-length adiponectin). LPA treatment increased production of NO by approximately 4-fold. Interestingly, adiponectin treatment significantly increased production of NO by approximately 3-fold. Preincubation of cells with wortmannin (phosphatidylinositol 3-kinase inhibitor) blocked only adiponectin- but not LPA-mediated production of NO. Using phospho-specific antibodies, we observed that either adiponectin or insulin treatment (but not LPA treatment) caused phosphorylation of both Akt at Ser473 and endothelial nitric-oxide synthase (eNOS) at Ser1179 that was inhibitable by wortmannin. We next transfected bovine aortic endothelial cells with dominant-inhibitory mutants of Akt (Akt-AAA) or AMP-activated protein kinase (AMPK) (AMPKK45R). Neither mutant affected production of NO in response to LPA treatment. Importantly, only AMPKK45R, but not Akt-AAA, caused a significant partial inhibition of NO production in response to adiponectin. Moreover, AMPK-K45R inhibited phosphorylation of eNOS at Ser1179 in response to adiponectin but not in response to insulin. [HYP] We conclude that   NO   has novel vascular actions to directly stimulate production of   adiponectin   in endothelial cells using phosphatidylinositol 3-kinase-dependent pathways involving phosphorylation of eNOS at Ser1179 by AMPK.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29860,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] A prospective study was undertaken to evaluate pudendal neuropathy in fecal incontinence. Fifty-two patients (38 women and 14 men) with fecal incontinence underwent manometric and electromyographic evaluation (measurement of pudendal nerve terminal motor latency [PNTML] and sphincter muscle mapping). The average age of all patients was 54 +/- 17 years. Fifty-two percent (27/52) were found to have a pudendal neuropathy (PNTML > 2.1 milliseconds). Seventeen of these 27 patients (63 percent) had a bilateral pudendal neuropathy. Patients with a pudendal neuropathy were older than those without a neuropathy (63.7 years vs. 51.9 years; P = 0.01). Women were significantly more likely than men to have a pudendal neuropathy (P = 0.03). Nine patients had an anatomic sphincter defect identified, and six of these (67 percent) had a neuropathy; 4/6 (67 percent) had a bilateral pudendal neuropathy. In the 43 patients who did not have an anatomic sphincter defect, there was no difference in resting pressure (69 mmHg vs. 60 mmHg; P = 0.4) or maximum voluntary contraction (95 mmHg vs. 86 mmHg; P = 0.5) when patients without a neuropathy were compared with those with a neuropathy. Patients with a pudendal neuropathy had a shorter sphincter length than those without a neuropathy (3.0 cm vs. 3.9 cm; P = 0.01). Bilateral pudendal neuropathy tended to occur more frequently in women (P = 0.08) and was not associated with poorer resting pressure, maximum voluntary contraction, or shorter sphincter length. [HYP] We conclude that   pudendal neuropathy   is a common cause of   fecal incontinence  , particularly in older women, and frequently occurs in association with a sphincter defect.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29861,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': \"[PRE] The glycogen-associated regulatory subunit of protein phosphatase-1 (PP-1G) plays a major role in insulin-stimulated glycogen synthesis and thus the regulation of nonoxidative glucose disposal in skeletal muscle. In a general population of Caucasians a polymorphism at codon 905 of PP-1G from an aspartate to tyrosine has been reported to be associated with insulin resistance and hypersecretion. In this report functional studies were performed on rat skeletal muscle L6 cells stably transfected with an Asp905Tyr mutant PP-1G to evaluate the impact of this mutation on cellular responsiveness to insulin and cAMP. Although transfection resulted in a 3-fold increase in mutant PP-1G subunit expression, basal and insulin-stimulated PP-1 catalytic activities were decreased when compared with L6 cells transfected with wild-type PP-1G. The Asp905Tyr mutation resulted in an increase in cellular sensitivity to cAMP agonist, resulting in an inhibition of insulin's stimulatory effect on glycogen synthesis. More importantly, low concentrations of (Bu)2cAMP completely reversed insulin's stimulatory effects on glycogen synthesis when added to insulin-treated cells expressing mutant PP-1G. This was due to a rapid activation of glycogen phosphorylase a and a simultaneous inactivation of glycogen synthase via cAMP-mediated reductions in insulin-stimulated PP-1 catalytic activities. [HYP] We conclude that an Asp905Tyr mutation of   insulin   is accompanied by a relative increase in sensitivity to cAMP agonists as well as a diminished capacity of the mutant   insulin   to effectively mediate the inhibitory effects of   PP-1G   on glycogen breakdown via PP-1 activation.\\nOUTPUT:\",\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29862,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': \"[PRE] 5'-AMP-activated protein kinase (AMPK) has been suggested to be a 'metabolic master switch' regulating various aspects of muscle glucose and fat metabolism. In isolated rat skeletal muscle, glucose suppresses the activity of AMPK and in human muscle glycogen loading decreases exercise-induced AMPK activation. We hypothesized that oral glucose ingestion during exercise would attenuate muscle AMPK activation. Nine male subjects performed two bouts of one-legged knee-extensor exercise at 60% of maximal workload. The subjects were randomly assigned to either consume a glucose containing drink or a placebo drink during the two trials. Muscle biopsies were taken from the vastus lateralis before and after 2 h of exercise. Plasma glucose was higher (6.0 +/- 0.2 vs. 4.9 +/- 0.1 mmol L-1, P < 0.001), whereas glycerol (44.8 +/- 7.8 vs. 165.7 +/- 22.3 micromol L-1), and free fatty acid (169.3 +/- 9.5 vs. 1161 +/- 144.9 micromol L-1) concentrations were lower during the glucose compared to the placebo trial (both P < 0.001). Calculated fat oxidation was lower during the glucose trial (0.17 +/- 0.02 vs. 0.25 +/- 0.03 g min-1, P < 0.001). Activation of alpha2-AMPK was attenuated in the glucose trial compared to the placebo trial (0.24 +/- 0.07 vs. 0.46 +/- 0.14 pmol mg-1 min-1, P = 0.03), whereas the alpha1-AMPK activity was not different between trials or affected by exercise. AMPK and the downstream target of AMPK, acetyl-CoA carboxylase-beta, were phosphorylated as a response to exercise, but neither was significantly different between the two trials. [HYP] We conclude that oral   alpha2-AMPK   ingestion attenuates the exercise-induced activation of   glucose  , bringing further support for a fuel-sensing role of AMPK in skeletal muscle.\\nOUTPUT:\",\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29863,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Analyze the relationship between the given premise and hypothesis. Categorize it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] A prospective study was undertaken to evaluate pudendal neuropathy in fecal incontinence. Fifty-two patients (38 women and 14 men) with fecal incontinence underwent manometric and electromyographic evaluation (measurement of pudendal nerve terminal motor latency [PNTML] and sphincter muscle mapping). The average age of all patients was 54 +/- 17 years. Fifty-two percent (27/52) were found to have a pudendal neuropathy (PNTML > 2.1 milliseconds). Seventeen of these 27 patients (63 percent) had a bilateral pudendal neuropathy. Patients with a pudendal neuropathy were older than those without a neuropathy (63.7 years vs. 51.9 years; P = 0.01). Women were significantly more likely than men to have a pudendal neuropathy (P = 0.03). Nine patients had an anatomic sphincter defect identified, and six of these (67 percent) had a neuropathy; 4/6 (67 percent) had a bilateral pudendal neuropathy. In the 43 patients who did not have an anatomic sphincter defect, there was no difference in resting pressure (69 mmHg vs. 60 mmHg; P = 0.4) or maximum voluntary contraction (95 mmHg vs. 86 mmHg; P = 0.5) when patients without a neuropathy were compared with those with a neuropathy. Patients with a pudendal neuropathy had a shorter sphincter length than those without a neuropathy (3.0 cm vs. 3.9 cm; P = 0.01). Bilateral pudendal neuropathy tended to occur more frequently in women (P = 0.08) and was not associated with poorer resting pressure, maximum voluntary contraction, or shorter sphincter length. [HYP] We conclude that   fecal incontinence   is a common cause of   pudendal neuropathy  , particularly in older women, and frequently occurs in association with a sphincter defect.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29864,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] In this study, we aimed to compare bone calcium system changes from children with diabetic ketoacidosis or acute metabolic acidosis due to dehydration to find out the relative contribution of metabolic acidosis and diabetes-related factors on expected negative calcium balance. We studied a set of non-invasive parameters of bone remodeling in 16 children with diabetic ketoacidosis due to new onset type 1 diabetes and 25 children with acute metabolic acidosis due to dehydration complicating acute gastroenteritis before and after the correction of acidosis. The two groups of subjects were matched for age, sex, pubertal status, and degree of metabolic acidosis and dehydration. A group of 18 age and sex-matched healthy children served as the control group. Plasma ionized calcium levels were increased in both groups, significantly more so in diabetic ketoacidosis. While osteoblastic markers, osteocalcin and alkaline phosphatase, were depressed to a comparable degree in both groups, urinary calcium/creatinine ratio and hydroxyproline excretion were significantly greater in diabetic ketoacidosis. No significant changes in calcitrophic hormone (intact PTH, calcitonin, 25-hydroxy vitamin D3) levels were observed. All study parameters except for serum phosphate levels behaved in parallel in both clinical conditions, and abnormalities disappeared with the correction of acidosis except for IGF-1, which remained low in diabetic subjects. [HYP] In conclusion, our results suggest that, in diabetic ketoacidosis, the observed severe negative   calcium   balance occurred through diminished bone formation mediated by metabolic   acidosis   per se and increased bone mineral dissolution and bone resorption because of severe insulin deficiency and secondarily via metabolic   acidosis  .\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29865,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] In order to assess the role of dietary sodium with or without chloride on the development of 2 kidney, 1 clip renovascular hypertension, 49 male Sprague-Dawley rats were fed 3 different diets for 4 weeks after clipping: ad libitum sodium chloride, sodium citrate or sodium-free diet. Sham operated rats were used as control. The final conscious systolic arterial pressure was similar in all hypertensive groups regardless of diet. No change in cardiac index occurred in clipped animals whereas total peripheral resistance raised to a similar extent. [HYP] In conclusion,   glucose   restriction did not prevent   hypertension  .\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29866,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] mTOR complex 1 (mTORC1) and p70 S6 kinase (S6K1) are both involved in the development of obesity-linked insulin resistance. Recently, we showed that the S6K1 inhibitor PF-4708671 (PF) increases insulin sensitivity. However, we also reported that PF can increase glucose metabolism even in the absence of insulin in muscle and hepatic cells. Here we further explored the potential mechanisms by which PF increases glucose metabolism in muscle and liver cells independent of insulin. Time course experiments revealed that PF induces AMP-activated protein kinase (AMPK) activation before inhibiting S6K1. However, PF-induced glucose uptake was not prevented in primary muscle cells from AMPK α1/2 double KO (dKO) mice. Moreover, PF-mediated suppression of hepatic glucose production was maintained in hepatocytes derived from AMPK α1/2-dKO mice. Remarkably, PF could still reduce glucose production and activate AMPK in hepatocytes from S6K1/2 dKO mice. Mechanistically, bioenergetics experiments revealed that PF reduces mitochondrial complex I activity in both muscle and hepatic cells. The stimulatory effect of PF on glucose uptake was partially reduced by expression of the Saccharomyces cerevisiae NADH:ubiquinone oxidoreductase in L6 cells. These results indicate that PF-mediated S6K1 inhibition is not required for its effect on insulin-independent glucose metabolism and AMPK activation. [HYP] We conclude that, although   PF   rapidly activates   adenylate cyclase-cyclic adenosine monophosphate  , its ability to acutely increase glucose uptake and suppress glucose production does not require   adenylate cyclase-cyclic adenosine monophosphate   activation.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29867,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': \"[PRE] Accumulation of intracellular lipid by pancreatic islet beta-cells has been proposed to inhibit normal glucose-regulated insulin secretion ('glucolipotoxicity'). In the present study, we determine whether over-expression in rat islets of the lipogenic transcription factor SREBP1c (sterol-regulatory-element-binding protein-1c) affects insulin release, and whether changes in islet lipid content may be reversed by activation of AMPK (AMP-activated protein kinase). Infection with an adenovirus encoding the constitutively active nuclear fragment of SREBP1c resulted in expression of the protein in approx. 20% of islet cell nuclei, with a preference for beta-cells at the islet periphery. Real-time PCR (TaqMan) analysis showed that SREBP1c up-regulated the expression of FAS (fatty acid synthase; 6-fold), acetyl-CoA carboxylase-1 (2-fold), as well as peroxisomal-proliferator-activated receptor-gamma (7-fold), uncoupling protein-2 (1.4-fold) and Bcl2 (B-cell lymphocytic-leukaemia proto-oncogene 2; 1.3-fold). By contrast, levels of pre-proinsulin, pancreatic duodenal homeobox-1, glucokinase and GLUT2 (glucose transporter isoform-2) mRNAs were unaltered. SREBP1c-transduced islets displayed a 3-fold increase in triacylglycerol content, decreased glucose oxidation and ATP levels, and a profound inhibition of glucose-, but not depolarisation-, induced insulin secretion. Culture of islets with the AMPK activator 5-amino-4-imidazolecarboxamide riboside decreased the expression of the endogenous SREBP1c and FAS genes, and reversed the effect of over-expressing active SREBP1c on FAS mRNA levels and cellular triacylglycerol content. [HYP] We conclude that   insulin secretion   over-expression, even when confined to a subset of beta-cells, leads to defective   SREBP1c   from islets and may contribute to some forms of Type II diabetes.\\nOUTPUT:\",\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29868,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the hypothesis contradict the premise or is it entailed by it? If neither, classify it as neutral.',\n",
       "  'input': '[PRE] Insulin-like growth factor binding proteins (IGFBPs) may participate in regulating ovarian function by modifying effects of insulin-like growth factors (IGFs) or by directly affecting ovarian steroidogenesis in both normal and pathological circumstances. The latter include hyperinsulinemic insulin resistant states, such as polycystic ovary syndrome. We examined regulation of IGFBP-1 production in human granulosa cells by insulin and IGF-I. The cells were obtained during in vitro fertilization, plated in McCoy-5A tissue culture medium supplemented with 10% fetal calf serum (10(5) cells/0.5 mL), and incubated at 37 C, 90% humidity, 5% CO2 for 48 h. After additional 24 h incubation without fetal calf serum, 1, 10, or 100 ng/mL of insulin or IGF-I were added with or without 2 h preincubation with 10 micrograms/mL monoclonal anti insulin receptor antibody IR-47-9. After 48 h incubation with insulin or IGF-I, the medium was collected and IGFBP-1 and progesterone concentrations were measured, using kits from Diagnostic Systems Laboratories, Webster, TX. Progesterone concentration ranged between 50-100 ng/mL/10(5) cells, without consistent stimulatory effect of either insulin or IGF-I. Control cells produced 7.0 +/- 1.7 ng/mL of IGFBP-1. Incubation with 1 or 10 ng/mL of insulin resulted in culture medium IGFBP-1 concentrations of 7.1 +/- 1.3 ng/mL and 5.4 +/- 0.7 ng/mL, respectively (P = NS). Incubation with 100 ng/mL of insulin reduced IGFBP-1 culture medium concentration to 1.6 +/- 0.3 ng/mL (P < 0.01, compared with controls). 1, 10, and 100 ng/mL of IGF-I inhibited IGFBP-1 concentrations in the conditioned culture medium to 1.3 +/- 0.3 ng/mL, 0.4 +/- 0.1 ng/mL and 0.3 +/- 0.1 ng/mL, respectively (P < 0.01, compared with controls). Preincubation with antiinsulin receptor antibody IR-47-9 alleviated inhibitory effect of insulin, but not of IGF-I on IGFBP-1 production. After preincubation with IR-47-9, IGFBP-1 culture medium concentrations were 5.9 +/- 0.8 ng/mL, 4.9 +/- 1.2 ng/mL, and 4.8 +/- 1.3 ng/mL for 1, 10, and 100 ng/mL of insulin, respectively. The latter number was significantly higher than IGFBP-1 concentration in the medium collected from cells incubated with 100 ng/mL of insulin without IR-47-9 (1.6 +/- 0.3 ng/mL, P < 0.01) and not significantly different from the control cells. For cells preincubated with IR-47-9 and then incubated with 1, 10, or 100 ng/mL of IGF-I, the IGFBP-1 conditioned culture medium concentrations were 1.7 +/- 0.1 ng/mL, 0.5 +/- 0.2 ng/mL, and 0.3 +/- 0.1 ng/mL, respectively. None of these were significantly different from the IGFBP-1 concentrations in the medium collected from cells incubated with the respective concentrations of IGF-I without preincubation with IR-47-9. [HYP] We conclude that 1) both   insulin   and IGF-I inhibit   IGFBP-1   production by cultured human granulosa cells; 2) IGF-I is a more potent inhibitor of   IGFBP-1   production than   insulin  ; 3) in the range of hormone concentrations tested,   insulin   exerts its inhibitory effect on   IGFBP-1   production via   insulin   receptor, while IGF-I appears to exert its effect via another receptor.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29869,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Analyze the relationship between the given premise and hypothesis. Categorize it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Dietary iron deficiency in rats results in increased blood glucose turnover and recycling. We measured the rates of glucose production in isolated hepatocytes from iron-sufficient (Fe+) and iron-deficient (Fe-) rats to assess the intrinsic capacity of the Fe- liver to carry out gluconeogenesis. Low-iron and control diets were given to 21-day-old female rats. After 4-5 wk, hemoglobin concentrations averaged 4.1 g/dl in the Fe- and 14.3 g/dl in the Fe+ animals. In the hepatocytes from Fe- rats, there was a 35% decrease in the rate of glucose production from 1 mM pyruvate + 10 mM lactate, a 48% decrease from 0.1 mM pyruvate + 1 mM lactate, a 39% decrease from 1 mM alanine, and a 48% decrease from 1 mM glycerol. The addition of 5 microM norepinephrine or 0.5 microM glucagon to the incubation media produced stimulatory effects on hepatocytes from both Fe- and Fe+ rats, resulting in the maintenance of an average difference of 38% in the rates of gluconeogenesis between the two groups. Studies on isolated liver mitochondria and cytosol revealed alpha-glycerophosphate-cytochrome c reductase and phospho(enol)pyruvate carboxykinase activities to be decreased by 27% in Fe- rats. [HYP] We conclude that because severe dietary   pentobarbital   deficiency decreases   gluconeogenesis   in isolated rat hepatocytes, the increased   gluconeogenesis   demonstrated by Fe- rats in vivo is attributable to increased availability of gluconeogenic substrates and upregulation of the pathway.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29870,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] 5-Lipoxygenase (5-LOX) is a key enzyme catalyzing arachidonic acid to form leukotrienes. We have reported that ischemic-like injury activates 5-LOX in PC12 cells; however, the mechanisms are unknown. To determine whether ischemic-like injury activates 5-LOX mediated by oxidative stress through the p38 MAPK pathway, we transfected GFP-5-LOX into PC12 cells and induced ischemic-like injury by oxygen-glucose deprivation (OGD). We found that the transfected GFP-5-LOX was localized primarily in the nuclei and translocated to the nuclear envelope after OGD/recovery reaching a maximum 2 hr after a 2-hr exposure to OGD. The nonselective 5-LOX inhibitor caffeic acid, 5-LOX-activating protein inhibitor MK886, and selective 5-LOX inhibitor zileuton attenuated the cell injury and reduced the production of 5-LOX products, cysteinyl leukotrienes, after OGD/recovery. However, only caffeic acid inhibited OGD/recovery-induced 5-LOX translocation. OGD/recovery also increased reactive oxygen species (ROS), which was inhibited by caffeic acid only. Hydrogen peroxide, an exogenous ROS, evoked similar cell injury and 5-LOX translocation, and the inhibitors had effects on the changes after H(2)O(2) similar to those after OGD/recovery. Both OGD/recovery and H(2)O(2) increased the phosphorylated p38 MAPK level, which was inhibited by caffeic acid and the ROS scavenger edaravone, but not by MK886 or zileuton. Moreover, SB203580 (a p38 MAPK inhibitor) and edaravone inhibited the cell injury and 5-LOX translocation induced by OGD/recovery and H(2)O(2). [HYP] Thus, we conclude that OGD/recovery-induced ischemic-like injury induces   5-LOX   activation, which is not mediated by oxidative stress through activating the   p38 MAPK   pathway.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29871,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Analyze the relationship between the given premise and hypothesis. Categorize it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] 1. The effects of glucosamine concentration on the size of the lactate pool, on the levels of ATP, ADP, AMP and on the radioactivity incorporation from [1-14-C] glucosamine into lactate, N-acetylglucosamine and glucosamine-6-P were studied using whole bovine retinas. 2. The radioactive lactate, evaluated in relation to glucosamine molarity, after a modest initial increase, diminishes significantly. On the contrary the N-acetyl [1-14-C] glucosamine, the [1-14-C] glucosamine-6-P and, consequently, also the [1-14-C] glucosamine-6-P/[-14-C] lactate ratio increase with glucosamine molarity. 3. The retinal content of ATP shows a modest increment after incubation with low concentrations of D-glucosamine (0.5--2.0 mM) and a remarkable fall at higher concentrations. 4. Using retinal homogenates D-glucosamine clearly lowers the lactate production from glucose, glucose-6-P and fructose-1, 6-P2. 5. D-Glucosamine acts as an inhibitor of retinal glyceraldehyde-3-P dehydrogenase and lactate dehydrogenase by decreasing the initial velocity of these reactions. 6. [HYP] It is concluded that   D-glucosamine   causes a reduction in the   lactate   production, by inhibiting two enzymes of the glycolytic pathway: glyceraldehyde-3-P dehydrogenase and   lactate   dehydrogenase.\\nOUTPUT:',\n",
       "  'output': 'entailment',\n",
       "  '__index_level_0__': 29872,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] The stimulatory effects of insulin on de novo lipogenesis (DNL) in the liver, where it is an important contributor to non-alcoholic fatty liver disease (NAFLD), hepatic and systemic insulin resistance, is strong and well established. In contrast, insulin plays only a minor role in DNL in adipose tissue. The reason why insulin stimulates DNL more in liver than in fat is not known but may be due to differential regulation of the transcription and post-translational activation of sterol regulatory element binding proteins (SREBPs). To test this hypothesis, we have examined effects of insulin on activation of SREBP-1c in liver of rats and in adipose tissue of rats and human subjects. Liver and epidydimal fat were obtained from alert rats and subcutaneous adipose tissue from human subjects in response to 4 h euglycemic-hyperinsulinemic clamps. Here we show that acutely raising plasma insulin levels in rats and humans increased SREBP-1 mRNA comparably 3-4 fold in rat liver and rat and human adipose tissue, but increased post-translational activation of SREBP-1c only in rat liver, while decreasing it in adipose tissue. These differential effects of insulin on SREBP-1c activation in liver and adipose tissue were associated with robust changes in the opposite direction of INSIG-1 and to a lesser extent of INSIG-2 mRNA and proteins. [HYP] We conclude that these findings support the hypothesis that   insulin   stimulated activation of   low density lipoproteins   in the liver, at least in part, by suppressing INSIG-1 and -2, whereas in adipose tissue, an increase in INSIG-1 and -2 prevented   low density lipoproteins   activation.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29873,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the premise logically support the hypothesis? Answer as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Insulin (0.1 microM) and 1 microM epinephrine each increased the uptake and phosphorylation of 2-deoxyglucose by the perfused rat heart by increasing the apparent Vmax without altering the Km. Isoproterenol (10 microM), 50 microM methoxamine and 10 mM CaCl2 also increased uptake. Lowering of the perfusate Ca2+ concentration from 1.27 to 0.1 mM Ca2+, addition of the Ca2+ channel blocker nifedipine (1 microM) or addition of 1.7 mM EGTA decreased the basal rate of uptake of 2-deoxyglucose and prevented the stimulation due to 1 microM epinephrine. Stimulation of 2-deoxyglucose uptake by 0.1 microM insulin was only partly inhibited by Ca2+ omission, nifedipine or 1 mM EGTA. Half-maximal stimulation of 2-deoxyglucose uptake by insulin occurred at 2 nM and 0.4 nM for medium containing 1.27 and 0.1 mM Ca2+, respectively. Maximal concentrations of insulin (0.1 microM) and epinephrine (1 microM) were additive for glucose uptake and lactate output but were not additive for uptake of 2-deoxyglucose. Half-maximal stimulation of 2-deoxyglucose uptake by epinephrine occurred at 0.2 microM but maximal concentrations of epinephrine (e.g., 1 microM) gave lower rates of 2-deoxyglucose uptake than that attained by maximal concentrations of insulin. The addition of insulin increased uptake of 2-deoxyglucose at all concentrations of epinephrine but epinephrine only increased uptake at sub-maximal concentrations of insulin. The role of Ca2+ in signal reversal was also studied. Removal of 1 microM epinephrine after a 10 min exposure period resulted in a rapid return of contractility to basal values but the rate of 2-deoxyglucose uptake increased further and remained elevated at 20 min unless the Ca2+ concentration was lowered to 0.1 mM or nifedipine (1 microM) was added. Similarly, removal of 0.1 microM insulin after a 10 min exposure period did not affect the rate of 2-deoxyglucose uptake, which did not return to basal values within 20 min unless the concentration of Ca2+ was decreased to 0.1 mM. Insulin-mediated increase in 2-deoxyglucose uptake at 0.1 mM Ca2+ reversed upon hormone removal. [HYP] It is concluded that catecholamines mediate a   Ca2  +-dependent decrease in   2-deoxyglucose   transport from either alpha or beta receptors.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29874,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] We have studied the pharmacokinetics and the effects of BIM 23,014 (BIM), a new, long-acting octapeptide somatostatin analogue, on basal and stimulated GH secretion in normal men. BIM 250 micrograms sc significantly reduced a GHRH-induced increase in plasma GH. The continuous sc administration of BIM for 24 h dramatically blunted spontaneous GH secretion; 2000 and 3000 micrograms daily reduced GH secretion to a greater extent than 1000 micrograms daily. During these experiments a significant negative correlation (r - 0.66) was found between plasma GH and BIM levels. Acute sc administration of 1000 micrograms BIM significantly reduced the rise in plasma GH observed in the second part of the oral glucose tolerance test. Plasma BIM levels peaked around 30 min, and the elimination half life was 90 min. Plasma BIM levels were below 1 ng/ml 6 h after the injection of 1000 micrograms BIM, and at that time GH started to rise again. [HYP] We conclude that   BIM   23,014 250 to 1000 micrograms sc is able to reduce the plasma GH response to GHRH or to the fall in glucose following an oral glucose tolerance test; a constant infusion of   BIM  , in doses 1000 micrograms daily, dramatically suppresses spontaneous   GH secretion  ; 6 micrograms/day by chronic subcutaneous infusion was the most effective dose of   BIM   in the suppression of   GH secretion  , and was associated only with minor adverse effects.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29875,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Classify the relationship between the premise and the hypothesis into one of three categories: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] In this study, we examined the effect of phosphorylation on GLUT-4 function in isolated rat adipocytes. Adipocytes labeled with 32P for 2 h were incubated with parathyroid hormone (PTH) (20 ng/ml) for 60 min and then exposed to insulin (25 ng/ml) for an additional 30 min. 32P-GLUT-4 was immunoprecipitated from the plasma membrane and low density microsomal fractions, and its degree of phosphorylation was determined by autoradiography and densitometry. Results were expressed as 32P-GLUT-4 specific activity (phosphorylation/unit of protein). GLUT-4 intrinsic activity was measured using [14C]2-deoxyglucose uptake in plasma membrane vesicles. PTH significantly increased GLUT-4 phosphorylation and eliminated the insulin-stimulated dephosphorylation of GLUT-4. Western blotting revealed normal distribution of GLUT-4 before and after insulin stimulation in control and PTH-treated cells, suggesting that phosphorylation of GLUT-4 does not interfere with its recruitment to the plasma membrane. In contrast, intrinsic activity of phosphorylated GLUT-4 was significantly reduced (p < 0.01). Preincubation of adipocytes with calcium channel blocker (nitrendipine) and cyclic AMP antagonist (RpcAMP) restored GLUT-4 intrinsic activity in the PTH-treated cells. In several experiments, GLUT-4 was phosphorylated in vitro in plasma membrane vesicles isolated from normal adipocytes exposed to insulin. This in vitro phosphorylation reduced GLUT-4 intrinsic activity by approximately 35% (p < 0.01). [HYP] We conclude that phosphorylation of   insulin   significantly impairs the ability of   GLUT-4   to stimulate its intrinsic activity.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29876,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166) has a structure which differs from those of other known blood glucose-lowering agents including sulfonylureas. It has been shown that oral administration of A-4166 exerts blood glucose-lowering effects in animal in vivo studies. In the present study, we investigated the effects of A-4166 on insulin and glucagon secretion at several glucose concentrations using isolated perfused rat pancreas preparations. Both 3.0 and 30 mumol/l A-4166 significantly stimulated insulin secretion as compared with basal levels at glucose concentrations of 8.0 and 11.0 mmol (p < 0.01 and p < 0.05, respectively). In contrast, glucagon secretion was not affected by administration of A-4166 up to 30 mumol/l at these glucose concentrations. At a glucose concentration of 5.6 mmol/l, neither 0.3 nor 3.0 mumol/l A-4166 produced significant changes in insulin and glucagon secretion. However, A-4166 at 30 mumol/l significantly stimulated insulin secretion and inhibited glucagon secretion as compared with basal levels (p < 0.01 and p < 0.01, respectively). [HYP] We conclude that   insulin secretion   at 3.0 and 30 mumol/l directly stimulates   A-4166   but has little effect on glucagon secretion in isolated perfused rat pancreas at glucose concentrations of 8.0 and 11.0 mmol/l.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29877,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Given a premise and a hypothesis, determine their relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Renal calcium binding protein (CaBP), a vitamin D-dependent protein of 28,000 Mr, may be involved in calcium transport by cells of the renal tubule. The streptozotocin-diabetic rat is hypercalciuric and shows markedly decreased concentration of 1,25-dihydroxycholecalciferol [1,25-(OH)2D3] in serum and of CaBP in small intestine. To examine the relationship of renal CaBP in diabetes to 1,25-(OH)2D3 and urinary calcium excretion, renal CaBP, serum 1,25-(OH)2D3, and urinary calcium were measured in control, diabetic, and insulin-treated diabetic rats. Treatment of the diabetic rat with insulin decreased urinary calcium excretion and elevated 1,25-(OH)2D3 toward normal. Renal CaBP was found to be the same in controls and diabetics despite a tenfold difference in concentration of 1,25-(OH)2D3 in serum, and to be unaffected by insulin treatment, which elevated 1,25-(OH)2D3 by a factor of 7 above untreated diabetics. [HYP] We conclude that in the streptozotocin-diabetic rat, renal   CaBP   is unaffected by serum 1,25\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29878,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Evaluate if the hypothesis can be inferred from the premise. Label it as entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] 1. The effects of glucosamine concentration on the size of the lactate pool, on the levels of ATP, ADP, AMP and on the radioactivity incorporation from [1-14-C] glucosamine into lactate, N-acetylglucosamine and glucosamine-6-P were studied using whole bovine retinas. 2. The radioactive lactate, evaluated in relation to glucosamine molarity, after a modest initial increase, diminishes significantly. On the contrary the N-acetyl [1-14-C] glucosamine, the [1-14-C] glucosamine-6-P and, consequently, also the [1-14-C] glucosamine-6-P/[-14-C] lactate ratio increase with glucosamine molarity. 3. The retinal content of ATP shows a modest increment after incubation with low concentrations of D-glucosamine (0.5--2.0 mM) and a remarkable fall at higher concentrations. 4. Using retinal homogenates D-glucosamine clearly lowers the lactate production from glucose, glucose-6-P and fructose-1, 6-P2. 5. D-Glucosamine acts as an inhibitor of retinal glyceraldehyde-3-P dehydrogenase and lactate dehydrogenase by decreasing the initial velocity of these reactions. 6. [HYP] It is concluded that   lactate   causes a reduction in the   D-glucosamine   production, by inhibiting two enzymes of the glycolytic pathway: glyceraldehyde-3-P dehydrogenase and   D-glucosamine   dehydrogenase.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29879,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the hypothesis contradict the premise or is it entailed by it? If neither, classify it as neutral.',\n",
       "  'input': '[PRE] To study the mechanism of altered glucose homeostasis in hyperthyroidism, the effects of a 2-h physiological infusion of epinephrine (0.05 microgram/kg x min) or glucagon (3 ng/kg x min) on glucose kinetics and glucoregulatory hormones were determined in nine normal subjects and five untreated hyperthyroid patients. Under basal conditions, hyperthyroid patients exhibited increased glucose turnover (2.2 +/- 0.09 vs. 1.62 +/- 0.1 mg/kg x min in normals), a modest hyperglycemia, hyperglucagonemia, and normal levels of plasma insulin, cortisol, and GH. In normal subjects, epinephrine induced a sustained increase in plasma glucose (45 mg/dl), reflecting a transient 100% rise in glucose output, and a sustained 28% decrease in glucose clearance. In hyperthyroid patients, the rise in plasma glucose was significantly lower (22 mg/dl) due to a smaller but sustained increase in glucose output (45%) and the lack of a fall in glucose clearance. Plasma insulin rose to a peak 80% higher than baseline in hyperthyroid patients, whereas in normals it initially declined and then rose to levels 50% higher than basal. Plasma glucagon displayed only minor changes in both groups. Glucagon infusion induced similar increments in plasma glucagon levels in the two groups (120-150 pg/ml). Insulin, cortisol, and GH remained unchanged. Plasma glucose rose by 4 mg/dl in hyperthyroid patients and by 11 mg/dl in normal subjects. The net increments were significantly lower in the former group (P < 0.05-0.01). Glucose output increased by 40% in normals and returned to baseline by 75 min, whereas it increased by only 15% in hyperthyroid patients and remained above baseline until the end of the infusion. Glucagon had no appreciable effect on glucose clearance in either group. [HYP] We conclude that hyperthyroidism is characterized by 1) increased   epinephrine   turnover and hyperglucagonemia in the basal state, 2) a reduced glucemic response to physiological infusions of   glucose   and glucagon, 3) a sustained response of   epinephrine   production to   glucose   and glucagon, and 4) the lack of   glucose  -induced suppression of   epinephrine   clearance, presumably due to an exaggerated response of insulin secretion to   glucose  .\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29880,\n",
       "  'model_output': 'entailment'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] Perfused hindlimb muscle from fed adrenalectomized rats accumulated more 2-deoxyglucose at submaximal concentrations of insulin in comparison to muscle from fed normal rats. However, in the fasted state, insulin-stimulated 2-deoxyglucose uptake was largely inhibited by adrenalectomy. Basal 2-deoxyglucose uptake did not differ between fed and fasted normal or adrenalectomized rats. The changes in insulin effects caused by adrenalectomy were due to altered hexose transport as shown by measurements of 3-O-methylglucose uptake and of intracellular free and phosphorylated 2-deoxyglucose. Muscles of fasted normal and fed or fasted adrenalectomized rats showed higher basal glycogen synthase --glucose-6-P/+glucose-6-P activity ratios than those of fed normal rats probably because of decreased glycogen content. However, muscles from fed or fasted adrenalectomized rats did not show any alterations in insulin effects on the activity ratio and half-maximal activation constant (A0.5) for glucose-6-P of glycogen synthase. [HYP] In conclusion, in the fasted state,   insulin   -stimulated   hexose transport   is inhibited by adrenalectomy.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29881,\n",
       "  'model_output': 'contrary_to'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'For the given premise and hypothesis, determine their logical relationship: entailment, contradiction, or neutral.',\n",
       "  'input': '[PRE] The current controversy concerning the role of glucagon in the pathogenesis of diabetes is reviewed. The traditional \"unihormonal abnormality concept,\" namely, that all of the metabolic derangements of diabetes are the direct consequence of deficient insulin secretion or activity, and the newer so-called bihormonal abnormality hypothesis, proposing that the fullblown diabetic syndrome requires, in addition to the insulin abnormality, a relative glucagon excess, are scrutinized. The relationship of insulin deficiency to the A-cell malfunction of diabetes, the conflicting evidence concerning the essential role of glucagon in mediating the marked overproduction of glucose and ketones in severe insulin deficiency and the contribution of glucagon to the endogenous hyperglycemia of diabetics without insulin deficiency are examined. Finally, the possibility that therapeutic suppression of diabetic hyperglucagonemia may make possible better control of hyperglycemia than is presently attainable by conventional therapeutic methods is considered. [HYP] It is concluded that (1) although insulin lowers   PI(4,5)P2   levels, restoration to normal of the A-cell dysfunction of diabetes requires that plasma insulin levels vary appropriately with glycemic change; (2) that   PI(4,5)P2   mediates the severe endogenous   hyperglycemia   and hyperketonemia observed in the absence of insulin; (3) that in diabetics in whom insulin is present but relatively fixed an increase in   PI(4,5)P2   causes   hyperglycemia   and glycosuria; and (4) that   PI(4,5)P2   suppression could be a potentially useful adjunct to conventional antihyperglycemic treatment of diabetics.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29882,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Read the given premise and hypothesis. Decide if the hypothesis logically follows from the premise.',\n",
       "  'input': '[PRE] Glucose utilization increases markedly in the normal dog during stress induced by the intracerebroventricular (ICV) injection of carbachol. To determine the extent to which insulin, glucagon, and selective (alpha/beta)-adrenergic activation mediate the increment in glucose metabolic clearance rate (MCR) and glucose production (R(a)), we used five groups of normal mongrel dogs: 1) pancreatic clamp (PC; n = 7) with peripheral somatostatin (0.8 microg x kg(-1) x min(-1)) and intraportal replacement of insulin (1,482 +/- 84 pmol x kg(-1) x min(-1)) and glucagon (0.65 ng x kg(-1) x min(-1)) infusions; 2) PC plus combined alpha (phentolamine)- and beta (propranolol)-blockade (7 and 5 microg x kg(-1) x min(-1), respectively; alpha+beta; n = 5); 3) PC plus alpha-blockade (alpha; n = 6); 4) PC plus beta-blockade (beta; n = 5); and 5) a carbachol control group without PC (Con; n = 10). During ICV carbachol stress (0-120 min), catecholamines, ACTH, and cortisol increased in all groups. Baseline insulin and glucagon levels were maintained in all groups except Con, where glucagon rose 33%, and alpha, where insulin increased slightly but significantly. Stress increased (P < 0.05) plasma glucose in Con, PC, and alpha but decreased it in beta and alpha+beta. The MCR increment was greater (P < 0.05) in beta and alpha+beta than in Con, PC, and alpha. R(a) increased (P < 0.05) in all groups but was attenuated in alpha+beta. Stress-induced lipolysis was abolished in beta (P < 0.05). The marked rise in lactate in Con, PC, and alpha was abolished in alpha+beta and beta. [HYP] We conclude that the stress-induced increase in MCR is largely independent of changes in insulin, markedly augmented by beta-blockade, and related, at least in part, to inhibition of lipolysis and glycogenolysis, and that   glucagon   is augmented by   R(a)   and alpha- and beta-catecholamine effects.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29883,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'bionli',\n",
       "  'split_data': 'test',\n",
       "  'task': 'nli',\n",
       "  'instruction': 'Does the hypothesis contradict the premise or is it entailed by it? If neither, classify it as neutral.',\n",
       "  'input': '[PRE] Glucose metabolism is subjected to diurnal variation, which might be mediated by alterations in the transcription pattern of clock genes and regulated by hormonal factors, as has been demonstrated for insulin. However, whether also glucagon is involved in the diurnal variation of glucose homeostasis is not known. We therefore examined glucagon secretion after meal ingestion (meal tolerance test) and during hypoglycemia (hyperinsulinemic hypoglycemic clamp at 2.5mmol/L glucose) and in vitro from isolated islets at ZT3 versus ZT15 in normal C57BL/6J mice and, furthermore, glucose levels and the insulin response to meal ingestion were also examined at these time points in glucagon receptor knockout mice (GCGR-/-) and their wildtype (wt) littermates. We found in normal mice that whereas the glucagon response to meal ingestion was not different between ZT3 and ZT15, the glucagon response to hypoglycemia was lower at ZT3 than at ZT15 and glucagon secretion from isolated islets was higher at ZT3 than at ZT15. GCGR-/- mice displayed lower basal glucose, a lower insulin response to meal and a higher insulin sensitivity than wt mice at ZT3 but not at ZT15. [HYP] We conclude that there is a time dependent variation in glucagon secretion in normal   insulin  , which is dependent both on intraislet and extraislet regulatory mechanisms and that the phenotype characteristics of a lower glucose and reduced   mice   response to meal in GCGR-/-   insulin   are evident only during the light phase.\\nOUTPUT:',\n",
       "  'output': 'contradiction',\n",
       "  '__index_level_0__': 29884,\n",
       "  'model_output': 'contradiction'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'using the isolated working heart preparation , we observed a depression of myocardial function in rats 6 weeks after the induction of diabetes , which was characterized by the inability of these hearts to develop left ventricular pressures and rates of ventricular contraction and relaxation as well as control hearts at higher left atrial filling pressures .',\n",
       "  'output': 'anatomic_structure_is_physical_part_of',\n",
       "  '__index_level_0__': 30285,\n",
       "  'model_output': 'has_physical_part_of_anatomic_structure'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'quantitative precipitin inhibition studies with type 1 antigen and antibody indicate that d-glucose and n-acetylglucosamine may be components of the antigenic determinant .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30286,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'the sensitivities of glycolysis ( which is an excellent index of glucose transport ) and glycogen synthesis to insulin were greatest in muscles isolated at 0900 and 2100 .',\n",
       "  'output': 'biological_process_involves_gene_product',\n",
       "  '__index_level_0__': 30287,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'effects of clofibrate therapy on glucose tolerance , insulin secretion and serum lipids in subjects with hyperlipoproteinemia and impaired glucose tolerance .',\n",
       "  'output': 'may_treat',\n",
       "  '__index_level_0__': 30288,\n",
       "  'model_output': 'is_associated_anatomic_site_of'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'antibodies directed at fab of iga in the sera of normal individuals and iga nephropathy patients .',\n",
       "  'output': 'is_biochemical_function_of_gene_product',\n",
       "  '__index_level_0__': 30289,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'vitamin e is used to ameliorate retinopathy of prematurity , but little is known about baseline vitamin e levels in retinas of premature infants or the effect of vitamin e supplementation on these levels .',\n",
       "  'output': 'disease_has_associated_anatomic_site',\n",
       "  '__index_level_0__': 30290,\n",
       "  'model_output': 'disease_has_associated_anatomic_site'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'tubular reticular structures are markers of the renal lesion of sle and may be helpful in differentiation from membranous nephropathy .',\n",
       "  'output': 'is_associated_anatomic_site_of',\n",
       "  '__index_level_0__': 30291,\n",
       "  'model_output': 'may_treat'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': '53 % would have referred the eye classified as proliferative retinopathy without high risk characteristics , and 79 % would have referred the eye with macular edema .',\n",
       "  'output': 'is_associated_anatomic_site_of',\n",
       "  '__index_level_0__': 30292,\n",
       "  'model_output': 'has_nichd_parent'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'the order of effectiveness of sugars was maltose greater than fructose greater than or equal to lactose greater than sucrose greater than glucose greater than galactose in rat and sucrose greater than fructose greater than or equal to glucose greater than or equal to galactose greater than maltose greater than lactose in hamster .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30293,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'five infants with hypoglycaemia due to hyperinsulinism were treated for between three and 11 days with a somatostatin analogue , which raised the mean blood glucose concentration and lowered the glucose requirements in all .',\n",
       "  'output': 'may_be_treated_by',\n",
       "  '__index_level_0__': 30294,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'in order to clarify the effects of insulin on the cardiovascular system in patients with and without coronary heart disease ( chd ) , we studied the changes of electrocardiogram ( ecg ) , blood pressure , pulse rate , along with those of blood glucose , free fatty acid , immunoreactive insulin , cortisol and potassium during insulin tolerance test ( itt ) .',\n",
       "  'output': 'is_associated_anatomic_site_of',\n",
       "  '__index_level_0__': 30295,\n",
       "  'model_output': 'may_treat'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'in experiments where the blood sugar was raised by the ingestion of glucose in normal air , no significant changes in the thresholds were observed except when the blood sugar was rapidly falling toward the end of the glucose tolerance tests .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30296,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'the phorbol ester 4 beta-phorbol 12-myristate 13-acetate ( pma ) , at concentrations of 0.1 microm and above , stimulated secretion of glucagon and of insulin from isolated rat islets of langerhans incubated in the presence of 5.5 mm-glucose .',\n",
       "  'output': 'gene_product_expressed_in_tissue',\n",
       "  '__index_level_0__': 30297,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': '[ intensive insulin therapy in adolescents with type 1 diabetes mellitus : initial experiences with a semiautomatic insulin injection device ( the insulin pen ) ] .',\n",
       "  'output': 'may_treat',\n",
       "  '__index_level_0__': 30298,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'these results suggest that patients with non-insulin-dependent diabetes who flush in response to chlorpropamide and alcohol are significantly less likely to develop large-vessel disease than those who do not .',\n",
       "  'output': 'may_be_treated_by',\n",
       "  '__index_level_0__': 30299,\n",
       "  'model_output': 'disease_has_associated_anatomic_site'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'a previously healthy 20-year-old man developed bilateral chorioretinitis that included mild anterior uveitis , vitreous cells , multifocal chorioretinitis , and optic nerve swelling that progressed to severe optic neuropathy in one eye .',\n",
       "  'output': 'disease_has_associated_anatomic_site',\n",
       "  '__index_level_0__': 30300,\n",
       "  'model_output': 'is_associated_anatomic_site_of'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'this article reviews the clinical features of heart disease in the diabetic in three categories : ( 1 ) coronary atherosclerosis ( cad ) , ( 2 ) autonomic neuropathy , and ( 3 ) cardiomyopathy .',\n",
       "  'output': 'nichd_parent_of',\n",
       "  '__index_level_0__': 30301,\n",
       "  'model_output': 'may_treat'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'patterns and location of reaction products for glucose-6-phosphatase ( g-6-pase ) , glucose-6-phosphate dehydrogenase ( g-6-pdh ) , and magnesium-dependent adenosine triphosphatase ( atpase ) , enzymes preferentially distributed in mammalian liver , were demonstrated in trout liver .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30302,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'the proinsulin shows in the oral glucose tolerance test compared to insulin a lower and delayed increase .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30303,\n",
       "  'model_output': 'may_treat'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'the increase in insulin sensitivity at the same time as a decrease in plasma insulin concentration may represent a mechanism to ensure continued glucose supply to insulin-sensitive tissues while the concomitant decrease in plasma i : g stimulates hepatic gluconeogenesis .',\n",
       "  'output': 'chemical_or_drug_is_product_of_biological_process',\n",
       "  '__index_level_0__': 30304,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'gluconeogenesis does not occur , and glycogen stores are limited so that the lung depends on the circulation for its glucose requirement .',\n",
       "  'output': 'biological_process_has_result_chemical_or_drug',\n",
       "  '__index_level_0__': 30305,\n",
       "  'model_output': 'is_location_of_biological_process'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'in normal humans glucagon plays a primary role in promoting glucose recovery from hypoglycemia , glucagon deficiency is largely compensated for by enhanced epinephrine secretion , and recovery from hypoglycemia fails to occur only in the absence of both glucagon and epinephrine .',\n",
       "  'output': 'may_be_treated_by',\n",
       "  '__index_level_0__': 30306,\n",
       "  'model_output': 'has_nichd_parent'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'the freshwater fish notopterus notopterus were exposed to various sublethal concentrations ( 0.088 , 0.044 , 0.029 , 0.022 , and 0.017 ) of mercuric chloride ( hgcl2 ) mg/liter for 15 , 30 , 45 , and 60 days , and their effects on glucose , lactate , cholesterol , plasma glutamic oxalacetic transaminase ( pgot ) and plasma glutamic pyruvic transaminase ( pgpt ) of the blood were observed .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30307,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'the activities of glucose-6-phosphate dehydrogenase ( d-glucose-6-phosphate : nadp oxidoreductase , g6pd ) , 6-phosphogluconate dehydrogenase ( 6-phospho-d-gluconate : nadp oxidoreductase , 6pgd ) , hexokinase ( atp : d-hexose 6-phosphotransferase , hx ) , lactate dehydrogenase ( d-lactate : nad oxidoreductase , ldh ) .',\n",
       "  'output': 'gene_product_has_biochemical_function',\n",
       "  '__index_level_0__': 30308,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': '[ combination treatment of insulin dependent elderly diabetics ( type ii diabetes ) with the sulfonylurea compound glibenclamide ] .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30309,\n",
       "  'model_output': 'may_treat'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'the identification of factors that modulate insulin production has engendered much interest because of their potential importance in the altered dynamics of insulin secretion in response to glucose characteristic of maturity-onset diabetes mellitus .',\n",
       "  'output': 'may_treat',\n",
       "  '__index_level_0__': 30310,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'endocrine pancreatic insufficiency may account directly for alterations observed in individuals with decreased or absent insulin response to glucose load , wheras metabolic factors such as adipose mass , hepatic steatosis , and peripheral insulin resistance appear to be responsible for alterations in carbohydrate oxidation and storage in subjects with relative endocrine pancreatic insufficiency , particularly obese diabetics .',\n",
       "  'output': 'gene_product_expressed_in_tissue',\n",
       "  '__index_level_0__': 30311,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'compared with isolated rat pancreatic islets , however , insulin secretory responsiveness to glucose stimulation and insulin content were reduced in tumour tissue .',\n",
       "  'output': 'tissue_is_expression_site_of_gene_product',\n",
       "  '__index_level_0__': 30312,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'the cytoplasmic membrane isolated from cells of citrobacter freundii growing in a cultivation medium with glucose was found to exhibit a decreased ability to oxidize formate and succinate and a decreased activity of formate , succinate and lactate dehydrogenase as compared with the cytoplasmic membrane of cells growing on galactose .',\n",
       "  'output': 'anatomic_structure_is_physical_part_of',\n",
       "  '__index_level_0__': 30313,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': \"this suggests the intensification of the redox reactions in crebs ' cycle , the increased utilization of fatty acids by cardiomyocytes to meet energy requirements , a decreased degree of acidosis in these myocardial sites and the intensification of glucose direct oxidation and nitrogen metabolism normalization .\",\n",
       "  'output': 'anatomic_structure_is_physical_part_of',\n",
       "  '__index_level_0__': 30314,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'the wolfram , or didmoad , syndrome is a rare congenital disease that is associated with diabetes insipidus , insulin dependent diabetes mellitus of an early onset , bilateral optic atrophy and deafness .',\n",
       "  'output': 'has_nichd_parent',\n",
       "  '__index_level_0__': 30315,\n",
       "  'model_output': 'disease_has_associated_anatomic_site'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'hearts perfused with palmitate or linoleate ( 1.5 mm , fatty acid/albumin ratio , 3.4 ) showed a significantly higher rate of lactate dehydrogenase release in both control and ischaemic conditions than hearts perfused with glucose ( 10 mm ) .',\n",
       "  'output': 'is_associated_anatomic_site_of',\n",
       "  '__index_level_0__': 30316,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'changes in food consumption and blood glucose levels in the domestic chicken , gallus domesticus , in response to the administration of 2-deoxy-d-glucose .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30317,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'the non-responders were among those patients who reacted to hyperglycaemia with a hgh increase ( paradox glucose response ) .',\n",
       "  'output': 'has_contraindicated_drug',\n",
       "  '__index_level_0__': 30318,\n",
       "  'model_output': 'may_treat'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'the use of the ba2+ and glucose methods provides alternatives to cell cable determinations for the calculation of cell membrane resistances .',\n",
       "  'output': 'has_physical_part_of_anatomic_structure',\n",
       "  '__index_level_0__': 30319,\n",
       "  'model_output': 'is_primary_anatomic_site_of_disease'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'after caloreen , the rise in plasma glucose concentration occurred more slowly but was better sustained , and hyperglycaemia was seen less often than after glucose .',\n",
       "  'output': 'has_contraindicated_drug',\n",
       "  '__index_level_0__': 30320,\n",
       "  'model_output': 'may_be_treated_by'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'the increase in pgi2 production after the adhesion of red cells from patients with diabetes or sickle cell anemia to endothelial cells indicates that endothelium may be damaged by abnormal erythrocyte adhesion .',\n",
       "  'output': 'anatomic_structure_is_physical_part_of',\n",
       "  '__index_level_0__': 30321,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'experimental infusion solutions with a sufficient , marginal or deficient level of glucose contained either the conventional amino acid composition ( 22.6 % bcaas ) or a bcaa-enriched amino acid composition ( 36 % bcaas ) .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30322,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': \"the biochemical methods used throughout this work for the determination of monoamine oxidase , nadh cytochrome c reductase , nadph cytochrome c reductase , cytochrome oxidase , catalase , aminopyrine demethylase , cytochromes b ( 5 ) and p 450 , glucuronyltransferase , galactosyltransferase , esterase , alkaline and acid phosphatases , 5'-nucleotidase , glucose 6-phosphatase , alkaline phosphodiesterase i , n-acetyl-beta-glucosaminidase , beta-glucuronidase , nucleoside diphosphatase , aldolase , fumarase , glutamine synthetase , protein , phospholipid , cholesterol , and rna are described and justified when necessary .\",\n",
       "  'output': 'is_biochemical_function_of_gene_product',\n",
       "  '__index_level_0__': 30323,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'the immunoglobulin pattern and the variability of symptoms in this familial peripheral neuropathy suggest that a thymic or gut-associated immune deficiency or both , may be causally related to the disease process .',\n",
       "  'output': 'may_treat',\n",
       "  '__index_level_0__': 30324,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'in the metabolic subsystem , glucose and insulin were injected by infusion pump so as to maintain blood sugar within 100 to 200 mg/dl , whereas the environmental system preserved the isolated heart at 37 degrees c in a sterile water bath .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30325,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'myocytes lose both adenosine triphosphate and adenine nucleotide when incubated anaerobically in the absence of glucose , and the lost adenine nucleotide can be accounted for as increased inosine , adenosine , and inosine monophosphate .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30326,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'it is important to identify the patients destined to develop nephropathy , to define the pathophysiology responsible for the nephropathy in this subset of patients and to develop programs to interrupt the pathophysiology early in its course and hopefully prevent the progression to end-stage renal failure .',\n",
       "  'output': 'nichd_parent_of',\n",
       "  '__index_level_0__': 30327,\n",
       "  'model_output': 'has_physical_part_of_anatomic_structure'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'her illness is characterised by seizures , buccolingual dyskinesia , choreiform movements , arreflexia and mild sensorimotor polyneuropathy .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30328,\n",
       "  'model_output': 'is_associated_anatomic_site_of'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'in metabolically stable nonazotemic diabetes , exchangeable sodium is increased by 10 % on average , regardless of age , insulin dependence or nondependence , or the presence or absence of diabetic retinopathy or clinical nephropathy ( proteinuria greater than or equal to 0.3 g/24 hr ) .',\n",
       "  'output': 'may_be_treated_by',\n",
       "  '__index_level_0__': 30329,\n",
       "  'model_output': 'has_nichd_parent'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'eleven women were selected on the presence , in postpartum renal biopsies , of focal glomerulosclerosis ( fgs ) superimposed to glomerular lesions of typical pregnancy-induced nephropathy .',\n",
       "  'output': 'has_nichd_parent',\n",
       "  '__index_level_0__': 30330,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'during exercise norepinephrine increases and insulin decreases independent of plasma glucose changes whereas receptors sensitive to glucose privation but not to acute changes in insulin levels enhance the exercise-induced secretion of glucagon , epinephrine , growth hormone and cortisol .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30331,\n",
       "  'model_output': 'biological_process_has_associated_concept'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'the stimulant action of branched-chain amino acids upon insulin release was examined in rat pancreatic islets incubated at physiological concentrations of d-glucose and l-glutamine .',\n",
       "  'output': 'chemical_structure_of',\n",
       "  '__index_level_0__': 30332,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'sublethal doses of either drug , resulted in a similar , chronic , progressive nephropathy which was delayed in onset and was characterized by polyuria , enzymuria , a decrease in urine concentrating ability , and in renal slice organic ion accumulation .',\n",
       "  'output': 'disease_has_associated_anatomic_site',\n",
       "  '__index_level_0__': 30333,\n",
       "  'model_output': 'has_nichd_parent'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'iga nephropathy ( igan ) is a common form of glomerulonephritis that leads to end-stage renal disease at variable rates in 20 % to 30 % of cases .',\n",
       "  'output': 'has_nichd_parent',\n",
       "  '__index_level_0__': 30334,\n",
       "  'model_output': 'disease_has_associated_anatomic_site'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'open sky vitrectomy was performed on 23 eyes in 18 children between 4 and 35 months of age with stage v retinopathy of prematurity ( rop ) .',\n",
       "  'output': 'procedure_has_target_anatomy',\n",
       "  '__index_level_0__': 30335,\n",
       "  'model_output': 'may_be_treated_by'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'the content of insulin antagonists ( growth hormone , cortisol , catecholamine , dopa , free fatty acids ) was studied in 40 women suffering from diabetes mellitus , including 12 insulin-sensitive and 15 insulin-resistant , and 13 women with freshly diagnosed untreated diabetes .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30336,\n",
       "  'model_output': 'is_associated_anatomic_site_of'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'a possible role for ca2+ in the alpha-adrenoceptor-induced inhibition of glucose-stimulated insulin secretion was studied in isolated rat islets by the use of the selective alpha 2-adrenoceptor agonist clonidine .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30337,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'the antiarrhythmic effect of verapamil was tested on spontaneous ventricular arrhythmias during reoxygenation after 15 min of glucose-free hypoxia and on programmed electrical stimulation- ( 8 stimuli + 1 or 2 extrastimuli ) induced ventricular fibrillation in isolated langendorff perfused guinea pig hearts .',\n",
       "  'output': 'nichd_parent_of',\n",
       "  '__index_level_0__': 30338,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'to test the hypothesis that in subjects with low intestinal lactase activity ( lla ) lactose solutions leaves the stomach at an abnormally fast rate , we have measured the gastric emptying rate of solutions of lactose and glucose-galactose in patients with lla ( n = 9 ) and in control subjects with high intestinal lactase levels ( n = 7 ) as proved by the assay of disaccharidases in specimens of intestinal mucosa .',\n",
       "  'output': 'has_physical_part_of_anatomic_structure',\n",
       "  '__index_level_0__': 30339,\n",
       "  'model_output': 'is_associated_anatomic_site_of'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'to analyze the role of cell coupling in glucose-induced insulin release , single b-cells were reaggregated in vitro and then tested for their secretory capability .',\n",
       "  'output': 'is_location_of_biological_process',\n",
       "  '__index_level_0__': 30340,\n",
       "  'model_output': 'is_associated_anatomic_site_of'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'phosphoglucomutase , in addition to catalyzing the interconversion of glucose 1-p and glucose 6-p , catalyzes both the synthesis of glucose 1,6-p2 from glucose monophosphate and either fructose 1,6-p2 or glycerate 1,3-p2 , and the hydrolysis of glucose 1,6-p2 .',\n",
       "  'output': 'biological_process_has_result_chemical_or_drug',\n",
       "  '__index_level_0__': 30341,\n",
       "  'model_output': 'gene_product_plays_role_in_biological_process'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'in both cases , glucose increased the 32p content of phosphatidic acid ( pa ) , phosphatidylinositol ( pi ) , and polyphosphoinositides ( ppi ) .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30342,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'the possibility that the stimulation of hexose transport in human fibroblasts by phorbol myristate acetate ( pma ) , insulin , platelet-derived growth factor ( pdgf ) or epidermal growth factor ( egf ) is associated with phosphorylation of the glucose transporter has been investigated .',\n",
       "  'output': 'is_organism_source_of_gene_product',\n",
       "  '__index_level_0__': 30343,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'diabetic retinopathy ( an index of microangiopathy ) and absence of peripheral pulses , amputation , or history of myocardial infarction , stroke , or transient ischemic attacks ( as evidence of macroangiopathy ) caused surprisingly little increase in relative risk for cardiovascular death .',\n",
       "  'output': 'disease_has_associated_anatomic_site',\n",
       "  '__index_level_0__': 30344,\n",
       "  'model_output': 'may_be_treated_by'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'immunoglobulin was separated from islet cell antibody positive plasma of six children with newly diagnosed insulin-dependent ( type i ) diabetes mellitus .',\n",
       "  'output': 'may_treat',\n",
       "  '__index_level_0__': 30345,\n",
       "  'model_output': 'is_a'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': \"after maintaining euglycemia overnight with an infusion of insulin or proinsulin and then acutely stopping these infusions , the rise in plasma glucose after proinsulin was delayed significantly compared to insulin , consistent with proinsulin 's slower clearance .\",\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30346,\n",
       "  'model_output': 'is_associated_anatomic_site_of'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'however , hyperglycemia stimulates the secretion of insulin and inhibits the secretion of glucagon , effects that will diminish the degree of hyperglycemia resulting from direct actions of stress hormones on glucose production and disposal .',\n",
       "  'output': 'has_contraindicated_drug',\n",
       "  '__index_level_0__': 30347,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'the protein droplet nephropathy induced in male rats after per and pent treatment appears identical to that observed with other male-rat-specific renal carcinogens such as unleaded gasoline .',\n",
       "  'output': 'disease_has_associated_anatomic_site',\n",
       "  '__index_level_0__': 30348,\n",
       "  'model_output': 'may_be_treated_by'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': '1 ) individual monosaccharides ( uronic acids and aminosugars ) have been purified following specific hydrolysis of the mucopolysaccharides from new born rat skin ( hyaluronic acid , heparin + heparan sulfate , chondroitin sulfate a , b and c ) , after incubation with [ u14c ] -glucose under various conditions and for varying incubation periods .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30349,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'twice daily nph insulin maintained mild hypoglycemia ( glucose = 84 +/- 12 mg/dl ) compared to once daily nph insulin which resulted in hyperglycemia ( glucose = 140 +/- 8 mg/dl , p less than 0.001 ) prior to next dose .',\n",
       "  'output': 'has_contraindicated_drug',\n",
       "  '__index_level_0__': 30350,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'a complete analysis of the components of refractive error was performed on ten eyes of five patients with myopia and retinopathy of prematurity ( rop ) .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30351,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'we analyzed 102 pregnancies in 65 women with iga nephropathy , noting hypertension in 63 % of the gestations ( severe in 18 % ) , decreases in renal function in 22 % , and biopsy evidence demonstrating a significantly greater amount of glomerular proliferation and crescents as well as focal and segmental hyalinosis and sclerosis when the renal histology from women who were pregnant and those who had never conceived were compared .',\n",
       "  'output': 'disease_has_associated_anatomic_site',\n",
       "  '__index_level_0__': 30352,\n",
       "  'model_output': 'has_nichd_parent'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': \"inhibition by somatostatin of glucose induced 3':5'-monophsophate ( cyclic amp ) accumulation and insulin release in isolated pancreatic islets of the rat .\",\n",
       "  'output': 'gene_product_expressed_in_tissue',\n",
       "  '__index_level_0__': 30353,\n",
       "  'model_output': 'is_associated_anatomic_site_of'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'thus , despite the fact that cmv can successfully infect a variety of cells in fetal islets of langerhans , the absence of a significant effect on beta cells does not support the notion that congenital cmv infection is involved in the origin of insulin-dependent diabetes mellitus .',\n",
       "  'output': 'is_primary_anatomic_site_of_disease',\n",
       "  '__index_level_0__': 30354,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'this hypothesis is borne out by the association of diabetes mellitus with coxsackie b , mumps , rubella and herpes simplex virus infections , the presence of high persistent titers of neutralizing antibodies in diabetic patients , the in vitro permissiveness of human beta cells to viruses , and the recovery of viruses from the pancreas of diabetic patients .',\n",
       "  'output': 'disease_has_associated_anatomic_site',\n",
       "  '__index_level_0__': 30355,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'data from the 1976 national health interview survey were used to study the independent and interactive relationship of race , sex , obesity , and age with the reported prevalence of noninsulin-dependent diabetes .',\n",
       "  'output': 'concept_in_subset',\n",
       "  '__index_level_0__': 30356,\n",
       "  'model_output': 'may_be_treated_by'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'glucose pool and decay rate of specific radioactivity of blood glucose was measured after bolus injection of a mixture of 3h- ( 2 ) - and 14c- ( u ) -glucose under steady state conditions .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30357,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'in cases with thromboses of the central retinal veins , occlusion of the central retinal arteries , stenoses of the internal carotid arteries , diabetic retinopathy and arterial hypertension , the extent of the retinal circulation disturbances could be defined by measuring the avp and the fbg .',\n",
       "  'output': 'disease_has_associated_anatomic_site',\n",
       "  '__index_level_0__': 30358,\n",
       "  'model_output': 'may_be_treated_by'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'changes in glucose production rates were correlated with changes in the enzymatic activities controlling gluconeogenesis .',\n",
       "  'output': 'chemical_or_drug_is_product_of_biological_process',\n",
       "  '__index_level_0__': 30359,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'hyperglycaemia may enhance insulin resistance typical of non-insulin dependent diabetes mellitus , as well as insulin dependent diabetes mellitus , and thus initiate a vicious pathogenetic cycle .',\n",
       "  'output': 'nichd_parent_of',\n",
       "  '__index_level_0__': 30360,\n",
       "  'model_output': 'may_be_treated_by'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'interactions of glucose-6-phosphate isomerase ( d-glucose-6-phosphate ketol-isomerase , ec 5.3.1.9 ) , aldolase ( d-fructose-1,6-bisphosphate d-glyceraldehyde-3-phosphate lyase , ec 4.1.2.13 ) , glyceraldehyde-3-phosphate dehydrogenase ( d-glyceraldehyde-3-phosphate : nad+ oxidoreductase ( phosphorylating ) , ec 1.2.1.12 ) , triose-phosphate isomerase ( d-glyceraldehyde-3-phosphate ketol-isomerase , ec 5.3.1.1 ) , phosphoglycerate mutase ( d-phosphoglycerate 2,3-phosphomutase , ec 5.4.2.1 ) , phosphoglycerate kinase ( atp:3-phospho-d-glycerate 1-phosphotransferase , ec 2.7.3 ) , enolase ( 2-phospho-d-glycerate hydro-lyase , ec 4.2.1.11 ) , pyruvate kinase ( atp : pyruvate o2-phosphotransferase , ec 2.7.1.40 ) and lactate dehydrogenase [ s ) -lactate : nad+ oxidoreductase , ec 1.1.1.27 ) with f-actin , among the glycolytic enzymes listed above , and with phosphofructokinase ( atp : d-fructose-6-phosphate 1-phosphotransferase , ec 2.7.1.11 ) were studied in the presence of poly ( ethylene glycol ) .',\n",
       "  'output': 'gene_product_has_biochemical_function',\n",
       "  '__index_level_0__': 30361,\n",
       "  'model_output': 'chemical_or_drug_is_associated_with_gene_product'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'involvement of rat lateral hypothalamus ( lha ) neurons in integration of motivation , reward , and learning processes was studied by recording single-neuron activity during cuetone discrimination , learning behavior to obtain glucose , or electrical rewarding intracranial self-stimulation ( icss ) of the posterior lha .',\n",
       "  'output': 'biological_process_is_part_of_process',\n",
       "  '__index_level_0__': 30362,\n",
       "  'model_output': 'may_be_treated_by'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'at 0.01 m either sorbitol or fructose inhibited alpha-amylase by 8 % , maltose 7 % , sucrose 6 % , phenol , glucose and galactose each by 5 % , ethanol , glycerol , arabinose and sodium benzoate each by 4 % , isopropanol and mannitol 1 % , but methanol and ammonium citrate dibasic did not inhibit alpha-amylase .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30363,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': \"glucose intolerance did not occur when rats were injected with 1 ml of the following control sera : the patient 's serum following 6 months of treatment with cyclophosphamide when her insulin resistance was in remission , pooled sera from idd 's without insulin resistance , serum from an insulin resistant idd with a high titre of insulin binding capacity ( greater than 40 u/l ) or with serum from a normal human subject .\",\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30364,\n",
       "  'model_output': 'may_be_treated_by'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'excellent metabolic control ( = all blood glucose concentrations less than 150 mg/dl ) was achieved with procine insulin on day 4.6 +/- 1.7 and with bhi on day 4.3 +/- 1.5 .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30365,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'a cdna library , complementary to mrnas of alkane-grown candida tropicalis , was screened by differential dna dot-blot hybridization with [ 32p ] cdna reverse-transcribed from mrna of alkane-grown cells or from cells in which peroxisome formation was repressed by growth on glucose .',\n",
       "  'output': 'has_physical_part_of_anatomic_structure',\n",
       "  '__index_level_0__': 30366,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'independent of the type of diabetes , serum laminin concentrations in patients without nephropathy or with early renal damage as assessed by microalbuminuria were comparable with those of the control subjects .',\n",
       "  'output': 'disease_has_associated_anatomic_site',\n",
       "  '__index_level_0__': 30367,\n",
       "  'model_output': 'has_contraindicated_drug'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'a diabetes-independent haemoglobin variant was suspected and further investigations , including electrophoresis , purification and sequential analysis of the tryptic peptide , identified the abnormal haemoglobin as haemoglobin d punjab ( beta 121 glu-gln ) .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30368,\n",
       "  'model_output': 'biological_process_involves_gene_product'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'fractional extraction in normal subjects under near-basal conditions of glycemia and insulinemia was 19 % in normal subjects and in patients with noninsulin-dependent diabetes mellitus ( niddm ) elevation of serum insulin , with or without hyperglycemia , which led to an average extraction rate of 32 % of the ingested glucose .',\n",
       "  'output': 'has_contraindicated_drug',\n",
       "  '__index_level_0__': 30369,\n",
       "  'model_output': 'may_treat'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'optic neuropathy developed in a patient with rheumatoid arthritis who had been receiving d-penicillamine for about 1 year .',\n",
       "  'output': 'may_be_treated_by',\n",
       "  '__index_level_0__': 30370,\n",
       "  'model_output': 'may_treat'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'in contrary , severe problems result from eye complications such as reversible keratopathy and mostly irreversible retinopathy .',\n",
       "  'output': 'is_associated_anatomic_site_of',\n",
       "  '__index_level_0__': 30371,\n",
       "  'model_output': 'has_nichd_parent_of_anatomic_site'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': \"furthermore , blood glucose and 2-deoxyglucose levels were also maintained ( `` '' clamped '' '' ) in a steady state by infusion of glucose and 2-deoxy- [ 14c ] -glucose .\",\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30372,\n",
       "  'model_output': 'has_physical_part_of_anatomic_structure'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': '3 mu/kg per min insulin caused more rapid and greater hypoglycemia , greater glucose clearance , and greater glucagon increments without suppression of glucose production , which indicates that with larger doses of insulin counterregulation can absolutely mask the suppressive effect of insulin .',\n",
       "  'output': 'may_be_treated_by',\n",
       "  '__index_level_0__': 30373,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'only pge2 levels ( normal range : 2.0-16.4 ng/h per 1.73 m2 ) are elevated in bartter syndrome ( median : 43.4 , range : 6.7-166.3 ) , nephrogenic diabetes insipidus ( 46.2 , 12.1-1290 ) , fanconi syndrome ( 96.6 , 19.3-135.5 ) , and in a complex tubular disorder in premature infants ( 40.7 , 22.3-132.1 ) , for which the term hyperprostaglandin e syndrome has been introduced .',\n",
       "  'output': 'nichd_parent_of',\n",
       "  '__index_level_0__': 30374,\n",
       "  'model_output': 'has_physical_part_of_anatomic_structure'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'under conditions of steady-state hyperglycemia ( +75 mg/100 ml hyperglycemic clamp , insulin secretion was reduced by 75 % in the streptozotocin-treated dogs ( p less than 0.025 ) , and the total amount of glucose metabolized decreased from 13.56 +/- 1.04 to 4.74 +/- 0.70 mg/min x kg ( p less than 0.001 ) .',\n",
       "  'output': 'has_contraindicated_drug',\n",
       "  '__index_level_0__': 30375,\n",
       "  'model_output': 'may_treat'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'to determine the effect of enalapril maleate and low-dose hydrochlorothiazide therapy on blood pressure and glucose and lipid homeostasis in hypertensive type ii diabetic patients , we treated nine of these patients sequentially with placebo , hydrochlorothiazide ( 25 mg/d with supplemental potassium chloride ) , and enalapril ( 10 to 20 mg/d ) .',\n",
       "  'output': 'contraindicated_with_disease',\n",
       "  '__index_level_0__': 30376,\n",
       "  'model_output': 'contraindicated_with_treatment'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': '[ the effect of compensation in diabetes mellitus on energy metabolism in conventionally treated insulin-dependent diabetics ] .',\n",
       "  'output': 'biological_process_involves_gene_product',\n",
       "  '__index_level_0__': 30377,\n",
       "  'model_output': 'is_treated_for'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'the unusual feature for the ruffle-inducing agent ( s ) produced by knrk cells was that this activity was not subject , in either nrk or knrk cells , to the cellular off-regulation that limits the responses to insulin or glucose .',\n",
       "  'output': 'is_location_of_biological_process',\n",
       "  '__index_level_0__': 30378,\n",
       "  'model_output': 'is_associated_anatomic_site_of'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'From the text, describe the relationship that exists between the provided entities.',\n",
       "  'input': 'gastric inhibitory polypeptide ( gip ; 1 or 10 mug/ml ) potentiated glucose-induced ( 8 or 16.6 mm ) insulin ( iri ) release from isolated rat pancreatic islets .',\n",
       "  'output': 'gene_product_expressed_in_tissue',\n",
       "  '__index_level_0__': 30379,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': 'light microscopy of renal biopsy specimens showed evidence of an extramembranous nephropathy in 6 cases , with epimembranous spikes infrequently described previously in association with penicillamine .',\n",
       "  'output': 'has_contraindicated_drug',\n",
       "  '__index_level_0__': 30380,\n",
       "  'model_output': 'has_nichd_parent'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Identify the type of relationship that connects the specified entities based on the provided text.',\n",
       "  'input': 'when the brains are removed by freeze-blowing , the time courses of the [ 14c ] deoxyglucose and [ 14c ] deoxyglucose-6-phosphate concentrations in brain during the 45 min after the intravenous pulse are close to those predicted by the model of the deoxyglucose method .',\n",
       "  'output': 'biological_process_has_associated_location',\n",
       "  '__index_level_0__': 30381,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'after withdrawal of medication , blood glucose control was determined by measuring glucose before and 2 h after each meal for 48 h , and beta-cell function by insulin or c-peptide response to glucagon and to iv glucose .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30382,\n",
       "  'model_output': 'may_be_associated_with'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Determine the specific relationship mentioned between the entities in the text.',\n",
       "  'input': 'if the patient has lactase deficiency and is unable to hydrolyze lactose and absorb its monosaccharides , glucose and galactose , the blood glucose does not usually increase greater than 20 mg/100 ml .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30383,\n",
       "  'model_output': 'NA'},\n",
       " {'dataset': 'biorel',\n",
       "  'split_data': 'test',\n",
       "  'task': 'ie_extract_relation',\n",
       "  'instruction': 'Extract the relationship described between the given entities in the text.',\n",
       "  'input': '[ symptomatic renal diabetes . concerning a case of normoglycemic glycosuria in the course of chronic glomerulonephritis with the nephrotic syndrome ] .',\n",
       "  'output': 'NA',\n",
       "  '__index_level_0__': 30384,\n",
       "  'model_output': 'may_treat'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Generate a comprehensive medical response based on the patient's query.\",\n",
       "  'input': 'Hello doctor,I have a blood sugar level of 8.3 mmol/l during fasting. Is this diabetic or still at the pre-diabetic stage? Can I reduce the sugar level without medication?',\n",
       "  'output': 'Hello. This falls in diabetic range. You should also get post-lunch sugar done. You will eventually need medicine. However, you can try a healthy lifestyle for some time period. You should have a healthy lifestyle like avoiding fatty, oily, sweet, and high-calorie diet. Regular exercises like brisk walking, jogging according to your capacity at least 30 minutes a day and five days a week. Try to achieve weight loss which is important. Repeat fasting and post lunch sugar after two weeks to look for the response. All the best.',\n",
       "  '__index_level_0__': 31285,\n",
       "  'model_output': 'Thank you for your query. As per your query you have a blood sugar level of 8.3 mmol/l during fasting. The blood sugar level of 8.3 mmol/l during fasting is definitely diabetic. To know if you are diabetic or prediabetic, you need to do a fasting blood sugar test and an oral glucose tolerance test (OGTT). As per your query you have a blood sugar level of 8.3 mmol/l during fasting. The blood sugar level of 8.3 mmol/l during fasting is definitely diabetic. To know if you are diabetic or prediabetic, you need to do a fasting blood sugar test and an oral glucose tolerance test (OGTT). If you have a fasting blood sugar level of 126 mg/dl or higher, you have diabetes. If your fasting blood sugar level is between 100 and 125 mg/dl, you have impaired fasting glucose. If you have a fasting blood sugar level below 100 mg/dl and a 2-hour blood sugar level of 140 to 199 mg/dl, you have impaired glucose tolerance. If you have a fasting blood sugar level below 100 mg/dl and a 2-hour blood sugar level below 140 mg/dl, you have normal glucose tolerance. The blood sugar level of 8.3 mmol/l during fasting is definitely diabetic. To know if you are diabetic or prediabetic, you need to do a fasting blood sugar test and an oral glucose tolerance test (OGTT). If you have a fasting blood sugar level of 126 mg/dl or higher, you have diabetes. If your fasting blood sugar level is between 100 and 125 mg/dl, you have impaired fasting glucose. If you have a fasting blood sugar level below 100 mg/dl and a 2-hour blood sugar level of 140 to 199 mg/dl, you have impaired glucose tolerance. If you have a fasting blood sugar level below 100 mg/dl and a 2-hour blood sugar level below 140 mg/dl, you have normal glucose tolerance. You can reduce your sugar level without medication by following a healthy diet and exercise routine. A healthy diet for diabetes includes: - Whole grains, such as brown rice, quinoa, and whole-wheat pasta - Fruits and vegetables, such as berries, leafy greens, and sweet potatoes - Lean proteins, such as chicken, fish, and beans - Healthy fats, such as olive oil, nuts, and avocados Exercise can help reduce your blood sugar level by improving insulin sensitivity. Some exercises that can help include: - Walking or jogging - Cycling - Swimming - Yoga or Pilates You can also try some natural remedies to help lower your blood sugar level, such as: - Drinking green tea - Taking ginger supplements - Eating cinnamon - Using turmeric You should also monitor your blood sugar level regularly and consult with your doctor if you have any concerns.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hi doctor,My nephew is a premature baby. On the third day, his blood glucose level was decreased to 34. Later, he was admitted and kept under surveillance. His blood test revealed elevated bilirubin level. Four days later, his blood values become normal. On the same day, suddenly there was swelling on his body. The biochemistry examination revealed urine spot protein to creatinine ratio 2.19 and moderate grade proteinuria.',\n",
       "  'output': 'Hi, Welcome to Chat Doctor forum. Your baby probably has a problem with his kidneys. A urine spot protein to creatinine ratio of more than two usually suggests that your baby is losing a lot of protein through his kidneys called nephrotic range proteinuria. So, the swelling of the body might have appeared due to protein loss. But, a single value may not be significant, so get it tested once again. If it is still high, then you need to worry. It could be a congenital nephrotic syn ChatDoctor.   If the repeat test value is high, and body swelling is persisting, then consult a pediatric nephrologist for further evaluation and treatment plan.',\n",
       "  '__index_level_0__': 31286,\n",
       "  'model_output': 'Hi, Thanks for contacting us. Please consult with a pediatrician for the same.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Generate a comprehensive medical response based on the patient's query.\",\n",
       "  'input': 'Hello doctor,I have non-alcoholic fatty liver grade 2, bilirubin 1.7, and creatinine is 1.2. How to reduce cholesterol and bring back to normal liver function?',\n",
       "  'output': 'Hello. Your fasting glucose is high so that you might also have diabetes. Should treat it adequately, apart from diet and lifestyle changes. Cholesterol is fine, and if you follow the changes in diet and lifestyle regimen, cholesterol will get normalized too. Excessive sleeping and always feeling tired is due to alcoholic fatty liver damages. Should stop  ChatDoctor.  Stinging nettle supplement will help detox your liver. Keep following up with gastroenterologist regularly.  Take care.',\n",
       "  '__index_level_0__': 31287,\n",
       "  'model_output': 'Hi, I am glad you reached out to me. It is good to know that you have a fatty liver and have been taking the necessary steps to manage it. However, it is essential to understand that fatty liver is not a disease in itself but rather a symptom of an underlying condition. It is often associated with obesity, diabetes, and high cholesterol. Therefore, it is crucial to address these underlying issues to effectively manage your fatty liver. Here are some steps you can take to reduce cholesterol and improve your liver function: 1. Lifestyle changes: Lose weight through a healthy diet and regular exercise. Reduce your intake of sugar, processed foods, and alcohol. 2. Medications: Consult with your doctor about medications that can help manage your cholesterol levels and liver function. 3. Supplements: Certain supplements, such as omega-3 fatty acids and vitamin D, may help reduce inflammation and improve liver function. 4. Regular monitoring: It is important to monitor your liver function regularly through blood tests and liver scans to ensure that your condition is not worsening. Please note that I am not a medical professional and cannot provide specific medical advice. I recommend consulting with your doctor or a registered dietitian for personalized guidance. Best wishes for a healthy and happy life!'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,What is the normal blood sugar level for open heart surgery patient in the morning test before fasting and after fasting?',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. Normal fasting glucose levels are the same for all types of patients, persons of different age group. The range of fasting glucose is 70 to 100 mg/100 ml (earlier upper margin was allowed up to 110 mg). The usual levels measured are fasting (10 plus hours after dinner) and after food or PP level ( two hours after food). Your terminology is not correct (before fasting and after fasting). Normal PP (postprandial) level is less than 140 mg/100 ml for all persons including one going for any surgery.',\n",
       "  '__index_level_0__': 31288,\n",
       "  'model_output': 'Hi, I am a medical doctor. I will help you. The normal blood sugar level for open heart surgery patient in the morning test before fasting and after fasting is 70 to 99 mg/dL. The normal blood sugar level for open heart surgery patient in the morning test before fasting and after fasting is 70 to 99 mg/dL. Please let me know if you have any other questions. Thanks for using Just Below!'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello doctor,My reports are as follows. My blood phosphorous level is 4.58 mg, and it was always 3.2 mg. Rest kidney test is fine. Seeing my report, can you please tell me if my kidney is failing? I am too much worried. I am having Metformin 1000 mg as I am prediabetic and Voveron painkiller last week?',\n",
       "  'output': 'Hi. As such increase in phosphorus is not a marker of kidney disease. It can happen due to an increase in the daily products intake, pain-killer intake, and dehy ChatDoctor.  I do not find any reason to worry.',\n",
       "  '__index_level_0__': 31289,\n",
       "  'model_output': 'Hi, I am a doctor. I have seen your reports. Your serum creatinine is 1.4, which is slightly high but not alarming. Your urine albumin is 16, which is very low. So, your kidney function is good. Please take care of your blood pressure and blood sugar. Avoid painkillers as much as possible. You can take paracetamol if you have pain. Avoid metformin if you have kidney problem. Consult your doctor for the same.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Generate a comprehensive medical response based on the patient's query.\",\n",
       "  'input': 'Hello doctor,I am suffering from erectile dysfunction due to atherosclerosis causing less blood flow to the penis, this may be due to family history of high cholesterol. The allopathy medicine suggested for this is Tadalafil 5 mg every day (vasodilator).Is it manageable through Siddha medicines? I am 33 years old. My height is 176 cm, and I weigh 76 kg. I have borderline high cholesterol, and I do not have high blood pressure or diabetes. I do not have the habit of smoking or drinking. Please go through my blood reports.',\n",
       "  'output': 'Hi,Welcome to ChatDoctor. I have gone through your reports (attachment removed to protect patient identity). As per your blood report, your cholesterol profile is above the upper limit. This might be the cause for the penile artery blockage (atherosclerosis plaque). But, I think the other possible reasons for erectile dysfunction may be',\n",
       "  '__index_level_0__': 31290,\n",
       "  'model_output': 'Hi there, I am glad to help you out. I would like to know your complete blood report. I would also like to know your complete family history. I would also like to know your blood pressure, blood sugar, and cholesterol levels. I would also like to know if you have any history of any cardiac disease. I would also like to know if you have any history of any neurological disease. I would also like to know if you have any history of any kidney disease. I would also like to know if you have any history of any liver disease. I would also like to know if you have any history of any lung disease. I would also like to know if you have any history of any eye disease. I would also like to know if you have any history of any skin disease. I would also like to know if you have any history of any dental disease. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem. I would also like to know if you have any history of any urinary problem. I would also like to know if you have any history of any sexual problem. I would also like to know if you have any history of any mental problem. I would also like to know if you have any history of any skin problem. I would also like to know if you have any history of any dental problem. I would also like to know if you have any history of any hearing problem. I would also like to know if you have any history of any vision problem. I would also like to know if you have any history of any speech problem. I would also like to know if you have any history of any eating problem. I would also like to know if you have any history of any sleeping problem. I would also like to know if you have any history of any bowel problem'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello doctor,I have high sugar level in mornings around 140 plus and at night it is normal around 100. I am overweight rather obese and trying to lose weight. Now, I want to know whether I have insulin resistance or diabetes? I mean what is the difference? Can I get insulin test also?',\n",
       "  'output': 'Hello. Insulin resistance is a pre-condition towards diabetes. According to American heart association, there are criteria to decide pre-diabetic or diabetic. I would advise you to see a physician and get tested. It is a well-appreciated thought of losing weight, hope you stick with it and also control diet. For more information consult an internal medicine physician online',\n",
       "  '__index_level_0__': 31291,\n",
       "  'model_output': 'Hi, Insulin resistance is a condition in which the body can not use insulin properly. It is a pre-diabetic condition which leads to type 2 diabetes if left untreated. I would advise you to consult your doctor and get a blood sugar test done to rule out diabetes.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,I have periodontal disease and I do not know what had caused it. I do brush daily, floss and mouth wash. I even had those pink pill that showed if you brushed wrong and the results were perfect every time. So I am wondering what caused it. I do have a dead tooth. So I am wondering if I get that fixed, will my gums be healthier?',\n",
       "  'output': 'Hi. I have gone through your question. I can understand your concern. As per your history, signs, and, symptoms, it looks like you are having chronic generalized periodontitis. I want to know if you have any loose tooth or teeth, any systemic disease like diabetes, etc. If you are taking any  ChatDoctor.  Use mouthwash daily, brushing technique (modified Bass). You can take medication like Metronidazole 400 mg three times daily for a week if you do not have any allergic history to it.',\n",
       "  '__index_level_0__': 31292,\n",
       "  'model_output': 'Hi, It is very important to treat the dead tooth to avoid the spread of infection. Also, you may need to take antibiotics to control the infection. Please consult your dentist regarding the same.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Provide a concise and actionable answer to the patient's question.\",\n",
       "  'input': 'Hello doctor,My mother was just diagnosed with ovarian cancer. She underwent a hysterectomy and the pathology report, to my understanding, reads T3b NO MO. She is 72. What can you tell me about this and what are the survival odds? They said she will be treated with chemo for five to six months once a week.',\n",
       "  'output': 'Hello. It looks like FIGO stage III ovarian cancer. I need to know the histopathological type of this tumor. Does she have any co-morbidity like diabetes, hypertension, etc? Any family history of cancer? This tumor needs chemotherapy intravenous and maybe peritoneal chemotherapy depending upon the response and extension of peritoneal involvement. Overall, this tumor initially responds to chemotherapy. But, the recurrence rate is very high and also chemotherapy-induced toxicity mainly neuropathy is significant in this age group. For more information consult a medical oncologist online',\n",
       "  '__index_level_0__': 31293,\n",
       "  'model_output': \"Hi, I'm sorry to hear about your mother. Based on the information you provided, it appears that your mother has been diagnosed with ovarian cancer and has undergone a hysterectomy. The pathology report indicates that the cancer has spread to the pelvic peritoneum and lymph nodes (T3b NO MO). The T3b indicates that the cancer has spread to the pelvic peritoneum, and the NO MO indicates that the cancer has not spread to the lymph nodes. The treatment for ovarian cancer typically involves surgery, chemotherapy, and/or radiation therapy, depending on the stage and severity of the disease. The survival odds for ovarian cancer depend on several factors, including the stage of the cancer, the patient's overall health, and the effectiveness of the treatment. According to the American Cancer Society, the five-year survival rate for ovarian cancer is approximately 47%. However, this rate can vary depending on the stage of the cancer at the time of diagnosis. For example, the five-year survival rate for stage 1 ovarian cancer is approximately 92%, while the five-year survival rate for stage 4 ovarian cancer is approximately 17%. It is important to note that the survival odds for ovarian cancer can be improved with early diagnosis and effective treatment. Therefore, it is crucial for your mother to consult with her healthcare provider to discuss the best course of action for her specific situation. I hope this information is helpful. Please let me know if you have any further questions.\"},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello doctor,What is the normal blood sugar level for open heart surgery patient in the morning test before fasting and after fasting?',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. Normal fasting glucose levels are the same for all types of patients, persons of different age group. The range of fasting glucose is 70 to 100 mg/100 ml (earlier upper margin was allowed up to 110 mg). The usual levels measured are fasting (10 plus hours after dinner) and after food or PP level ( two hours after food). Your terminology is not correct (before fasting and after fasting). Normal PP (postprandial) level is less than 140 mg/100 ml for all persons including one going for any surgery.',\n",
       "  '__index_level_0__': 31294,\n",
       "  'model_output': 'Hi, 120-140 mg/dl is the normal blood sugar level for open heart surgery patient in the morning test before fasting and after fasting.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,My sugar level is 210 after breakfast. Is it normal or high? Can I control sugar level?',\n",
       "  'output': 'Hi. The sugar level 210 after eating food cannot be considered normal. It is suggestive of diabetes mellitus. However, you should repeat your serum fasting blood sugar estimation, serum post-prandial blood sugar estimation, and HbA1c estimation to confirm diabetes. In this early stage, you can control diabetes with weight reduction, less fatty foods, and regular exercise.',\n",
       "  '__index_level_0__': 31295,\n",
       "  'model_output': 'Hi, I suggest you to take your sugar level after 2 hours of breakfast. If it is more than 180 mg/dl, then you have to start taking medicine to control your sugar level. Consult a doctor for further treatment.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello,I am 30 years old male. For the last 1 week, I am having severe itching inside my penis head and bottom side. And while urinating it becomes very severe. When I wash it with hot water and soap, I could not take my hand out of my penis as the itching is heavy, so I had to massage my penis head a lot to control that. After using fourderm ointment outside the itching area, it is little bit in control. But the itching everytime starts again after I urinate. I do not see any visible difference outside the penis that is causing this itching and I do not see any discharge also. I had sex with a friend 2 weeks ago and used condoms. After 2 years I used condoms this time. I am not sure whether this is caused by any infection due to the condom or any other infections such as STD from my partner. I do not know whom should I consult for this issue, an Urologist or a Sexologist? Kindly help me get rid of this itching.',\n",
       "  'output': 'Hi, Welcome to Chat Doctor forum. First of all get one urine routine test and Fasting Blood Sugar test done. Your problem could be either a fungal infection or a reaction to the condom. I advise you to take consultation with a urologist online',\n",
       "  '__index_level_0__': 31296,\n",
       "  'model_output': 'Please consult a dermatologist or a sexologist. You may need to take antibiotics and anti-allergic medicines.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,I am a 21-year-old female with a really bad skin condition. The acne outbreak happened about a year ago, a time when I stopped the birth control pill, Diane, which I was on it for over five years due to a negative side effect I had swollen legs. Then I was on Almina 28 for about three to four months, with no positive impact on the skin condition. Please help.',\n",
       "  'output': 'Hello. I think your acne is due to hormonal imbalance, and there are other natural ways to treat this condition. You will need some more work up to find the leading cause. And some more detail in history to find a permanent solution. Lab test suggested are,  1. Complete metabolic profile, including liver enzyme levels.  2. Thyroid-stimulating hormone levels (TSH). 3. Total and free testosterone levels (this points towards if you have polycystic ovarian syn ChatDoctor.  4. Check for A1C to rule out pre-diabetes.  5. Estrogen and progesterone levels. 6. Complete blood picture. Until you get complete workup, I can suggest simple remedies. To get rid of acne, I recommend your system with natural remedies. 1. Use 1/2 teaspoon daily of Manuka honey or nay pure raw honey in 8 oz of warm water and with lemon,  Take care.',\n",
       "  '__index_level_0__': 31297,\n",
       "  'model_output': 'Follow-up with your dermatologist to determine the appropriate treatment for your acne.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Provide a concise and actionable answer to the patient's question.\",\n",
       "  'input': 'Hi doctor,I am a 58 year old female. I am suffering from both blood pressure and diabetes. I was diagnosed with endometrial cancer and undergone hysterectomy. I have also attached my reports. Please guide me.',\n",
       "  'output': 'Hello. I had verified your report (attachment removed to protect patient identity) and I must say that you have undergone hysterectomy which is the best-known treatment for grade 2 endometrial cancer. I advise you to consult your doctor regularly even after surgery and do not forget to take adjuvant therapy which is very important to prevent cancer in the future. For blood pressure and diabetes, I hope you will control them with medication and lifestyle changes.',\n",
       "  '__index_level_0__': 31298,\n",
       "  'model_output': 'Dear patient, Thank you for your query. Please find below my response. 1. Blood sugar: Fasting- 90 mg/dl, Post lunch- 130 mg/dl, HbA1C- 5.2% 2. Blood pressure: 130/80 mm Hg 3. Endometrial cancer: There is no cancer in the endometrium. 4. Please follow up with your treating physician for further management. Regards, Dr. Dheeraj'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"What advice or recommendations does the doctor provide in response to the patient's concerns?\",\n",
       "  'input': 'Hi doctor,I am suffering from premature ejaculation. I ejaculate within 20 seconds of penetration. Is it curable? Suggest me some medicines for the same.',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. Premature ejaculation is a common condition which affects men. If you are perfectly healthy without any medical conditions such as type-2 diabetes mellitus or hypertension, you can easily overcome your problem. Mostly, it is due to anxiety. I advise you to get rid of any anxiety which can affect your performance. Talk to your spouse, so that she understands your problem. Be more relaxed during the intercourse. There are some climax-delay condoms available, which you can try. Also, start taking tablet Cobadex CZS (vitamin supplement) and vitamin E capsules.',\n",
       "  '__index_level_0__': 31299,\n",
       "  'model_output': 'Hi, premature ejaculation is a common sexual problem. There are a number of causes and some of them are physical and some are psychological. Treatment is possible for both the causes. There are a number of medications that are used for this condition. You can start with fluoxetine 20 mg once daily. You can also use a topical anesthetic cream that can be applied on the penis before intercourse. However, if the problem is psychological then you need to consult a sex therapist or a psychiatrist. Please consult a doctor for proper diagnosis and treatment. Regards.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"What advice or recommendations does the doctor provide in response to the patient's concerns?\",\n",
       "  'input': 'Hi doctor,I am a diabetic. Does chewing nicotine gum will increase sugar level? Does stress in the heart increase the sugar level?',\n",
       "  'output': 'Hello. I went through your post. Nicotine chewing gum causes dental issues and sometimes hair loss and flushing. However, it does not increase blood sugar. So, you can take that it is 1000 times better to take nicotine chewing gum than cigarette especially once you have diabetes.',\n",
       "  '__index_level_0__': 31300,\n",
       "  'model_output': 'Hi, Chewing nicotine gum will not increase sugar level. Stress in the heart does not increase sugar level. However, stress in general can increase sugar level.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,I am a 53-year-old female. I had gestational diabetes and 11 years later my sugar levels were high so started taking Glycomet. However, the fasting sugar level in the morning is always high and PP is less than fasting. Recent HbA1c is 6.9. Do I have to continue medicine? I walk daily for one hour and eat raw vegetables for breakfast. I have constipation problem. By any chance is it related to high sugar levels? Please advice me as to how to control or keep HbA1c below 7. Suggest me natural way of reducing sugar levels without medication.',\n",
       "  'output': 'Hi, Welcome to ChatDoctor. Diabetes is not curable but controllable. The first line in the management of type 2 diabetes is lifestyle modifications. Fasting should not be higher than 110, postprandial should not be higher than 140, and HbA1c should not be higher than 7.5. My advice',\n",
       "  '__index_level_0__': 31301,\n",
       "  'model_output': 'Hi, I am Dr. Rishi. I read your query. You have gestational diabetes and you have been on Glycomet for 11 years. You have constipation problem. Please consult a diabetologist or an endocrinologist. The doctor will do a detailed evaluation and decide whether you need to continue Glycomet or not.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,I am 34 years old, hypertensive since 18 months. A few months back, I suffered from erectile dysfunction with different groups like Amlodipine, Ramipril, Natrilix, and even Telmisartan. I am not obese and I practice three days a week. Recently, Tadalafil stopped giving an effect, while before I used to have three days of erection with one pill.',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. Get your blood pressure regularly checked and take your medicines to keep BP under control. Get your blood sugar levels checked in order to rule out diabetes which is one of the main causes of erectile dysfunction.  ChatDoctor.  This will help make your erection strong. Consult your specialist doctor, discuss with him or her and start taking the medicines with their consent. For more information consult a sexologist online',\n",
       "  '__index_level_0__': 31302,\n",
       "  'model_output': 'The doctor suggests further evaluation with an ultrasound of the scrotum and testicles, as well as a blood test for testosterone and prolactin. They also suggest a consultation with a urologist to discuss the possibility of a penile implant.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello doctor,Diffusion-weighted images, ADC maps, and postcontrast sequences were also performed.Findings',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. Your MRI shows mild cerebral atrophy with some small vessel disease changes. I would like to know about your memory, speech, gait and urinary symptoms. Are there any abnormalities? These changes are much common at the age of 70 but still, you have to take some precautions. Life style modifications like regular sleep and healthy foods like low sugar, low fat, high fiber, and protein will do. Do exercise 45 minutes regularly. It is good that your BP and cholesterol are under control. Keep a watch on it. Check your blood sugar at least yearly and if raised then control it. Do regular meditation and yoga.',\n",
       "  '__index_level_0__': 31303,\n",
       "  'model_output': 'Yes, this is a case of brain abscess with multiple ring enhancing lesions. Please consult a neurosurgeon and start antibiotics asap.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Provide a concise and actionable answer to the patient's question.\",\n",
       "  'input': 'Hello doctor,I was diagnosed with prediabetics (102) two months before. Now I noticed white spots on my upper gums. Are the spots related to diabetes or some serious problem? Please guide.',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. Before commenting anything about diabetes and its relationship with oral problems, I would like to see images of your gums having a white spot so that we can discuss appropriately.',\n",
       "  '__index_level_0__': 31304,\n",
       "  'model_output': 'Dear patient, There is a chance that you are suffering from some fungal infection which is causing the white patches on your gums. If you have diabetes then you are more prone to develop fungal infection. So, I would advise you to consult a dentist for the diagnosis and treatment.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Provide a concise and actionable answer to the patient's question.\",\n",
       "  'input': 'Hello doctor, I am a 38-year-old male. My height is 5 feet 10 inches and weighs about 90 kg. I am a non-alcoholic and non-smoking person. I have two children. Now I am facing erectile dysfunction problem. First time I used Suhagra 25 mg and I enjoyed successfully. How long I have to use this tablet for natural erections? And what are the habits to overcome this problem?',\n",
       "  'output': 'Hi,  Welcome to ChatDoctor.  You can use this tablet for the long term as this tablet does not cure your erectile dysfunction. It works when you use it and its effect lasts for few hours to days.  Now coming to the habit to overcome this includes daily exercise or morning walk for at least 40 minutes. Avoid too much oily food. Consume low fat diet, whole grain foods, fruits, and vegetables will be useful. If having diabetes or hypertension then manage them effectively with the help of  ChatDoctor.   Take care.',\n",
       "  '__index_level_0__': 31305,\n",
       "  'model_output': 'Erectile dysfunction is a common problem. It is usually due to stress and anxiety. It can be treated with sildenafil, a phosphodiesterase 5 inhibitor. However, if you are taking sildenafil, you need to follow some precautions. Do not take sildenafil with alcohol or nitrates (nitroglycerin, isosorbide dinitrate, etc.). Do not take sildenafil with grapefruit juice. Do not take sildenafil if you are taking nitrates or alpha-blockers (for high blood pressure). Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that contains sildenafil or vardenafil. Do not take sildenafil if you are taking any other medication that'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello doctor,I have depression, feeling of failure in life, no more attraction to live life. Sad, anxious, or empty mood. Loss of interest or pleasure in activities. Thoughts of death or suicide, including suicide attempts.',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. I understand what you must be feeling right now. Depression is a serious but treatment illness. I can see you have thoughts of suicide and suicide attempts are also there which indicates that your depression worsened now. But do not worry, there are various treatment options available, with which your condition can be improved. Depression is a biological illness just like diabetes. It is neither your fault nor your wish to be in the pain that you are in right now and you cannot overcome these feelings and thoughts. Every disease needs appropriate treatment. I would advise you to consult a psychiatrist online or offline as soon as possible. Remember help is there please avail it. I would require more details about your problem. Thyroid function test, serum B12. May require inpatient care, medicines, therapy.',\n",
       "  '__index_level_0__': 31306,\n",
       "  'model_output': \"Hi, I'm sorry to hear about your depression. I would suggest you to take the help of a psychiatrist. He will be able to treat your depression and anxiety. Please visit a psychiatrist and take his advice.\"},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"What advice or recommendations does the doctor provide in response to the patient's concerns?\",\n",
       "  'input': 'Hello doctor,My mom is 56 years old. She is a patient of hypertension, diabetes, and mild nephropathy. BP 140/80, pulse 96/ min, creatinine 1.3, fasting sugar 125, postprandial 157. From a few months, my mother is suffering from chest pain. The doctor told it is chronic stable angina. All other tests are done like Na, K, hemoglobin, urea, and uric acid. The reports are quite fine. Our family doctor suggests me to take angiography. So, what should I do now? Please suggest. She is taking the following medicines',\n",
       "  'output': 'Hello. With these kidney function tests, she can perform the coronary angiography. I agree with her doctor\\\\\\\\s recommendation because this would help identify possible coronary artery stenosis and also perform angioplasty, if necessary. Another test which can help investigate the presence of coronary ischemia is Dobutamine cardiac stress test. If this test results positive, the next step would be performing a coronary angiography. For more information consult a cardiologist online',\n",
       "  '__index_level_0__': 31307,\n",
       "  'model_output': 'Hello, Please consult your family doctor. There are several other tests that need to be done. I hope your mother is taking her diabetes and hypertension medications regularly. Please let us know if you have any other questions.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Generate a comprehensive medical response based on the patient's query.\",\n",
       "  'input': 'Hi doctor,My mother has been suffering from acute back pain and leg pain for the past one year. She is unable to stand or walk for a long time. She is 73 years old. Also, she has type 2 diabetes and high BP. Her MRI revealed a diffuse bulge of L4-L5 disc with ligamentum flavum hypertrophy causing severe canal stenosis with compression over transversing and existing nerve roots. What is the meaning of above? What treatment is necessary for her now?',\n",
       "  'output': 'Hello. The following is a radiological report (MRI) of her intervertebral disc status. Revert back with the reports to an orthopaedician and traumatologist online',\n",
       "  '__index_level_0__': 31308,\n",
       "  'model_output': \"Hi, I have reviewed your mother's MRI. The MRI shows degenerative changes of the spine with disc bulge at L4-L5 level and ligamentum flavum hypertrophy. Ligamentum flavum hypertrophy is a condition where the ligamentum flavum, which is a ligament that connects the lamina of two adjacent vertebrae, becomes thickened and inflamed. This can cause narrowing of the spinal canal, which can lead to nerve compression and pain. The MRI also shows a diffuse bulge of the disc, which means that the disc is bulging outwards and putting pressure on the spinal canal. The compression of the spinal canal and nerve roots can cause pain and weakness in the legs, as well as difficulty walking and standing. Your mother's symptoms are consistent with the findings on the MRI. Treatment options for your mother may include physical therapy, pain medication, and surgery. Physical therapy can help to strengthen the muscles around the spine and improve flexibility, which can help to reduce pain and improve mobility. Pain medication can help to manage the pain and improve your mother's quality of life. Surgery may be necessary in severe cases where conservative treatments have failed to provide relief. The type of surgery will depend on the specific cause of the nerve compression and the severity of the symptoms. I would recommend that your mother consults with a neurosurgeon to discuss the best treatment option for her. Thank you for your question.\"},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hi doctor,My father was previosuly diagnosed with renal tubular acidosis and diabetes mellitus, was maintained on Potassium citrate and Gliclazide OD. Currently he had an infected insect bite on the left anterior lateral aspect of the leg. He was started on CO-Amoxiclav BID. Currently on its 4th day, I had his labs taken which revealed HbA1c',\n",
       "  'output': 'Hi. High creatinine suggests a CKD picture for a long term diabetes particularly uncontrolled DM. Your fathers HbA1c is high which shows his diabetic status is not under control. High potassium levels is one of the complications of CKD, in this picture taking Potassium citrate is not advisable as it may increase its levels. And diabetic  ChatDoctor.  It is safe to shift the treatment with Insulin. You need to visit a Nephrologist for alterations in your medications and appropriate advice for CKD. serum potassium, sodium, phosphorusurine routineUSG abdomen DM, CKD',\n",
       "  '__index_level_0__': 31309,\n",
       "  'model_output': 'Hi, As per the labs the HbA1c is normal. You can continue the current medicines.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,I have recently felt lightheadedness for about a week. I went to the ER and they could not find anything wrong. They did all neuro testing and I passed. Blood work and urine are perfect. Blood sugar and blood pressure were perfect. Ekg came back perfect, no stomach issues. I do not feel like I have to vomit and drinking or eating does not help or make it worse. I have not fainted at all. I do have high cholesterol but I take fish oil every day and red yeast rice as recommended by the doctor. The only thing that makes it go away is if I lay down and sleep for a bit then I feel better. I have had a headache every now and then but it does not last very long. Is this a neuro or heart issue or something to do with my sinus? My ears do pop a lot lately. I do not feel dizzy. The room does not spin. Just a few times I feel like I have to lay down or I will faint.',\n",
       "  'output': 'Hello, Welcome to iclliniq.com. Probably you have an issue with your ear that may cause a block in the eustachian tube due to allergy or infection leading to vertigo. Other possibilities like acute labyrinthitis or vestibular neuronitis may cause your symptoms. Avoid smoking and caffeine  ChatDoctor.',\n",
       "  '__index_level_0__': 31310,\n",
       "  'model_output': 'The doctor suggests further discussion with the primary care physician or cardiologist to assess for any underlying conditions that may be contributing to the symptoms.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hi doctor,I seem to have a recurring spot on my back. Feels like a bite but it never heals and never goes away. It also has a brownish dark area on the skin around it. No pain.',\n",
       "  'output': 'Hi, Welcome to Chat Doctor forum. Exactly how long it has been there? Please send few more close up photographs? Any family history? Any history of diabetes mellitus or hypertension or any other medical illness?',\n",
       "  '__index_level_0__': 31311,\n",
       "  'model_output': 'Please consult a dermatologist for further evaluation.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hi doctor,My father has got a heart attack and was admitted to the hospital. He had chest pain, shortness of breath and no palpitations. He also has diabetes. I will post the picture of the medical report. Please share your opinion.',\n",
       "  'output': 'Hi, Welcome to Chat Doctor forum. He has got heart attack and also had old asymptomatic heart attacks which were painless due to diabetes (attachment removed to protect patient identity). At present, his heart function is weak at around 30%. Normally, it is more than 55% and due to which his blood pressure was low and fluid accumulation in lungs leading to shortness of breath. From now onwards, he should be very regular in his medicine which is prescribed. The prescription is good and contains all necessary medication. He should have a strict restriction of salt and liquids intake like water, tea, and coffee. Otherwise, there may be an increase in shortness of breath.',\n",
       "  '__index_level_0__': 31312,\n",
       "  'model_output': 'Hi, the diagnosis of heart attack is based on the clinical findings and the results of the cardiac biomarkers (troponin and creatinine kinase MB). In your father, the diagnosis of heart attack is unlikely because he did not have any chest pain or palpitations. He also did not have any abnormal ECG findings. He has diabetes which can lead to heart attack but he does not have any other risk factors such as smoking, high blood pressure, high cholesterol or obesity. So, the diagnosis of heart attack is unlikely in your father. However, he should be evaluated by a cardiologist to rule out any other underlying heart condition. He should also be evaluated for any other possible causes of his symptoms such as pneumonia or lung disease.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"What advice or recommendations does the doctor provide in response to the patient's concerns?\",\n",
       "  'input': 'Hello doctor,I am 14 years old and I weigh 220 pounds. I am 5 feet in height. I have this wound on my belly for two months and I have been trying to heal it but I put a Band-Aid on it and then it became red and swollen. Please help. I have been on growth hormones in the past.',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. From what you have mentioned, you have an unhealed wound in the abdomen for two months. This is considered delayed healing as the wound should heal within one week. Causes of delayed healing could be due to an infected wound, presence of a foreign body and/or diabetes. Please provide me with a photo of the wound and it will be helpful. Your blood sugar level and CBC (complete blood count) are important. I feel a local antibiotic is required. Systemic antibiotic if fever is present. You need regular  ChatDoctor.  Follow up is required. For more information consult a general practitioner online',\n",
       "  '__index_level_0__': 31313,\n",
       "  'model_output': \"Hi there, I'm sorry to hear about your wound. I would recommend that you see a dermatologist for a proper evaluation. In the meantime, you can try to keep the wound clean and dry, and apply an antibiotic ointment to help prevent infection. It's also important to maintain a healthy diet and exercise routine to help promote healing and weight loss. I hope this helps! Please let me know if you have any other questions.\"},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello doctor,My 2 year old daughter was diagnosed diabetic and I am giving four units of Lantus and two boluses Novo rapid for each meal three times. But still, her sugar levels are not in control. We give her low-carb and proper diet. What should we do now as none of the doctors we consulted are able to guide us in the proper direction?',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. I just read your query. From what you have mentioned, it appears that your daughter has insulin-dependent diabetes mellitus and you are concerned about her high blood sugar. Hope you will do the needful and get back. Revert with more information to an endocrinologist online',\n",
       "  '__index_level_0__': 31314,\n",
       "  'model_output': 'Hi, I would like to know how high are the sugar levels? And what is the sugar level at the time of breakfast and dinner? I would like to know the sugar level before and after meals. Also, I would like to know what is the blood sugar level at the time of breakfast and dinner? If the sugar levels are high, I would recommend insulin injections. You can consult a doctor who can guide you. Regards.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Generate a comprehensive medical response based on the patient's query.\",\n",
       "  'input': 'Hi doctor,I have ringworm on my arm. I used Daktarin and that did not work. Then I used cider vinegar and it has turned black. Should I be worried?',\n",
       "  'output': 'Hi. I have read your query in detail and do understand your concern. Also I have viewed the attached pictures (attachment removed to protect patient identity). This is irritant dermatitis which has developed due to the use of vinegar. It is very less probable that the fungal infection has been cured. Proper oral and topical medicine for one or two months is needed to cure your disease. Remember to wear loose cotton clothing especially when at home. Avoid hot humid climate, keep the affected area  ChatDoctor.  If any other family members are affected, they must also be adequately treated to prevent recurrence. Also get your blood sugar levels tested. Meanwhile, you may apply antifungal cream such as Clotrimazole twice daily over the lesions of ringworm. Revert back with the answers for the above questions to a dermatologist online  Take care.',\n",
       "  '__index_level_0__': 31315,\n",
       "  'model_output': 'Hi, Thanks for writing in to us. Yes, you can be worried. It is always better to consult a dermatologist and get a prescription for an antifungal cream. I would suggest you to use a combination of antifungal creams like Lamisil and ketoconazole cream. If you have any doubts, please feel free to write back to us. Thanks.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"What advice or recommendations does the doctor provide in response to the patient's concerns?\",\n",
       "  'input': 'Hello doctor,My mother is 75 years old. She had been treated for TB (tuberculosis) of the abdomen as her ultrasound of abdomen finding was thicken bowel loop. In general terms, it was informed about TB in her abdomen. Accordingly, medicines were given to her as per the advise of a local MD doctor. Treatment continued for three months and due to some discontinuation of medicine it relapsed and again she was diagnosed with Thicken bowel loop as per USG. Again treatment continued.However, while undergoing treatment she lost sensation in her legs and complained of losing sensation in her legs and numbness in her feet and was unable to put on slippers in her feet with difficulty in moving. She also complained that while moving she felt as if she was moving on a bed of soft cotton.Subsequent treatment by neuro experts revealed that overdose of treatment of her TB in abdomen resulted in this condition and she was diagnosed for peripheral neuropathy and was advised for biopsy for proper diagnosis. Meanwhile, she fell and hurt herself which was later on diagnosed that her spine at L3 - L4 was compressed due to felling abruptly and accordingly she was advised to take bed rest for three months. Slowly, she recovered from this condition felt pain in her back and was facing another kind of problem as she could not sit for a longer time and preferred to lay down on the bed.Finding her bad condition subsequetly, we also took consultation from other neuro experts at a prestigious institution where she was prescribed Lupivitin one tablet and Sammy one tablet.When condition persisted thereafter she was given Primosa one tablet daily, Neurox one tablet daily, Maxglobin 50 mg one tablet and Defart 6 mg.But, whenever she was given medicine her condition further aggravated. After about six months of treatment by the neuro expert, she has now been referred to the department of immunology for their advice. Meanwhile, we also took advice from a rheumatologist who diagnosed a kind of arthritis and started treating accordingly. He also started the course of Defzacort (steroid) along with other medicines. The steroid was prescribed with a decreasing dose per week from 60 mg per day to 6 mg per day.However, after taking about two months of steroid course her condition deteriorated and had severe breathlessness. Her blood sugar level also shot up and ultimately she was hospitalized and the treatment of steroid withdrawn. After 15 days of treatment at the hospital she recovered to her previous condition. But, her neuro problem of numbness in her legs and loss of sensation in legs still continues. Please help.',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. I have carefully gone through the details provided by you and have short-listed the following possibilities. Isoniazid-induced peripheral neuropathy, which occurs in a few patients who are on anti-tubercular  ChatDoctor.  The specific treatment for',\n",
       "  '__index_level_0__': 31316,\n",
       "  'model_output': \"Hi,Thank you for your query. I have gone through your mother's medical history and understand her concern. I would like to inform you that her numbness and loss of sensation in legs is due to peripheral neuropathy. It is a complication of Tuberculosis treatment. It is due to Vitamin B deficiency. I would advise her to take Vitamin B complex for 3 months. It will help her in recovery. Please do not stop the medicines. It is very important for her. If the numbness is not improving then please consult with your doctor. I hope this helps. Regards,Dr. Gaurav\"},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Provide a concise and actionable answer to the patient's question.\",\n",
       "  'input': 'Hi doctor,I have few questions which I would like to ask a professional. As I am not able to find the answers by myself, I would love to hear from a practicing professional.How is the best Insulin treatment (syringe, pen, pump and pod) selected for a type 1 diabetes patient? Generally, how long the patients need to learn the injecting technique? Why does injecting Insulin into the same location cause a hard bump in that area? Is this reaction the reason ports are not used to deliver Insulin? How common is the use of the new inhaled Insulin? Does it have to be supplemented by another method of injection? When would an islet cell transplant be recommended? When would a patient be given an entire pancreas transplant operation rather than an islet cell transplant? In both situations, what keeps the beta cells from being tagged by autoantibodies and destroyed again?',\n",
       "  'output': 'Hi, Welcome to Chat Doctor forum. Rather than the best way, we consider more convenient and economical ways for the patient. The best is always an Insulin pump, but it is costly and requires continued patient education. Injecting Insulin into the same site will cause damage to the fat tissue which results in necrosis (cell death). Because of the fat damage, hard bump forms. New inhalation Insulin is not yet come into usage in full fledges. Also, I have not put any of my patients yet on inhaled Insulin, so cannot comment. But yes, initially it has to be supplemented with subcutaneous Insulin as dosing and efficacy is not completely established for Inhaled Insulin. Islet cell transplant is recommended for patients of type 1 diabetes who are difficult to control on Insulin (by any method). If the transplant is considered for only diabetes purpose then only islet cell transplant is sufficient. The pancreas has other functions like digestion. If the digestion system gets impaired in a patient who is requiring islet cell transplant, in such a patient\\\\\\\\sentire pancreas transplant would be helpful. Well, if no immunosuppressant is used post-transplant, these autoantibodies can destroy the newly transplanted pancreas also.',\n",
       "  '__index_level_0__': 31317,\n",
       "  'model_output': \"Dear Patient, I have addressed your questions below: How is the best Insulin treatment (syringe, pen, pump and pod) selected for a type 1 diabetes patient? Generally, how long the patients need to learn the injecting technique? Why does injecting Insulin into the same location cause a hard bump in that area? Is this reaction the reason ports are not used to deliver Insulin? How common is the use of the new inhaled Insulin? Does it have to be supplemented by another method of injection? When would an islet cell transplant be recommended? When would a patient be given an entire pancreas transplant operation rather than an islet cell transplant? In both situations, what keeps the beta cells from being tagged by autoantibodies and destroyed again? Best Insulin treatment is chosen based on patient's preference, convenience, and adherence. Generally, patients need to learn injecting technique within 1-2 weeks. Injecting insulin into the same location can cause a hard bump due to tissue damage and inflammation. This reaction is not the reason ports are not used to deliver insulin. Inhaled insulin is not commonly used due to its short duration of action and potential side effects. It may be supplemented by another method of injection. Islet cell transplant is recommended for patients with type 1 diabetes who have severe hypoglycemia despite optimal insulin therapy and have no contraindications for transplantation. Pancreas transplant is recommended for patients with type 1 diabetes who have severe hypoglycemia and have failed islet cell transplant or have contraindications for transplantation. In both situations, beta cells are protected from being tagged by autoantibodies through immunosuppression therapy. Please consult your healthcare provider for further guidance and personalized advice. Best regards,\"},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,I have white patch on my face. It was very pale but when I apply Fluticasone, it appears as white even my cheeks are rough and slightly depigmented.',\n",
       "  'output': 'Hello. How long it has been there? What are the symptoms of it? Any other area affected? Any other family members affected? Any history of hypertension? Diabetes mellitus? Thyroid disorder? Any known  ChatDoctor.',\n",
       "  '__index_level_0__': 31318,\n",
       "  'model_output': 'Please consult your dermatologist for further evaluation.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Generate a comprehensive medical response based on the patient's query.\",\n",
       "  'input': \"Hello doctor,I have had a lot of hair loss in the past year. Mostly on top of my head. Lost half my hair. My regular doctor did not find anything wrong with my blood test and said hair loss affects a lot of women and accept it. My new Naturopath thought my numbers seemed low and suggested iron and thyroid supplements. I need another opinion.I have tested positive for Hashimoto's, and I have ankylosing spondylitis. The dermatologist did scalp bio negative for inflammation. My TSH is 3.71, T4 is 99, T3 is 110, and FSH is 8.1. The values of zinc is 82, ferritin 36, Iron 93 and TIBC 315. Please help me know what I should do?\",\n",
       "  'output': 'Hello. Hair loss in females can be due to many causes, most common being 1. Telogen effluvium stress-induced, due to illness, a diet with low protein intake, surgery, post-pregnancy, and mental stress. 2. Female pattern alopecia is genetic and hormone-mediated, runs in the family. 3. Diffuse alopecia areata is autoimmune condition usually associated with other autoimmune disorders like diabetes, thyroid disorders, and ulcerative colitis. 4.  ChatDoctor.',\n",
       "  '__index_level_0__': 31319,\n",
       "  'model_output': 'Hi there, Thanks for writing in. I read your query and understand your concern. I would like to know more about your symptoms and treatment taken so far. I would suggest you to take the following tests: -Complete blood count -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D levels -Rheumatoid factor -Erythrocyte sedimentation rate -Ultrasonography of abdomen -Chest X-ray -ESR -Complete blood count -Serum iron -Total iron binding capacity -Ferritin -TIBC -Serum zinc -Vitamin D'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor, I have an erection problem and I cannot have a morning erection too. I am married but my penis becomes soft while having intercourse. I have done all tests like penile doppler, scrotum, diabetes, and prolactin but all were normal. What is wrong with my sexual organs? Please guide me to solve this problem. I am currently taking Eract X twice daily.',\n",
       "  'output': 'Hi. Coming to your query, I have some questions. Do you have diabetes or hypertension? Are you on any kind of medication other than you mentioned? What does Eract contain (is it L-arginine with a multivitamin)? Is your erection tight enough such that you able to penetrate into the vagina and after that it becomes flaccid? Are you able to masturbate and ejaculate?',\n",
       "  '__index_level_0__': 31320,\n",
       "  'model_output': \"Hi, thanks for writing in. I understand your concern. Erection problem can be due to various reasons. It can be due to psychological problems like stress, anxiety, depression. It can also be due to low testosterone levels. It can also be due to diabetes. Diabetes can affect the blood vessels and nerves of the penis. This can lead to erectile dysfunction. It can also be due to nerve damage from spinal cord injury or surgery. It can also be due to side effects of certain medications. It can also be due to vascular disease. It can also be due to hormonal imbalances. It can also be due to Peyronie's disease. It can also be due to prostate cancer. It can also be due to heart disease. It can also be due to kidney disease. It can also be due to liver disease. It can also be due to blood pressure. It can also be due to cholesterol. It can also be due to obesity. It can also be due to smoking. It can also be due to alcohol. It can also be due to stress. It can also be due to anxiety. It can also be due to depression. It can also be due to low testosterone levels. It can also be due to low libido. It can also be due to low self-esteem. It can also be due to low confidence. It can also be due to low motivation. It can also be due to low energy levels. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It can also be due to low mood. It\"},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hi doctor,I am a 53 year old lady with controlled DM for four years and mild hypertensive for two years, I have received Influenza vaccine and Meningococcal vaccine on the same day in both upper arm sides before one week. Today, I developed painful swelling with redness in my left upper arm at the injection site. What is the home treatment for my case?',\n",
       "  'output': 'Hi. High blood sugar or poor control. Blood sugar profile and HbA1C. Cellulitis. Injection site infection in people with diabetes. Antiseptic cleaning, reduce blood sugar and dose adjustment of Glucophage.  Take care.',\n",
       "  '__index_level_0__': 31321,\n",
       "  'model_output': '16-08-2017 - 05:22 PM, Dr. Saurabh Gupta\\nHi, You should consult your doctor and get the injection site checked for any abscess or infection.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,I would like to know the results of my brain MRI. I do not know what this bright spot near the vestibular nerve is? Can it be vestibular schwannoma? Or something else in some cranial nerves or near the brain stem. In the second picture that is highlighted what can this white cluster shaped thing be?I have got a few symptoms. For the past three months, I have had tingling and needle sensation starting from the right eyebrow then radiating towards the left side and the entire forehead and right eyelid and sometimes even towards the tip of the nose. The sensation never stops no matter what I do. I feel dizzy all the time like if I am on a boat. When I tilt my head and move it gets even worse and starts spinning. I have a hard time looking at an object and cannot focus. My left eye is getting blood red whenever I look at a screen. My doctor prescribed Cortisone tablets that did not help. My left ear feels clogged and my hearing on that ear is reduced too.I also have tinnitus lately on the same ear. Doctors at first thought it was due to B12 or Iron deficiency but both are at normal range. My blood pressure is normal too. Lately, I have this numbness and tingling sensations om my feet and fingers too and whenever I visit the toilet when I check the stool is yellowish color and floats on the water and no solid shape. The full blood tests show absolutely normal for liver, pancreas and bile. Blood sugar levels are also normal.',\n",
       "  'output': 'Hi, Welcome to Chat Doctor forum. I have seen the reports. (attachment removed to protect patient identity).  The white area in the circle is likely minimal fluid and mastoid effusion in the left mastoid temporal bone, in the inferior air cells area. It can be due to a mild left middle ear infection. Your symptoms of feeling dizzy and spinning and left ear problems can be explained by the finding. There are less changes of vestibular schwannoma in the area. There are no other lesions in the brain.',\n",
       "  '__index_level_0__': 31322,\n",
       "  'model_output': \"Hello,Thank you for your query. I have seen your MRI report and it shows a bright spot at the right vestibular nerve. This bright spot is not a tumor. It is a normal finding. The cluster shaped thing in the second picture is a normal finding. It is called choroid plexus. It is the structure which secretes the cerebrospinal fluid. Your symptoms are related to Meniere's disease. Meniere's disease is a condition which affects the inner ear. It is characterized by episodic attacks of vertigo (spinning sensation), hearing loss, tinnitus (ringing in the ear) and aural fullness (sensation of ear being full). The cause of Meniere's disease is not known. It is thought to be due to abnormal fluid collection in the inner ear. The mainstay of treatment for Meniere's disease is a low salt diet. Salt restriction helps to reduce the fluid collection in the inner ear. In addition to this, diuretics are used to decrease the fluid collection in the inner ear. In some patients, the symptoms are severe and require surgical intervention. In severe cases, a surgery called vestibular nerve section is performed. In this surgery, the vestibular nerve is cut. This nerve is responsible for transmitting the signals from the inner ear to the brain. Cutting of this nerve reduces the vertigo and other symptoms. I hope this helps. Please feel free to ask any follow-up questions.\"},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello doctor,Please advise me. I have blood pressure 157/77 and pulse 97, blood sugar 88. My age is 44 years, sex is male and very light pain in the heart at the same time.',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. Your systolic blood pressure is elevated. Do you smoke? Do you have diabetes? Are you overweight? Some advice to lower BP is as follows. Stop smoking and paan, etc. Reduce weight, adopt an active lifestyle, do a brisk walk, reduce salt intake in the diet, reduce saturated and trans fat in the diet. Check BP regularly. If after adopting all these, still, BP remains elevated, you may take medication after one month or so. Tablet Lisinopril 10 mg at bed time daily. Make sure your kidney function is normal before starting this medicine. This medicine may cause reduced BP in initial days. So, take it at bed time only. After 15 to 20 days you may switch it to day time. Check BP regularly. I recommend first to make lifestyle modifications. If BP normalizes, then there is no need to take medicine.',\n",
       "  '__index_level_0__': 31323,\n",
       "  'model_output': 'Hi,Please consult your physician for further evaluation. Regards,Dr. Anil'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,I am a 19-year-old male. A week ago my thumb became numb below the fingernail. It was numb for two days and this went away. Now my left middle finger and the ring finger are numb and my right thumb feels sore. I also have a burning sensation in the feet, sometimes it feels like there is water or ice on my feet. My right knee feels stiff and then I switch to my left knee. My doctor looked confused and said it was all anxiety. Really, I do not think so. Could this be an early sign of diabetes?',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. I have read through your question and I would like to tell you that peripheral neuropathy can happen in a patient with diabetes which does present in the form of burning sensation in the feet and neuropathic pain. At your age, type 1 diabetes that is insulin-dependent diabetes mellitus is more common. It can be diagnosed by a blood sugar profile. I would advise you to get an ESR (erythrocyte sedimentation rate), RF (rheumatoid factor), and CRP (C-reactive protein) done to diagnose the cause of the stiffness. If these tests come clear then most likely it a neuropathic pain caused due to a nerve compression for which we may need to get an MRI (magnetic resonance imaging). In the meanwhile, I suggest you can start taking tablet Neurobion Forte (multivitamin supplement) and let me know if you feel any improvement. Consult your specialist doctor, discuss with him or her and with their consent take the medicines. Thank you. For more information consult a family physician online',\n",
       "  '__index_level_0__': 31324,\n",
       "  'model_output': 'Follow-up steps may include: 1) Lab testing to assess blood glucose levels, 2) Diet and lifestyle changes to manage blood glucose levels, 3) Monitoring for signs and symptoms of complications associated with diabetes, and 4) Referral to a specialist for further evaluation and management.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Generate a comprehensive medical response based on the patient's query.\",\n",
       "  'input': 'Hello doctor,I am a 27-year-old man. Sometimes, I feel very weak. My BP goes down and I am unable to stand properly. Also, there is a pain in my foot. Please tell me the treatment to cover this type of problem.',\n",
       "  'output': 'Hello. You have two main concerns. The weakness is not due to low blood pressure. The low blood pressure can lead to dizziness and inability to stand as described by you. For that try to maintain hy ChatDoctor.  You can check your blood sugar level as well. For tiredness, I suggest you investigate with serum potassium, serum sodium estimation, serum TSH (thyroid stimulating hormone) estimation, CBC (complete blood count), liver profile, and kidney profile. You can revert back with reports. For pain in the foot, avoid prolonged standing or walking. It is advisable to investigate with X-ray foot for further work up. You should get checked your serum calcium and vitamin D level as well.',\n",
       "  '__index_level_0__': 31325,\n",
       "  'model_output': 'Hi, Thanks for writing in. Please clarify the following: 1) Is the pain in your foot a constant pain or is it only there when you are walking? 2) Do you have any history of diabetes or any other illness? 3) Do you have any history of injury to your foot? 4) What is your blood sugar level? 5) Is there any swelling in your foot? Please answer the above questions so that we can provide a more accurate diagnosis. Thanks, Dr. Raghunandan'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Provide a concise and actionable answer to the patient's question.\",\n",
       "  'input': 'Hi doctor,My fasting blood sugar is 159.8 mg/dL. My postprandial blood sugar is 280.7 mg/dL. My BP is 160 by 90 mmHg.',\n",
       "  'output': 'Hi. From your laboratory report, I can see your blood glucose levels at a higher level than its normal range. HbA1C level (glycosylated hemoglobin) in blood will give us a better idea about your blood sugar control. You may need to start a treatment to reduce the blood sugar levels. Also, your blood pressure is also slightly high. Treatment for reducing your blood pressure and blood sugar will require a detailed study of your past medical history, your family history, your  ChatDoctor.  It is difficult to achieve all this soon. I suggest you meet a doctor for proper clinical evaluation and subsequent treatment of your condition. Try to avoid taking processed sugar and sweets, and salty food. Take increased intake of water and raw vegetables, and try to do exercise for at least 30 minutes daily.',\n",
       "  '__index_level_0__': 31326,\n",
       "  'model_output': 'Please consult a doctor in person.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello doctor,I am a 40-year-old dental surgeon with no past or present health issues and I am trying to conceive. I have a regular cycle of 28 days and I have consulted a gynaecologist before who has put me on Clomid for three months. I have also taken all the required fertility tests which show normal values that are needed for conceiving. This cycle I had all the pregnancy symptoms like implantation spotting for two days, tender breasts and lower abdominal mild cramps for a week after spotting. However, I have got a negative urine and blood test, blood hCG level being 1.2 mIU/mL. On the first day of the last period, there was spotting and light bleeding was seen for three to four days. I tested for blood hCG after seven days and it showed <1.2 mIU/mL. I want to know if there is still a chance that I could be pregnant and retest myself after a few days?',\n",
       "  'output': 'Hello. As your serum beta hCG (human chorionic gonadotropin) result is also negative it definitely indicates you have not got pregnant in this cycle. The symptoms you have mentioned could also be possible because of the progesterone hormone secretion in the postovulatory phase which may mimic pregnancy and the spotting could be due to the breakthrough bleed. A possibility of delayed conception can be taken into consideration but because the serum beta hCG is negative it is ruled out. I would suggest you get your day two LH (luteinizing hormone), FSH (follicle-stimulating hormone), prolactin, TSH (thyroid-stimulating hormone) levels, fasting blood sugar and postprandial blood sugar levels, and serum AMH (anti-Mullerian hormone) levels and an HSG (hysterosalpingography) done and let me know the results.  The treatment plan would be ovulation induction with a follicular study. For more information consult an obstetrician and gynaecologist online',\n",
       "  '__index_level_0__': 31327,\n",
       "  'model_output': 'Hi, thank you for your query. The most common cause of implantation bleeding is implantation of the fertilized egg in the endometrium. This happens about 6 to 12 days after ovulation and fertilization. Implantation bleeding is usually light and lasts only a few days. This type of bleeding is different from the bleeding that occurs with a normal menstrual period. The bleeding with implantation is usually pink or brown and does not cause cramps or other symptoms. It is important to note that implantation bleeding does not always mean that a woman is pregnant. There are other causes of implantation bleeding, such as ectopic pregnancy or an incomplete miscarriage. If you are concerned about your pregnancy, it is important to consult your doctor. They will be able to perform the necessary tests to determine if you are pregnant and if there are any complications. I hope this information is helpful. Best wishes.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor,Last night I ate a cheese pizza and a chocolate bar. Eight hours later (after fasting) I tested my blood sugar and it came out at 128, and 30 minutes later it dropped to 106, and 15 minutes later it raised to 109 (without eating and drinking anything). My question is, do I have diabetes or did I initially have high sugar because I ate pizza very late at night?',\n",
       "  'output': 'Hello. Usually fasting blood glucose is 126 mg and above is considered as diagnostic for diabetes. However, it is also possible that because of the dinner, fasting glucose might have shown a higher level. So to confirm whether there is diabetes or not, you may have to get a PP (postprandial) glucose level and HbA1c %. If PP is 200 mg and above and HbA1c % 6.5 % and above, then diabetes is considered to confirm. Looking at your weight and height, another important fact is with a BMI of 42.92 kgs/Sq meter you are already in grade 3 obesity. With a significant amount of excess weight. This itself is an invitation for getting diabetes.',\n",
       "  '__index_level_0__': 31328,\n",
       "  'model_output': \"Hi, I'm Dr. Sangeetha. I'm a certified doctor on JustBelowDiabetes.com. I would like to help you with your question. Please provide me with more details about your condition.\"},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Provide a concise and actionable answer to the patient's question.\",\n",
       "  'input': 'Hello doctor,I am 70 years old. My blood pressure is usually normal. However, it spikes. This morning I woke up feeling nauseous, dizzy, cold feet, shaky and it is 146/86, pulse 84. Why does this happen?',\n",
       "  'output': 'Hello. After reviewing your medical history, I would like to explain that you need to closely monitor your blood pressure values for a couple of days (several times daily) in order to conclude on your average BP trends. It seems that an abnormally elevated high BP value may have caused your complaints. Anyway, it is necessary to discuss with your doctor on the possibility of performing a medical checkup, including a careful physical exam and some laboratory tests like complete blood count, thyroid, renal and liver function tests, fasting blood glucose level, blood electrolytes level, an ECG at rest. In case several BP values result abnormally high you may need to start an anti-hypertensive therapy. You should discuss with your attending doctor on the above-mentioned issues.',\n",
       "  '__index_level_0__': 31329,\n",
       "  'model_output': 'Hi, Thanks for writing in. It could be due to dehydration or due to some other reason. Please consult your doctor and get yourself checked. Regards.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello doctor,I am 24 years old, student. Recently, during a sexual intercourse I felt an acute pain after which I suddenly stopped. The next day I had swelling all around my penis. It seems like the foreskin has swollen. I was a bit worried so I visited the GP here who advised me to take anti-bacterial, anti-fungal and anti-inflammatory medicines. The dosage is over but the swelling still persists. The penis and genital area feels itchy at times and sometimes has a foul smell too. The medications recommened by the GP were as follows',\n",
       "  'output': 'Hello, Welcome to Chat Doctor forum. The foreskin of your glans is edematous and little inflammatory (attachment removed to protect patient identity). This condition may be due to vigorous sexual activity against the  ChatDoctor.  Possibility of balanoposthitis. So you may check blood sugar levels, complete blood picture. Wear soft cotton related innerwear. Apply Clotrimazole plus Betamethazone gel locally twice a day for five days. Use tablet Fluconazole 150 mg once a week for five weeks. If no improvement get it done local swab culture and microscopy. But do not worry, it is a simple condition, it may subside within one to two weeks. Take care.',\n",
       "  '__index_level_0__': 31330,\n",
       "  'model_output': 'It is possible that you have a bacterial infection. The GP’s recommendation for antibiotics is a good start. If the swelling has not improved after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections are more common in warm, moist areas, such as the genital area. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after a week of antibiotics, then it is possible that you have a bacterial infection. Bacterial infections can be treated with antibiotics. If the swelling does not improve after a week of antibiotics, then it is possible that you have a fungal infection. Fungal infections can be treated with antifungal medications. It is also possible that you have an allergic reaction to the antibiotics or the antifungal medication. If the swelling does not improve after'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What follow-up steps does the doctor suggest in their response?',\n",
       "  'input': 'Hello doctor, I am 45 years old, suffering from diabetes. I have fasting blood sugar avarage 140 to 150 and also I have urine infection showing pus cell in plenty. Kindly suggest me for controlling infection in urine.',\n",
       "  'output': 'Hello. I have read through your post and I can see that you are on antibiotic. However, the one you are taking is most likely not effective against urinary tract infections you are suffering from. It is important to treat the infection so I would advise you to get a culture and antibiotic sensitivity testing of your urine to see, what kind of organism is causing the infection and what antibiotic will likely to be effective against it. Based on the results, you can be put on the most suitable antibiotic for this. Please go to the hospital, if your symptoms worsen or if you develop fever, shivering or generally start to feel unwell.  Take care.',\n",
       "  '__index_level_0__': 31331,\n",
       "  'model_output': 'Hi, Thank you for writing in. You have to take antibiotics for urine infection. And for diabetes you have to take insulin and medicine for diabetes. And you have to take proper diet and exercise for controlling diabetes. Please consult your doctor for more details.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Provide a concise and actionable answer to the patient's question.\",\n",
       "  'input': 'Hi doctor,My doctor has advised taking Adava stat F tablet to reduce cholesterol. I have type 2 diabetes and my cholesterol 175.6, triglycerides 297, and HDL 24.5. So, do I need to take this and how long I need to take? The doctor said only three months or lifelong.',\n",
       "  'output': 'Hi, Welcome to Chat Doctor forum. We can say you have mix dyslipidemia with your results. This means you have a lipid disorder but at this point, you do not need medication. Medication for an increase in triglycerides should be taken when greater than 450 to 600 mg/dL or cholesterol LDL is greater than 130 and you have increased cardiovascular risk (which is not your case). DM (diabetes mellitus) 2 increases your heart risk so it is important you meet your goals of control. Treatment at this point includes exercise 30 min/day for five days per week with a low carbohy ChatDoctor.',\n",
       "  '__index_level_0__': 31332,\n",
       "  'model_output': \"Hi, I am glad that you are asking your doctor about the medication. Adava stat F is a combination of atorvastatin and fenofibrate, which are two different types of medications used to lower cholesterol levels. Atorvastatin is a statin, which works by blocking the production of cholesterol in the liver, while fenofibrate is a fibrate, which works by increasing the breakdown of triglycerides in the blood. Both medications can be effective in lowering cholesterol levels, but they have different mechanisms of action and may be prescribed together for individuals who have high cholesterol and triglyceride levels. However, it is important to note that fenofibrate can cause liver damage, and it is generally not recommended for individuals with liver disease or who are taking other medications that can affect liver function. It is also important to note that statins can increase the risk of muscle damage, especially in individuals with kidney disease. Therefore, it is important to discuss the potential risks and benefits of this medication with your doctor. In terms of how long you need to take this medication, it depends on your individual cholesterol levels and other factors. Your doctor may recommend a specific duration of treatment, or they may monitor your cholesterol levels over time and adjust your treatment accordingly. It is important to follow your doctor's instructions and to report any side effects or concerns you have while taking this medication.\"},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': 'What are the next steps or follow-up actions suggested in the doctor’s response?',\n",
       "  'input': 'Hello doctor,My mother is now 55 years and has been suffering from irritable bowel syndrome (IBS) for over a year. Her condition was not so bad before. She was diagnosed with intestinal disease and was given some antibiotics like Flagyl or Metronidazole. After she took those pills for a month, she had frequent loose or watery stool (without blood) and could not eat spicy or fatty food, sugar or any foods containing lactose. I found a probiotic supplement called Bifina, which helped a lot in controlling her toilet routine and her diet but needed to use together with Smecta. She still cannot eat spicy or fatty food, but she can have a drink or juice with an acceptable amount of sugar, which serves as a rehydration drink. She no longer has loose or watery stool. Once in a while if she reacts with a kind of food or eat more sugar than necessary, her stool will be softer with a few bubbles. In general, her bowel movement is under control.She is starting to recover but her long-term IBS resulted in her exhaustion. As I previously mentioned, she is now still using the probiotic supplement, Bifina, which helps a lot with the intestine treatment makes her easily feel tired or a little dizzy. I asked for support from a relative who works as a nurse because the doctors in my neighborhood just told her to get a rest and give her pills that did not help a lot. So, the nurse frequently gives her some vitamin B12 shots, Glucose 5% intravenous infusion and lactated Ringer\\\\\\\\s solution 500 ml for injection. This proves to help, but she tells me that she do not have enough energy. We went back to phlebotomy department to have her blood tested. It turned out to be fine, but every time her scores were very low. We thought the hospital could give her any session like fluid infusion or blood transfusion because she had diarrhea for over 10 months. It just stopped about 2 months ago and really has worn her out. But, they just informed me to go to another department like division of general internal medicine. We have already been there and have checked everything like x-ray, heart, liver, and kidney. Attached below are some images of her test results. Could you tell me if we are right to say she needs blood transfusion to help her recover better? Or she needs another solution? Or just stick to what we are doing now? I express a huge thanks for being patient and reading for so long now. I appreciate every answer. Thanks again.',\n",
       "  'output': 'Hi, Welcome to Chat Doctor forum. I have gone through your query and reports (attachment removed to protect patient identity). I can understand your concern. As you told that your mother had IBS (irritable bowel syn ChatDoctor.  Probiotics can help. She might have developed antibiotic induced diarrhea after taking tablet Flagyl (Metronidazole). I have seen her reports and they seem to be normal except ultrasound which is difficult to interpret as it is not clear.  No need to worry she might have developed malabsorption syn',\n",
       "  '__index_level_0__': 31333,\n",
       "  'model_output': 'Hello, Thank you for your question. I have read your query and I will be happy to help you. Your mother has been suffering from irritable bowel syndrome (IBS) for over a year. Irritable bowel syndrome (IBS) is a common condition that affects the large intestine (colon). It causes abdominal pain, bloating, and changes in bowel habits. The exact cause of IBS is unknown, but it is believed to be related to abnormalities in the way the gut and brain communicate with each other. IBS is more common in women than men and often begins during adolescence or young adulthood. It is estimated that IBS affects up to 20% of people in the United States. IBS can be classified into four main types based on the symptoms that are present: IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), mixed IBS (IBS-M), and unclassified IBS (IBS-U). The symptoms of IBS can vary from person to person, but they generally include abdominal pain, bloating, gas, and changes in bowel habits. These symptoms can be triggered by certain foods, stress, or hormonal changes. IBS can be difficult to diagnose because the symptoms are similar to those of other gastrointestinal disorders, such as inflammatory bowel disease (IBD) and celiac disease. A diagnosis of IBS is typically made based on the patient’s symptoms and a physical examination. There is no cure for IBS, but treatment can help manage the symptoms and improve the quality of life. Treatment options may include lifestyle changes, such as eating a low-fat, high-fiber diet and avoiding trigger foods, stress management techniques, and medications such as laxatives, antispasmodics, and antidepressants. It is important to work with a healthcare provider to develop a treatment plan that is tailored to the individual’s needs. IBS can be a chronic condition that can cause significant distress and impact quality of life. However, with proper treatment and management, it is possible to live a fulfilling life with IBS. I hope this helps. Regards, Dr. Parul.'},\n",
       " {'dataset': 'icliniq',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_subjective',\n",
       "  'instruction': \"Generate a comprehensive medical response based on the patient's query.\",\n",
       "  'input': 'Hi doctor,My Mother is 78 years old. She has high BP and diabetes. She takes regular tablets. She gets UTI at least once a year. She is currently complaining of a burning sensation all over the body. During the daytime, she passes very less urine. But during night time, she is going very frequently. I have uploaded her urine culture report. Please suggest.',\n",
       "  'output': 'Hi, Welcome to Chat Doctor forum. Do you have sonography of abdomen? If not, please do an ultrasound of abdomen with post-void residual urine to rule out any physical cause of UTI (urinary tract infection). As per the history, you can give tablet Levofloxacin 500 mg once daily for seven days and tablet Cranpac (Cranberry extract) twice daily for 30 days to prevent UTI. For more information consult an an ChatDoctor. ChatDoctor/ask-a-doctor-online/an',\n",
       "  '__index_level_0__': 31334,\n",
       "  'model_output': 'Hi, Thank you for writing to us. Please find attached the prescription. Regards, Dr. Prateek Agarwal.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': \"A known case of diabetes develops annular orange skin lesions, which disappear after biopsy. This phenomenon is known as? Please select one of the following: A) Koebner's phenomenon, B) Reverse Koebner's phenomenon, C) Asboe Henson sign, D) Isotopic phenomenon.\",\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31410,\n",
       "  'model_output': \"The answer is B) Reverse Koebner's phenomenon. Explanation: Reverse Koebner's phenomenon is a condition in which skin lesions disappear after biopsy.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': 'Muscle pain, nephropathy caused by which metal poisoning Please select one of the following: A) Arsenic, B) Cadmium, C) Mercury, D) Lead.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31411,\n",
       "  'model_output': \"The answer is C) Mercury. Explanation: Ans. is 'c' i.e., Mercury\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'Anticoagulant used  for blood glucose estimation is? Please select one of the following: A) Sodium fluoride, B) Oxalate, C) Double oxalate, D) Citrate.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31412,\n",
       "  'model_output': 'The answer is A) Sodium fluoride. Explanation: Sodium fluoride is an anticoagulant used for blood glucose estimation. It inhibits glycolysis and prevents glycolysis from glucose to pyruvate. It is also used for blood gas analysis and for preservation of blood samples.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 65 old male with a history of hypeension and diabetes, presents to the OPD with complaints of diplopia and squint. On examination, the secondary detion is more than the primary detion. Which of the following is most likely diagnosis Please select one of the following: A) concomitant squint, B) paralytic squint, C) Restrictive squint, D) Pseudo squint.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31413,\n",
       "  'model_output': 'The answer is B) Paralytic squint.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'True about gestational diabetes is ? Please select one of the following: A) These are increased chances of congenital malformation, B) Only 2% of women present with ove diabetes, C) There is chance of macrosomia, D) Usually diagnosed in early pregnancy.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31414,\n",
       "  'model_output': 'The answer is D) Usually diagnosed in early pregnancy. Explanation: Gestational diabetes is usually diagnosed in early pregnancy.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': 'Insulin mediated transpo of glucose is ? Please select one of the following: A) Seen in adipose tissue, B) Via GLUT-2, C) Main Mechanism in RBCs, D) All are true.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31415,\n",
       "  'model_output': \"The answer is A) Seen in adipose tissue. Explanation: Ans. is 'a' i.e., Seen in adipose tissue\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'Which common tracer in PET is usually administered in the form of a glucose sugar Please select one of the following: A) Oxygen 15, B) Fluorine 18, C) Saccharide - 12, D) Aluminum - 12.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31416,\n",
       "  'model_output': \"The answer is B) Fluorine 18. Explanation: Ans. is 'b' i.e., Fluorine 18 o PET imaging is based on the use of radioactive tracers (radiopharmaceuticals).o These tracers are injected into the blood stream and are distributed in the body according to their physicochemical properties.o They are detected by a PET scanner.o PET scanners detect the emission of positrons (positively charged electrons) from the tracers.o The tracers are usually administered in the form of glucose sugar (FDG).o The FDG is metabolized by the cells in the body.o The cells that use glucose actively are cancerous cells.o The FDG is also metabolized by the normal cells.o But because of the increased glucose metabolism, the cancerous cells take up more FDG than the normal cells.o The FDG is detected by the PET scanner and the areas with increased FDG uptake are cancerous areas.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': \"Prutchners retinopathy in associated with - Please select one of the following: A) Diabetes Mellitus, B) Wilson's disease, C) Head trauma, D) Rheumatoid ahritis.\",\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31417,\n",
       "  'model_output': \"The answer is A) Diabetes Mellitus. Explanation: Ans. A) Diabetes Mellitus (Ref: Nelson's 17/e, 1/e p. 1320)Purtscher's retinopathy (Purtscher retinopathy, Purtscher's retinopathy, Purtscher's syndrome, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, retinal Purtscher's angiopathy, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's retinopathy, Purtscher's retinal angiosclerosis, Purtscher's retinal angiopathy, retinal angiosclerosis, retinal angiopathy, Purtscher's angiosclerosis, Purtscher's angiopathy, Purtscher's\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'CSF/plasma glucose ratio is ? Please select one of the following: A) 0.2 - 0.4, B) 0.6 - 0.8, C) 1.2 - 1.6, D) 1.6 - 2.2.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31418,\n",
       "  'model_output': 'The answer is A) 0.2 - 0.4. Explanation: CSF/plasma glucose ratio is 0.2 - 0.4'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'In a case having multiple caries, peripheral neuropathy and salivary gland aplasia. Lab investigation of choice is: Please select one of the following: A) Serum folate, B) Anti Ro/La, C) Serum iron, D) Alkaline phosphatase.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31419,\n",
       "  'model_output': \"The answer is B) Anti Ro/La. Explanation: Ans. is 'b' i.e., Anti Ro/La\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'Insulin stimulated glucose uptake is by? Please select one of the following: A) SGLT-1, B) GLUT-1, C) GLUT-2, D) GLUT-4.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31420,\n",
       "  'model_output': \"The answer is D) GLUT-4. Explanation: Ans. d. GLUT-4 (Ref: Harper's Biochemistry, 29th ed/pg. 668)Insulin stimulated glucose uptake is by GLUT-4. Insulin stimulates glucose uptake in skeletal muscle and adipose tissue by: Inducing translocation of GLUT-4 from intracellular vesicles to the plasma membrane.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'Which of the following is the complication of diabetes mellitus: Please select one of the following: A) Macrovascular, B) Neuropathy, C) Nephropathy, D) All of the above.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31421,\n",
       "  'model_output': 'The answer is D) All of the above. Explanation: The answer is D) All of the above.Diabetes mellitus is a major risk factor for macrovascular and microvascular complications. The microvascular complications are retinopathy, neuropathy, and nephropathy. Macrovascular complications are coronary artery disease, peripheral vascular disease, and cerebrovascular disease.Diabetes is the most common cause of end-stage renal disease. In addition, diabetes is a major risk factor for atherosclerosis, coronary artery disease, and peripheral vascular disease.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': 'Ove gestational diabetes is defined as blood glucose more than_? Please select one of the following: A) >200 mg/dl, B) >126 mg/dl, C) >100 mg/dl, D) >180 mg/dl.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31422,\n",
       "  'model_output': 'The answer is A) >200 mg/dl. Explanation: Ove gestational diabetes is defined as blood glucose more than 200 mg/dl.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'Glucose transpoer affected in diabetes mellitus? Please select one of the following: A) GLUT-2, B) GLUT-5, C) GLUT-4, D) SGLT-2.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31423,\n",
       "  'model_output': 'The answer is C) GLUT-4. Explanation: GLUT-4 is a glucose transpoer affected in diabetes mellitus.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'Where can glucose 6 phosphate not be conveed to glucose ? Please select one of the following: A) Muscle, B) Liver, C) Adipose tissue, D) Kidney.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31424,\n",
       "  'model_output': 'The answer is A) Muscle. Explanation: Glucose 6-phosphate is conveed to glucose in muscle. Glucose 6-phosphate is conveed to glucose in the following order: Glucose 6-phosphate - 6-phosphogluconate - ribulose 5-phosphate - xylulose 5-phosphate - xylulose - glyceraldehyde.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': 'Glucose-6-phosphate is the initial substrate for all of the following reactions except– Please select one of the following: A) Glycolysis, B) HMP shunt, C) Glycogenesis, D) Neoglucogenesis.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31425,\n",
       "  'model_output': 'The answer is D) Neoglucogenesis. Explanation: Glucose-6-phosphate is the initial substrate for glycolysis, HMP shunt and glycogenesis. Glucose-6-phosphate is not the initial substrate for neoglucogenesis.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': 'Vitreous hemorrhage in diabetic retinopathy ? Please select one of the following: A) Non-proliferative diabetic retinopathy, B) Proliferative diabetic retinopathy, C) Both, D) None.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31426,\n",
       "  'model_output': \"The answer is A) Non-proliferative diabetic retinopathy. Explanation: Ans. is 'a' i.e., Non-proliferative diabetic retinopathy\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'Drug used in both type 1 and type 2 Diabetes mellitus is? Please select one of the following: A) Metformin, B) Pramlintide, C) Coleselvam, D) Panconeline.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31427,\n",
       "  'model_output': 'The answer is A) Metformin. Explanation: Ans. A. MetforminDrug used in both type 1 and type 2 Diabetes mellitus isMetformin,Pramlintide, Coleselvam, Panconeline,'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'Characteristic feature of IgA nephropathy - Please select one of the following: A) Serum compliment level is normal, B) More common in old age, C) It is a tFpe of membranoproliferative GN, D) Gross hematuria presents after l0 days.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31428,\n",
       "  'model_output': \"The answer is A) Serum compliment level is normal. Explanation: IgA nephropathy is the most common cause of gross hematuria in children and young adults. It is also known as Berger's disease. The histopathological feature is the presence of mesangial deposits of IgA. IgA nephropathy is associated with hypocomplementemia and is characterized by a normal serum complement level.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'Which fungus is most commonly associated with orbital cellulitis in patients with diabetic ketoacidosis. Please select one of the following: A) Candida, B) Mucor, C) Aspergillus, D) Rhizopus.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31429,\n",
       "  'model_output': \"The answer is B) Mucor. Explanation: Ans. (b) Mucor(Ref: Harrison's Principles of Internal Medicine, 18th edition, Chapter 99)Mucormycosis is a rare, opportunistic, and potentially fatal infection caused by fungi of the order Mucorales. It is most commonly seen in patients with poorly controlled diabetes mellitus, chronic granulomatous disease, or prolonged corticosteroid therapy. The most common clinical syndrome is rhinocerebral mucormycosis, which involves the nasal cavity, sinuses, and adjacent structures and is associated with a high mortality rate. The fungus is most commonly associated with orbital cellulitis in patients with diabetic ketoacidosis.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'Glucose is principally absorbed by: Please select one of the following: A) Passive diffusion, B) Active transport, C) Facilitated transport, D) Exchange transport.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31430,\n",
       "  'model_output': 'The answer is C) Facilitated transport. Explanation: Facilitated transport is the mechanism by which glucose is absorbed in the intestine.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'Niacin therapy is contraindicated in diabetes because - Please select one of the following: A) Increases the blood sugar levels, B) Causes scleroderma, C) Difficult to give injection, D) Increases the metabolism of oral hypoglycemic drugs.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31431,\n",
       "  'model_output': 'The answer is A) Increases the blood sugar levels. Explanation: Niacin is a water-soluble vitamin of B complex. It is a coenzyme in many metabolic reactions and is involved in the synthesis of fatty acids and cholesterol. Niacin therapy is contraindicated in diabetes because it increases blood sugar levels. Niacin is contraindicated in patients with peptic ulcer, severe liver disease, and gout. Niacin therapy is associated with flushing, pruritus, and hepatotoxicity. Niacin increases the blood sugar levels. Niacin therapy is contraindicated in diabetes because it increases blood sugar levels. Niacin is contraindicated in patients with peptic ulcer, severe liver disease, and gout. Niacin therapy is associated with flushing, pruritus, and hepatotoxicity.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'Post Prandial capillary glucose should be mg/dl for adequate diabetes control Please select one of the following: A) < 100mg / dl, B) < 140 mg / dl, C) < 180 mg/dl, D) < 200 mg/dl.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31432,\n",
       "  'model_output': 'The answer is C) < 180 mg/dl. Explanation: Post prandial capillary glucose should be < 180 mg/dl for adequate diabetes control.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'Purtscher retinopathy is seen in? Please select one of the following: A) Alcoholic hepatitis, B) Acute pancreatitis, C) Methyl alcohol poisoning, D) None of the above.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31433,\n",
       "  'model_output': 'The answer is C) Methyl alcohol poisoning. Explanation: Purtscher retinopathy is a rare condition characterized by retinal infarction, which can be caused by a variety of underlying conditions, including systemic lupus erythematosus, thrombosis, pancreatitis, and sepsis. It is characterized by retinal hemorrhages, cotton-wool spots, and vascular occlusions, and is often associated with neurological manifestations such as confusion, seizures, and coma.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'A patient with diabetes and COPD developed postoperative urinary retention. Which of the following drugs can be used for sho term treatment to relieve the symptoms of this person? Please select one of the following: A) Bethanechol, B) Methacholine, C) Terazosin, D) Tamsulosin.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31434,\n",
       "  'model_output': 'The answer is A) Bethanechol. Explanation: Urinary retention is a common problem in men with prostatic hyperplasia and diabetes. The cholinergic drugs (bethanechol) increase urinary flow by relaxing the smooth muscle of the prostate and bladder neck. Methacholine is a parasympathetic agonist, which can be used to test bronchial hyperactivity in patients with asthma. Terazosin and tamsulosin are alpha-1 adrenergic antagonists, which are used in the treatment of prostatic hyperplasia.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'In poorly controlled Type I diabetes, most common infection is: Please select one of the following: A) Mucormycosis, B) Histoplasmosis, C) Cryptococcus, D) Rhinosporidiosis.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31435,\n",
       "  'model_output': \"The answer is A) Mucormycosis. Explanation: Ans. is 'a' i.e., Mucormycosis Infection in diabetes is most commonly caused by Mucormycosis.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'Normal renal threshold for glucose is at plasma glucose level ? Please select one of the following: A) 100 mg/dl, B) 200 mg/dl, C) 300 mg/dl, D) 400 mg/dl.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31436,\n",
       "  'model_output': 'The answer is B) 200 mg/dl. Explanation: Renal threshold for glucose is at 200 mg/dl.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': 'Traumatic optic neuropathy due to closed head trauma commonly affects which pa of optic nerve - Please select one of the following: A) Optic canal, B) Intra ocular pa, C) Intracranial pa, D) Optic tract.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31437,\n",
       "  'model_output': \"The answer is C) Intracranial pa. Explanation: (Ref: Harrison's Principles of Internal Medicine, 18th edition, pg. 2599) The optic nerve is vulnerable to injury by closed head trauma. The injury occurs in the intracranial pa of the nerve.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'Organ which can utilize glucose, FA and ketone bodies is - Please select one of the following: A) Liver, B) Brain, C) Skeletal muscle, D) RBC.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31438,\n",
       "  'model_output': \"The answer is A) Liver. Explanation: Ans. is 'a' i.e., Liver Liver is the only organ which can utilize glucose, FA and ketone bodies.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'Most common form of Diabetic neuropathy is? Please select one of the following: A) Distal symmetric sensory neurpathy, B) Distal symmetric sensory and motor neuropathy, C) Autonomic neuropathy, D) Motor neuropathy.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31439,\n",
       "  'model_output': 'The answer is A) Distal symmetric sensory neurpathy. Explanation: The most common form of diabetic neuropathy is distal symmetric sensory neuropathy.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'Hyperglycemia in Neonate if blood sugar is above – Please select one of the following: A) 150 mg/dl, B) 125 mg/dl, C) 180 mg/dl, D) 100 mg/dl.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31440,\n",
       "  'model_output': 'The answer is A) 150 mg/dl. Explanation: Hyperglycemia in neonate if blood sugar is above 150 mg/dl.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': 'The earliest feature of 3rd cranial nerve involvement in diabetes mellitus patient is - Please select one of the following: A) Normal light reflex, B) Abnormal light reflex, C) Normal light and accommodation reflex, D) Abnormal light and accommodation reflex.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31441,\n",
       "  'model_output': \"The answer is C) Normal light and accommodation reflex. Explanation: Ref: Harrison's Principles of Internal Medicine, 17th edition, page 2314.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'Earliest marker of renal damage in a known case of diabetes mellitus is Please select one of the following: A) Microalbuminuria, B) Glycosuria, C) Increased serum creatinine, D) Increased serum urea.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31442,\n",
       "  'model_output': \"The answer is A) Microalbuminuria. Explanation: Ans. is 'a' i.e., Microalbuminuria\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'Insulin is essential for glucose entry in? Please select one of the following: A) Muscle, B) Coical neurons, C) Renal tubular cells, D) Beta cells of pancreas.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31443,\n",
       "  'model_output': 'The answer is A) Muscle. Explanation: Insulin is essential for glucose entry in muscle, fat, and liver cells.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'Gene for insulin responsive glucose transpoer is located on chromosome? Please select one of the following: A) 7, B) 21, C) 17, D) 13.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31444,\n",
       "  'model_output': \"The answer is C) 17. Explanation: Ref: Harrison's Principles of Internal Medicine, 17th edition, Page 2656\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'Relationship between insulin and glucose concentration? Please select one of the following: A) Linear, B) Hyperbola, C) Sigmoidal, D) Bell Shaped.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31445,\n",
       "  'model_output': 'The answer is B) Hyperbola. Explanation: Ref: DM by V. Ramalingam, 1st edn, pg. 4'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'Neuropathy with INH therapy is least in patients? Please select one of the following: A) Having malnutrition, B) Alcoholics, C) Fast acetylators, D) Vitamin B complex deficiency.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31446,\n",
       "  'model_output': 'The answer is A) Having malnutrition. Explanation: Neuropathy is common with INH therapy, but it is least in patients with malnutrition.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'Glucose oxidase conves glucose to? Please select one of the following: A) Gluconic acid, B) Glucuronic acid, C) Iduronic acid, D) Galactic acid.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31447,\n",
       "  'model_output': 'The answer is A) Gluconic acid. Explanation: Glucose oxidase conves glucose to gluconic acid.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'Which is the best indicator for sho term control (2-3 weeks] of blood glucose ? Please select one of the following: A) Serum fructosamine, B) HbA lc, C) Blood sugar, D) Urine sugar.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31448,\n",
       "  'model_output': 'The answer is A) Serum fructosamine. Explanation: Serum fructosamine is an indicator of sho term control (2-3 weeks) of blood glucose. It is a glycated protein and is an indicator of control of blood glucose for the previous 2-3 weeks. HbA1c is an indicator of control of blood glucose for the previous 3 months. Blood sugar is a sho term indicator of control of blood glucose. Urine sugar is an indicator of sho term control of blood glucose.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'Glucose – 6- phosphatase enzyme is absent in? Please select one of the following: A) Liver, B) Kidney, C) Brain, D) Muscles.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31449,\n",
       "  'model_output': 'The answer is A) Liver. Explanation: Glucose-6-phosphatase is a key enzyme in gluconeogenesis and is found in liver and kidney. It is not found in brain and muscle.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'Following are the features of neuropathy associated with varicella-zoster infection except Please select one of the following: A) Persistent infection in neurons of sensory ganglia, B) With reactivation virus transpoed along nerves to skin, C) Shingles are distributed along motor dermatomes, D) Intranuclear inclusions are not found in peripheral nervous system.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31450,\n",
       "  'model_output': 'The answer is C) Shingles are distributed along motor dermatomes. Explanation: Varicella-zoster virus (VZV) is a neurotropic virus that causes two clinical syndromes: varicella (chicken pox) and herpes zoster (shingles). The virus is transmitted by direct contact with infected skin lesions, respiratory droplets, or aerosols. The incubation period for varicella is 14 to 21 days, whereas the incubation period for herpes zoster is 3 to 4 weeks. Infection with VZV produces a primary viremia, resulting in the seeding of neurons in the dorsal root ganglia and trigeminal ganglia. The virus remains dormant in these neurons until reactivation occurs, usually in the setting of immunosuppression. Reactivation results in a secondary viremia, which produces the characteristic dermatomal rash. The most common sites of herpes zoster reactivation are the thoracic (50%), trigeminal (25%), and lumbar (15%) dermatomes. VZV can be isolated from the vesicular fluid of the rash. The virus can be cultured from the cerebrospinal fluid of patients with encephalitis, and the virus can be detected in the cerebrospinal fluid of patients with meningitis. The virus can also be isolated from the blood of patients with disseminated infection. The diagnosis of herpes zoster is made clinically by the presence of a vesicular rash in a dermatomal distribution. However, the rash can be confused with other vesicular eruptions, such as herpes simplex, bullous impetigo, and varicella. The diagnosis of herpes zoster can be confirmed by the presence of intranuclear inclusions in the nuclei of infected cells, which are identified by immunohistochemical staining. VZV can be cultured from vesicular fluid, and polymerase chain reaction (PCR) can be used to detect the presence of viral DNA in vesicular fluid and cerebrospinal fluid. The diagnosis of herpes zoster can also be made by the detection of VZV-specific IgG and IgM antibodies in the blood.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'Urine test done for blood sugar level estimation is? Please select one of the following: A) Prescriptive screening, B) Prospective screening, C) Both of the above, D) None of the above.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31451,\n",
       "  'model_output': \"The answer is C) Both of the above. Explanation: Ans. is 'c' i.e., Both of the above Prescriptive screening - Screening is done when the doctor thinks that the patient is at risk of developing the disease. e.g., Screening for diabetes in a patient with obesity. Prospective screening - Screening is done on all individuals. e.g., Screening for diabetes in general population.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'Delayed onset polyneuropathy after OP poisoning is seen after? Please select one of the following: A) 1-2 weeks, B) 2-4 weeks, C) 4-6 weeks, D) 6-8 weeks.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31452,\n",
       "  'model_output': 'The answer is A) 1-2 weeks. Explanation: Delayed onset polyneuropathy after OP poisoning is seen after 1-2 weeks.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'HLA marker associated with diabetes mellitus type 1 is - Please select one of the following: A) B 7, B) DR 4, C) DQ 3, D) DQ 4.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31453,\n",
       "  'model_output': 'The answer is B) DR 4. Explanation: DR 4 is the most common HLA marker associated with diabetes mellitus type 1.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'Glucose-6-phosphate dehydrogenase need - Please select one of the following: A) NAD, B) NADP, C) FAD, D) FMN.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31454,\n",
       "  'model_output': 'The answer is B) NADP. Explanation: Glucose-6-phosphate dehydrogenase requires NADP.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'Female with blood sugar of 600 mg% and sodium of 110 mEq. Insulin was given, what will happen to serum sodium levels ? Please select one of the following: A) Sodium increase, B) Sodium decrease, C) Sodium unaffected, D) Relative sodium deficiency.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31455,\n",
       "  'model_output': 'The answer is C) Sodium unaffected. Explanation: Insulin increases the entry of potassium into the cells. This increases the serum sodium levels.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'Glucose is conveed to glucuronate by ? Please select one of the following: A) Oxidation of aldehyde group, B) Oxidation of terminal alcohol, C) Oxidation of both, D) None.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31456,\n",
       "  'model_output': \"The answer is B) Oxidation of terminal alcohol. Explanation: Ans. is 'b' i.e., Oxidation of terminal alcohol\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'In glycogen synthesis the active form of glucose used is- Please select one of the following: A) Glucose 6 phosphate, B) Glucose I phosphate, C) UDP glucose, D) UTP glucose.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31457,\n",
       "  'model_output': 'The answer is A) Glucose 6 phosphate. Explanation: Glucose 6-phosphate is the active form of glucose used in glycogen synthesis.'},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': 'Diabetes insipidus is said to be present when Please select one of the following: A) > 30ml/hr urine output in 24 hrs and < 260 mosml/L osmolarity, B) > 40ml/hr urine output in 24 hrs and < 280 mosml/L osmolarity, C) > 50ml/hr urine output in 24 hrs and < 300 mosml/L osmolarity, D) > 60ml/hr urine output in 24 hrs and < 320 mosml/L osmolarity.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31458,\n",
       "  'model_output': \"The answer is A) > 30ml/hr urine output in 24 hrs and < 260 mosml/L osmolarity. Explanation: Ans. is 'a' i.e. > 30ml/hr urine output in 24 hrs and < 260 mosml/L osmolarity o The most common cause of Diabetes insipidus is Neuronal (or Nephrogenic) diabetes insipidus. It is characterized by polyuria, polydipsia and hypernatremia. o The urine output is > 30ml/hr urine output in 24 hrs and < 260 mosmol/L osmolarity. o In central diabetes insipidus (CDI) the urine output is > 40ml/hr urine output in 24 hrs and < 280 mosmol/L osmolarity. o In nephrogenic diabetes insipidus (NDI) the urine output is > 50ml/hr urine output in 24 hrs and < 300 mosmol/L osmolarity. o In gestational diabetes insipidus (GDI) the urine output is > 60ml/hr urine output in 24 hrs and < 320 mosmol/L osmolarity.\"},\n",
       " {'dataset': 'medmcqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'Hypoglycemia in infants more than 24 hours of age is defined as blood glucose levels less than Please select one of the following: A) 50 mg/dl, B) 45 mg/dl, C) 40 mg/dl, D) 55 mg/dl.',\n",
       "  'output': 'The answer is Unknwon) Invalid cop value. Explanation: ',\n",
       "  '__index_level_0__': 31459,\n",
       "  'model_output': 'The answer is C) 40 mg/dl. Explanation: Hypoglycemia in infants more than 24 hours of age is defined as blood glucose levels less than 40 mg/dl.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': \"A 41-year-old man presents to the emergency department with a 6-hour history of muscle cramping, decreased appetite, and diarrhea. He says that these symptoms came on rapidly but does not recall anything that may have triggered the episode. He has never experienced these symptoms before. His past medical history is significant for obesity, sleep apnea, and type 2 diabetes that is well controlled on metformin. He also has gastroesophageal reflux disease for which he occasionally takes antacids. On presentation he is found to have fast, shallow breathing and abdominal pain that is poorly localized. Basic labs as well as an arterial blood gas are obtained and the results are shown below:\\n\\nNa+: 139 mEq/L\\nCl-: 106 mEq/L\\nHCO3-: 11 mEq/L\\npH: 7.25\\npCO2: 22 mmHg\\n\\nWhich of the following is the most likely cause of the changes seen in this patient's labs? Please select one of the following: A) Anxiety, B) Diarrhea, C) Metformin, D) Sleep apnea.\",\n",
       "  'output': 'The answer is C) Metformin.',\n",
       "  '__index_level_0__': 31479,\n",
       "  'model_output': 'The answer is C) Metformin.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': \"A 60-year-old woman presents to a physician for worsening shortness of breath and increasing abdominal distention over the last 3 months. She says that the shortness of breath is worse on exertion and improves with rest. While she could previously walk to the nearby store for her groceries, she now has to drive because she gets ''winded'' on the way. The patient was diagnosed with diabetes 5 years ago and is compliant with her medications. The medical history is otherwise unremarkable. The physical examination reveals gross ascites and visibly engorged periumbilical veins. Bilateral pitting edema is noted around the ankles. The finger-prick blood glucose level is 100 mg/dL. What is the mechanism of action of the anti-diabetic medication this patient is most likely taking? Please select one of the following: A) Binding to the alpha subunit of the insulin receptor, B) Closure of ATP-sensitive K-channels in the pancreatic beta-cell, C) Increased gene expression of GLUT-4, D) Glucagon-like peptide-1 receptor agonist.\",\n",
       "  'output': 'The answer is C) Increased gene expression of GLUT-4.',\n",
       "  '__index_level_0__': 31480,\n",
       "  'model_output': 'The answer is C) Closure of ATP-sensitive K-channels in the pancreatic beta-cell.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 40-year-old man presents to the emergency department with altered mental status. He has a history of cirrhosis of the liver secondary to alcoholism. He started becoming more confused a few days ago and it has been getting gradually worse. His temperature is 98.8°F (37.1°C), blood pressure is 134/90 mmHg, pulse is 83/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam reveals a distended abdomen that is non-tender. Neurological exam is notable for a confused patient and asterixis. Laboratory values are ordered as seen below.\\n\\nSerum:\\nNa+: 139 mEq/L\\nCl-: 100 mEq/L\\nK+: 3.3 mEq/L\\nHCO3-: 22 mEq/L\\nBUN: 20 mg/dL\\nGlucose: 59 mg/dL\\nCreatinine: 1.1 mg/dL\\nCa2+: 10.2 mg/dL\\n\\nWhich of the following is the best next treatment for this patient? Please select one of the following: A) Dextrose, B) Lactulose, C) Potassium, D) Rifaximin.',\n",
       "  'output': 'The answer is C) Potassium.',\n",
       "  '__index_level_0__': 31481,\n",
       "  'model_output': 'The answer is D) Rifaximin.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'A 59-year-old man is evaluated for progressive joint pain. There is swelling and tenderness over the first, second, and third metacarpophalangeal joints of both hands. His hand radiograph is shown. He has had diabetes mellitus for 2 years which is not well controlled with medications. Lab studies show a transferrin saturation of 88% and serum ferritin of 1,200 ng/mL. Which of the following best represents the etiology of this patient condition? Please select one of the following: A) Deposition of urate crystals, B) Deposition of calcium pyrophosphate (CPP) crystals, C) Inflammatory rheumatological syndrome, D) Pathogenic inoculation of microbes.',\n",
       "  'output': 'The answer is B) Deposition of calcium pyrophosphate (CPP) crystals.',\n",
       "  '__index_level_0__': 31482,\n",
       "  'model_output': 'The answer is D) Pathogenic inoculation of microbes. Explanation: This patient has a polyarticular arthritis with joint erosions and the presence of crystals in the synovial fluid. This is consistent with gout, which is caused by the deposition of urate crystals in joints. The patient has a history of diabetes mellitus, which can cause hyperuricemia and gout. CPP crystals are found in CPP disease, also known as pseudogout. Inflammatory rheumatological syndromes include arthritis caused by systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases. Pathogenic inoculation of microbes is seen in septic arthritis.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'A 75-year-old man presents to the emergency department with a racing heart and lightheadedness for 3 hours. He has had similar episodes in the past, but the symptoms never lasted this long. He denies chest pain, shortness of breath, headaches, and fevers. He had a myocardial infarction 4 years ago and currently takes captopril, metoprolol, and atorvastatin. His pulse is irregular and cardiac auscultation reveals an irregular heart rhythm. Laboratory reports show:\\nSerum glucose 88 mg/dL\\nSodium 142 mEq/L\\nPotassium 3.9 mEq/L\\nChloride 101 mEq/L\\nSerum creatinine 0.8 mg/dL\\nBlood urea nitrogen 10 mg/dL\\nCholesterol, total 170 mg/dL\\nHDL-cholesterol 40 mg/dL\\nLDL-cholesterol 80 mg/dL\\nTriglycerides 170 mg/dL\\nHematocrit 38%\\nHemoglobin 13 g/dL\\nLeucocyte count 7,500/mm3\\nPlatelet count 185,000 /mm3\\nActivated partial thromboplastin time (aPTT) 30 seconds\\nProthrombin time (PT) 12 seconds\\nCardiac enzymes Negative\\nAn ECG shows the absence of P-waves with an irregular RR complex. A few hours later, his symptoms subside and he is discharged with an additional anticoagulation drug. Which of the following mechanisms explains how this new medication will exert its effects? Please select one of the following: A) Activation of the antithrombin enzyme, B) Inhibition of the cyclooxygenase enzyme, C) Inhibition of vitamin K-dependent clotting factors, D) Blockage of glycoprotein IIb/IIIa receptors.',\n",
       "  'output': 'The answer is C) Inhibition of vitamin K-dependent clotting factors.',\n",
       "  '__index_level_0__': 31483,\n",
       "  'model_output': 'The answer is D) Blockage of glycoprotein IIb/IIIa receptors.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 15-year-old girl comes to the physician because she has not had menstrual bleeding for the past 3 months. Menses had previously occurred at irregular 15–45 day intervals with moderate to heavy flow. Menarche was at the age of 14 years. She started having sexual intercourse with her boyfriend about 3 months ago. Six months ago she had a manic episode, which was treated with risperidone. Her mother has PCOS and her father has diabetes mellitus. She is very conscious of her weight and appearance. She is 171 cm (5 ft 6 in) tall and weighs 79 kg (174 lb); BMI is 27.02 kg/m2. Her temperature is 37°C (98.6°F), pulse is 60/min, and blood pressure is 116/70 mm Hg. The abdomen is soft and nontender. Pelvic examination shows a normal vagina and cervix. Serum hormone studies show:\\nProlactin 16 ng/mL\\nThyroid-stimulating hormone 3.8 μU/mL\\nFollicle-stimulating hormone 6 mIU/mL\\nLuteinizing hormone 5.1 mIU/mL\\nProgesterone 0.8 ng/mL (follicular N <3; luteal N >3–5)\\nTestosterone 2.2 nmol/L (N <3.5)\\nA urine pregnancy test is negative. Which of the following is the most likely cause of her symptoms?\" Please select one of the following: A) Uterine fibroids, B) Congenital defect of the Mullerian ducts, C) Purging behavior, D) Anovulation.',\n",
       "  'output': 'The answer is D) Anovulation.',\n",
       "  '__index_level_0__': 31484,\n",
       "  'model_output': 'The answer is C) Purging behavior.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'A 54-year-old woman with a past medical history of mental retardation, hypertension, and diabetes presents to the emergency department with a change in her behavior. Her caretakers state that the patient’s gait suddenly became ataxic, and she became less responsive than her normal non-verbal baseline. Her temperature is 98.5°F (36.9°C), blood pressure is 125/68 mmHg, pulse is 90/min, respirations are 15/min, and oxygen saturation is 99% on room air. Physical exam is notable for an unremarkable HEENT exam with normal facial features and no signs of airway compromise. Neurological exam is remarkable for new onset spasticity. The patient has 3+ reflexes and a positive Babinski sign. Musculoskeletal exam is only notable for symmetric swelling and deformities of the patient’s hands bilaterally. Additionally, there is a \"clunk\" when posterior force is applied to the head while anterior force is applied to the cervical spine. Which of the following is the most likely risk factor that predisposed this patient to this condition? Please select one of the following: A) Cerebral palsy, B) Diabetes mellitus, C) Down syndrome, D) Rheumatoid arthritis.',\n",
       "  'output': 'The answer is D) Rheumatoid arthritis.',\n",
       "  '__index_level_0__': 31485,\n",
       "  'model_output': 'The answer is C) Down syndrome.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'A 5-year-old boy is brought to his pediatrician’s office by his parents after they noticed blood in his urine. The child has been complaining of difficulty in passing urine and has lower abdominal pain. He seems more bloated than usual. On some occasions, he starts crying while passing urine, primarily because of a burning sensation. A urinalysis is performed, and the results are as follows:\\nUrine pH 6.2\\nUrine specific gravity 1.010\\nGlucose Negative\\nKetones Negative\\nRBCs 1-2/hpf\\nWBCs 0-1/hpf\\nCasts 2-3/hpf\\nThe pediatrician believes the boy has a bladder infection with a double-stranded DNA virus. Which of the following conditions is also commonly associated with this viral infection? Please select one of the following: A) Gastroenteritis, B) Painful dermatomal vesicles, C) Lymphadenopathy, D) Vesicular rash.',\n",
       "  'output': 'The answer is A) Gastroenteritis.',\n",
       "  '__index_level_0__': 31486,\n",
       "  'model_output': 'The answer is B) Painful dermatomal vesicles.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': 'A 45-year-old woman presents with sudden-onset dyspnea. Her past medical history is significant for varicose veins in her lower extremities, well-controlled diabetes mellitus type 2, and a 25 pack-year smoking history. The patient currently takes metformin and pioglitazone. Family history is significant for her sister who died at the age of 35 because of a pulmonary embolism. Her temperature is 37.8°C (100.0°F), the pulse is 111/min, the respirations are 18/min, and the blood pressure is 130/60 mm Hg. On physical examination, the patient is pale and diaphoretic. Cardiac exam is significant for an S3 gallop. There is erythema and swelling over multiple varicose veins in her left leg. Ultrasound of her left leg is positive for a deep vein thrombosis. The patient is admitted, and anticoagulation is started with a vitamin K inhibitor. However, despite these interventions, she dies shortly after admission. Which of the following was the most likely etiology of this patient’s condition? Please select one of the following: A) Distal peripheral microembolism, B) Necrotizing fasciitis, C) Protein S deficiency, D) Waldenström macroglobulinemia.',\n",
       "  'output': 'The answer is C) Protein S deficiency.',\n",
       "  '__index_level_0__': 31487,\n",
       "  'model_output': 'The answer is A) Distal peripheral microembolism.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': 'A 56-year-old woman comes to the physician because of a 2-week history of fatigue and painless bruising over her arms and trunk. She has also had several episodes of nosebleeds that resolved with compression after a few minutes. She recently completed treatment for a urinary tract infection. She has had no changes in her weight. She has type 2 diabetes mellitus and hypertension. Her last menstrual cycle was 5 years ago. She does not smoke or drink alcohol. Home medications include metformin, amlodipine, and enalapril. Her vital signs are within normal limits. Physical examination shows pale conjunctivae. There are ecchymoses and petechiae over the upper extremities, chest, and back. There is no lymphadenopathy. The remainder of the physical examination is unremarkable. Laboratory studies show:\\nHemoglobin 8.7 mg/dL\\nLeukocyte count 1100/mm3\\nPlatelet count 54,000/mm3\\nReticulocyte count 0.1%\\nMean corpuscular volume 93 μm3\\nSerum\\nTotal bilirubin 1.1 mg/dL\\nLDH 80 U/L\\nWhich of the following is most likely to confirm the diagnosis?\" Please select one of the following: A) Serum transferrin level, B) Bone marrow biopsy, C) Peripheral blood smear, D) Serum porphobilinogen level.',\n",
       "  'output': 'The answer is B) Bone marrow biopsy.',\n",
       "  '__index_level_0__': 31488,\n",
       "  'model_output': 'The answer is A) Serum transferrin level.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': 'A 24-year-old woman is brought to the physician because of agitation, confusion, and lethargy. She has also had progressive recurring headaches and visual impairment over the last month. Three days ago, she had a seizure but has not seen a physician. She is oriented only to person. Her temperature is 36.7°C (98.1°F), pulse is 90/min, and blood pressure is 110/80 mm Hg. Capillary refill time is more than 3 seconds. Her laboratory studies show:\\nHemoglobin 11.2 g/dL\\nLeukocyte count 7000/mm3\\nSerum\\nNa+ 148 mEq/L\\nCl- 100 mEq/L\\nK+ 3.8 mEq/L\\nHCO3- 26 mEq/L\\nUrea nitrogen 18 mg/L\\nGlucose 90 mg/L\\nCreatinine 0.8 mg/L\\nOsmolality 300 mOsmol/kg H2O\\nUrine osmolality 240 mOsm/kg H2O\\nWhich of the following is the most likely explanation for this patient\\'s hypernatremia?\" Please select one of the following: A) Increased water intake, B) Increased adrenocorticotropin hormone secretion, C) Decreased antidiuretic hormone secretion, D) Decreased adrenocorticotropin hormone secretion.',\n",
       "  'output': 'The answer is C) Decreased antidiuretic hormone secretion.',\n",
       "  '__index_level_0__': 31489,\n",
       "  'model_output': 'The answer is C) Decreased antidiuretic hormone secretion.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'An 18-year-old woman is brought to the emergency department because of lightheadedness and a feeling of dizziness. She has had nausea, occasional episodes of vomiting, myalgia, and a generalized rash for the past week. She also reports feeling lethargic. She has no shortness of breath. There is no family history of serious illness. She appears ill. Her temperature is 39.1°C (102.3°F), pulse is 118/min, and blood pressure is 94/60 mm Hg. Cardiac examination shows no abnormalities. There is a widespread erythematous rash on the trunk and extremities with skin peeling on the palms and soles. Laboratory studies show:\\nHemoglobin 13.6 g/dL\\nLeukocyte count 19,300/mm3\\nPlatelet count 98,000/mm3\\nSerum\\nUrea nitrogen 47 mg/dL\\nGlucose 88 mg/dL\\nCreatinine 1.8 mg/dL\\nTotal bilirubin 2.1 mg/dL\\nAST 190 U/L\\nALT 175 U/L\\nUrinalysis shows no abnormalities. Further evaluation of this patient\\'s history is most likely to reveal which of the following?\" Please select one of the following: A) Recent hiking trip, B) Intravenous heroin abuse, C) Exposure to a patient with mengingococcemia, D) Currently menstruating.',\n",
       "  'output': 'The answer is D) Currently menstruating.',\n",
       "  '__index_level_0__': 31490,\n",
       "  'model_output': 'The answer is C) Exposure to a patient with mengingococcemia.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'Two weeks after undergoing an emergency cardiac catherization with stenting for unstable angina pectoris, a 61-year-old man has decreased urinary output and malaise. He has type 2 diabetes mellitus and osteoarthritis of the hips. Prior to admission, his medications were insulin and naproxen. He was also started on aspirin, clopidogrel, and metoprolol after the coronary intervention. His temperature is 38°C (100.4°F), pulse is 93/min, and blood pressure is 125/85 mm Hg. Examination shows mottled, reticulated purplish discoloration of the feet. Laboratory studies show:\\nHemoglobin count 14 g/dL\\nLeukocyte count 16,400/mm3\\nSegmented neutrophils 56%\\nEosinophils 11%\\nLymphocytes 31%\\nMonocytes 2%\\nPlatelet count 260,000/mm3\\nErythrocyte sedimentation rate 68 mm/h\\nSerum\\nUrea nitrogen 25 mg/dL\\nCreatinine 4.2 mg/dL\\nRenal biopsy shows intravascular spindle-shaped vacuoles. Which of the following is the most likely cause of this patient\\'s symptoms?\" Please select one of the following: A) Renal papillary necrosis, B) Cholesterol embolization, C) Eosinophilic granulomatosis with polyangiitis, D) Polyarteritis nodosa.',\n",
       "  'output': 'The answer is B) Cholesterol embolization.',\n",
       "  '__index_level_0__': 31491,\n",
       "  'model_output': 'The answer is B) Cholesterol embolization.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'A 67-year-old man presents to his primary care physician for erectile dysfunction. He states that for the past month he has been unable to engage in sexual intercourse with his wife despite having appropriate sexual desire. He also endorses deep and burning buttock and hip pain when walking, which is relieved by rest. The patient states that he does not have erections at night or in the morning. His past medical history is notable for diabetes, coronary artery disease, and hypertension, and he has a 40 pack-year smoking history. Physical exam is notable for weak lower extremity and femoral pulses. Which of the following is the most specific etiology of this patient’s symptoms? Please select one of the following: A) Anxiety, B) Aortoiliac atherosclerosis, C) Spinal stenosis, D) Vascular claudication.',\n",
       "  'output': 'The answer is B) Aortoiliac atherosclerosis.',\n",
       "  '__index_level_0__': 31492,\n",
       "  'model_output': 'The answer is B) Aortoiliac atherosclerosis. Explanation: The most specific etiology of this patient’s symptoms is aortoiliac atherosclerosis. This is a disease of the large arteries, and patients typically present with atherosclerotic plaques in the femoral and iliac arteries. The patient may also present with claudication in the lower extremities, which is a deep and burning pain in the buttocks and hips that is relieved by rest. The patient also may present with erectile dysfunction, which is a condition where the patient is unable to achieve or maintain an erection. This is due to the patient’s inability to have a sufficient blood flow to the penis. Anxiety is not a cause of erectile dysfunction, and it is not a specific etiology of the patient’s symptoms. Spinal stenosis is a condition where the patient has narrowing of the spinal canal, which can cause pain and weakness in the lower extremities. This is not a specific etiology of the patient’s symptoms, and it is not a cause of erectile dysfunction. Vascular claudication is a condition where the patient has pain in the lower extremities due to decreased blood flow to the legs. This is not a specific etiology of the patient’s symptoms, and it is not a cause of erectile dysfunction.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': 'A 60-year-old female presents to her gynecologist with vaginal bleeding. She underwent menopause ten years prior. She has a past medical history of hypertension and diabetes mellitus. On physical examination, her uterus is uniformly enlarged. Ultrasound reveals a thickened endometrial stripe and tissue biopsy reveals neoplastic endometrial cells. A workup for metastatic disease is negative and the gynecologist recommends a laparoscopic hysterectomy. During the procedure, the surgeon ligates multiple vessels in order to remove the entire uterus. In the immediate postoperative period, the patient develops left-sided flank pain and oliguria. Serum creatinine is found to be 1.4 mg/dl whereas it was 1.0 mg/dl prior to the operation. Renal ultrasound is normal. Urinalysis is notable for hematuria. Ligation of which of the following vessels most likely contributed to this patient’s condition? Please select one of the following: A) Artery of Sampson, B) Ovarian artery, C) Superior vesical artery, D) Uterine artery.',\n",
       "  'output': 'The answer is D) Uterine artery.',\n",
       "  '__index_level_0__': 31493,\n",
       "  'model_output': 'The answer is A) Artery of Sampson.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'A 55-year-old caucasian male is transferred to a tertiary care hospital from a small county hospital where he presented with jaundice and severe abdominal pain that radiates to the back. While in the county hospital, he did not develop fever, and his vital signs were stable for the 48 hours he spent at there. Initial laboratory tests are given below:\\nTotal bilirubin 7 mg/dL\\nDirect bilirubin 6.4 mg/dL\\nAST 100\\nALT 40\\nAlkaline phosphatase 480 IU/L\\nGlucose 160 mg/dL\\nThe patient’s medical history is relevant for hypertension and diabetes mellitus. He admits to smoking cigarettes since his early teenage years. Moderate icterus is evident during physical examination, the abdomen is distended and dull to percussion, and there is periumbilical tenderness. Which of the following markers would you expect to be elevated in this patient? Please select one of the following: A) CA 125, B) Desmin, C) CA 27-29, D) CA 19-9.',\n",
       "  'output': 'The answer is D) CA 19-9.',\n",
       "  '__index_level_0__': 31494,\n",
       "  'model_output': 'The answer is D) CA 19-9.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 27-year-old college student presents to his physician for constant fatigue. The patient states that for the past several weeks he has felt oddly fatigued and has struggled to complete his work. He is a foreign exchange student and is concerned he will fail out of his academic program. He has experienced some occasional nausea and vomiting which has caused him to lose weight. The patient is a first year college student, drinks alcohol regularly, smokes marijuana, and has unprotected sex with multiple partners. His temperature is 99.5°F (37.5°C), blood pressure is 127/68 mmHg, pulse is 90/min, respirations are 17/min, and oxygen saturation is 98% on room air. Laboratory values are ordered as seen below.\\n\\nSerum:\\nNa+: 139 mEq/L\\nCl-: 100 mEq/L\\nK+: 4.3 mEq/L\\nHCO3-: 25 mEq/L\\nBUN: 20 mg/dL\\nGlucose: 99 mg/dL\\nCreatinine: 1.1 mg/dL\\nCa2+: 10.2 mg/dL\\nTotal bilirubin: 2.0 mg/dL\\nAST: 85 U/L\\nALT: 92 U/L\\n\\nUrine\\nColor: Amber/brown\\nMarijuana: Positive\\nAmphetamines: Positive\\nCocaine: Positive\\n\\nThe patient refuses an examination of his genitals. Which of the following is the best diagnostic test? Please select one of the following: A) CAGE questions, B) Uretheral swab and culture, C) Viral core antibody, D) Viral surface antibody.',\n",
       "  'output': 'The answer is C) Viral core antibody.',\n",
       "  '__index_level_0__': 31495,\n",
       "  'model_output': 'The answer is C) Viral core antibody.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': \"A 27-year-old woman presents to the emergency department with acute onset bloody diarrhea. The patient has had severe abdominal pain throughout her entire life with occasional episodes of bloody diarrhea. She has recently lost 7 pounds and has felt generally ill for the past 2 days. She has a past medical history of generalized seizures with her most recent one having occurred 5 days ago. One month ago, the patient was treated for impetigo. The patient admits to occasional cocaine use and binge drinking. Her temperature is 98.7°F (37.1°C), blood pressure is 107/58 mmHg, pulse is 127/min, respirations are 16/min, and oxygen saturation is 99% on room air. Physical exam is notable for diffuse abdominal tenderness and guaiac positive stools. Laboratory values are ordered as seen below.\\n\\nHemoglobin: 9 g/dL\\nHematocrit: 30%\\nLeukocyte count: 9,400/mm^3 with normal differential\\nPlatelet count: 199,000/mm^3\\n\\nSerum:\\nNa+: 139 mEq/L\\nCl-: 101 mEq/L\\nK+: 4.9 mEq/L\\nHCO3-: 25 mEq/L\\nBUN: 37 mg/dL\\nGlucose: 99 mg/dL\\nCreatinine: 1.8 mg/dL\\nAST: 62 U/L\\nALT: 80 U/L\\nBlood alcohol: .15 g/dL\\n\\nUrine:\\nColor: Yellow\\nProtein: Positive\\nCocaine: Positive\\nMarijuana: Positive\\n\\nWhich of the following is the best explanation for this patient's laboratory findings? Please select one of the following: A) Alcohol-induced liver injury, B) Immune response to streptococcal infection, C) Intestinal IgA deficiency, D) Protein deposition.\",\n",
       "  'output': 'The answer is D) Protein deposition.',\n",
       "  '__index_level_0__': 31496,\n",
       "  'model_output': 'The answer is C) Intestinal IgA deficiency.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'A 58-year-old woman comes to the physician because of intermittent painful retrosternal dullness for 4 weeks. The pain is recurrent and occurs when she exerts herself or when she is outside during cold weather. She also experiences shortness of breath and palpitations during these episodes. The symptoms resolve spontaneously when she stops or sits down for a while. Over the past few days, the episodes have increased in frequency. She has hypertension, type 2 diabetes mellitus, and osteoarthritis. Her left leg was amputated below the knee after a motorcycle accident 25 years ago. She is currently waiting for a new prosthesis and walks with crutches. Current medications include captopril, glyburide, and ibuprofen. She does not smoke or drink alcohol. Her pulse is 88/min, respirations are 20/min, and blood pressure is 144/90 mm Hg. Cardiac examination shows no abnormalities. An x-ray of the chest shows no abnormalities. An ECG shows a normal sinus rhythm without any signs of ischemia. Serum cardiac markers are within the reference range. Which of the following is the most appropriate next step in diagnosis? Please select one of the following: A) Myocardial perfusion scan under pharmacological stress, B) Upper endoscopy, C) Coronary angiography, D) Echocardiography at rest.',\n",
       "  'output': 'The answer is A) Myocardial perfusion scan under pharmacological stress.',\n",
       "  '__index_level_0__': 31497,\n",
       "  'model_output': 'The answer is C) Coronary angiography.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'Current recommendations state that a single hemoglobin A1c value of greater than 6.5% is diagnostic of diabetes mellitus. If this 6.5% cut-off is to be increased to 7.0%, which of the following would be true? Please select one of the following: A) Increase in false negative test results, B) Increase in false positive test results, C) Decrease in true negative test results, D) Increase in true positive test results.',\n",
       "  'output': 'The answer is A) Increase in false negative test results.',\n",
       "  '__index_level_0__': 31498,\n",
       "  'model_output': 'The answer is B) Increase in false positive test results. Explanation: If the cut-off for HbA1c is increased to 7.0%, then the false positive test results will increase.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 57-year-old man presents to his primary care physician for follow-up of his diabetes. He was diagnosed with type 2 diabetes 3 months ago and has been started on metformin and lifestyle modifications. The patient does not have any current complaints except for occasional numbness in both hands and feet. His HbA1C is 8.5% and serum glucose is 240 mg/dL. Which of the following is the best next step in this patient’s condition? Please select one of the following: A) Start basal-bolus insulin, B) Continue metformin monotherapy, C) Add a sulfonylurea, D) Add a thiazolidinedione.',\n",
       "  'output': 'The answer is C) Add a sulfonylurea.',\n",
       "  '__index_level_0__': 31499,\n",
       "  'model_output': 'The answer is A) Start basal-bolus insulin.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 78-year-old man is brought to the emergency department because of a 1-day history of painful enlarging bruises and skin ulceration over his thighs and external genitalia. He has type 2 diabetes mellitus, mitral regurgitation, and atrial fibrillation. Three days ago, he was started on treatment with warfarin. His only other medications are metformin and lisinopril. His temperature is 37.8°C (100.0°F), pulse is 108/min and irregularly irregular, and blood pressure is 155/89 mm Hg. Examination of the skin shows large purpura, hemorrhagic bullae, and areas of skin necrosis over his anterior legs, gluteal region, and penis. This patient is most likely to benefit from treatment with which of the following? Please select one of the following: A) Hyperbaric oxygen, B) Protein C concentrate, C) Argatroban, D) Tranexamic acid.',\n",
       "  'output': 'The answer is B) Protein C concentrate.',\n",
       "  '__index_level_0__': 31500,\n",
       "  'model_output': 'The answer is A) Hyperbaric oxygen.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'A 36-year-old man is brought to the emergency department because of multiple episodes of nonbilious emesis for 3 days. The vomitus consists of undigested food and he has also had dark brown emesis twice today. He has been having early satiety during this period. He has had progressive severe episodic epigastric pain and dyspepsia for the past week. The pain is partially relieved with food or over-the-counter antacids, but worsens at night and several hours after eating. He has also had a weight gain of 2 kg (4.4 lbs) during this period. His father underwent surgery for colon cancer 3 years ago. He has smoked one pack of cigarettes daily for the last 15 years. He drinks two to three beers daily. His temperature is 37.1°C (98.8°F), pulse is 106/min and blood pressure is 108/68 mm Hg. Examination shows dry mucous membranes. The abdomen is mildly tender to palpation in the left upper quadrant; there is a tympanitic mass in the epigastrium. A succussion splash is heard with a stethoscope when the patient is rocked back and forth at the hips. Bowel sounds are reduced. Rectal examination is unremarkable. Test of the stool for occult blood is positive. The remainder of the examination shows no abnormalities. Serum studies show:\\nNa+ 135 mEq/L\\nK+ 3.3 mEq/L\\nCl- 97 mEq/L\\nUrea nitrogen 46 mg/dL\\nGlucose 77 mg/dL\\nCreatinine 1.4 mg/dL\\nWhich of the following is the underlying cause of this patient\\'s vomiting?\" Please select one of the following: A) Inflammation and edema, B) Abnormal gastric rotation, C) Neoplastic growth, D) Walled-off pancreatic fluid collection.',\n",
       "  'output': 'The answer is A) Inflammation and edema.',\n",
       "  '__index_level_0__': 31501,\n",
       "  'model_output': 'The answer is D) Walled-off pancreatic fluid collection.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': 'A 65-year-old female patient comes to the physician’s office for her annual check-up. The patient’s only complaint is that she feels her vision has been getting more blurry over the past year. The patient has a past medical history of diabetes diagnosed 20 years ago and osteoarthritis. Her medications include metformin, glimepiride, and ibuprofen as needed for pain. Fundoscopic examination of this patient reveals narrowing of retinal arteries and microaneurysms. This patient’s symptoms are likely caused by tissue specific differences in expression of which of the following enzymes? Please select one of the following: A) Sorbitol dehydrogenase, B) Galactocerebrosidase, C) Arylsulfatase A, D) Sphingomyelinase.',\n",
       "  'output': 'The answer is A) Sorbitol dehydrogenase.',\n",
       "  '__index_level_0__': 31502,\n",
       "  'model_output': 'The answer is A) Sorbitol dehydrogenase.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': 'A 66-year-old man with high blood pressure, high cholesterol, and diabetes presents to the clinic with elevated liver function tests from baseline. He has a blood pressure of 136/92 mm Hg and a heart rate of 69/min. On physical examination, his heart sounds are regular and lung sounds are clear. Current medications include simvastatin, metformin, fenofibrate, hydrochlorothiazide, aspirin, glyburide, and lisinopril. Of these medications, which could contribute to the patient’s transaminitis? Please select one of the following: A) Metformin, B) Simvastatin, C) Glyburide, D) Lisinopril.',\n",
       "  'output': 'The answer is B) Simvastatin.',\n",
       "  '__index_level_0__': 31503,\n",
       "  'model_output': 'The answer is B) Simvastatin.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'A 7-month-old boy is brought to the physician because of a 2-month history of fatigue, weakness, and difficulty feeding. He was delivered at term to a 32-year-old woman. He is not able to sit upright on his own. He is at the 75th percentile for height and 25th percentile for weight. His temperature is 37.7°C (99.8°F), blood pressure is 110/68 mm Hg, pulse is 150/min, and respirations are 50/min. His tongue protrudes beyond the teeth. Neck veins are distended. Crackles are heard at both lung bases. Cardiac examination shows an S3 gallop. The liver is palpated 2 cm below the right costal margin. Neurologic examination shows profound weakness in proximal and distal muscles of the upper and lower extremities. He has 2+ reflexes bilaterally. A chest x-ray shows cardiomegaly. Serum glucose is 105 mg/dL. Which of the following is the enzyme most likely to be defective in this patient? Please select one of the following: A) Muscle glycogen phosphorylase, B) Very-long-chain acyl-CoA dehydrogenase, C) Lysosomal acid maltase, D) Glycogen debranching enzyme.',\n",
       "  'output': 'The answer is C) Lysosomal acid maltase.',\n",
       "  '__index_level_0__': 31504,\n",
       "  'model_output': 'The answer is C) Lysosomal acid maltase.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'A 68-year-old man presents to his primary care physician with complaints of increased fatigue and back pain for the past year. His symptoms are progressively getting worse over the past few months despite adequate rest and trial of over the counter analgesics. His back pain is constant and non-radiating in nature. He denies any trauma to his back. His past medical history is insignificant. On examination, there is mild tenderness over the lumbar region in the midline with an absence of paraspinal muscle tenderness. Straight leg raise test is negative. His skin and conjunctiva appear pale. The physician orders basic blood work. His results are provided below.\\nComplete blood count\\nRBC 4.9 million cells/µL\\nHemoglobin 9.8 g/dL\\nHematocrit 41%\\nTotal leukocyte count 6,800 cells/µL\\nNeutrophils 70%\\nLymphocyte 26%\\nMonocytes 3%\\nEosinophil 1%\\nBasophils 0%\\nPlatelets 230,000 cells/µL\\nBasic Metabolic Panel\\nSodium 136 mEq/L\\nPotassium 5.1 mEq/L\\nChloride 101 mEq/L\\nBicarbonate 24 mEq/L\\nAlbumin 3.6 mg/ dL\\nUrea nitrogen 31 mg/dL\\nCreatinine 2.7 mg/dL\\nUric Acid 6.7 mg/dL\\nCalcium 12.1 mg/dL\\nGlucose 105 mg/dL\\nUrinalysis shows proteinuria without any RBCs or pus cells. The patient’s proteinuria best fits in which of the following category? Please select one of the following: A) Overflow proteinuria, B) Transient (functional) proteinuria, C) Orthostatic proteinuria, D) Isolated proteinuria.',\n",
       "  'output': 'The answer is A) Overflow proteinuria.',\n",
       "  '__index_level_0__': 31505,\n",
       "  'model_output': 'The answer is C) Orthostatic proteinuria.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': \"A 75-year-old woman presents to the emergency department with 30 minutes of slurred speech and arm weakness. On the drive over to the hospital, her symptoms have resolved completely. The patient has a past medical history of hypertension, atrial fibrillation, diabetes, morbid obesity, gout, and vascular claudication. Her temperature is 99.0°F (37.2°C), blood pressure is 184/111 mmHg, pulse is 88/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam reveals cranial nerves II-XII as grossly intact with normal strength and sensation in the patient's upper and lower extremities. The patient's memory is intact and her speech seems normal and fluent. Her gait is stable with no ataxia. An initial head CT demonstrates diffuse atrophy which is consistent with previous head CT scans. Which of the following is the best next step in management? Please select one of the following: A) CT angiogram, B) Echocardiogram, C) Heparin, D) MRI.\",\n",
       "  'output': 'The answer is A) CT angiogram.',\n",
       "  '__index_level_0__': 31506,\n",
       "  'model_output': 'The answer is B) Echocardiogram.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'A 49-year-old woman is brought to the emergency department with progressive dyspnea and cough which she developed approx. 8 hours ago. 2 weeks ago she had a prophylactic ovariectomy because of a family history of ovarian cancer. She is known to have type 2 diabetes mellitus and stage 1 hypertension, but she does not take her antihypertensives because she is not concerned about her blood pressure. Also, she has a history of opioid abuse. She takes metformin 1000 mg and aspirin 81 mg. She has been smoking 1 pack of cigarettes per day for 22 years. Her vital signs are as follows: blood pressure 155/80 mm Hg, heart rate 101/min, respiratory rate 31/min, and temperature 37.9℃ (100.2℉). Blood saturation on room air is 89%. On examination, the patient is dyspneic and acrocyanotic. Lung auscultation reveals bilateral rales over the lower lobes. A cardiac examination is significant for S2 accentuation best heard in the second intercostal space at the left sternal border and S3 presence. There is no leg edema. Neurological examination is within normal limits. Arterial blood gases analysis shows the following results:\\npH 7.49\\nPaO2 58 mm Hg\\nPaCO2 30 mm Hg\\nHCO3-  22 mEq/L\\nBased on the given data, which of the following could cause respiratory failure in this patient? Please select one of the following: A) Increased alveolar dead space due to absent perfusion of certain alveoli, B) Alveolar fibrosis, C) Depression of the respiratory center via opioid receptors activation, D) Decreased V/Q due to bronchial obstruction.',\n",
       "  'output': 'The answer is A) Increased alveolar dead space due to absent perfusion of certain alveoli.',\n",
       "  '__index_level_0__': 31507,\n",
       "  'model_output': 'The answer is A) Increased alveolar dead space due to absent perfusion of certain alveoli.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 51-year-old man is brought to the emergency department because of a 2-day history of fever, abdominal pain, and confusion. His wife states that he has been unable to recall his birthday or her name. He was diagnosed with hepatitis C 3 years ago but refused treatment. He has been treated twice in the past year for acute pancreatitis. There is no family history of serious illness. His only medication is a calcium supplement. He emigrated from India 15 years ago. He appears ill. His temperature is 38.3°C (100.9°F), pulse is 101/min, and blood pressure is 104/68 mm Hg. He is confused and oriented only to person. Examination shows scleral icterus and spider angiomas. There are fine tremors of the hands bilaterally. The abdomen is distended and shifting dullness is present. There is diffuse tenderness to palpation with no guarding. Bowel sounds are absent. Laboratory studies show:\\nHemoglobin 12.6 g/dL\\nLeukocyte count 13,900/mm3\\nPlatelet count 342,000/mm3\\nSerum\\nAlbumin 2.6 g/dL\\nTotal bilirubin 2.56 mg/dL\\nAlkaline phosphatase 54 U/L\\nAST 17 U/L\\nALT 44 U/L\\nParacentesis is performed. Ascitic fluid analysis shows an albumin concentration of 0.8 g/dL, glucose concentration of 62 mg/dL, and a leukocyte count of 1900/mm3 with 60% neutrophils. Which of the following is the most likely explanation for these findings?\" Please select one of the following: A) Aseptic peritoneal inflammation, B) Neoplastic growth, C) Bacterial translocation, D) Perforated viscus.',\n",
       "  'output': 'The answer is C) Bacterial translocation.',\n",
       "  '__index_level_0__': 31508,\n",
       "  'model_output': 'The answer is C) Bacterial translocation.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'A 60-year-old woman is brought to the emergency department because of sudden, painless loss of vision in her right eye that occurred 30 minutes ago while watching TV. She has coronary artery disease, hypertension, and type 2 diabetes mellitus; she has had trouble adhering to her medication regimen. Her blood pressure is 160/85 mm Hg. Examination shows 20/50 vision in the left eye and no perception of light in the right eye. Direct pupillary reflex is present in the left eye, but absent in the right eye. Accommodation is intact bilaterally. Intraocular pressure is 16 mm Hg in the left eye and 18 mm Hg in the right eye. Fundoscopic examination of the right eye shows a pale, white retina with a bright red area within the macula. The optic disc appears normal. Which of the following is the most likely diagnosis? Please select one of the following: A) Retinal detachment, B) Central retinal artery occlusion, C) Acute angle-closure glaucoma, D) Anterior ischemic optic neuropathy.',\n",
       "  'output': 'The answer is B) Central retinal artery occlusion.',\n",
       "  '__index_level_0__': 31509,\n",
       "  'model_output': 'The answer is D) Anterior ischemic optic neuropathy.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': \"A 30-year-old G4P3 woman at 38 weeks gestation is admitted to the labor and delivery unit complaining of contractions every 5 minutes for the past hour. Her previous births have been via uncomplicated caesarean sections, but she wishes to attempt vaginal delivery this time. Her prenatal care is notable for gestational diabetes controlled with diet and exercise. The delivery is prolonged, but the patient's pain is controlled with epidural analgesia. She delivers a male infant with Apgar scores of 8 and 9 at 1 and 5 minutes, respectively. Fundal massage is performed, but the placenta does not pass. The obstetrician manually removes the placenta, but a red mass protrudes through the vagina attached to the placenta. The patient loses 500 mL of blood over the next minute, during which her blood pressure decreases from 120/80 mmHg to 90/65 mmHg. What is the best next step in management? Please select one of the following: A) Hysterectomy, B) Intravenous oxytocin, C) Elevate posterior fornix, D) Red blood cell transfusion.\",\n",
       "  'output': 'The answer is C) Elevate posterior fornix.',\n",
       "  '__index_level_0__': 31510,\n",
       "  'model_output': 'The answer is B) Intravenous oxytocin.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'A 38-year-old man is brought to the emergency room by his father because of altered mental status. According to the father, the patient was unable to get out of bed that morning and has become increasingly confused over the past several hours. The father also noticed it was “pretty cold” in his son\\'s apartment because all of the windows were left open overnight. He has a history of hypothyroidism, schizoaffective disorder, type 2 diabetes mellitus, dyslipidemia, and hypertension for which he takes medication. Ten days ago, he was started on a new drug. He appears lethargic. His rectal temperature is 32°C (89.6°F), pulse is 54/min, respirations are 8/min, and blood pressure is 122/80 mm Hg. Examination shows weakness in the lower extremities with absent deep tendon reflexes. Deep tendon reflexes are 1+ in the upper extremities. The pupils are dilated and poorly reactive to light. Throughout the examination, the patient attempts to remove his clothing. Which of the following drugs is the most likely cause of these findings? Please select one of the following: A) Lisinopril, B) Fluphenazine, C) Levothyroxine, D) Atorvastatin\\n\".',\n",
       "  'output': 'The answer is B) Fluphenazine.',\n",
       "  '__index_level_0__': 31511,\n",
       "  'model_output': 'The answer is B) Fluphenazine.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'A 39-year-old man presents to the emergency department complaining of a sharp pain that radiates along his right hemithorax, which worsens with deep inspiration. He says this started abruptly about 6 hours ago. He says that he has not noticed that anything that makes his pain better or worse. He also denies any other symptoms. He works as a long-haul truck driver, and he informs you that he recently returned to the east coast from a trip to Utah. His medical history is significant for gout, hypertension, hypercholesterolemia, diabetes mellitus type 2, and acute lymphoblastic leukemia from when he was a child. He currently smokes 2 packs of cigarettes/day, drinks a 6-pack of beer/day, and he denies any illicit drug use. The vital signs include: temperature 36.7°C (98.0°F), blood pressure 126/74 mm Hg, heart rate 98/min, and respiratory rate 23/min. His physical examination shows minimal bibasilar rales, but otherwise clear lungs on auscultation, normal heart sounds, and a benign abdominal physical examination. Which of the following is the most reasonable 1st step towards ruling out the diagnosis of pulmonary embolism in a low-risk patient? Please select one of the following: A) ECG, B) V/Q scan, C) D-dimer, D) CT pulmonary angiogram with IV contrast.',\n",
       "  'output': 'The answer is C) D-dimer.',\n",
       "  '__index_level_0__': 31512,\n",
       "  'model_output': 'The answer is C) D-dimer.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'An experimental new drug in the treatment of diabetes mellitus type 2 was found to increase the levels of incretins by preventing their degradation at the endothelium. This further increased glucose-dependent insulin production. Which of the following drugs has a mechanism of action most similar to this new experimental drug? Please select one of the following: A) Sitagliptin, B) Glimepiride, C) Canagliflozin, D) Pioglitazone.',\n",
       "  'output': 'The answer is A) Sitagliptin.',\n",
       "  '__index_level_0__': 31513,\n",
       "  'model_output': 'The answer is A) Sitagliptin. Explanation: The new experimental drug in this question is DPP-4 inhibitor. DPP-4 inhibitors increase the levels of incretins by preventing their degradation at the endothelium. This further increases glucose-dependent insulin production. Sitagliptin is a DPP-4 inhibitor. Glimepiride is a sulfonylurea drug which increases insulin secretion from the pancreas. Canagliflozin is a SGLT2 inhibitor which increases urinary glucose excretion. Pioglitazone is a thiazolidinedione drug which increases the action of insulin.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'A 53-year-old male presents to his primary care physician complaining of fatigue and joint and muscle pain. He reports a 6-month history of slowly progressive tiredness associated with dull achy pain in his knees, hips, and shoulders. His past medical history is notable for hypertension, diabetes, and stable angina. He takes lisinopril, metformin, glyburide, and aspirin. He has a history of intravenous drug use and was homeless in his early 30’s. He drinks alcohol socially and has a 30 pack-year smoking history. His temperature is 98.6°F (37°C), blood pressure is 130/85 mmHg, pulse is 95/min, and respirations are 18/min. Physical examination reveals a generally well-appearing male without evidence of ascites, peripheral edema, or jaundice. Results from laboratory tests are below:\\n\\nHepatitis A IgM: Negative\\nHepatitis A IgG: Negative\\nHepatitis B surface antigen: Negative\\nHepatitis B E antigen: Negative\\nHepatitis B core antigen: Negative\\nHepatitis B surface IgG: Positive\\nHepatitis B E IgG: Negative\\nHepatitis B core IgG: Negative\\nHepatitis C IgG: Positive\\nHCV RNA: 100,000,000 IU/ml\\n\\nThis patient should be started on which of the following medications? Please select one of the following: A) Sofosbuvir and simeprevir, B) Interferon-gamma, C) Ribavirin, D) Lamivudine.',\n",
       "  'output': 'The answer is A) Sofosbuvir and simeprevir.',\n",
       "  '__index_level_0__': 31514,\n",
       "  'model_output': 'The answer is A) Sofosbuvir and simeprevir.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': \"A 27-year-old female is brought to the emergency department by police when she attacked her date outside of a pizza restaurant. The patient refused to explain her behavior to the police. She seemed to be responding to internal stimuli when being initially interviewed. The patient has a past medical history of depression, anxiety, and obesity. The patient has a known history of medication non-compliance. Her temperature is 99.5°F (37.5°C), pulse is 112/min, blood pressure is 100/70 mmHg, respirations are 18/min, and oxygen saturation is 98% on room air. On physical exam the patient is poorly kempt and has an odd body odor. Inspection of her oropharynx reveals multiple ulcers. Cardiac exam is unrevealing with the exception of a friction rub. Since the incident, the patient has calmed down and is currently resting. She is no longer responding to internal stimuli and is more cooperative. Lab values are obtained and are below.\\n\\nSerum:\\nNa+: 135 mEq/L\\nCl-: 100 mEq/L\\nK+: 3.9 mEq/L\\nHCO3-: 24 mEq/L\\nBUN: 20 mg/dL\\nGlucose: 70 mg/dL\\nCreatinine: 1.7 mg/dL\\nCa2+: 10.0 mg/dL\\nMg2+: 1.5 mEq/L\\n\\nHemoglobin: 10 g/dL\\nHematocrit: 35%\\nReticulocyte count: 4.9%\\nPlatelet count: 275,000/mm^3\\nLeukocyte count: 5,500/mm^3\\n\\nWhich of the following is the next best step in management for this patient's underlying condition? Please select one of the following: A) IM haloperidol, B) Clozapine, C) Urine toxicology, D) ANA and anti-dsDNA levels.\",\n",
       "  'output': 'The answer is D) ANA and anti-dsDNA levels.',\n",
       "  '__index_level_0__': 31515,\n",
       "  'model_output': 'The answer is A) IM haloperidol.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 68-year-old woman presents to the emergency room with chest pain. She reports sudden severe and crushing substernal chest pain that started 1 hour ago. Her past medical history is notable for hypertension, hyperlipidemia, diabetes mellitus, obesity, and a prior myocardial infarction requiring a coronary artery bypass graft 2 years ago. She takes aspirin, metoprolol, lisinopril, spironolactone, atorvastatin, and insulin. She is retired and lives a sedentary lifestyle at home. Her temperature is 98.8°F (37.1°C), blood pressure is 109/68 mmHg, pulse is 118/min, and respirations are 24/min. Before being able to start the physical examination, the patient loses consciousness. Her pulse is palpable but weak. Her blood pressure is now 88/50 mmHg and pulse is 130/min. Her skin is pale, cold, and clammy. An electrocardiogram demonstrates ST elevations in leads I, aVL, V3, V4, V5, and V6. A medication that primarily stimulates which of the following receptors would be most appropriate to improve the hemodynamic status of this patient? Please select one of the following: A) Alpha-2 adrenergic receptor, B) Beta-1 adrenergic receptor, C) Beta-2 adrenergic receptor, D) D2 receptor.',\n",
       "  'output': 'The answer is B) Beta-1 adrenergic receptor.',\n",
       "  '__index_level_0__': 31516,\n",
       "  'model_output': 'The answer is C) Beta-2 adrenergic receptor.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'A 72-year-old man in a nursing home was brought to the emergency department with right hand and leg weakness for 1 hour. There has been a gradual increase in the degree of weakness. The patient is disoriented. The medical history includes ischemic heart disease diagnosed 2 months ago, and long histories of diabetes and hypertension (30 and 25 years, respectively). On examination, the reflexes are hypertonic and the Babinski reflex is positive. The CT scan is shown. What is the most likely pathologic change? Please select one of the following: A) Gangrenous necrosis, B) Liquefactive necrosis, C) Caseous necrosis, D) Fibrinoid necrosis.',\n",
       "  'output': 'The answer is B) Liquefactive necrosis.',\n",
       "  '__index_level_0__': 31517,\n",
       "  'model_output': 'The answer is D) Fibrinoid necrosis. Explanation: The CT scan shows a large infarction in the right basal ganglia. The most common cause of stroke in the elderly is atherosclerosis of the large arteries of the brain. The most common cause of atherosclerosis is hypertension. The CT scan shows a large infarction in the right basal ganglia. The most common cause of stroke in the elderly is atherosclerosis of the large arteries of the brain. The most common cause of atherosclerosis is hypertension. The most common type of atherosclerotic infarction is fibrinoid necrosis, which is characterized by a fibrinoid zone, hemorrhage, and a neutrophilic infiltrate.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'A 3-day-old boy is brought to the emergency department because of a 4-hour history of somnolence, poor feeding, and one episode of vomiting. He is exclusively breastfed. His serum glucose concentration is 88 mg/dL and his serum ammonia concentration is 850 μmol/L (N<90). Urinalysis shows an increased orotic acid to creatinine ratio. Urinary ketones are absent. This patient is most likely deficient in an enzyme that catalyzes which of the following reactions? Please select one of the following: A) Ornithine and carbamoyl phosphate to citrulline, B) Orotic acid to uridine monophosphate, C) Pyruvate to acetyl-coenzyme A, D) Glutamate and acetyl-coenzyme A to N-acetylglutamate.',\n",
       "  'output': 'The answer is A) Ornithine and carbamoyl phosphate to citrulline.',\n",
       "  '__index_level_0__': 31518,\n",
       "  'model_output': 'The answer is A) Ornithine and carbamoyl phosphate to citrulline.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'The parents of a 16-year-old boy with type 1 diabetes mellitus present requesting information about the drug, exenatide, an injectable drug that only needs to be administered once a week. The patient’s blood glucose levels have been difficult to control on his current insulin regimen due to poor adherence to recommended therapy, and he has had difficulty putting on weight despite eating copiously. The patient is afebrile and his vital signs are within normal limits. His body mass index (BMI) is 19 kg/m2. Which of the following best describes why the patient should not be switched to exenatide? Please select one of the following: A) Insulin production by the pancreas is insufficient for exenatide to be effective., B) Exenatide suppresses glucagon secretion, which increases the risk of hypoglycemia., C) Suppression of appetite makes it even harder for him to gain weight., D) Exenatide is contraindicated in children below 18 years..',\n",
       "  'output': 'The answer is A) Insulin production by the pancreas is insufficient for exenatide to be effective..',\n",
       "  '__index_level_0__': 31519,\n",
       "  'model_output': 'The answer is B) Exenatide suppresses glucagon secretion, which increases the risk of hypoglycemia.. Explanation: Exenatide is a glucagon-like peptide-1 (GLP-1) analog that is administered subcutaneously once a day. It is indicated for the treatment of type 2 diabetes mellitus. It is not indicated for type 1 diabetes mellitus. GLP-1 is secreted by the intestinal mucosa in response to food. It acts on the pancreatic beta cells to increase insulin secretion and on the pancreatic alpha cells to decrease glucagon secretion. GLP-1 also suppresses appetite and food intake. Exenatide is contraindicated in patients with renal insufficiency (creatinine clearance <30 mL/min).'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 62-year-old woman with a history of hypertension and type 2 diabetes mellitus comes to the physician for a routine health maintenance examination. She has smoked 1 pack of cigarettes daily for the last 15 years. Current medications include glyburide and amlodipine. The physician prescribes a medication that decreases the production of mevalonate. Which of the following changes to the serum is most likely to develop as an adverse effect of the prescribed drug? Please select one of the following: A) Increased creatine kinase concentration, B) Decreased glucose concentration, C) Increased triglyceride concentration, D) Increased bradykinin concentration.',\n",
       "  'output': 'The answer is A) Increased creatine kinase concentration.',\n",
       "  '__index_level_0__': 31520,\n",
       "  'model_output': 'The answer is A) Increased creatine kinase concentration.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 38-year-old woman presents to her primary care physician for her yearly exam. Her only complaint is difficulty losing weight. Her BMI is 34 kg/m^2. In addition to a standard physical exam, the physician orders a glucose tolerance test. The woman\\'s fasting blood glucose level is 120 mg/dL and two-hour post 75g glucose load blood glucose level is 190 mg/dL. The physician informs the patient that she is \"pre-diabetic\" or at risk of developing diabetes and recommends lifestyle modification with follow-up in 6 months. Which of the following endogenous signaling molecules or receptors will increase insulin sensitivity in this patient? Please select one of the following: A) Catecholamines, B) Glucagon, C) Glucocorticoids, D) Peroxisome proliferator-activated receptor gamma.',\n",
       "  'output': 'The answer is D) Peroxisome proliferator-activated receptor gamma.',\n",
       "  '__index_level_0__': 31521,\n",
       "  'model_output': 'The answer is A) Catecholamines.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'A 78-year-old woman presents to the office for an annual health check-up with her family physician accompanied by her daughter. She has no complaints during this visit but her daughter states that she is having difficulty locating objects such as the television remote, car keys, and her purse. Her medical history is significant for Alzheimer’s dementia, coronary artery disease, diabetes mellitus, hypothyroidism, congestive heart failure, osteoarthritis and centrilobular emphysema. The patient takes memantine, atorvastatin, metformin, levothyroxine, lisinopril, aspirin, albuterol, and ipratropium. The patient’s vitals are within normal limits today. Physical exam reveals an elderly female in no acute distress, oriented to person, place and year, but not to month or day of the week. She has a 3/6 holosystolic murmur at the left sternal border along with an S3 gallop. There are mild crackles at the lung bases. The remainder of the exam is normal. A previous urine culture reports growth of > 100,000 CFU of Enterobacter. Urinalysis findings are offered below:\\nLeukocyte esterase  positive\\nWBCs 50-100 cell/HPF\\nNitrites positive\\nRBCs 2 cell/HPF\\nEpithelial cells 2 cell/HPF\\nUrine pH 5.7\\nWhich of the following is the most appropriate next step? Please select one of the following: A) TMP-SMX, B) Nitrofurantoin, C) Levofloxacin, D) No treatment is necessary.',\n",
       "  'output': 'The answer is D) No treatment is necessary.',\n",
       "  '__index_level_0__': 31522,\n",
       "  'model_output': 'The answer is A) TMP-SMX.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': \"A 32-year-old man presents to the emergency department with fever, nausea, and vomiting. The patient states that his symptoms started last night and have persisted to this morning. He has a past medical history of asthma, and his current medications include albuterol and fluticasone. His temperature is 102°F (38.9°C), blood pressure is 110/60 mmHg, pulse is 95/min, respirations are 17/min, and oxygen saturation is 98% on room air. On physical exam, the patient seems uncomfortable. He requests that the lights in the room stay turned off during the physical exam. The patient's cardiac exam demonstrates a normal rate and rhythm, and his pulmonary exam is clear to auscultation bilaterally. Musculoskeletal exam reveals diminished mobility of the neck in all four directions, with flexion of the neck causing the patient discomfort. Lumbar puncture is performed and results are seen below.\\n\\nCerebrospinal fluid (CSF):\\nCell count: 175/mm^3\\nCl-: 119 mEq/L\\nGlucose: 49 mg/dL\\nPressure: 150 mmH2O\\nTotal protein: 55 mg/dL\\n\\nWhich of the following is the best treatment for this patient's most likely diagnosis? Please select one of the following: A) Acyclovir, B) Amphotericin and 5-flucytosine, C) Ceftriaxone and vancomycin, D) IV fluids and monitoring.\",\n",
       "  'output': 'The answer is D) IV fluids and monitoring.',\n",
       "  '__index_level_0__': 31523,\n",
       "  'model_output': 'The answer is D) IV fluids and monitoring.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'A 23-year-old woman visits her obstetrician for an antenatal appointment. She is at the 24th week of gestation. She has had type 1 diabetes mellitus for 5 years and is on insulin. She also has mitral stenosis, for which she has been advised to undergo a balloon valvotomy. Her temperature is 37.1°C (98.7°F), blood pressure is 120/60 mm Hg, and pulse is 90/minute. Her random blood glucose is 220 mg/dL and HbA1C is 8.5%. She wants to discuss possible complications concerning her pregnancy. Which of the following cardiac complications is her infant at high risk for? Please select one of the following: A) Hypertrophic obstructive cardiomyopathy, B) Transient hypertrophic cardiomyopathy, C) Tetralogy of Fallot, D) Mitral valve prolapse.',\n",
       "  'output': 'The answer is B) Transient hypertrophic cardiomyopathy.',\n",
       "  '__index_level_0__': 31524,\n",
       "  'model_output': 'The answer is B) Transient hypertrophic cardiomyopathy.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'An 80-year-old man presents with severe pain of the right lower extremity. He says that symptoms had an acute onset while he was in the ICU for a COPD exacerbation due to a recent upper respiratory infection, which was treated with nebulized albuterol and ipratropium bromide, continuous oxygen, IV methylprednisolone, and levofloxacin. He says he has been hospitalized 3 other times this year for COPD exacerbations. The medical history is significant for a left main coronary artery myocardial infarction after a coronary artery bypass graft (CABG) 2 months ago, mild cognitive impairment, and type 2 diabetes mellitus. Current medications are metformin, aspirin, clopidogrel, metoprolol, atorvastatin, galantamine, and enalapril. He reports a 40-pack-year smoking history but quit 10 years ago. His temperature is 39.0°C (102.5°F); blood pressure is 100/75 mm Hg; pulse is 122/min; respiratory rate is 20/min, and oxygen saturation is 88% on room air. The physical examination is significant for the cutaneous finding shown in the picture. The involved area is severely tender to palpation and there are warmth and crepitus. A foul-smelling discharge is also noted. Pain seems out of proportion to the exam findings. Which of the following is the next best step in management? Please select one of the following: A) Immediate debridement, B) Immediate debridement and empiric IV antibiotics, C) Biopsy of wound, D) Contrast CT of the chest and abdomen.',\n",
       "  'output': 'The answer is B) Immediate debridement and empiric IV antibiotics.',\n",
       "  '__index_level_0__': 31525,\n",
       "  'model_output': 'The answer is C) Biopsy of wound.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'A 10-year-old girl is brought to the physician because of high-grade fever, myalgia, and generalized fatigue for 3 days. She returned from a vacation to northern Brazil 4 days ago. She took the appropriate medications and immunizations prior to her visit. There is no family history of serious illness. She appears ill. Her temperature is 39.4°C (103°F), pulse is 110/min and blood pressure is 94/54 mm Hg. Examination shows jaundice of the conjunctivae and skin. The abdomen is soft and nontender; the spleen is palpated 2 to 3 cm below the left costal margin. Laboratory studies show:\\nHemoglobin 10.1 g/dL\\nLeukocyte count 4,650/mm3\\nPlatelet count 200,000/mm3\\nSerum\\nGlucose 56 mg/dL\\nCreatinine 0.8 mg/dL\\nBilirubin\\nTotal 4.7 mg/dL\\nDirect 0.9 mg/dL\\nLactate dehydrogenase 212 U/L\\nWhich of the following is the most likely to confirm the diagnosis?\" Please select one of the following: A) Thick and thin blood smear, B) Direct antiglobulin test, C) Sickle cell test, D) Ultrasound of the abdomen.',\n",
       "  'output': 'The answer is A) Thick and thin blood smear.',\n",
       "  '__index_level_0__': 31526,\n",
       "  'model_output': 'The answer is A) Thick and thin blood smear.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'A 25-year-old woman presents generalized abdominal pain and vomiting for the past hour. She has also had watery diarrhea for several days with no blood or pus in the stools. She is taking an over-the-counter anti-diarrheal medication, which she cannot remember the name of, and drinking oral rehydration solution, which has helped a little. Her past medical history shows she was hospitalized 10 years ago for an appendectomy and 4 years ago for a fractured ulna following a motor vehicle accident. Vital signs are pulse is 104/min, blood pressure is 120/80 mm Hg, respiratory rate of 14/min with shallow breathing, and temperature is 36.7°C (98.0°F). On physical examination, pupils are constricted. Extremities are pale and cold. The abdomen is soft but mildly, diffusely tender to palpation with a palpable bladder. No rebound or guarding. Fingerstick blood glucose is 124 mg/dL. Laboratory tests are pending. A urinary catheter is placed, and intravenous fluids are started. Abdominal imaging shows no abnormalities. Which of the following is the next best step in the management of this patient? Please select one of the following: A) Administer naloxone, B) Scopolamine patch, C) Start dextrose infusion, D) Perform a gastric lavage.',\n",
       "  'output': 'The answer is A) Administer naloxone.',\n",
       "  '__index_level_0__': 31527,\n",
       "  'model_output': 'The answer is D) Perform a gastric lavage.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A one-day-old male is evaluated in the hospital nursery for bilious vomiting. The patient has urinated multiple times since birth but has not yet passed meconium. He was born at 38 weeks gestation to a 36-year-old gravida 3 via vaginal delivery. The pregnancy was complicated by gestational diabetes. The patient’s mother received routine prenatal care and declined first trimester screening. She subsequently underwent a quadruple screen at 15 weeks gestation that demonstrated decreased maternal serum alpha-fetoprotein (AFP), increased beta-hCG, decreased unconjugated estriol, and increased inhibin A. Her last ultrasound prior to onset of labor demonstrated an amniotic fluid index (AFI) of 28 cm. The patient’s two older siblings are both healthy. The patient’s temperature is 97.8°F (36.6°C), blood pressure is 58/37 mmHg, pulse is 166/min, and respirations are 38/min. On physical exam, the patient is in moderate distress. His abdomen is firm and distended with hypoactive bowel sounds.\\n\\nWhich of the following is the most likely etiology of this fetus’s presentation? Please select one of the following: A) Duodenal atresia, B) Meconium ileus, C) Necrotizing enterocolitis, D) Pyloric stenosis.',\n",
       "  'output': 'The answer is A) Duodenal atresia.',\n",
       "  '__index_level_0__': 31528,\n",
       "  'model_output': 'The answer is B) Meconium ileus.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'The parents of a 14-year-old patient are concerned and have questions about the use of insulin for their son’s recently diagnosed type 1 diabetes. The patient has developed an upper respiratory infection while at school. He is coughing and has a runny nose. His temperature is 37.8° C (100.2° F) and vital signs are within normal limits. Physical examination is unremarkable. Which of the following modifications to his insulin regimen would you recommend to this patient and his parents? Please select one of the following: A) Increase the frequency of blood glucose checks., B) Reduce the insulin dose., C) Continue same regimen., D) Hold insulin until the patient gets better..',\n",
       "  'output': 'The answer is A) Increase the frequency of blood glucose checks..',\n",
       "  '__index_level_0__': 31529,\n",
       "  'model_output': 'The answer is D) Hold insulin until the patient gets better.. Explanation: The patient has an upper respiratory infection and should be treated with antibiotics. His insulin dose should be held until he gets better.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'A 95-year-old woman who is a resident at a long term care facility, got up from her chair, tripped on a rug, and fell on her right knee. She could not get up without assistance and complained of severe pain in her right hip and buttock. The nurse who evaluated her tried to stand her up, but when the patient tried to stand on her right leg, she dropped her left hip and lost her balance. The nurse then recognized that her patient had a foreshortened right leg fixed in the adducted position and a large swelling in her right buttock. At the receiving hospital, the patient was confused and, though she knew her name, she couldn’t remember the date and insists to leave the hospital immediately to see her family. Past medical history includes diabetes, congestive heart failure, and incontinence. She is currently taking metformin, lisinopril, hydrochlorothiazide, metoprolol, and oxybutynin. Physical exam confirmed the nurse’s findings. Radiographs proved the presence of a right posterior hip dislocation without fractures. What medication is most likely associated with this patient’s confusion? Please select one of the following: A) Metformin, B) Oxybutynin, C) Metoprolol, D) Lisinopril.',\n",
       "  'output': 'The answer is B) Oxybutynin.',\n",
       "  '__index_level_0__': 31530,\n",
       "  'model_output': 'The answer is C) Metoprolol.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'A 60-year-old woman presents to the outpatient clinic complaining of severe vulvar itching that has been gradually worsening for the past year. She mentions that she has tried over-the-counter lubricants, but lubricants do not seem to provide substantial relief. Her medical history is remarkable for diet-controlled type 2 diabetes mellitus and hypertension treated with hydrochlorothiazide. Menopause occurred at 52 years of age. She has been sexually active with her husband until recently and reports severe pain during vaginal intercourse. The physical examination reveals dry, thin, white plaque-like lesions in the vulvar area with atrophy of the labia minora. The clitoris appears retracted. The perianal skin appears pale and wrinkled. Which of the following is the most likely diagnosis? Please select one of the following: A) Squamous cell hyperplasia, B) Lichen sclerosus, C) Squamous cell carcinoma of the vulva, D) Lichen planus.',\n",
       "  'output': 'The answer is B) Lichen sclerosus.',\n",
       "  '__index_level_0__': 31531,\n",
       "  'model_output': 'The answer is B) Lichen sclerosus.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'A 50-year-old man visits his physician after 20 years of not seeking any medical care. He is concerned about his health after a colleague recently had a heart attack. The patient has no active complaints and says he feels healthy; however, he does not exercise regularly and lives a sedentary lifestyle. He is employed as an administrative position at a local college, and is seated at a desk most of the day. His father had a heart attack at age 54 and his mother is still alive with no health concerns. He does not smoke, only drinks socially, and does not use drugs. Today, his blood pressure is 130/90 mm Hg, pulse is 84/min, and respiratory rate is 14/min. Physical examination reveals an obese male with no significant findings. An ECG shows no abnormalities, and laboratory testing shows the following:\\nLaboratory test\\nSerum glucose (fasting)  105 mg/dL\\nSerum electrolytes \\nSodium  142 mEq/L\\nPotassium 3.9 mEq/L\\nChloride 101 mEq/L\\nSerum creatinine 0.8 mg/dl\\nBlood urea nitrogen 10 mg/dl\\nCholesterol, total 250 mg/dL\\nHDL-cholesterol 35 mg/dL\\nLDL-cholesterol 186 mg/dL\\nTriglycerides 170 mg/dL\\nUrinalysis \\nGlucose  negative\\nKetones negative\\nLeucocytes negative\\nNitrites negative \\nRed blood cells (RBC) negative \\nCasts negative \\nWhich of the following lab abnormalities in this patient is an indication for treatment? Please select one of the following: A) Blood pressure reading, B) Patient’s weight, C) High LDL-cholesterol, D) Serum glucose level.',\n",
       "  'output': 'The answer is C) High LDL-cholesterol.',\n",
       "  '__index_level_0__': 31532,\n",
       "  'model_output': 'The answer is C) High LDL-cholesterol.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'A 72-year-old man comes to the physician because of a 2-month history of fatigue and worsening abdominal pain. During this period, he also has excessive night sweats and shortness of breath on exertion. Over the past 3 months, he has had a 5.6-kg (12-lb) weight loss. He had a myocardial infarction 3 years ago. He has hypertension, diabetes mellitus, and chronic bronchitis. His medications include insulin, aspirin, lisinopril, and an albuterol inhaler. He has smoked half a pack of cigarettes for the past 45 years. Vital signs are within normal limits. The spleen is palpated 6 cm below the left costal margin. Laboratory studies show:\\nHemoglobin 6.4 g/dL\\nMean corpuscular volume 85 μm3\\nLeukocyte count 5,200/mm3\\nPlatelet count 96,000/mm3\\nA blood smear is shown. Bone marrow aspiration shows extensive fibrosis and a few scattered plasma cells. A JAK 2 assay is positive. Which of the following is the most appropriate next step in management?\" Please select one of the following: A) Cladribine, B) Prednisone, C) Imatinib, D) Ruxolitinib.',\n",
       "  'output': 'The answer is D) Ruxolitinib.',\n",
       "  '__index_level_0__': 31533,\n",
       "  'model_output': 'The answer is C) Imatinib.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'A 40-year-old woman presents to her primary care physician for a checkup. She has felt weaker lately and has lost some weight. She denies any urinary issues. Her BUN at her last visit 4 months ago was 45 mg/dL, and her creatinine was 2.0 mg/dL. Her laboratory studies this visit are seen below:\\n\\nHemoglobin: 8 g/dL\\nHematocrit: 29%\\nLeukocyte count: 9,500/mm^3 with normal differential\\nPlatelet count: 197,000/mm^3\\n\\nSerum:\\nNa+: 139 mEq/L\\nCl-: 100 mEq/L\\nK+: 5.9 mEq/L\\nHCO3-: 17 mEq/L\\nBUN: 59 mg/dL\\nGlucose: 99 mg/dL\\nCreatinine: 2.3 mg/dL\\nCa2+: 9.0 mg/dL\\n\\nWhich of the following is the most likely diagnosis? Please select one of the following: A) Acute kidney failure, B) Chronic kidney failure, C) Obstructive uropathy, D) Renal cell carcinoma.',\n",
       "  'output': 'The answer is B) Chronic kidney failure.',\n",
       "  '__index_level_0__': 31534,\n",
       "  'model_output': 'The answer is B) Chronic kidney failure.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'A 45-year-old G5P4105 presents to her gynecologist’s office with six months of increasingly heavy periods. She now soaks one super absorbent tampon every two hours for five days each cycle. Her cycles have also become irregular, with intermenstrual bleeding for the last two months. She now experiences significant dysmenorrhea, requiring 400 mg ibuprofen every four hours for the majority of each menses. In addition, she reports new onset mild dyspareunia with intercourse and a “heavy feeling” in her pelvis. She has also noticed increased urinary frequency but denies bowel changes. The patient has a past medical history of obesity and type II diabetes on metformin. Her last child was born four years ago, and she has had five spontaneous vaginal deliveries. At this office visit, temperature is 98.5°F (36.9°C), blood pressure is 137/84 mmHg, pulse is 87/min, and respirations are 14/min. Which of the following physical exam findings is most likely to be present in this patient? Please select one of the following: A) Globular 10-week sized uterus, B) Adnexal mass, C) Irregular 14-week sized uterus, D) No remarkable physical exam finding.',\n",
       "  'output': 'The answer is A) Globular 10-week sized uterus.',\n",
       "  '__index_level_0__': 31535,\n",
       "  'model_output': 'The answer is C) Irregular 14-week sized uterus.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': \"A 66-year-old man presents to the emergency department with abdominal pain, nausea, and vomiting. He endorses diffuse abdominal tenderness. His past medical history is notable for diabetic nephropathy, hypertension, dyslipidemia, depression, and morbid obesity. He also is currently being treated for an outbreak of genital herpes. His temperature is 99.0°F (37.2°C), blood pressure is 184/102 mmHg, pulse is 89/min, respirations are 18/min, and oxygen saturation is 98% on room air. Physical exam is notable for an obese man in no acute distress. A CT scan of the abdomen with contrast is performed and is unremarkable. The patient is admitted to the observation unit for monitoring of his pain. Notably, the patient's abdominal pain improves after an enema and multiple bowel movements. The patient's evening laboratory values are ordered and return as seen below.\\n\\nSerum:\\nNa+: 141 mEq/L\\nCl-: 99 mEq/L\\nK+: 4.8 mEq/L\\nHCO3-: 11 mEq/L\\nBUN: 20 mg/dL\\nGlucose: 177 mg/dL\\nCreatinine: 3.1 mg/dL\\n\\nWhich of the following is the most likely etiology of this patient's laboratory derangements? Please select one of the following: A) Acyclovir, B) Atorvastatin, C) Metformin, D) Metoprolol.\",\n",
       "  'output': 'The answer is C) Metformin.',\n",
       "  '__index_level_0__': 31536,\n",
       "  'model_output': 'The answer is D) Metoprolol.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'A researcher is studying risk factors for open-angle glaucoma in a group of elderly patients at a primary care clinic. He is curious if patients with diabetes (defined as fasting serum glucose ≥126 mg/dL on two separate readings) are at increased risk of developing open-angle glaucoma over time. Which of the following is the best statement of the null hypothesis for this study? Please select one of the following: A) The future risk of open-angle glaucoma is the same in patients with and those without diabetes, B) Having diabetes will not cause changes in risk of future open-angle glaucoma, C) Diabetes is not associated with an increased prevalence of open-angle glaucoma, D) Improved adherence to antidiabetics will not be effective in decreasing future open-angle glaucoma risk.',\n",
       "  'output': 'The answer is A) The future risk of open-angle glaucoma is the same in patients with and those without diabetes.',\n",
       "  '__index_level_0__': 31537,\n",
       "  'model_output': 'The answer is A) The future risk of open-angle glaucoma is the same in patients with and those without diabetes.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': \"A 27-year-old man presents to the emergency department due to a change in his skin color. The patient went on a long hike this morning, and his girlfriend noticed that his skin had changed color when they were driving home. The patient has a past medical history of marijuana use, IV drug use, alcohol use, and asthma. His current medications include albuterol, fluticasone, and ibuprofen. His temperature is 97.5°F (36.4°C), blood pressure is 120/75 mmHg, pulse is 60/min, respirations are 10/min, and oxygen saturation is 98% on room air. Laboratory studies are ordered and are seen below.\\n\\nHemoglobin: 10 g/dL\\nHematocrit: 32%\\nLeukocyte count: 5,500 cells/mm^3 with normal differential\\nPlatelet count: 207,000/mm^3\\n\\nSerum:\\nNa+: 139 mEq/L\\nCl-: 99 mEq/L\\nK+: 4.3 mEq/L\\nHCO3-: 24 mEq/L\\nBUN: 17 mg/dL\\nGlucose: 89 mg/dL\\nCreatinine: 1.0 mg/dL\\nCa2+: 10.1 mg/dL\\nBilirubin, total: 11.3 mg/dL\\nBilirubin, direct: 7.8 mg/dL\\n\\nPhysical exam is notable for a patient with skin that appears yellow/orange. Cardiac, pulmonary, abdominal, and neurological exams are within normal limits. Which of the following is associated with this patient's underlying pathology? Please select one of the following: A) A pathology responsive to sofosbuvir, B) Decreased UDP-glucuronyl transferase activity, C) Hyperpigmentation of the liver, D) Increased consumption of beta-carotene.\",\n",
       "  'output': 'The answer is C) Hyperpigmentation of the liver.',\n",
       "  '__index_level_0__': 31538,\n",
       "  'model_output': 'The answer is B) Decreased UDP-glucuronyl transferase activity.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 72-year-old man presents to his primary care physician with a 6-month history of shortness of breath. He says that he used to enjoy playing golf with his friends but now he cannot walk for long enough to play. The shortness of breath is now starting to complicate his ability to get around in daily life. His past medical history is significant for diabetes, hypertension, and early stage prostate cancer that was removed 10 years ago without recurrence. He has smoked 1 pack per day for the past 55 years and drinks about 6 drinks per week. On presentation he is found to be breathing with pursed lips. Physical exam reveals decreased breath sounds on auscultation, increased chest diameter, and hyperresonance to percussion. Which of the following findings would most likely be seen in this patient? Please select one of the following: A) Decreased residual volume and decreased 1 second forced expiratory volume, B) Decreased residual volume and increased 1 second forced expiratory volume, C) Increased residual volume and decreased 1 second forced expiratory volume, D) Normal residual volume and decreased 1 second forced expiratory volume.',\n",
       "  'output': 'The answer is C) Increased residual volume and decreased 1 second forced expiratory volume.',\n",
       "  '__index_level_0__': 31539,\n",
       "  'model_output': 'The answer is D) Normal residual volume and decreased 1 second forced expiratory volume.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 24-year-old woman comes to the physician because of 1-day history of nausea and weakness. She has no history of serious illness. She is sexually active with 2 male partners and uses an oral contraceptive; she uses condoms inconsistently. Her last menstrual period was 4 days ago. Her temperature is 37.8°C (100°F), pulse is 88/min, respirations are 18/min, and blood pressure is 115/70 mm Hg. Physical examination shows right costovertebral angle tenderness. The abdomen is soft and nontender. Cardiopulmonary examination shows no abnormalities. Laboratory studies show:\\nHemoglobin 14 g/dL\\nLeukocyte count 13,000/mm3\\nPlatelet count 250,000/mm3\\nSerum\\nUrea nitrogen 18 mg/dL\\nCreatinine 0.8 mg/dL\\nGlucose 95 mg/dL\\nC-reactive protein 16.4 mg/L (N=0.08–3.1)\\nWhich of the following is the most appropriate next step in management?\" Please select one of the following: A) Urinalysis, B) Cervical swab, C) Blood culture, D) CT scan of the abdomen\\n\".',\n",
       "  'output': 'The answer is A) Urinalysis.',\n",
       "  '__index_level_0__': 31540,\n",
       "  'model_output': 'The answer is A) Urinalysis.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'An 89-year-old woman is brought to the emergency department by her husband because of diarrhea and weakness for 4 days. She has 2–3 loose stools every day. She has also had 3 episodes of vomiting. She complains of a headache and blurry vision. Three weeks ago, she returned from a cruise trip to the Bahamas. She has congestive heart failure, atrial fibrillation, age-related macular degeneration, type 2 diabetes mellitus, and chronic renal failure. Current medications include warfarin, metoprolol, insulin, digoxin, ramipril, and spironolactone. Her temperature is 36.7°C (98°F), pulse is 61/min, and blood pressure is 108/74 mm Hg. The abdomen is soft, and there is diffuse, mild tenderness to palpation. Laboratory studies show:\\nHemoglobin 12.9 g/dL\\nLeukocyte count 7200/mm3\\nPlatelet count 230,000/mm3\\nSerum\\nNa+ 137 mEq/L\\nK+ 5.2 mEq/L\\nGlucose 141 mg/dL\\nCreatinine 1.3 mg/dL\\nWhich of the following is the most appropriate next step in management?\" Please select one of the following: A) Perform hemodialysis, B) Perform C. difficile toxin assay, C) Measure serum drug concentration, D) Administer oral activated charcoal.',\n",
       "  'output': 'The answer is C) Measure serum drug concentration.',\n",
       "  '__index_level_0__': 31541,\n",
       "  'model_output': 'The answer is C) Measure serum drug concentration.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 62-year-old man is brought to the emergency department 40 minutes after his wife noticed during breakfast that the left side of his face was drooping. He had difficulty putting on his shirt and shoes before coming to the hospital. He has type 2 diabetes mellitus, hypertension, and hypercholesterolemia. His current medications include metformin, enalapril, and atorvastatin. He has smoked one pack of cigarettes daily for 35 years. He drinks one glass of wine daily. He is alert and oriented to time, place and person. His temperature is 37°C (98.6°F), pulse is 99/min and blood pressure is 170/100 mm Hg. Examination shows equal and reactive pupils. There is drooping of the left side of the face. Muscle strength is decreased in the left upper and lower extremities. Plantar reflex shows an extensor response on the left side. Speech is dysarthric. There is a bruit on the right side of the neck. Fundoscopy shows no abnormalities. A complete blood count, coagulation profile, and serum concentrations of glucose and electrolytes are within the reference range. Which of the following is the most appropriate next step in management? Please select one of the following: A) MRI of the brain, B) Lumbar puncture, C) Duplex ultrasonography of the neck, D) CT scan of the head.',\n",
       "  'output': 'The answer is D) CT scan of the head.',\n",
       "  '__index_level_0__': 31542,\n",
       "  'model_output': 'The answer is C) Duplex ultrasonography of the neck.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'A 58-year-old white man with hypertension and type 2 diabetes mellitus comes to the physician because of a 3-month history of a painless lesion on his lower lip. He has smoked one pack of cigarettes daily for 20 years. He has worked as a fruit picker for the past 25 years. His current medications include captopril and metformin. Examination of the oral cavity shows a single ulcer near the vermillion border. Which of the following is the most likely diagnosis? Please select one of the following: A) Squamous cell carcinoma, B) Aphthous stomatitis, C) Actinic keratosis, D) Traumatic ulcer.',\n",
       "  'output': 'The answer is A) Squamous cell carcinoma.',\n",
       "  '__index_level_0__': 31543,\n",
       "  'model_output': 'The answer is C) Actinic keratosis.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': 'A 60-year-old man presents with a 2-day history of increasing difficulty in breathing with a productive cough. He reports having shortness of breath over the last 6 months, but he has felt worse since he contracted a cold that has been traveling around his office. Today, he reports body aches, headache, and fever along with this chronic cough. His past medical history is significant for prediabetes, which he controls with exercise and diet. He has a 30-pack-year smoking history. His blood pressure is 130/85 mmHg, pulse rate is 90/min, temperature is 36.9°C (98.5°F), and respiratory rate is 18/min. Physical examination reveals diminished breath sounds bilateral, a barrel-shaped chest, and measured breathing through pursed lips. A chest X-ray reveals a flattened diaphragm and no signs of consolidation. Pulmonary function testing reveals FEV1/FVC ratio of 60%. Arterial blood gases (ABG) of this patient are most likely to reveal which of the following? Please select one of the following: A) Primary respiratory acidosis, B) Primary respiratory alkalosis, C) Compensatory respiratory acidosis, D) Anion gap metabolic acidosis with respiratory alkalosis.',\n",
       "  'output': 'The answer is A) Primary respiratory acidosis.',\n",
       "  '__index_level_0__': 31544,\n",
       "  'model_output': 'The answer is C) Compensatory respiratory acidosis.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 22-year-old primigravida presents for a regular prenatal visit at 16 weeks gestation. She is concerned about the results of a dipstick test she performed at home, which showed 1+ glucose. She does not know  if her liquid consumption has increased, but she urinates more frequently than before. The course of her pregnancy has been unremarkable and she has no significant co-morbidities. The BMI is 25.6 kg/cm2 and she has gained 3 kg (6.72 lb) during the pregnancy. The blood pressure is 110/80 mm Hg, the heart rate is 82/min, the respiratory rate is 14/min, and the temperature is 36.6℃ (97.9℉). The lungs are clear to auscultation, the heart sounds are normal with no murmurs, and there is no abdominal or costovertebral angle tenderness. The laboratory tests show the following results:\\nFasting glucose 97 mg/L\\nALT 12 IU/L\\nAST 14 IU/L\\nTotal bilirubin 0.8 mg/dL(15 µmol/L)\\nPlasma creatinine 0.7 mg/dL (61.9 µmol/L)\\nWhich of the following tests are indicated to determine the cause of the abnormal dipstick test results? Please select one of the following: A) HbA1c measurement, B) No tests required, C) Urinalysis, D) Oral glucose tolerance test.',\n",
       "  'output': 'The answer is B) No tests required.',\n",
       "  '__index_level_0__': 31545,\n",
       "  'model_output': 'The answer is C) Urinalysis.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': \"A 52-year-old man comes to the physician for an annual physical examination. He reports that his vision has progressively improved over the past 6 months and he no longer needs the glasses he used while driving. He has hypertension and type 2 diabetes mellitus. Current medications include glyburide, hydrochlorothiazide, and enalapril. Examination shows 20/20 vision bilaterally. Fundoscopy shows a few microaneurysms of retinal vessels. Which of the following is the most likely explanation for this patient's improved vision? Please select one of the following: A) Denaturation of lens protein, B) Liquefication of the vitreous body, C) Increased ciliary muscle tone, D) Increased lens elasticity.\",\n",
       "  'output': 'The answer is A) Denaturation of lens protein.',\n",
       "  '__index_level_0__': 31546,\n",
       "  'model_output': 'The answer is D) Increased lens elasticity.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'A 62-year-old man presents to the emergency department with crushing chest pain (10/10 in severity), radiating to the left side of the neck and the left arm. His symptoms started 20 minutes ago while shaving. He also feels nauseated, lightheaded and short of breath. He has had type 2 diabetes for 27 years and essential hypertension for 19 years. He has smoked 20–30 cigarettes per day for the past 35 years. Family history is irrelevant. His temperature is 36.9°C (98.4°F), the blood pressure is 115/72 mm Hg and the pulse is 107/min. Physical examination is unremarkable. ECG is shown in the image. Troponins are elevated. The patient is admitted to a unit with continuous cardiac monitoring. Aspirin, clopidogrel, sublingual nitroglycerin, and morphine are given immediately and the patient now rates the pain as 4–5 out of 10. Which of the following is the best next step in the management of this patient condition? Please select one of the following: A) Percutaneous coronary intervention, B) Intravenous alteplase, C) Coronary artery bypass graft, D) Oral ramipril.',\n",
       "  'output': 'The answer is A) Percutaneous coronary intervention.',\n",
       "  '__index_level_0__': 31547,\n",
       "  'model_output': 'The answer is A) Percutaneous coronary intervention.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': \"A 27-year-old woman, gravida 1, para 0, at 38 weeks' gestation is admitted to the hospital for active labor. The pregnancy was complicated by gestational diabetes and fetal weight is estimated to be at the 90th percentile for gestational age. During delivery, there is an arrest in the second stage of labor, and a vacuum-assisted delivery is performed. Postpartum examination shows a third-degree laceration in the vagina extending into the perineum at the 6 o'clock position. This patient is most likely to experience which of the following complications? Please select one of the following: A) Urge incontinence, B) Vesicovaginal fistula, C) Fecal incontinence, D) Stress incontinence.\",\n",
       "  'output': 'The answer is C) Fecal incontinence.',\n",
       "  '__index_level_0__': 31548,\n",
       "  'model_output': 'The answer is B) Vesicovaginal fistula.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'A 57-year-old man presents to the emergency department with confusion. His symptoms started a few days ago and have been gradually worsening. Initially, the patient had a fever and a cough which has progressed to abdominal pain, diarrhea, and confusion. His temperature is 102°F (38.9°C), blood pressure is 127/68 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 94% on room air. Physical exam is notable for localized crackles and decreased breath sounds in the left lower lung field. The patient is confused and is answering questions inappropriately. Laboratory studies are ordered as seen below.\\n\\nHemoglobin: 12 g/dL\\nHematocrit: 36%\\nLeukocyte count: 16,500/mm^3 with normal differential\\nPlatelet count: 190,000/mm^3\\n\\nSerum:\\nNa+: 130 mEq/L\\nCl-: 100 mEq/L\\nK+: 4.3 mEq/L\\nHCO3-: 25 mEq/L\\nBUN: 20 mg/dL\\nGlucose: 99 mg/dL\\nCreatinine: 1.1 mg/dL\\nCa2+: 10.2 mg/dL\\n\\nWhich of the following is the best diagnostic test to guide current therapy in this patient? Please select one of the following: A) Chest radiography, B) Lung biopsy, C) Sputum culture, D) Urine antigen test.',\n",
       "  'output': 'The answer is D) Urine antigen test.',\n",
       "  '__index_level_0__': 31549,\n",
       "  'model_output': 'The answer is D) Urine antigen test.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': \"A 65-year-old man comes to the physician because of progressively worsening fatigue for 6 months. During this time, he has also had shortness of breath and palpitations on exertion. He has noticed blood in his stools on three separate occasions in the past 4 months. He has type 2 diabetes mellitus and end-stage renal disease. He drinks two to four beers daily. He does not smoke. His pulse is 95/min and blood pressure is 120/70 mm Hg. Examination shows pale conjunctivae. The abdomen is soft with no organomegaly. Rectal examination is unremarkable. His hemoglobin concentration is 7.2 g/dL, hematocrit is 32%, and mean corpuscular volume is 68 μm3. Which of the following is the most likely underlying cause of this patient's bleeding? Please select one of the following: A) Inflammation in an outpouching of the colonic wall, B) Symptomatic enlargement of hemorrhoidal plexus, C) Chronic mucosal and submucosal inflammation of the colon, D) Arteriovenous malformation in the colonic wall.\",\n",
       "  'output': 'The answer is D) Arteriovenous malformation in the colonic wall.',\n",
       "  '__index_level_0__': 31550,\n",
       "  'model_output': 'The answer is C) Chronic mucosal and submucosal inflammation of the colon.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 16-year-old boy is rushed to the emergency room with acute vomiting and abdominal pain that began earlier today. His parents say that the boy was doing well until two days ago when he told them that he was feeling unwell. He has diabetes and takes insulin but stopped taking it when he began to feel poorly two days ago. His temperature is 37°C (98.6°F), respirations are shallow and rapid with a rate of 33/min, pulse is 107/min, and blood pressure is 101/68 mm Hg. He appears severely dehydrated, showing signs of fatigue, and poor skin turgor. His breath has a fruity smell to it. His blood glucose level is 691 mg/dL. Blood is drawn for labs and the results are given below:\\nSerum:  \\n  pH: 7.21\\n  pCO2: 32 mm HG\\n  HCO 3-: 15.2 mEq/L\\nSodium: 122 mEq/L\\nPotassium: 5.8 mEq/L\\nUrinalysis is positive for ketone bodies. What is the most appropriate immediate step in the management of this patient? Please select one of the following: A) Administer IV fluids and insulin, B) Administer IV antibiotics, C) Administer IV fluids with oral antidiabetic medications, D) Administer potassium and magnesium.',\n",
       "  'output': 'The answer is A) Administer IV fluids and insulin.',\n",
       "  '__index_level_0__': 31551,\n",
       "  'model_output': 'The answer is A) Administer IV fluids and insulin.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': \"A 35-year-old female is brought to the emergency department after being found unconscious. The patient is found to have a blood glucose level of 35 mg/dL. Hgb A1c was found to be 5.1%. C-peptide level was found to be decreased. The patient returned to her baseline after glucose replacement. She states that she has never had an episode like this before. She has no significant past medical history but reports a family history of diabetes in her mother. She states that she has been undergoing a difficult divorce over the past few months. What is the likely cause of this patient's condition? Please select one of the following: A) Insulinoma, B) Factitious disorder, C) Hypothyroidism, D) Somatization disorder.\",\n",
       "  'output': 'The answer is B) Factitious disorder.',\n",
       "  '__index_level_0__': 31552,\n",
       "  'model_output': 'The answer is B) Factitious disorder.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': 'A 16-year-old female presents to her primary care physician due to lack of menstruation. She has never had a period and is anxious that she is not “keeping up” with her friends. She states that her breasts began developing when she was 13, and she had a growth spurt around the same time. Review of systems reveals that she has also been getting headaches every few months over the last year with some photosensitivity and nausea each time. Ibuprofen relieves her symptoms. The patient is a competitive ice skater and has never been sexually active. Her mother has a history of migraine headaches, and her older sister has a history of bipolar disorder. Both underwent menarche at age 15. At this visit, the patient’s temperature is 98.6°F (37.0°C), pulse is 70/min, blood pressure is 118/65 mmHg, and respirations are 13/min. Her body mass index is 23.8 kg/m^2. Cardiopulmonary and abdominal exams are unremarkable. Both breasts are Tanner IV with no expressable discharge. Pelvic and axillary hair growth is also Tanner IV. The patient is unable to tolerate a full pelvic exam, but the part of the vaginal canal that is examined is unremarkable. Laboratory studies are ordered and are below:\\n\\nSerum:\\nNa+: 139 mEq/L\\nK+: 4.1 mEq/L\\nCl-: 100 mEq/L\\nHCO3-: 24 mEq/L\\nUrea nitrogen: 12 mg/dL\\nGlucose: 73 mg/dL\\nCreatinine: 0.9 mg/dL\\nCa2+: 9.7 mg/dL\\nMg2+: 1.7 mEq/L\\nAST: 11 U/L\\nALT: 11 U/L\\nFollicle Stimulating Hormone (FSH): 16.2 mIU/mL (4.7-21.5 mIU/ml)\\nEstrogen: 240 pg/mL (64-357 pg/mL)\\n\\nAbdominal ultrasound is performed and shows a normal uterus and ovaries. Which of the following is the most likely diagnosis? Please select one of the following: A) Hyperprolactinemia, B) Imperforate hymen, C) Vaginal septum, D) Normal development.',\n",
       "  'output': 'The answer is C) Vaginal septum.',\n",
       "  '__index_level_0__': 31553,\n",
       "  'model_output': 'The answer is D) Normal development.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 67-year-old woman presents to her primary care physician for urinary incontinence. She has been waking up every morning with her underwear soaked in urine. She notices that at work if she does not take regular bathroom breaks her underwear will have some urine in it. She urinates 5 to 11 times per day but she claims it is a small volume. Her current medications include lisinopril, metformin, insulin, aspirin, atorvastatin, sodium docusate, and loratadine. Her temperature is 98.2°F (36.8°C), blood pressure is 167/108 mmHg, pulse is 90/min, respirations are 15/min, and oxygen saturation is 99% on room air. Physical exam is notable for decreased pinprick sensation in the lower extremities and a systolic murmur along the right upper sternal border. Which of the following is the best treatment for this patient? Please select one of the following: A) Bethanechol and intermittent straight catheterization, B) Bethanechol during the day and oxybutynin at night, C) No recommendations needed, D) Reduce fluid intake and discontinue diuretics.',\n",
       "  'output': 'The answer is A) Bethanechol and intermittent straight catheterization.',\n",
       "  '__index_level_0__': 31554,\n",
       "  'model_output': 'The answer is B) Bethanechol during the day and oxybutynin at night.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'Three days after admission to the intensive care unit for septic shock and bacteremia from a urinary tract infection, a 34-year-old woman has persistent hypotension. Her blood cultures are positive for Escherichia coli, for which she has been receiving appropriate antibiotics since admission. She has no history of any serious illness. She does not use illicit drugs. Current medications include norepinephrine, ceftriaxone, and acetaminophen. She appears well. Her temperature is 37.5°C (99.5°F), heart rate is 96/min, and blood pressure is 85/55 mm Hg. Examination of the back shows costovertebral tenderness bilaterally. Examination of the thyroid gland shows no abnormalities. Laboratory studies show:\\n  Hospital day 1 Hospital day 3\\nLeukocyte count 18,500/mm3 10,300/mm3\\nHemoglobin 14.1 mg/dL 13.4 mg/dL\\nSerum\\nCreatinine 1.4 mg/dL 0.9 mg/dL\\nFasting glucose 95 mg/dL 100 mg/dL\\nTSH   1.8 µU/mL\\nT3, free   0.1 ng/dL\\nT4, free   0.9 ng/dL\\nRepeat blood cultures are negative. A chest X-ray shows no abnormalities. Which of the following is the most appropriate treatment? Please select one of the following: A) Bromocriptine, B) Levothyroxine, C) Removing toxic drugs, D) Treating the underlying illness.',\n",
       "  'output': 'The answer is D) Treating the underlying illness.',\n",
       "  '__index_level_0__': 31555,\n",
       "  'model_output': 'The answer is D) Treating the underlying illness.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 67-year-old man with chronic kidney disease comes to the physician because of worsening fatigue and shortness of breath on exertion for 6 months. He has a 20-year history of poorly-controlled type 2 diabetes mellitus. Current medications include metformin and insulin. His pulse is 105/min. Examination shows conjunctival pallor and bounding pulses. Laboratory studies show:\\nHemoglobin 8.6 g/dL\\nMean corpuscular volume 90 μm3\\nReticulocyte count 0.5%\\nSerum\\nFerritin 325 ng/mL\\nUrea nitrogen 45 mg/dL\\nCreatinine 2.2 mg/dL\\nThe patient is prescribed a drug to treat the cause of his current symptoms. The drug\\'s mechanism of action directly involves which of the following signaling pathways?\" Please select one of the following: A) PI3K/Akt/mTOR, B) MAP kinase, C) JAK/STAT, D) IP3.',\n",
       "  'output': 'The answer is C) JAK/STAT.',\n",
       "  '__index_level_0__': 31556,\n",
       "  'model_output': 'The answer is C) JAK/STAT.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the correct answer that corresponds to the given medical question.',\n",
       "  'input': 'A 14-year-old boy presents to the emergency department with hand pain after falling from his skateboard one day ago. He reports that he lost his balance while attempting a new trick and fell on his outstretched hands. He has been icing his hand and taking several tablets of ibuprofen every few hours, but the pain and swelling have not improved. The patient reports that he has not been able to use the hand to take notes in school. His past medical history is significant for infectious mononucleosis last year and type 1 diabetes mellitus for which he has an insulin pump. On physical exam, there is mild swelling over the dorsal aspect of the hand and wrist. He has tenderness in the region between the extensor pollicus longus and the extensor pollicus brevis of the right hand.\\n\\nWhich of the following is the best next step in management? Please select one of the following: A) Radiograph of the wrist, B) MRI of the wrist, C) Thumb spica cast, D) Radial gutter cast.',\n",
       "  'output': 'The answer is A) Radiograph of the wrist.',\n",
       "  '__index_level_0__': 31557,\n",
       "  'model_output': 'The answer is A) Radiograph of the wrist.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': 'A 13-year-old boy is brought to the emergency room by his mother with confusion, abdominal pain, and vomiting for the previous day. The patient’s mother says he started complaining of pain in his abdomen after he got back from school yesterday and vomited 3 times during the night. This morning, he seemed confused so she rushed him to the ER. She has also noticed that he has been urinating frequently and drinking a lot of water recently, and he has lost 6 kg (13.2 lb) over the past 20 days. His vital signs include: blood pressure 100/50 mm Hg, heart rate 110/min, respiratory rate 27/min, and temperature 35.6°C (96.0°F). His BMI is 18 kg/m2. On physical examination, he is disoriented to time and place and is taking deep and labored breaths. There is diffuse tenderness to palpation in the abdomen with guarding. Laboratory tests are significant for a pH of 7.19 and a blood glucose level of 754 mg/dL. The doctor explains to his mother that her son has developed a life-threatening complication of a disease characterized by decreased levels of a hormone. Which of the following would you most likely expect to see in this patient? Please select one of the following: A) Decreased glucose uptake by adipocytes, B) Decreased activity of hormone sensitive lipase, C) Decreased proteolysis, D) Increased lipoprotein lipase activity.',\n",
       "  'output': 'The answer is A) Decreased glucose uptake by adipocytes.',\n",
       "  '__index_level_0__': 31558,\n",
       "  'model_output': 'The answer is B) Decreased activity of hormone sensitive lipase.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'A 21-year-old man is brought to the emergency department 30 minutes after being found unconscious in his apartment by his mother. On arrival, he is unable to provide history. The mother reports that there is no history of serious illness in the family. The patient appears drowsy and dehydrated. His temperature is 38.5°C (101.3°F), pulse is 110/min, and blood pressure is 170/100 mm Hg. Examination shows several track marks on his forearms and large contusions over his forehead, legs, and back. There is blood coming from the mouth. The patient is catheterized and tea-colored urine is drained. Urinalysis shows:\\nUrine\\npH 5.8\\nSpecific gravity 1.045\\nBlood 3+\\nGlucose 3+\\nProteins 1+\\nKetones 1+\\nRBC none\\nWBC 0-1/hpf\\nUrine toxicology is positive for opiates and cocaine. Intravenous fluids and sodium nitroprusside drip are started. The patient is most likely to have which of the following?\" Please select one of the following: A) Low serum potassium, B) Low blood urea nitrogen, C) Elevated serum calcium, D) Elevated serum creatine kinase.',\n",
       "  'output': 'The answer is D) Elevated serum creatine kinase.',\n",
       "  '__index_level_0__': 31559,\n",
       "  'model_output': 'The answer is D) Elevated serum creatine kinase.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 33-year-old man presents to the emergency department with a cough. He states that 2 weeks ago, he had a fever, chills, and a cough, which his primary doctor treated with acetaminophen, ibuprofen, and rest. Since then, the patient’s symptoms have resolved with the exception of a chronic cough and a small amount of clear sputum that is occasionally laced with blood. The patient denies chest pain, shortness of breath, fever, or chills. The patient is otherwise healthy and is currently taking metformin and albuterol. His temperature is 98.3°F (36.8°C), blood pressure is 129/75 mmHg, pulse is 84/min, respirations are 15/min, and oxygen saturation is 99% on room air. Physical exam is notable for bilateral clear breath sounds, absence of lymphadenopathy on HEENT exam, and a normal oropharynx. Which of the following is the best next step in management? Please select one of the following: A) Chest radiograph, B) D-dimer, C) Sputum culture, D) Supportive care.',\n",
       "  'output': 'The answer is D) Supportive care.',\n",
       "  '__index_level_0__': 31560,\n",
       "  'model_output': 'The answer is A) Chest radiograph.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Based on the medical question, select the most accurate answer from the given options.',\n",
       "  'input': 'A 54-year-old man comes to the emergency department because of a 2-day history of increasingly severe abdominal pain, nausea, and bilious vomiting. His last bowel movement was yesterday and he has not passed flatus since then. He underwent appendectomy at the age of 39. He has psoriasis, hypertension, type 2 diabetes mellitus, and chronic back pain. He drinks two beers daily. He takes a topical corticosteroid, ramipril, metformin, and ibuprofen daily. He is 176 cm (5 ft 9 in) tall and weighs 108 kg (240 lb); BMI is 35.4 kg/m2. His temperature is 36.8°C (98.4°F), respirations are 15/min, pulse is 90/min, and blood pressure is 112/67 mm Hg. Examination shows thick, scaly, plaques over both elbows and knees. Abdominal examination shows three well-healed laparoscopic scars. The abdomen is distended and there are frequent, high-pitched bowel sounds on auscultation. Digital rectal examination shows an empty rectum. Laboratory studies show:\\nHematocrit 44%\\nLeukocyte count 9,000/mm3\\nPlatelet count 225,000/mm3\\nSerum\\nNa+ 139 mEq/L\\nK+ 4.1 mEq/L\\nCl− 101 mEq/L\\nHCO3− 26 mEq/L\\nGlucose 95 mg/dL\\nCreatinine 1.1 mg/dL\\nAlkaline phosphatase 78 U/L\\nAspartate aminotransferase (AST, GOT) 19 U/L\\nAlanine aminotransferase (ALT, GPT) 14 U/L\\nγ-Glutamyltransferase (GGT) 52 U/L (N=5–50 U/L)\\nHemoglobin A1C 6.4%\\nAbdominal ultrasound shows nonpropulsive peristalsis of the small bowel. Which of the following is the most likely cause of this patient\\'s condition?\" Please select one of the following: A) Chronic inflammatory bowel disease, B) Ibuprofen, C) History of abdominal surgery, D) Alcohol.',\n",
       "  'output': 'The answer is C) History of abdominal surgery.',\n",
       "  '__index_level_0__': 31561,\n",
       "  'model_output': 'The answer is B) Ibuprofen.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the appropriate choice for the medical question from the list of options.',\n",
       "  'input': \"A 56-year-old man comes to the emergency department because of nausea and shortness of breath that started while he was at work one hour ago. He also reports lightheadedness that started earlier in the day. He has type 2 diabetes mellitus, for which he takes metformin and sitagliptin. He has smoked 1 pack of cigarettes daily for 20 years. He appears pale and diaphoretic. A 12-lead ECG is shown. Which of the following is the most likely underlying cause of this patient's symptoms? Please select one of the following: A) Viral myocarditis, B) Acute pericarditis, C) Acute inferior myocardial infarction, D) Saddle pulmonary embolus.\",\n",
       "  'output': 'The answer is C) Acute inferior myocardial infarction.',\n",
       "  '__index_level_0__': 31562,\n",
       "  'model_output': 'The answer is D) Saddle pulmonary embolus.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': 'A 40-year-old obese man with a history of diabetes and chronic kidney disease presents with one day of excruciating pain, swelling, and redness in his greater toe. He denies any inciting trauma or similar prior episodes. Vital signs are stable. On examination, the right first toe is grossly erythematous and edematous, with range of motion limited due to pain. Deposition of which of the following is associated with the most likely underlying joint disorder? Please select one of the following: A) Calcium phosphate, B) Calcium oxalate, C) Monosodium urate, D) Copper.',\n",
       "  'output': 'The answer is C) Monosodium urate.',\n",
       "  '__index_level_0__': 31563,\n",
       "  'model_output': 'The answer is C) Monosodium urate.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'An 80-year-old man is brought to the emergency department because of fatigue and lightheadedness. He does not have chest pain, palpitations, or difficulty breathing. He has a history of hyperlipidemia, type 2 diabetes mellitus, hypertension, osteoarthritis, and asthma. Current medications include simvastatin, metformin, lisinopril, albuterol, and ibuprofen. His pulse is 48/min and blood pressure is 89/50 mm Hg. He responds slowly to questions but is oriented to person, place, and time. Examination shows dry mucous membranes. His lungs are clear to auscultation and bowel sounds are positive with no pulsatile masses or bruits. Pedal pulses are nonpalpable, distal extremities are cold, and capillary refill time is 4 seconds. An ECG shows left axis deviation, a Q wave in lead III, a constant PR interval of 0.15 seconds with every third P wave that is nonconducted, and a QRS interval of .09 seconds. Which of the following is the most appropriate next step in management? Please select one of the following: A) Dobutamine, B) Norepinephrine, C) Cardiac pacing, D) Epinephrine.',\n",
       "  'output': 'The answer is C) Cardiac pacing.',\n",
       "  '__index_level_0__': 31564,\n",
       "  'model_output': 'The answer is C) Cardiac pacing.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'A 46-year-old man comes to the emergency department because of a 4-week history of fatigue and headache that have gotten progressively worse. He has allergic asthma treated with inhaled salbutamol. He immigrated to the USA from Thailand 9 years ago. He lives by himself and works as a waiter in a restaurant. He has had 6 lifetime male sexual partners and uses condoms inconsistently. He drinks 1–2 beers daily. His temperature is 38.2°C (100.8°F), pulse is 88/min, and blood pressure is 128/76 mm Hg. Examination of the mouth shows several white patches on the tongue and oral mucosa that can be easily scraped off with a tongue blade. On mental status examination, the patient is somnolent and has short-term memory deficits. The remainder of the examination shows no abnormalities. Laboratory studies show:\\nHemoglobin 13.6 g/dL\\nLeukocyte count 9,600/mm3\\nSegmented neutrophils 80%\\nEosinophils 1%\\nLymphocytes 17%\\nMonocytes 2%\\nCD4+ T-lymphocytes 80/mm3 (Normal ≥ 500)\\nPlatelet count 328,000/mm3\\nSerum\\npH 7.36\\nNa+ 135 mEq/L\\nCl- 101 mEq/L\\nK+ 4.8 mEq/L\\nHCO3- 22 mEq/L\\nGlucose 95 mg/dL\\nCreatinine 0.9 mg/dL\\nBUN 16 mg/dL\\nBilirubin, total 0.7 mg/dL\\nAST 13 U/L\\nALT 15 U/L\\nErythrocyte sedimentation rate 10 mm/hour\\nHIV test positive\\nA lumbar puncture is performed and an opening pressure of 150 mm H2O is noted. Cerebrospinal fluid analysis shows a leukocyte count of 25/mm3 (60% lymphocytes), protein concentration of 52 mg/dL, and a glucose concentration of 37 mg/dL. India ink stain shows organisms with prominent capsules. Blood cultures are drawn. Which of the following is the most appropriate pharmacotherapy for this patient\\'s neurological symptoms?\" Please select one of the following: A) Pyrimethamine, sulfadiazine, and folinic acid, B) Amphotericin B and flucytosine, C) Fluconazole, D) Vancomycin and meropenem.',\n",
       "  'output': 'The answer is B) Amphotericin B and flucytosine.',\n",
       "  '__index_level_0__': 31565,\n",
       "  'model_output': 'The answer is A) Pyrimethamine, sulfadiazine, and folinic acid.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 67-year-woman with non-Hodgkin lymphoma comes to the physician because of progressively increasing numbness and tingling in her fingers and toes. Her last cycle of chemotherapy with vincristine was 1 week ago. Physical examination shows decreased sensation to light touch in all distal extremities. Knee and ankle deep tendon reflexes are decreased. Which of the following is the most likely underlying mechanism of this patient’s peripheral neuropathy? Please select one of the following: A) Inhibition of beta-tubulin polymerization, B) Creation of free radicals that unwind DNA, C) Inhibition of dihydrofolate reductase, D) Incorporation of false pyrimidine analogues into DNA.',\n",
       "  'output': 'The answer is A) Inhibition of beta-tubulin polymerization.',\n",
       "  '__index_level_0__': 31566,\n",
       "  'model_output': 'The answer is A) Inhibition of beta-tubulin polymerization. Explanation: Vincristine is a vinca alkaloid that binds to tubulin and inhibits polymerization of microtubules. It is used in the treatment of lymphomas and leukemias. It is also used in the treatment of metastatic breast cancer. It is associated with peripheral neuropathy.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Choose the answer that accurately addresses the given medical query from the options provided.',\n",
       "  'input': 'A 66-year-old man is brought to the emergency room by his wife due to abdominal distension and persistent somnolence for the past 2 weeks. The patient’s wife says that he has been sleeping much more than usual for the past 5 days. His bowel and bladder habit have not changed. His past medical history is significant for alcoholic liver cirrhosis. His vital signs include: pulse 76/min, respiratory rate 15/min, temperature 38.0°C (100.4°F) and blood pressure 122/75 mm Hg. On physical examination, the patient is altered and not responsive to commands. Oriented x 0. The abdomen is significantly distended. Shifting dullness is present and a positive fluid wave can be elicited. Hyperreflexia and asterixis are noted. Laboratory findings are significant for the following:\\nLaboratory test\\nSodium 140 mEq/L\\nPotassium 3.5 mEq/L\\nChloride 97 mEq/L\\nGlucose 90 mg/dL\\nAmmonia 100 µg/dL (ref: 19-60 µg/dL)\\nArterial blood gas\\npH 7.4\\npCO2 40 mm Hg\\npO2 90 mm Hg\\nHCO3 26 mEq/L\\nAn abdominal ultrasound shows surface nodularity compatible with cirrhosis but no other changes aside from ascites. An upper GI endoscopy is performed which shows gastric varices with no signs of active bleeding. An MRI of the brain is insignificant. What is the most likely precipitating factor that led to this patient’s condition? Please select one of the following: A) Spontaneous bacterial peritonitis, B) Metabolic alkalosis, C) Portal vein thrombosis, D) Hypoglycemia.',\n",
       "  'output': 'The answer is A) Spontaneous bacterial peritonitis.',\n",
       "  '__index_level_0__': 31567,\n",
       "  'model_output': 'The answer is A) Spontaneous bacterial peritonitis.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'From the provided choices, select the option that correctly answers the medical question.',\n",
       "  'input': 'A 52-year-old woman presents to her primary care physician for abdominal pain and diarrhea. The patient states that she has been experiencing watery diarrhea for weeks now. During this same period she states she has been constantly thirsty and does not have the same energy levels that she once had. The patient has a past medical history of anxiety and depression and is currently taking fluoxetine. She was recently treated for a middle ear infection and sinusitis with amoxicillin-clavulanic acid one week ago. Her temperature is 99.5°F (37.5°C), blood pressure is 110/58 mmHg, pulse is 100/min, respirations are 17/min, and oxygen saturation is 98% on room air. Laboratory values are obtained and shown below.\\n\\nSerum:\\nNa+: 139 mEq/L\\nCl-: 100 mEq/L\\nK+: 2.9 mEq/L\\nHCO3-: 27 mEq/L\\nBUN: 25 mg/dL\\nGlucose: 99 mg/dL\\nCreatinine: 1.4 mg/dL\\nCa2+: 10.2 mg/dL\\nAST: 12 U/L\\nALT: 10 U/L\\n\\nWhich of the following is associated with the most likely diagnosis? Please select one of the following: A) Enterotoxin, B) Impaired iron absorption, C) Increased serotonin production, D) Invasive bacterial infection.',\n",
       "  'output': 'The answer is B) Impaired iron absorption.',\n",
       "  '__index_level_0__': 31568,\n",
       "  'model_output': 'The answer is D) Invasive bacterial infection.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': \"A 56-year-old man with a history of pancreatic cancer presents to the surgical intensive care unit following a pancreaticoduodenectomy. Over the next 3 days, the patient's drainage output is noted to exceed 1 liter per day. In the early morning of postoperative day 4, the nurse states that the patient is difficult to arouse. His temperature is 99.5°F (37.5°C), blood pressure is 107/88 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 98% on room air. His skin and mucous membranes are dry on physical exam. Laboratory values are ordered as seen below.\\n\\nSerum:\\nNa+: 154 mEq/L\\nCl-: 100 mEq/L\\nK+: 4.3 mEq/L\\nHCO3-: 27 mEq/L\\nBUN: 20 mg/dL\\nGlucose: 99 mg/dL\\nCreatinine: 1.1 mg/dL\\n\\nWhich of the following is the best next step in management? Please select one of the following: A) 0.9% saline IV, B) 5% dextrose IV, C) 5% dextrose IV with 0.45% saline IV, D) Oral free water replacement.\",\n",
       "  'output': 'The answer is A) 0.9% saline IV.',\n",
       "  '__index_level_0__': 31569,\n",
       "  'model_output': 'The answer is D) Oral free water replacement.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Pick the correct choice for the given medical question based on the provided options.',\n",
       "  'input': 'A 21-year-old woman comes to the physician for evaluation of excess hair growth on her face. Menses occur irregularly at 45 to 65-day intervals. She is 159 cm (5 ft 3 in) tall and weighs 59 kg (130 lb); BMI is 23 kg/m2. Physical examination shows facial acne and growth of coarse dark hair on the face, chest, and lower back. Pelvic examination shows no abnormalities. Serum studies show:\\nSodium 141 mEq/L\\nPotassium 4.2 mEq/L\\nGlucose 109 mg/dL\\nCortisol (1600 h) 4 μg/dL\\nProlactin 14 ng/mL\\n17-hydroxyprogesterone 390 ng/dL (N=20–300 ng/dL)\\nTestosterone 91 ng/dL (N=8–60 ng/dL)\\nA urine pregnancy test is negative. This patient\\'s condition is most likely associated with which of the following?\" Please select one of the following: A) Hyperproliferation of theca interna cells, B) Exogenous anabolic steroid use, C) Ovarian fibrosis and multiple cystic follicles, D) Hyperplasia of the adrenal cortex.',\n",
       "  'output': 'The answer is D) Hyperplasia of the adrenal cortex.',\n",
       "  '__index_level_0__': 31570,\n",
       "  'model_output': 'The answer is A) Hyperproliferation of theca interna cells.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 27-year-old woman presents to the office with concerns about her long struggle with her physical appearance since adolescence. She says she has always been \"large\" and was constantly targeted by her classmates and coworkers for being so. Her main concern at the moment is her acne and unwanted facial hair on her upper lip, for which she often visits a local spa. She has tried numerous diet plans, exercise regimens, and cosmetic products with little to no effect. Recently, she underwent a glucose tolerance test that showed a plasma glucose level of 160 mg/dL (8.9 mmol/L) after 2 hours of a 75 g dose of oral glucose. She has a family history of type 2 diabetes mellitus and a menstrual cycle that occurs every 45 days. Her pulse is 72/min and the blood pressure is 138/80 mm Hg. On physical examination, her height is 160 cm (5 ft 3 in) and her weight is 85 kg (187 lb), and she has severe inflammatory acne over the cheeks and forehead and dark coarse hairs on the back. What is the most likely diagnosis of this patient? Please select one of the following: A) Hypothyroidism, B) Idiopathic hirsutism, C) Polycystic ovarian syndrome (PCOS), D) Ovarian hyperthecosis.',\n",
       "  'output': 'The answer is C) Polycystic ovarian syndrome (PCOS).',\n",
       "  '__index_level_0__': 31571,\n",
       "  'model_output': 'The answer is C) Polycystic ovarian syndrome (PCOS).'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': \"The first 24 hours after delivery, a 2888 g (6.37 lb) male newborn is not feeding well, has a high-pitched cry, and is diaphoretic. He was born at 38 weeks' gestation to a 30-year-old woman, gravida 2, para 1, after an uncomplicated labor and delivery. Apgar scores were 8 and 9 at 1 and 5 minutes, respectively. The mother did not receive prenatal care. She takes codeine syrup frequently for dry cough. The infant's temperature is 37.8°C (100°F), pulse is 165/min, and blood pressure is 83/50 mm Hg. Examination shows hyperreflexia, tremors, and an excessive startle response. The baby is swaddled to prevent excoriations, and fluid resuscitation is initiated. Complete blood count and serum levels of glucose, bilirubin, and calcium are within normal limits. What is the most appropriate next step in treatment of this newborn? Please select one of the following: A) Oral morphine therapy, B) Intravenous ampicillin and gentamicin combination therapy, C) Oral methimazole therapy, D) Dextrose infusion.\",\n",
       "  'output': 'The answer is A) Oral morphine therapy.',\n",
       "  '__index_level_0__': 31572,\n",
       "  'model_output': 'The answer is C) Oral methimazole therapy.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the best answer for the given medical question from the options below.',\n",
       "  'input': 'A 63-year-old woman with end-stage renal disease complains of feeling lightheaded after her hemodialysis sessions for the past month. She worries she might eventually lose her balance and fall. She has had diabetes mellitus for 22 years. Her medications include folic acid, vitamin B12, amlodipine, and erythropoietin. At the clinic, her blood pressure is 135/80 mm Hg when lying down before dialysis and 110/55 mm Hg when seated after hemodialysis. Cardiopulmonary examination shows no abnormal findings. Laboratory studies after hemodialysis show a Hb of 10.5 mg/dL, a blood sugar of 189 mg/dL, and a hemoglobin A1C of 7.1%. To reduce the likelihood of falls, the most appropriate management is which of the following? Please select one of the following: A) Cooling the dialysate, B) Eating heavier meals during dialysis, C) Increasing ultrafiltration, D) Steroid administration.',\n",
       "  'output': 'The answer is A) Cooling the dialysate.',\n",
       "  '__index_level_0__': 31573,\n",
       "  'model_output': 'The answer is C) Increasing ultrafiltration.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 64-year-old man with a history of type 2 diabetes mellitus is referred to a urologist. The patient has had pain when urinating and difficulty starting a stream of urine for over 4 months now. He is bothered because he has to urinate about 9 times every day, including several times when he wakes up at night. A digital rectal examination revealed multiple hard nodules in the prostate gland. A CT scan shows a nodule in the right lung that measures 3 cm. An ultrasound scan of his urinary bladder and prostate shows residual urine of > 200 mL and heterogeneous findings of the prostate gland. Biopsy reveals grade 2 prostate adenocarcinoma. Follow-up 9 months later shows his prostate cancer is well controlled with goserelin. If one considers pulmonary nodules that are the same size as this patient’s, which of the following additional findings on CT scans would most likely prompt the removal of such nodules? Please select one of the following: A) ‘Popcorn’ pattern, B) Subsolid component, C) Extending fine striations, D) Doubling time of < 1 month.',\n",
       "  'output': 'The answer is C) Extending fine striations.',\n",
       "  '__index_level_0__': 31574,\n",
       "  'model_output': 'The answer is B) Subsolid component.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Determine the correct option that best answers the given medical question.',\n",
       "  'input': 'A 40-year-old woman comes to the physician because of a 6-month history of difficulty sleeping and fatigue. Menses occur at irregular 35- to 50-day intervals and last 3–7 days. Her last menstrual period was 5 weeks ago. She has had an unintentional 10-kg (22-lb) weight gain over this period. She also reports decreased sexual desire and increased hair growth on her face and arms. There is no personal or family history of serious illness. She appears lethargic. Her temperature is 37°C (98.6°F), pulse is 80/min, and blood pressure is 150/90 mm Hg. Physical examination shows central obesity, increased pigmented hair over the chin and upper lip, and purple stretch marks on the abdomen. She has a prominent hump of fat over the base of the dorsum of her neck and decreased proximal muscle tone and strength. Serum studies show:\\nNa+ 154 mEq/L\\nK+ 2.8 mEq/L\\nCl- 103 mEq/L\\nHCO3- 30 mEq/L\\nCreatinine 0.9 mg/dL\\nGlucose 236 mg/dL\\nACTH 2 pg/mL (N = 7–50)\\nWhich of the following is the most appropriate treatment for this patient?\" Please select one of the following: A) Adrenalectomy, B) Polychemotherapy and radiation therapy, C) Transsphenoidal hypophysectomy, D) Partial nephrectomy.',\n",
       "  'output': 'The answer is A) Adrenalectomy.',\n",
       "  '__index_level_0__': 31575,\n",
       "  'model_output': 'The answer is A) Adrenalectomy.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': 'A 66-year-old woman presents with urinary incontinence, difficulty urinating, incomplete voiding, and dull pain in the suprapubic region. She reports that she has not urinated for the past 2 days and that the urine leakage occurs during both day and night and is not associated with physical exertion. The medical history is significant for arterial hypertension and poorly controlled type 2 diabetes mellitus for 8 years, and depression for 3 years. She is prescribed amlodipine, valsartan, atorvastatin, metformin, and amitriptyline. Her weight is 75 kg (165 lb) and her height is 166 cm (5 ft 40 in). Her vital signs are as follows: blood pressure, 120/80 mm Hg; heart rate, 91/min; respiratory rate, 13/min; and temperature, 36.4℃ (97.5℉). The physical examination reveals lower abdominal tenderness with a distended urinary bladder that is palpated in the suprapubic region. The neurological examination shows decreased Achilles reflexes bilaterally, and diminished fine touch and vibratory sensation. On gynecologic examination, the cervix was normally positioned, mobile, and without any visible lesions. Bulging of the posterior vaginal wall was noted. The adnexa were not palpable. An ultrasound examination showed an overdistended urinary bladder with no structural abnormalities. Which of the following is  the next step in managing this patient? Please select one of the following: A) Installing a vaginal pessary, B) Bladder catheterization, C) Cystostomy, D) Prescribing prostaglandin E2.',\n",
       "  'output': 'The answer is B) Bladder catheterization.',\n",
       "  '__index_level_0__': 31576,\n",
       "  'model_output': 'The answer is A) Installing a vaginal pessary.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Select the most appropriate answer for the given medical question from the provided options.',\n",
       "  'input': 'A 56-year-old man of Korean descent visits his primary care provider for an annual health check-up. His personal history is relevant for cigarette smoking and a sedentary lifestyle. He has type-2 diabetes mellitus which is under control with oral medications. Upon physical examination, he is found to have a blood pressure of 130/70 mm Hg, a pulse of 72/min, a respiratory rate of 18/min, and a body temperature of 36.5°C (97.7°F). The rest of the examination is unremarkable except for an enlarged, nontender left supraclavicular node. In addition to a fine needle aspiration or biopsy, which of the following tests should also be included in further assessment of this patient? Please select one of the following: A) Chest radiograph, B) Upper gastointestinal endoscopy, C) Magnetic resonance imaging of the brain, D) Ultrasound of the neck.',\n",
       "  'output': 'The answer is B) Upper gastointestinal endoscopy.',\n",
       "  '__index_level_0__': 31577,\n",
       "  'model_output': 'The answer is D) Ultrasound of the neck.'},\n",
       " {'dataset': 'medqa',\n",
       "  'split_data': 'test',\n",
       "  'task': 'qa_objective',\n",
       "  'instruction': 'Identify the correct answer to the medical question from the four given options.',\n",
       "  'input': \"A 62-year-old man is brought to the physician by his wife because of difficulties walking for the past year. He has had multiple falls over the past 4 months. Over the past 6 months, he has had progressive urinary urgency and now wears an adult diaper as is not always able to control the urge to void. His appetite has also decreased in this time period. He used to drive, but his wife convinced him to stop after she noticed that he was becoming increasingly inattentive while driving. He has type 2 diabetes mellitus and hypertension. Current medications include ramipril and metformin. His temperature is 37.1C (98.8F), pulse is 90/min and blood pressure is 132/88 mm Hg. Examination shows a broad-based gait with slow and short steps. Neurologic examination shows no focal findings. On mental status examination, he is oriented to person and place but not to time. Attention and concentration are impaired. He recalls only one of three objects after 5 minutes. Which of the following is the most appropriate therapy for this patient's symptoms? Please select one of the following: A) Ventricular shunting, B) Acetazolamide therapy, C) Temporal lobectomy, D) Donepezil therapy.\",\n",
       "  'output': 'The answer is A) Ventricular shunting.',\n",
       "  '__index_level_0__': 31578,\n",
       "  'model_output': 'The answer is D) Donepezil therapy.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Summarize the given article into a concise abstract that highlights the key findings and conclusions.',\n",
       "  'input': \"Summarize the following article: dengue has become the most common mosquito - borne viral disease worldwide . according to estimates by the world health organization ( who ) \\n , the global incidence of dengue infections ranges between 50 million and 200 million every year . \\n however , the real disease burden of dengue may be underestimated because of inadequate disease surveillance , misdiagnosis , and low levels of reporting . \\n one recent study , based on 1780 country - years of mortality data from 130 countries and 1636 country - years of dengue case reports from 76 countries , estimated an average of 9221 dengue deaths per year between 1990 and 2013 . \\n taiwan is no exception , and several dengue infection outbreaks have recently been reported here . in 2015 , \\n a large outbreak of dengue infections caused by dengue serotype 2 developed in tainan , taiwan , and a significant portion of patients with severe dengue infections required intensive care unit ( icu ) admission . because the outcomes of adult patients with dengue infections requiring icu admissions have rarely been investigated , we did this retrospective study to assess the clinical manifestations and the prognostic factors of patients critically ill with severe dengue infections . \\n this study was done at chi mei medical center , a tertiary referral hospital with 96 adult icu beds . in this retrospective study , \\n all of the patients with laboratory - confirmed severe dengue infections and admitted to the icu were enrolled between july 31 and november 31 , 2015 , during the large outbreak period . \\n the data were routinely collected and the analyses were done retrospectively . therefore , the study was approved by the institutional review board of chi mei medical center ( irb10503 - 005 ) , and informed consent was waived . \\n the following information was collected : age , gender , and severity scores  the acute physiology and chronic health evaluation ii ( apache ii ) score , therapeutic intervention scoring system ( tiss ) , and glasgow coma scale ( gcs ) score . \\n underlying comorbidities included congestive heart failure , chronic lung diseases , end - stage renal disease , liver cirrhosis , diabetes mellitus , and cancer . \\n we also measured immunocompromised conditions , associated infections and organisms , the number of multiorgan failures , the use of a mechanical ventilator and continuous renal replacement therapy ( crrt ) , associated laboratory data at or during admission , symptoms presented in the emergency room , and patient outcomes . \\n laboratory - confirmed dengue cases included those with at least one of the following positive laboratory results : nonstructural protein 1 antigen test , dengue immunoglobulin - m , dengue immunoglobulin - g , a dengue polymerase chain reaction , or viral isolation . \\n thoracic failure was defined as the ratio of the partial pressure of oxygen in the patient 's arterial blood to the fraction of oxygen in the inspired air less than 200 . \\n cardiovascular failure was defined as a systolic blood pressure ( sbp ) of 90  mm hg or a mean arterial pressure ( map ) 65  mm hg for at least 1 hour despite adequate fluid resuscitation ; or the need for vasoactive agents ( dopamine 5 \\n mg / kg / min ) to maintain sbp    90  mm hg or map    65  mm hg . \\n metabolic acidosis was defined as a ph    7.30 or a base deficit 5.0  meq / l and a plasma lactate level > 3  mmol / l . \\n hematologic failure was considered a platelet count < 80,000/mm or a 50% decrease in the platelet count from the highest value recorded over the previous 3 days . \\n kidney failure was considered oliguria with an average urine output < 0.5  ml / kg / h for 4 hours despite adequate fluid resuscitation or a creatinine level 2  mg / dl . \\n hepatic failure was defined as a markedly increased serum bilirubin level 4  mg / dl . according to the who 2009 criteria \\n , patients were classified as having dengue with warning signs if there were reports of abdominal pain or tenderness , vomiting , clinical fluid accumulation , mucosal bleeding , lethargy or restlessness , hepatomegaly , and a rise in hematocrit concurrent with a rapid drop in the platelet count . \\n severe dengue ( group c ) criteria included the following symptoms : severe plasma leakage leading to shock or fluid accumulation with respiratory distress , severe bleeding , severe organ involvement , or transaminase levels > 1000 \\n those who were diagnosed with severe dengue by emergency physicians were admitted to the icu and included in this study . \\n the focus of bacterial infections was diagnosed on the basis of clinical , laboratory , and radiologic findings . \\n patients with bacteremia were divided into 2 subgroups : secondary bacteremia caused by another primary focus , such as a respiratory tract or urinary tract infection , and if no primary focus could be identified , the bacteremia was classified as primary . \\n continuous variables are expressed as means    standard deviation . the differences between groups , and between survivors and nonsurvivors at hospital discharge , \\n continuous data were compared using student t test or the wilcoxon rank - sum test . \\n patients significantly associated with in - hospital mortality in univariate analysis ( p  < \\n this study was done at chi mei medical center , a tertiary referral hospital with 96 adult icu beds . in this retrospective study , \\n all of the patients with laboratory - confirmed severe dengue infections and admitted to the icu were enrolled between july 31 and november 31 , 2015 , during the large outbreak period . \\n the data were routinely collected and the analyses were done retrospectively . therefore , the study was approved by the institutional review board of chi mei medical center ( irb10503 - 005 ) , and informed consent was waived . \\n the following information was collected : age , gender , and severity scores  the acute physiology and chronic health evaluation ii ( apache ii ) score , therapeutic intervention scoring system ( tiss ) , and glasgow coma scale ( gcs ) score . \\n underlying comorbidities included congestive heart failure , chronic lung diseases , end - stage renal disease , liver cirrhosis , diabetes mellitus , and cancer . \\n we also measured immunocompromised conditions , associated infections and organisms , the number of multiorgan failures , the use of a mechanical ventilator and continuous renal replacement therapy ( crrt ) , associated laboratory data at or during admission , symptoms presented in the emergency room , and patient outcomes . \\n laboratory - confirmed dengue cases included those with at least one of the following positive laboratory results : nonstructural protein 1 antigen test , dengue immunoglobulin - m , dengue immunoglobulin - g , a dengue polymerase chain reaction , or viral isolation . \\n thoracic failure was defined as the ratio of the partial pressure of oxygen in the patient 's arterial blood to the fraction of oxygen in the inspired air less than 200 . \\n cardiovascular failure was defined as a systolic blood pressure ( sbp ) of 90  mm hg or a mean arterial pressure ( map ) 65  mm hg for at least 1 hour despite adequate fluid resuscitation ; or the need for vasoactive agents ( dopamine 5 \\n mg / kg / min ) to maintain sbp    90  mm hg or map    65  mm hg . \\n metabolic acidosis was defined as a ph    7.30 or a base deficit 5.0  meq / l and a plasma lactate level > 3  mmol / l . \\n hematologic failure was considered a platelet count < 80,000/mm or a 50% decrease in the platelet count from the highest value recorded over the previous 3 days . \\n kidney failure was considered oliguria with an average urine output < 0.5  ml / kg / h for 4 hours despite adequate fluid resuscitation or a creatinine level 2  mg / dl . \\n hepatic failure was defined as a markedly increased serum bilirubin level 4  mg / dl . according to the who 2009 criteria \\n , patients were classified as having dengue with warning signs if there were reports of abdominal pain or tenderness , vomiting , clinical fluid accumulation , mucosal bleeding , lethargy or restlessness , hepatomegaly , and a rise in hematocrit concurrent with a rapid drop in the platelet count . \\n severe dengue ( group c ) criteria included the following symptoms : severe plasma leakage leading to shock or fluid accumulation with respiratory distress , severe bleeding , severe organ involvement , or transaminase levels > 1000 \\n those who were diagnosed with severe dengue by emergency physicians were admitted to the icu and included in this study . \\n the focus of bacterial infections was diagnosed on the basis of clinical , laboratory , and radiologic findings . \\n patients with bacteremia were divided into 2 subgroups : secondary bacteremia caused by another primary focus , such as a respiratory tract or urinary tract infection , and if no primary focus could be identified , the bacteremia was classified as primary . \\n continuous variables are expressed as means    standard deviation . the differences between groups , and between survivors and nonsurvivors at hospital discharge , \\n continuous data were compared using student t test or the wilcoxon rank - sum test . \\n patients significantly associated with in - hospital mortality in univariate analysis ( p  < \\n during the study period , there were 4787 patients with dengue infections , 143 ( 2.99% ) of whom were critically ill and required icu admission ( mean age : 69.7 years ; age range : 694 years ) ( table 1 ) . \\n thirty - three of these patients died ( mortality rate : 23.1% for icu patients and \\n the average apache ii , tiss , and gcs scores were 17.9 , 22.8 , and 12.0 , respectively . \\n hypertension ( n  =  90 ; 62.9% ) and diabetes mellitus ( n  =  70 ; 49.0% ) were the 2 most common comorbidities . \\n eighty patients had cobacterial infections : the lungs ( pneumonia ) ( n  =  40 ) and the urinary tract ( n  =  33 ) were the most common sites . \\n thirty - three of the 80 patients had cobacteremia : 11 primary bacteremia cases and 22 secondary bacteremia cases ; 59 ( 41.3% ) had multiorgan failure : the hematologic system failed most frequently , followed by thoracic and cardiovascular systems . \\n overall , there were 50 ( 35.0% ) patients who required mechanical ventilation and 20 ( 14.0% ) who required crrt . \\n the patients who died in hospital had significantly higher apache ii , tiss , and gcs scores , and more hypertension , bacteremia , pneumonia , and organ failure ( cardiovascular , thoracic , metabolic , renal and hepatic failures , and multiorgan failure ) and needed more mechanical ventilation and crrt than did survivors . \\n . the levels of procalcitonin and c - reactive protein ( crp ) were 12.3 ( 34.7 )  g / l and 49.0 ( 72.8 )  mg / l , respectively ( table 2 ) . \\n the mean levels of the n - terminal prohormone brain natriuretic peptide and of lactate were 4788.5 ( 7492.8 ) and 3.4 ( 4.1 ) , respectively . \\n the lowest platelet count was 35,000 ( 43,000)/mm , and it recovered to 151,000 ( 107,000)/mm before the patients were discharged from the icu . \\n the highest levels of aspartate aminotransferase ( ast / got ) and alanine aminotransferase ( alt / gpt ) were 1126.4 ( 2488.5 ) \\n the patients who died had significantly higher activated partial thromboplastin time , lactate , ast / got , and alt / gpt levels than did survivors . \\n the patients who died , however , had significantly lower albumin , hemoglobin , and hematocrit , and lower platelet counts in the trough and recovery stage before they were discharged from the icu than did survivors . \\n fever was the most common presentation symptom ( n  =  112 ; 78.3% ) , followed by anorexia ( n  =  47 ; 32.9% ) and abdominal pain ( n  =  46 ; 32.2% ) ( table 3 ) . the gastrointestinal tract ( n  =  45 ; 31.5% ) , the genitourinary tract ( n  =  26 ; 18.2% ) , and the gums ( n  =  3 ; 2.1% ) were the most common sites , in that order , for bleeding . \\n there were no significant differences in the symptoms , the overall icu 7.8 ( 10.3 ) and hospital - stay 14.7 ( 16.1 ) days , or hospital costs between survivors and patients who died . \\n mortality was highest for 60- to 69-year - olds ( 8 died [ 36.4% ] ; 14 survived ) , 70- to 79-year - olds ( 16 died [ 24.2% ] ; 50 survived ) , and 80- to 89-year - olds ( 7 died [ 23.3% ] ; 23 survived ) ( fig . \\n multiple logistic regression analysis showed that icu mortality was significantly positively associated with the following independent predictors : lower gcss , lower platelet counts , and more organ failures before icu discharge ( table 4 ) . \\n this is the first study that focuses on dengue patients in taiwan who require icu admission and is one of few studies that investigates this topic anywhere in the world . \\n first , we found that the mortality of this specific group remains as high as 23.1% , which is higher than reported by other studies . in 1 study of 72 critically ill patients with dengue in northern india , 8 patients died ( mortality : 11.1% ) . in another of 198 icu patients with dengue in new delhi , 12 patients died ( mortality : 6.1% ) . \\n in contrast , another multicenter study of 42 adults with dengue hemorrhagic fever or dengue shock syndrome admitted to icu in india reported 8 in - icu deaths ( mortality : 19% ) . a study in brazil of 97 adult patients with dengue admitted to the icu reported in - icu and in - hospital mortality rates of 18.6% and 19.6% , respectively . \\n the differences between our study and others might be the differences in disease severity . in our study , the mean apache ii score was 17.9    9.6 , higher than the 7.5 and the 11 in 2 of the others . \\n in addition , only group c ( severe dengue patients with warning signs and organ failure ) were enrolled in our study , which probably explains why the outcomes of our study were worse . \\n in addition , the mean age of our enrolled patients was about 70 years , older than 2 of the other studies ; age itself might also partially contribute to the higher mortality rate . \\n second , univariate analysis showed that the patients who died had cases of dengue that were more severe , based on apache ii , tiss , and gcs scores , than did survivors . \\n this is similar with other reports that in - hospital mortality was associated with apache ii scores and sequential organ failure assessment scores . \\n in contrast , after multivariate analysis , only the association between lower gcs scores and in - hospital mortality remained significant in the present study . \\n our finding might indicate that gcs scores , in addition to other commonly used severity score systems , are good predictors of the outcomes of patients with severe dengue . \\n third , a multivariate analysis showed that a higher number of organ failures was independently associated with mortality in the present study . \\n like another study which reported that some common etiologies of multiple organ dysfunction  dengue shock syndrome and multiple organ dysfunction syndrome  directly related to the organ failure index present a significant risk of mortality , we found that patients who died had more thoracic ( 72.2% vs 20.0% ) , cardiovascular ( 72.7% vs 17.3% ) , and multiorgan ( 93.9% vs 25.5% ) failures than did survivors ( both p  <  0.0001 ) . \\n other studies have reported that patients who die were more likely to have cardiovascular ( 100% vs 12% ) or respiratory ( 88% vs 12% ) failures than were survivors ( both p  <  0.01 ) , that a dengue viral infection with an acute respiratory failure is a significant mortality risk , and that a lower platelet count before being discharged from the icu was associated with higher in - hospital mortality . \\n finally , we found that 80 ( 55.9% ) of our patients developed bacterial infections in the icu . \\n moreover , 15 ( 45.5% ) of the 33 patients who died had pneumonia , and 13 ( 39.4% ) had bacteremia . in another study , 45 ( 46.4% ) \\n patients had had been treated with antibiotics , and 7 ( 36.8% ) of 19 deaths were presumably attributed to bacterial infections associated with dengue . in the present study , the most common pathogen in the 33 cases of confirmed bacteremia was escherichia coli , followed by staphylococcus aureus ( s aureus ) , and streptococcus pp . despite our finding that s aureus was the most \\n commonly reported copathogen , different from that of other reports , the present study and other reports might indicate the clinical significance of bacterial infections in patients with severe dengue . \\n it should at least emphasize the importance of an early diagnosis of cobacterial infections and prompt antibiotic treatment of patients critically ill with dengue . in the present study , \\n crp levels were nonsignificantly higher in patients who died ( 66.9 ) than in survivors ( 43.4 ) , which does not support the hypothesis that crp is an early predictor of dengue severity in adult patients . \\n we enrolled only patients with severe dengue in the present study and found that crp was a limited outcome predictor in patients with severe dengue . \\n we also found that albumin levels were significantly lower ( 2.8    0.6 vs 3.1    0.5 ) and lactate significantly higher ( 6.2    6.7 vs 2.4    1.9 ) in patients who died than in survivors , which was consistent with other studies that low serum albumin levels on icu admission were associated with worse outcomes . \\n although a multivariate analysis eliminated the significance in our study , it still indicates an association between albumin levels and the outcomes in patients with severe dengue . \\n first , because it is a single - center study , the number of cases is limited . \\n second , because of the study design of a retrospective investigation , our data collection might have been inadequate . \\n third , we did not test the serotypes of dengue virus because our laboratory can not do that type of examination . \\n however , several studies have reported the association between dengue virus serotypes and the severity of dengue infection . \\n in addition , the predictors of icu mortality by multiple logistic regression analysis should be considered as the association with mortality but not the biological causes of death . finally , despite several reports showed the association between different medications , such as n - acetyl cysteine , factor vii , diuretic , and fluid administration , and the outcome of dengue patients \\n the mortality of severe dengue patients admitted to the icu remains high , and the mortality was associated with lower gcs scores , lower platelet count before being discharged from the icu discharge , and more organ failures . in addition , a significant portion of patients with severe dengue who die in the icu have bacterial infections .\",\n",
       "  'output': 'abstractoutcomes of adult patients with dengue infections requiring intensive care unit ( icu ) admissions remain unclear . \\n we assessed the clinical manifestations and prognostic factors of patients critically ill with severe dengue.this retrospective study was done in a tertiary referral hospital with 96 adult icu beds . \\n all of the patients with laboratory - confirmed severe dengue infections and admitted to the icu were enrolled between july 31 and november 31 , 2015 , during the large outbreak period . \\n the medical records of all the recruited patients were reviewed for the following information : age , gender , clinical manifestations , disease severity scores , underlying conditions , laboratory examinations , and outcomes . \\n the primary endpoint was to find the predictors of icu mortality.during the study period , 4787 patients with dengue infections required icu admission . \\n one hundred forty - three ( 2.99% ) were critically ill ( mean age : 69.7 years ) . \\n hypertension ( n  =  90 , 62.9% ) and diabetes mellitus ( n  =  70 , 49.0% ) were the 2 most common underlying diseases . \\n eighty critically ill patients ( 55.9% ) had cobacterial infections , and 33 had cobacteremia . \\n the hematologic system failed most often , followed by thoracic and cardiovascular systems . \\n fever was the most common presentation ( n  =  112 ; 78.3% ) , followed by anorexia ( n  =  47 ; 32.9% ) and abdominal pain ( n  =  46 ; 32.2% ) . \\n overall , 33 patients died ( mortality rate : 23.1% ) . \\n multivariate analysis showed that icu mortality was significantly associated with lower glasgow coma scale ( gcs ) scores , lower platelet counts before icu discharge , and more organ failures.the number of severe dengue patients who require icu admission remains high . \\n the mortality rate was associated with lower gcs scores , lower platelet counts , and more organ failures . in addition \\n , more than half of the critically ill dengue patients had comorbid bacterial infections .',\n",
       "  '__index_level_0__': 31666,\n",
       "  'model_output': 'this is a retrospective study of 143 patients with severe dengue admitted to the icu during a large outbreak of dengue in tainan, taiwan. \\n the authors found a 23% in - hospital mortality rate and a 36% mortality rate for patients aged 60 to 69 years. \\n the authors also found that patients who died had significantly higher apache ii, tiss, and gcs scores, and more hypertension, bacteremia, pneumonia, and organ failure ( cardiovascular, thoracic, metabolic, renal and hepatic failures, and multiorgan failure ) and needed more mechanical ventilation and crrt than did survivors. \\n the patients who died had significantly lower activated partial thromboplastin time, lactate, ast / got, and alt / gpt levels than did survivors. \\n the patients who died, however, had significantly lower albumin, hemoglobin, and hematocrit, and lower platelet counts in the trough and recovery stage before they were discharged from the icu than did survivors. \\n the authors found that the mortality was significantly positively associated with the following independent predictors : lower gcs scores, lower platelet counts, and more organ failures before icu discharge. \\n the authors concluded that the mortality of severe dengue patients admitted to the icu remains high, and the mortality was associated with lower gcs scores, lower platelet count before being discharged from the icu discharge, and more organ failures. in addition, a significant portion of patients with severe dengue who die in the icu have bacterial infections. \\n the authors are to be commended for this important study, which provides a unique opportunity to learn about the outcomes of severe dengue in taiwan. \\n however, there are some limitations to the study. the authors did not provide details regarding the study population, such as the ethnicity of the patients. \\n the authors also did not provide the details of the dengue serotypes and the duration of illness before the patients were admitted to the icu. \\n the authors did not provide the details of the severity of the pneumonia, such as the need for mechanical ventilation, the need for extracorporeal membrane oxygenation, or the need for tracheostomy. \\n the authors did not provide the details of the need for vasopressors and the doses of vasopressors used. \\n the authors did not provide the details of the need for renal replacement therapy. \\n the authors did not provide the details of the need for a central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter - related blood stream infections. \\n the authors did not provide the details of the need for tracheostomy and the details of the tracheostomy - related infections. \\n the authors did not provide the details of the need for central venous catheter and the details of the catheter'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Condense the given article into a clear and concise abstract that represents its core content.',\n",
       "  'input': \"Summarize the following article: type 2 diabetes mellitus ( t2 dm ) is a progressive disease , meaning that most patients will require the introduction of insulin into their treatment regimen at some point during the continuum of care 1 . to facilitate the transition to insulin \\n , numerous clinical and real - world studies have investigated the efficacy and safety of initiating long - acting analogue insulins . in clinical studies , both insulin glargine ( gla ; lantus , sanofi us , inc . , \\n bridgewater , nj , usa ) and insulin detemir ( det ; levemir , novo nordisk a / s , bagsvaerd , denmark ) have been shown to result in equivalent improvements in glycaemic control with a low incidence of hypoglycaemia when used as part of a basal - bolus regimen 24 . \\n although glycaemic outcomes in such trials have been similar for these two basal analogue insulins , it has been noted that higher doses and twice - daily dosing are often required with det compared with gla 3,4 . a recent trial has suggested that when both det and gla are used once daily as an adjunct to metformin , a greater proportion of patients treated with gla reached glycated haemoglobin ( hba1c ) levels  < 7.0% than did patients treated with det 5 . \\n attempts to examine the relative advantages of these insulin analogues in a real - world setting have proved difficult to interpret . \\n some studies have reported enhanced glycaemic control with gla compared with det , along with improved adherence and persistence , with no difference with regard to hypoglycaemia , healthcare costs or weight gain 68 ; however , other studies found no difference in glycaemic control between the two insulin types 9,11 , with one suggesting that patients initiating det were 30% less likely to gain 0.9  kg or more in body weight than gla users 10 . \\n studies investigating the efficacy and safety of switching from gla to det are similarly conflicting in their findings . \\n although once - daily dosing of gla and det has been shown to result in equivalent 24-h glycaemic control , switching from gla to det was associated with improved hba1c levels and fewer hypoglycaemic events , compared with remaining on gla in an observational study of patients with type 1 diabetes mellitus ( t1 dm ) and t2 dm 7,11,12 . a retrospective analysis , however , reported that switching from gla to det did not improve glycaemic control among a cohort of patients with t2 dm 13 . a recent longitudinal study sought to expand on these data by assessing real - world outcomes using a retrospective analysis of two large , independent , national , us databases comprising commercially insured and medicare populations : the impact and humana cohorts 14 \\n the study found that , at 1-year follow - up , patients who had remained on gla showed significantly higher persistence with and adherence to treatment compared with those who switched to det ( p  <  0.001 ) . \\n in addition , 37% of patients who switched to det restarted gla ( p  <  0.05 ) , compared with only 20% of gla users returning to det after having switched to gla . \\n overall hypoglycaemia rates were significantly higher for patients continuing on gla than for patients switching to det in the humana cohort ( 16 vs. 11% ; p  <  0.05 ) , but overall hypoglycaemia rates were similar in the impact cohort ( 11 vs. 12% ; p  =  0.490 ) . in the present study , to further evaluate the consequences of insulin switching , we used data from patients ' medical records to investigate retrospectively the real - world clinical outcomes for patients with t2 dm who switched between these two basal insulin analogues . \\n the present analysis was a retrospective cohort study using the ge centricity electronic medical records ( emr ) database from 1 july 2005 to 31 december 2012 . in 2007 , \\n the ge centricity emr database contained the medical records of 30  million patients in 49 us states . \\n as the analysis was performed on de - indentified data , approval from an ethics committee was not necessary . \\n we analysed two cohorts in the present study : cohort 1 included patients who were previously treated with gla and switched to det ( det - s ) or who remained on gla ( gla - c ) ; and cohort 2 included patients previously treated with det and subsequently switched to gla ( gla - s ) or who remained on det ( det - c ) . in cohort 1 \\n , the patients in the det - s subgroup were required to have  1 physician prescription for gla  < 6  months before first det physician prescription order date ( after 1 january 2006 ) . \\n patients in the gla - c subgroup were required to have  2 gla physician prescriptions starting from the third - quarter of 2005 , without a subsequent physician prescription order of det , with  1 of the orders being \\n the index date was a randomly selected date between the second to the last gla physician prescription . in cohort 2 \\n , patients in the gla - s subgroup were required to have  1 physician prescription for det  < 6  months before the first gla prescription order date ( after 1 july 2006 ) . \\n patients in the det - c subgroup were required to have  2 det physician prescriptions starting from the first - quarter of 2006 , without a subsequent physician prescription order for gla . \\n the index date was a randomly selected date between the second and last det physician prescriptions dates . \\n patients aged 18  years on the index date were included in the analysis if they had a diagnosis of t2 dm [ international classification of diseases , ninth revision , clinical modification ( icd-9-cm ) codes : 250.x0 or 250.x2 ] with emr activity data for  6  months pre - index ( baseline ) and 12  months post - index ( follow - up ) . \\n patients were further required to have : 1 baseline hba1c measure taken during the period 90  days before up to 15  days after the index date ; 1 baseline body mass index ( bmi ) measure taken in the period 30  days before up to 15  days after the index date ; and  1 follow - up hba1c measure from the second - quarter until 3  months after the 1-year follow - up . in cohort 1 , patients with baseline prescriptions for premixed insulin or basal insulins other than gla [ i.e. neutral protamine hagedorn ( nph ) insulin , lente , or ultralente ] were excluded . \\n similarly , in cohort 2 , patients with baseline prescriptions for premixed insulin or basal insulins other than det ( i.e. nph insulin , lente or ultralente ) were excluded . \\n baseline demographic and clinical characteristics included age , gender , region , race , geographic region , insurance type , bmi , weight , individual comorbidities and prescribed diabetes medications . \\n in addition , the charlson comorbidity index ( cci ) score was calculated , which is the weighted sum of 19 categories of comorbidity defined using icd-9-cm diagnoses codes , with a higher score indicating a more severe burden of comorbidity and a higher mortality risk 15,16 . \\n clinical outcome variables were measured 1  year after the index date ( follow - up ) and included follow - up hba1c , change in hba1c from baseline , follow - up hypoglycaemic events , follow - up bmi , change in bmi from baseline follow - up body weight , change in body weight from baseline and follow - up oral antidiabetes drug ( oad ) use ( including gla , det and rapid - acting insulin ) . \\n baseline hba1c measures were defined as those occurring between 90  days before and up to 15  days after the index date ; baseline body weight and bmi measures were defined as  1 baseline measurement between 30  days before and up to 15  days after the index date . \\n follow - up hba1c values were defined as those occurring during the period from the second - quarter until 3  months after 1-year follow - up , and follow - up body weight and bmi values were defined as those occurring during the 30  days before or after the end of the 1-year follow - up period ( index date  +  360  days ) . \\n if patients had multiple hba1c , body weight or bmi results during this period , the value dated closest to the index date was used as the baseline value , and the value dated closest to the end of the follow - up period was used as the follow - up value . \\n hypoglycaemia was defined as a healthcare encounter ( outpatient , inpatient or emergency department visit ) with a primary or secondary icd-9-cm diagnosis code for hypoglycaemia , based on the algorithm published by ginde et al . \\n 17 . both the proportion of patients with  1 hypoglycaemic event ( prevalence rate ) and the average number of hypoglycaemic events per patient ( event rate ) during the baseline and 1-year follow - up period were identified . \\n treatment persistence was defined as the patient remaining on the index long - acting insulin ( gla for gla - c and det for det - s for cohort 1 ; det for det - c and gla for gla - s for cohort 2 ) during the 1-year follow - up period without discontinuation after study drug initiation . \\n based on the published methodology 18 , study medication was considered discontinued if the prescription was not re - ordered by the physician within the expected time of medication coverage ( the pre - defined 90th percentile of the time between first and second physician prescriptions among patients with  1 prescription ) . \\n patients who restarted their initial medication after a period of not having used this medication during follow - up were considered non - persistent . \\n persistence days were measured as the number of days between the index date and the discontinuation date . \\n sensitivity analyses were also conducted using 75th and 95th percentiles of the expected time of medication coverage . \\n descriptive and multivariate statistical methodologies were used to assess the baseline characteristics and to compare the outcomes over the 1-year follow - up period . to address potential selection bias in the real - world setting , in each cohort , \\n patients from the two subgroups were matched by propensity - score matching , with a 1 up to 5 ratio in cohort 1 and a 1 up to 3 ratio in cohort 2 , to balance baseline age , gender , race , geographic region , insurance type , physician specialty , index year , baseline comorbidity , baseline oad use , concomitant medication , hba1c and bmi . \\n these ratios and matchings were chosen because our preliminary analysis revealed a prescription imbalance , with significantly more eligible patients in the gla group when compared with the det group , and a much lower number of patients in the \\n additionally , one - to - many matching has previously been validated as a method to increase precision in cohort studies , compared with one - to - one matching , and has also been supported in a recent review assessing the quality of statistical methodologies in matched case \\n matching was implemented without replacement and any patient without  1 match was excluded from the analysis . between - group \\n covariate balance was evaluated using descriptive t - tests and chi - squared tests ( with corresponding p - values ) and standardized differences , where a standardized difference < 10 indicated adequate balance 21 . because not every patient in the matched cohorts had follow - up bmi or body weight data , we conducted , as sensitivity analysis , ordinary least squares regressions for bmi and body weight changes , adjusting for potential baseline imbalances . \\n the model used a larger set of covariates , which included patient demographics ( age , gender , geographic locations and bmi categories ) , baseline comorbidities and some basic clinical characteristics ( baseline oad use , statins for baseline concomitant medication use , baseline hba1c level and baseline hypoglycaemic events ) . \\n we analysed two cohorts in the present study : cohort 1 included patients who were previously treated with gla and switched to det ( det - s ) or who remained on gla ( gla - c ) ; and cohort 2 included patients previously treated with det and subsequently switched to gla ( gla - s ) or who remained on det ( det - c ) . in cohort 1 \\n , the patients in the det - s subgroup were required to have  1 physician prescription for gla  < 6  months before first det physician prescription order date ( after 1 january 2006 ) . \\n patients in the gla - c subgroup were required to have  2 gla physician prescriptions starting from the third - quarter of 2005 , without a subsequent physician prescription order of det , with  1 of the orders being \\n the index date was a randomly selected date between the second to the last gla physician prescription . in cohort 2 \\n , patients in the gla - s subgroup were required to have  1 physician prescription for det  < 6  months before the first gla prescription order date ( after 1 july 2006 ) . \\n patients in the det - c subgroup were required to have  2 det physician prescriptions starting from the first - quarter of 2006 , without a subsequent physician prescription order for gla . \\n the index date was a randomly selected date between the second and last det physician prescriptions dates . \\n patients aged 18  years on the index date were included in the analysis if they had a diagnosis of t2 dm [ international classification of diseases , ninth revision , clinical modification ( icd-9-cm ) codes : 250.x0 or 250.x2 ] with emr activity data for  6  months pre - index ( baseline ) and 12  months post - index ( follow - up ) . \\n patients were further required to have : 1 baseline hba1c measure taken during the period 90  days before up to 15  days after the index date ; 1 baseline body mass index ( bmi ) measure taken in the period 30  days before up to 15  days after the index date ; and  1 follow - up hba1c measure from the second - quarter until 3  months after the 1-year follow - up . in cohort 1 , patients with baseline prescriptions for premixed insulin or basal insulins other than gla [ i.e. neutral protamine hagedorn ( nph ) insulin , lente , or ultralente ] were excluded . \\n similarly , in cohort 2 , patients with baseline prescriptions for premixed insulin or basal insulins other than det ( i.e. nph insulin , lente or ultralente ) were excluded . \\n baseline demographic and clinical characteristics included age , gender , region , race , geographic region , insurance type , bmi , weight , individual comorbidities and prescribed diabetes medications . \\n in addition , the charlson comorbidity index ( cci ) score was calculated , which is the weighted sum of 19 categories of comorbidity defined using icd-9-cm diagnoses codes , with a higher score indicating a more severe burden of comorbidity and a higher mortality risk 15,16 . \\n clinical outcome variables were measured 1  year after the index date ( follow - up ) and included follow - up hba1c , change in hba1c from baseline , follow - up hypoglycaemic events , follow - up bmi , change in bmi from baseline follow - up body weight , change in body weight from baseline and follow - up oral antidiabetes drug ( oad ) use ( including gla , det and rapid - acting insulin ) . \\n baseline hba1c measures were defined as those occurring between 90  days before and up to 15  days after the index date ; baseline body weight and bmi measures were defined as  1 baseline measurement between 30  days before and up to 15  days after the index date . \\n follow - up hba1c values were defined as those occurring during the period from the second - quarter until 3  months after 1-year follow - up , and follow - up body weight and bmi values were defined as those occurring during the 30  days before or after the end of the 1-year follow - up period ( index date  +  360  days ) . \\n if patients had multiple hba1c , body weight or bmi results during this period , the value dated closest to the index date was used as the baseline value , and the value dated closest to the end of the follow - up period was used as the follow - up value . \\n hypoglycaemia was defined as a healthcare encounter ( outpatient , inpatient or emergency department visit ) with a primary or secondary icd-9-cm diagnosis code for hypoglycaemia , based on the algorithm published by ginde et al . \\n 17 . both the proportion of patients with  1 hypoglycaemic event ( prevalence rate ) and the average number of hypoglycaemic events per patient ( event rate ) during the baseline and 1-year follow - up period were identified . \\n treatment persistence was defined as the patient remaining on the index long - acting insulin ( gla for gla - c and det for det - s for cohort 1 ; det for det - c and gla for gla - s for cohort 2 ) during the 1-year follow - up period without discontinuation after study drug initiation . based on the published methodology 18 , \\n study medication was considered discontinued if the prescription was not re - ordered by the physician within the expected time of medication coverage ( the pre - defined 90th percentile of the time between first and second physician prescriptions among patients with  1 prescription ) . \\n patients who restarted their initial medication after a period of not having used this medication during follow - up were considered non - persistent . \\n persistence days were measured as the number of days between the index date and the discontinuation date . \\n sensitivity analyses were also conducted using 75th and 95th percentiles of the expected time of medication coverage . \\n descriptive and multivariate statistical methodologies were used to assess the baseline characteristics and to compare the outcomes over the 1-year follow - up period . to address potential selection bias in the real - world setting , in each cohort , \\n patients from the two subgroups were matched by propensity - score matching , with a 1 up to 5 ratio in cohort 1 and a 1 up to 3 ratio in cohort 2 , to balance baseline age , gender , race , geographic region , insurance type , physician specialty , index year , baseline comorbidity , baseline oad use , concomitant medication , hba1c and bmi . \\n these ratios and matchings were chosen because our preliminary analysis revealed a prescription imbalance , with significantly more eligible patients in the gla group when compared with the det group , and a much lower number of patients in the \\n additionally , one - to - many matching has previously been validated as a method to increase precision in cohort studies , compared with one - to - one matching , and has also been supported in a recent review assessing the quality of statistical methodologies in matched case \\n matching was implemented without replacement and any patient without  1 match was excluded from the analysis . between - group covariate balance was evaluated using descriptive t - tests and chi - squared tests ( with corresponding p - values ) and standardized differences , where a standardized difference < 10 indicated adequate balance 21 . because not every patient in the matched cohorts had follow - up bmi or body weight data , we conducted , as sensitivity analysis , ordinary least squares regressions for bmi and body weight changes , adjusting for potential baseline imbalances . \\n the model used a larger set of covariates , which included patient demographics ( age , gender , geographic locations and bmi categories ) , baseline comorbidities and some basic clinical characteristics ( baseline oad use , statins for baseline concomitant medication use , baseline hba1c level and baseline hypoglycaemic events ) . \\n a total of 25  290 eligible patients were identified with 19  811 patients from cohort 1 ( gla - c , n  =  17  783 and det - s , n  =  2028 ) and 5479 from cohort 2 ( det - c , n  =  4431 and gla - s , n  =  1048 ) . \\n significant baseline differences existed between the subgroups in each cohort ( table s1 ) . in cohort 1 , \\n when compared with patients in the det - s subgroup , patients in the gla - c subgroup were older , were more likely to be black , were more likely to reside in the midwest or west , were more likely to be enrolled in medicare , had higher cci scores and had lower hba1c values . \\n no significant differences were found for bmi or body weight between the gla - c and det - s subgroups at baseline . in cohort 2 , when compared with the det - c subgroup , patients in the gla - s subgroup were younger , were more likely to be black , were more likely to reside in the midwest or west , had higher hba1c values , and had higher body weight and bmi values . \\n patients in the gla - s and det - c subgroups had similar cci scores at baseline . \\n for both cohorts , no significant differences were found for baseline hypoglycaemic events between groups . \\n bmi , body mass index ; emr , electronic medical records ; hba1c , glycated haemoglobin ; t2 dm , type 2 diabetes mellitus . \\n after propensity - score matching , the final matched study population included 13  942 patients overall , with 10  657 from cohort 1 ( gla - c , n  =  8860 and det - s , n  =  1797 ; female patients 54.7% , age 58.4  years , hba1c level 8.7% , bmi 35.1  kg / cm , weight 99.3  kg ) and 3285 patients from cohort 2 ( det - c , n  =  2427 and gla - s , n  =  858 ; female 53.5% , age 58.3  years , hba1c level 8.8% , bmi 35.4  kg / cm , weight 100.7  kg ) . \\n the baseline demographic and clinical characteristics were balanced between treatment groups in each cohort ( table1 ) . \\n baseline characteristics among matched patients in cohorts 1 and 2 det , insulin detemir ; gla , insulin glargine ; det - s , patients previously treated with gla who switched to det ; gla - c , patients who remained on gla ; gla - s , patients previously treated with det who switched to gla ; det - c , patients who remained on det ; bmi , body mass index ; cci , charlson comorbidity index ; hba1c , glycated haemoglobin ; oad , oral antidiabetes drug ; s.d . , standard deviation . during 1-year follow - up , \\n overall , switching from gla to det resulted in lower persistence with treatment , whereas switching from det to gla resulted in higher persistence . among patients in cohort 1 , \\n those in the det - s subgroup versus those in the gla - c subgroup had significantly lower persistence with treatment ( 52.4 vs. 61.3% , respectively ; p  <  0.0001 ) and significantly fewer treatment persistent days ( 311.6 vs. 331.0  days ; p  <  0.0001 ) . in cohort 2 , however , the gla - s and the det - c subgroups had similar levels of treatment persistence ( 56.5 vs. 58.5% , respectively ; p  =  0.292 ) yet fewer treatment persistent days ( 320.7 vs. 325.3  days ; p  =  0.015 ) . sensitivity analysis using 75th and 95th percentile of the time duration yielded similar results : 75th percentile : cohort 1 gla - c versus det - s subgroup , 21.2 versus 35.7% ( p  < \\n 0.0001 ) ; cohort 2 det - c versus gla - s subgroup , 24.7 versus 31.6% ( p  =  0.0001 ) ; 95th percentile : cohort 1 gla - c versus det - s subgroup , 63.1 versus 68.2% ( p  < \\n 0.0001 ) ; cohort 2 det - c versus gla - s subgroup , 67.0 versus 66.0% ( p  =  0.622 ) . in cohort 1 , \\n the use of rapid - acting insulin was significantly higher among the patients in the det - s subgroup than among those in the gla - c subgroup ( 57.6 vs. 52.5% ; p  <  0.0001 ; figure 2 ) , and 26.9% of patients in the det - s subgroup restarted gla . in cohort 2 \\n , however , similar proportions of patients used rapid - acting insulin in the det - c and gla - s subgroups ( 50.4 vs. 51.1% ; p  =  0.712 ) , and 18.6% of patients in the gla - s subgroup restarted det . patients requiring rapid - acting insulin ( rai ) . \\n det , insulin detemir ; gla , insulin glargine ; det - s , patients previously treated with gla who switched to det ; gla - c , patients who remained on gla ; gla - s , patients previously treated with det who switched to gla ; det - c , patients who remained on det . \\n the baseline mean hba1c level was similar between the treatment groups in each of the cohorts . in cohort 1 , \\n patients in the det - s subgroup had a significantly higher follow - up hba1c level ( figure 3a ) , a significantly lower hba1c reduction ( figure 3b ) , and significantly lower proportions of patients achieved hba1c < 7.0% ( figure 3c ) and hba1c  < 8.0% ( figure 3d ) at the end of 1-year follow - up compared with patients in the gla - c subgroup . in cohort 2 , however , compared with patients in the det - c subgroup , patients in the gla - s subgroup had a significantly lower follow - up hba1c ( figure 3a ) and a numerically higher ( although not statistically significant ) hba1c reduction ( figure 3b ) , but there were no differences in the proportions of patients achieving an hba1c level  < 7.0% ( figure 3c ) or  < 8.0% ( figure 3d ) . \\n ( a ) one - year follow - up glycated haemoglobin ( hba1c ) values , ( b ) change in hba1c from baseline , ( c ) proportion of patients achieving target hba1c  < 7.0% , and ( d ) proportion of patients achieving target hba1c  < 8.0% . \\n det , insulin detemir ; gla , insulin glargine ; det - s , patients previously treated with gla who switched to det ; gla - c , patients who remained on gla ; gla - s , patients previously treated with det who switched to gla ; det - c , patients who remained on det . for both prevalence and event rates of any hypoglycaemic events , \\n no significant differences were found after follow - up between the det - s and gla - c subgroups in cohort 1 or between the gla - s and det - c subgroups in cohort 2 [ prevalence rate : 2.0 vs. 2.1% , p  =  0.889 ; event rate ( number of events / patient year ) : 0.023 vs. 0.026 , p  =  0.4424 ] or between the gla - c and det - s subgroups in cohort 2 ( 2.3 vs. 1.6% , p  =  0.2314 ; event rate : 0.028 vs. 0.021 , p  =  0.3727 ) . in both cohorts , \\n baseline bmi and body weight were similar between the groups ( table1 ) . in cohort 1 , \\n bmi at 1-year follow - up was 35.0  kg / m for both the det - s and gla - c subgroups ( p  =  0.843 ) . \\n there were also no significant differences in bmi change for patients in the det - s and gla - c subgroups after follow - up ( figure 4a ) . \\n the 1-year follow - up weight was similar for the det - s and gla - c subgroups ( 99.3 vs. 99.4  kg ; p  =  0.881 ) , with similar weight changes between patients in the det - s subgroup and those in the gla - c subgroup ( figure 4b ) . \\n changes in ( a ) body mass index ( bmi ) and ( b ) body weight at 1-year follow - up . \\n det , insulin detemir ; gla , insulin glargine ; det - s , patients previously treated with gla who switched to det ; gla - c , patients who remained on gla ; gla - s , patients previously treated with det who switched to gla ; det - c , patients who remained on det . in cohort 2 , at the end of 1-year follow - up , patients in the gla - s subgroup had a higher bmi ( 36.3 vs. 35.5  kg / m ; p  =  0.052 ) , but this was not statistically significant . \\n there were no significant differences at 1-year follow - up for body weight between patients in the gla - s and det - c subgroups ( 102.2 vs. 100.9  kg ; p  =  0.299 ) ; however , patients in the gla - s subgroup had a greater change from baseline in body weight compared with those in the det - c subgroup ( figure 4b ) . \\n sensitivity analyses using ordinary least squares regressions yielded similar results : adjusted weight change : cohort 1 det - s versus gla - c subgroup , 0.18 versus + 0.10  kg ( p  =  0.329 ) ; cohort 2 gla - s versus det - c subgroup , + 1.48 versus + 0.02  kg ( p  < \\n 0.001 ) ; adjusted bmi change : cohort 1 gla - c versus det - s subgroup , 0.18 versus 0.04  kg ( p  =  0.122 ) ; cohort 2 gla - s versus det - c subgroup , + 0.48 versus    0.05  kg ( p  <  0.001 ) . \\n during 1-year follow - up , overall , switching from gla to det resulted in lower persistence with treatment , whereas switching from det to gla resulted in higher persistence . among patients in cohort 1 , \\n those in the det - s subgroup versus those in the gla - c subgroup had significantly lower persistence with treatment ( 52.4 vs. 61.3% , respectively ; p  <  0.0001 ) and significantly fewer treatment persistent days ( 311.6 vs. 331.0  days ; p  <  0.0001 ) . in cohort 2 , however , the gla - s and the det - c subgroups had similar levels of treatment persistence ( 56.5 vs. 58.5% , respectively ; p  =  0.292 ) yet fewer treatment persistent days ( 320.7 vs. 325.3  days ; p  =  0.015 ) . sensitivity analysis using 75th and 95th percentile of the time duration yielded similar results : 75th percentile : cohort 1 gla - c versus det - s subgroup , 21.2 versus 35.7% ( p  < \\n 0.0001 ) ; cohort 2 det - c versus gla - s subgroup , 24.7 versus 31.6% ( p  =  0.0001 ) ; 95th percentile : cohort 1 gla - c versus det - s subgroup , 63.1 versus 68.2% ( p  < \\n 0.0001 ) ; cohort 2 det - c versus gla - s subgroup , 67.0 versus 66.0% ( p  =  0.622 ) . in cohort 1 , \\n the use of rapid - acting insulin was significantly higher among the patients in the det - s subgroup than among those in the gla - c subgroup ( 57.6 vs. 52.5% ; p  <  0.0001 ; figure 2 ) , and 26.9% of patients in the det - s subgroup restarted gla . in cohort 2 \\n , however , similar proportions of patients used rapid - acting insulin in the det - c and gla - s subgroups ( 50.4 vs. 51.1% ; p  =  0.712 ) , and 18.6% of patients in the gla - s subgroup restarted det . \\n det , insulin detemir ; gla , insulin glargine ; det - s , patients previously treated with gla who switched to det ; gla - c , patients who remained on gla ; gla - s , patients previously treated with det who switched to gla ; det - c , patients who remained on det . \\n the baseline mean hba1c level was similar between the treatment groups in each of the cohorts . in cohort 1 , \\n patients in the det - s subgroup had a significantly higher follow - up hba1c level ( figure 3a ) , a significantly lower hba1c reduction ( figure 3b ) , and significantly lower proportions of patients achieved hba1c < 7.0% ( figure 3c ) and hba1c  < 8.0% ( figure 3d ) at the end of 1-year follow - up compared with patients in the gla - c subgroup . in cohort 2 , however , compared with patients in the det - c subgroup , patients in the gla - s subgroup had a significantly lower follow - up hba1c ( figure 3a ) and a numerically higher ( although not statistically significant ) hba1c reduction ( figure 3b ) , but there were no differences in the proportions of patients achieving an hba1c level  < 7.0% ( figure 3c ) or  < 8.0% ( figure 3d ) . \\n ( a ) one - year follow - up glycated haemoglobin ( hba1c ) values , ( b ) change in hba1c from baseline , ( c ) proportion of patients achieving target hba1c  < 7.0% , and ( d ) proportion of patients achieving target hba1c  < 8.0% . \\n det , insulin detemir ; gla , insulin glargine ; det - s , patients previously treated with gla who switched to det ; gla - c , patients who remained on gla ; gla - s , patients previously treated with det who switched to gla ; det - c , patients who remained on det . for both prevalence and event rates of any hypoglycaemic events , \\n no significant differences were found after follow - up between the det - s and gla - c subgroups in cohort 1 or between the gla - s and det - c subgroups in cohort 2 [ prevalence rate : 2.0 vs. 2.1% , p  =  0.889 ; event rate ( number of events / patient year ) : 0.023 vs. 0.026 , p  =  0.4424 ] or between the gla - c and det - s subgroups in cohort 2 ( 2.3 vs. 1.6% , \\n p  =  0.2314 ; event rate : 0.028 vs. 0.021 , p  =  0.3727 ) . in both cohorts , \\n baseline bmi and body weight were similar between the groups ( table1 ) . in cohort 1 , \\n bmi at 1-year follow - up was 35.0  kg / m for both the det - s and gla - c subgroups ( p  =  0.843 ) . \\n there were also no significant differences in bmi change for patients in the det - s and gla - c subgroups after follow - up ( figure 4a ) . \\n the 1-year follow - up weight was similar for the det - s and gla - c subgroups ( 99.3 vs. 99.4  kg ; p  =  0.881 ) , with similar weight changes between patients in the det - s subgroup and those in the gla - c subgroup ( figure 4b ) . \\n changes in ( a ) body mass index ( bmi ) and ( b ) body weight at 1-year follow - up . \\n det , insulin detemir ; gla , insulin glargine ; det - s , patients previously treated with gla who switched to det ; gla - c , patients who remained on gla ; gla - s , patients previously treated with det who switched to gla ; det - c , patients who remained on det . in cohort 2 , at the end of 1-year follow - up , patients in the gla - s subgroup had a higher bmi ( 36.3 vs. 35.5  kg / m ; p  =  0.052 ) , but this was not statistically significant . change in bmi was significantly different ( figure 4a ) . \\n there were no significant differences at 1-year follow - up for body weight between patients in the gla - s and det - c subgroups ( 102.2 vs. 100.9  kg ; p  =  0.299 ) ; however , patients in the gla - s subgroup had a greater change from baseline in body weight compared with those in the det - c subgroup ( figure 4b ) . \\n sensitivity analyses using ordinary least squares regressions yielded similar results : adjusted weight change : cohort 1 det - s versus gla - c subgroup , 0.18 versus + 0.10  kg ( p  =  0.329 ) ; cohort 2 gla - s versus det - c subgroup , + 1.48 versus + 0.02  kg ( p  < \\n 0.001 ) ; adjusted bmi change : cohort 1 gla - c versus det - s subgroup , 0.18 versus 0.04  kg ( p  =  0.122 ) ; cohort 2 gla - s versus det - c subgroup , + 0.48 versus    0.05  kg ( p  <  0.001 ) . \\n the aim of the present study was to evaluate retrospectively the real - world clinical outcomes of switching between basal insulin analogues , compared with continuing on previous basal insulin , among patients with t2 dm identified from the us ge centricity emr database . \\n overall , contrasting findings were observed when patients switched from gla to det , as compared with switching from det to gla . in cohort 1 , \\n compared with patients in the det - s subgroup , patients in the gla - c subgroup had better clinical outcomes at 1-year follow - up , including lower hba1c levels and significantly higher hba1c reductions . \\n in addition , significantly more patients in the gla - c subgroup achieved the targeted hba1c levels of  < 7.0% or  < 8.0% and those in the det - s subgroup had significantly higher rapid - acting insulin use . \\n in addition , no significant differences in hypoglycaemia rates and weight / bmi were observed between the two groups . \\n these results could be attributable to lower persistence / adherence as patients might not be taking their full medication . in cohort 2 , however , patients in the gla - s subgroup had lower hba1c levels and a numerically higher ( but non - significant ) hba1c reduction ; similar proportions of patients achieved hba1c levels of < 7.0 or < 8.0% , and similar hypoglycaemia rates were seen in the two groups . \\n although 1-year follow - up body weight and bmi were similar , patients in the det - c subgroup had a decreased bmi and a lower body weight increase , whereas patients in the gla - s subgroup had increased bmi and significantly greater body weight increase . \\n although the patients in the gla - s subgroup gained weight , the increase was  < 1% which , \\n it is suggested , is not clinically relevant 22 , and may reflect differences in follow - up plasma glucose levels or other factors . furthermore , the increase in weight with gla could be taken to be a sign of better compliance . \\n if a switch between insulin analogues is of a  disruptive nature , it will result in decreased compliance . \\n for example , if a regimen becomes more complex ( from once daily to twice daily , adding a rapid - acting insulin etc . ) , it could lead to less of the typical weight gain associated with insulin treatment . in cohort 1 , \\n the patients in the det - s subgroup , who switched from gla to det , had lower persistence than those who remained on gla ( robust in sensitivity analyses ) . this could be attributable to the fact that most patients on det administer twice daily , whereas most patients on gla administer once daily 13,23 . unfortunately , this information is not captured in the ge centricity emr database . by contrast , in cohort 2 , data on patients in the gla - s subgroup switching from det to gla suggested similar overall persistence with treatment . \\n approximately 27% of the patients in the det - s subgroup restarted gla during the follow - up period . of patients in the gla - s subgroup \\n although the reasons for restarting the former insulin are not captured in the ge centricity emr database , these findings are consistent with a previous impact and humana database study 14 . \\n unlike randomized controlled trials , where patients are required to be  persistent with their therapy , real - world patients and physicians do not follow a stringent protocol and , therefore , any differences in patients ' persistence with their insulin treatment can translate into differences in clinical and economic  outcomes 17 . \\n overall , contrasting outcomes were observed when patients were switched from gla to det , when compared with switching from det to gla . \\n this raises questions about the therapeutic interchangeability of these two basal analogue insulins in clinical practice , although further studies are required to confirm this non - interchangeability . \\n the results of the present ge centricity emr switching analysis , however , were highly consistent with the previously performed claims database analysis 14 . \\n the ge centricity emr database is a large and comprehensive source of data to understand clinical practice and outcomes in the real - world setting . \\n this database contains rich clinical information , such as hba1c level , weight and bmi , that is not available in insurance claim databases . \\n overall 25  000 patients were identified in this study , and almost 15  000 were propensity - score - matched and analysed , including those switching from det to gla and those switching from gla to det during the same time period . in previous observational studies on switching from gla to det 11,13,24 , \\n conflicting results were shown with relatively low numbers of patients included ( 301300 patients ) and including either only patients with t1 dm , or a mixed group of patients with t1 dm and t2 dm . \\n our previous study used administrative claims data 14 , and the results described in the present study not only validate our previous findings with a different data source but also strengthen them with additional data on weight . \\n one of the key limitations of the present study , however , is that the emr analysis was carried out on primary care physician prescription data , rather than on claims databases . \\n prescription orders do not necessarily mean that the prescriptions were filled and taken as directed . \\n in addition , certain data were not available , including glucose levels , the duration of treatment with the initial insulin , the duration of t2 dm , and the reason for switching insulin ( e.g. insurance required switching to other insulin ) . although propensity - score matching was used to balance the baseline data between treatment groups , the differences between the groups were quite significant ( table s1 ) and the potential residual confounding might therefore still be present , particularly unobserved selection bias . in a real - world setting , \\n switching patients to another treatment regimen may introduce confounding by indication , an important limitation to observational studies reporting on patients changing their treatment regimens , including the study described here . \\n other potential sources of bias and confounding include the range of time from measurement of hba1c to index date , differences in time for follow - up hba1c and follow - up bmi , and patient / physician preference . \\n in addition , the dose of insulin at the time of switching was not available in the ge centricity emr database and might have impacted on clinical outcomes , especially in patients who had recently switched insulin analogues and had not had the opportunity to titrate their dosage . specifically , the present study was designed to compare between patients who switched to a different basal insulin and those who continued on the previous basal insulin . in the case of comparing patients in the det - s with those in the gla - c subgroup , \\n patients in the latter subgroup may already be fully titrated , while it takes time for patients switching to det to titrate . \\n this may lead to an overestimation of the benefits of gla compared with det , representing a further limitation of this analysis . \\n the same limitation applies to the comparison of the gla - s with the det - c subgroup . \\n one approach to account for confounding by indication is to compare patients in the gla - s subgroup with those in the det - s subgroup directly ; however , these patients had different baseline doses of basal insulin , and based on a real - world study among us patients initiating gla or det , it may be that higher insulin doses were used in the det - treated patients 6 . \\n it is not possible to establish causality from the differences in outcomes , nor are the data necessarily representative of all patients with t2 dm . \\n patients could drop out for various reasons and thus selection may occur . in the present study , \\n more patients treated with det than those treated with gla dropped out from the study population ( 56 vs. 35% ) when 6-month baseline and 12-month follow - up were required . \\n similarly , only 8% of patients on det treatment compared with 40% on gla , dropped out when being aged > 18  years was required ( figure 1 ) . \\n sufficient data on hba1c levels and bmi were missing for half of the patients in this analysis , and this lack of completeness should be considered as a major limitation of emr databases . when interpreting the findings of the present study , it should be remembered that , because of its limitations , the methodology used may have introduced bias or affected the \\n because of the real - world nature of the present study , patients did not have their hba1c levels or bmi evaluated regularly and thus were excluded if they did not have baseline and/or follow - up hba1c / bmi values . \\n overall , recognizing the inherent limitations of real - world data analyses , the findings of the present study alone should not be used to guide clinicians in the decision to switch insulin , but the findings do merit further investigation . \\n future studies should look more closely at a number of other factors , including the dose , duration of treatment , reasons for and cost - effectiveness of switching in patients with t2 dm . \\n in addition , although previous studies have suggested that in patients with t1 dm det was associated with a higher dose and more frequent twice - daily dosing than gla 13,24 , large cohort comparative studies in patients with t1 dm should be conducted to confirm these findings . in conclusion , \\n the results of the present study suggest that switching patients with t2 dm from gla to det might lead to decreases in treatment persistence alongside having a negative effect on glycaemic outcomes . \\n maintaining patients on gla or switching from det to gla , however , might be beneficial , although may result in minor weight gain . \\n this suggests that the two basal insulin analogues might not be therapeutically interchangeable , and further studies are required to investigate this hypothesis . \\n p. l. is a member of the advisory panel for sanofi us , inc . and \\n , has received research support from eli lilly and co. , sanofi us , inc . , novo nordisk , inc . , amylin pharmaceuticals , inc . and boehringer ingelheim pharmaceuticals , inc . , and serves on speaker 's bureaus for eli lilly and co. , novo nordisk , inc . , amylin pharmaceuticals , inc . and boehringer ingelheim pharmaceuticals , inc . \\n w. w. , r. m. , f. y. and j. g. are employees of sanofi us , inc . \\n l. x. and o. b. are employees of statinmed , which received funding to carry out this work from sanofi us , inc . \\n p. l. co - developed the concept , interpreted the results of the analyses , reviewed manuscript outline and drafts and provided comments . \\n w. w. proposed and co - developed the concept , co - developed the analysis plan , interpreted the results of the analyses , reviewed manuscript outline and drafts and provided comments . \\n r. m. co - developed the concept , co - developed the analysis plan , interpreted the results of the analyses , reviewed manuscript outline and drafts and provided comments . \\n f. y. collected the data , co - developed the analysis plan , conducted statistical analyses and interpreted the results , reviewed manuscript outline and drafts and provided comments . \\n l. x. collected the data , co - developed the analysis plan , conducted statistical analyses and interpreted the results , reviewed manuscript outline and drafts and provided comments . \\n o. b. interpreted the results of the analyses , reviewed manuscript outline and drafts and provided comments . \\n j. g. developed the concept , co - developed the analysis plan , interpreted the results of the analyses , reviewed manuscript outline and drafts and provided comments . \\n additional supporting informationmay be found in the online version of this article : baseline characteristics among prematched patients of cohorts 1 and 2 .\",\n",
       "  'output': 'aimsto evaluate real - world clinical outcomes for switching basal insulin analogues [ insulin glargine ( gla ) and insulin detemir ( det ) ] among us patients with type 2 diabetes mellitus ( t2dm).methodsusing the ge centricity electronic medical records database , this retrospective study examined two cohorts : cohort 1 , comprising patients previously on gla and then either switching to det ( det - s ) or continuing with gla ( gla - c ) ; and cohort 2 , comprising patients previously on det and then either switching to gla ( gla - s ) or continuing with det ( det - c ) . within each cohort , \\n treatment groups were propensity - score - matched on baseline characteristics . at 1-year follow - up , insulin treatment patterns , glycated haemoglobin ( hba1c ) levels , hypoglycaemic events , weight and body mass index ( bmi ) were evaluated.resultsthe analysis included 13  942 patients : cohort 1 : \\n n  =  10  657 ( det - s , n  =  1797 matched to gla - c , n  =  8860 ) and cohort 2 : n  =  3285 ( gla - s , n  =  858 matched to det - c , n  =  2427 ) . \\n baseline characteristics were similar between the treatment groups in each cohort . at 1-year follow - up , in cohort 1 , patients in the det - s subgroup were significantly less persistent with treatment , more likely to use a rapid - acting insulin analogue , had higher hba1c values , lower hba1c reductions and lower proportions of patients achieving hba1c < 7.0 or < 8.0% compared with patients in the gla - c subgroup , while hypoglycaemia rates and bmi / weight values and change from baseline were similar in the two subgroups . in cohort 2 , \\n overall , there were contrasting findings between patients in the gla - s and those in the det - c subgroup.conclusionsthis study showed contrasting results when patients with t2 dm switched between basal insulin analogues , although these preliminary results may be subject to limitations in the analysis . \\n nevertheless , this study calls into question the therapeutic interchangeability of gla and det , and this merits further investigation .',\n",
       "  '__index_level_0__': 31667,\n",
       "  'model_output': 'The following response was generated to the provided request.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Summarize the given article into a concise abstract that highlights the key findings and conclusions.',\n",
       "  'input': 'Summarize the following article: in korea , the incidence rate of prostate cancer was 32.5 per 100,000 during 2012   and has increased annually with the widespread use of prostate - specific antigen ( psa ) screening and transrectal ultrasound ( trus)-guided prostate biopsy . \\n the current trend in trus - guided prostate biopsy involves the use of an extended number of biopsy cores ( 10- to 12-core biopsy ) , because this scheme results in a higher cancer detection rate . \\n however , as the number of biopsy cores has increased , many patients have described this procedure as uncomfortable and painful . \\n a randomized trial demonstrated that intrarectal 2% lidocaine gel before prostate biopsy was simple , safe , and effective for providing satisfactory anesthesia during prostate biopsy . \\n in addition , the combination of lidocaine suppository and periprostatic nerve block ( ppnb ) was effective in controlling pain during trus - guided prostate biopsy . \\n intravenous sedation with an opioid drug was also shown to reduce the discomfort and pain caused by prostate biopsy . despite the use of these techniques to reduce pain \\n , many patients still experience a considerable degree of pain during trus - guided prostate biopsy . \\n some studies have reported that a patient \\'s pain perception during prostate biopsy is related to the patient \\'s position , such as the left lateral decubitus ( lld ) or lithotomy position , although this is controversial . \\n homogeneous data with regard to pain perception during trus - guided prostate biopsy are currently sparse , especially in asian populations . in this background \\n , we retrospectively investigated the effect of the patient \\'s position ( lld vs. lithotomy position ) on pain perception during trus - guided prostate biopsy performed as an extended 12-core biopsy with the intrarectal administration of 2% lidocaine gel . \\n we also analyzed the clinical factors that affected pain during trus - guided prostate biopsy in a korean population . \\n this study was approved by the institutional review board of the yeungnam university medical center ( approval no . 2015 - 03 - 028 ) . \\n a total of 128 men who underwent trus - guided prostate biopsy from july 2012 to june 2013 at a single center were included . \\n the indications for biopsy were an abnormal digital rectal examination or an elevated psa level . \\n exclusion criteria were anal or rectal pathologies , chronic pelvic pain syndrome , the presence of urinary tract infection , a history of prostate biopsy , and contraindication for the lithotomy position . \\n after informed consent was obtained , patients underwent prostate biopsy in the lithotomy position ( n=70 , wednesday and friday ) performed by a qualified urologist in an operation room or prostate biopsy in the lld position ( n=58 , tuesday and thursday ) performed by a qualified radiologist in the radiology department . \\n all patients underwent 12-core biopsy with the same protocol ( 2 from the base , 2 from the mid lobe , 1 from the apex , and 1 from the transitional zone ) . with the use of an 18-gauge 20-cm disposable needle , \\n all biopsies were performed with the hitachi high vision 5500 ultrasound machine with the ust-675p prostate probe ( hitachi aloka medical ltd . , \\n antibiotic prophylaxis with 250-mg intravenous ciprofloxacin was started on the night before and morning of the procedure . \\n all biopsies were performed by using intrarectal application of 10 ml of 2% lidocaine gel 10 minutes before the procedure . immediately after the procedure , \\n all patients were asked to complete a questionnaire addressing pain perception that evaluated the level of pain associated with the procedure . \\n pain was evaluated by using a 10-point visual analogue scale ( vas ) from 0 to 10 ( 0=painless , 10=intolerable pain ) . \\n the clinical variables included age , international prostate symptom score ( ipss ) , psa levels , prostate volume , body mass index ( bmi ) , diabetes mellitus ( dm ) , cancer detection rate , microscopic hematuria , and pyuria . \\n results were expressed as mean and standard deviation for age , ipss , psa levels , prostate volume , bmi , cancer detection rate , and vas . \\n statistical analysis was performed by using the spss ver . 17.0 ( spss inc . , \\n chi - square test and paired t - test were used for comparison of clinical variables between the lithotomy and lld position . \\n pearson correlation coefficients and a multiple linear regression model were used for analysis of relationships between clinical variables and vas . \\n this study was approved by the institutional review board of the yeungnam university medical center ( approval no . 2015 - 03 - 028 ) . \\n a total of 128 men who underwent trus - guided prostate biopsy from july 2012 to june 2013 at a single center were included . \\n the indications for biopsy were an abnormal digital rectal examination or an elevated psa level . \\n exclusion criteria were anal or rectal pathologies , chronic pelvic pain syndrome , the presence of urinary tract infection , a history of prostate biopsy , and contraindication for the lithotomy position . \\n after informed consent was obtained , patients underwent prostate biopsy in the lithotomy position ( n=70 , wednesday and friday ) performed by a qualified urologist in an operation room or prostate biopsy in the lld position ( n=58 , tuesday and thursday ) performed by a qualified radiologist in the radiology department . \\n all patients underwent 12-core biopsy with the same protocol ( 2 from the base , 2 from the mid lobe , 1 from the apex , and 1 from the transitional zone ) . with the use of an 18-gauge 20-cm disposable needle , \\n all biopsies were performed with the hitachi high vision 5500 ultrasound machine with the ust-675p prostate probe ( hitachi aloka medical ltd . , \\n antibiotic prophylaxis with 250-mg intravenous ciprofloxacin was started on the night before and morning of the procedure . \\n all biopsies were performed by using intrarectal application of 10 ml of 2% lidocaine gel 10 minutes before the procedure . \\n immediately after the procedure , all patients were asked to complete a questionnaire addressing pain perception that evaluated the level of pain associated with the procedure . \\n pain was evaluated by using a 10-point visual analogue scale ( vas ) from 0 to 10 ( 0=painless , 10=intolerable pain ) . \\n the clinical variables included age , international prostate symptom score ( ipss ) , psa levels , prostate volume , body mass index ( bmi ) , diabetes mellitus ( dm ) , cancer detection rate , microscopic hematuria , and pyuria . \\n results were expressed as mean and standard deviation for age , ipss , psa levels , prostate volume , bmi , cancer detection rate , and vas . \\n statistical analysis was performed by using the spss ver . 17.0 ( spss inc . , \\n chi - square test and paired t - test were used for comparison of clinical variables between the lithotomy and lld position . \\n pearson correlation coefficients and a multiple linear regression model were used for analysis of relationships between clinical variables and vas . \\n the patients \\' mean age and mean psa levels were 66.99.4 years and 15.5716.89 ng / ml , respectively . \\n similar oncologic outcomes of the biopsies were observed between the lithotomy and the lld positions . \\n the cancer detection rate was 32.8% and 34.4% in the lithotomy and lld positions , respectively ( p=0.941 ) . \\n no statistically significant differences related to other clinical variables , including age , bmi , prostate volume , psa level , microscopic hematuria , pyuria , ipss , and dm , were observed between the lithotomy and lld positions . \\n vas score showed a significant correlation with dm ( r=-0.141 , p=0.038 ) , psa level ( r=0.183 , p=0.019 ) , and lithotomy position ( r=-0.225 , p=0.011 ) ( fig . \\n however , there were no significant correlations with age , microscopic hematuria , pyuria , ipss , prostate cancer , or bmi . \\n result of the multiple linear regression analysis for the correlation between vas score and clinical variables are shown in table 3 . \\n vas score showed a significant correlation with lithotomy position ( =-0.772 , p=0.003 ) and dm ( =-0.803 , p=0.033 ) . \\n the final regression equation was as follows : vas=3.351 - 0.772\"lithotomy position\"-0.803\"dm \" ( r=0.085 ) . \\n rectal bleeding , hematuria , and hematospermia were observed in the lithotomy and lld positions , all of which resolved within 2 weeks after biopsy without proper treatment . \\n as the overall number of trus - guided prostate biopsies performed for the diagnosis of prostate cancer increases , it is essential for urologists to understand the patient tolerance associated with this procedure . \\n approximately 65% to 90% of patients report pain of moderate to severe intensity , and 20% do not want to repeat the examination . \\n pain during trus - guided prostate biopsy is generated by transducer insertion and needle penetration in the rectal wall , prostate capsule , and periprostatic tissue . by focusing on this mechanism , several techniques and agents for the alleviation of pain associated with prostate biopsy have been reported . among the techniques to relieve pain during trus - guided prostate biopsy \\n , ppnb is the most effective method . in a meta - analysis , compared with no anesthesia , placebo , and intrarectal lidocaine gel injection , ppnb significantly reduced the pain arising from trus - guided prostate biopsy . \\n however , ppnb can have several complications resulting from repeated injections during the biopsy , systemic lidocaine toxicity , urinary incontinence , and degradation of the image resolution as the result of anesthetic injection . \\n in addition , several studies have reported that patients who underwent periprostatic local anesthetic infiltration felt that the pain of probe introduction was as bad as or worse than the needle biopsies themselves . therefore , other methods to relieve pain during trus - guided prostate biopsy should be considered . in the current study , \\n patients in the lithotomy position experienced less pain during trus - guided prostate biopsy than did those in the lld position . regarding the anatomy of the pelvic floor \\n , we hypothesized that the lithotomy position may result in release of the external anal sphincter as the pelvic floor muscles are relaxed . \\n some studies have evaluated the activity of the pelvic floor muscle resting tone in different positions . \\n resende et al .   conducted a study comparing three different positions ( lithotomy , lld , and supine position ) to evaluate the myoelectrical activity of the pelvic floor muscle resting tone . \\n the lld position presented a significantly greater myoelectrical signal of pelvic floor resting tone compared with the lithotomy and supine positions . \\n therefore , we anticipate that pain experienced while undergoing trus - guided prostate biopsy from the insertion of the ultrasound probe may be relieved in the lithotomy position . \\n in addition , we hypothesized that the lithotomy position may be more acceptable than the lld position regarding communication between patients and physicians . \\n some studies have reported that pain perception during prostate biopsy was related to the level of anxiety . \\n bruyere et al .   published a study comparing the pain experienced during prostate biopsy in two different positions : lithotomy and lld . \\n the results of that study suggested that the lld position may be less acceptable and more humiliating than the lithotomy position because of less eye contact and less gentle handling than in the lithotomy position . \\n although the relationship between the level of anxiety and the patient \\'s position during trus - guided prostate biopsy was not analyzed from a psychobehavioral aspect besides the vas score in our study , we anticipate that the lithotomy position may be more acceptable than the lld position because patients in the lithotomy position can see the process of the procedure and the physician \\'s movements . \\n in contrast to our results , kilciler et al .   and lodeta and lodeta   reported that pain perception during trus - guided prostate biopsy is less profound in patients in the lld position than in the lithotomy position . \\n those studies suggested that the lithotomy position may be more unpleasant or embarrassing than the lld position in terms of psychological phenomenon , because the lld position is a more relaxed and physiological position typically used for sleep and rest . by using an adjustable stirrup in the operation room \\n , however , we minimized the physical discomfort induced by the lithotomy position during trus - guided prostate biopsy . also , our study was the first to report that the lithotomy position was a significant independent factor related to pain during trus - guided prostate biopsy , compared with other factors related to pain , such as psa , age , and ipss . \\n our study also demonstrated that pain scores during trus - guided prostate biopsy are lower in dm patients than in patients without diabetes . \\n chronic elevation of blood glucose levels leads to damage to blood vessels and results in diabetic neuropathy . \\n we hypothesize that pain scores during trus - guided prostate biopsy are lower in patients with dm because sensation is significantly decreased in these patients . \\n first , because this study was conducted retrospectively in a single center and included a small number of subjects , we did not investigate other questionnaires regarding anxiety and depression related to prostate biopsy . \\n therefore , additional prospective studies with larger numbers of patients should be conducted to further evaluate this finding . \\n second , we did not evaluate pain scores at each step , such as insertion of ultrasound probe and penetration of the needle . \\n nevertheless , to the best of our knowledge , this series was the first report to investigate the effect of the patient \\'s position on pain during trus - guided prostate biopsy in asian men . \\n in addition , it demonstrated that the patient \\'s positioning during trus - guided prostate biopsy is a significant independent factor related to pain and that patients in the lithotomy position experienced less pain than did patients in the lld position . \\n patients who underwent trus - guided prostate biopsy in the lithotomy position experienced less pain than did those in the lld position , without a significant difference in the prostate cancer detection rate between the two positions . \\n we suggest that the lithotomy position is the proper way to perform trus - guided prostate biopsy to reduce the patient \\'s pain perception , especially in asian men .',\n",
       "  'output': \"purposetransrectal ultrasound ( trus)-guided prostate biopsy is the most useful technique for the diagnosis of prostate cancer ; however , many patients describe the procedure as uncomfortable and painful . \\n we investigated the effect of the patient 's position on pain scales during trus - guided prostate biopsy.materials and methodsbetween july 2012 and june 2013 , a total of 128 consecutive patients who underwent trus - guided prostate biopsy were included in this study . \\n seventy patients underwent the procedure in the lithotomy position performed by a urologist and the other patients ( n=58 ) underwent the procedure in the left lateral decubitus ( lld ) position performed by a radiologist . \\n pain was assessed by using visual analogue scale ( vas ) scores from 0 to 10 . using a linear regression model \\n , we analyzed the correlation between pain scale score and clinical variables with a focus on patient position.resultsno significant differences related to age , body mass index , prostate volume , prostate - specific antigen ( psa ) , hematuria , pyuria , international prostate symptom score , or the cancer detection rate were observed between the lithotomy and the lld groups . in the correlation analysis , vas score showed a significant correlation with diabetes mellitus , psa level , and lithotomy position ( p<0.05 ) . in the multiple linear regression model , \\n vas score showed a significant correlation with lithotomy position ( =-0.772 , p=0.003 ) and diabetes mellitus ( =-0.803 , p=0.033).conclusionswe suggest that the lithotomy position may be the proper way to reduce pain during trus - guided prostate biopsy .\",\n",
       "  '__index_level_0__': 31668,\n",
       "  'model_output': \"summary: in this retrospective study, the authors found that patients in the lithotomy position experienced less pain during trus - guided prostate biopsy than did those in the lld position. \\n however, they also found that pain scores during trus - guided prostate biopsy are lower in patients with dm. the authors concluded that the lithotomy position is the proper way to perform trus - guided prostate biopsy to reduce the patient's pain perception, especially in asian men. \\n this study was limited by its retrospective design, a single-center setting, and a small number of subjects. \\n prospective studies with larger numbers of patients should be conducted to further evaluate this finding. \\n also, the authors did not evaluate pain scores at each step, such as insertion of ultrasound probe and penetration of the needle. \\n in conclusion, this study provides an important insight into the patient's position during trus - guided prostate biopsy. however, additional studies are needed to further evaluate the effect of the patient's position on pain during trus - guided prostate biopsy.\"},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Write a summary of the article that captures the main ideas and significant details.',\n",
       "  'input': 'Summarize the following article: regulation of body weight and adiposity relies on a homeostatic system balancing energy intake with energy expenditure . \\n well - documented evidence gathered during the past 35 years has established that induction of thermogenesis in brown adipocytes of mice and rats can reduce obesity ( rothwell and stock , 1979 ) . the maintenance of body temperature by brown adipose tissue ( bat ) thermoregulation utilizes energy stores in proportion to ambient temperature ( kozak , 2010 ) . \\n importantly , bat - based non - shivering thermogenesis may be important in humans as well ( yoneshiro and saito , 2015 ) . \\n therefore , adiposity may be regulated by the capacity of the individual to manipulate brown adipocyte phenotypes at reduced temperature , thereby constituting a strategy to reduce metabolic efficiency ( jaroslawska et  al . , 2015 ) . \\n during the past decade , accumulating data have demonstrated that the gut microbiota impacts body weight and energy homeostasis ( tremaroli and bckhed , 2012 ) . \\n microbial diversity as well as the relative proportions between the members of main phyla firmicutes and bacteroidetes have been associated with regulation of obesity in both mice and humans ( ley et  al . , 2005 , \\n the gut microbiota is important for energy harvest on a polysaccharide - rich diet ( bckhed et  al . , 2004 ) and also contributes to diet - induced obesity ( dio ) by modulating different pathways involving triglyceride storage and fatty acid oxidation ( bckhed et  al . , 2007 ) . \\n interestingly , microbiota from lean twins can protect against obesity induced by microbiota from obese twins , when transferred to mice ( ridaura et  al . \\n bile acids ( bas ) produced by hepatocytes , stored in the gall bladder and released into the gut after a meal , are metabolized by the gut microbiota to generate an array of ba species such as secondary bas , e.g. , lithocholic and deoxycholic acid ( sayin et  al . , 2013 ) . \\n these can activate nuclear receptor farnesoid x receptor ( fxr ) and g - coupled receptor tgr5 , located on ibat , to regulate thermogenesis ( prawitt et  al . \\n recent studies have linked changes in the gut microbiota in a cold environment to the thermogenic potential of brite cells through enhanced type 2 cytokine signaling by the innate immune system ( lee et  al . , 2015 , chevalier et  al . , 2015 ) . \\n here we show , in contrast to the role of brite cells in determining resistance to dio in c57bl/6j mice at reduced temperature ( surez - zamorano et  al . , 2015 ) , that acute changes in energy balance in mice fed a high - fat diet at 12c is associated with changes in the gut microbiota , increased ba metabolism , and induction of ibat thermogenesis . \\n we fed mice with high - fat diet ( hfd ) and chow diet ( chd ) at thermoneutrality and at reduced ambient temperatures to assess the effects of reduced temperature on cold - induced energy expenditure and development of dio . at 12c and 17c , \\n the reduced fat mass and adiposity ( figures 1a , 1b , s1a , and s1b ) together with increased food intake in mice fed either hfd or chd resulted in increased energy expenditure ( figures 1c and 1d ) , demonstrating that reduced temperature blocks dio . \\n reduction of ambient temperature from 29c to 17c and 12c induced ibat and inguinal fat ( ing ) uncoupling protein 1 ( ucp1 ) mrna and protein expression in mice fed either chd or hfd ( figures 1e1h and s1c ) . \\n however , ucp1 expression in ing was only 6% of that observed in ibat . in addition , pgc1a ( peroxisome proliferator - activated receptor coactivator 1-alpha ) and adrb1 ( beta3-adrenergic receptor ) expression , which are associated with improved metabolism , was significantly induced in ibat and ing by cold ( figures s1d and s1e ) . reduced cellular energy levels lead to increased phosphorylation of ampk and was associated with increased phosphorylation of acc and increased expression of cpt1a , indicating increased hepatic fatty acid oxidation ( figures 1i1k ) . at 12c mice had decreased expression of biomarkers of hepatic lipogenesis ( figure  s1f ) , a phenotype associated with reduced plasma cholesteryl esters ( ces ) and triacylglycerols ( tags ) in mice fed hfd at 12c compared to 29c ( ces , 12c 6,102.5   446 versus 29c 8,421.1   490.7 , p  < 0.05 ; tags , 12c 155.1   50.4 versus 29c 409.4   43.4 , p  < 0.05 ) . \\n consistent with reduced adiposity , glucose tolerance was improved in mice fed hfd at 12c compared to 17c or 29c and was similar in both hfd- and chd - fed mice at 12c ( figure  1l ) . \\n reduced ambient temperature also improved insulin tolerance of mice on either hfd or chd ( figures s1 g and s1h ) . \\n the improved glucose tolerance was associated with increased glut4 ( glucose transporter type 4 ) mrna and protein levels in ibat and skeletal muscle ( figures s1i  s1k ) . \\n induction of irs1 ( insulin receptor substrate 1 ) mrna at 17c reflected the improved insulin tolerance at reduced ambient temperature ( figure  s1l ) . \\n furthermore , expression of pepck ( phosphoenolpyruvate carboxykinase ) and g6pc ( glucose-6-phosphatase catalytic subunit ) mrna levels was increased in liver of mice housed at 17c and 12c ( figures s1 m and s1n ) , indicating increased hepatic gluconeogenesis , which provides energy for thermogenesis in the cold ( himms - hagen , 1995 ) . to directly investigate the impact of diet and ambient temperature on mouse gut microbiota , the variable region 4 ( v4 ) of bacterial 16s rrna genes was amplified by pcr and sequenced using the illumina miseq platform . \\n we observed 4,090 distinct otus ( from 9,442,775 reads ; ranging from 75,344 to 159,323 reads per sample ) . to investigate how diet and ambient temperature affected the microbiota phylogenetic richness in each caecum sample \\n , we analyzed the -diversity , as assessed by  rarefication and phylogenetic diversity ( figure  2a ) . \\n similar to previous reports , we found that diet is a key factor in shaping phylogenetic diversity ( hildebrandt et  al . , 2009 , turnbaugh et  al . , 2009 ) and observed that the caecal microbiota of mice on chd had higher phylogenetic diversity compared with mice on hfd . \\n we next performed principal coordinate analysis ( pcoa ) of unweighted unifrac distances between the caecum samples from the different groups to determine the effects of diet and ambient temperature on the microbiota . a clear separation between the communities , driven by diet , \\n was observed at the first principal coordinate ( x axis ) , which explained 27% of the variance ( figure  2b ) . \\n the second principal coordinate ( y  axis ) accounted for 13% of the variance and separated the communities by ambient temperature within the diets ( figure  2b ) . \\n moreover , the communities of mice maintained at 12c separated from those at 17c and 29c independently of the diets with the strongest effect in the hfd groups ( figure  2b ) . \\n analysis at the phylum level indicated that the caecal microbiota was dominated by five major phyla : actinobacteria , bacteroidetes , firmicutes , proteobacteria , and verrucomicrobia ( figure  2c ) . \\n mice fed hfd at 12c and 17c were associated with a bloom of proteobacteria and a reduction in bacteroidetes and an increase in firmicutes ( figure  2c ) . \\n shifts in bacteroidaceae , rikenellaceae , and s24 - 7 ( all bacteroidetes ) , particularly in s24 - 7 on chd and bacteroidaceae on hfd , were observed ( figure  2d ) . \\n the increase in firmicutes under all conditions was due to increases in clostridiaceae , lachnospiraceae , and ruminococcaceae ( figure  2d ) . \\n interestingly , a bloom in erysipelotrichaceae was observed in both diets , but only at 29c ( figure  2d ) . \\n the bloom in proteobacteria at reduced temperature was largely accounted for  by desulfovibrionaceae ( figure  2d ) , which has been previously associated with metabolic health ( caesar et  al . , 2015 ) . to identify taxonomic differences in the microbiota composition of mice fed hfd or chd and \\n challenged by differences in the ambient temperature and to identify specific bacterial taxa or species - level phylotypes that contribute to the adiposity phenotype , we applied linear discriminant analysis ( lda ) effect size ( lefse ) with lda score > 2 ( segata et  al . , 2011 ) . \\n this analysis revealed 46 discriminative features in the chd - fed mice ( figure  s2a ) and 34 in the microbiota of hfd - fed mice ( figure  s2b ) . \\n similar otus belonging to class bacilli in particular orders turicibacterales and lactobacillales , the genus allobaculum in the family erysipelotrichaceae , as well as the genus rc4 - 4 in the family peptococcaceae ( figures s2a and s2b ) were increased in mice maintained at 29c independent of diet . \\n the microbiota of mice fed hfd maintained at 12c was enriched in a corriobacteria such as adlercreutzia , number of clostridia from the mogibacteriaceae and ruminococcaceae families , and desulfovibrionales such as desulfovibrio ( figure  s2b ) . \\n similar changes were observed in mice fed chd maintained at 17c ( figure  s2a ) , all of which were lean and glucose tolerant . \\n reduced ambient temperature caused a robust induction of hepatic enzymes engaged in the conversion of cholesterol to primary bas , including cyp7a1 ( cholesterol 7alpha - hydroxylase ) , cyp8b1 ( sterol 12alpha - hydroxylase ) , and cyp27a1 ( sterol 27-hydroxylase ) , as well as in taurine production and taurine conjugation to bas ( figures 2e , s2c , and s2d ) . \\n accordingly , the ba profile was drastically altered and dominated by unconjugated ba ( ca , and - , mca ) at 29c in mice fed a hfd , whereas primary taurine - conjugated bas , i.e. , tca , tmca , and tmca , were elevated in plasma of mice maintained at 12c on both diets ( figures 2f2h ) . \\n fgf21 was 7- and 2.5-fold upregulated in ibat at 12c on a hfd and chd , respectively ( figure  s2e ) . \\n furthermore , type 2 iodothyronine deiodinase expression , which is associated with increased thermogenesis , was induced at reduced temperature ( figure  s2e ) , as previously observed ( de jesus et  al . , 2001 ) . \\n the tgr5 receptor , which binds to microbially produced secondary bas ( kawamata et  al . , 2003 ) , was induced at 12c while thyroid hormone receptor beta was not ( figures s2e  s2 g ) . to investigate whether the gut microbiota and bas were altered in response to reduced temperature or reduction in obesity \\n , we performed a kinetic experiment and analyzed the microbiota in mice that were fed hfd for 4  weeks at 29c and then transferred to 12c for 6  days . increased fat mass and adiposity after 4  weeks of a hfd at 29c was not affected by reduced ambient temperature ( figures 3a and 3b ) , and the increased demand for fuel was satisfied by a 20% increase in food intake within 2  days of cold exposure ( figure  3c ) . \\n cold exposure induced ucp1 expression 5-fold in ibat after 1  day at 12c ( figure  3d ) , similar to the increase observed after 4  weeks at 12c ( compare with figure  1e ) . \\n the induction of ucp1 in ing was very low and therefore not associated with  the initial response required for survival in the cold ( figure  3d ) . \\n the gut microbiota and ba composition were shifted to the cold - adapted state within 1  day , demonstrating that these changes were independent of reduced adiposity ( figures 3e3h ) . \\n the bas profile , already modified 1  day after cold exposure , was dominated by conjugated bas ( tca , tmca , tmca , and tmca ) , whereas the levels of unconjugated bas ( mca , mca , and mca ) were reduced compared to 29c ( figure  3e ) . \\n analysis on caecal microbiota composition showed a significant decrease in the phylogenetic diversity already 2  days after cold exposure compared to 29c ( figure  3f ) . at the phylum level , deferribacteres increased and verrucomicrobia decreased within 1  day of cold ( figure  3 g ) . \\n bacteroidetes increased and firmicutes decreased , but not until after 6  days at 12c ( figure  3 g ) , to increase the bacteroidetes / firmicutes ratio ( figure  3h ) . at the family level , the most abundant phylotypes affected by cold exposure were bacteroidaceae , rikenellaceae , porphyromonadaceae , deferribacteraceae , lactobacillaceae , clostridiaceae , and peptostreptococcaceae ( figure  s3a ) . \\n the fraction of others , such as s24 - 7 , clostridiales , lachnospiraceae , ruminococcaceae , erysipelotrichaceae , and desulfovibrionaceae ( figure  s3a ) did not change when mice were transferred to cold for 6  days , suggesting that these microbial phylotypes are associated with hfd feeding . \\n similar to the initial cold - exposure experiment for 4  weeks , we observed that adlercreutzia and bacteroides were increased after 6  days of cold exposure ( figure  s3b ) . \\n the firmicutes , lactobacillus , clostridiaceae , genus smb53 , dehalobacterium , peptostreptococcaceae , and mogibacteriaceae decreased at 12c ( figure  s3b ) . \\n long - term cold exposure induced a bloom in proteobacteria , particularly in desulfovibrionaceae ( figure  s2b ) , but it did not change during the short - term exposure at 12c ( figure  s3a ) . \\n these data suggest that in parallel with ucp1 induction , changes in microbiota and bas occur when ambient temperature is reduced , but independent of changes in adiposity . to assess the capacity of the gut microbiota from mice maintained at reduced ambient temperature to modulate the development of dio \\n mice colonized with microbiota from donors kept at 12c had reduced fat mass and adiposity as well as significantly higher expression of ucp1 and dio2 mrna and protein in ibat compared with mice colonized with microbiota from 29c ( figures 4a4e ) . \\n expression of adrb3 , pgc1a , and fgf21was not altered in ibat ( figure  4c ) ; no changes in gene expression were detected in ing of recipient mice ( figure  4f ) . \\n the glucose response was improved in the recipient mice colonized with microbiota from donor kept at 12c , but no differences occurred in glut4 protein levels in muscle and ibat ( figures 4 g , s4a , and s4b ) . \\n recipient mice , colonized with microbiota from donors kept at 12c , had increased hepatic expression of cyp8b1 and cyp7b1 ( 25-hydroxycholesterol 7alpha - hydroxylase ) and csd ( cysteine sulfinic acid decarboxylase ) , leading to an altered ba profile ( figures s4c and 4h ) . \\n these mice had an increased proportion of conjugated , and a reduced proportion of primary unconjugated , bas ( ca , cdca , and mca ) and secondary bas ( dca and udca ) in the plasma ( figure  4h ) . \\n gut microbiota transferred from donors housed at 12c influenced hepatic lipid metabolism , inducing ampk phosphorylation augmenting lipid -oxidation in liver compared with microbiota from 29c ( figures 4i4k and s4d ) . \\n nonetheless , lipid analysis showed a modest increase in total tag in plasma in mice colonized with microbiota from  donor kept at 12c ( figure  s4e ) . \\n these results suggest that functional differences between microbiota of mice kept  at 12c and 29c can be transferred to recipient mice kept at 23c . \\n a primary and essential task of all endothermic animals is to maintain a normal body temperature by inducing thermogenesis in response to cold . here , we demonstrate that reducing ambient temperature from 29c to 12c or even 17c also protects the host from dio , an effect that is associated with increased ucp1 expression in ibat . \\n however , recent studies have shown that the pathway for activating thermogenesis may be more complex than the traditional model based on ibat thermogenesis . \\n thermogenesis occurs not only in ibat , but also by the induction of brite cells in wat at 29c by administration of interleukin 4 ( qiu et  al . , \\n similarly , the thermogenic program in ibat may be activated by bas at 29c ( zietak and kozak , 2016 ) . \\n recently , it was shown that the depletion of the microbiota by antibiotic treatment or gf conditions stimulates the induction of brite cells by enhanced type 2 cytokine signaling from eosinophil infiltration ( surez - zamorano et  al . , 2015 ) . here , we show that both the acute and chronic exposure to reduced ambient temperature leads to induction of ucp1 in ibat and rapid changes in the composition of the gut microbiota and ba metabolism . \\n the results suggest that the induction of cold - mediated thermogenesis involves the activation of ibat thermogenesis by a mechanism involving modulation of ba metabolism and ampk phosphorylation by the gut microbiota . \\n a key question is whether the improved obesity / diabetic phenotype of mice with dio reared in the cold is dependent on the effects of the gut microbiota . \\n we observed that cold exposure is linked to altered caecal microbiota and that mice on both diets shared microbial phylotypes associated with changes in ambient temperature . \\n bacteria belonging to bacilli and erysipelotrichaceae , usually associated with obesity ( turnbaugh et  al . , 2009 ) , were enriched in mice at 29c , whereas adlercreutzia and desulfovibrio , associated with leanness ( caesar et  al . \\n , 2015 , goodrich et  al . , 2014 ) , were increased at 12c . \\n changes in the composition of gut microbiota occurring within 1  day of exposure at 12c and in the absence of changes in adiposity suggest that the changes in microbiota are driven by changes in temperature rather than merely reflecting obesity . \\n the major microbiota changes occurring in parallel with induction of ucp1 were reduced firmicutes apparent after 1  day and an increase in bacteroidetes after 6  days , changes previously linked with protection against obesity ( ley et  al . , 2005 , turnbaugh et  al . , 2008 ) . \\n ( 2015 ) , we identified a decreased abundance of verrucomicrobia and an increased abundance of deferribacteres when mice were exposed to cold , suggesting that altered abundance of members in these phyla contribute to the cold - induced phenotype . \\n changes in other bacteria after longer cold exposure may be in response to altered adiposity of the host . \\n the mechanism by which the gut microbiota influences adiposity may include modulation of ba metabolism ( sayin et  al . , 2013 ) . \\n bas are microbial - derived metabolic regulators , which can suppress dio through increased energy expenditure ( watanabe et  al . , 2012 ) . here \\n we show that lower ambient temperature increased production of bas and expression of genes related to ba synthesis . \\n the increased levels of conjugated bas may be attributed to reduced levels of lactobacillus , which has high deconjugation capacity upon cold exposure . \\n these observations were confirmed in the kinetics study where conjugated bas were increased and lactobacillus was decreased after 1  day at 12c . \\n the increased prevalence of taurine species in the cold might antagonize fxr receptor ( sayin et  al . , 2013 ) and protect against dio as fxr - deficient mice are resistant to dio ( prawitt et  al . \\n , 2011a ) . in agreement with inhibition of fxr signaling in the cold - exposed animals , we observed increased expression of enzymes involved in ba synthesis and increased ba pool size . \\n the cold - exposed mice had a ba profile that resembled that of gf mice , which also are resistant to dio and have increased expression of phosphorylated ampk in the liver ( bckhed et  al . , 2007 ) . \\n ampk activation inhibits fxr activity ( lien et  al . , 2014 ) and also promotes energy expenditure . \\n accordingly , we observed increased expression of phosphorylated acc as well as downstream cpt1a expression , which is associated with increased fatty acid oxidation and energy expenditure . \\n importantly , we observed this phenotype both following cold - exposure as well as after microbiota transfer , suggesting that the phenotype is linked to the altered microbiota . in the current study , \\n cold exposure at 12c causes a strong and rapid induction of the brown adipose phenotype in ibat , but not in ing , an increased whole - animal energy expenditure , and a complete suppression of dio . \\n we demonstrated that transplantation of caecal material from mice reared at 12c to gf recipients improved their metabolic phenotype . \\n ( 2015 ) demonstrated that transplantation of caecal material from cold - exposed mice reduced obesity and improved insulin sensitivity . \\n however , the brown adipocyte phenotype in ing wat in our study is minor ( 1%5% ) compared to the robust ibat thermogenic phenotype . \\n our investigations suggest that changes in the gut microbiota in response to the cold exposure mediate ba metabolism , possibly through changes in ampk and fxr signaling , to complement sympathetic signaling in the regulation of thermogenesis in ibat and resistance to dio . \\n protocol i. breeding pairs of c57bl6/j ( b6 ) mice were obtained from the jackson laboratory . \\n adult b6 mice at 1220  weeks of age were divided into 6 groups ( n  = 810 mice / group ) . \\n three groups were ad libitum fed hfd ( 58% energy in kcal from fat , ain-76a 9g03 research diets ) ; another three groups received chd ( 11% energy in kcal from fat , 5053 , rodent diet 20 , labdiet ) . \\n mice were single - housed with a 12  hr light/12  hr dark cycle at environmental temperatures of 12c , 17c , and 29c for 4  weeks . \\n b6 mice at 8  weeks of age were individually housed at 29c and ad libitum fed a hfd for 4  weeks ( n  = 6 mice ) . \\n thereafter , mice were transferred to 12c for 1 , 2 , 4 , and 6  days and received ad libitum a hfd ( n  = 6 mice / time point ) . for both protocols , mice were anaesthetized with an overdose of cocktail composed of ketamine / xylazine / chlorpromazine administered subcutaneously to collect blood samples by cardiac puncture . \\n blood samples were centrifuged for 10  min at 2,400  rpm and stored at 20c . \\n mice were sacrificed by cervical dislocation , and tissues and caecal content were quickly removed and stored at 80c for further analysis . \\n animal experiments performed at  different temperatures were approved by the local committee for the ethical treatment of experimental animals of warmia - mazury university ( nr 38/2011 ) , olsztyn , poland . \\n fat mass and lean mass were measured by nuclear magnetic resonance ( nmr , bruker ) . \\n food intake was calculated on a weekly basis and expressed as the amount of energy in kj . at the end of the experiment \\n bacterial gdna was extracted using the genematrix stool dna purification kit ( eurx ) from the caecum of mice fed hfd and maintained at 17c or 29c . \\n genomic dna from caecum of mice fed hfd at 12c and chd at 12c , 17c , and 29c was isolated using the repeated bead beating ( rbb ) method ( salonen et  al . , 2010 ) . \\n details about 16s rrna amplification , sequencing , microbiota data analysis , and ba analyses are provided in supplemental experimental procedures . \\n the data are expressed as mean   sem and analyzed using graphpad prism 6.0 . \\n statistical differences for single variables were analyzed by mann - whitney test or one - way anova and tukey s multiple comparison post hoc test for  three groups ( 29c , 17c , and 12c ) the level of significance was set at p  < 0.05 ; p  < \\n 0.05 ; p  < 0.01 ; p  < 0.001 ; p  < 0.0001 . \\n m.z . was involved in design of the experiment and performed physiological and molecular phenotypes and participated in writing the manuscript ; p.k .- d . was involved in design and performed experiments concerning microbial profiling and transplant experiments and participated in writing the manuscript ; l.h.m . and m.s . \\n designed the initial hypothesis and participated in the design and the writing of the manuscript ; f.b . was involved in design and interpretation of experiments concerning microbial profiling and transplant experiments and participated in the design and the writing of the manuscript .',\n",
       "  'output': 'summarymaintenance of body temperature in cold - exposed animals requires induction of thermogenesis and management of fuel . here \\n , we demonstrated that reducing ambient temperature attenuated diet - induced obesity ( dio ) , which was associated with increased ibat thermogenesis and a plasma bile acid profile similar to that of germ - free mice . \\n we observed a marked shift in the microbiome composition at the phylum and family levels within 1  day of acute cold exposure and after 4  weeks at 12c . \\n gut microbiota was characterized by increased levels of  adlercreutzia , mogibacteriaceae , ruminococcaceae , and desulfovibrio and reduced levels of bacilli , erysipelotrichaceae , and the genus rc4 - 4 . \\n these genera have been associated with leanness and obesity , respectively . \\n germ - free mice fed a high - fat diet at room temperature gained less adiposity and improved glucose tolerance when transplanted with caecal microbiota of mice housed at 12c compared to mice transplanted with microbiota from 29c . \\n thus , a microbiota - liver - bat axis may mediate protection against obesity at reduced temperature .',\n",
       "  '__index_level_0__': 31669,\n",
       "  'model_output': 'Summarize the following article: regulation of body weight and adiposity relies on a homeostatic system balancing energy intake with energy expenditure. \\n well - documented evidence gathered during the past 35 years has established that induction of thermogenesis in brown adipocytes of mice and rats can reduce obesity ( rothwell and stock, 1979 ). the maintenance of body temperature by brown adipose tissue ( bat ) thermoregulation utilizes energy stores in proportion to ambient temperature ( kozak, 2010 ). \\n importantly, bat - based non - shivering thermogenesis may be important in humans as well ( yoneshiro and saito, 2015 ). \\n therefore, adiposity may be regulated by the capacity of the individual to manipulate brown adipocyte phenotypes at reduced temperature, thereby constituting a strategy to reduce metabolic efficiency ( jaroslawska et  al., 2015 ). \\n during the past decade, accumulating data have demonstrated that the gut microbiota impacts body weight and energy homeostasis ( tremaroli and bckhed, 2012 ). \\n microbial diversity as well as the relative proportions between the members of main phyla firmicutes and bacteroidetes have been associated with regulation of obesity in both mice and humans ( ley et  al., 2005, \\n the gut microbiota is important for energy harvest on a polysaccharide - rich diet ( bckhed et  al., 2004 ) and also contributes to diet - induced obesity ( dio ) by modulating different pathways involving triglyceride storage and fatty acid oxidation ( bckhed et  al., 2007 ). \\n interestingly, microbiota from lean twins can protect against obesity induced by microbiota from obese twins, when transferred to mice ( ridaura et  al. \\n bile acids ( bas ) produced by hepatocytes, stored in the gall bladder and released into the gut after a meal, are metabolized by the gut microbiota to generate an array of ba species such as secondary bas, e.g., lithocholic and deoxycholic acid ( sayin et  al., 2013 ). \\n these can activate nuclear receptor farnesoid x receptor ( fxr ) and g - coupled receptor tgr5, located on ibat, to regulate thermogenesis ( prawitt et  al. \\n recent studies have linked changes in the gut microbiota in a cold environment to the thermogenic potential of brite cells through enhanced type 2 cytokine signaling by the innate immune system ( lee et  al., 2015, chevalier et  al., 2015 ). \\n here we show, in contrast to the role of brite cells in determining resistance to dio in c57bl/6j mice at reduced temperature ( surez - zamorano et  al., 2015 ), that acute changes in energy balance in mice fed a high - fat diet at 12c is associated with changes in the gut microbiota, increased ba metabolism, and induction of ibat thermogenesis. \\n we fed mice with high - fat diet ( hfd ) and chow diet ( chd ) at thermoneutrality and at reduced ambient temperatures to assess the effects of reduced temperature on cold - induced energy expenditure and development of dio. at 12c and 17c, \\n the reduced fat mass and adiposity ( figures 1a, 1b, s1a, and s1b ) together with increased food intake in mice fed either hfd or chd resulted in increased energy expenditure ( figures 1c and 1d ), demonstrating that reduced temperature blocks dio. \\n reduction of ambient temperature from 29c to 17c and 12c induced ibat and inguinal fat ( ing ) uncoupling protein 1 ( ucp1 ) mrna and protein expression in mice fed either chd or hfd ( figures 1e1h and s1c ). \\n however, ucp1 expression in ing was only 6% of that observed in ibat. in addition, pgc1a ( peroxisome proliferator - activated receptor coactivator 1-alpha ) and adrb1 ( beta3-adrenergic receptor ) expression, which are associated with improved metabolism, was significantly induced in ibat and ing by cold ( figures s1d and s1e ). reduced cellular energy levels lead to increased phosphorylation of ampk and was associated with increased phosphorylation of acc and increased expression of cpt1a, indicating increased hepatic fatty acid oxidation ( figures 1i1k ). at 12c mice had decreased expression of biomarkers of hepatic lipogenesis ( figure  s1f ), a phenotype associated with reduced plasma cholesteryl esters ( ces ) and triacylglycerols ( tags ) in mice fed hfd at 12c compared to 29c ( ces, 12c 6,102.5   446 versus 29c 8,421.1   490.7, p  < 0.05 ; tags, 12c 155.1   50.4 versus 29c 409.4   43.4, p  < 0.05 ). \\n consistent with reduced adiposity, glucose tolerance was improved in mice fed hfd at 12c compared to 17c or 29c and was similar in both hfd- and chd - fed mice at 12c ( figure  1l ). \\n reduced ambient temperature also improved insulin tolerance of mice on either hfd or chd ( figures s1 g and s1h ). \\n the improved glucose tolerance was associated with increased glut4 ( glucose transporter type 4 ) mrna and protein levels in ibat and skeletal muscle ( figures s1i  s1k ). \\n induction of irs1 ( insulin receptor substrate 1 ) mrna at 17c reflected the improved insulin tolerance at reduced ambient temperature ( figure  s1l ). \\n furthermore, expression of pepck ( phosphoenolpyruvate carboxykinase ) and g6pc ( glucose-6-phosphatase catalytic subunit ) mrna levels was increased in liver of mice housed at 17c and 12c ( figures s1 m and s1n ), indicating increased hepatic gluconeogenesis, which provides energy for thermogenesis in the cold ( himms - hagen, 1995 ). to directly investigate the impact of diet and ambient temperature on mouse gut microbiota, the variable region 4 ( v4 ) of bacterial 16s rrna genes was amplified by pcr and sequenced using the illumina miseq platform. \\n we observed 4,090 distinct otus ( from 9,442,775 reads ; ranging from 75,344 to 159,323 reads per sample ). to investigate how diet and ambient temperature affected the microbiota phylogenetic richness in each caecum sample \\n, we analyzed the -diversity, as assessed by  rarefication and phylogenetic diversity ( figure  2a ). \\n similar to previous reports, we found that diet is a key factor in shaping phylogenetic diversity ( hildebrandt et  al., 2009, turnbaugh et  al., 2009 ) and observed that the caecal microbiota of mice on chd had higher phylogenetic diversity compared with mice on hfd. \\n we next performed principal coordinate analysis ( pcoa ) of unweighted unifrac distances between the caecum samples from the different groups to determine the effects of diet and ambient temperature on the microbiota. a clear separation between the communities, driven by diet, \\n was observed at the first principal coordinate ( x axis ), which explained 27% of the variance ( figure  2b ). \\n the second principal coordinate ( y  axis ) accounted for 13% of the variance and separated the communities by ambient temperature within the diets ( figure  2b ). \\n moreover, the communities of mice maintained at 12c separated from those at 17c and 29c independently of the diets with the strongest effect in the hfd groups ( figure  2b ). \\n analysis at the phylum level indicated that the caecal microbiota was dominated by five major phyla : actinobacteria, bacteroidetes, firmicutes, proteobacteria, and verrucomicrobia ( figure  2c ). \\n mice fed hfd at 12c and 17c were associated with a bloom of proteobacteria and a reduction in bacteroidetes and an increase in firmicutes ( figure  2c ). \\n shifts in bacteroidaceae, rikenellaceae, and s24 - 7 ( all bacteroidetes ), particularly in s24 - 7 on chd and bacteroidaceae on hfd, were observed ( figure  2d ). \\n the increase in firmicutes under all conditions was due to increases in clostridiaceae, lachnospiraceae, and ruminococcaceae ( figure  2d ). \\n interestingly, a bloom in erysipelotrichaceae was observed in both diets, but only at 29c ( figure  2d ). \\n the bloom in proteobacteria at reduced temperature was largely accounted for  by desulfovibrionaceae ( figure  2d ), which has been previously associated with metabolic health ( caesar et  al., 2015 ). to identify taxonomic differences in the microbiota composition of mice fed hfd or chd and \\n challenged by differences in the ambient temperature and to identify specific bacterial taxa or species - level phylotypes that contribute to the adiposity phenotype, we applied linear discriminant analysis ( lda ) effect size ( lefse ) with lda score > 2 ( segata et  al., 2011 ). \\n this analysis revealed 46 discriminative features in the chd - fed mice ( figure  s2a ) and 34 in the microbiota of hfd - fed mice ( figure  s2b ). \\n similar otus belonging to class bacilli in particular orders turicibacterales and lactobacillales, the genus allobaculum in the family erysipelotrichaceae, as well as the genus rc4 - 4 in the family peptococcaceae ( figures s2a and s2b ) were increased in mice maintained at 29c independent of diet. \\n the microbiota of mice fed hfd maintained at 12c was enriched in a corriobacteria such as adlercreutzia, number of clostridia from the mogibacteriaceae and ruminococcaceae families, and desulfovibrionales such as desulfovibrio ( figure  s2b ). \\n similar changes were observed in mice fed chd maintained at 17c ( figure  s2a ), all of which were lean and glucose tolerant. \\n reduced ambient temperature caused a robust induction of hepatic enzymes engaged in the conversion of cholesterol to primary bas, including cyp7a1 ( cholesterol 7alpha - hydroxylase ), cyp8b1 ( sterol 12alpha - hydroxylase ), and cyp27a1 ( sterol 27-hydroxylase ), as well as in taurine production and taurine conjugation to bas ( figures 2e, s2c, and s2d ). \\n accordingly, the ba profile was drastically altered and dominated by unconjugated ba ( ca, and -, mca ) at 29c in mice fed a hfd, whereas primary taurine - conjugated bas, i.e., tca, tmca, and tmca, were elevated in plasma of mice maintained at 12c on both diets ( figures 2f2h ). \\n fgf21 was 7- and 2.5-fold upregulated in ibat at 12c on a hfd and chd, respectively ( figure  s2e ). \\n furthermore, type 2 iodothyronine deiodinase expression, which is associated with increased thermogenesis, was induced at reduced temperature ( figure  s2e ), as previously observed ( de jesus et  al., 2001 ). \\n the tgr5 receptor, which binds to microbially produced secondary bas ( kawamata et  al., 2003 ), was induced at 12c while thyroid hormone receptor beta was not ( figures s2e  s2 g ). to investigate whether the gut microbiota and bas were altered in response to reduced temperature or reduction in obesity \\n, we performed a kinetic experiment and analyzed the microbiota in mice that were fed hfd for 4  weeks at 29c and then transferred to 12c for 6  days. increased fat mass and adiposity after 4  weeks of a hfd at 29c was not affected by reduced ambient temperature ( figures 3a and 3b ), and the increased demand for fuel was satisfied by a 20% increase in food intake within 2  days of cold exposure ( figure  3c ). \\n cold exposure induced ucp1 expression 5-fold in ibat after 1  day at 12c ( figure  3d ), similar to the increase observed after 4  weeks at 12c ( compare with figure  1e ). \\n the induction of ucp1 in ing was very low and therefore not associated with  the initial response required for survival in the cold ( figure  3d ). \\n the gut microbiota and ba composition were shifted to the cold - adapted state within 1  day, demonstrating that these changes were independent of reduced adiposity ( figures 3e3h ). \\n the bas profile, already modified 1  day after cold exposure, was dominated by conjugated bas ( tca, tmca, tmca, and tmca ), whereas the levels of unconjugated bas ( mca, mca, and mca ) were reduced compared to 29c ( figure  3e ). \\n analysis on caecal microbiota composition showed a significant decrease in the phylogenetic diversity already 2  days after cold exposure compared to 29c ( figure  3f ). at the phylum level, deferribacteres increased and verrucomicrobia decreased within 1  day of cold ( figure  3 g ). \\n bacteroidetes increased and firmicutes decreased, but not until after 6  days at 12c ( figure  3 g ), to increase the bacteroidetes / firmicutes ratio ( figure  3h ). at the family level, the most abundant phylotypes affected by cold exposure were bacteroidaceae, rikenellaceae, porphyromonadaceae, deferribacteraceae, lactobacillaceae, clostridiaceae, and peptostreptococcaceae ( figure  s3a ). \\n the fraction of others, such as s24 - 7, clostridiales, lachnospiraceae, ruminococcaceae, erysipelotrichaceae, and desulfovibrionaceae ( figure  s3a ) did not change when mice were transferred to cold for 6  days, suggesting that these microbial phylotypes are associated with hfd feeding. \\n similar to the initial cold - exposure experiment for 4  weeks, we observed that adlercreutzia and bacteroides were increased after 6  days of cold exposure ( figure  s3b ). \\n the firmicutes, lactobacillus, clostridiaceae, genus smb53, dehalobacterium, peptostreptococcaceae, and mogibacteriaceae decreased at 12c ( figure  s3b ). \\n long - term cold exposure induced a bloom in proteobacteria, particularly in desulfovibrionaceae ( figure  s2b ), but it did not change during the short - term exposure at 12c ( figure  s3a ). \\n these data suggest that in parallel with ucp1 induction, changes in microbiota and bas occur when ambient temperature is reduced, but independent of changes in adiposity of the host. to assess the capacity of the gut microbiota from mice maintained at reduced ambient temperature to modulate the development of dio \\n mice colonized with microbiota from donors kept at 12c had reduced fat mass and adiposity as well as significantly higher expression of ucp1 and dio2 mrna and protein in ibat compared with mice colonized with microbiota from 29c ( figures 4a4e ). \\n expression of adrb3, pgc1a, and fgf21was not altered in ibat ( figure  4c ) ; no changes in gene expression were detected in ing of recipient mice ( figure  4f ). \\n the glucose response was improved in the recipient mice colonized with microbiota from donor kept at 12c, but no differences occurred in glut4 protein levels in muscle and ibat ( figures 4 g, s4a, and s4b ). \\n recipient mice, colonized with microbiota from donors kept at 12c, had increased hepatic expression of cyp8b1 and cyp7b1 ( 25-hydroxycholesterol 7alpha - hydroxylase ) and csd ( cysteine sulfinic acid decarboxylase ), leading to an altered ba profile ( figures s4c and 4h ). \\n these mice had an increased proportion of conjugated, and a reduced proportion of primary unconjugated, bas ( ca, cdca, and mca ) and secondary bas ( dca and udca ) in the plasma ( figure  4h ). \\n gut microbiota transferred from donors housed at 12c influenced hepatic lipid metabolism, inducing ampk phosphorylation augmenting lipid -oxidation in liver compared with microbiota from 29c ( figures 4i4k and s4d ). \\n nonetheless, lipid analysis showed a modest increase in total tag in plasma in mice colonized with microbiota from  donor kept at 12c ( figure  s4e ). \\n these results suggest that functional differences between microbiota of mice kept  at 12c and 29c can be transferred to recipient mice kept at 23c. \\n a primary and essential task of all endothermic animals is to maintain a normal body temperature by inducing thermogenesis in response to cold. here, we demonstrate that reducing ambient temperature from 29c to 12c or even 17c also protects the host from dio, an effect that is associated with increased ucp1 expression in ibat. \\n however, recent studies have shown that the pathway for activating thermogenesis may be more complex than the traditional model based on ibat thermogenesis. \\n thermogenesis occurs not only in ibat, but also by the induction of brite cells in wat at 29c by administration of interleukin 4 ( qiu et  al., \\n similarly, the thermogenic program in ibat may be activated by bas at 29c ( zietak and kozak, 2016 ). \\n recently, it was shown that the depletion of the microbiota by antibiotic treatment or gf conditions stimulates the induction of brite cells by enhanced type 2 cytokine signaling from eosinophil infiltration ( surez - zamorano et  al., 2015 ). here, we show that both the acute and chronic exposure to reduced ambient temperature leads to induction of ucp1 in ibat and rapid changes in the composition of the gut microbiota and ba metabolism. \\n the results suggest that the induction of cold - mediated thermogenesis involves the activation of ibat thermogenesis by a mechanism involving modulation of ba metabolism and ampk phosphorylation by the gut microbiota. \\n a key question is whether the improved obesity / diabetic phenotype of mice with dio reared in the cold is dependent on the effects of the gut microbiota. \\n we observed that cold exposure is linked to altered caecal microbiota and that mice on both diets shared microbial phylotypes associated with changes in ambient temperature. \\n bacteria belonging to bacilli and erysipelotrichaceae, usually associated with obesity ( turnbaugh et  al., 2009 ), were enriched in mice at 29c, whereas adlercreutzia and desulfovibrio, associated with leanness ( caesar et  al. \\n, 2015, goodrich et  al., 2014 ), were increased at 12c. \\n changes in the composition of gut microbiota occurring within 1  day of exposure at 12c and in the absence of changes in adiposity suggest that the changes in microbiota are driven by changes in temperature rather than merely reflecting obesity. \\n the major microbiota changes occurring in parallel with induction of ucp1 were reduced firmicutes apparent after 1  day and an increase in bacteroidetes after 6  days, changes previously linked with protection against obesity ( ley et  al., 2005, turnbaugh et  al., 2008 ). \\n ( 2015 ), we identified a decreased abundance of verrucomicrobia and an increased abundance of deferribacteres when mice were exposed to cold, suggesting that altered abundance of members in these phyla contribute to the cold - induced phenotype. \\n changes in other bacteria after longer cold exposure may be in response to altered adiposity of the host. \\n the mechanism by which the gut microbiota influences adiposity may include modulation of ba metabolism ( sayin et  al., 2013 ). \\n bas are microbial - derived metabolic regulators, which can suppress dio through increased energy expenditure ( watanabe et  al., 2012 ). here \\n we show that lower ambient temperature increased production of bas and expression of genes related to ba synthesis. \\n the increased levels of conjugated bas may be attributed to reduced levels of lactobacillus, which has high deconjugation capacity upon cold exposure. \\n these observations were confirmed in the kinetics study where conjugated bas were increased and lactobacillus was decreased after 1  day at 12c. \\n the increased prevalence of taurine species in the cold might antagonize fxr receptor ( sayin et  al., 2013 ) and protect against dio as fxr - deficient mice are resistant to dio ( prawitt et  al. \\n, 2011a ). in agreement with inhibition of fxr signaling in the cold - exposed animals, we observed increased expression of enzymes involved in ba synthesis and increased ba pool size. \\n the cold - exposed mice had a ba profile that resembled that of gf mice, which also are resistant to dio and have increased expression of phosphorylated ampk in the liver ( bckhed et  al., 2007 ). \\n ampk activation inhibits fxr activity ( lien et  al., 2014 ) and also promotes energy expenditure. \\n accordingly, we observed increased expression of phosphorylated acc as well as downstream cpt1a expression, which is associated with increased fatty acid oxidation and energy expenditure. \\n importantly, we observed this phenotype both following cold - exposure as well as after microbiota transfer, suggesting that the phenotype is linked to the altered microbiota. in the current study, \\n cold exposure at 12c causes a strong and rapid induction of the brown adipose phenotype in ibat, but not in ing, an increased whole - animal energy expenditure, and a complete suppression of dio. \\n we demonstrated that transplantation of caecal material from mice reared at 12c to gf recipients improved their metabolic phenotype. \\n ( 2015 ) demonstrated that transplantation of caecal material from cold - exposed mice reduced obesity and improved insulin sensitivity. \\n however, the brown adipocyte phenotype in ing wat in our study is minor ( 1%5% ) compared to the robust ibat thermogenic phenotype. \\n our investigations suggest that changes in the gut microbiota in response to the cold exposure mediate ba metabolism, possibly through changes in ampk and fxr signaling, to complement sympathetic signaling in the regulation of thermogenesis in ibat and resistance to dio. \\n protocol i. breeding pairs of c57bl6/j ( b6 ) mice were obtained from the jackson laboratory. \\n adult b6 mice at 1220  weeks of age were divided into 6 groups ( n  = 810 mice / group ). \\n three groups were ad libitum fed hfd ( 58% energy in kcal from fat, ain-76a 9g03 research diets ) ; another three groups received chd ( 11% energy in kcal from fat, 5053, rodent diet 20, labdiet ). \\n mice were single - housed with a 12  hr light/12  hr dark cycle at environmental temperatures of 12c, 17c, and 29c for 4  weeks. \\n b6 mice at 8  weeks of age were individually housed at 29c and ad libitum fed a hfd for 4  weeks ( n  = 6 mice ). \\n thereafter, mice were transferred to 12c for 1, 2, 4, and 6  days and received ad libitum a hfd ( n  = 6 mice / time point ). for both protocols, mice were anaesthetized with an overdose of cocktail composed of ketamine / xylazine / chlorpromazine administered subcutaneously to collect blood samples by cardiac puncture. \\n blood samples were centrifuged for 10  min at 2,400  rpm and stored at 20c. \\n mice were sacrificed by cervical dislocation, and tissues and caecal content were quickly removed and stored at 80c for further analysis. \\n animal experiments performed at  different temperatures were approved by the local committee for the ethical treatment of experimental animals of warmia - mazury university ( nr 38/2011 ), olsztyn, poland. \\n fat mass and lean mass were measured by nuclear magnetic resonance ( nmr, bruker ). \\n food intake was calculated on a weekly basis and expressed as the amount of energy in kj. at the end of the experiment \\n bacterial gdna was extracted using the genematrix stool dna purification kit ( eurx ) from the caecum of mice fed hfd and maintained at 17c or 29c. \\n genomic dna from caecum of mice fed hfd at 12c and chd at 12c, 17c, and 29c was isolated using the repeated bead beating ( rbb ) method ( salonen et  al., 2010 ). \\n details about 16s rrna amplification, sequencing, microbiota data analysis, and ba analyses are provided in supplemental experimental procedures. \\n the data are expressed as mean   sem and analyzed using graphpad prism 6.0. \\n statistical differences for single variables were analyzed by mann - whitney test or one - way anova and tukey s multiple comparison post hoc test for  three groups ( 29c, 17c, and 12c ) the level of significance was set at p  < 0.05 ; p  < \\n 0.05 ; p  < 0.01 ; p  < 0.001 ; p  < 0.0001. \\n m.z. was involved in design of the experiment and performed physiological and molecular phenotypes and participated in writing the manuscript ; p.k.- d. was involved in design and performed experiments concerning microbial profiling and transplant experiments and participated in writing the manuscript ; l.h.m. and m.s. \\n designed the initial hypothesis and participated in the design and the writing of the manuscript ; f.b. was involved in design and interpretation of experiments concerning microbial profiling and transplant experiments and participated in the design and the writing of the manuscript.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Write a summary of the article that captures the main ideas and significant details.',\n",
       "  'input': \"Summarize the following article: it has been well established that patients with end - stage renal disease ( esrd ) undergoing hemodialysis ( hd ) had a higher association of peripheral arterial disease ( pad ) , lower extremity amputation ( lea ) , and foot ulcerations ( fu ) [ 13 ] . such an association could be attributed to a common atherosclerotic cause . moreover , \\n diabetic patients with esrd had a 10-fold increased risk of lea in comparison to diabetes patients without renal insufficiency . \\n several studies have reported increased rates of lea among esrd patients , irrespective of the concomitant presence of diabetes mellitus ( dm ) [ 46 ] . \\n the mechanism of fu development is multifactorial which depends upon various physiological , mechanical , and treatment factors . \\n reported significantly higher incidence of foot complications in patients with concomitant esrd and dm in comparison to those who had only dm suggesting a possible relationship between esrd and fu . \\n in addition , lea and fu are well established complication of diabetic nephropathy [ 8 , 9 ] . \\n margolis et al .   observed a strong correlation between progressions of chronic kidney disease ( ckd ) with the development of diabetic fu . \\n game et al .   also demonstrated a close association of fu and amputations in diabetic patients started to undergo dialysis . \\n performed a meta - analysis to look for the relationship of diabetic fu with cardiovascular disease ( cvd ) and all - cause mortality . \\n the authors found an increased association of cvd and mortality in diabetic patients with fu in comparison to those without fu . \\n interestingly , a recent study advocated a higher incidence of risk factors ( pad and peripheral neuropathy ) for fu among hd patients . in qatar , an earlier report from our center identified a high incidence of pad in hd patients . \\n however , there is a lack of information that describes the risk factors and prognostic implications of fu among hd patients in the arab middle east . \\n we aim to evaluate this association and its impact on the outcomes over a 5-year period . \\n we conducted a retrospective analysis of all hemodialysis patients enrolled at the hd unit at hamad general hospital ( hgh ) , qatar , over five years ( 20072012 ) duration . \\n patients surviving for at least 3 months on the initial hd were included in the study . \\n hd patients were categorized into two groups according to whether they had foot ulcer ( fu ) or not ( no - fu ) based on physical examination . \\n the attending physician in the hd unit collected the data regarding the demographics characteristics , clinical evaluation , medical history , and comorbidities . during the follow - up period over 5 years , hd - related procedures such as vascular access ( arteriovenous fistula , arteriovenous grafting , and tunneled catheter ) , renal transplantation , and vascular complication were also reported . \\n the need for 3 vascular accesses ( due to mechanical obstruction , poor flow , or infection ) had been analyzed . \\n we speculated that hd patients with fu had poor outcomes compared to no - fu patients . \\n the study end - points ( major amputation , vascular complications , and mortality ) were also subanalyzed according to the presence or absence of dm and pad . \\n fu was defined according to the clinical findings as a full thickness skin break below the level of malleoli . \\n patients were considered to have pad if they had one of the following criteria : abi < 0.9 , history of intermittent claudication , vascular bypass or endovascular intervention for occlusive vascular disease , or amputation due to occlusive vascular disease . \\n major amputations were defined as amputations proximal to the ankle joint , and minor amputations were defined as those through or distal to the ankle joint . \\n diabetic nephropathy was diagnosed during patient follow - up in the nephrology out - patient clinic according to the patient chart . \\n it was defined as presence of macroalbuminuria that is a urinary albumin excretion of more than 300  mg in a 24-hour collection or macroalbuminuria and abnormal renal function as represented by an abnormality in serum creatinine , calculated creatinine clearance , or glomerular filtration rate . \\n analyses were conducted using the student 's t - test for continuous variables and pearson chi - square (  ) test for categorical variables . \\n multivariate logistic regression analysis was performed for predictors of development of fu and mortality . adjusted odds ratios ( or ) , 95% ci , and p values \\n a significant difference was considered when the two - tailed p value was < 0.05 . \\n data analysis was carried out using the statistical package for social sciences version 18 ( spss inc . , \\n the study has been approved by the medical research center , hamad medical corporation , qatar ( irb # 12007/12 ) . \\n a cohort of 252 hd patients was included in the study , of which 42 had fu ( 17% ) and 210 were without fu . \\n demographic , clinical characteristics , and risk factors for hd patients with and without fu were shown in table 1 and figure 1 . \\n patients with fu were 6 years older and had higher incidence of retinopathy ( 67% versus 40.5% ; p = 0.002 ) , polyvascular disease ( 26.2% versus 6.7% ; p = 0.001 ) , angina ( 24% versus 11% ; p = 0.02 ) , pad ( 71% versus 32% ; p = 0.001 ) , and nephropathy ( 79% versus 42% ; p = 0.001 ) compared to no - fu patients . \\n also , a high percent of patients needed tunneled catheters ( 88% versus 82% ; p = 0.03 ) and aspirin ( 62% versus 45% ; p = 0.04 ) in the fu group , whereas , history of renal transplant ( 14% versus 2.4% ; p = 0.03 ) was observed more in no - fu group . \\n patients in fu group also had higher percentage of dm ( 83.3% versus 56% ; p = 0.001 ) , major amputation ( 26% versus 1% ; p = 0.001 ) , need for 3 vascular accesses ( 69% versus 47% ; p = 0.01 ) , and coronary artery disease \\n the two groups were comparable regarding the mean baseline laboratory investigations ( table 2 ) . \\n similarly , the percentage of dyslipidemia , hypertension , smoking , and cerebral vascular accident ( cva ) was comparable between the two groups ( table 1 ) . \\n the types of hd vascular accesses such as arteriovenous fistulas , graft , or catheter were comparable in the 2 groups . \\n overall mortality rate within 3 years was 24.2% among the study cohort and was comparable between the two groups . \\n development of pad ( 71% versus 32% ; p = 0.001 ) , new foot ulcers ( 47.6% versus 2.4% ; p = 0.001 ) , and need for major amputation ( 16.7% versus 1% ; p = 0.001 ) were significantly higher among fu group as compared to no - fu group . in the following two years , \\n significantly more number of patients in fu group developed new pad ( 22% versus 1.4% ; p = 0.001 ) , underwent major amputation ( 22% versus 0% ; p = 0.001 ) , and died ( 70.4% versus 17.5% ; p = 0.001 ) in comparison to no - fu group ( table 1 ) . \\n the frequency of renal transplant and angina was comparable among both the groups , while cerebral vascular accident ( 3.5% ) was only observed in no - fu group . \\n figure 2 shows that dm patients had significantly higher incidence of fu ( 23% versus 7% ; p = 0.001 ) , need for major amputation ( 8.6% versus 0% ; p = 0.003 ) , and mortality ( 65% versus 23% ; p = 0.001 ) than non - dm patients . in dm group , \\n figure 3 demonstrates the outcomes in hd patients based on the presence / absence of dm and/or pad . \\n patients who had pad showed increased incidence of fu ( 41% versus 4% ; p = 0.001 ) , major amputation ( 14% versus 2% ; p = 0.02 ) , and mortality ( 80.5% versus 29% ; p = 0.001 ) than non - pad . on the other hand , among non - dm patients \\n of these patients , mortality rate was significantly higher among pad group ( 39% versus 13% ; p = 0.007 ) in comparison to non - pad . \\n univariate analysis ( figure 1 ) shows the mortality rate in patients with fu in both diabetic and nondiabetic patients . on multivariate analysis , after adjusting for dm , hba1c , age , and gender , the presence of pad was the major independent predictor of development of fu in hd patients with an adjusted odd ratio ( aor ) of 16.0 ( 95% confidence interval ( ci ) : 4.4162.18 , p = 0.001 ) followed by duration of hd with aor 1.14 ( 95% ci : 1.0051.299 , p = 0.042 ) . \\n furthermore , after adjusting for age , sex , and cad , predictors of mortality in hd patients were pad ( aor 4.1 ; 95% ci : 1.948.59 , p = 0.001 ) , fu ( aor 3.6 ; 95% ci : 1.2810.002 , p = 0.01 ) , and dm ( aor 2.7 , 95% ci : 1.235.89 , p = 0.01 ) ( figures 4 and 5 ) . \\n the present study highlights the frequency and implications of fu in patients undergoing maintenance hd over a 5-year duration . \\n the mortality rates were higher in patients with fu in both diabetic and nondiabetic patients ; however it was relatively higher in diabetic patients . \\n moreover , fu was associated with 4-fold increased risk of mortality after adjusting for age , sex , and cad . \\n presence of pad was associated with 16-fold increased risk of fu in hd after adjustment for age , sex , dm , and duration of hd . \\n patients in the fu group underwent higher number of repeated hd vascular accesses in comparison to non - fu group . \\n recent studies have identified an increased risk of fu and lea in ckd patients who did not receive renal replacement therapy [ 10 , 17 ] . \\n other studies investigated patients of combined dm with esrd and found a higher risk of fu in patients undergoing hd [ 11 , 15 ] . \\n a swedish study demonstrated a 2.45 times increased risk of lea in esrd patients compared to those without esrd . \\n similarly , prompers et al .   found the risk of nonhealing of fu to be 2.3-fold higher in esrd than in non - esrd patients . \\n the correlation between dialysis and foot complications among patients with dm and ckd has been initially described by mcgrath and curran . \\n they observed 50% mortality rate at one - year follow - up after lea . in our study , the rate of major amputation was significantly higher in fu patients which corroborates with an earlier study showing increased rate of amputation in ckd patients undergoing dialysis ( 57% ) as compared to those without dialysis ( 25% ) . \\n the relevance of selecting fu in our report is that it is potentially preventable , and its progression generally leads to serious foot complications , major amputation , and mortality . in their long - term follow - up study \\n ( 10 years ) , morbach and coworkers   concluded that patients with diabetic foot had high mortality particularly in the presence of pad or renal failure . in comparison to that study \\n , our 5-year study showed that fu patients had higher mortality ( 81% versus 70.4% ) although our patients were 6 years younger and less likely to have dm ( 83% versus 100% ) and pad ( 34% versus 55.5% ) . \\n moreover , the entire cohort of the present study was undergoing hd ( 100% versus 4% ) . \\n the association of severe complications in hd patients might be attributed to the cardiovascular risk factors . \\n several contributing factors have been proposed for the development of fu in patients with esrd and dm . \\n the important risk factors for the development of diabetic fu involve distal polyneuropathy , microangiopathy , and macroangiopathy . also , cardiovascular autonomic neuropathy is another coexisting complication of dm . \\n the authors found that pad is independently associated with esrd . according to one of our recent studies , \\n pad patients had 4- to 5-fold increased incidence of fu and lea in comparison to non - pad patients . in our study , \\n a higher incidence of retinopathy , polyvascular disease , angina , pad , and nephropathy was associated with fu . \\n studied the risk factors associated with prevalent fu in patients with dm and ckd ( predialysis versus on - dialysis ) . \\n the authors reported that dialysis therapy and previous fu were the only independent predictors of the development of new fu . \\n kaminski et al .   reported a high prevalence of risk factors for fu present in patients with esrd either with or without the coexistence of dm . \\n the authors did not indicate the severity of esrf or whether the patients were on dialysis or not . \\n .   found that dm , preexisting comorbidities , cvd , hd inadequacy , and lower serum albumin level are the major factors for lea . \\n consistent with our findings , a recent meta - analysis reported higher association of cvd , dm , and fu . ischemic in comparison to neuropathic ulcers are associated with higher mortality rate . moreover , \\n the marked inflammatory response during the process of ulceration has a significant role in the initiation and worsening of the atherosclerosis . in our study , among hd patients without diabetes , only 7% developed fu , despite a high prevalence of pad and cad . \\n wolf et al .   reported that the presence of dm in esrf patients increases the risk of lea 10 times in comparison to those who are diabetic without esrf . \\n moreover , during hd , around 4% of patients require an amputation each year [ 17 , 25 ] . \\n our subanalysis showed significantly higher incidence of fu , amputation , and mortality in diabetic patients than in non - dm patients . \\n also , patients with combined dm and pad revealed increased association of fu , amputation , and mortality . \\n our findings are supported by a large meta - analysis which showed that pad is independently associated with cvd and all - cause mortality . \\n further , the authors reported an increased risk of all - cause mortality in diabetic patients who developed fu than in diabetics without fu . \\n it is not possible to specify the extent of infection , neuropathy , ischemia , depth , or extent of tissue loss grade of fu . \\n another limitation is the additive effect of diabetes on hd patients who developed foot ulcers . \\n we did not know how many hd patients developed dm during the follow - up . in order to confirm our findings \\n , large sample - sized studies are needed to establish the implications of fu in hd patients . \\n abi < 9 was used as a part of the diagnosis of pad which may lead to underestimation of the disease . \\n previous data showed that as with low abi , high rates of mortality , vascular events , and amputation were reported in patients with high abi or noncompressible vessels . in a large study of patients with dm and cad , singh et al .   reported a high prevalence of arterial stiffness , similar to that seen in older individuals and dialysis patients . \\n ( 2014 ) defined pad as an abi < 0.9 or > 1.4 , these high abi values were observed in patients with diabetes , particularly for those with concomitant ckd . in conclusion , hemodialysis is a significant risk factor for fu which needs special attention . \\n further , pad is significantly associated with fu , amputation , and mortality in diabetic hd patients . \\n the increased risk of mortality could be explained by the greater burden of cvd in these patients . \\n therefore , hd patient needs intensive foot care to avoid complications of the lower limb and warrant progressive modification of cvd risk factors .\",\n",
       "  'output': 'foot ulceration ( fu ) remains a serious concern for patients worldwide . \\n we analyzed the incidence , risk factors , and outcome of fu in hemodialysis ( hd ) patients . \\n a retrospective cohort study was conducted for 252 hd patients who were followed up for 5 years . \\n patients were categorized according to whether they developed fu or not . \\n the fu group ( 17% ) was older and had significantly higher incidence of nephropathy , retinopathy , peripheral ( pad ) , coronary artery disease ( cad ) , and diabetes mellitus ( dm ) as compared to no - fu group . \\n fu group had higher frequency of major amputation ( p = 0.001 ) and hd vascular access ( p = 0.01 ) . \\n patients with combined dm and pad had a 10-fold increased risk of fu in comparison to those who had dm alone . \\n presence of pad was the main independent predictor for development of fu in hd with an adjusted odd ratio ( aor ) of 16.0 ( 95% ci : 4.4162.18 ; p = 0.001 ) . \\n after adjusting for age , sex , and cad , predictors for mortality were pad ( aor 4.3 ) , fu ( aor 3.6 ) , and dm ( aor 2.6 ) . \\n fu is common in hd patients regardless of dm . \\n however , the presence of pad is significantly associated with more fu and mortality in hd . \\n hd patients need intensive foot care and warrant progressive modification of vascular risk factors .',\n",
       "  '__index_level_0__': 31670,\n",
       "  'model_output': \"summarize the following article: it has been well established that patients with end - stage renal disease ( esrd ) undergoing hemodialysis ( hd ) had a higher association of peripheral arterial disease ( pad ), lower extremity amputation ( lea ), and foot ulcerations ( fu ) [ 13 ]. such an association could be attributed to a common atherosclerotic cause. moreover, \\n diabetic patients with esrd had a 10-fold increased risk of lea in comparison to diabetes patients without renal insufficiency. \\n several studies have reported increased rates of lea among esrd patients, irrespective of the concomitant presence of diabetes mellitus ( dm ) [ 46 ]. \\n the mechanism of fu development is multifactorial which depends upon various physiological, mechanical, and treatment factors. \\n reported significantly higher incidence of foot complications in patients with concomitant esrd and dm in comparison to those who had only dm suggesting a possible relationship between esrd and fu. \\n in addition, lea and fu are well established complication of diabetic nephropathy [ 8, 9 ]. \\n margolis et al.   observed a strong correlation between progressions of chronic kidney disease ( ckd ) with the development of diabetic fu. \\n game et al.   also demonstrated a close association of fu and amputations in diabetic patients started to undergo dialysis. \\n performed a meta - analysis to look for the relationship of diabetic fu with cardiovascular disease ( cvd ) and all - cause mortality. \\n the authors found an increased association of cvd and mortality in diabetic patients with fu in comparison to those without fu. \\n interestingly, a recent study advocated a higher incidence of risk factors ( pad and peripheral neuropathy ) for fu among hd patients. in qatar, an earlier report from our center identified a high incidence of pad in hd patients. \\n however, there is a lack of information that describes the risk factors and prognostic implications of fu among hd patients in the arab middle east. \\n we aim to evaluate this association and its impact on the outcomes over a 5-year period. \\n we conducted a retrospective analysis of all hemodialysis patients enrolled at the hd unit at hamad general hospital ( hgh ), qatar, over five years ( 20072012 ) duration. \\n patients surviving for at least 3 months on the initial hd were included in the study. \\n hd patients were categorized into two groups according to whether they had foot ulcer ( fu ) or not ( no - fu ) based on physical examination. \\n the attending physician in the hd unit collected the data regarding the demographics characteristics, clinical evaluation, medical history, and comorbidities. during the follow - up period over 5 years, hd - related procedures such as vascular access ( arteriovenous fistula, arteriovenous grafting, and tunneled catheter ), renal transplantation, and vascular complication were also reported. \\n the need for 3 vascular accesses ( due to mechanical obstruction, poor flow, or infection ) had been analyzed. \\n we speculated that hd patients with fu had poor outcomes compared to no - fu patients. \\n the study end - points ( major amputation, vascular complications, and mortality ) were also subanalyzed according to the presence or absence of dm and pad. \\n fu was defined according to the clinical findings as a full thickness skin break below the level of malleoli. \\n patients were considered to have pad if they had one of the following criteria : abi < 0.9, history of intermittent claudication, vascular bypass or endovascular intervention for occlusive vascular disease, or amputation due to occlusive vascular disease. \\n major amputations were defined as amputations proximal to the ankle joint, and minor amputations were defined as those through or distal to the ankle joint. \\n diabetic nephropathy was diagnosed during patient follow - up in the nephrology out - patient clinic according to the patient chart. \\n it was defined as presence of macroalbuminuria that is a urinary albumin excretion of more than 300  mg in a 24-hour collection or macroalbuminuria and abnormal renal function as represented by an abnormality in serum creatinine, calculated creatinine clearance, or glomerular filtration rate. \\n analyses were conducted using the student's t - test for continuous variables and pearson chi - square (  ) test for categorical variables. \\n multivariate logistic regression analysis was performed for predictors of development of fu and mortality. adjusted odds ratios ( or ), 95% ci, and p values \\n a significant difference was considered when the two - tailed p value was < 0.05. \\n data analysis was carried out using the statistical package for social sciences version 18 ( spss inc., \\n the study has been approved by the medical research center, hamad medical corporation, qatar ( irb # 12007/12 ). \\n a cohort of 252 hd patients was included in the study, of which 42 had fu ( 17% ) and 210 were without fu. \\n demographic, clinical characteristics, and risk factors for hd patients with and without fu were shown in table 1 and figure 1. \\n patients with fu were 6 years older and had higher incidence of retinopathy ( 67% versus 40.5% ; p = 0.002 ), polyvascular disease ( 26.2% versus 6.7% ; p = 0.001 ), angina ( 24% versus 11% ; p = 0.02 ), pad ( 71% versus 32% ; p = 0.001 ), and nephropathy ( 79% versus 42% ; p = 0.001 ) compared to no - fu patients. \\n also, a high percent of patients needed tunneled catheters ( 88% versus 82% ; p = 0.03 ) and aspirin ( 62% versus 45% ; p = 0.04 ) in the fu group, whereas, history of renal transplant ( 14% versus 2.4% ; p = 0.03 ) was observed more in no - fu group. \\n patients in fu group also had higher percentage of dm ( 83.3% versus 56% ; p = 0.001 ), major amputation ( 26% versus 1% ; p = 0.001 ), need for 3 vascular accesses ( 69% versus 47% ; p = 0.01 ), and coronary artery disease \\n the two groups were comparable regarding the mean baseline laboratory investigations ( table 2 ). \\n similarly, the percentage of dyslipidemia, hypertension, smoking, and cerebral vascular accident ( cva ) was comparable between the two groups ( table 1 ). \\n the types of hd vascular accesses such as arteriovenous fistulas, graft, or catheter were comparable in the 2 groups. \\n overall mortality rate within 3 years was 24.2% among the study cohort and was comparable between the two groups. \\n development of pad ( 71% versus 32% ; p = 0.001 ), new foot ulcers ( 47.6% versus 2.4% ; p = 0.001 ), and need for major amputation ( 16.7% versus 1% ; p = 0.001 ) were significantly higher among fu group as compared to no - fu group. in the following two years, \\n significantly more number of patients in fu group developed new pad ( 22% versus 1.4% ; p = 0.001 ), underwent major amputation ( 22% versus 0% ; p = 0.001 ), and died ( 70.4% versus 17.5% ; p = 0.001 ) in comparison to no - fu group ( table 1 ). \\n the frequency of renal transplant and angina was comparable among both the groups, while cerebral vascular accident ( 3.5% ) was only observed in no - fu group. \\n figure 2 shows that dm patients had significantly higher incidence of fu ( 23% versus 7% ; p = 0.001 ), need for major amputation ( 8.6% versus 0% ; p = 0.003 ), and mortality ( 65% versus 23% ; p = 0.001 ) than non - dm patients. in dm group, \\n figure 3 demonstrates the outcomes in hd patients based on the presence / absence of dm and/or pad. \\n patients who had pad showed increased incidence of fu ( 41% versus 4% ; p = 0.001 ), major amputation ( 14% versus 2% ; p = 0.02 ), and mortality ( 80.5% versus 29% ; p = 0.001 ) than non - pad. on the other hand, among non - dm patients \\n of these patients, mortality rate was significantly higher among pad group ( 39% versus 13% ; p = 0.007 ) in comparison to non - pad. \\n univariate analysis ( figure 1 ) shows the mortality rate in patients with fu in both diabetic and nondiabetic patients. on multivariate analysis, after adjusting for dm, hba1c, age, and gender, the presence of pad was the major independent predictor of development of fu in hd patients with an adjusted odd ratio ( aor ) of 16.0 ( 95% confidence interval ( ci ) : 4.4162.18, p = 0.001 ) followed by duration of hd with aor 1.14 ( 95% ci : 1.0051.299, p = 0.042 ). \\n furthermore, after adjusting for age, sex, and cad, predictors of mortality in hd patients were pad ( aor 4.1 ; 95% ci : 1.948.59, p = 0.001 ), fu ( aor 3.6 ; 95% ci : 1.2810.002, p = 0.01 ), and dm ( aor 2.7, 95% ci : 1.235.89, p = 0.01 ) ( figures 4 and 5 ). \\n the present study highlights the frequency and implications of fu in patients undergoing maintenance hd over a 5-year duration. \\n the mortality rates were higher in patients with fu in both diabetic and nondiabetic patients ; however it was relatively higher in diabetic patients. \\n moreover, fu was associated with 4-fold increased risk of mortality after adjusting for age, sex, and cad. \\n presence of pad was associated with 16-fold increased risk of fu in hd after adjustment for age, sex, dm, and duration of hd. \\n patients in the fu group underwent higher number of repeated hd vascular accesses in comparison to non - fu group. \\n recent studies have identified an increased risk of fu and lea in ckd patients who did not receive renal replacement therapy [ 10, 17 ]. \\n other studies investigated patients of combined dm with esrd and found a higher risk of fu in patients undergoing hd [ 11, 15 ]. \\n a swedish study demonstrated a 2.45 times increased risk of lea in esrd patients compared to those without esrd. \\n similarly, prompers et al.   found the risk of nonhealing of fu to be 2.3-fold higher in esrd than in non - esrd patients. \\n the correlation between dialysis and foot complications among patients with dm and ckd has been initially described by mcgrath and curran. \\n they observed 50% mortality rate at one - year follow - up after lea. in our study, the rate of major amputation was significantly higher in fu patients which corroborates with an earlier study showing increased rate of amputation in ckd patients undergoing dialysis ( 57% ) as compared to those without dialysis ( 25% ). \\n the relevance of selecting fu in our report is that it is potentially preventable, and its progression generally leads to serious foot complications, major amputation, and mortality. in their long - term follow - up study \\n ( 10 years ), morbach and coworkers   concluded that patients with diabetic foot had high mortality particularly in the presence of pad or renal failure. in comparison to that study \\n, our 5-year study showed that fu patients had higher mortality ( 81% versus 70.4% ) although our patients were 6 years younger and less likely to have dm ( 83% versus 100% ) and pad ( 34% versus 55.5% ). \\n moreover, the entire cohort of the present study was undergoing hd ( 100% versus 4% ). \\n the association of severe complications in hd patients might be attributed to the cardiovascular risk factors. \\n several contributing factors have been proposed for the development of fu in patients with esrd and dm. \\n the important risk factors for the development of diabetic fu involve distal polyneuropathy, microangiopathy, and macroangiopathy. also, cardiovascular autonomic neuropathy is another coexisting complication of dm. \\n the authors found that pad is independently associated with esrd. according to one of our recent studies, \\n pad patients had 4- to 5-fold increased incidence of fu and lea in comparison to non - pad patients. in our study, \\n a higher incidence of retinopathy, polyvascular disease, angina, pad, and nephropathy was associated with fu. \\n studied the risk factors associated with prevalent fu in patients with dm and ckd ( predialysis versus on - dialysis ). \\n the authors reported that dialysis therapy and previous fu were the only independent predictors of the development of new fu. \\n kaminski et al.   reported a high prevalence of risk factors for fu present in patients with esrd either with or without the coexistence of dm. \\n the authors did not indicate the severity of esrf or whether the patients were on dialysis or not. \\n.   found that dm, preexisting comorbidities, cvd, hd inadequacy, and lower serum albumin level are the major factors for lea. \\n consistent with our findings, a recent meta - analysis reported higher association of cvd, dm, and fu. ischemic in comparison to neuropathic ulcers are associated with higher mortality rate. moreover, \\n the marked inflammatory response during the process of ulceration has a significant role in the initiation and worsening of the atherosclerosis. in our study, among hd patients without diabetes, only 7% developed fu, despite a high prevalence of pad and cad. \\n wolf et al.   reported that the presence of dm in esrf patients increases the risk of lea 10 times in comparison to those who are diabetic without esrf. \\n moreover, during hd, around 4% of patients require an amputation each year [ 17, 25 ]. \\n our subanalysis showed significantly higher incidence of fu, amputation, and mortality in diabetic patients than in non - dm patients. \\n also, patients with combined dm and pad revealed increased association of fu, amputation, and mortality. \\n our findings are supported by a large meta - analysis which showed that pad is independently associated with cvd and all - cause mortality. \\n further, the authors reported an increased risk of all - cause mortality in diabetic patients who developed fu than in diabetics without fu. \\n it is not possible to specify the extent of infection, neuropathy, ischemia, depth, or extent of tissue loss grade of fu. \\n another limitation is the additive effect of diabetes on hd patients who developed foot ulcers. \\n we did not know how many hd patients developed dm during the follow - up. in order to confirm our findings \\n, large sample - sized studies are needed to establish the implications of fu in hd patients. \\n abi < 9 was used as a part of the diagnosis of pad which may lead to underestimation of the disease. \\n previous data showed that as with low abi, high rates of mortality, vascular events, and amputation were reported in patients with high abi or noncompressible vessels. in a large study of patients with dm and cad, singh et al.   reported a high prevalence of arterial stiffness, similar to that seen in older individuals and dialysis patients. \\n ( 2014 ) defined pad as an abi < 0.9 or > 1.4, these high abi values were observed in patients with diabetes, particularly for those with concomitant ckd. in conclusion, hemodialysis is a significant risk factor for fu which needs special attention. \\n further, pad is significantly associated with fu, amputation, and mortality in diabetic hd patients. \\n the increased risk of mortality could be explained by the greater burden of cvd in these patients. \\n therefore, hd patient needs intensive foot care to avoid complications of the lower limb and warrant progressive modification of cvd risk factors.\"},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Write a summary of the article that captures the main ideas and significant details.',\n",
       "  'input': 'Summarize the following article: dietary sugar intake , in the form of sucrose or high - fructose corn syrup ( hfcs ) , has dramatically increased and correlates with a rise in obesity , metabolic syndrome , and diabetes . \\n because a broad range of physiological , behavioural , and neurological variables influences food choices and eating behaviour , it is difficult to understand the mechanisms of eating behaviour and their alterations . \\n the hedonic value of highly palatable foods and their wide availability can override the physiological mechanisms related to energy homeostasis [ 2 , 3 ] . \\n the hedonic reward value of food is closely linked to the sensory perception of food ( including food taste , odour , and texture ) and refers to the driving force behind the motivation to eat . \\n the nutrient detection by the gut is mainly controlled by enteroendocrine ( ee ) cells and might activate a cascade of physiological phenomena , including endocrine regulations ( e.g. insulin , leptin , glucagon - like peptide-1 or glp-1 , secretion ) , inhibition of gastric emptying , inhibition of food intake , stimulation of intake   as well as psychobehavioural responses . \\n dietary sugar overconsumption might provoke deleterious effects at both central and peripheral levels , including alterations in ( i ) the regulation of secretion of satiety peptides and neuropeptides [ 7 , 8 ] ; ( ii ) gut permeability leading to low - grade inflammation and liver disease ; ( iii ) blood  brain barrier ( bbb ) permeability ; ( iv ) the endocannabinoid , opioid , and mesolimbic dopaminergic systems , as well as ( v ) brain structures involved in reward processing . \\n both drugs and food have powerful reinforcing effects partly mediated by dopamine increases in the limbic system that , under certain circumstances or in vulnerable individuals , could overwhelm the brain s homeostatic control mechanisms , but the plausibility of sugar addiction and its role in obesity and eating disorders in humans is still a subject of controversy . \\n much of the research on the effects of dietary sugars on health has recently focused on fructose , given the striking parallel increases in obesity and in fructose intake over the past decades . \\n these studies have found important fructose - induced health disturbances that are different from those provoked by glucose or sucrose . \\n most of fructose intake in diets originates from sucrose ( containing 50  % fructose and 50  % glucose ) and soft drinks containing high - fructose corn syrup ( hfcs ) ( range 4765  % fructose , and 5335  % glucose ) . \\n an estimate of the consumption of hfcs from beverages indicates a daily range between 132 and 316  kcal for americans aged over 2  years , and patients with non - alcoholic fatty liver disease ( nafld ) consume twofold more calories from hfcs from beverages than healthy patients ( 365 vs. 170  kcal / day ) . in the united states , average fructose consumption from sugar - sweetened beverages has increased from 37 to 49  g / day during the last 30  years ( + 0.4  % per year ) . \\n thus , it is not clear whether the fructose - induced metabolic disturbances observed in human and animal studies are due to fructose itself or the associated increase in energy intake . \\n moreover , since fructose and glucose intake may vary simultaneously , this raises the consideration that other dietary sugars ( e.g. sucrose and glucose ) might also contribute to the development of obesity and associated co - morbidities . \\n in fact , there are controversial findings on metabolic effects between the different sugars ( i.e. glucose , fructose , and sucrose ) . \\n while some studies have disclosed significant differences between these sugars , other studies have found small or no difference . \\n for example , in overweight or obese humans , intake of a fructose - sweetened beverage led to a significant increase in visceral adipose tissue , hepatic de novo lipogenesis , and postprandial triglycerides compared to subjects offered a glucose - sweetened beverage . in lean and obese subjects , de novo lipogenesis increased to the same extent after overfeeding with glucose and sucrose . \\n both high - glucose and high - fructose diets stimulated lipogenic gene expression in rodents . \\n most of the studies on the effects of sugars on health and disease , at both peripheral and central levels , have been performed in rodents , and studies are missing in humans or other animal models closer to humans , such as the pig model . \\n given that human studies are limited due to ethical considerations , future studies should privilege the use of animal models that closely resembles humans . \\n on the other hand , there is an impressive number of studies available concerning the effects of dietary sugars , using different experimental paradigms , with different approaches , animal models , oral intake doses , in the form of sugar solutions or added in the diet , or peripheral or central administrations . \\n therefore , it becomes extremely difficult to interpret and find a definite conclusion on these effects . in this context , we considered essential to gather all the information available to give a global view of the current research in this domain , in order to highlight the need to reformulate the questions and approach to these questions , under similar conditions between studies , and using integrated approaches , from the molecular to the behavioural level . \\n the main goal of this review was to provide an overview of the impact of different dietary sugars on peripheral and central functions . it will gather ( i ) results from studies regarding the effects of sucrose , glucose , and/or fructose on metabolism , eating behaviour , and brain responses ; ( ii ) current available data comparing the effects of these sugars , at both peripheral and central levels . \\n it will also propose some clues and hypotheses for future research perspectives regarding the effects of these sugars , with special focus on fructose and glucose . \\n even though this review synthetises data from different animal models and humans , we wanted to dedicate a short section to the presentation of the pig model , which is of particular interest in nutrition and neurosciences . \\n pigs have emerged as an ideal model for nutritional and biomedical research because of their anatomical and physiological similarities to humans [ 2022 ] , as well as blood chemical and biochemical characteristics , plasma hormone levels , and energy metabolism . \\n pigs are able to distinguish the palatability of different diets , and they have a high innate preference for sweet taste   and a strong appetite for sugar solutions . \\n the digestive system of pigs has anatomical differences with that of humans ; however , the physiology of digestion is essentially similar . \\n the pig has been used extensively as a model of digestion in connection with nutrition ( and determination of food value ) of the pig and for studying human digestive phenomena . \\n the metabolic functions , intestinal transit times , and characteristics of nutrients absorption have made them useful in basic nutritional research . \\n other specific functional characteristics of swine that relate directly to humans include ion transport and motility , neonatal development of the gastrointestinal tract , and splanchnic blood flow characteristics . like humans , \\n these physiological characteristics of the gastrointestinal tract are probably due to the omnivorous diet they consume , unlike that of carnivores , ruminants , rabbits , and rodents . \\n similar to carbohydrate ( sucrose and starch ) digestion in humans , it was shown in non - anaesthetised mature pigs following the intake of different sugar - containing meals ( with glucose , sucrose , lactose , or maize starch ) that the absorption pattern was different for each sugar . \\n the kinetics of appearance of glucose and of sucrose hydrolysis products in the portal blood were faster for glucose and sucrose than for sugars resulting from maize starch hydrolysis . \\n recent studies have shown the convenience for the use of pig model in brain imaging , behavioural , and physiological effects of obesity induced by highly palatable diets [ 20 , 22 , 28 , 29 ] . compared to the rodent brain \\n , the pig brain more closely resembles the human brain in terms of anatomy and biochemistry , which associates the pig with a higher translational value . \\n several brain disorders have been fully or partially modelled in the pig , and this has further spurred an interest in having access to behavioural tasks for pigs and in particular to cognitive tasks . \\n cognitive testing of pigs has been conducted for several years in animal science , but it has only recently received interest in the wider neuroscience community . \\n several behavioural tasks have successfully been adapted to the pig , and valuable results have been produced . \\n aside of having similar brain structures to humans , the pig might develop metabolic disorders observed in humans ( excessive fat deposition , diabetes , atherosclerosis , hypertension ) . \\n taken together , these data position the pig model as a valuable model for biomedical studies in nutrition and neuroscience \\n . therefore , future studies on the effects of dietary sugars on health and disease should favour the use of the pig model in order to extrapolate data to humans and propose modifications in the nutritional recommendations for humans . \\n gut microbiota operates like a metabolic organ , influencing nutrient availability and uptake , energy homeostasis , and the control of body weight . \\n diet composition may strongly influence changes in the microbiota , which in turn , when subjected to deleterious nutritional environment , might affect intestinal permeability and result in low - grade inflammation , obesity , and associated chronic metabolic diseases such as nafld , dyslipidaemia , and insulin resistance [ 9 , 32 ] . \\n increases in gut permeability , low - grade endotoxemia ( provoked by increased plasma lipopolysaccharides  lps ) , and hepatic lipid accumulation have been reported in animal models of obesity induced by high - fat or high - fructose diets . \\n a high - fructose diet has been associated with hepatic and extra - hepatic insulin resistance and obesity - related metabolic disturbances through a mechanism implicating gut microbiota and its effects on intestinal permeability . \\n the hepatic manifestation of the metabolic syndrome is nafld , starting from simple steatosis and ending as liver cirrhosis . \\n dietary sugar intake might participate to nafld pathogenic history , and the type of sugar ( e.g. fructose ) may affect the development of the disease . \\n consistent evidence has demonstrated the implication of fructose or hfcs in the development of nafld in several animal models [ 17 , 3338 ] . \\n the effects of dietary sugars , especially fructose , on the development of hepatic steatosis , liver damage , and other features of the metabolic syndrome found in several animal models are presented in table  1.table  1effects of dietary sugars intake on hepatic steatosis , liver damage , and various features of the metabolic syndrome in several animal models and in humansdietary interventiondurationhepatic steatosis / liver injuryplasma or hepatic measurementsother effectsmodelanimal studies20  % hfcs in maternal diet20  % hfcs  +  msg9  monthshepatic steatosis hepatic and serum tg , serum ffa srebf2 expressionc57bl/6  j micecollison high - fat / high - fructose diet:(a ) 8  % trans - fat , 20  % hfcs ( b ) trans - fat ( 8  % ) , hfcs   ( 20  % ) , 1  % msg9  months alp , alt serum creatinine , cortisol serum leptin and fasting insulindomestic cat ( male , n  =  18)collison ( a ) trans - fat ( 9  % ) + hfcs ( 24  % ) ( b ) trans - fat ( 9  % ) , hfcs ( 24  % ) , 1  % msg9  monthsfibrous expansion markers of hepatic fibrosis , angiogenesis , hepatocellular carcinoma alp and altcreatinine and cortisol ( a)domestic cat ( male , n  =  18)collison 30  % glucose solution30  % fructose solution8  weekslipid accumulation endotoxin levels in portal bloodtnf higher with fructose than glucoseantibiotics prevented some effects of fructosec57bl / j6 micebergheim \\n fructose  +  antibiotics \\n 30  % fructose solution ( f)tap water ( c)30  % fructose solution  +  antibiotics polymyxin b and neomycin ( ab)8  weekshepatic fat accumulation and tnf and inos mrna expression in liver with f suppressed by ab endotoxin tlr4 receptors , suppressed by ab tight junction occludin in duodenum ( f)c57bl / j6 micewagnerberger 30  % fructose solution8  weeksinduction of hepatic steatosis and inflammation alt levels hepatic lipidperoxidation , phospho- , nf- b and tnfc57bl / j6 micespruss fructose group : 10.5  % fat 20  % fructoseatherogenic diet : 20  % fructose 46  % fat , 2  % cholesterol , 0.7  % choline24  weeksfructose diet : normal liver histologyatherogenic diet : abnormal liver histology with microvesicular steatosis and fatty kupffer cells but not fibrosisfructose group :  body weight , hypertension , and insulin resistanceatherogenic diet : metabolic syndromeosabaw minipiglee standard chow diet : ( s)41  % starch , 5  % sugar , 4.5  % fat , iron ( 120  mg / kg)fructose - enriched diet ( f ) 60  % fructose , 5  % fat  +  iron ( 5  mg / kg)5  weeks  f : higher liver lipids , tg , and cholesterol than s group  mild - to - moderate deposition of macrovesicular and microvesicular fat  similar hepatic iron concentration in both groupsf :  tg , insulin , homa scoref :  blood pressuresprague  dawley rats n  =  49ackerman dietary interventiondurationhepatic steatosis / liver injuryplasma or hepatic measurementsother effectsrecruitment criteriahuman studiesusual ad libitum diet + fructose ( n  =  16 ) or glucose ( n  =  15 ) sweetened beverages at 25  % of energy requirements10  weeksnot investigatedfructose group :  fasting plasma mcp-1 , pai-1 , and e - selectin  postprandial pai-1bmi : 2535  kg / m \\n healthy,4072  yearcox usual ad libitum diet  +  fructose ( n  =  17 ) or glucose ( n  =  15 ) sweetened beverages at 25  % of energy requirements10 \\n weeks fractional hepatic de novo lipogenesis only in fructose groupfructose group :   plasma lipid and lipoprotein   postprandial tg , lipoproteins , and ldl cholesterolglucose group :   fasting tg and ffa in glucose group   postprandial lipoprotein lipase activity body weight , fat mass in both groups abdominal and visceral adipose tissue only in fructose group insulin sensitivity only in fructose groupbmi : 2535  kg / m \\n healthy , 4072  yearstanhope \\n hfcs high - fructose corn syrup , tg triglycerides , srebf2 sterol regulatory element - binding transcription factor 2 , alp alkaline phosphatase , alt alanine aminotransferase , tnf tumour necrosis factor alpha , inos inducible nitric oxide synthase , ab antibiotics , nf-  nuclear factor  , tlr toll - like receptors , homa homeostatic model assessment , mcp-1 monocyte chemoattractant protein 1 , pai-1 plasminogen activator inhibitor type 1 , ffa free fatty acids effects of dietary sugars intake on hepatic steatosis , liver damage , and various features of the metabolic syndrome in several animal models and in humans \\n hfcs high - fructose corn syrup , tg triglycerides , srebf2 sterol regulatory element - binding transcription factor 2 , alp alkaline phosphatase , alt alanine aminotransferase , tnf tumour necrosis factor alpha , inos inducible nitric oxide synthase , ab antibiotics , nf-  nuclear factor  , tlr toll - like receptors , homa homeostatic model assessment , mcp-1 monocyte chemoattractant protein 1 , pai-1 plasminogen activator inhibitor type 1 , ffa free fatty acids it seems that hfcs or fructose exposure is able to induce hepatic steatosis , liver dysfunction , hepatic fibrosis as well as several features of the metabolic syndrome and inflammation in rodents and cats ( e.g. [ 3944 ] ) . \\n however , in other species such as pigs or in humans , this concept remains incompletely clear . \\n data obtained from humans   and osabaw minipigs   suggested that it is the association between high - fructose intake with other components in the diet , such as glucose , sucrose , fat , and cholesterol , responsible for the development of the metabolic syndrome and liver steatosis , rather than high - fructose intake itself . \\n the approach used in several human studies where fructose daily intake pattern is assessed in patients with previously established hepatic steatosis [ 33 , 46 , 47 ] is not the best way to evaluate fructose as a risk factor for nafld . \\n this question should be addressed in a more controlled experimental paradigm where dietary intake is closely monitored . to our knowledge , \\n one of the few human studies that has assessed the effect of glucose- or fructose - sweetened beverages on the development of hepatic de novo lipogenesis under controlled conditions is the one performed by stanhope et al . . \\n however , this study did not confirm the presence of hepatic steatosis using standard diagnostic methods such as mri , ct scan , or liver biopsy . \\n thus , studies in humans are needed to investigate the effects of dietary sugars on the development of hepatic steatosis under controlled experimental conditions . taken together , studies with rodents and cats suggest that fructose induces liver damage , in part through mechanisms involving intestinal bacterial overgrowth , increased intestinal permeability , inflammation , and metabolic endotoxemia \\n . however , underlying mechanisms explaining how fructose leads to bacterial overgrowth , inflammation , and increases in intestinal permeability remain poorly understood . \\n since it is difficult to achieve controlled experimental conditions in humans , for ethical reasons , studies in animal models closer to humans , e.g. pigs [ 20 , 28 , 31 ] , are a valuable approach that allows close monitoring of dietary interventions . \\n if similar mechanisms occur in humans and pigs , novel strategies including low - fructose diets might be considered for the prevention / management of nafld . \\n however , there seems to be substantial differences between rodents or cats and humans or pig studies . \\n thus , in the absence of clear evidence for a detrimental role for fructose , there is no justification for replacing it with other dietary sugars such as glucose or sucrose in human diets for the prevention of hepatic steatosis . \\n the hepatic manifestation of the metabolic syndrome is nafld , starting from simple steatosis and ending as liver cirrhosis . \\n dietary sugar intake might participate to nafld pathogenic history , and the type of sugar ( e.g. fructose ) may affect the development of the disease . \\n consistent evidence has demonstrated the implication of fructose or hfcs in the development of nafld in several animal models [ 17 , 3338 ] . \\n the effects of dietary sugars , especially fructose , on the development of hepatic steatosis , liver damage , and other features of the metabolic syndrome found in several animal models are presented in table  1.table  1effects of dietary sugars intake on hepatic steatosis , liver damage , and various features of the metabolic syndrome in several animal models and in humansdietary interventiondurationhepatic steatosis / liver injuryplasma or hepatic measurementsother effectsmodelanimal studies20  % hfcs in maternal diet20  % hfcs  +  msg9  monthshepatic steatosis hepatic and serum tg , serum ffa srebf2 expressionc57bl/6  j micecollison high - fat / high - fructose diet:(a ) 8  % trans - fat , 20  % hfcs ( b ) trans - fat ( 8  % ) , hfcs   ( 20  % ) , 1  % msg9  months alp , alt serum creatinine , cortisol serum leptin and fasting insulindomestic cat ( male , n  =  18)collison ( a ) trans - fat ( 9  % ) + hfcs ( 24  % ) ( b ) trans - fat ( 9  % ) , hfcs ( 24  % ) , 1  % msg9  monthsfibrous expansion markers of hepatic fibrosis , angiogenesis , hepatocellular carcinoma alp and altcreatinine and cortisol ( a)domestic cat ( male , n  =  18)collison 30  % glucose solution30  % fructose solution8  weekslipid accumulation endotoxin levels in portal bloodtnf higher with fructose than glucoseantibiotics prevented some effects of fructosec57bl / j6 micebergheim \\n fructose  +  antibiotics \\n 30  % fructose solution ( f)tap water ( c)30  % fructose solution  +  antibiotics polymyxin b and neomycin ( ab)8  weekshepatic fat accumulation and tnf and inos mrna expression in liver with f suppressed by ab endotoxin tlr4 receptors , suppressed by ab tight junction occludin in duodenum ( f)c57bl / j6 micewagnerberger 30  % fructose solution8  weeksinduction of hepatic steatosis and inflammation alt levels hepatic lipidperoxidation , phospho- , nf- b and tnfc57bl / j6 micespruss fructose group : 10.5  % fat 20  % fructoseatherogenic diet : 20  % fructose 46  % fat , 2  % cholesterol , 0.7  % choline24  weeksfructose diet : normal liver histologyatherogenic diet : abnormal liver histology with microvesicular steatosis and fatty kupffer cells but not fibrosisfructose group :  body weight , hypertension , and insulin resistanceatherogenic diet : metabolic syndromeosabaw minipiglee standard chow diet : ( s)41  % starch , 5  % sugar , 4.5  % fat , iron ( 120  mg / kg)fructose - enriched diet ( f ) 60  % fructose , 5  % fat  +  iron ( 5  mg / kg)5  weeks  f : higher liver lipids , tg , and cholesterol than s group  mild - to - moderate deposition of macrovesicular and microvesicular fat  similar hepatic iron concentration in both groupsf :  tg , insulin , homa scoref :  blood pressuresprague \\n dawley rats n  =  49ackerman dietary interventiondurationhepatic steatosis / liver injuryplasma or hepatic measurementsother effectsrecruitment criteriahuman studiesusual ad libitum diet + fructose ( n  =  16 ) or glucose ( n  =  15 ) sweetened beverages at 25  % of energy requirements10  weeksnot investigatedfructose group :  fasting plasma mcp-1 , pai-1 , and e - selectin  postprandial pai-1bmi : 2535  kg / m \\n healthy,4072  yearcox usual ad libitum diet  +  fructose ( n  =  17 ) or glucose ( n  =  15 ) sweetened beverages at 25  % of energy requirements10 \\n weeks fractional hepatic de novo lipogenesis only in fructose groupfructose group :   plasma lipid and lipoprotein   postprandial tg , lipoproteins , and ldl cholesterolglucose group :   fasting tg and ffa in glucose group   postprandial lipoprotein lipase activity body weight , fat mass in both groups abdominal and visceral adipose tissue only in fructose group insulin sensitivity only in fructose groupbmi : 2535  kg / m \\n healthy , 4072  yearstanhope \\n hfcs high - fructose corn syrup , tg triglycerides , srebf2 sterol regulatory element - binding transcription factor 2 , alp alkaline phosphatase , alt alanine aminotransferase , tnf tumour necrosis factor alpha , inos inducible nitric oxide synthase , ab antibiotics , nf-  nuclear factor  , tlr toll - like receptors , homa homeostatic model assessment , mcp-1 monocyte chemoattractant protein 1 , pai-1 plasminogen activator inhibitor type 1 , ffa free fatty acids effects of dietary sugars intake on hepatic steatosis , liver damage , and various features of the metabolic syndrome in several animal models and in humans \\n hfcs high - fructose corn syrup , tg triglycerides , srebf2 sterol regulatory element - binding transcription factor 2 , alp alkaline phosphatase , alt alanine aminotransferase , tnf tumour necrosis factor alpha , inos inducible nitric oxide synthase , ab antibiotics , nf-  nuclear factor  , tlr toll - like receptors , homa homeostatic model assessment , mcp-1 monocyte chemoattractant protein 1 , pai-1 plasminogen activator inhibitor type 1 , ffa free fatty acids it seems that hfcs or fructose exposure is able to induce hepatic steatosis , liver dysfunction , hepatic fibrosis as well as several features of the metabolic syndrome and inflammation in rodents and cats ( e.g. [ 3944 ] ) . \\n however , in other species such as pigs or in humans , this concept remains incompletely clear . \\n data obtained from humans   and osabaw minipigs   suggested that it is the association between high - fructose intake with other components in the diet , such as glucose , sucrose , fat , and cholesterol , responsible for the development of the metabolic syndrome and liver steatosis , rather than high - fructose intake itself . \\n the approach used in several human studies where fructose daily intake pattern is assessed in patients with previously established hepatic steatosis [ 33 , 46 , 47 ] is not the best way to evaluate fructose as a risk factor for nafld . \\n this question should be addressed in a more controlled experimental paradigm where dietary intake is closely monitored . to our knowledge , \\n one of the few human studies that has assessed the effect of glucose- or fructose - sweetened beverages on the development of hepatic de novo lipogenesis under controlled conditions is the one performed by stanhope et al . . \\n however , this study did not confirm the presence of hepatic steatosis using standard diagnostic methods such as mri , ct scan , or liver biopsy . \\n thus , studies in humans are needed to investigate the effects of dietary sugars on the development of hepatic steatosis under controlled experimental conditions . taken together , studies with rodents and cats suggest that fructose induces liver damage , in part through mechanisms involving intestinal bacterial overgrowth , increased intestinal permeability , inflammation , and metabolic endotoxemia . however , \\n underlying mechanisms explaining how fructose leads to bacterial overgrowth , inflammation , and increases in intestinal permeability remain poorly understood . \\n since it is difficult to achieve controlled experimental conditions in humans , for ethical reasons , studies in animal models closer to humans , e.g. pigs [ 20 , 28 , 31 ] , are a valuable approach that allows close monitoring of dietary interventions . \\n if similar mechanisms occur in humans and pigs , novel strategies including low - fructose diets might be considered for the prevention / management of nafld . \\n however , there seems to be substantial differences between rodents or cats and humans or pig studies . \\n thus , in the absence of clear evidence for a detrimental role for fructose , there is no justification for replacing it with other dietary sugars such as glucose or sucrose in human diets for the prevention of hepatic steatosis . \\n the regulation of food intake and energy homeostasis is achieved by a complex network communication between the periphery ( e.g. gut , liver , stomach , pancreas , and adipose tissue ) and the brain . \\n the different molecular structures of dietary sugars might result in different gastrointestinal peptide secretion profiles , leading to different metabolic and endocrine effects at both peripheral ( e.g. gut and liver ) and central ( e.g. hypothalamus ) levels [ 5254 ] . \\n it has been shown that fructose , compared to glucose intake , produces smaller increases in plasma glucose and circulating satiety hormones , i.e. insulin , leptin , glucagon - like peptide-1 ( glp-1 ) , peptide tyrosine tyrosine ( pyy ) , and attenuates postprandial suppression of ghrelin [ 37 , 5559 ] . \\n this suggested an endocrine mechanism by which fructose might induce a positive energy balance and weight gain . a possible explanation of smaller increases in satiety hormones by fructose could be the lower expression of glut5 in -cells   or lower absorption rates in the intestine . \\n in addition , it was found that central administration of fructose provokes feeding in rodents , whereas centrally administered glucose promotes satiety [ 54 , 62 ] . \\n these data together with parallel increases between fructose intake and obesity development   have led to the \\n fructose hypothesis which postulates that fructose , compared to glucose , may stimulate food - seeking behaviour , food intake , and body weight gain . however , the proposed effect of fructose on the induction of feeding is the subject of debate since this concept has not been replicated in rodents , and there is little evidence linking these phenomena in humans [ 56 , 58 , 59 , 63 , 64 ] . \\n the few studies linking fructose consumption with increased body weight compared fructose versus an artificial sweetener , evaluated 60-g fructose supplementation but did not compare it versus another sugar , or used higher doses of fructose compared sucrose . \\n even others found no substantial differences in endocrine and metabolic effects after consumption of sugar - sweetened beverages with hfcs , sucrose , fructose , and glucose in humans   or in body weight and food intake   or found greater increase in body adiposity with sucrose than with fructose solutions . \\n moreover , it appears that fructose orally ingested may cross the bbb to a small extent compared to glucose , which may have two opposite implications : 1 ) the limited fructose access to glucose - sensing neurons could contribute to the deregulation of food intake and energy balance , or 2 ) fructose might have no effect at all on appetite regulation due to the lack of fructose transport to the brain . \\n the purpose of this section was to present available data on the main enteric and cephalic detection processes of dietary sugars , in association with satiety peptides , neuropeptides secretion , and neuronal activity , and to discuss their effects on food intake . \\n peripheral sweet taste and sugar detectors are key regulators of feeding behaviour and energy homeostasis . \\n taste - signalling mechanisms identified in the oral epithelium also operate in the gut and play a role in both sugar detection and regulation of intestinal and pancreatic hormone secretion . \\n there are two main groups of sugar detectors : members of the g - protein - coupled receptors ( gpcr ) family , and sugar transporters ( e.g. glut2 , glut5 , sodium - dependent glucose co - transporter 1 ( sglt1 ) , and glut8 ) . \\n enteroendocrine cells directly sense sugars via gpcr , including the sweet taste receptors of type 1 , t1r . \\n the initial step in taste recognition occurs on the apical surface of taste receptor cells , within taste buds of the tongue and palate . \\n the regulation of taste sensitivity by appetite peptides at the level of taste bud cells in the tongue as well as in enteroendocrine cells of the taste epithelium may be important in the control of eating behaviour and the regulation of energy homeostasis . \\n however , this concept remains unclear since it was found that knockout ( ko ) mice ( p2x2/p2x3 ) with adenosine triphosphate taste cell signalling deficits show relatively normal food intake and body weight . \\n they also develop strong preferences for non - taste nutrients by the post - oral actions of these nutrients . \\n furthermore , much of the research on appetite peptides and taste detection in the mouth has been performed at the cell / neuron level ; however , little empirical evidence exists to date for these peptides impacting taste function at the level of the mouth . \\n therefore , more studies should be performed in large animal models to clarify these concepts . \\n appetite regulatory peptides , such as leptin , endocannabinoids , glp-1 , glucagon , oxytocin , insulin , cholecystokinin ( cck ) , neuropeptide y ( npy ) , and vasoactive intestinal peptide ( vip ) , modulate taste sensitivity at the level of oral sweet taste cells . \\n leptin selectively suppressed sweet taste responses of cells isolated from circumvallate papillae from non - diabetic mice , but not in diabetic db / db mice . \\n this indicated that the effect of leptin on sweet taste sensitivity is mediated by the leptin receptor expressed in these cells . \\n the t1r3 subunit is co - expressed with the leptin receptor in both fungiform and circumvallate taste bud cells , and leptin suppresses sweet taste sensitivity in mice by affecting responsiveness of t1r3-expressing taste cells via the leptin receptor . \\n therefore , leptin may play an important role in the regulation of sweet taste sensitivity in the tongue , besides its central actions on food intake . \\n co - expression of glp-1 with taste - signalling elements such as t1r2 , t1r3 , and -gustducin , a gi family member associated with taste perception , was found in human intestinal endocrine l cells . \\n these taste - signalling elements mediate the glucose - dependent secretion of glp-1 and maintain or enhance sweet taste sensitivity via paracrine action . \\n in addition to its intestinal expression , glp-1 was also found to be expressed in taste cells in mouse circumvallate papillae taste buds ; it was co - expressed with -gustducin and t1r3-expressing sweet taste cells in mouse taste buds , and it was produced in taste buds from lingual extracts in its active form . \\n in contrast to its presence in blood and ileum , dipeptidyl peptidase 4 was not found to be expressed in taste buds , suggesting that the half - life of glp-1 in taste tissue should be high , ensuring sufficient concentrations within the taste bud to stimulate the glp-1 receptor . \\n hek-293 cells expressing g15 ( a phospholipase c - linked g - protein ) , cotransfected with human and rat t1r2/t1r3 , respond to all sweet taste stimuli : sucrose , fructose , galactose , glucose , lactose , and maltose . in the rat , however , the relative lack of t1r2 expression in taste bud cells of the fungiform papillae is consistent with the relative low response to sucrose recorded at the level of the chorda tympani nerve   the activation of t1r1/t1r3 and t1r2/t1r3 in rat small intestine by glutamate , glucose , and artificial sweeteners increases the apical expression of glut2 and sugar absorption [ 83 , 84 ] . \\n given this effect of sweet taste per se to activate t1r2/t1r3 and sugar absorption , it would have been expected that artificial sweeteners might also slow gastric emptying . \\n however , intragastric or intestinal administration of equisweet solutions with artificial sweeteners and/or fructose did not modify glucose absorption rates , plasma glucose , incretin levels , or gastric emptying in humans [ 8587 ] or rodents   as a glucose solution did . \\n collectively , these findings did not support the concept that the sweet taste per se is the principal detection mechanism , responsible for the regulation of gastric emptying , glucose absorption , or incretin release . \\n therefore , these data are in contrast to previously reported parallels between nutrient - sensing pathways in the oral cavity and gut . \\n it seems that artificial sweeteners may influence the expression of sugar transporters such as glut2 [ 83 , 84 ] and sglt1 , but they may not influence other physiological functions such as gastric emptying or glucose absorption , and their effect on incretin release seems contradictory since some studies reported an effect of artificial sweeteners ( sucralose ) on glp-1 secretion from the ileum via t1r3 activation , while other studies did not find any effect of artificial sweeteners on incretin levels in humans [ 8587 ] or rodents   when compared to glucose effects . therefore , these data make unclear whether sweet taste receptors are necessary in such gastrointestinal functions . t1r1/t1r3 and t1r2/t1r3 stimulation leads to the activation of -gustducin . t1r3 and -gustducin are necessary for increased stimulation of ( sglt1 ) by dietary sugars . \\n t1r3 inhibition with lactisole decreased fructose stimulation of human sglt1 , glut5 , and l - pyruvate kinase mrna expression , demonstrating the implication of t1r3 in fructose signalling , whereas t1r3 did not control glut2 expression and activity . in enterocytes , cell polarity may influence the regulation of sweet taste receptor signalling . \\n tir2 and t1r3 are located at the basolateral membrane of differentiated enterocytes . whereas the apical supply of fructose increased glut5 mrna expression , the basolateral supply of sugars increased glut2 expression , suggesting that sugars can directly signal from the basolateral membrane . when intestinal luminal glucose concentration is lower than in plasma , glucose is transported by sglt1 through the apical membrane against the concentration gradient . \\n dietary fructose is transported across the apical membrane by the facilitative transporter glut5 . in the basolateral membrane , both glucose and fructose \\n are transported by glut2 [ 94 , 95 ] . at high glucose or fructose concentrations , when sglt1 and glut5 , respectively , are saturated , glut2 translocates to the apical membrane where it complements sglt1 and glut5 transport capacities . \\n depending on its relative abundance in the apical and basolateral membranes , it may stimulate sugar signals from intestinal lumen or bloodstream . \\n chronic exposure to a high - sugar diet promotes increased apical glut2 levels , increases glucose absorption , and excessive postprandial excursions . \\n insulin induces the internalisation of apical glut2 , a process that is impaired in insulin resistance , contributing to further glucose absorption . \\n since glut2 depends on glucose transport by sglt1 , i.e. it promotes glut2 upregulation , long - term regulation by sglt1 may also be reflected in changes in apical glut2 . in piglets fed isocaloric diets with variable concentrations of digestible carbohydrates ( i.e. sucrose and maize starch ) , \\n sglt1 expression remains constant after exposure to diets containing up to 40  % digestible carbohydrate . \\n however , after exposure of > 50  % carbohydrate diets , sglt1 expression is markedly increased . \\n in contrast , under both low- and high - carbohydrate diets , glut2 is expressed on the basolateral membrane of pig enterocytes . \\n these results suggest that sglt1 is the major route for the absorption of dietary sugars across the luminal membrane of swine enterocytes . \\n moreover , duodenal and jejunal infusions of glucose , fructose , and saccharin induced up - regulation of sglt1 in mice apparently involving vagal afferents . \\n altogether , these data suggest that sglt1 and apical glut2 are potential targets for antidiabetic therapy [ 90 , 93 , 94 ] . \\n duodenal sglt1 and glut5 mrna expressions and protein levels are substantially increased in diabetic patients . \\n reduction in plasma glucose in these patients promoted a reduction in both sglt1 and glut5 levels , suggesting that under hyperglycaemic conditions , the absorption of sugars is enhanced . \\n moreover , postprandial plasma fructose levels are increased in diabetic patients and are associated with the prevalence of diabetic retinopathy . \\n in contrast , in zucker diabetic rats , mrna and protein levels of sglt1 , glut5 , and glut2 were unchanged compared to lean controls . \\n this suggests that the zucker diabetic rat might not be a good model for the study of diabetes since it does not reproduce results observed in humans . \\n consumption of a large amount of pure fructose can exceed the capacity of intestinal fructose absorption , resulting in diarrhoea . \\n however , the consumption of glucose along with fructose , as it is usually consumed in beverages and with meals ( e.g. when provided as sucrose ) , appears to enhance fructose absorption . \\n in addition , fructose absorption increases during sustained fructose consumption , suggesting an adaptation to increased fructose intake . \\n glut8 , expressed only in the intracellular compartment , potentially mediates sugar transport into or out of intracellular organelles . \\n glut8 has high affinity for glucose , whereas fructose and galactose compete with glucose transport activity . \\n its deficiency enhances fructose uptake in cultured caco2 human intestinal epithelial cells and in jejunum isolated from mice lacking the gene encoding glut8 . \\n moreover , mice lacking glut8 rapidly develop higher serum fructose concentrations after oral fructose gavage . \\n these effects are possibly mediated by the stabilisation of the dual - specificity glucose / fructose transporter glut12 . \\n these data might lead to the speculation that this transporter could , in part , be implicated in fructose malabsorption previously reported when ingested at high levels in humans . \\n the glucose - dependent secretion of glp-1 plays a critical role in the regulation of glucose homeostasis . \\n it was shown that t1r3 , but not t1r2 , affects both incretin secretion from the intestine and insulin secretion from the pancreas . \\n exposure to glucose , fructose , and sucralose induced glp-1 secretion from the ileum of wild - type ( t1r3 ) but not from t1r3 null mice ( t1r3 ) . \\n t1r2 mice showed normal glycaemic control and partial small intestine glucose - stimulated glp-1 secretion , suggesting that t1r3 can mediate glucose - stimulated glp-1 secretion without t1r2 . \\n sglt1 and sglt3 may also be involved in enteric sugar - sensing and hormonal secretion stimulation . \\n sglt1 triggers glucose - induced secretion of gastrointestinal polypeptide ( gip ) from k - cells in the duodenum and jejunum . \\n this in turn stimulates the release of glp-1 and glp-2 from l cells located in the ileum [ 107 , 108 ] . \\n some evidence has revealed an anorexigenic effect of glucose and an orexigenic effect of fructose through different secretory profile of appetite peptides . \\n for example , glucose and , to a lesser extent , galactose , but not fructose , mannose , or sorbitol , stimulated the release of gip . \\n glucose intragastrically infused or orally ingested induced an increase in plasma glucose levels , stimulated insulin , leptin , glp-1 and peptide tyrosine  tyrosine ( pyy ) secretion , and reduced ghrelin secretion , while fructose did not substantially affect these hormones [ 37 , 5759 ] . \\n however , in one of these studies , the amounts of intragastric load of glucose and fructose were different ( 50 and 25  g/250  ml , respectively ) , which might have contributed to the observed differences . \\n a possible explanation for the lack of effects of fructose on insulin secretion may be related to lower intestinal mrna and protein glut5 levels compared to glut2 levels , with the subsequent lower fructose transport compared to glucose . \\n in addition , it was previously shown that glucose absorption rate was higher than that of fructose in yucatan minipigs . a substantial portion ( 12  % ) of ingested fructose \\n is metabolised to lactate by the gut during absorption , while only 2  % of glucose ingested is metabolised in the gut and almost all of the absorbed glucose appears in the portal vein as glucose . in concordance with lower fructose absorption rates compared to glucose , \\n insulin concentrations were 7.5-fold above basal conditions following glucose intake , compared to threefold following fructose intake . \\n another possible explanation for the lack of effects of fructose on insulin secretion is the low level of expression of the glut5 fructose transporter in -cells . taking together these data , i.e. lower expression levels of glut5 than glut2 in the intestine , lower rate of fructose transport compared to glucose , partial intestinal fructose , but not glucose , metabolism , and the low level of glut5 expression in -cells \\n could explain in part the lower increases in other gut peptides , besides insulin , induced by fructose ingestion , compared to glucose . \\n further studies are needed to confirm this concept . in this context , since insulin and leptin function as key signals in the central nervous system through the modulation of hypothalamic neuropeptides for the long - term regulation of energy balance , chronic fructose intake could lead to increased calorie intake , thereby contributing to weight gain and obesity . \\n hunger is regulated by the hypothalamus and the dorsal vagal complex in conjunction with an integrated network of limbic brain structures such as the striatum , orbitofrontal cortex , amygdala and insula , which control motivation - reward systems associated with the hedonic drive to eat . \\n the arcuate nucleus of the hypothalamus is an integrator of hormonal and nutrient information to regulate both energy and glucose homeostasis . \\n brain cells are provided with mechanisms that sense energy availability in the extracellular space , such as an increase in adenosine monophosphate kinase ( ampk ) activity in response to an increase in amp - to - atp ratio . \\n glucose - sensing neurons are located in brain areas involved in the control of neuroendocrine function , nutrient metabolism , and energy homeostasis ( e.g. hypothalamic arcuate nucleus and the dorsal vagal complex ) and also receive direct and indirect neural input from the periphery and from other brain areas that carry information about the characteristics of the ingested nutrients . \\n glucose - sensing neurons express receptors for and respond to peripheral hormones such as leptin and insulin that convey signals relating to carbohydrate and fat stores . \\n these hormones as well as metabolic substances are transported across the bbb but can also freely diffuse from capillaries to the adjacent median eminence . \\n anabolic arcuate npy / agouti - related protein ( agrp ) and catabolic proopiomelanocortin ( pomc ) neurons are metabolic sensors with important roles as regulators of energy homeostasis . \\n arcuate npy / agrp neurons are inhibited by insulin and leptin and , when activated , stimulate food intake ( orexigenic ) , whereas pomc neurons reduce food intake ( anorexigenic ) and are stimulated by insulin and leptin . both neuronal subsets project to secondary order neurons located adjacent to hypothalamic areas including the paraventricular nucleus , where anorexigenic neurons are concentrated , and the lateral hypothalamic area , which contains orexigenic neurons . \\n npy / agrp neurons also inhibit pomc neurons via synaptic release of the inhibitory transmitter , -aminobutyric acid . through smaller increases in insulin and leptin \\n secretion induced by fructose intake , compared to glucose [ 55 , 59 ] , fructose - containing diets may lead to a lower inhibitory effect of orexigenic neurons npy / agrp , as well as a reduced reward value from food . \\n differential fuel utilisation responsible for the distinct responses of the npy / agrp and pomc neurons to metabolic signals has been characterised , whereas pomc neurons utilise glucose as the main fuel , npy / agrp neurons do not use glucose , but free fatty acids instead . \\n this differential fuel utilisation implies two distinct and competitive mechanisms , glycolysis and  - oxidation , in these neuronal populations . \\n the by - products of substrate oxidation are reactive oxygen species ( ros ) that have a crucial role in the acute and the long - term regulation of feeding , satiety , and associated metabolic changes ( i.e. glucose and fatty acid homeostasis ) . \\n mitochondrial ros ( mros ) is a necessary signal to initiate the response to glucose sensing . \\n a finely controlled mros production might be considered as an essential physiological messenger in metabolic - sensitive cells [ 114 , 115 ] . \\n alteration of the hypothalamic glucose - sensing mechanism induced dramatic effects on energy balance correlated to abnormal redox signalling originated from mitochondrial dysfunction . during negative energy balance , \\n npy / agrp neurons utilise free fatty acids as fuel , but ros levels are not increased in these cells despite increased firing and substrate utilisation . \\n in contrast , during positive energy balance , when glucose - utilising pomc neurons are firing at high levels , ros accumulate in these pomc cells because they do not need to be buffered . sustained \\n the fact that satiety is associated with the highest levels of ros production in the pomc neurons indicates that these cells are more exposed to ros - induced damage than npy / agrp neurons , which do not produce elevated ros levels even if highly active . \\n thus , it seems plausible that pomc neurons are more exposed to elevated firing ( positive energy balance ) over time , thus leading to pomc system impairment . \\n in contrast , since npy / agrp neurons are inherently able to buffer ros , their increased activity during negative energy balance is not associated with ros - induced degeneration . \\n regulatory mechanisms of food intake controlled by central ampk activity in response to an i.c.v . \\n glucose injection through inactivation of ampk , an increase in malonyl coa , and in anorexigenic neuropeptides mrna levels in the hypothalamus , whereas i.c.v . \\n fructose injection resulted in the inverse effects [ 50 , 54 , 117 , 118 ] ( see fig .  1 ) . \\n however , whether fructose orally ingested can also produce these effects than when administered i.p . or \\n fructose bypasses the rate - limiting step in glycolysis , which generates a decrease in amp / atp ratio , the phosphorylation and activation of ampk ( the cell sensor of amp / atp ratio ) in the liver , and in hypothalamic neurons [ 50 , 54 ] . \\n this stimulates corticosterone secretion , activating glucocorticoid receptors followed by activation of phosphoenol pyruvate carboxykinase ( pepck ) and gluconeogenesis . \\n the activation of pepck induced by fructose was prevented by ru486 , a glucocorticoid receptor antagonist . \\n intracerebroventricular ( i.c.v ) injection of the glp-1 receptor ( glp-1r ) agonist exendin-4 ( ex-4 ) , suppressed ampk activity in hypothalamic cells and food intake ; i.c.v fructose attenuated the anorectic effect of ex-4 , suggesting a mechanism for the increased food intake by fructose via impairment of central glp-1r action . \\n glucose injected i.c.v . increased atp / amp ratio , activated ampk , acetyl - coa carboxylase ( acc ) and malonyl coa , leading to decreased mrna levels of orexigenic neuropeptides npy and agouti - related protein ( agrp ) , while activating the expression of the anorexigenic peptides cocaine  amphetamine - related transcript ( cart ) and proopiomelanocortin ( pomc ) . \\n fructose i.c.v injected exerts an orexigenic effect by lowering malonyl coa mrna levels   effects of an i.c.v . \\n fructose bypasses the rate - limiting step in glycolysis , which generates a decrease in amp / atp ratio , the phosphorylation and activation of ampk ( the cell sensor of amp / atp ratio ) in the liver , and in hypothalamic neurons [ 50 , 54 ] . \\n this stimulates corticosterone secretion , activating glucocorticoid receptors followed by activation of phosphoenol pyruvate carboxykinase ( pepck ) and gluconeogenesis . \\n the activation of pepck induced by fructose was prevented by ru486 , a glucocorticoid receptor antagonist . \\n intracerebroventricular ( i.c.v ) injection of the glp-1 receptor ( glp-1r ) agonist exendin-4 ( ex-4 ) , suppressed ampk activity in hypothalamic cells and food intake ; i.c.v fructose attenuated the anorectic effect of ex-4 , suggesting a mechanism for the increased food intake by fructose via impairment of central glp-1r action . \\n glucose injected i.c.v . increased atp / amp ratio , activated ampk , acetyl - coa carboxylase ( acc ) and malonyl coa , leading to decreased mrna levels of orexigenic neuropeptides npy and agouti - related protein ( agrp ) , while activating the expression of the anorexigenic peptides cocaine  amphetamine - related transcript ( cart ) and proopiomelanocortin ( pomc ) . \\n fructose i.c.v injected exerts an orexigenic effect by lowering malonyl coa mrna levels   another potential mechanism for the fructose effects on food intake might be through the nuclear receptors liver x receptor ( lxr )  and . these receptors have been previously implicated in the regulation of carbohydrate and lipid metabolism   and were shown to be expressed in the hypothalamus and implicated in the regulation of food intake . \\n free access to a diet - containing 10  % fructose for 6  weeks in glucose - intolerant rats induced a decrease in lxr and an increase in lxr in the hypothalamus , but not in the hippocampus , cerebellum , or neocortex . \\n it is possible that the specific hypothalamic increase in lxr by fructose may trigger neurochemical and neurophysiological responses for the control of food intake and energy expenditure . but \\n circulating fructose levels could possibly promote central effects in humans even if hepatic clearance of fructose is extremely efficient , given the following observations : ( i ) the presence of glut5 in the bbb and ketohexokinase mrna , the necessary cellular machinery for fructose metabolism ; ( ii ) fructose administered i.p . \\n can cross the bbb and trigger neuronal activation in rodents ; ( iii ) fructose administrated i.p . \\n these data suggested the capacity of fructose to cross the bbb into the hypothalamus , where it could be metabolised and used as an energy source . \\n thus , consumption of high - fructose diets might probably have a direct effect on the brain , but no study has clearly proven this concept yet . while it is well established that glucose orally ingested undergoes facilitated transport across the bbb , the demonstration that fructose orally ingested can cross the bbb is still missing . \\n another question is how changes in feeding behaviour associated with glucose- and fructose - induced activation of brain regions observed in animals could be extrapolated to humans , especially when most of the studies investigating these effects have been performed on rodents . \\n new technologies are available to facilitate the translation of animal to human studies and help understanding of brain functions . \\n one such technique is the single - photon emission computed tomography ( spect ) that provides a way to compare brain circuits implicated in the processing of oral and/or visceral ( e.g. duodenal or portal ) sugar signals . \\n the authors found that both duodenal and portal glucose infusions activated the dorsolateral prefrontal cortex and primary somatosensory cortex . \\n however , only duodenal glucose infusion induced the activation of the prepyriform area , orbitofrontal cortex , caudate and putamen , and the deactivation of the anterior prefrontal cortex and anterior entorhinal cortex , whereas only portal glucose infusion induced the activation of the insular cortex . \\n these results indicated that duodenal and portal glucose infusions modulate differentially the activity of brain areas implicated in the regulation of eating behaviour , which probably explains the decrease in food intake after both stimulations . \\n another spect study in pigs ( clouard et al . , 2013 , unpublished data ) demonstrated that combined oral and duodenal sucrose sensing induced activation of brain regions involved in memory , reward processes , and hedonic identification of sensory stimuli ( i.e. amygdala , dorsal striatum : caudate and putamen , and the anterior prefrontal cortex ) , whereas oral or duodenal sucrose sensing individually administered did not . \\n these findings suggested that ( 1 ) the concordance between oral and visceral signals ( sweet taste and calories ) during sugar sensing is necessary for the onset of responses in these brain structures , or ( 2 ) the synergy between oral and visceral signals during sugar sensing is required to obtain a signal that is strong enough to trigger brain responses in these structures ( clouard , et al . \\n positron emission tomography ( pet ) studies with 18-fluorodeoxyglucose ( 18-fdg ) to measure brain glucose metabolism in normal - weight individuals reported that exposure to food cues increased metabolic activity in the orbitofrontal cortex , similar to that observed in cocaine - addicted subjects , which was an effect associated with the perception of hunger and the desire for food . \\n functional magnetic resonance imaging ( fmri ) is another technique that provides a non - invasive way to assess the effects of glucose and fructose intake , as well as of obesity , on regional cerebral blood flow ( abbreviated rcbf and estimated via the blood  oxygen - level - dependent or bold signal ) . \\n previous studies have explored the temporal response to glucose intake or infusion using fmri and found suppression of hypothalamic bold signalling after the administration of glucose to rats and humans . \\n obese subjects presented diminished attenuation of the bold signal in response to glucose ingestion compared with lean subjects , and patients with type 2 diabetes did not show any hypothalamic signal changes compared with non - diabetic patients . \\n this might suggest a reduced neuronal activation in obese relative to lean subjects , which might translate in no suppression of appetite and less rewarding signals from glucose intake leading to overeating . \\n cortical responses to sugars in healthy subjects as assessed by fmri appear to be opposite between glucose and fructose infusion : increased and decreased cortical activation , respectively . \\n the suppressive effect of fructose on cortical bold signal occurred despite the fact that cortical - specific receptors ( glut5 ) are present in low concentrations throughout the brain , where the glucose transporter glut3 predominates . \\n whether this cortical response to fructose is due to effects mediated by glut2 and glut5 carriers in the bbb or in local glial cells , due to increased osmolality , or is the indirect result of changes in the levels of peripheral neural input or metabolic intermediaries is yet to be understood . \\n however , the overall observations suggest a major implication of fructose on changes in brain activity similar to those observed with addictive drugs , which may lead to an altered reward response to palatable food . \\n in contrast to the effects of sugars in cortical activation , their effects in other brain regions involved in food intake control , i.e. hypothalamus , appear to be opposite . \\n another fmri study in humans showed that glucose , but not fructose intake , induced a marked reduction in hypothalamic bold signal , as well as a reduction in cbf within the thalamus , insula , anterior cingulate , striatum , and hypothalamus , i.e. brain regions that act together to sense the metabolic state of an individual and drive motivation and reward . \\n moreover , fructose produced a transient increase in hypothalamic activity and reduced cbf in the hippocampus , a region implicated not only in memory but also influencing emotional responses to food intake . \\n these findings suggest that ingestion of glucose , but not fructose , initiates a coordinated response between the homeostatic and striatal networks that regulate eating behaviour . in line with these data , ingestion of glucose but \\n what are the underlying mechanisms of these effects of fructose on cbf changes is a remaining question since no study has clearly demonstrated the capacity of fructose orally ingested to cross the bbb . \\n figures  2 and 3 represent hypothetical and controversial models summarising the findings that support the  fructose hypothesis which postulates an orexigenic and less rewarding effect of fructose intake , compared to glucose . \\n it presents the underlying molecular mechanisms throughout the gut  brain communication supporting this hypothesis.fig . \\n vagal afferents express glp-1 and 5-ht receptors , and are implicated in the regulation of insulin secretion . \\n many neuronal signals are communicated via the vagus nerve to the brain stem , which relays the glucose signal to hypothalamic nuclei and then to the pertinent target cells : npy / agrp and pomc / cart neurons . \\n npy neuropeptide y , agrp agouti - related protein , pomc proopiomelanocortin , cart cocaine  amphetamine - related transcript , amp adenosine monophosphate , ampk amp kinase , acc acetyl - coa carboxylase . \\n black arrows activation ; discontinued \\n red lines inhibition ; thin discontinued red line weak activation [ 4 , 51 , 52 , 54 , 57 , 58 , 72 , 182]fig . \\n luminal fructose induces weak release of 5-ht and glp-1 from enteroendocrine and l cells , respectively , weak pyy , insulin and leptin secretion , as well as weak ghrelin suppression . \\n many neuronal signals are communicated via the vagus nerve to the brain stem , which relays the glucose signal to hypothalamic nuclei and then to the pertinent target cells : npy / agrp and pomc / cart neurons . \\n npy neuropeptide y , agrp agouti - related protein , pomc proopiomelanocortin , cart cocaine  amphetamine - related transcript , amp adenosine monophosphate , ampk amp kinase , acc acetyl - coa carboxylase . \\n black arrows activation ; discontinued red lines inhibition ; grey arrows low secretion or low activation [ 4 , 37 , 51 , 52 , 54 , 58 , 59 , 72 , 182 ] hypothetical model of the peripheral and central effects of glucose on food intake . \\n vagal afferents express glp-1 and 5-ht receptors , and are implicated in the regulation of insulin secretion . \\n many neuronal signals are communicated via the vagus nerve to the brain stem , which relays the glucose signal to hypothalamic nuclei and then to the pertinent target cells : npy / agrp and pomc / cart neurons . \\n npy neuropeptide y , agrp agouti - related protein , pomc proopiomelanocortin , cart cocaine  amphetamine - related transcript , amp adenosine monophosphate , ampk amp kinase , acc acetyl - coa carboxylase . \\n black arrows activation ; discontinued \\n red lines inhibition ; thin discontinued red line weak activation [ 4 , 51 , 52 , 54 , 57 , 58 , 72 , 182 ] hypothetical model of the peripheral and central effects of fructose on food intake . \\n luminal fructose induces weak release of 5-ht and glp-1 from enteroendocrine and l cells , respectively , weak pyy , insulin and leptin secretion , as well as weak ghrelin suppression . \\n many neuronal signals are communicated via the vagus nerve to the brain stem , which relays the glucose signal to hypothalamic nuclei and then to the pertinent target cells : npy / agrp and pomc / cart neurons . \\n npy neuropeptide y , agrp agouti - related protein , pomc proopiomelanocortin , cart cocaine  amphetamine - related transcript , amp adenosine monophosphate , ampk amp kinase , acc acetyl - coa carboxylase . \\n black arrows activation ; discontinued red lines inhibition ; grey arrows low secretion or low activation [ 4 , 37 , 51 , 52 , 54 , 58 , 59 , 72 , 182 ] \\n peripheral sweet taste and sugar detectors are key regulators of feeding behaviour and energy homeostasis . \\n taste - signalling mechanisms identified in the oral epithelium also operate in the gut and play a role in both sugar detection and regulation of intestinal and pancreatic hormone secretion . \\n there are two main groups of sugar detectors : members of the g - protein - coupled receptors ( gpcr ) family , and sugar transporters ( e.g. glut2 , glut5 , sodium - dependent glucose co - transporter 1 ( sglt1 ) , and glut8 ) . \\n enteroendocrine cells directly sense sugars via gpcr , including the sweet taste receptors of type 1 , t1r . \\n the initial step in taste recognition occurs on the apical surface of taste receptor cells , within taste buds of the tongue and palate . \\n the regulation of taste sensitivity by appetite peptides at the level of taste bud cells in the tongue as well as in enteroendocrine cells of the taste epithelium may be important in the control of eating behaviour and the regulation of energy homeostasis . \\n however , this concept remains unclear since it was found that knockout ( ko ) mice ( p2x2/p2x3 ) with adenosine triphosphate taste cell signalling deficits show relatively normal food intake and body weight . \\n they also develop strong preferences for non - taste nutrients by the post - oral actions of these nutrients . \\n furthermore , much of the research on appetite peptides and taste detection in the mouth has been performed at the cell / neuron level ; however , little empirical evidence exists to date for these peptides impacting taste function at the level of the mouth . \\n therefore , more studies should be performed in large animal models to clarify these concepts . \\n appetite regulatory peptides , such as leptin , endocannabinoids , glp-1 , glucagon , oxytocin , insulin , cholecystokinin ( cck ) , neuropeptide y ( npy ) , and vasoactive intestinal peptide ( vip ) , modulate taste sensitivity at the level of oral sweet taste cells . \\n leptin selectively suppressed sweet taste responses of cells isolated from circumvallate papillae from non - diabetic mice , but not in diabetic db / db mice . \\n this indicated that the effect of leptin on sweet taste sensitivity is mediated by the leptin receptor expressed in these cells . \\n the t1r3 subunit is co - expressed with the leptin receptor in both fungiform and circumvallate taste bud cells , and leptin suppresses sweet taste sensitivity in mice by affecting responsiveness of t1r3-expressing taste cells via the leptin receptor . \\n therefore , leptin may play an important role in the regulation of sweet taste sensitivity in the tongue , besides its central actions on food intake . \\n co - expression of glp-1 with taste - signalling elements such as t1r2 , t1r3 , and -gustducin , a gi family member associated with taste perception , was found in human intestinal endocrine l cells . \\n these taste - signalling elements mediate the glucose - dependent secretion of glp-1 and maintain or enhance sweet taste sensitivity via paracrine action . \\n in addition to its intestinal expression , glp-1 was also found to be expressed in taste cells in mouse circumvallate papillae taste buds ; it was co - expressed with -gustducin and t1r3-expressing sweet taste cells in mouse taste buds , and it was produced in taste buds from lingual extracts in its active form . \\n in contrast to its presence in blood and ileum , dipeptidyl peptidase 4 was not found to be expressed in taste buds , suggesting that the half - life of glp-1 in taste tissue should be high , ensuring sufficient concentrations within the taste bud to stimulate the glp-1 receptor . \\n hek-293 cells expressing g15 ( a phospholipase c - linked g - protein ) , cotransfected with human and rat t1r2/t1r3 , respond to all sweet taste stimuli : sucrose , fructose , galactose , glucose , lactose , and maltose . in the rat , however , the relative lack of t1r2 expression in taste bud cells of the fungiform papillae is consistent with the relative low response to sucrose recorded at the level of the chorda tympani nerve   the activation of t1r1/t1r3 and t1r2/t1r3 in rat small intestine by glutamate , glucose , and artificial sweeteners increases the apical expression of glut2 and sugar absorption [ 83 , 84 ] . \\n given this effect of sweet taste per se to activate t1r2/t1r3 and sugar absorption , it would have been expected that artificial sweeteners might also slow gastric emptying . \\n however , intragastric or intestinal administration of equisweet solutions with artificial sweeteners and/or fructose did not modify glucose absorption rates , plasma glucose , incretin levels , or gastric emptying in humans [ 8587 ] or rodents   as a glucose solution did . \\n collectively , these findings did not support the concept that the sweet taste per se is the principal detection mechanism , responsible for the regulation of gastric emptying , glucose absorption , or incretin release . \\n therefore , these data are in contrast to previously reported parallels between nutrient - sensing pathways in the oral cavity and gut . \\n it seems that artificial sweeteners may influence the expression of sugar transporters such as glut2 [ 83 , 84 ] and sglt1 , but they may not influence other physiological functions such as gastric emptying or glucose absorption , and their effect on incretin release seems contradictory since some studies reported an effect of artificial sweeteners ( sucralose ) on glp-1 secretion from the ileum via t1r3 activation , while other studies did not find any effect of artificial sweeteners on incretin levels in humans [ 8587 ] or rodents   when compared to glucose effects . \\n therefore , these data make unclear whether sweet taste receptors are necessary in such gastrointestinal functions . t1r1/t1r3 and t1r2/t1r3 stimulation leads to the activation of -gustducin . t1r3 and -gustducin are necessary for increased stimulation of ( sglt1 ) by dietary sugars . \\n t1r3 inhibition with lactisole decreased fructose stimulation of human sglt1 , glut5 , and l - pyruvate kinase mrna expression , demonstrating the implication of t1r3 in fructose signalling , whereas t1r3 did not control glut2 expression and activity . in enterocytes , \\n tir2 and t1r3 are located at the basolateral membrane of differentiated enterocytes . whereas the apical supply of fructose increased glut5 mrna expression , the basolateral supply of sugars increased glut2 expression , suggesting that sugars can directly signal from the basolateral membrane . \\n when intestinal luminal glucose concentration is lower than in plasma , glucose is transported by sglt1 through the apical membrane against the concentration gradient . \\n dietary fructose is transported across the apical membrane by the facilitative transporter glut5 . in the basolateral membrane , both glucose and fructose \\n are transported by glut2 [ 94 , 95 ] . at high glucose or fructose concentrations , when sglt1 and glut5 , respectively , are saturated , glut2 translocates to the apical membrane where it complements sglt1 and glut5 transport capacities . \\n depending on its relative abundance in the apical and basolateral membranes , it may stimulate sugar signals from intestinal lumen or bloodstream . \\n chronic exposure to a high - sugar diet promotes increased apical glut2 levels , increases glucose absorption , and excessive postprandial excursions . \\n insulin induces the internalisation of apical glut2 , a process that is impaired in insulin resistance , contributing to further glucose absorption . \\n since glut2 depends on glucose transport by sglt1 , i.e. it promotes glut2 upregulation , long - term regulation by sglt1 may also be reflected in changes in apical glut2 . in piglets fed isocaloric diets with variable concentrations of digestible carbohydrates ( i.e. sucrose and maize starch ) , \\n sglt1 expression remains constant after exposure to diets containing up to 40  % digestible carbohydrate . \\n however , after exposure of > 50  % carbohydrate diets , sglt1 expression is markedly increased . \\n in contrast , under both low- and high - carbohydrate diets , glut2 is expressed on the basolateral membrane of pig enterocytes . \\n these results suggest that sglt1 is the major route for the absorption of dietary sugars across the luminal membrane of swine enterocytes . \\n moreover , duodenal and jejunal infusions of glucose , fructose , and saccharin induced up - regulation of sglt1 in mice apparently involving vagal afferents . \\n altogether , these data suggest that sglt1 and apical glut2 are potential targets for antidiabetic therapy [ 90 , 93 , 94 ] . \\n duodenal sglt1 and glut5 mrna expressions and protein levels are substantially increased in diabetic patients . \\n reduction in plasma glucose in these patients promoted a reduction in both sglt1 and glut5 levels , suggesting that under hyperglycaemic conditions , the absorption of sugars is enhanced . \\n moreover , postprandial plasma fructose levels are increased in diabetic patients and are associated with the prevalence of diabetic retinopathy . \\n in contrast , in zucker diabetic rats , mrna and protein levels of sglt1 , glut5 , and glut2 were unchanged compared to lean controls . \\n this suggests that the zucker diabetic rat might not be a good model for the study of diabetes since it does not reproduce results observed in humans . \\n consumption of a large amount of pure fructose can exceed the capacity of intestinal fructose absorption , resulting in diarrhoea . \\n however , the consumption of glucose along with fructose , as it is usually consumed in beverages and with meals ( e.g. when provided as sucrose ) , appears to enhance fructose absorption . \\n in addition , fructose absorption increases during sustained fructose consumption , suggesting an adaptation to increased fructose intake . \\n glut8 , expressed only in the intracellular compartment , potentially mediates sugar transport into or out of intracellular organelles . \\n glut8 has high affinity for glucose , whereas fructose and galactose compete with glucose transport activity . \\n its deficiency enhances fructose uptake in cultured caco2 human intestinal epithelial cells and in jejunum isolated from mice lacking the gene encoding glut8 . \\n moreover , mice lacking glut8 rapidly develop higher serum fructose concentrations after oral fructose gavage . \\n these effects are possibly mediated by the stabilisation of the dual - specificity glucose / fructose transporter glut12 . \\n these data might lead to the speculation that this transporter could , in part , be implicated in fructose malabsorption previously reported when ingested at high levels in humans . \\n the glucose - dependent secretion of glp-1 plays a critical role in the regulation of glucose homeostasis . \\n it was shown that t1r3 , but not t1r2 , affects both incretin secretion from the intestine and insulin secretion from the pancreas . \\n exposure to glucose , fructose , and sucralose induced glp-1 secretion from the ileum of wild - type ( t1r3 ) but not from t1r3 null mice ( t1r3 ) . \\n t1r2 mice showed normal glycaemic control and partial small intestine glucose - stimulated glp-1 secretion , suggesting that t1r3 can mediate glucose - stimulated glp-1 secretion without t1r2 . \\n sglt1 and sglt3 may also be involved in enteric sugar - sensing and hormonal secretion stimulation . \\n sglt1 triggers glucose - induced secretion of gastrointestinal polypeptide ( gip ) from k - cells in the duodenum and jejunum . \\n this in turn stimulates the release of glp-1 and glp-2 from l cells located in the ileum [ 107 , 108 ] . \\n some evidence has revealed an anorexigenic effect of glucose and an orexigenic effect of fructose through different secretory profile of appetite peptides . \\n for example , glucose and , to a lesser extent , galactose , but not fructose , mannose , or sorbitol , stimulated the release of gip . \\n glucose intragastrically infused or orally ingested induced an increase in plasma glucose levels , stimulated insulin , leptin , glp-1 and peptide tyrosine  tyrosine ( pyy ) secretion , and reduced ghrelin secretion , while fructose did not substantially affect these hormones [ 37 , 5759 ] . \\n however , in one of these studies , the amounts of intragastric load of glucose and fructose were different ( 50 and 25  g/250  ml , respectively ) , which might have contributed to the observed differences . \\n a possible explanation for the lack of effects of fructose on insulin secretion may be related to lower intestinal mrna and protein glut5 levels compared to glut2 levels , with the subsequent lower fructose transport compared to glucose . \\n in addition , it was previously shown that glucose absorption rate was higher than that of fructose in yucatan minipigs . a substantial portion ( 12  % ) of ingested fructose \\n is metabolised to lactate by the gut during absorption , while only 2  % of glucose ingested is metabolised in the gut and almost all of the absorbed glucose appears in the portal vein as glucose . in concordance with lower fructose absorption rates compared to glucose , \\n insulin concentrations were 7.5-fold above basal conditions following glucose intake , compared to threefold following fructose intake . \\n another possible explanation for the lack of effects of fructose on insulin secretion is the low level of expression of the glut5 fructose transporter in -cells . taking together these data , i.e. lower expression levels of glut5 than glut2 in the intestine , lower rate of fructose transport compared to glucose , partial intestinal fructose , but not glucose , metabolism , and \\n the low level of glut5 expression in -cells could explain in part the lower increases in other gut peptides , besides insulin , induced by fructose ingestion , compared to glucose . \\n further studies are needed to confirm this concept . in this context , since insulin and leptin function as key signals in the central nervous system through the modulation of hypothalamic neuropeptides for the long - term regulation of energy balance , chronic fructose intake could lead to increased calorie intake , thereby contributing to weight gain and obesity . \\n hunger is regulated by the hypothalamus and the dorsal vagal complex in conjunction with an integrated network of limbic brain structures such as the striatum , orbitofrontal cortex , amygdala and insula , which control motivation - reward systems associated with the hedonic drive to eat . \\n the arcuate nucleus of the hypothalamus is an integrator of hormonal and nutrient information to regulate both energy and glucose homeostasis . \\n brain cells are provided with mechanisms that sense energy availability in the extracellular space , such as an increase in adenosine monophosphate kinase ( ampk ) activity in response to an increase in amp - to - atp ratio . \\n glucose - sensing neurons are located in brain areas involved in the control of neuroendocrine function , nutrient metabolism , and energy homeostasis ( e.g. hypothalamic arcuate nucleus and the dorsal vagal complex ) and also receive direct and indirect neural input from the periphery and from other brain areas that carry information about the characteristics of the ingested nutrients . \\n glucose - sensing neurons express receptors for and respond to peripheral hormones such as leptin and insulin that convey signals relating to carbohydrate and fat stores . \\n these hormones as well as metabolic substances are transported across the bbb but can also freely diffuse from capillaries to the adjacent median eminence . \\n anabolic arcuate npy / agouti - related protein ( agrp ) and catabolic proopiomelanocortin ( pomc ) neurons are metabolic sensors with important roles as regulators of energy homeostasis . \\n arcuate npy / agrp neurons are inhibited by insulin and leptin and , when activated , stimulate food intake ( orexigenic ) , whereas pomc neurons reduce food intake ( anorexigenic ) and are stimulated by insulin and leptin . both neuronal subsets project to secondary order neurons located adjacent to hypothalamic areas including the paraventricular nucleus , where anorexigenic neurons are concentrated , and the lateral hypothalamic area , which contains orexigenic neurons . \\n npy / agrp neurons also inhibit pomc neurons via synaptic release of the inhibitory transmitter , -aminobutyric acid . through smaller increases in insulin and leptin \\n secretion induced by fructose intake , compared to glucose [ 55 , 59 ] , fructose - containing diets may lead to a lower inhibitory effect of orexigenic neurons npy / agrp , as well as a reduced reward value from food . \\n differential fuel utilisation responsible for the distinct responses of the npy / agrp and pomc neurons to metabolic signals has been characterised , whereas pomc neurons utilise glucose as the main fuel , npy / agrp neurons do not use glucose , but free fatty acids instead . \\n this differential fuel utilisation implies two distinct and competitive mechanisms , glycolysis and  - oxidation , in these neuronal populations . when glycolysis is elevated ,  - oxidation is inhibited and vice versa . \\n the by - products of substrate oxidation are reactive oxygen species ( ros ) that have a crucial role in the acute and the long - term regulation of feeding , satiety , and associated metabolic changes ( i.e. glucose and fatty acid homeostasis ) . \\n mitochondrial ros ( mros ) is a necessary signal to initiate the response to glucose sensing . \\n a finely controlled mros production might be considered as an essential physiological messenger in metabolic - sensitive cells [ 114 , 115 ] . \\n alteration of the hypothalamic glucose - sensing mechanism induced dramatic effects on energy balance correlated to abnormal redox signalling originated from mitochondrial dysfunction . during negative energy balance , \\n npy / agrp neurons utilise free fatty acids as fuel , but ros levels are not increased in these cells despite increased firing and substrate utilisation . \\n in contrast , during positive energy balance , when glucose - utilising pomc neurons are firing at high levels , ros accumulate in these pomc cells because they do not need to be buffered . sustained \\n the fact that satiety is associated with the highest levels of ros production in the pomc neurons indicates that these cells are more exposed to ros - induced damage than npy / agrp neurons , which do not produce elevated ros levels even if highly active . \\n thus , it seems plausible that pomc neurons are more exposed to elevated firing ( positive energy balance ) over time , thus leading to pomc system impairment . \\n in contrast , since npy / agrp neurons are inherently able to buffer ros , their increased activity during negative energy balance is not associated with ros - induced degeneration . \\n regulatory mechanisms of food intake controlled by central ampk activity in response to an i.c.v . \\n glucose injection through inactivation of ampk , an increase in malonyl coa , and in anorexigenic neuropeptides mrna levels in the hypothalamus , whereas i.c.v . \\n fructose injection resulted in the inverse effects [ 50 , 54 , 117 , 118 ] ( see fig .  1 ) . \\n however , whether fructose orally ingested can also produce these effects than when administered i.p . or \\n fructose bypasses the rate - limiting step in glycolysis , which generates a decrease in amp / atp ratio , the phosphorylation and activation of ampk ( the cell sensor of amp / atp ratio ) in the liver , and in hypothalamic neurons [ 50 , 54 ] . \\n this stimulates corticosterone secretion , activating glucocorticoid receptors followed by activation of phosphoenol pyruvate carboxykinase ( pepck ) and gluconeogenesis . \\n the activation of pepck induced by fructose was prevented by ru486 , a glucocorticoid receptor antagonist . \\n intracerebroventricular ( i.c.v ) injection of the glp-1 receptor ( glp-1r ) agonist exendin-4 ( ex-4 ) , suppressed ampk activity in hypothalamic cells and food intake ; i.c.v fructose attenuated the anorectic effect of ex-4 , suggesting a mechanism for the increased food intake by fructose via impairment of central glp-1r action . \\n glucose injected i.c.v . increased atp / amp ratio , activated ampk , acetyl - coa carboxylase ( acc ) and malonyl coa , leading to decreased mrna levels of orexigenic neuropeptides npy and agouti - related protein ( agrp ) , while activating the expression of the anorexigenic peptides cocaine  amphetamine - related transcript ( cart ) and proopiomelanocortin ( pomc ) . \\n fructose i.c.v injected exerts an orexigenic effect by lowering malonyl coa mrna levels   effects of an i.c.v . \\n fructose bypasses the rate - limiting step in glycolysis , which generates a decrease in amp / atp ratio , the phosphorylation and activation of ampk ( the cell sensor of amp / atp ratio ) in the liver , and in hypothalamic neurons [ 50 , 54 ] . \\n this stimulates corticosterone secretion , activating glucocorticoid receptors followed by activation of phosphoenol pyruvate carboxykinase ( pepck ) and gluconeogenesis . \\n the activation of pepck induced by fructose was prevented by ru486 , a glucocorticoid receptor antagonist . \\n intracerebroventricular ( i.c.v ) injection of the glp-1 receptor ( glp-1r ) agonist exendin-4 ( ex-4 ) , suppressed ampk activity in hypothalamic cells and food intake ; i.c.v fructose attenuated the anorectic effect of ex-4 , suggesting a mechanism for the increased food intake by fructose via impairment of central glp-1r action . glucose injected i.c.v . increased atp / amp ratio , activated ampk , acetyl - coa carboxylase ( acc ) and malonyl coa , leading to decreased mrna levels of orexigenic neuropeptides npy and agouti - related protein ( agrp ) , while activating the expression of the anorexigenic peptides cocaine  amphetamine - related transcript ( cart ) and proopiomelanocortin ( pomc ) . \\n fructose i.c.v injected exerts an orexigenic effect by lowering malonyl coa mrna levels   another potential mechanism for the fructose effects on food intake might be through the nuclear receptors liver x receptor ( lxr )  and . these receptors have been previously implicated in the regulation of carbohydrate and lipid metabolism   and were shown to be expressed in the hypothalamus and implicated in the regulation of food intake . \\n free access to a diet - containing 10  % fructose for 6  weeks in glucose - intolerant rats induced a decrease in lxr and an increase in lxr in the hypothalamus , but not in the hippocampus , cerebellum , or neocortex . \\n it is possible that the specific hypothalamic increase in lxr by fructose may trigger neurochemical and neurophysiological responses for the control of food intake and energy expenditure . but \\n circulating fructose levels could possibly promote central effects in humans even if hepatic clearance of fructose is extremely efficient , given the following observations : ( i ) the presence of glut5 in the bbb and ketohexokinase mrna , the necessary cellular machinery for fructose metabolism ; ( ii ) fructose administered i.p . \\n can cross the bbb and trigger neuronal activation in rodents ; ( iii ) fructose administrated i.p . \\n these data suggested the capacity of fructose to cross the bbb into the hypothalamus , where it could be metabolised and used as an energy source . \\n thus , consumption of high - fructose diets might probably have a direct effect on the brain , but no study has clearly proven this concept yet . while it is well established that glucose orally ingested undergoes facilitated transport across the bbb , the demonstration that fructose orally ingested can cross the bbb is still missing . \\n another question is how changes in feeding behaviour associated with glucose- and fructose - induced activation of brain regions observed in animals could be extrapolated to humans , especially when most of the studies investigating these effects have been performed on rodents . \\n new technologies are available to facilitate the translation of animal to human studies and help understanding of brain functions . \\n one such technique is the single - photon emission computed tomography ( spect ) that provides a way to compare brain circuits implicated in the processing of oral and/or visceral ( e.g. duodenal or portal ) sugar signals . \\n the authors found that both duodenal and portal glucose infusions activated the dorsolateral prefrontal cortex and primary somatosensory cortex . \\n however , only duodenal glucose infusion induced the activation of the prepyriform area , orbitofrontal cortex , caudate and putamen , and the deactivation of the anterior prefrontal cortex and anterior entorhinal cortex , whereas only portal glucose infusion induced the activation of the insular cortex . \\n these results indicated that duodenal and portal glucose infusions modulate differentially the activity of brain areas implicated in the regulation of eating behaviour , which probably explains the decrease in food intake after both stimulations . \\n another spect study in pigs ( clouard et al . , 2013 , unpublished data ) demonstrated that combined oral and duodenal sucrose sensing induced activation of brain regions involved in memory , reward processes , and hedonic identification of sensory stimuli ( i.e. amygdala , dorsal striatum : caudate and putamen , and the anterior prefrontal cortex ) , whereas oral or duodenal sucrose sensing individually administered did not . \\n these findings suggested that ( 1 ) the concordance between oral and visceral signals ( sweet taste and calories ) during sugar sensing is necessary for the onset of responses in these brain structures , or ( 2 ) the synergy between oral and visceral signals during sugar sensing is required to obtain a signal that is strong enough to trigger brain responses in these structures ( clouard , et al . \\n positron emission tomography ( pet ) studies with 18-fluorodeoxyglucose ( 18-fdg ) to measure brain glucose metabolism in normal - weight individuals reported that exposure to food cues increased metabolic activity in the orbitofrontal cortex , similar to that observed in cocaine - addicted subjects , which was an effect associated with the perception of hunger and the desire for food . functional magnetic resonance imaging ( fmri ) \\n is another technique that provides a non - invasive way to assess the effects of glucose and fructose intake , as well as of obesity , on regional cerebral blood flow ( abbreviated rcbf and estimated via the blood  oxygen - level - dependent or bold signal ) . \\n previous studies have explored the temporal response to glucose intake or infusion using fmri and found suppression of hypothalamic bold signalling after the administration of glucose to rats and humans . \\n obese subjects presented diminished attenuation of the bold signal in response to glucose ingestion compared with lean subjects , and patients with type 2 diabetes did not show any hypothalamic signal changes compared with non - diabetic patients . \\n this might suggest a reduced neuronal activation in obese relative to lean subjects , which might translate in no suppression of appetite and less rewarding signals from glucose intake leading to overeating . \\n cortical responses to sugars in healthy subjects as assessed by fmri appear to be opposite between glucose and fructose infusion : increased and decreased cortical activation , respectively . \\n the suppressive effect of fructose on cortical bold signal occurred despite the fact that cortical - specific receptors ( glut5 ) are present in low concentrations throughout the brain , where the glucose transporter glut3 predominates . \\n whether this cortical response to fructose is due to effects mediated by glut2 and glut5 carriers in the bbb or in local glial cells , due to increased osmolality , or is the indirect result of changes in the levels of peripheral neural input or metabolic intermediaries is yet to be understood . \\n however , the overall observations suggest a major implication of fructose on changes in brain activity similar to those observed with addictive drugs , which may lead to an altered reward response to palatable food . \\n in contrast to the effects of sugars in cortical activation , their effects in other brain regions involved in food intake control , i.e. hypothalamus , appear to be opposite . \\n another fmri study in humans showed that glucose , but not fructose intake , induced a marked reduction in hypothalamic bold signal , as well as a reduction in cbf within the thalamus , insula , anterior cingulate , striatum , and hypothalamus , i.e. brain regions that act together to sense the metabolic state of an individual and drive motivation and reward . \\n moreover , fructose produced a transient increase in hypothalamic activity and reduced cbf in the hippocampus , a region implicated not only in memory but also influencing emotional responses to food intake . \\n these findings suggest that ingestion of glucose , but not fructose , initiates a coordinated response between the homeostatic and striatal networks that regulate eating behaviour . in line with these data , ingestion of glucose but \\n not fructose produced increased ratings of satiety and fullness . what are the underlying mechanisms of these effects of fructose on cbf changes is a remaining question \\n since no study has clearly demonstrated the capacity of fructose orally ingested to cross the bbb . \\n figures  2 and 3 represent hypothetical and controversial models summarising the findings that support the  fructose hypothesis which postulates an orexigenic and less rewarding effect of fructose intake , compared to glucose . \\n vagal afferents express glp-1 and 5-ht receptors , and are implicated in the regulation of insulin secretion . \\n many neuronal signals are communicated via the vagus nerve to the brain stem , which relays the glucose signal to hypothalamic nuclei and then to the pertinent target cells : npy / agrp and pomc / cart neurons . \\n npy neuropeptide y , agrp agouti - related protein , pomc proopiomelanocortin , cart cocaine  amphetamine - related transcript , amp adenosine monophosphate , ampk amp kinase , acc acetyl - coa carboxylase . \\n black arrows activation ; discontinued \\n red lines inhibition ; thin discontinued red line weak activation [ 4 , 51 , 52 , 54 , 57 , 58 , 72 , 182]fig . \\n luminal fructose induces weak release of 5-ht and glp-1 from enteroendocrine and l cells , respectively , weak pyy , insulin and leptin secretion , as well as weak ghrelin suppression . \\n many neuronal signals are communicated via the vagus nerve to the brain stem , which relays the glucose signal to hypothalamic nuclei and then to the pertinent target cells : npy / agrp and pomc / cart neurons . \\n npy neuropeptide y , agrp agouti - related protein , pomc proopiomelanocortin , cart cocaine  amphetamine - related transcript , amp adenosine monophosphate , ampk amp kinase , acc acetyl - coa carboxylase . \\n black arrows activation ; discontinued red lines inhibition ; grey arrows low secretion or low activation [ 4 , 37 , 51 , 52 , 54 , 58 , 59 , 72 , 182 ] hypothetical model of the peripheral and central effects of glucose on food intake . \\n vagal afferents express glp-1 and 5-ht receptors , and are implicated in the regulation of insulin secretion . \\n many neuronal signals are communicated via the vagus nerve to the brain stem , which relays the glucose signal to hypothalamic nuclei and then to the pertinent target cells : npy / agrp and pomc / cart neurons . \\n npy neuropeptide y , agrp agouti - related protein , pomc proopiomelanocortin , cart cocaine  amphetamine - related transcript , amp adenosine monophosphate , ampk amp kinase , acc acetyl - coa carboxylase . \\n black arrows activation ; discontinued \\n red lines inhibition ; thin discontinued red line weak activation [ 4 , 51 , 52 , 54 , 57 , 58 , 72 , 182 ] hypothetical model of the peripheral and central effects of fructose on food intake . \\n luminal fructose induces weak release of 5-ht and glp-1 from enteroendocrine and l cells , respectively , weak pyy , insulin and leptin secretion , as well as weak ghrelin suppression . \\n many neuronal signals are communicated via the vagus nerve to the brain stem , which relays the glucose signal to hypothalamic nuclei and then to the pertinent target cells : npy / agrp and pomc / cart neurons . \\n npy neuropeptide y , agrp agouti - related protein , pomc proopiomelanocortin , cart cocaine  amphetamine - related transcript , amp adenosine monophosphate , ampk amp kinase , acc acetyl - coa carboxylase . \\n black arrows activation ; discontinued red lines inhibition ; grey arrows low secretion or low activation [ 4 , 37 , 51 , 52 , 54 , 58 , 59 , 72 , 182 ] \\n the mesolimbic dopamine ( da ) system plays a critical role in the reinforcing effects of reward and is implicated in conditions such as drug addiction and eating disorders . \\n dopamine is the primary neurotransmitter involved in the brain reward pathways   and in the reward value of sweet taste , mainly because sweet taste activates mesolimbic da circuits involved in the mediation of natural as well as drug rewards . \\n mice lacking the cellular machinery required for sweet taste transduction ( trpm5 ) learned to prefer the postingestive effects of sucrose . \\n these mice did not develop a preference for sucrose per se probably due to the short training sessions . \\n however , zuckerman et al .   reported that trpm5 ko mice learned to prefer glucose but not fructose solutions in 24-h two - bottle choice tests . \\n furthermore , trpm5 ko mice developed a robust preference for sucrose solutions based solely on caloric content . \\n sucrose intake induced da release and increased neuronal responses in the ventral striatum of these mice in the absence of gustatory input . \\n these findings suggested that calorie - rich nutrients could directly influence brain reward circuits that control food intake independently of palatability or functional taste transduction . \\n dopamine release is stimulated in the nac by the sweet taste in the mouth . \\n it was reported that the neurochemical effects observed with intermittent sugar access are not only due to sucrose postingestive properties but also to the sweet taste of sucrose . the mesolimbic da projection from the ventral tegmental area ( vta ) to the nac \\n data from animal models of binge - eating but with normal weight show that behavioural and neuronal consequences of bingeing on a palatable food are different from those that result from simply consuming the palatable food in a non - binge manner , i.e. physiological , neural , and behavioural effects independent of a dio \\n . excessive intake of palatable foods under specific conditions can produce behaviours and changes in the brain that resemble an addiction - like state , such as greater activation of the anterior cingulate cortex , the medial orbitofrontal cortex , and the amygdala , regions associated with motivation . \\n these changes may be more closely correlated with binge - eating behaviour than they are to body weight . \\n it was recently suggested that people at risk of obesity initially show a hyperfunctioning in the gustatory and somatosensory cortices that increases pleasure perception from food , leading to increased reward , overeating , and weight gain . \\n this overeating may induce receptor down - regulation in the striatum , increasing the likelihood of further overeating and continued weight gain . \\n obese versus lean humans show less activation in the dorsolateral prefrontal cortex , and greater activation of regions involved in the reward value of stimuli ( striatum , amygdala , orbitofrontal cortex , and mid - insula ) , in attention regions ( ventral lateral prefrontal cortex ) , and in somatosensory regions , in response to high - fat / high - sugar food images relative to control images . \\n similarly , dio minipigs showed deactivations in the dorsolateral and anterior prefrontal cortices and activations in the ventral posterior nucleus of the thalamus and middle temporal gyrus , compared to lean minipigs . \\n moreover , the anterior and dorsolateral prefrontal cortices as well as the insular cortex activity were negatively associated with body weight . \\n these data suggested that the reduced activation of the prefrontal cortex observed in obese subjects is an acquired feature of obesity . \\n mccutcheon et al .   showed that da release in the nac core to food - predictive cues is strongly modulated by food s characteristics . \\n cues paired with sucrose ( the preferred reward ) evoked greater da release , than cues predicting saccharin ( the non - preferred reward ) . \\n this subjective preference and greater da release could result from a difference in the orosensory qualities of the pellets or an aversion to the bitter taste of saccharin , and suggests that sucrose may more powerfully motivate behaviour . \\n the nac , the amygdala , and the medial prefrontal cortex are implicated as central sites of action for the suppressive effects of the da-1 receptor ( d1r ) and da-2 receptor ( d2r ) antagonists ( sch23390 and raclopride , respectively ) , on sugar intake and on the expression of flavour preferences conditioned by the sweet taste of sugars . \\n subcutaneous administration of d1r agonist prior to food preference test reduced the intake of the regular diet and induced a strong preference for high - fat / high - sucrose food , whereas d2/d3 receptor agonist had the opposite effects . \\n these results suggested that the da receptor subtype is a major determining factor of the direction in which sweet food preference is modulated , in addition to the level of da release in the nac . \\n subcutaneous injections of d1r and d2r antagonists substantially and dose dependently reduced the intake and preference of sucrose solutions but not saccharin solutions , suggesting that the antagonists decreased the reinforcing value of sucrose , but not saccharin , solution . \\n systemic administration of dopamine d1r ( sch23390 ) and d2r ( raclopride ) antagonists in the medial prefrontal cortex and amygdala , but not in the nac shell , blocked the acquisition and expression of fructose - conditioned flavour preferences in rats . \\n in contrast to the effect of intragastric glucose following bilateral injection of the d1r antagonist on blocking the acquisition of conditioned flavour preferences , bilateral hypothalamic injections of d1r and d2r antagonists failed to alter the acquisition of fructose - conditioned flavour preference in rats . \\n these findings suggest an important difference between flavour  flavour and flavour  nutrient - conditioned flavour preferences . \\n fructose intake and fructose - conditioned flavour preference appear to be more dependent on d2r activity than sucrose intake . \\n injections of d1r antagonist into the amygdala or nac during training did not block fructose conditioning , but did block the acquisition of a flavour preference produced by glucose infusions . \\n rats under a high - fat diet responded to all raclopride doses with reductions in sucrose intake , but not in fructose intake , while rats fed a high - fat and sugar diet only responded to the highest dose of raclopride , with significant reductions in fructose intake . \\n these data indicate that there is a differential involvement of d1r and d2r in flavour  flavour and flavour  nutrient preference , respectively \\n . an explanation may include differential neural and hormonal postingestive effects exerted by fructose and sucrose . in this context \\n , it may be possible that the high - fat diet and the high - fat and high - sugar diet altered sucrose and fructose preferences differently as a result of their differential effects on oral and gastrointestinal signals upstream the reward system . \\n anatomical and functional evidence demonstrates multiple interactions between the mesolimbic da system and peripheral signals regulating food intake . \\n one such system is the cck system . in an obese rat model lacking the cck-1 receptors ( oletf ) , treatment with d2r antagonist raclopride , but not d1r antagonist sch23390 , showed increased potency to reduce sucrose real intake , indicating that d2r are involved in heightened increased consumption of sucrose observed in these obese rats . \\n these findings confirm the notion that da increases sucrose intake due to the assignment of an actual rewarding value of sucrose primarily based on its sensory stimulatory effects . \\n they also confirm that altered da signalling present in obesity is involved in the increased potency of sucrose palatability to maintain ingestion in obese subjects . \\n ghrelin has recently emerged as a potent modulator of the mesolimbic dopaminergic reward pathway , suggesting a role for ghrelin in food reward . \\n ghrelin targets a key mesolimbic circuit involved in food and drug - induced reinforcement , i.e. da projection from the vta to the nac . \\n skibicka et al .   identified the vta , a key structure in the mesolimbic reward system , as a primary target for ghrelin s effects to increase motivation for a sweet food reward . \\n conversely , blockade of ghs - r1a ( ghrelin type 1a receptor ) signalling significantly decreased operant responding for sucrose . \\n these findings indicate that ghrelin plays an important role in motivation and reinforcement for sucrose . \\n they suggest that ghrelin antagonists have therapeutic potential for the treatment for obesity and for suppressing sweet food overconsumption [ 143 , 144 ] . \\n lustig   reviewed that chronic hyperinsulinemia may prevent da clearance from the nac and leptin signalling , leading to leptin resistance and increased food intake . \\n thus , by promoting insulin resistance and hyperinsulinemia , fructose excessive intake may alter da neurotransmission and the hedonic response to food leading to overeating . \\n increasing the palatability of food by the addition of sucrose undermines normal satiety signals and motivates energy intake independent of energy needs . \\n animal models of intermittent sugar administration can induce behavioural alterations consistent with dependence , i.e. bingeing , withdrawal and anxiety , craving , and cross - sensitisation to other drugs of abuse . \\n anatomical and functional evidence demonstrates multiple interactions between the mesolimbic da system and peripheral signals regulating food intake . \\n one such system is the cck system . in an obese rat model lacking the cck-1 receptors ( oletf ) , treatment with d2r antagonist raclopride , but not d1r antagonist sch23390 , showed increased potency to reduce sucrose real intake , indicating that d2r are involved in heightened increased consumption of sucrose observed in these obese rats . \\n these findings confirm the notion that da increases sucrose intake due to the assignment of an actual rewarding value of sucrose primarily based on its sensory stimulatory effects . \\n they also confirm that altered da signalling present in obesity is involved in the increased potency of sucrose palatability to maintain ingestion in obese subjects . \\n ghrelin has recently emerged as a potent modulator of the mesolimbic dopaminergic reward pathway , suggesting a role for ghrelin in food reward . \\n ghrelin targets a key mesolimbic circuit involved in food and drug - induced reinforcement , i.e. da projection from the vta to the nac . \\n identified the vta , a key structure in the mesolimbic reward system , as a primary target for ghrelin s effects to increase motivation for a sweet food reward . \\n conversely , blockade of ghs - r1a ( ghrelin type 1a receptor ) signalling significantly decreased operant responding for sucrose . \\n these findings indicate that ghrelin plays an important role in motivation and reinforcement for sucrose . \\n they suggest that ghrelin antagonists have therapeutic potential for the treatment for obesity and for suppressing sweet food overconsumption [ 143 , 144 ] . \\n lustig   reviewed that chronic hyperinsulinemia may prevent da clearance from the nac and leptin signalling , leading to leptin resistance and increased food intake . \\n thus , by promoting insulin resistance and hyperinsulinemia , fructose excessive intake may alter da neurotransmission and the hedonic response to food leading to overeating . \\n increasing the palatability of food by the addition of sucrose undermines normal satiety signals and motivates energy intake independent of energy needs . \\n animal models of intermittent sugar administration can induce behavioural alterations consistent with dependence , i.e. bingeing , withdrawal and anxiety , craving , and cross - sensitisation to other drugs of abuse . \\n the endocannabinoid system is a lipid - signalling system composed of three non - ubiquitous receptors ( cb1 , cb2 , and likely cb3 receptor ) , two endogenous ligands ( i.e. anandamide and 2-arachidonoyl - glycerol , 2-ag ) , and the enzymatic machinery for their synthesis and degradation . \\n this system is implicated in the regulation of appetite , eating behaviour , and body weight homeostasis at both peripheral and central levels . in the brain , the endocannabinoid system appears to control food intake mainly at three functional levels , i.e. the hypothalamus , the dorsal vagal complex , and the limbic system , by affecting satiety signals and interacting with brain reward pathways [ 148 , 149 ] . \\n previous studies have revealed the ability of marijuana , or of its main psychoactive component -tetrahydrocannabinoid ( -thc ) , to induce not only hyperphagia , but also to increase the desire to consume highly palatable food and to impact food selection concomitantly . \\n endocannabinoids have been implicated in the regulation of consumption of palatable food , sugar in particular . \\n cb1 receptor antagonist ( sr 141716 , also known as rimonabant , an anorectic anti - obesity drug ) resulted in reduced body weight and appetite for sweet foods and drinks . \\n following low oral doses of -thc ( 0.25 and 0.40  mg / kg ) , there was a dose - dependent increase in preference for palatable food and sucrose intake in rats . \\n similarly , administration of -thc ( 0.5 , 1.0 , and 3.0  mg / kg ) , anandamide ( 1.0 and 3.0  mg / kg ) , and 2-ag ( 0.2 , 1.0 , and 2.0  mg / kg ) substantially increased the number of licks of 10  % sucrose solution , due to increased bout duration rather than bout number , whereas administration of cb1 antagonist sr141716 significantly decreased total licks . \\n rimonabant also specifically reduced sucrose , alcohol , and sweet food intake in rats and marmosets . \\n endocannabinoids ( anandamide and 2-ag ) peripherally administered selectively enhanced gustatory nerve ( chorda tympani ) responses and electrophysiological responses of taste cells , located on the anterior tongue innervated by the chorda tympani nerve , to sweeteners ( i.e. saccharin , glucose , and sucrose ) in mice . \\n these sweet - enhancing effects of endocannabinoids were mediated by cb1 receptors , which were coexpressed in taste cells with the sweet receptor subunit t1r3 in taste cells . \\n however , since no differences were previously found in gustatory nerve ( chorda tympani ) responses to glucose , sucrose , and fructose in pigs , one might speculate that endocannabinoids may exert similar degree of taste enhancement sensitivities between these three sugars . \\n but this hypothesis remains unclear since neural responses do not always predict functional sensitivity ; moreover , the observed responses do differ at various stimulus concentrations , and it is unclear how endocannabinoids would interact with this . \\n intraperitoneal administration of endocannabinoids to wild - type mice selectively enhanced gustatory nerve responses and electrophysiological responses of taste cells , located on the anterior tongue innervated by the chorda tympani nerve , to sweet compounds ( sucrose , saccharin , and glucose ) . \\n these sweet - enhancing effects of endocannabinoids were mediated by cb1 receptors , which are coexpressed in taste cells with the sweet receptor component t1r3 . \\n consumption of fructose solution in combination with standard rat chow resulted in increased mrna levels of cb1 in the rat hypothalamus . \\n intake of sucrose , glucose , and fructose solutions during 7  days affected the mrna expression of the majority of enzymes involved in the synthesis and degradation of anandamide and 2-ag , in rats . fructose solution increased mrna levels of fatty acid amide hydrolase ( faah ) ( involved in anandamide degradation ) , compared to water , glucose , and sucrose solutions . \\n this suggests that fructose intake might induce an overproduction of anandamide and that an up - regulation of this enzyme is necessary to maintain normal levels of anandamide . \\n the three sugar solutions induced a down - regulation of phospholipase c ( involved in anandamide synthesis ) . \\n this may suggest an attempt to maintain anandamide at physiological levels during periods of high - sugar consumption irrespective of the nature of the sugar . \\n monoglyceride lipase ( mgll ) , the main enzyme involved in 2-ag degradation , was also down - regulated by the three sugar solutions compared to water intake . \\n this would suggest that 2-ag is degraded less readily in rats drinking sugar solutions than in water drinking rats . \\n however , only fructose intake increased mrna levels of diacylglycerol lipase 1 ( involved in 2-ag synthesis ) , suggesting that more 2-ag is being produced . \\n however , the interpretation of these results is conflicting , given the simultaneous increase or decrease in enzymes involved in the synthesis and degradation of endocannabinnoids , respectively , induced by the sugar solutions . \\n besides , neither protein levels nor actual concentrations of endocannabinoids were measured , making it difficult to draw a conclusion . \\n .   demonstrated that a diet - induced obesity ( dio ) by excess dietary lipid intake is associated with altered expression of cb1 mrna , higher plasma endocannabinoids , or increased adipose tissue endocannabinoid synthesis . \\n blockade of cb1 receptor improves the gut barrier and reduces metabolic endotoxemia , by a mechanism independent of eating behaviour , suggesting a control of gut permeability by cb1 receptors through interactions with gut microbiota . \\n it is possible that fructose could also modulate the intestinal endocannabinoid system by a similar mechanism , but future studies are needed to investigate this hypothesis . \\n finally , endocannabinoids have been proven to interact with brain reward pathways in a manner similar to other reward - enhancing drugs . \\n therefore , the endocannabinoid system might affect eating behaviour through the modulation of the reward circuit . which are the effects of the different dietary sugars on the endocannabinoid system and their interaction with brain reward pathways to affect eating behaviour \\n as presented in the previous section on the da system , different types of sugars differentially modulate this system . \\n therefore , it is possible that these differences might also be observed in the endocannabinoid system and this requires further investigation . \\n . chronic suppression of the endogenous -opioid receptor signalling in the nucleus accumbens ( nac ) shell and core significantly attenuates the development of a dio by reducing the intake of palatable , high - sugar foods in rats . \\n opioid antagonism in the nac is associated with a reduction in sweet food preference and sucrose intake , and weakens hedonic properties of sucrose and motivation for sucrose [ 156158 ] . \\n conversely , stimulation of -opioid signalling in the nac increases sucrose intake and motivation . the consumption of sweet tastants results in neurochemical changes within the brain , which may reflect a shift in opioid - mediated responses . \\n sucrose and glucose intake paired with opioid receptor antagonism ( naloxone ) induced an increase in the number of c - fos - positive nuclear profiles   and an elevation in opioid -1 receptor binding in the cingulate cortex , hippocampus , locus coeruleus , and accumbens shell , associated with the presence of opiate withdrawal - like symptoms , such as teeth chattering . \\n these results suggest that ingestion of sucrose and glucose induces neurochemical changes within the opioid brain circuitry . \\n opioids support a drive to consume sugar , and this mechanism is mainly dependent on their ability to act through the reward system . \\n similar to the reports in the cocaine studies for drug euphoria and craving , sweet liking may increase with the dose while sweet wanting may not . \\n overall , opioid signalling , particularly through its -receptor in the nac , is involved in the expression of reward behaviours induced by the consumption of sweet - palatable foods and may be involved in the development of dio . \\n however , the vast majority of these studies , in both animals and humans , regarding opioids and sugar intake have used sucrose as the source of sugar . \\n one of the few studies using both glucose and fructose was performed by bernal et al . . \\n they found that rats develop strong preferences for flavours paired with the sweet taste of fructose or the post - oral nutrient effects of glucose . \\n opioid antagonism at the nac shell and core did not block sugar - conditioned flavour preference at any dose and with neither glucose nor fructose solutions . \\n however , the authors did not directly compared to glucose versus fructose stimulus so there is no clear evidence about possible differences between these sugars following opioid antagonism in the nac . given the high amounts of fructose currently consumed in western diets , it would be interesting to directly compare the effects of free fructose and glucose to those observed with sucrose on the opioid system . given the observations of the effects of fructose intake on appetite , its higher palatability compared to glucose , and its differential effects at both peripheral and central levels , including the da system , one might speculate that fructose could induce more profound effects on this system than sucrose or glucose . \\n however , since fructose may not cross the bbb at typical intake levels , this hypothesis seems unrealistic . \\n further research directly comparing the effects of sucrose , glucose , and fructose is needed to investigate this hypothesis . \\n several pieces of evidence have led to the assumption that fructose excessive intake may be responsible for the increasing prevalence of obesity since the last decades . \\n this has stimulated research aiming at understanding the underlying mechanisms of this fructose - induced obesity . \\n for example , epidemiologic and experimental evidence indicates that a greater consumption of sugar - sweetened beverages with hfcs is , in fact , associated with weight gain and obesity , and that hfcs accounts for 40  % of caloric sweeteners used in the united states [ 13 , 16 , 17 , 164 , 165 ] . \\n in addition to these epidemiological data , evidence has shown that fructose induces smaller increases in insulin , leptin , and other satiety peptides compared to glucose [ 37 , 5559 ] . \\n this suggested an endocrine mechanism by which fructose might induce greater food intake and weight gain than glucose . \\n however , while it is true that fructose intake in the form of hfcs makes up a significant proportion of energy intake in the western diet [ 13 , 164 ] , it is also true that this increase in fructose intake is necessarily associated with an increase in total energy intake and in glucose ( from hfcs ) . \\n besides , equal amounts of glucose and fructose are necessary for maximal fructose absorption in humans . \\n this makes questionable the effect of fructose per se for increasing food intake , inducing weight gain and metabolic diseases . \\n in fact , there are some well - controlled studies showing divergent findings in this regard that are important to discuss here given the extended great concern regarding the fructose - induced obesity . \\n .   found no differences in terms of food intake , pyy , and leptin serum levels following 2-week intake of sucrose , glucose , or fructose solutions in rats . \\n moreover , these authors found that the fructose - drinking group had the smallest increase in food intake , probably attributed to the lowest intake of fructose solution . \\n this was attributed to the fact that fructose is sweeter than sucrose and glucose , and it may also be attributable to the short period ( 2  weeks ) of sugar solution intake . \\n in addition , no difference was found in energy intake and weight gain following 50-day intake of sucrose , glucose , or fructose solutions , but body adiposity increase was greater with sucrose than with fructose solutions . in humans , no differences in terms of energy intake , satiety , and energy compensation , nor in plasma glucose , glp-1 , insulin , and ghrelin release were found following acute ingestion of preload drinks containing sucrose or hfcs ( 1.5  mj ) . \\n this lack of difference in satiety was found despite different biochemical properties ( leading to different transport across the gut epithelium and thus different transit time ) as well as different mechanisms underlying satiety between sucrose- and hfcs - containing drinks [ 64 , 110 , 168 ] . \\n therefore , more studies are needed to clarify these discrepancies . glendinning et al .   investigated in four strains of mice given free access to sugar solutions and showed that sucrose promoted more overeating , resulting in increased weight gain and adiposity compared to fructose , regardless of mouse strain . \\n these authors reported as well that mice and rats consume less fructose than isocaloric sucrose . \\n fructose orally ingested or intraduodenally infused induced insulin release and inhibited food intake more than glucose in rats and humans [ 7 , 170 , 171 ] , whereas another study found no difference between these sugars orally ingested on food intake . \\n sclafani and ackroff   reported that 16  % glucose intragastric infusion condition a strong flavour preference in mice , whereas fructose and galactose infusions failed to do so . \\n the latter findings are opposed to other findings , suggesting that fructose is a weaker elicitor of satiation signals [ 54 , 62 ] and may have a more rewarding effect probably due to its higher sweetness than glucose . \\n the only rodent study that appears in the literature reporting fructose - induced weight gain more than sucrose - fed mice used a 15  % fructose solution or a 10  % sucrose solution , which invalidates the findings . \\n white   recently reviewed that many animal studies have used extremely high - fructose doses , or altered the usual glucose - to - fructose ratio that are not predictive of typical human diets , leading to abnormal metabolism . \\n he exposed as well that ( i ) the increased energy intake per capita coupled with insufficient compensating exercise is a more consistent explanation to the obesity epidemics ; ( ii ) there has been no positive correlation between fructose intake and increasing rates of obesity ; ( iii ) consumption of added sugars has not increased , but actually decreased for more than a decade ; and ( iv ) all sources of fructose in human diets contain comparable amounts of glucose , and glucose is the dominant sugar in the human diet ( 5 times more glucose than fructose ) . \\n the fructose hypothesis is refuted by studies using real - world fructose exposures showing no differential effects versus control , and cause - and - effect evidence of adverse effects is lacking at typical human exposure levels and patterns . \\n sun et al .   analysed the intake patterns of  >  25,000 subjects in the nhanes 19992006 databases and found that daily fructose intakes with the american diet averaged 9  % of daily intake , that fructose is rarely consumed solely or in excess over non - fructose sugars , and that fructose and non - fructose sugar ordinary intake was not positively associated with indicators of metabolic syndrome , uric acid , or bmi . \\n a metaanalysis by sievenpiper et al .   reported the effects of fructose on body weight in controlled feeding trials . \\n they found that fructose has no effect on body weight in isocaloric trials ( 637 participants ) compared to isocaloric diets containing a non - fructose sugar . \\n in contrast , high doses of fructose in hypercaloric trials ( 119 participants ) induced weight gain . \\n the effect of fructose - induced body weight gain in hypercaloric trials may have been due to excess energy intake rather than fructose itself because ( i ) weight gain is similar to that which would be predicted with consumption of a 2,000-kcal diet with similar amount excess energy ; ( ii ) high - precision estimates of energy expenditure , fat , and carbohydrate oxidation using whole - body calorimetry showed no differences among fructose , glucose , or sucrose . taken together , \\n these data suggest that an excess energy may be a more important factor for weight gain than the type of sugar . concerning some of the central effects , both oral intake of glucose and \\n fructose solutions during 2  weeks produced a down - regulation of pomc mrna levels . \\n processing of pomc by pro - hormone convertases results in the production of -msh , which suppresses feeding , and  - endorphin , which stimulates it . \\n thus , pomc mrna decrease , together with a decrease in  - endorphin , may indicate the down - regulation of a potent suppressor of food intake and less rewarding signals through the opioid pathway by sugar solutions . \\n thus , the observed reduction in npy mrna levels in this study may attempt to balance for calorie overconsumption . despite the down - regulation of hypothalamic npy and pomc mrna , there was no reduction in hyperphagia induced by the consumption of sugar solutions . taken together , \\n fructose hypothesis remains controversial , and a cause - and - effect association between fructose intake and the metabolic syndrome and obesity has not been clearly confirmed yet . \\n thus , there is a need for more research on fructose with experimental designs based on physiological conditions so that a consensus could be established . \\n the aim of this review was to critically discuss the effects of dietary sugars at both central and peripheral levels . \\n based on the current findings , diverse hypotheses were postulated all along the review sections with two main goals : ( i ) to open new perspectives for future research that may contribute to our understanding of current data with a special focus on fructose , and ( ii ) to clarify controversial findings in order to advance in the establishment of a consensus concerning the differential effects of the main dietary sugars found in humans diets at both peripheral and central levels . in summary , \\n contrary to glucose , excessive fructose intake may provoke metabolic disturbances , such as an increased gut permeability , low - grade inflammation , nafld , insulin resistance , and dyslipidaemia . through luminal gut detection and following the activation of sweet taste receptors \\n , glucose triggers the secretion of peripheral anorexigenic peptides , i.e. insulin , leptin , glp-1 , pyy , and suppression of orexigenic peptides ( e.g. ghrelin ) that activate vagal pathways and act on brain target regions controlling appetite ( e.g. the arcuate nucleus of the hypothalamus and the dorsal vagal complex ) , thus leading to appetite suppression and reward response . \\n glucose may also directly induce its effects on appetite suppression by crossing the bbb , where it suppresses ampk activity , an effect that stimulates neuronal activity of pomc / cart expressing neurons , which contributes as well in the satiety response . \\n fructose may have different effects on the secretory profile of appetite peptides and neuropeptides , leading to reduced appetite suppression as well as an indirect effect on the reward response , i.e. through a deficient stimulation of leptin and insulin secretion , hormones implicated in the rewarding effects of palatable food , fructose may provoke a deficient reward response leading to overeating \\n . however , most of these results were obtained from rodents and using extremely high doses of fructose far from the typical human diets . \\n other studies found small or no differences between glucose , sucrose , and fructose in appetite peptide secretion , food intake , and weight gain . \\n these discrepancies may be due to differences in species , metabolic phenotype , experimental approaches , form of administration ( peripheral or central infusions ) , in the form of solutions or added in the diet , doses , duration of exposure , and experimental diet compositions . \\n several clues and hypothesis were proposed for future research aiming at clarifying these controversial findings . besides , fructose \\n is rarely consumed isolated in the diet , but rather in the form of hfcs or sucrose , or consumed along with glucose . \\n therefore , no definite conclusions could be established for giving any nutritional recommendations to suppress or reduce fructose from the human diets . \\n overall , data obtained from well - controlled studies in pigs or rodents , and epidemiological studies in humans , suggest that it is the association between fructose and other components in the diet , such as fat , cholesterol , and other dietary sugars , as well as total caloric intake coming from dietary sugars , responsible for the metabolic effects and weight gain , rather than fructose intake per se . \\n given the difficulty to perform controlled studies in humans for ethical reasons , a valuable approach may be through the use of the pig model that has been shown to present greater similarities to humans than smaller animals ( e.g. cats and rodents ) . at the central level , \\n consistent evidence has suggested the capacity of fructose to induce changes in neuropeptides or brain activity , with a resulting decrease in the satiety response . \\n however , there is no clear evidence of the capacity of fructose orally ingested to cross the bbb . \\n thus , it seems unlikely that fructose could directly induce changes in brain appetite peptides to produce its effects on satiety . \\n fructose is partially ( 12  % ) metabolised in the gut during absorption , and the liver and kidneys rapidly metabolise the remaining fraction . \\n this leads to very low fructose plasma concentrations and during a very short time , as well as the low glut5 affinity for fructose and low glut5 concentrations in the bbb , and the possibility of a fructose malabsorption when ingested in high doses . \\n these factors make unlikely that fructose could cross the bbb and induce significant effects on the brain . \\n contrary to the well - established direct central effects of glucose on energy homeostasis and food intake through central glucose - sensing mechanisms , the fructose effects on eating behaviour are more likely to be exclusively through indirect mechanisms , i.e. via activation of t1r2/t1r3-sensing mechanism in the mouth and gut , as well as intestinal glucose transporters . \\n this activation triggers the secretion of appetite peptides that may affect thereafter brain neuropeptides involved in appetite control , as well as the activation or deactivation of brain regions involved in appetite and reward . \\n therefore , fructose may indirectly influence appetite and reward through changes in the levels of peripheral neural input or metabolic intermediaries modifying the activation of brain regions implicated in appetite and reward . while fructose effects on the reward circuitry seem to be consistent when administered i.c.v . or intragastrically , \\n this review presented consistent evidence showing the implication of the endocannabinoid , opioid , and mesolimbic dopaminergic systems in the modulation of sweet taste reward and in the development of preferences for sweet taste that may lead to aberrant eating behaviours . \\n this addictive - like condition could be explained by a desensitisation of the reward pathways . however , most of these studies used sucrose as the source of sugar in the experiments , thus making it impossible to separate the specific effects of glucose and fructose or their interaction . \\n the apparent parallel increases between fructose intake and obesity development make necessary more research to elucidate possible differences between glucose , sucrose , and fructose on the reward circuitry . \\n for example , the satiety hormones insulin and leptin are implicated in the reward effect from palatable food . in this regard , \\n a hypothesis was postulated arguing that if fructose induces lower leptin and insulin secretions , it may also induce less satiety effect and a less rewarding effect compared to glucose intake , and therefore an increase in food intake to compensate for this lack of reward from food . \\n however , the opposite may also be plausible : if fructose is less rewarding than glucose , it may not stimulate excessive intake , as is the case of several studies reported in the  controversial findings section . \\n this may be another angle for weighing detrimental effects of sugars and thus should be investigated in future studies . \\n we presented results showing that sucrose intake induces da release and increases neuronal activity in the brain reward circuitry . \\n dopamine release is stimulated in the nac by the sweet taste in the mouth and by the postingestive actions of sugars . \\n considering that fructose is sweeter than glucose and sucrose for humans , one might hypothesise that fructose could induce greater da release compared to glucose and sucrose , which may lead to increased reward from food , increased food intake , and aberrant eating behaviours . \\n however , this hypothesis remains controversial since calorie - rich nutrients ( i.e. sucrose ) can directly influence brain reward circuits that control food intake independently of palatability or functional sweet taste transduction . on the other hand , \\n most of the studies comparing the effects of intermittent and/or excessive sugar intake with the effects of addiction to drugs on the dopamine system have used sucrose as well , and very few have used glucose ; to our knowledge , none has compared fructose versus glucose on the characteristics of addiction ( e.g. escalation of intake ) . \\n it was until recent years that researchers began to compare the effects of da receptor antagonists on the expression of fructose - conditioned preferences compared with sucrose . \\n these studies have mainly found that  fructose intake and fructose - conditioned flavour preference appear to be more dependent on d2r activity than sucrose intake ( e.g. [ 136 , 138 , 139 ] ) . \\n therefore , future studies should directly compare da release levels , da transporter expression and da receptor expression patterns following ingestion of glucose , sucrose , and fructose . \\n concomitantly , these studies should also measure appetite peptide secretion levels , neuropeptides , brain activity of regions implicated in appetite and reward , and feeding behaviour tests ( e.g. food choice , eating microstructure , operant conditioning , and progressive ratio ) . \\n this integrated approach may clarify the possible links between satiety and reward effects induced by the ingestion of different dietary sugars . \\n while some recent evidence exists showing a differential effect between glucose and fructose on the function of brain regions implicated in appetite and food reward , this concept needs to be confirmed in humans and a non - rodent animal , under controlled experimental conditions and using a physiological fructose intake . \\n an additional question that should be addressed in future studies is which are the underlying mechanisms leading to fructose effects on brain functions , considering that this sugar might not be able to cross the bbb and directly produce these observed effects . in this regard , \\n several hypotheses were presented here that may contribute to address this question in future studies . \\n future research should therefore focus on resolving the apparently inconsistent findings , suggesting that excessive fructose intake may promote adverse effects at both peripheral and central levels to a greater extent than those provoked by glucose or sucrose . \\n there is a particular need to integrate the metabolic , behavioural , and neurological effects of these sugars . \\n an approach combining behavioural ( e.g. progressive ratio ) and metabolic ( e.g. plasma and protein levels of peptides and neuropeptides ) measurements , pet , and fmri imaging , together with the use of an animal model closer to humans ( i.e. the pig ) , would contribute to an improved understanding of the complexity of the development of diseases induced by dietary sugars .',\n",
       "  'output': 'abstractbackgroundsubstantial increases in dietary sugar intake together with the increasing prevalence of obesity worldwide , as well as the parallels found between sugar overconsumption and drug abuse , have motivated research on the adverse effects of sugars on health and eating behaviour . \\n given that the gut  brain axis depends on multiple interactions between peripheral and central signals , and because these signals are interdependent , it is crucial to have a holistic view about dietary sugar effects on health.methodsrecent data on the effects of dietary sugars ( i.e. sucrose , glucose , and fructose ) at both peripheral and central levels and their interactions will be critically discussed in order to improve our understanding of the effects of sugars on health and diseases . \\n this will contribute to the development of more efficient strategies for the prevention and treatment for obesity and associated co-morbidities.resultsthis review highlights opposing effects of glucose and fructose on metabolism and eating behaviour . \\n peripheral glucose and fructose sensing may influence eating behaviour by sweet - tasting mechanisms in the mouth and gut , and by glucose - sensing mechanisms in the gut . \\n glucose may impact brain reward regions and eating behaviour directly by crossing the blood  brain barrier , and indirectly by peripheral neural input and by oral and intestinal sweet taste / sugar - sensing mechanisms , whereas those promoted by fructose orally ingested seem to rely only on these indirect mechanisms.conclusionsgiven the discrepancies between studies regarding the metabolic effects of sugars , more studies using physiological experimental conditions and in animal models closer to humans are needed . \\n additional studies directly comparing the effects of sucrose , glucose , and fructose should be performed to elucidate possible differences between these sugars on the reward circuitry .',\n",
       "  '__index_level_0__': 31671,\n",
       "  'model_output': \"Summarize the following article: Dietary Sugar Intake, in the Form of Sucrose or High-Fructose Corn Syrup (HFCS), Has Dramatically Increased and Correlates with a Rise in Obesity, Metabolic Syndrome, and Diabetes. Because a Broad Range of Physiological, Behavioural, and Neurological Variables Influences Food Choices and Eating Behaviour, it is Difficult to Understand the Mechanisms of Eating Behaviour and their Alterations. The Hedonic Value of Highly Palatable Foods and their Wide Availability can Override the Physiological Mechanisms Related to Energy Homeostasis [2,3]. The Hedonic Reward Value of Food is Closely Linked to the Sensory Perception of Food (including Food Taste, Odour, and Texture) and Refers to the Driving Force behind the Motivation to Eat. Dietary Sugar Overconsumption might Provoke Deleterious Effects at both Central and Peripheral Levels, including Alterations in (i) the Regulation of Secretion of Satiety Peptides and Neuropeptides [7,8]; (ii) Gut Permeability Leading to Low-Grade Inflammation and Liver Disease; (iii) Blood Brain Barrier (BBB) Permeability; (iv) the Endocannabinoid, Opioid, and Mesolimbic Dopaminergic Systems, as Well as (v) Brain Structures Involved in Reward Processing. Both Drugs and Food have Powerful Reinforcing Effects Partly Mediated by Dopamine Increases in the Limbic System that, under Certain Circumstances or in Vulnerable Individuals, could Overwhelm the Brain's Homeostatic Control Mechanisms, but the Plausibility of Sugar Addiction and its Role in Obesity and Eating Disorders in Humans is still a Subject of Controversy. Much of the Research on the Effects of Dietary Sugars on Health has Recently Focused on Fructose, Given the Striking Parallel Increases in Obesity and in Fructose Intake over the Past Decades. These Studies have Found Important Fructose-Induced Health Disturbances that are Different from those Provoked by Glucose or Sucrose. Most of Fructose Intake in Diets originates from Sucrose (Containing 50% Fructose and 50% Glucose) and Soft Drinks Containing High-Fructose Corn Syrup (HFCS) (Range 4765% Fructose, and 5335% Glucose). An Estimate of the Consumption of HFCS from Beverages indicates a Daily Range between 132 and 316 kcal for Americans Aged over 2 Years, and Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Consume Twofold More Calories from HFCS from Beverages than Healthy Patients (365 vs. 170 kcal/day). In the United States, Average Fructose Consumption from Sugar-Sweetened Beverages has Increased from 37 to 49 g/day during the Last 30 Years (+0.4% per year). Thus, it is not Clear whether the Fructose-Induced Metabolic Disturbances Observed in Human and Animal Studies are due to Fructose itself or the Associated Increase in Energy Intake. Moreover, since Fructose and Glucose Intake may Vary Simultaneously, this Raises the Consideration that other Dietary Sugars (e.g. Sucrose and Glucose) might also Contribute to the Development of Obesity and Associated Co-Morbidities. In fact, there are Controversial Findings on Metabolic Effects between the Different Sugars (i.e. Glucose, Fructose, and Sucrose). While some Studies have Disclosed Significant Differences between these Sugars, other Studies have Found Small or no Difference. For Example, in Overweight or Obese Humans, Intake of a Fructose-Sweetened Beverage Led to a Significant Increase in Visceral Adipose Tissue, Hepatic De Novo Lipogenesis, and Postprandial Triglycerides compared to Subjects Offered a Glucose-Sweetened Beverage. In Lean and Obese Subjects, De Novo Lipogenesis Increased to the Same Extent after Overfeeding with Glucose and Sucrose. Both High-Glucose and High-Fructose Diets Stimulated Lipogenic Gene Expression in Rodents. Most of the Studies on the Effects of Sugars on Health and Disease, at both Peripheral and Central Levels, have been Performed in Rodents, and Studies are Missing in Humans or other Animal Models Closer to Humans, such as the Pig Model. Given that Human Studies are Limited due to Ethical Considerations, Future Studies should Privilege the Use of Animal Models that Closely Resembles Humans. On the Other Hand, there is an Impressive Number of Studies Available Concerning the Effects of Dietary Sugars, using Different Experimental Paradigms, with Different Approaches, Animal Models, Oral Intake Doses, in the Form of Sugar Solutions or Added in the Diet, or Peripheral or Central Administrations. Therefore, it Becomes Extremely Difficult to Interpret and Find a Definite Conclusion on these Effects. In this Context, we Considered Essential to Gather all the Information Available to give a Global View of the Current Research in this Domain, in order to Highlight the Need to Reformulate the Questions and Approach to these Questions, under Similar Conditions between Studies, and using Integrated Approaches, from the Molecular to the Behavioural Level. The Main Goal of this Review was to Provide an Overview of the Impact of Different Dietary Sugars on Peripheral and Central Functions. It will Gather (i) Results from Studies regarding the Effects of Sucrose, Glucose, and/or Fructose on Metabolism, Eating Behaviour, and Brain Responses; (ii) Current Available Data Comparing the Effects of these Sugars, at both Peripheral and Central Levels. It will also Propose some Clues and Hypotheses for Future Research Perspectives regarding the Effects of these Sugars, with Special Focus on Fructose and Glucose. Even though this Review Synthesises Data from Different Animal Models and Humans, we Wanted to Dedicate a Short Section to the Presentation of the Pig Model, which is of Particular Interest in Nutrition and Neurosciences. Pigs have Emerged as an Ideal Model for Nutritional and Biomedical Research because of their Anatomical and Physiological Similarities to Humans [2022], as well as Blood Chemical and Biochemical Characteristics, Plasma Hormone Levels, and Energy Metabolism. Pigs are Able to Distinguish the Palatability of Different Diets, and they have a High Innate Preference for Sweet Taste and a Strong Appetite for Sugar Solutions. The Digestive System of Pigs has Anatomical Differences with that of Humans; however, the Physiology of Digestion is Essentially Similar. The Pig has been Used Extensively as a Model of Digestion in Connection with Nutrition (and Determination of Food Value) of the Pig and for Studying Human Digestive Phenomena. The Metabolic Functions, Intestinal Transit Times, and Characteristics of Nutrients Absorption have Made them Useful in Basic Nutritional Research. Other Specific Functional Characteristics of Swine that Relate Directly to Humans include Ion Transport and Motility, Neonatal Development of the Gastrointestinal Tract, and Splanchnic Blood Flow Characteristics. Like Humans, these Physiological Characteristics of the Gastrointestinal Tract are Probably due to the Omnivorous Diet they Consume, unlike that of Carnivores, Ruminants, Rabbits, and Rodents. Similar to Carbohydrate (Sucrose and Starch) Digestion in Humans, it was Shown in Non-Anaesthetised Mature Pigs following the Intake of Different Sugar-Containing Meals (with Glucose, Sucrose, Lactose, or Maize Starch) that the Absorption Pattern was Different for each Sugar. The Kinetics of Appearance of Glucose and of Sucrose Hydrolysis Products in the Portal Blood were Faster for Glucose and Sucrose than for Sugars Resulting from Maize Starch Hydrolysis. Recent Studies have Shown the Convenience for the Use of Pig Model in Brain Imaging, Behavioural, and Physiological Effects of Obesity Induced by Highly Palatable Diets [20,22,28,29]. Compared to the Rodent Brain, the Pig Brain More Closely Resembles the Human Brain in Terms of Anatomy and Biochemistry, which Associates the Pig with a Higher Translational Value. Several Brain Disorders have been Fully or Partially Modelled in the Pig, and this has Further Spurred an Interest in having Access to Behavioural Tasks for Pigs and in Particular to Cognitive Tasks. Cognitive Testing of Pigs has been Conducted for Several Years in Animal Science, but it has only Recently Received Interest in the Wider Neuroscience Community. Several Behavioural Tasks have Successfully been Adapted to the Pig, and Valuable Results have been Produced. Aside of having Similar Brain Structures to Humans, the Pig might Develop Metabolic Disorders Observed in Humans (Excessive Fat Deposition, Diabetes, Atherosclerosis, Hypertension). Taken Together, these Data Position the Pig Model as a Valuable Model for Biomedical Studies in Nutrition and Neuroscience. Gut Microbiota Operates like a Metabolic Organ, Influencing Nutrient Availability and Uptake, Energy Homeostasis, and the Control of Body Weight. Diet Composition may Strongly Influence Changes in the Microbiota, which in turn, when Subjected to Deleterious Nutritional Environment, might Affect Intestinal Permeability and result in Low-Grade Inflammation, Obesity, and Associated Chronic Metabolic Diseases such as NAFLD, Dyslipidaemia, and Insulin Resistance [9,32]. Increases in Gut Permeability, Low-Grade Endotoxemia (Provoked by Increased Plasma Lipopolysaccharides (LPS)), and Hepatic Lipid Accumulation have been Reported in Animal Models of Obesity Induced by High-Fat or High-Fructose Diets. A High-Fructose Diet has been Associated with Hepatic and Extra-Hepatic Insulin Resistance and Obesity-Related Metabolic Disturbances through a Mechanism Implicating Gut Microbiota and its Effects on Intestinal Permeability. The Hepatic Manifestation of the Metabolic Syndrome is NAFLD, Starting from Simple Steatosis and Ending as Liver Cirrhosis. Dietary Sugar Intake might Participate to NAFLD Pathogenic History, and the Type of Sugar (e.g. Fructose) may Affect the Development of the Disease. Consistent Evidence has Demonstrated the Implication of Fructose or HFCS in the Development of NAFLD in several Animal Models [17,33-38]. The Effects of Dietary Sugars, especially Fructose, on the Development of Hepatic Steatosis, Liver Damage, and other Features of the Metabolic Syndrome found in several Animal Models are Presented in Table 1.Table 1Effects of Dietary Sugars Intake on Hepatic Steatosis, Liver Damage, and Various Features of the Metabolic Syndrome in several Animal Models and in HumansDietary InterventionDurationHepatic Steatosis / Liver InjuryPlasma or Hepatic MeasurementsOther EffectsModelAnimal Studies20% HFCS in Maternal Diet20% HFCS + MSG9 monthsHepatic Steatosis Hepatic and Serum TG, Serum FFA SREBF2 Expressionc57BL/6 J MiceCollison High-Fat / High-Fructose Diet:(a) 8% Trans-Fat, 20% HFCS (b) Trans-Fat (8%), HFCS (20%), 1% MSG9 months ALP, ALT Serum Creatinine, Cortisol Serum Leptin and Fasting Insulindomestic Cat (Male, n = 18)Collison (a) Trans-Fat (9%) + HFCS (24%) (b) Trans-Fat (9%), HFCS (24%), 1% MSG9 months Fibrous Expansion Markers of Hepatic Fibrosis, Angiogenesis, Hepatocellular Carcinoma ALP and ALTCreatinine and Cortisol (a)domestic Cat (Male, n = 18)Collison 30% Glucose Solution30% Fructose Solution8 weeksLipid Accumulation Endotoxin Levels in Portal BloodTNF Higher with Fructose than GlucoseAntibiotics Prevented Some Effects of Fructosec57BL/6 Micespruss Fructose Group: 10.5% Fat 20% FructoseAtherogenic Diet: 20% Fructose 46% Fat, 2% Cholesterol, 0.7% Choline24 weeksFructose Diet: Normal Liver HistologyAtherogenic Diet: Abnormal Liver Histology with Microvesicular Steatosis and Fatty Kupffer Cells but not FibrosisFructose Group: Body Weight, Hypertension, and Insulin ResistanceAtherogenic Diet: Metabolic SyndromeOsabaw MinipigLEE Standard Chow Diet: (S)41% Starch, 5% Sugar, 4.5% Fat, Iron (120 mg/kg)Fructose-Enriched Diet (F) 60% Fructose, 5% Fat + Iron (5 mg/kg)5 weeks F: Higher Liver Lipids, TG, and Cholesterol than S Group Mild-to-Moderate Deposition of Macrovesicular and Microvesicular Fat Similar Hepatic Iron Concentration in Both GroupsF: TG, Insulin, HOMA ScoreF: Blood PressurePrague Dawley Rats n = 49Ackerman Dietary InterventionDurationHepatic Steatosis / Liver InjuryPlasma or Hepatic MeasurementsOther EffectsRecruitment CriteriaHuman StudiesUsual Ad Libitum Diet + Fructose (n = 16) or Glucose (n = 15) Sweetened Beverages at 25% of Energy Requirements10 weeksNot InvestigatedFructose Group: Fasting Plasma MCP-1, PAI-1, and E-Selectin Postprandial PAI-1BMI: 25-35 kg/m healthy,40-72 yearCox Usual Ad Libitum Diet + Fructose (n = 17) or Glucose (n = 15) Sweetened Beverages at 25% of Energy Requirements10 weeksFractional Hepatic De Novo Lipogenesis Only in Fructose GroupFructose Group: Plasma Lipid and Lipoprotein Postprandial TG, Lipoproteins, and LDL CholesterolGlucose Group: Fasting TG and FFA in Glucose Group Postprandial Lipoprotein Lipase Activity Body Weight, Fat Mass in Both Groups Abdominal and Visceral Adipose Tissue only in Fructose GroupInsulin Sensitivity only in Fructose GroupBMI: 25-35 kg/m healthy,40-72 yearStanhope HFCS High-Fructose Corn Syrup, TG Triglycerides, SREBF2 Sterol Regulatory Element-Binding Transcription Factor 2, ALP Alkaline Phosphatase, ALT Alanine Aminotransferase, TNF Tumour Necrosis Factor Alpha, INOS Inducible Nitric Oxide Synthase, AB Antibiotics, NF- Nuclear Factor, TLR Toll-Like Receptors, HOMA Homeostatic Model Assessment, MCP-1 Monocyte Chemoattractant Protein 1, PAI-1 Plasminogen Activator Inhibitor Type 1, FFA Free Fatty AcidsEffects of Dietary Sugars Intake on Hepatic Steatosis, Liver Damage, and Various Features of the Metabolic Syndrome in several Animal Models and in HumansHFCS High-Fructose Corn Syrup, TG Triglycerides, SREBF2 Sterol Regulatory Element-Binding Transcription Factor 2, ALP Alkaline Phosphatase, ALT Alanine Aminotransferase, TNF Tumour Necrosis Factor Alpha, INOS Inducible Nitric Oxide Synthase, AB Antibiotics, NF- Nuclear Factor, TLR Toll-Like Receptors, HOMA Homeostatic Model Assessment, MCP-1 Monocyte Chemoattractant Protein 1, PAI-1 Plasminogen Activator Inhibitor Type 1, FFA Free Fatty AcidsIt seems that HFCS or Fructose Exposure is Able to Induce Hepatic Steatosis, Liver Dysfunction, Hepatic Fibrosis as Well as several Features of the Metabolic Syndrome and Inflammation in Rodents and Cats (e.g. [34-44]). However, in other Species such as Pigs or in Humans, this Concept Remains Incompletely Clear. Data Obtained from Humans [33,46,47] and Osabaw Minipigs [45] Suggested that it is the Association between High-Fructose Intake with other Components in the Diet, such as Glucose, Sucrose, Fat, and Cholesterol, Responsible for the Development of the Metabolic Syndrome and Liver Steatosis, rather than High-Fructose Intake itself. The Approach used in several Human Studies where Fructose Daily Intake Pattern is Assessed in Patients with Previously Established Hepatic Steatosis [33,46,47] is not the Best Way to Evaluate Fructose as a Risk Factor for NAFLD. This Question should be Addressed in a More Controlled Experimental Paradigm where Dietary Intake is Closely Monitored. To our Knowledge, one of the Few Human Studies that has Assessed the Effect of Glucose- or Fructose-Sweetened Beverages on the Development of Hepatic De Novo Lipogenesis under Controlled Conditions is the one performed by Stanhope et al. However, this Study did not Confirm the Presence of Hepatic Steatosis using Standard Diagnostic Methods such as MRI, CT Scan, or Liver Biopsy. Thus, Studies in Humans are Needed to Investigate the Effects of Dietary Sugars on the Development of Hepatic Steatosis under Controlled Experimental Conditions. Taken Together, Studies with Rodents and Cats suggest that Fructose induces Liver Damage, in Part through Mechanisms involving Intestinal Bacterial Overgrowth, Increased Intestinal Permeability, Inflammation, and Metabolic Endotoxemia [9,32]. However, Underlying Mechanisms Explaining how Fructose Leads to Bacterial Overgrowth, Inflammation, and Increases in Intestinal Permeability remain Poorly Understood. Since it is Difficult to Achieve Controlled Experimental Conditions in Humans, for Ethical Reasons, Studies in Animal Models Closer to Humans, e.g. Pigs [20,28,31], are a Valuable Approach that allows Close Monitoring of Dietary Interventions. If Similar Mechanisms Occur in Humans and Pigs, Novel Strategies including Low-Fructose Diets might be Considered for the Prevention/Management of NAFLD. However, there seems to be Substantial Differences between Rodents or Cats and Humans or Pig Studies. Thus, in the Absence of Clear Evidence for a Detrimental Role for Fructose, there is no Justification for Replacing it with other Dietary Sugars such as Glucose or Sucrose in Human Diets for the Prevention of Hepatic Steatosis. The Regulation of Food Intake and Energy Homeostasis is Achieved by a Complex Network Communication between the Periphery (e.g. Gut, Liver, Stomach, Pancreas, and Adipose Tissue) and the Brain. The Different Molecular Structures of Dietary Sugars might Result in Different Gastrointestinal Peptide Secretion Profiles, leading to Different Metabolic and Endocrine Effects at both Peripheral (e.g. Gut and Liver) and Central (e.g. Hypothalamus) Levels [25-54]. It has been Shown that Fructose, compared to Glucose Intake, Produces Smaller Increases in Plasma Glucose and Circulating Satiety Hormones, i.e. Insulin, Leptin, Glucagon-Like Peptide-1 (GLP-1), Peptide Tyrosine Tyrosine (PYY), and Attenuates Postprandial Suppression of Ghrelin [37,55-59]. This Suggested an Endocrine Mechanism by which Fructose might Induce a Positive Energy Balance and Weight Gain. A Possible Explanation of Smaller Increases in Satiety Hormones by Fructose could be the Lower Expression of GLUT5 in -Cells [7] or Lower Absorption Rates in the Intestine. In addition, it was Found that Central Administration of Fructose Provokes Feeding in Rodents, whereas Centrally Administered Glucose Promotes Satiety [54,62]. These Data together with Parallel Increases between Fructose Intake and Obesity Development [56,58,59,63,64] have Led to the Fructose Hypothesis which Postulates that Fructose, compared to Glucose, may Stimulate Food-Seeking Behaviour, Food Intake, and Body Weight Gain. However, the Proposed Effect of Fructose on the Induction of Feeding is the Subject of Debate since this Concept has not been Replicated in Rodents, and there is little Evidence Linking these Phenomena in Humans [56,58,59,63,64]. The few Studies Linking Fructose Consumption with Increased Body Weight compared Fructose versus an Artificial Sweetener, Evaluated 60-g Fructose Supplementation but did not Compare it versus another Sugar, or used Higher Doses of Fructose compared Sucrose. Even Others Found no Substantial Differences in Endocrine and Metabolic Effects after Consumption of Sugar-Sweetened Beverages with HFCS, Sucrose, Fructose, and Glucose in Humans [64,110,168] or found Greater Increase in Body Adiposity with Sucrose than with Fructose Solutions. Moreover, it appears that Fructose Orally Ingested may Cross the BBB to a Small Extent compared to Glucose, which may have two Opposite Implications: 1) the Limited Fructose Access to Glucose-Sensing Neurons could Contribute to the Deregulation of Food Intake and Energy Balance, or 2) Fructose might have no Effect at all on Appetite Regulation due to the Lack of Fructose Transport to the Brain. The Purpose of this Section was to Present Available Data on the Main Enteric and Cephalic Detection Processes of Dietary Sugars, in Association with Satiety Peptides, Neuropeptides Secretion, and Neuronal Activity, and to Discuss their Effects on Food Intake. Peripheral Sweet Taste and Sugar Detectors are Key Regulators of Feeding Behaviour and Energy Homeostasis. Taste-Signalling Mechanisms Identified in the Oral Epithelium also Operate in the Gut and Play a Role in both Sugar Detection and Regulation of Intestinal and Pancreatic Hormone Secretion. There are two Main Groups of Sugar Detectors: Members of the G-Protein-Coupled Receptors (GPCR) Family, and Sugar Transporters (e.g. GLUT2, GLUT5, Sodium-Dependent Glucose Co-Transporter 1 (SLC5A1), and GLUT8). Enteroendocrine Cells Directly Sense Sugars via GPCR, including the Sweet Taste Receptors of Type 1, T1R. The Initial Step in Taste Recognition Occurs on the Apical Surface of Taste Receptor Cells, within Taste Buds of the Tongue and Palate. The Regulation of Taste Sensitivity by Appetite Peptides at the Level of Taste Bud Cells in the Tongue as well as in Enteroendocrine Cells of the Taste Epithelium may be Important in the Control of Eating Behaviour and the Regulation of Energy Homeostasis. However, this Concept Remains unclear since it was Found that Knockout (KO) Mice (P2X2/P2X3) with Adenosine Triphosphate Taste Cell Signalling Deficits show Relatively Normal Food Intake and Body Weight. They also Develop Strong Preferences for Non-Taste Nutrients by the Post-Oral Actions of these Nutrients. Furthermore, much of the Research on Appetite Peptides and Taste Detection in the Mouth has been Performed at the Cell/Neuron Level; however, little Empirical Evidence Exists to date for these Peptides Impacting Taste Function at the Level of the Mouth. Therefore, more Studies should be performed in Large Animal Models to Clarify these Concepts. Appetite Regulatory Peptides, such as Leptin, Endocannabinoids, GLP-1, Glucagon, Oxytocin, Insulin, Cholecystokinin (CCK), Neuropeptide Y (NPY), and Vasoactive Intestinal Peptide (VIP), Modulate Taste Sensitivity at the Level of Oral Sweet Taste Cells. Leptin Selectively Suppressed Sweet Taste Responses of Cells Isolated from Circumvallate Papillae from Non-Diabetic Mice, but not in Diabetic db/db Mice. This Indicated that the Effect of Leptin on Sweet Taste Sensitivity is Mediated by the Leptin Receptor Expressed in these Cells. The T1R3 Subunit is Co-Expressed with the Leptin Receptor in both Fungiform and Circumvallate Taste Bud Cells, and Leptin Suppresses Sweet Taste Sensitivity in Mice by Affecting Responsiveness of T1R3-Expressing Taste Cells via the Leptin Receptor. Therefore, Leptin may Play an Important Role in the Regulation of Sweet Taste Sensitivity in the Tongue, besides its Central Actions on Food Intake. Co-Expression of GLP-1 with Taste-Signalling Elements such as T1R2, T1R3, and -Gustducin, a GI Family Member Associated with Taste Perception, was Found in Human Intestinal Endocrine L Cells. These Taste-Signalling Elements Mediate the Glucose-Dependent Secretion of GLP-1 and Maintain or Enhance Sweet Taste Sensitivity via Paracrine Action. In addition to its Intestinal Expression, GLP-1 was also Found to be Expressed in Taste Cells in Mouse Circumvallate Papillae Taste Buds; it was Co-Expressed with -Gustducin and T1R3-Expressing Sweet Taste Cells in Mouse Taste Buds, and it was Produced in Taste Buds from Lingual Extracts in its Active Form. In Contrast to its Presence in Blood and Ileum, Dipeptidyl Peptidase 4 was not Found to be Expressed in Taste Buds, suggesting that the Half-Life of GLP-1 in Taste Tissue should be High, Ensuring Sufficient Concentrations within the Taste Bud to Stimulate the GLP-1 Receptor. Hek-293 Cells Expressing G15 (a Phospholipase C-Linked G-Protein), Cotransfected with Human and Rat T1R2/T1R3, Respond to all Sweet Taste Stimuli: Sucrose, Fructose, Galactose, Glucose, Lactose, and Maltose. In the Rat, however, the Relative Lack of T1R2 Expression in Taste Bud Cells of the Fungiform Papillae is Consistent with the Relative Low Response to Sucrose Recorded at the Level of the Chorda Tympani Nerve The Activation of T1R1/T1R3 and T1R2/T1R3 in Rat Small Intestine by Glutamate, Glucose, and Artificial Sweeteners Increases the Apical Expression of GLUT2 and Sugar Absorption [83,84]. Given this Effect of Sweet Taste per se to Activate T1R2/T1R3 and Sugar Absorption, it would have been Expected that Artificial Sweeteners might also Slow Gastric Emptying. However, Intragastric or Intestinal Administration of Equisweet Solutions with Artificial Sweeteners and/or Fructose did not Modify Glucose Absorption Rates, Plasma Glucose, Incretin Levels, or Gastric Emptying in Humans [85-87] or Rodents [88] as a Glucose Solution did. Collectively, these Findings did not Support the Concept that the Sweet Taste per se is the Principal Detection Mechanism, Responsible for the Regulation of Gastric Emptying, Glucose Absorption, or Incretin Release. Therefore, these Data are in Contrast to Previously Reported Parallels between Nutrient-Sensing Pathways in the Oral Cavity and Gut. It seems that Artificial Sweeteners may Influence the Expression of Sugar Transporters such as GLUT2 [83,84] and SLC5A1, but they may not Influence other Physiological Functions such as Gastric Emptying or Glucose Absorption, and their Effect on Incretin Release seems Contradictory since some Studies reported an Effect of Artificial Sweeteners (Sucralose) on GLP-1 Secretion from the Ileum via T1R3 Activation, while other Studies did not Find any Effect of Artificial Sweeteners on Incretin Levels in Humans [85-87] or Rodents [88] when Compared to Glucose Effects. Therefore, these Data make unclear whether Sweet Taste Receptors are Necessary in such Gastrointestinal Functions. T1R1/T1R3 and T1R2/T1R3 Stimulation Leads to the Activation of -Gustducin. T1R3 and -Gustducin are Necessary for Increased Stimulation of (SLC5A1) by Dietary Sugars. T1R3 Inhibition with Lactisole Decreased Fructose Stimulation of Human SLC5A1, GLUT5, and L-Pyruvate Kinase mRNA Expression, Demonstrating the Implication of T1R3 in Fructose Signalling, whereas T1R3 did not Control GLUT2 Expression and Activity. In Enterocytes, Cell Polarity may Influence the Regulation of Sweet Taste Receptor Signalling. TIR2 and T1R3 are Located at the Basolateral Membrane of Differentiated Enterocytes. Whereas the Apical Supply of Fructose Increased GLUT5 mRNA Expression, the Basolateral Supply of Sugars Increased GLUT2 Expression, suggesting that Sugars can Directly Signal from the Basolateral Membrane. When Intestinal Luminal Glucose Concentration is Lower than in Plasma, Glucose is Transported by SLC5A1 through the Apical Membrane against the Concentration Gradient. Dietary Fructose is Transported across the Apical Membrane by the Facilitative Transporter GLUT5. In the Basolateral Membrane, both Glucose and Fructose are Transported by GLUT2 [94,95]. At High Glucose or Fructose Concentrations, when SLC5A1 and GLUT5, respectively, are Saturated, GLUT2 Translocates to the Apical Membrane where it Complements SLC5A1 and GLUT5 Transport Capacities. Depending on its Relative Abundance in the Apical and Basolateral Membranes, it may Stimulate Sugar Signals from Intestinal Lumen or Bloodstream. Chronic Exposure to a High-Sugar Diet Promotes Increased Apical GLUT2 Levels, Increases Glucose Absorption, and Excessive Postprandial Excursions. Insulin Induces the Internalisation of Apical GLUT2, a Process that is Impaired in Insulin Resistance, Contributing to Further Glucose Absorption. Since GLUT2 Depends on Glucose Transport by SLC5A1, i.e. it Promotes GLUT2 Upregulation, Long-Term Regulation by SLC5A1 may also be Reflected in Changes in Apical GLUT2. In Contrast, under both Low- and High-Carbohydrate Diets, GLUT2 is Expressed on the Basolateral Membrane of Pig Enterocytes. These Results suggest that SLC5A1 is the Major Route for the Absorption of Dietary Sugars across the Luminal Membrane of Swine Enterocytes. Moreover, Duodenal and Jejunal Infusions of Glucose, Fructose, and Saccharin Induced up-Regulation of SLC5A1 in Mice Apparently involving Vagal Afferents. Altogether, these Data suggest that SLC5A1 and Apical GLUT2 are Potential Targets for Antidiabetic Therapy [90,93,94]. Duodenal SLC5A1 and GLUT5 mRNA Expressions and Protein Levels are Substantially Increased in Diabetic Patients. Reduction in Plasma Glucose in these Patients Promoted a Reduction in both SLC5A1 and GLUT5 Levels, suggesting that under Hyperglycaemic Conditions, the Absorption of Sugars is Enhanced. Moreover, Postprandial Plasma Fructose Levels are Increased in Diabetic Patients and are Associated with the Prevalence of Diabetic Retinopathy. In Contrast, in Zucker Diabetic Rats, mRNA and Protein Levels of SLC5A1, GLUT5, and GLUT2 were Unchanged compared to Lean Controls. This suggests that the Zucker Diabetic Rat might not be a Good Model for the Study of Diabetes since it does not Reproduce Results Observed in Humans. Consumption of a Large Amount of Pure Fructose can Exceed the Capacity of Intestinal Fructose Absorption, resulting in Diarrhoea. However, the Consumption of Glucose along with Fructose, as it is Usually Consumed in Beverages and with Meals (e.g. when Provided as Sucrose), appears to Enhance Fructose Absorption. In addition, Fructose Absorption Increases during Sustained Fructose Consumption, suggesting an Adaptation to Increased Fructose Intake. GLUT8, Expressed only in the Intracellular Compartment, Potentially Mediates Sugar Transport into or out of Intracellular Organelles. GLUT8 has High Affinity for Glucose, whereas Fructose and Galactose Compete with Glucose Transport Activity. Its Deficiency Enhances Fructose Uptake in Cultured Caco2 Human Intestinal Epithelial Cells and in Jejunum Isolated from Mice Lacking the Gene Encoding GLUT8. Moreover, Mice Lacking GLUT8 Rapidly Develop Higher Serum Fructose Concentrations after Oral Fructose Gavage. These Effects are Possibly Mediated by the Stabilisation of the Dual-Specificity Glucose/Fructose Transporter GLUT12. These Data might Lead to the Speculation that this Transporter could, in Part, be Implicated in Fructose Malabsorption Previously Reported when Ingested at High Levels in Humans. The Glucose-Dependent Secretion of GLP-1 Plays a Critical Role in the Regulation of Glucose Homeostasis. It was Shown that T1R3, but not T1R2, Affects both Incretin Secretion from the Intestine and Insulin Secretion from the Pancreas. Exposure to Glucose, Fructose, and Sucralose Induced GLP-1 Secretion from the Ileum of Wild-Type (T1R3) but not from T1R3 Null Mice (T1R3). T1R2 Mice Showed Normal Glycaemic Control and Partial Small Intestine Glucose-Stimulated GLP-1 Secretion, suggesting that T1R3 can Mediate Glucose-Stimulated GLP-1 Secretion without T1R2. SLC5A1 and SLC5A3 may also be involved in Enteric Sugar-Sensing and Hormonal Secretion Stimulation. SLC5A1 Triggers Glucose-Induced Secretion of Gastrointestinal Polypeptide (GIP) from K-Cells in the Duodenum and Jejunum. This in turn Stimulates the Release of GLP-1 and GLP-2 from L Cells Located in the Ileum [107,108]. Some Evidence has Revealed an Anorexigenic Effect of Glucose and an Orexigenic Effect of Fructose through different Secretory Profile of Appetite Peptides. For Example, Glucose and, to a Lesser Extent, Galactose, but not Fructose, Mannose, or Sorbitol, Stimulated the Release of GIP. Glucose Intragastrically Infused or Orally Ingested Induced an Increase in Plasma Glucose Levels, Stimulated Insulin, Leptin, GLP-1 and Peptide Tyrosine Tyrosine (PYY) Secretion, and Reduced Ghrelin Secretion, while Fructose did not Substantially Affect these Hormones [37,55-59]. However, in one of these Studies, the Amounts of Intragastric Load of Glucose and Fructose were Different (50 and 25 g/250 ml, respectively), which might have Contributed to the Observed Differences. A Possible Explanation for the Lack of Effects of Fructose on Insulin Secretion may be related to Lower Intestinal mRNA and Protein GLUT5 Levels compared to GLUT2 Levels, with the Subsequent Lower Fructose Transport compared to Glucose. In addition, it was Previously Shown that Glucose Absorption Rate was Higher than that of Fructose in Yucatan Minipigs. A Substantial Portion (12%) of Ingested Fructose is Metabolised to Lactate by the Gut during Absorption, while only 2% of Glucose Ingested is Metabolised in the Gut and almost all of the Absorbed Glucose Appears in the Portal Vein as Glucose. In Concordance with Lower Fructose Absorption Rates compared to Glucose, Insulin Concentrations were 7.5-Fold above Basal Conditions following Glucose Intake, compared to Threefold following Fructose Intake. Another Possible Explanation for the Lack of Effects of Fructose on Insulin Secretion is the Low Level of Expression of the GLUT5 Fructose Transporter in -Cells. Taking together these Data, i.e. Lower Expression Levels of GLUT5 than GLUT2 in the Intestine, Lower Rate of Fructose Transport compared to Glucose, Partial Intestinal Fructose, but not Glucose, Metabolism, and the Low Level of GLUT5 Expression in -Cells could Explain in Part the Lower Increases in other Gut Peptides, besides Insulin, Induced by Fructose Ingestion, compared to Glucose. Further Studies are Needed to Confirm this Concept. In this Context, since Insulin and Leptin Function as Key Signals in the Central Nervous System through the Modulation of Hypothalamic Neuropeptides for the Long-Term Regulation of Energy Balance, Chronic Fructose Intake could Lead to Increased Calorie Intake, thereby Contributing to Weight Gain and Obesity. Hunger is Regulated by the Hypothalamus and the Dorsal Vagal Complex in Conjunction with an Integrated Network of Limbic Brain Structures such as the Striatum, Orbitofrontal Cortex, Amygdala and Insula, which Control Motivation-Reward Systems Associated with the Hedonic Drive to Eat. The Arcuate Nucleus of the Hypothalamus is an Integrator of Hormonal and Nutrient Information to Regulate both Energy and Glucose Homeostasis. Brain Cells are Provided with Mechanisms that Sense Energy Availability in the Extracellular Space, such as an Increase in Adenosine Monophosphate Kinase (AMPK) Activity in Response to an Increase in AMP-to-ATP Ratio. Glucose-Sensing Neurons are Located in Brain Areas Involved in the Control of Neuroendocrine Function, Nutrient Metabolism,\"},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Write a summary of the article that captures the main ideas and significant details.',\n",
       "  'input': 'Summarize the following article: the online version of this article ( doi:10.1007/s13300 - 015 - 0133-z ) contains supplementary material , which is available to authorized users . \\n chronic kidney disease ( ckd ) is a common condition in patients with type 2 diabetes ( t2 dm ) . \\n an estimated 2035% of patients with t2 dm have moderate to severe renal impairment [ 1 , 2 ] \\n . however , many antihyperglycemic medications are contraindicated or need to be used with caution in patients with ckd , complicating t2 dm treatment choices and management . \\n patients with t2 dm and ckd are particularly susceptible to safety and tolerability issues related to many classes of oral antihyperglycemic agents ( oaha ) . \\n dipeptidyl peptidase-4 inhibitors ( dpp-4i ) such as sitagliptin are well tolerated in a broad range of t2 dm patient types , including those with renal disease , and may therefore be preferentially used in patients with ckd . \\n prior studies have demonstrated the preferential use of sitagliptin in several populations [ 47 ] . in general , patients initiating treatment with sitagliptin were older and had more complications of diabetes and comorbidities than patients initiating other antihyperglycemic therapies [ 47 ] . if not recognized and appropriately considered in the analysis , this preferential selection of patients with specific demographic and disease characteristics for treatment with sitagliptin ( channeling bias ) could lead to inaccurate treatment effect estimates in comparative analyses that include sitagliptin . \\n the objective of this study was to describe the baseline characteristics of patients with t2 dm and ckd initiating treatment with sitagliptin or non - dpp-4i oahas to ascertain whether channeling exists in this patient population . \\n the truven health marketscan databases ( marketscan , truven health analytics , ann arbor , mi , usa ) contain medical claims records for more than 150  million unique patients dating from 1996 . \\n the records are derived from outpatient and inpatient insurance claims for employees of over 100 employers participating in more than 12 health plans , and their beneficiaries in the united states . \\n records consist of commercial claims and healthcare encounters , including information on demographics , health plan membership , international classification of diseases , ninth revision , clinical modification ( icd-9-cm ) codes , and current procedure terminology ( cpt ) codes . \\n the records of retirees with supplemental insurance are included in the database thus providing data on the elderly with continuity of care across those < 65 and 65  years of age . \\n patients 25  years of age with t2 dm and ckd , with claims in the united states ( us ) between january 2006 and june 2012 , were identified in marketscan . of these patients , \\n those initiating sitagliptin or a non - dpp-4i oaha were categorized by complexity of antihyperglycemic treatment . \\n patients were identified as having t2 dm if marketscan records for the patient indicated at least one inpatient or outpatient diagnosis of diabetes and at least one prescription for oaha medication . \\n patients with ckd were identified by icd-9-cm diagnostic codes ( 585 , 585.3 , 585.4 , 585.5 , 585.6 , 585.9 , 403 , 403.0 , 403.00 , 403.01 , 403.1 , 403.10 , 403.11 , 403.9 , 403.90 , 403.91 , 250.4 , 404 , 404.0 , 404.00 , 404.01 , 404.02 , 404.03 , 404.1 , 404.10 , 404.11 , 404.12 , 404.13 , 404.9 , 404.90 , 404.91 , 404.92 , 404.93 , 582 , 582.0 , 582.1 , 582.2 , 582.4 , 582.8 , 582.81 , 582.89 , 582.9 ) . \\n antihyperglycemic treatment was defined as : ( 1 ) initiating monotherapy ( 1 new outpatient prescription record on or after the t2 dm diagnosis ) ; ( 2 ) escalating to dual combination therapy ( 1 new prescription for a 2nd class 90  days after the 1st class , with prescription for 1st class overlapping the index date of 2nd class ) ; ( 3 ) escalating to triple combination therapy ( 1 new prescription for a 3rd class 90  days after the 2nd class , with prescriptions for 1st and 2nd classes overlapping the index date of 3rd class ) . \\n patients were required to have at least 1  year of continuous enrollment in the database prior to initiation / escalation of antihyperglycemic treatment . \\n patients were excluded from the analysis if they had a diagnosis of type 1 diabetes , ketoacidosis , malnutrition - associated diabetes , drug - induced diabetes or gestational diabetes without a subsequent t2 dm diagnosis code . \\n patients with icd-9-cm codes explicit for mild renal disease ( stage 1 and 2 ) and patients on insulin or other injectable therapy were also excluded from the analysis . \\n demographics , and clinical conditions and health care resource utilization recorded up to 5  years before therapy initiation were assessed as baseline characteristics . over 70 clinical conditions and comorbidities may have been recorded in the database , including diabetes complications , cancers , and cardiovascular ( cv ) , metabolic , gastrointestinal , hepatic , infectious , psychiatric , pulmonary , and neurological events . \\n types of health care resource utilization recorded in the database included physician and emergency department visits , hospitalizations , days hospitalized , and number of medications received . \\n differences between sitagliptin and non - dpp-4i oaha treatment groups were compared using absolute standardized differences ( asd ) . \\n asd is the difference of two means or proportions divided by the pooled estimate of the standard deviation . unlike the traditional p value , asd is a measure of difference that is not influenced by large sample sizes and has been demonstrated to be a better measure of covariate balance [ 10 , 12 ] . \\n an asd of at least 10% was used to indicate a meaningful difference between treatment groups . \\n this article does not contain any new studies with human or animal subjects performed by any of the authors . \\n a total of 35,922 patients with t2 dm and ckd were identified as meeting the inclusion criteria . over 45% of patients ( 46.7% ; n  =  16,742 ) initiated sitagliptin ( n  =  1234 ) or a non - dpp-4i oaha monotherapy ( n  =  15,508 ) , 40.5% ( n  =  14,540 ) initiated an escalation to dual combination therapy ( sitagliptin , n  =  2683 ; oaha , n  =  11,857 ) , and 12.9% ( n  =  4640 ) initiated an escalation to triple combination therapy ( sitagliptin , n  =  1385 ; oaha , n  =  3255 ) . roughly , 15% of patients with t2 dm and ckd ( 14.8% ; n  =  5302 ) initiated treatment with sitagliptin . in comparison , in the patients excluded from this analysis due to a lack of recorded ckd , the percentage of patients initiating sitagliptin was 7.4% . \\n the greatest differences between treatment groups were observed in patients initiating monotherapy or an escalation to dual combination therapy . compared to patients initiating monotherapy with non - dpp-4i oahas , \\n patients initiating monotherapy with sitagliptin were older ( mean [ standard deviation ( sd ) ] : sitagliptin 68.8  [ 12.5 ]  years , non - dpp-4i 66.6  [ 12.8 ]  years ; asd 17% ) , were more likely to have a history of heart failure ( fig . \\n 1a ; sitagliptin 23.0% , non - dpp-4i 18.6% ; asd 11% ) or arrhythmia ( fig . \\n 1a ; sitagliptin 37.7% , non - dpp-4i 31.7% ; asd 13% ) , were more likely to use loop diuretics ( fig . \\n 1a ; sitagliptin 44.2% , non - dpp-4i 38.0% ; asd 13% ) or beta - blockers ( fig .  1a \\n ; sitagliptin 66.3% , non - dpp-4i 61.3% ; asd 11% ) , and had more physician visits ( fig . \\n 1b ; mean [ sd ] : sitagliptin 73.2  [ 57.6 ] physician visits , non - dpp-4i 66.3  [ 55.4 ] physician visits ; asd 12% ) . \\n the differences between treatment groups ( non - dpp-4i oaha users versus sitagliptin users ) observed in patients initiating an escalation to dual therapy were similar to those observed in patients initiating monotherapy , with the exception that the between - group age difference was not as great ( mean [ sd ] : sitagliptin 71.1  [ 11.1 ]  years , non - dpp-4i 70.0  [ 11.0 ]  years ; asd 10% ) and the differences for history of arrhythmia and use of beta - blockers were not meaningful ( fig .  1c , d).fig . \\n 1baseline characteristics of patients with type 2 diabetes and chronic renal disease up to 5  years before initiating treatment with sitagliptin or non - dpp-4i oral antihyperglycemic agent as monotherapy or as part of dual or triple therapy . a , c , e clinical conditions and comorbidities . \\n asd of 10% indicates a meaningful difference between treatment groups . for any between - group difference of asd of at least 10% \\n asd absolute standardized difference , chf congestive heart failure , dpp-4i dipeptidyl peptidase-4 inhibitor , hosp hospital , htn hypertension , meds medications , mi myocardial infarction , phys physician , tia transient ischemic attack baseline characteristics of patients with type 2 diabetes and chronic renal disease up to 5  years before initiating treatment with sitagliptin or non - dpp-4i oral antihyperglycemic agent as monotherapy or as part of dual or triple therapy . a , c , e clinical conditions and comorbidities . \\n asd of 10% indicates a meaningful difference between treatment groups . for any between - group difference of asd of at least 10% , \\n asd absolute standardized difference , chf congestive heart failure , dpp-4i dipeptidyl peptidase-4 inhibitor , hosp hospital , htn hypertension , meds medications , mi myocardial infarction , phys physician , tia transient ischemic attack in patients initiating an escalation to triple combination therapy , the differences between treatment groups ( non - dpp-4i oaha users versus sitagliptin users ) were not as pronounced as those seen in patients initiating monotherapy or escalation to dual therapy , including the between - group age difference ( mean [ sd ] : sitagliptin 68.9  [ 10.9 ]  years , non - dpp-4i 68.4  [ 10.5 ]  years ; asd 5% ; fig . \\n in this study of patients with t2 dm from an employee - based insurance database , sitagliptin was initiated in a higher percentage of patients with t2 dm and ckd ( 14.8% ) compared to patients with t2 dm but no record of ckd ( 7.4% ) . unlike many other oahas , sitagliptin is approved for patients with any stage of renal disease . in light of this and its favorable renal safety profile [ 1215 ] , \\n the higher use of sitagliptin in patients with ckd observed in the current analysis is not surprising . in general , \\n patients with t2 dm and ckd who initiated treatment with sitagliptin tended to be older and were more likely to have a pre - treatment history of heart failure , arrhythmia , or use of loop diuretics or beta - blockers than patients initiating other classes of oaha . in this context , it is worth noting the results of a large , recently completed clinical trial examining the effects of adding  sitagliptin to usual care in patients with t2 dm and cv disease . in the overall study population , no difference in cv event rates compared with placebo was observed ( hazard ratio [ hr ] for the primary composite cv outcome was 0.98 ; 95%  confidence interval ( ci ) : 0.88 , 1.09 ; p  <  0.001 for noninferiority ) . additionally , in patient subgroups evaluated by renal function , \\n no difference in cv risk was noted for patients with ckd [ estimated glomerular filtration rate ( egfr ) < 60  ml / min/1.73  m ; hr  =  0.92 ; 95%  ci : 0.78 , 1.10 ) or those without ckd ( egfr 60  ml / min/1.73  m ; hr  =  1.00 ; 95%  ci : 0.89 , 1.13 ) . \\n the most pronounced differences in baseline characteristics between the treatment groups were observed between patients initiating monotherapy . \\n as treatment complexity increased , the differences in baseline characteristics between treatment groups persisted but were attenuated , presumably due to diminishing treatment options with increasing treatment complexity . \\n these observations of channeling in patients receiving treatment with sitagliptin are similar to those previously reported in a general t2 dm population [ 47 ] . \\n while the marketscan database includes insurance claims data on a large , diverse population from the us , these results may not be generalizable to the overall us population or to ex - us populations . \\n in addition , the primary uses of these data are for administrative purposes , not research . \\n consequently , the database has missing or limited data on a number of important disease characteristics and comorbidities . \\n importantly for this study , patients with end - stage renal disease are likely underrepresented since these patients are medicare eligible . \\n chronic renal disease was defined solely through icd-9-cm codes as laboratory data are not available in our dataset . \\n this study further documents the presence of channeling in patients initiating treatment with sitagliptin . in this study , patients with ckd initiating treatment with sitagliptin were generally older and were more likely to have a pre - treatment history of heart failure , arrhythmia , or use of loop diuretics or beta - blockers than patients initiating other classes of oral therapies . if not recognized and analyzed appropriately , this channeling could lead to biased treatment effect estimates in comparative analyses , including those involving users of sitagliptin . \\n  \\n k. g. brodovicz was an employee of merck sharp & dohme corp . , a subsidiary of merck & co. , inc . , \\n kenilworth , nj , at the time this analysis was carried out and may own stock and/or hold stock options in the company . \\n kenilworth , nj , at the time this analysis was carried out and may own stock and/or hold stock options in the company . \\n , a subsidiary of merck & co. , inc . , kenilworth , nj and may own stock and/or hold stock options in the company . \\n this article does not contain any new studies with human or animal subjects performed by any of the authors . \\n this article is distributed under the terms of the creative commons attribution - noncommercial 4.0 international license ( http://creativecommons.org/licenses/by-nc/4.0/ ) , which permits any noncommercial use , distribution , and reproduction in any medium , provided you give appropriate credit to the original author(s ) and the source , provide a link to the creative commons license , and indicate if changes were made .',\n",
       "  'output': 'introductionchronic kidney disease ( ckd ) is common in patients with type 2 diabetes ( t2 dm ) and makes them particularly susceptible to safety / tolerability issues related to many classes of oral antihyperglycemic agents ( oaha ) . \\n dipeptidyl peptidase-4 inhibitors ( dpp-4is ) like sitagliptin are generally well tolerated in patients with t2 dm and renal disease and therefore may be preferentially used in patients with ckd . to assess the extent of this preference , the characteristics of sitagliptin users with t2 dm and ckd were compared with those of other ( non - dpp-4i ) oaha users with t2 dm and ckd.methodspatients with t2 dm and ckd with claims between 2006 and 2012 were identified from a united states insurance claims database . \\n patients starting sitagliptin or another oaha as mono , dual , or triple therapy were compared . \\n demographic and clinical characteristics within 5  years before starting or escalating to new therapies were assessed.resultscompared to patients with ckd starting other oahas , patients with ckd starting sitagliptin as mono or dual therapy were older , had more physician visits , were more likely to have a history of heart failure and to use loop diuretics . in triple \\n therapy patients , the differences between groups were not as pronounced , but the overall prevalences of comorbidities was higher.conclusionsimilar to prior observations in a general t2 dm population , patients with t2 dm and ckd prescribed sitagliptin tend to be older and have more comorbidities than those prescribed other classes of oaha . if not recognized and analyzed appropriately , this channeling could lead to biased treatment effect estimates in comparative analyses that include users of sitagliptin.fundingmerck & co. , inc . , \\n kenilworth , nj , usa.electronic supplementary materialthe online version of this article ( doi:10.1007/s13300 - 015 - 0133-z ) contains supplementary material , which is available to authorized users .',\n",
       "  '__index_level_0__': 31672,\n",
       "  'model_output': 'summary : the objective of this study was to describe the baseline characteristics of patients with type 2 diabetes and chronic kidney disease initiating treatment with sitagliptin or non-dipeptidyl peptidase-4 inhibitor oral antihyperglycemic agents to ascertain whether channeling exists in this patient population. \\n the results of this study showed that patients with type 2 diabetes and chronic kidney disease who initiated treatment with sitagliptin were generally older and were more likely to have a pre-treatment history of heart failure, arrhythmia, or use of loop diuretics or beta-blockers than patients initiating other classes of oral therapies. if not recognized and analyzed appropriately, this channeling could lead to biased treatment effect estimates in comparative analyses, including those involving users of sitagliptin. \\n the most pronounced differences in baseline characteristics between the treatment groups were observed between patients initiating monotherapy. \\n as treatment complexity increased, the differences in baseline characteristics between treatment groups persisted but were attenuated, presumably due to diminishing treatment options with increasing treatment complexity. \\n these observations of channeling in patients receiving treatment with sitagliptin are similar to those previously reported in a general type 2 diabetes population [ 47 ].'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Summarize the given article into a concise abstract that highlights the key findings and conclusions.',\n",
       "  'input': \"Summarize the following article: in this issue of critical care , protti and colleagues   report the effects of metformin on human platelets both in vitro and ex vivo . in vitro experiments \\n were performed on healthy platelets incubated with increasing doses of metformin , whereas ex vivo experiments were done on platelets from patients presenting accidental metformin - induced lactic acidosis . in both situations , \\n platelets ' lactate production and mitochondrial functions were measured . in vitro , a dose - dependent relationship between metformin con centration and lactate production was found . in both conditions , \\n high levels of metformin decreased mitochondrial respiratory chain complex i activity , mitochondria polarization , and oxygen consumption . \\n metformin is a biguanide that has been used as a first - line drug for type 2 diabetes treatment since 1957 in europe and 1995 in the us . \\n metformin was reputed to induce lactic acidosis , partly because phenformin , another biguanide , was withdrawn from the market because of an unacceptable rate of this complication . \\n however , numerous clinical studies reported a similar incidence of lactic acidosis in diabetic patients with or without metformin , leading some authors to deny the existence of metformin - associated lactic acidosis . however , in usual clinical practice , metformin contraindications are not often respected . \\n moreover , physicians do not really monitor adequately their prescription . as a result , numerous publications reported the association between metformin and lactic acidosis . when a cause of lactic acidosis such as shock state or acute renal failure is present , the responsibility of metformin could be questioned . \\n but when healthy patients without risk factors develop metformin poisoning leading to lactic acidosis , there is no doubt about this link . \\n however , metformin inhibits hepatic gluconeogenesis in different animal species and decreases mitochondrial respiratory chain complex i activity in different organs . \\n the clinical research on metformin - associated lactic acidosis was limited to retrospective studies describing incidence , risk factors , and supportive treatments . \\n a big step forward was made when the gattinoni group   reported a decrease in oxygen consumption after metformin poisoning in humans , strongly suggesting that metformin was able to induce mitochondrial dysfunction in humans . \\n the study by protti and colleagues elegantly confirms the implication of mitochondria in the pathophysiology of this disease . \\n of course , the importance of platelet mitochondrial dysfunction per se has to be put in perspective . \\n however , as demonstrated previously in the pig , platelet mitochondrial dysfunction mirrors the mitochondrial dysfunction in other vital organs . \\n platelets are more easily accessible than vital organs like the liver or kidney . for research purposes in humans \\n now that serious research on this rare disease has started , we can also imagine improving its care . \\n currently , the treatment is only supportive : increasing blood pressure with fluid infusion and catecholamines and promoting metformin elimination by renal replacement therapy . restoring atp production during energy failure due to mitochondria dysfunction is still challenging . \\n another condition associated with mitochondrial dysfunction , succinate can bypass respiratory chain complex i inhibition and restore oxygen consumption . in isolated cells \\n , succinate is reputed not to cross the plasma membrane , but methyl succinate ( a cellpermeant succinate ) has been used to bypass metformin blockade of respiratory chain complex i .\",\n",
       "  'output': 'does metformin - associated lactic acidosis really exist ? despite an old controversy , there is no doubt about it . but \\n do we understand what is going on ? \\n laboratory findings raised several hypotheses explaining the pathophysiology of this disease . \\n the main cause could be an inhibition of either gluconeogenesis or mitochondrial respiratory chain complex i. from bench to bedside , one hypothesis is now confirmed in humans . \\n metformin poisoning involves , at least partially , a mitochondrial dysfunction .',\n",
       "  '__index_level_0__': 31673,\n",
       "  'model_output': \"summary: in this issue of critical care, protti and colleagues   report the effects of metformin on human platelets both in vitro and ex vivo. in vitro experiments \\n were performed on healthy platelets incubated with increasing doses of metformin, whereas ex vivo experiments were done on platelets from patients presenting accidental metformin - induced lactic acidosis. in both situations, \\n platelets'lactate production and mitochondrial functions were measured. in vitro, a dose - dependent relationship between metformin con centration and lactate production was found. in both conditions, \\n high levels of metformin decreased mitochondrial respiratory chain complex i activity, mitochondria polarization, and oxygen consumption. \\n metformin is a biguanide that has been used as a first - line drug for type 2 diabetes treatment since 1957 in europe and 1995 in the us. \\n metformin was reputed to induce lactic acidosis, partly because phenformin, another biguanide, was withdrawn from the market because of an unacceptable rate of this complication. \\n however, numerous clinical studies reported a similar incidence of lactic acidosis in diabetic patients with or without metformin, leading some authors to deny the existence of metformin - associated lactic acidosis. however, in usual clinical practice, metformin contraindications are not often respected. \\n moreover, physicians do not really monitor adequately their prescription. as a result, numerous publications reported the association between metformin and lactic acidosis. when a cause of lactic acidosis such as shock state or acute renal failure is present, the responsibility of metformin could be questioned. \\n but when healthy patients without risk factors develop metformin poisoning leading to lactic acidosis, there is no doubt about this link. \\n however, metformin inhibits hepatic gluconeogenesis in different animal species and decreases mitochondrial respiratory chain complex i activity in different organs. \\n the clinical research on metformin - associated lactic acidosis was limited to retrospective studies describing incidence, risk factors, and supportive treatments. \\n a big step forward was made when the gattinoni group   reported a decrease in oxygen consumption after metformin poisoning in humans, strongly suggesting that metformin was able to induce mitochondrial dysfunction in humans. \\n the study by protti and colleagues elegantly confirms the implication of mitochondria in the pathophysiology of this disease. \\n of course, the importance of platelet mitochondrial dysfunction per se has to be put in perspective. \\n however, as demonstrated previously in the pig, platelet mitochondrial dysfunction mirrors the mitochondrial dysfunction in other vital organs. \\n platelets are more easily accessible than vital organs like the liver or kidney. for research purposes in humans \\n now that serious research on this rare disease has started, we can also imagine improving its care. \\n currently, the treatment is only supportive : increasing blood pressure with fluid infusion and catecholamines and promoting metformin elimination by renal replacement therapy. restoring atp production during energy failure due to mitochondria dysfunction is still challenging. \\n another condition associated with mitochondrial dysfunction, succinate can bypass respiratory chain complex i inhibition and restore oxygen consumption. in isolated cells \\n, succinate is reputed not to cross the plasma membrane, but methyl succinate ( a cellpermeant succinate ) has been used to bypass metformin blockade of respiratory chain complex i.\"},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': 'Summarize the following article: gestational diabetes mellitus ( gdm ) is defined as glucose intolerance 1st recognized during pregnancy with a prevalence of 2% to 14% in all pregnant women . \\n gdm is associated with maternal , fetal , and neonatal adverse outcomes such as cesarean delivery , preeclampsia , shoulder dystocia , macrosomia , neonatal hypoglycemia , and perinatal death . \\n although yet to be proven , screening and treating gdm may contribute to prevent adverse outcomes . \\n the most commonly used screening and diagnostic methods of gdm are flawed because they give relatively poor negative and positive predictive values . \\n the 2-step diagnosis method , the 1-hour 50-g glucose challenge test ( gct ) , and the 3-hour 100-g oral glucose tolerance test ( ogtt ) are currently used in the united states , and the single - step 2-hour 75-g ogtt is used in european countries . in korea , the 2-step diagnosis approach has been used predominantly as in the united states , but several hospitals have adopted new guidelines for the diagnosis of gdm . it is also necessary to change the current counseling and treatment approaches for gdm patients because perinatal outcomes tend to differ according to glucose levels . \\n patients with 50-g gct within 140 to 199  mg / dl had 2.5-fold increasing risk of large for gestational age ( lga ) and 2.9-fold increasing risk of macrosomia . \\n langer et al demonstrated that every 10  mg / dl increment in fasting blood glucose ( fbg ) resulted in 15% increase in adverse composite outcomes . \\n the purpose of this study is to evaluate the association between perinatal outcomes and 50-g gct values as well as fbg among gdm women . \\n a retrospective analysis of 3434 pregnant women who had 50-g gct was carried out between march 2001 and april 2013 at severance hospital , seoul , korea . \\n women with fetal anomalies , multiple gestations , overt diabetes mellitus ( dm ) , and hypertension were excluded from the study . \\n a total of 2631 pregnant women received the normal 50-g gct and 803 received the100-g ogtt because their 50-g gct value was greater than 140  mg / dl . \\n as a result , 307 patients were diagnosed with gdm ( gdm group ) and 496 showed false - positive result ( impaired glucose tolerance group ) . \\n a false - positive result was defined as showing positive in the 1-hour 50-g gct but negative in the 3-hour 100-g ogtt . \\n gdm was defined as showing 2 or more abnormal duration ( hours ) of 100-g ogtt values : fbg of 95  mg / dl or more ; 180  mg / dl or more for 1-hour ; 155  mg / dl or more for 2-hours ; and 140  mg / dl or more for 3-hours . \\n a total of 171 patients had normal fbg ( < 95  mg / dl ) and 136 patients had abnormal fbg ( 95  mg / dl ) ( fig . \\n the 1-hour 50-g gct result was also divided into 20-unit increments , and these subgroups were used to evaluate maternal and perinatal outcomes . \\n a total of 307 pregnant women ( the same number as gdm patients ) were randomly selected from the normal 1-hour 50-g gct group ( n = 2631 ) to be the control . \\n the risks of adverse maternal and perinatal outcomes for subgroups of the gdm group were then analyzed and compared against the control group . \\n maternal composite adverse outcomes included cesarean delivery and preeclampsia , while fetal composite adverse outcomes included lga , apgar score , intensive care unit admission , neonatal hypoglycemia , and hyperbilirubinemia . \\n preeclampsia was diagnosed according to the criteria of the acog practice bulletin : new onset of blood pressure of 140/90  mm  hg or more on 2 separate readings taken 6  hours apart after 20 gestational weeks ; and proteinuria of 300  mg/24  hours or more . \\n lga was defined as birth weight greater than the 90th percentile compared with gestational age . \\n neonatal hypoglycemia was defined as blood glucose level of less than 40  mg / dl , and hyperbilirubinemia was defined as bilirubin level of more than 5  mg / dl . for statistical processing , the chi - square test or fisher exact test \\n was used for categorical variables and the 2-sample t test or the wilcoxon rank sum test was used for continuous variables . \\n multiple logistic regression analysis was performed to estimate the odds ratios ( ors ) of adverse outcomes with adjustment for confounders . \\n cary , nc ) and statistical significance was considered for p - values  < 0.05 . \\n based on the results of the 50-g gct , the clinical characteristics and perinatal outcomes of the impaired glucose tolerance ( igt ) group and the gdm group ( table 1 ) were compared . \\n significant differences were observed between the 2 groups in terms of their maternal age , body mass index ( bmi ) before pregnancy and at delivery , and family history of dm . for perinatal outcomes , \\n the gdm group showed higher incidence of cesarean delivery , macrosomia , lga , and neonatal hypoglycemia . \\n comparison of characteristics of igt and gdm groups . among gdm patients , maternal characteristics and perinatal outcomes \\n study findings show statistical significance in bmi before pregnancy and at delivery , rate of cesarean section , prevalence of gestational hypertension , gestational insulin therapy , and hba1c at diagnosis . \\n incidence of macrosomic newborn ( 3.5% for normal glycemic vs 22.1% hyperglycemic group , p  <  0.001 ) and lga newborn ( 10.5% for normal glycemic vs 36.0% hyperglycemic group , p  < \\n 0.001 ) was higher in the fasting hyperglycemic group , meeting the carpenter and coustan criteria . \\n moreover , the prevalence of neonatal hypoglycemia was 9.4% , and 15.4% in the normal glycemic and hyperglycemic groups , respectively ( p  <  0.001 ) . to compare perinatal outcomes between the 2 groups , the odds ratio was calculated after controlling for confounding factors ( table 3 ) . \\n the odds ratio for perinatal outcomes was 6.72 ( 95% ci : 2.5917.49 , p  <  0.001 ) with macrosomia , 3.75 ( 95% ci : 1.977.12 , p  <  0.001 ) with lga , and 1.65 ( 95% ci : 0.793.43 , p = 0.183 ) with neonatal hypoglycemia . \\n the maternal and perinatal outcomes of pregnant women with 50-g gct result of over 140  mg / dl were further stratified into 20-unit increments ( table 4 ) . \\n the findings showed significant differences in bmi before pregnancy and at delivery , incidence of gestational hypertension and gestational insulin therapy , hba1c at diagnosis of gdm , macrosomia , lga , and neonatal hypoglycemia . \\n the 50-g gct results were categorized and the perinatal outcomes were compared with 50-g gct normal group after adjusting for confounders ( table 5 ) . increased 50-g gct values in subgroups showed relevance with higher risk of perinatal outcomes . \\n the ors of macrosomia ( up to 20.31-fold ) , lga ( up to 6.15-fold ) , and neonatal hypoglycemia ( up to 84.00-fold ) were higher in subgroups with higher 50-g gct values . among gdm patients , \\n the group with 50-g gct level of 140 to 159  mg / dl was found to be associated with macrosomia ( or : 4.31 , 95% ci : 1.4213.13 , p = 0.010 ) and neonatal hypoglycemia ( or : 17.27 , 95% ci : 2.03147.12 , p = 0.009 ) when compared against the normal group . \\n however , lga ( or : 0.84 , 95% ci : 0.401.73 , p = 0.628 ) did not show statistical significance . \\n the subgroup in the 160 to 179  mg / dl range showed significant or for macrosomia ( or : 5.95 , 95% ci : 1.9218.49 , p = 0.002 ) and neonatal hypoglycemia ( or : 53.72 , 95% ci : 6.78425.70 , p  <  0.001 ) . \\n lga ( or : 1.48 , 95% ci : 0.733.03 , p = 0.279 ) showed the tendency to increase but there was no statistical significance . \\n also , the subgroups in the 180 to 199  mg / dl and the 200  mg / dl ranges showed a strong association with all adverse perinatal outcomes . \\n therefore , risks of adverse perinatal outcomes increased as the values of 50-g gct results increased . \\n maternal characteristics and perinatal outcomes according to fasting glucose values in gdm patients . or of perinatal outcomes for fasting glucose level 95  mg / dl in gdm group . maternal and perinatal outcomes according to 50-g glucose challenge test in gdm patients . or of perinatal outcomes according to 50-g glucose challenge test values in gdm patients . \\n this study investigated the maternal and perinatal outcomes according to fbg and 50-g gct values in gdm pregnant women . \\n the risks of macrosomia , lga , and neonatal hypoglycemia increased with fasting hyperglycemia and higher 50-g gct values . \\n study findings also showed that the association between fasting hyperglycemia and adverse perinatal outcomes remain to be significant after adjustment for potential confounders . \\n previous studies have found that postprandial hyperglycemia was associated with excessive fetal growth in gdm patients requiring insulin therapy or pregestational diabetes patients . \\n other studies have indicated that meal - related glucose threshold measurement did not increase the risk of adverse fetal outcomes . \\n recently , other researches have demonstrated significant association between fasting and 1-hour 75-g ogtt glucose values with lga newborns among gdm women . \\n it has been reported that strict glucose control in this risk group may be necessary in order to avoid lga newborns . \\n it has been emphasized in many studies that fbg is an important factor in gdm screening as well as in predicting neonatal adverse outcomes . \\n gdm women with an isolated abnormal fbg were more likely to need hypoglycemic agents to obtain good glycemic control . \\n the significance and magnitude of this association was consistent with the results of this study . in the abnormal fbg group , 47.1% ( 64/136 ) of gdm patients needed gestational insulin therapy to control the blood glucose but in the normal fbg group ( p  <  0.001 ) , only 12.9% ( 22/171 ) of pregnant women who were diagnosed with gdm required insulin treatment . \\n the hapo studies have demonstrated the continuously increasing relationship between maternal blood glucose levels and adverse perinatal outcomes such as frequency of lga , neonatal hypoglycemia , cord blood serum c - peptide level above the 90th percentile , and primary cesarean section delivery . \\n however , these studies are based on the single step 75-g ogtt , and gdm was diagnosed using the international association of diabetes and pregnancy study groups ( iadpsg ) criteria . in the hapo studies , the outcomes were compared after categorizing fasting , 1-hour , and 2-hour glucose values . in contrast , this study is based on the 2-step diagnosis of gdm , and the outcomes of the 50-g gct values and the fbg of 100-g ogtt were compared against each other . \\n the outcomes found in this study give a more accurate picture of the situation in korea , where the 2-step diagnosis is predominantly used . \\n in addition , without adjusting for confounding factors , such as prepregnancy bmi and gestational weight gain , adverse outcome risks may have been overestimated in other earlier studies . however , in this study , the relation between maternal hyperglycemia and adverse perinatal outcomes were analyzed after adjusting for bmi before pregnancy and gestational weight gain , because bmi is also related to maternal and perinatal outcomes in gdm patients . \\n fbg has been used as the most important indicator for the diagnosis of dm in nonpregnant adults because it reflects impaired insulin secretion and resistance . \\n fbg values tend to stay constant throughout the entire period of pregnancy and this is also true for nonpregnant patients . \\n fbg values have less individual variation compared to other glucose values ; therefore , abnormal fbg level is a significant indicator in diagnosing gdm . at present , fbg is a good screening test for gdm with advantages such as simple procedure , reasonable cost , reproducibility , easy access , and wide acceptance . \\n recently , other studies have reported that abnormal fbg alone is capable of detecting 50% of pregnant women with gdm from a pool of women who had already been diagnosed with gdm with another screening method . \\n if combined with the 2-hour plasma glucose level , another 25% of pregnant women with gdm can be detected . in 2016 , \\n park et al developed a more practical and efficient screening tool using fbg and prepregnancy bmi for predicting adverse outcomes of gdm . \\n this new screening tool focused on predicting the maternal and perinatal adverse outcomes of gdm patients . \\n the findings of this study show that bmi before pregnancy , bmi at delivery , hba1c value at diagnosis , and the application of gestational insulin therapy were much higher in the abnormal fbg group . \\n several studies have indicated that maternal prepregnancy bmi was associated with the risk of gdm . \\n sacks et al confirmed that maternal bmi had a powerful impact upon fetal birth weight . therefore , gdm patients with both higher bmi and abnormal fbg values can have potentially worse perinatal outcomes . \\n this study also showed that abnormal fbg values according to the carpenter and coustan criteria had significance association with higher incidence of lga , macrosomia , and neonatal hypoglycemia . \\n in addition , adverse perinatal outcomes according to different 50-g gct values among gdm patients were evaluated in this study . \\n the risks of macrosomia , lga , and neonatal hypoglycemia increased with increasing 50-g gct values . \\n several studies have examined the relationship of 50-g gct and perinatal outcomes . in 1987 , leikin et al reported that the false - positive gct group ( gct values of 135  mg / dl or more but normal ogtt values ) had higher incidence of macrosomia compared with the normal gct group ( 11.9% vs 6.4% , p = 0.009 ) . \\n recently , other retrospective cohort studies also showed that false - positive gct is an independent risk factor for adverse perinatal outcomes ( or : 5.96 , 95% ci : 1.310.3 ) . \\n the findings of this study suggest that the risks of the macrosomia ( up to 20.31-fold ) , lga ( up to 6.15-fold ) , and neonatal hypoglycemia ( up to 84.00-fold ) increased with higher 50-g gct values . more importantly , \\n 50-g gct values in the range of 140 to 159  mg / dl were not associated with lga compared to the normal 50-g gct group . \\n these results should be interpreted with caution since confidence intervals were very wide due to a limited number of cases in the 50-g gct normal group . in 2013 , figueroa et al evaluated the relationship between 50-g gct values and perinatal outcomes in mild gdm patients , and showed that gct values of 140  mg / dl or more were associated with an increase of composite perinatal outcomes , lga , and macrosomia . \\n however , there was no evaluation for the group with gct value of 200  mg / dl or more . \\n they only included mild gdm group with fasting glucose value less than 95  mg / dl . \\n the strength of this study is that a full spectrum of gdm patients were examined using the carpenter and coustan criteria , including the group with 50-g gct higher than 200  mg / dl . \\n therefore , it was possible to evaluate the continuous 50-g gct values in the lower or upper ranges . \\n this study also included normal and abnormal fasting glucose groups and the abnormal fbg group tended to have a greater risk for adverse perinatal outcomes . \\n a randomized clinical trial of a larger scale , using prospectively collected data from a well - characterized trial cohort , is ideal and necessary to validate the findings of this study . \\n all gdm women were treated to achieve the recommended value of their glycemic profiles and 28.0% ( 86/307 ) of the pregnant women with gdm needed insulin therapy . even without the influence of gdm management \\n in addition , long - term health complications such as childhood obesity , impaired insulin sensitivity , or type 2 diabetes mellitus were not considered for in this study . in conclusion , \\n also , composite perinatal outcomes such as macrosomia , lga , and neonatal hypoglycemia are more frequent with increasing 50-g gct values . \\n therefore , more attention and care should be given during prenatal counseling , as well as more active therapeutic intervention taken when necessary with closer fetal monitoring , with the objective to reduce adverse perinatal outcomes in gdm patients with abnormal fbg or high 50-g gct values .',\n",
       "  'output': 'abstractpregnancies complicated by gestational diabetes mellitus ( gdm ) are associated with increased risks of adverse maternal and fetal outcomes . \\n the risks of adverse pregnancy outcomes differ depending on the glucose values among gdm patients . for accurate and effective prenatal counseling , \\n it is necessary to understand the relationship between different maternal hyperglycemia values and the severity of adverse outcomes . with this objective \\n , this study reexamines the relationship between maternal hyperglycemia versus maternal and perinatal outcomes in gdm patients . for this study \\n , maternal hyperglycemia was diagnosed using the 2-step diagnostic approach.medical records of 3434 pregnant women , who received the 50-g glucose challenge test ( gct ) between march 2001 and april 2013 , were reviewed . as a result \\n , 307 patients were diagnosed with gdm , and they were divided into 2 groups according to their fasting glucose levels . \\n a total of 171 patients had normal fasting glucose level ( < 95  mg / dl ) , and 136 patients had abnormal fasting glucose level ( 95  mg / dl ) . \\n the 50-g gct results were subdivided by 20-unit increments ( 140159 , n = 123 ; 160179 , n = 84 ; 180199 , n = 50 ; and 200 , n = 50 ) , and the maternal and perinatal outcomes were compared against the normal 50-g gct group ( n = 307).maternal fasting blood glucose ( fbg ) level showed clear association with adverse perinatal outcomes . \\n the odds ratio ( or ) of macrosomia was 6.72 ( 95% ci : 2.5917.49 , p  <  0.001 ) between the 2 groups . \\n the ors of large for gestational age ( lga ) and neonatal hypoglycemia were 3.75 ( 95% ci : 1.977.12 , p  <  0.001 ) and 1.65 ( 95% ci : 0.793.43 , p   =  0.183 ) , respectively . also , the results of the 50-g gct for each category showed strong association with increased risks of adverse perinatal outcomes compared to the normal 50-g gct group . \\n the or of macrosomia ( up to 20.31-fold ) , lga ( up to 6.15-fold ) , and neonatal hypoglycemia ( up to 84.00-fold ) increased with increasing 50-g gct result .',\n",
       "  '__index_level_0__': 31674,\n",
       "  'model_output': 'abstract: gestational diabetes mellitus ( gdm ) is defined as glucose intolerance 1st recognized during pregnancy with a prevalence of 2% to 14% in all pregnant women. \\n gdm is associated with maternal, fetal, and neonatal adverse outcomes such as cesarean delivery, preeclampsia, shoulder dystocia, macrosomia, neonatal hypoglycemia, and perinatal death. \\n although yet to be proven, screening and treating gdm may contribute to prevent adverse outcomes. \\n the most commonly used screening and diagnostic methods of gdm are flawed because they give relatively poor negative and positive predictive values. \\n the 2-step diagnosis method, the 1-hour 50-g glucose challenge test ( gct ), and the 3-hour 100-g oral glucose tolerance test ( ogtt ) are currently used in the united states, and the single - step 2-hour 75-g ogtt is used in european countries. in korea, the 2-step diagnosis approach has been used predominantly as in the united states, but several hospitals have adopted new guidelines for the diagnosis of gdm. it is also necessary to change the current counseling and treatment approaches for gdm patients because perinatal outcomes tend to differ according to glucose levels. \\n patients with 50-g gct within 140 to 199  mg / dl had 2.5-fold increasing risk of large for gestational age ( lga ) and 2.9-fold increasing risk of macrosomia. \\n langer et al demonstrated that every 10  mg / dl increment in fasting blood glucose ( fbg ) resulted in 15% increase in adverse composite outcomes. \\n the purpose of this study is to evaluate the association between perinatal outcomes and 50-g gct values as well as fbg among gdm women. \\n a retrospective analysis of 3434 pregnant women who had 50-g gct was carried out between march 2001 and april 2013 at severance hospital, seoul, korea. \\n women with fetal anomalies, multiple gestations, overt diabetes mellitus ( dm ), and hypertension were excluded from the study. \\n a total of 2631 pregnant women received the normal 50-g gct and 803 received the100-g ogtt because their 50-g gct value was greater than 140  mg / dl. \\n as a result, 307 patients were diagnosed with gdm ( gdm group ) and 496 showed false - positive result ( impaired glucose tolerance group ). \\n a false - positive result was defined as showing positive in the 1-hour 50-g gct but negative in the 3-hour 100-g ogtt. \\n gdm was defined as showing 2 or more abnormal duration ( hours ) of 100-g ogtt values : fbg of 95  mg / dl or more ; 180  mg / dl or more for 1-hour ; 155  mg / dl or more for 2-hours ; and 140  mg / dl or more for 3-hours. \\n a total of 171 patients had normal fbg ( < 95  mg / dl ) and 136 patients had abnormal fbg ( 95  mg / dl ) ( fig. \\n the 1-hour 50-g gct result was also divided into 20-unit increments, and these subgroups were used to evaluate maternal and perinatal outcomes. \\n a total of 307 pregnant women ( the same number as gdm patients ) were randomly selected from the normal 1-hour 50-g gct group ( n = 2631 ) to be the control. \\n the risks of adverse maternal and perinatal outcomes for subgroups of the gdm group were then analyzed and compared against the control group. \\n maternal composite adverse outcomes included cesarean delivery and preeclampsia, while fetal composite adverse outcomes included lga, apgar score, intensive care unit admission, neonatal hypoglycemia, and hyperbilirubinemia. \\n preeclampsia was diagnosed according to the criteria of the acog practice bulletin : new onset of blood pressure of 140/90  mm  hg or more on 2 separate readings taken 6  hours apart after 20 gestational weeks ; and proteinuria of 300  mg/24  hours or more. \\n lga was defined as birth weight greater than the 90th percentile compared with gestational age. \\n neonatal hypoglycemia was defined as blood glucose level of less than 40  mg / dl, and hyperbilirubinemia was defined as bilirubin level of more than 5  mg / dl. for statistical processing, the chi - square test or fisher exact test \\n was used for categorical variables and the 2-sample t test or the wilcoxon rank sum test was used for continuous variables. \\n multiple logistic regression analysis was performed to estimate the odds ratios ( ors ) of adverse outcomes with adjustment for confounders. \\n cary, nc ) and statistical significance was considered for p - values  < 0.05. \\n based on the results of the 50-g gct, the clinical characteristics and perinatal outcomes of the impaired glucose tolerance ( igt ) group and the gdm group ( table 1 ) were compared. \\n significant differences were observed between the 2 groups in terms of their maternal age, body mass index ( bmi ) before pregnancy and at delivery, and family history of dm. for perinatal outcomes, \\n the gdm group showed higher incidence of cesarean delivery, macrosomia, lga, and neonatal hypoglycemia. \\n comparison of characteristics of igt and gdm groups. among gdm patients, maternal characteristics and perinatal outcomes \\n study findings show statistical significance in bmi before pregnancy and at delivery, rate of cesarean section, prevalence of gestational hypertension, gestational insulin therapy, and hba1c at diagnosis. \\n incidence of macrosomic newborn ( 3.5% for normal glycemic vs 22.1% hyperglycemic group, p  <  0.001 ) and lga newborn ( 10.5% for normal glycemic vs 36.0% hyperglycemic group, p  < \\n 0.001 ) was higher in the fasting hyperglycemic group, meeting the carpenter and coustan criteria. \\n moreover, the prevalence of neonatal hypoglycemia was 9.4%, and 15.4% in the normal glycemic and hyperglycemic groups, respectively ( p  <  0.001 ). to compare perinatal outcomes between the 2 groups, the odds ratio was calculated after controlling for confounding factors ( table 3 ). \\n the odds ratio for perinatal outcomes was 6.72 ( 95% ci : 2.5917.49, p  <  0.001 ) with macrosomia, 3.75 ( 95% ci : 1.977.12, p  <  0.001 ) with lga, and 1.65 ( 95% ci : 0.793.43, p = 0.183 ) with neonatal hypoglycemia. \\n the maternal and perinatal outcomes of pregnant women with 50-g gct result of over 140  mg / dl were further stratified into 20-unit increments ( table 4 ). \\n the findings showed significant differences in bmi before pregnancy and at delivery, incidence of gestational hypertension and gestational insulin therapy, hba1c at diagnosis of gdm, macrosomia, lga, and neonatal hypoglycemia. \\n the 50-g gct results were categorized and the perinatal outcomes were compared with 50-g gct normal group after adjusting for confounders ( table 5 ). increased 50-g gct values in subgroups showed relevance with higher risk of perinatal outcomes. \\n the ors of macrosomia ( up to 20.31-fold ), lga ( up to 6.15-fold ), and neonatal hypoglycemia ( up to 84.00-fold ) were higher in subgroups with higher 50-g gct values. among gdm patients, \\n the group with 50-g gct level of 140 to 159  mg / dl was found to be associated with macrosomia ( or : 4.31, 95% ci : 1.4213.13, p = 0.010 ) and neonatal hypoglycemia ( or : 17.27, 95% ci : 2.03147.12, p = 0.009 ) when compared against the normal group. \\n however, lga ( or : 0.84, 95% ci : 0.401.73, p = 0.628 ) did not show statistical significance. \\n the subgroup in the 160 to 179  mg / dl range showed significant or for macrosomia ( or : 5.95, 95% ci : 1.9218.49, p = 0.002 ) and neonatal hypoglycemia ( or : 53.72, 95% ci : 6.78425.70, p  <  0.001 ). \\n lga ( or : 1.48, 95% ci : 0.733.03, p = 0.279 ) showed the tendency to increase but there was no statistical significance. \\n also, the subgroups in the 180 to 199  mg / dl and the 200  mg / dl ranges showed a strong association with all adverse perinatal outcomes. \\n therefore, risks of adverse perinatal outcomes increased as the values of 50-g gct results increased. \\n maternal characteristics and perinatal outcomes according to fasting glucose values in gdm patients. or of perinatal outcomes for fasting glucose level 95  mg / dl in gdm group. maternal and perinatal outcomes according to 50-g glucose challenge test in gdm patients. or of perinatal outcomes according to 50-g glucose challenge test values in gdm patients. \\n this study investigated the maternal and perinatal outcomes according to fbg and 50-g gct values in gdm pregnant women. \\n the risks of macrosomia, lga, and neonatal hypoglycemia increased with fasting hyperglycemia and higher 50-g gct values. \\n study findings also showed that the association between fasting hyperglycemia and adverse perinatal outcomes remain to be significant after adjustment for potential confounders. \\n previous studies have found that postprandial hyperglycemia was associated with excessive fetal growth in gdm patients requiring insulin therapy or pregestational diabetes patients. \\n other studies have indicated that meal - related glucose threshold measurement did not increase the risk of adverse fetal outcomes. \\n recently, other researches have demonstrated significant association between fasting and 1-hour 75-g ogtt glucose values with lga newborns among gdm women. \\n it has been reported that strict glucose control in this risk group may be necessary in order to avoid lga newborns. \\n it has been emphasized in many studies that fbg is an important factor in gdm screening as well as in predicting neonatal adverse outcomes. \\n gdm women with an isolated abnormal fbg were more likely to need hypoglycemic agents to obtain good glycemic control. \\n the significance and magnitude of this association was consistent with the results of this study. in the abnormal fbg group, 47.1% ( 64/136 ) of gdm patients needed gestational insulin therapy to control the blood glucose but in the normal fbg group ( p  <  0.001 ), only 12.9% ( 22/171 ) of pregnant women who were diagnosed with gdm required insulin treatment. \\n the hapo studies have demonstrated the continuously increasing relationship between maternal blood glucose levels and adverse perinatal outcomes such as frequency of lga, neonatal hypoglycemia, cord blood serum c - peptide level above the 90th percentile, and primary cesarean section delivery. \\n however, these studies are based on the single step 75-g ogtt, and gdm was diagnosed using the international association of diabetes and pregnancy study groups ( iadpsg ) criteria. in the hapo studies, the outcomes were compared after categorizing fasting, 1-hour, and 2-hour glucose values. in contrast, this study is based on the 2-step diagnosis of gdm, and the outcomes of the 50-g gct values and the fbg of 100-g ogtt were compared against each other. \\n the outcomes found in this study give a more accurate picture of the situation in korea, where the 2-step diagnosis is predominantly used. \\n in addition, without adjusting for confounding factors, such as prepregnancy bmi and gestational weight gain, adverse outcome risks may have been overestimated in other earlier studies. however, in this study, the relation between maternal hyperglycemia and adverse perinatal outcomes were analyzed after adjusting for bmi before pregnancy and gestational weight gain, because bmi is also related to maternal and perinatal outcomes in gdm patients. \\n fbg has been used as the most important indicator for the diagnosis of dm in nonpregnant adults because it reflects impaired insulin secretion and resistance. \\n fbg values tend to stay constant throughout the entire period of pregnancy and this is also true for nonpregnant patients. \\n fbg values have less individual variation compared to other glucose values ; therefore, abnormal fbg level is a significant indicator in diagnosing gdm. at present, fbg is a good screening test for gdm with advantages such as simple procedure, reasonable cost, reproducibility, easy access, and wide acceptance. \\n recently, other studies have reported that abnormal fbg alone is capable of detecting 50% of pregnant women with gdm from a pool of women who had already been diagnosed with gdm with another screening method. \\n if combined with the 2-hour plasma glucose level, another 25% of pregnant women with gdm can be detected. in 2016, \\n park et al developed a more practical and efficient screening tool using fbg and prepregnancy bmi for predicting adverse outcomes of gdm. \\n this new screening tool focused on predicting the maternal and perinatal adverse outcomes of gdm patients. \\n the findings of this study show that bmi before pregnancy, bmi at delivery, hba1c value at diagnosis, and the application of gestational insulin therapy were much higher in the abnormal fbg group. \\n several studies have indicated that maternal prepregnancy bmi was associated with the risk of gdm. \\n sacks et al confirmed that maternal bmi had a powerful impact upon fetal birth weight. therefore, gdm patients with both higher bmi and abnormal fbg values can have potentially worse perinatal outcomes. \\n this study also showed that abnormal fbg values according to the carpenter and coustan criteria had significance association with higher incidence of lga, macrosomia, and neonatal hypoglycemia. \\n in addition, adverse perinatal outcomes according to different 50-g gct values among gdm patients were evaluated in this study. \\n the risks of macrosomia, lga, and neonatal hypoglycemia increased with increasing 50-g gct values. \\n several studies have examined the relationship of 50-g gct and perinatal outcomes. in 1987, leikin et al reported that the false - positive gct group ( gct values of 135  mg / dl or more but normal ogtt values ) had higher incidence of macrosomia compared with the normal gct group ( 11.9% vs 6.4%, p = 0.009 ). \\n recently, other retrospective cohort studies also showed that false - positive gct is an independent risk factor for adverse perinatal outcomes ( or : 5.96, 95% ci : 1.310.3 ). \\n the findings of this study suggest that the risks of the macrosomia ( up to 20.31-fold ), lga ( up to 6.15-fold ), and neonatal hypoglycemia ( up to 84.00-fold ) increased with higher 50-g gct values. more importantly, \\n 50-g gct values in the range of 140 to 159  mg / dl were not associated with lga compared to the normal 50-g gct group. \\n these results should be interpreted with caution since confidence intervals were very wide due to a limited number of cases in the 50-g gct normal group. in 2013, figueroa et al evaluated the relationship between 50-g gct values and perinatal outcomes in mild gdm patients, and showed that gct values of 140  mg / dl or more were associated with an increase of composite perinatal outcomes, lga, and macrosomia. \\n however, there was no evaluation for the group with gct value of 200  mg / dl or more. \\n they only included mild gdm group with fasting glucose value less than 95  mg / dl. \\n the strength of this study is that a full spectrum of gdm patients were examined using the carpenter and coustan criteria, including the group with 50-g gct higher than 200  mg / dl. \\n therefore, it was possible to evaluate the continuous 50-g gct values in the lower or upper ranges. \\n this study also included normal and abnormal fasting glucose groups and the abnormal fbg group tended to have a greater risk for adverse perinatal outcomes. \\n a randomized clinical trial of a larger scale, using prospectively collected data from a well - characterized trial cohort, is ideal and necessary to validate the findings of this study. \\n all gdm women were treated to achieve the recommended value of their glycemic profiles and 28.0% ( 86/307 ) of the pregnant women with gdm needed insulin therapy. even without the influence of gdm management \\n in addition, long - term health complications such as childhood obesity, impaired insulin sensitivity, or type 2 diabetes mellitus were not considered for in this study. in conclusion, \\n also, composite perinatal outcomes such as macrosomia, lga, and neonatal hypoglycemia are more frequent with increasing 50-g gct values. \\n therefore, more attention and care should be given during prenatal counseling, as well as more active therapeutic intervention taken when necessary with closer fetal monitoring, with the objective to reduce adverse perinatal outcomes in gdm patients with abnormal fbg or high 50-g gct values.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': \"Summarize the following article: a 21-year - old caucasian woman presented to an outside facility with altered mental status after being found lethargic by family . on arrival to the emergency department , plasma glucose was 20 mg / dl . \\n the patient was hospitalized and started on dextrose infusion , including 10% dextrose in water but remained hypoglycemic with capillary glucose ranging between 50 and 60 mg / dl . \\n she was transferred to our facility on suspicion of an insulinoma as the patient was unable to recall her prior diagnosis . \\n the patient reported repeated episodes of seizures , syncope , dizziness , headaches , palpitations , and sweating around age 12 ; however , symptoms were never formally investigated as she did not seek expert care . \\n these symptoms were also reported to have been present since birth but had been intermittent and of varying severity . \\n she remained seizure - free and without syncopal episodes until 17 when she experienced another syncopal episode . at that time \\n , she underwent extensive inpatient hypoglycemia evaluation with the following results : blood glucose of 47 mg / dl after 2 h of fasting , proinsulin levels varying from 10.4 to 84.1 pmol / l ( normal range 010 \\n pmol / l ) , c - peptide level 3.1 ng / ml ( normal range 1.14.4 ng / ml ) , negative insulin antibodies and sulfonylurea screen . \\n magnetic resonance imaging of the abdomen showed no insulinoma , but genetic studies revealed val452 leu activating mutation of the gck gene . \\n she was successfully treated with diazoxide and discharged home on oral diazoxide 250 mg daily , which she discontinued due to side effects of hirsutism and fluid retention . on current admission , \\n her blood glucose level remained low in spite of a continuous infusion of 5% dextrose necessitating transfer to an intensive care unit . \\n as review of her medication list did not show any implicating drugs , no additional work - up was pursued . \\n she was then placed on octreotide 200 g subcutaneously twice daily and diazoxide suspension 100 mg three times a day on consultation with the pediatric endocrinologist . \\n the patient 's hypoglycemia improved with capillary glucose of 55110 mg / dl by the time of discharge . \\n importance of compliance with the treatment and follow - up with an endocrinologist was emphasized . \\n when encountered in the inpatient setting , it is easily recognized as patients already have risk factors such as diabetes mellitus ( dm ) on treatment , sepsis , and end - organ failure . however , for patients presenting emergently with hypoglycemia alone , appropriate investigations are warranted to treat and prevent recurrence . after establishing a diagnosis of hypoglycemia by whipple 's triad ( low plasma glucose , hypoglycemic symptoms , and resolution of adrenergic / neuroglycopenic symptoms with correction of the blood sugar ) , interim treatment and search for risk / causative factors should ensue ( table 1 ) . \\n ideally , treatment is only given after obtaining a plasma sample to ensure accuracy of diagnosis . \\n medical history of ethanol use , surreptitious insulin ingestion , medication use and interaction , autoimmune disease , gastric bypass ( 4 ) , and subtle risk factors such as undiagnosed psychiatric disorder and polypharmacy should be excluded ( 5 ) . in seemingly well patients , \\n the timing of hypoglycemic spells ( fasting / postabsorptive or postprandial / reactive ) is required to determine diagnostic studies . \\n a mixed meal tolerance test under supervision is done for postprandial hypoglycemia while a 72-h fast should be done for fasting hypoglycemia . \\n hepatic or renal disease , endocrine disorders of growth hormone , cortisol , adrenal insufficiency , and hypopituitarism should be excluded . \\n plasma insulin , proinsulin , c - peptide , and beta - hydroxybutyrate levels should be assessed to exclude surreptitious use of insulin or insulin receptor antibodies . \\n intravenous glucagon can be given to distinguish disorders of gluconeogenesis from glycogenolysis ( 5 ) . \\n a 48-h supervised fast should be done to exclude insulinoma , with plasma insulin and proinsulin levels . \\n pro - igf ii to igf ii ratio can be measured to look for non - beta - cell tumors ( 5 ) . \\n negative findings suggest non - insulinoma pancreatogenous hypoglycemia syndrome ( niphs ) , which encompasses chi ( 4 , 6 ) . a selective pancreatic arterial calcium stimulation test ( spaci ) done at this time can detect hyperfunctioning of b - cells and confirm the diagnosis of niphs . \\n causes of hypoglycemia in adults chi is uncommon in the pediatric population with an estimated incidence of 1 in 40,000 to 50,000 live births annually in europe ( 7 ) . \\n gck mutations account for 7% of all causes of chi ( 8 , 9 ) ; gck facilitates phosphorylation of glucose to glucose-6-phosphate and is the main glucose sensor of the pancreatic beta cell and hepatocytes - controlling glucose - stimulated insulin secretion and glycogenesis ( 10 ) . activating mutations of the gck gene \\n are typically inherited in an autosomal dominant pattern , showing variable phenotypic penetrance and expressivity ranging from asymptomatic to marked hypoglycemia ( 11 , 12 ) . \\n inactivating forms of the mutation cause varying severity of persistent hyperglycemia depending on zygosity ( 13 ) . \\n de novo gck mutations are very rare and exhibit marked variation in phenotypic expression ( 14 ) . \\n over 600 heterozygous inactivating mutations have been reported , causing mild persistent hyperglycemia known as maturity onset diabetes of the young ( mody ) as opposed to only 13 known activating mutations of the gene ( 15 , 16 ) . \\n activating mutations are usually clustered around the allosteric activator site of the enzyme and led to hyperinsulinemic hypoglycemia by lowering the glucose set point and threshold for glucose stimulated insulin release . \\n the sheer numbers of existing mutations of the gck gene show it to be a highly mutable gene with varied disease outcomes depending on the type of activation . \\n it is key to blood glucose homeostasis and has been identified as a potential target for anti - diabetic therapy . \\n trials manipulating gck regulatory protein an allosteric switch for gck , which indirectly restores gck activity , are currently underway to evaluate its effect on blood glucose in patients with type 2 dm ( 17 , 18 ) . \\n treatment of niphs involves lifelong dietary modification consisting of frequent , low carbohydrate meals ( 5 ) , which prevent surges in plasma glucose level , insulin level , and the consequent hypoglycemic spells . \\n medications such as diazoxide , octreotide , glucagon , verapamil , and somatostatin , whose actions all involve inhibition of calcium channels , have been employed with varying degrees of success ( 7 ) . diazoxide binds to and activates the sulfonylurea receptor 1 subunit of the potassium adenosine triphosphate [ k(atp ) ] channel , causing calcium channel closure . \\n response to diazoxide therefore varies with genetic mutations [ ineffective in mutations of the k(atp ) channel genes ] ( 8) and with pattern of inheritance ( 7 ) . \\n octreotide , a somatostatin analogue ( secretin and insulin inhibitor ) , has been used in diazoxide unresponsive chi with improved blood glucose in these patients ; however , side effects such as gastrointestinal symptoms , dilated gallbladder , necrotizing enterocolitis , and qt prolongation sometimes limit its use ( 7 ) . \\n long - term use of glucagon is effective in diazoxide - unresponsive cases or severe / diffuse chi but gastrointestinal side effects and crystallization in infusion tubing have been reported ( 19 ) . \\n glucagon - like protein 1 receptor agonists such as exendin-4 are newer drugs that improve hypoglycemia in diazoxide - unresponsive patients by inhibiting insulin release ( 7 ) . \\n partial pancreatectomy is indicated for medical treatment failure [ suggesting a k(atp ) defect ] and is only curative for focal lesions while extensive resection is reserved for diffuse chi to limit pancreatic burden ( 7 , 8 , 11 , 20 ) . \\n affected patients can present in adulthood ; de novo mutations should be considered given the following:-  positive family history of unremitting hypoglycemia-  lifelong symptoms of low plasma glucose , even after eating-  increased bmi-  negative sulfonylurea and autoimmune work up-  positive glycemic response to octreotide \\n  -  positive family history of unremitting hypoglycemia -  lifelong symptoms of low plasma glucose , even after eating -  negative sulfonylurea and autoimmune work up -  positive glycemic response to octreotide to our knowledge , only three families with affected adults have been reported . \\n our case is unique because it expounds on genetic causes of hypoglycemia in adults . in addition \\n , this case highlights the pediatric - to - adulthood transition for rare diseases and the key role that coordination and transition of care plays in timely management . \\n after establishing a diagnosis of hypoglycemia by whipple 's triad ( low plasma glucose , hypoglycemic symptoms , and resolution of adrenergic / neuroglycopenic symptoms with correction of the blood sugar ) , interim treatment and search for risk / causative factors should ensue ( table 1 ) . \\n ideally , treatment is only given after obtaining a plasma sample to ensure accuracy of diagnosis . \\n medical history of ethanol use , surreptitious insulin ingestion , medication use and interaction , autoimmune disease , gastric bypass ( 4 ) , and subtle risk factors such as undiagnosed psychiatric disorder and polypharmacy should be excluded ( 5 ) . in seemingly well patients , \\n the timing of hypoglycemic spells ( fasting / postabsorptive or postprandial / reactive ) is required to determine diagnostic studies . \\n a mixed meal tolerance test under supervision is done for postprandial hypoglycemia while a 72-h fast should be done for fasting hypoglycemia . \\n hepatic or renal disease , endocrine disorders of growth hormone , cortisol , adrenal insufficiency , and hypopituitarism should be excluded . \\n plasma insulin , proinsulin , c - peptide , and beta - hydroxybutyrate levels should be assessed to exclude surreptitious use of insulin or insulin receptor antibodies . \\n intravenous glucagon can be given to distinguish disorders of gluconeogenesis from glycogenolysis ( 5 ) . \\n a 48-h supervised fast should be done to exclude insulinoma , with plasma insulin and proinsulin levels . \\n pro - igf ii to igf ii ratio can be measured to look for non - beta - cell tumors ( 5 ) . \\n negative findings suggest non - insulinoma pancreatogenous hypoglycemia syndrome ( niphs ) , which encompasses chi ( 4 , 6 ) . a selective pancreatic arterial calcium stimulation test ( spaci ) done at this time can detect hyperfunctioning of b - cells and confirm the diagnosis of niphs . \\n chi is uncommon in the pediatric population with an estimated incidence of 1 in 40,000 to 50,000 live births annually in europe ( 7 ) . \\n gck mutations account for 7% of all causes of chi ( 8 , 9 ) ; gck facilitates phosphorylation of glucose to glucose-6-phosphate and is the main glucose sensor of the pancreatic beta cell and hepatocytes - controlling glucose - stimulated insulin secretion and glycogenesis ( 10 ) . activating mutations of the gck gene \\n are typically inherited in an autosomal dominant pattern , showing variable phenotypic penetrance and expressivity ranging from asymptomatic to marked hypoglycemia ( 11 , 12 ) . \\n inactivating forms of the mutation cause varying severity of persistent hyperglycemia depending on zygosity ( 13 ) . \\n de novo gck mutations are very rare and exhibit marked variation in phenotypic expression ( 14 ) . \\n over 600 heterozygous inactivating mutations have been reported , causing mild persistent hyperglycemia known as maturity onset diabetes of the young ( mody ) as opposed to only 13 known activating mutations of the gene ( 15 , 16 ) . \\n activating mutations are usually clustered around the allosteric activator site of the enzyme and led to hyperinsulinemic hypoglycemia by lowering the glucose set point and threshold for glucose stimulated insulin release . \\n the sheer numbers of existing mutations of the gck gene show it to be a highly mutable gene with varied disease outcomes depending on the type of activation . \\n it is key to blood glucose homeostasis and has been identified as a potential target for anti - diabetic therapy . \\n trials manipulating gck regulatory protein an allosteric switch for gck , which indirectly restores gck activity , are currently underway to evaluate its effect on blood glucose in patients with type 2 dm ( 17 , 18 ) . \\n treatment of niphs involves lifelong dietary modification consisting of frequent , low carbohydrate meals ( 5 ) , which prevent surges in plasma glucose level , insulin level , and the consequent hypoglycemic spells . \\n medications such as diazoxide , octreotide , glucagon , verapamil , and somatostatin , whose actions all involve inhibition of calcium channels , have been employed with varying degrees of success ( 7 ) . diazoxide binds to and activates the sulfonylurea receptor 1 subunit of the potassium adenosine triphosphate [ k(atp ) ] channel , causing calcium channel closure . \\n response to diazoxide therefore varies with genetic mutations [ ineffective in mutations of the k(atp ) channel genes ] ( 8) and with pattern of inheritance ( 7 ) . \\n octreotide , a somatostatin analogue ( secretin and insulin inhibitor ) , has been used in diazoxide unresponsive chi with improved blood glucose in these patients ; however , side effects such as gastrointestinal symptoms , dilated gallbladder , necrotizing enterocolitis , and qt prolongation sometimes limit its use ( 7 ) . \\n long - term use of glucagon is effective in diazoxide - unresponsive cases or severe / diffuse chi but gastrointestinal side effects and crystallization in infusion tubing have been reported ( 19 ) . \\n glucagon - like protein 1 receptor agonists such as exendin-4 are newer drugs that improve hypoglycemia in diazoxide - unresponsive patients by inhibiting insulin release ( 7 ) . \\n partial pancreatectomy is indicated for medical treatment failure [ suggesting a k(atp ) defect ] and is only curative for focal lesions while extensive resection is reserved for diffuse chi to limit pancreatic burden ( 7 , 8 , 11 , 20 ) . \\n affected patients can present in adulthood ; de novo mutations should be considered given the following:-  positive family history of unremitting hypoglycemia-  lifelong symptoms of low plasma glucose , even after eating-  increased bmi-  negative sulfonylurea and autoimmune work up-  positive glycemic response to octreotide \\n  -  positive family history of unremitting hypoglycemia -  lifelong symptoms of low plasma glucose , even after eating -  negative sulfonylurea and autoimmune work up -  positive glycemic response to octreotide to our knowledge , only three families with affected adults have been reported . \\n in addition , this case highlights the pediatric - to - adulthood transition for rare diseases and the key role that coordination and transition of care plays in timely management . \\n despite the congenital nature of gck mutations , some patients can go undiagnosed till early adulthood . \\n future research into a cost - effective and prompt scheme of patient information dissemination is warranted for uncommon diseases . \\n the authors have not received any funding or benefits from industry or elsewhere to conduct this study .\",\n",
       "  'output': 'backgroundhypoglycemia occurs frequently in patients both in the inpatient and outpatient settings . while most hypoglycemia unrelated to diabetes treatment results from excessive endogenous insulin action , rare cases involve functional and congenital mutations in glycolytic enzymes of insulin regulation.casea 21-year - old obese woman presented to the emergency department with complaints of repeated episodes of lethargy , syncope , dizziness , and sweating . \\n she was referred from an outside facility on suspicion of insulinoma , with severe hypoglycemia unresponsive to repeated dextrose infusions . \\n her plasma glucose was 20 mg / dl at presentation , 44 mg / dl on arrival at our facility , and remained low in spite of multiple dextrose infusions . \\n the patient had been treated for persistent hyperinsulinemic hypoglycemia of infancy at our neonatal facility and 4 years ago was diagnosed as having an activating glucokinase ( gck ) mutation . \\n she was then treated with octreotide and diazoxide with improvement in symptoms and blood glucose levels.conclusionimproved diagnostication and management of uncommon genetic mutations as typified in this patient with an activating mutation of the gck gene has expanded the spectrum of disease in adult medicine . \\n this calls for improved patient information dissemination across different levels and aspects of the health care delivery system to ensure cost - effective and timely health care .',\n",
       "  '__index_level_0__': 31675,\n",
       "  'model_output': \"a 21-year - old caucasian woman presented to an outside facility with altered mental status after being found lethargic by family. on arrival to the emergency department, plasma glucose was 20 mg / dl. \\n the patient was hospitalized and started on dextrose infusion, including 10% dextrose in water but remained hypoglycemic with capillary glucose ranging between 50 and 60 mg / dl. \\n she was transferred to our facility on suspicion of an insulinoma as the patient was unable to recall her prior diagnosis. \\n the patient reported repeated episodes of seizures, syncope, dizziness, headaches, palpitations, and sweating around age 12 ; however, symptoms were never formally investigated as she did not seek expert care. \\n these symptoms were also reported to have been present since birth but had been intermittent and of varying severity. \\n she remained seizure - free and without syncopal episodes until 17 when she experienced another syncopal episode. at that time, she underwent extensive inpatient hypoglycemia evaluation with the following results : blood glucose of 47 mg / dl after 2 h of fasting, proinsulin levels varying from 10.4 to 84.1 pmol / l ( normal range 010 \\n pmol / l ), c - peptide level 3.1 ng / ml ( normal range 1.14.4 ng / ml ), negative insulin antibodies and sulfonylurea screen. \\n magnetic resonance imaging of the abdomen showed no insulinoma, but genetic studies revealed val452 leu activating mutation of the gck gene. \\n she was successfully treated with diazoxide and discharged home on oral diazoxide 250 mg daily, which she discontinued due to side effects of hirsutism and fluid retention. on current admission, \\n her blood glucose level remained low in spite of a continuous infusion of 5% dextrose necessitating transfer to an intensive care unit. \\n as review of her medication list did not show any implicating drugs, no additional work - up was pursued. \\n she was then placed on octreotide 200 g subcutaneously twice daily and diazoxide suspension 100 mg three times a day on consultation with the pediatric endocrinologist. \\n the patient's hypoglycemia improved with capillary glucose of 55110 mg / dl by the time of discharge. \\n importance of compliance with the treatment and follow - up with an endocrinologist was emphasized. \\n when encountered in the inpatient setting, it is easily recognized as patients already have risk factors such as diabetes mellitus ( dm ) on treatment, sepsis, and end - organ failure. however, for patients presenting emergently with hypoglycemia alone, appropriate investigations are warranted to treat and prevent recurrence. after establishing a diagnosis of hypoglycemia by whipple's triad ( low plasma glucose, hypoglycemic symptoms, and resolution of adrenergic / neuroglycopenic symptoms with correction of the blood sugar ), interim treatment and search for risk / causative factors should ensue ( table 1 ). \\n ideally, treatment is only given after obtaining a plasma sample to ensure accuracy of diagnosis. \\n medical history of ethanol use, surreptitious insulin ingestion, medication use and interaction, autoimmune disease, gastric bypass ( 4 ), and subtle risk factors such as undiagnosed psychiatric disorder and polypharmacy should be excluded ( 5 ). in seemingly well patients, \\n the timing of hypoglycemic spells ( fasting / postabsorptive or postprandial / reactive ) is required to determine diagnostic studies. \\n a mixed meal tolerance test under supervision is done for postprandial hypoglycemia while a 72-h fast should be done for fasting hypoglycemia. \\n hepatic or renal disease, endocrine disorders of growth hormone, cortisol, adrenal insufficiency, and hypopituitarism should be excluded. \\n plasma insulin, proinsulin, c - peptide, and beta - hydroxybutyrate levels should be assessed to exclude surreptitious use of insulin or insulin receptor antibodies. \\n intravenous glucagon can be given to distinguish disorders of gluconeogenesis from glycogenolysis ( 5 ). \\n a 48-h supervised fast should be done to exclude insulinoma, with plasma insulin and proinsulin levels. \\n pro - igf ii to igf ii ratio can be measured to look for non - beta - cell tumors ( 5 ). \\n negative findings suggest non - insulinoma pancreatogenous hypoglycemia syndrome ( niphs ), which encompasses chi ( 4, 6 ). a selective pancreatic arterial calcium stimulation test ( spaci ) done at this time can detect hyperfunctioning of b - cells and confirm the diagnosis of niphs. \\n causes of hypoglycemia in adults chi is uncommon in the pediatric population with an estimated incidence of 1 in 40,000 to 50,000 live births annually in europe ( 7 ). \\n gck mutations account for 7% of all causes of chi ( 8, 9 ) ; gck facilitates phosphorylation of glucose to glucose-6-phosphate and is the main glucose sensor of the pancreatic beta cell and hepatocytes - controlling glucose - stimulated insulin secretion and glycogenesis ( 10 ). activating mutations of the gck gene \\n are typically inherited in an autosomal dominant pattern, showing variable phenotypic penetrance and expressivity ranging from asymptomatic to marked hypoglycemia ( 11, 12 ). \\n inactivating forms of the mutation cause varying severity of persistent hyperglycemia depending on zygosity ( 13 ). \\n de novo gck mutations are very rare and exhibit marked variation in phenotypic expression ( 14 ). \\n over 600 heterozygous inactivating mutations have been reported, causing mild persistent hyperglycemia known as maturity onset diabetes of the young ( mody ) as opposed to only 13 known activating mutations of the gene ( 15, 16 ). \\n activating mutations are usually clustered around the allosteric activator site of the enzyme and led to hyperinsulinemic hypoglycemia by lowering the glucose set point and threshold for glucose stimulated insulin release. \\n the sheer numbers of existing mutations of the gck gene show it to be a highly mutable gene with varied disease outcomes depending on the type of activation. \\n it is key to blood glucose homeostasis and has been identified as a potential target for anti - diabetic therapy. \\n trials manipulating gck regulatory protein an allosteric switch for gck, which indirectly restores gck activity, are currently underway to evaluate its effect on blood glucose in patients with type 2 dm ( 17, 18 ). \\n treatment of niphs involves lifelong dietary modification consisting of frequent, low carbohydrate meals ( 5 ), which prevent surges in plasma glucose level, insulin level, and the consequent hypoglycemic spells. \\n medications such as diazoxide, octreotide, glucagon, verapamil, and somatostatin, whose actions all involve inhibition of calcium channels, have been employed with varying degrees of success ( 7 ). diazoxide binds to and activates the sulfonylurea receptor 1 subunit of the potassium adenosine triphosphate [ k(atp ) ] channel, causing calcium channel closure. \\n response to diazoxide therefore varies with genetic mutations [ ineffective in mutations of the k(atp ) channel genes ] ( 8) and with pattern of inheritance ( 7 ). \\n octreotide, a somatostatin analogue ( secretin and insulin inhibitor ), has been used in diazoxide unresponsive chi with improved blood glucose in these patients ; however, side effects such as gastrointestinal symptoms, dilated gallbladder, necrotizing enterocolitis, and qt prolongation sometimes limit its use ( 7 ). \\n long - term use of glucagon is effective in diazoxide - unresponsive cases or severe / diffuse chi but gastrointestinal side effects and crystallization in infusion tubing have been reported ( 19 ). \\n glucagon - like protein 1 receptor agonists such as exendin-4 are newer drugs that improve hypoglycemia in diazoxide - unresponsive patients by inhibiting insulin release ( 7 ). \\n partial pancreatectomy is indicated for medical treatment failure [ suggesting a k(atp ) defect ] and is only curative for focal lesions while extensive resection is reserved for diffuse chi to limit pancreatic burden ( 7, 8, 11, 20 ). \\n affected patients can present in adulthood ; de novo mutations should be considered given the following:-  positive family history of unremitting hypoglycemia-  lifelong symptoms of low plasma glucose, even after eating-  increased bmi-  negative sulfonylurea and autoimmune work up-  positive glycemic response to octreotide \\n  -  positive family history of unremitting hypoglycemia -  lifelong symptoms of low plasma glucose, even after eating -  negative sulfonylurea and autoimmune work up -  positive glycemic response to octreotide to our knowledge, only three families with affected adults have been reported. \\n in addition, this case highlights the pediatric - to - adulthood transition for rare diseases and the key role that coordination and transition of care plays in timely management. \\n after establishing a diagnosis of hypoglycemia by whipple's triad ( low plasma glucose, hypoglycemic symptoms, and resolution of adrenergic / neuroglycopenic symptoms with correction of the blood sugar ), interim treatment and search for risk / causative factors should ensue ( table 1 ). \\n ideally, treatment is only given after obtaining a plasma sample to ensure accuracy of diagnosis. \\n medical history of ethanol use, surreptitious insulin ingestion, medication use and interaction, autoimmune disease, gastric bypass ( 4 ), and subtle risk factors such as undiagnosed psychiatric disorder and polypharmacy should be excluded ( 5 ). in seemingly well patients, \\n the timing of hypoglycemic spells ( fasting / postabsorptive or postprandial / reactive ) is required to determine diagnostic studies. \\n a mixed meal tolerance test under supervision is done for postprandial hypoglycemia while a 72-h fast should be done for fasting hypoglycemia. \\n hepatic or renal disease, endocrine disorders of growth hormone, cortisol, adrenal insufficiency, and hypopituitarism should be excluded. \\n plasma insulin, proinsulin, c - peptide, and beta - hydroxybutyrate levels should be assessed to exclude surreptitious use of insulin or insulin receptor antibodies. \\n intravenous glucagon can be given to distinguish disorders of gluconeogenesis from glycogenolysis ( 5 ). \\n a 48-h supervised fast should be done to exclude insulinoma, with plasma insulin and proinsulin levels. \\n pro - igf ii to igf ii ratio can be measured to look for non - beta - cell tumors ( 5 ). \\n negative findings suggest non - insulinoma pancreatogenous hypoglycemia syndrome ( niphs ), which encompasses chi ( 4, 6 ). a selective pancreatic arterial calcium stimulation test ( spaci ) done at this time can detect hyperfunctioning of b - cells and confirm the diagnosis of niphs. \\n chi is uncommon in the pediatric population with an estimated incidence of 1 in 40,000 to 50,000 live births annually in europe ( 7 ). \\n gck mutations account for 7% of all causes of chi ( 8, 9 ) ; gck facilitates phosphorylation of glucose to glucose-6-phosphate and is the main glucose sensor of the pancreatic beta cell and hepatocytes - controlling glucose - stimulated insulin secretion and glycogenesis ( 10 ). activating mutations of the gck gene \\n are typically inherited in an autosomal dominant pattern, showing variable phenotypic penetrance and expressivity ranging from asymptomatic to marked hypoglycemia ( 11, 12 ). \\n inactivating forms of the mutation cause varying severity of persistent hyperglycemia depending on zygosity ( 13 ). \\n de novo gck mutations are very rare and exhibit marked variation in phenotypic expression ( 14 ). \\n over 600 heterozygous inactivating mutations have been reported, causing mild persistent hyperglycemia known as maturity onset diabetes of the young ( mody ) as opposed to only 13 known activating mutations of the gene ( 15, 16 ). \\n activating mutations are usually clustered around the allosteric activator site of the enzyme and led to hyperinsulinemic hypoglycemia by lowering the glucose set point and threshold for glucose stimulated insulin release. \\n the sheer numbers of existing mutations of the gck gene show it to be a highly mutable gene with varied disease outcomes depending on the type of activation. \\n it is key to blood glucose homeostasis and has been identified as a potential target for anti - diabetic therapy. \\n trials manipulating gck regulatory protein an allosteric switch for gck, which indirectly restores gck activity, are currently underway to evaluate its effect on blood glucose in patients with type 2 dm ( 17, 18 ). \\n treatment of niphs involves lifelong dietary modification consisting of frequent, low carbohydrate meals ( 5 ), which prevent surges in plasma glucose level, insulin level, and the consequent hypoglycemic spells. \\n medications such as diazoxide, octreotide, glucagon, verapamil, and somatostatin, whose actions all involve inhibition of calcium channels, have been employed with varying degrees of success ( 7 ). diazoxide binds to and activates the sulfonylurea receptor 1 subunit of the potassium adenosine triphosphate [ k(atp ) ] channel, causing calcium channel closure. \\n response to diazoxide therefore varies with genetic mutations [ ineffective in mutations of the k(atp ) channel genes ] ( 8) and with pattern of inheritance ( 7 ). \\n octreotide, a somatostatin analogue ( secretin and insulin inhibitor ), has been used in diazoxide unresponsive chi with improved blood glucose in these patients ; however, side effects such as gastrointestinal symptoms, dilated gallbladder, necrotizing enterocolitis, and qt prolongation sometimes limit its use ( 7 ). \\n long - term use of glucagon is effective in diazoxide - unresponsive cases or severe / diffuse chi but gastrointestinal side effects and crystallization in infusion tubing have been reported ( 19 ). \\n glucagon - like protein 1 receptor agonists such as exendin-4 are newer drugs that improve hypoglycemia in diazoxide - unresponsive patients by inhibiting insulin release ( 7 ). \\n partial pancreatectomy is indicated for medical treatment failure [ suggesting a k(atp ) defect ] and is only curative for focal lesions while extensive resection is reserved for diffuse chi to limit pancreatic burden ( 7, 8, 11, 20 ). \\n affected patients can present in adulthood ; de novo mutations should be considered given the following:-  positive family history of unremitting hypoglycemia-  lifelong symptoms of low plasma glucose, even after eating-  increased bmi-  negative sulfonylurea and autoimmune work up-  positive glycemic response to octreotide \\n  -  positive family history of unremitting hypoglycemia -  lifelong symptoms of low plasma glucose, even after eating -  negative sulfonylurea and autoimmune work up -  positive glycemic response to octreotide to our knowledge, only three families with affected adults have been reported. \\n in addition, this case highlights the pediatric - to - adulthood transition for rare diseases and the key role that coordination and transition of care plays in timely management. \\n despite the congenital nature of gck mutations, some patients can go undiagnosed till early adulthood. \\n future research into a cost - effective and prompt scheme of patient information dissemination is warranted for uncommon diseases. \\n the authors have not received any funding or benefits from industry or elsewhere to conduct this study.\"},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': 'Summarize the following article: the study population was composed of youth at the time of entry into a weight management program who enrolled in the determinants of change in childhood obesity ( decco ) study , a prospective , observational study examining determinants of health indicators at baseline and during weight management in an established weight management program . \\n all subjects aged 517 , with no untreated endocrine disorder , were eligible for study participation . \\n participants in the decco study had four study visits  baseline ( enrollment in weight management program ) , 6 months , 1 year , and 2 years ( 1 year after completion of monthly program)whereas this analysis considers only the baseline data in a cross - sectional manner . \\n written informed consent was provided by the legal guardian and the child provided signed assent . \\n the study was approved by the institutional review board at the hamilton health sciences corporation ( hamilton , on , canada ) . \\n the baseline study visit occurred in the morning , after an 8- to 12-h fast ( allowing water ) , and comprised an evaluation of cardiometabolic risk factors ( including an ogtt ) , anthropometric evaluation , and completion of questionnaires as described below . \\n bmi ( kg / m ) and bmi z score were calculated based on centers for disease control and prevention normative data , using nutstat , a component of the epi info program ( 15 ) . \\n waist circumference ( wc ) was measured half - way between the iliac crest and lower rib ( 16 ) using a nonstretching tape with attached spring balance pulled to a tension of 250 g. wc z scores were calculated based on age- and sex - specific canadian normative data ( 17,18 ) . blood pressure ( bp ) \\n was measured three times on the right arm , using an oscillometric method ( omron healthcare , inc . , \\n lake forest , il ) with appropriate - sized cuff after the children had been sitting at rest for 10 min ( 19 ) . \\n age , sex , and height cutoffs for defining hypertension were based on the 95th centile using u.s . \\n normative data as recommended ( 19 ) . parents reported the family history of premature coronary heart disease ( defined as events in first- or second - degree male relatives < 55 years old and/or female relatives < 65 years old ) , t2 dm , and obesity . \\n children aged 8 years completed a confidential questionnaire identifying their cigarette smoking history and self - assessed pubertal stage ( 20,21 ) . \\n boys and girls aged < 8 years were assumed to be prepubertal , based on normative data for pubertal onset . \\n an ogtt was conducted as follows : a baseline venous blood sample was taken and the patient consumed 1.75 g / kg glucose solution up to a maximum of 75 g orally . \\n prediabetes was defined as ifg , igt , or ifg + igt using ada criteria ( ifg : fasting glucose level 5.6 \\n baseline laboratory analyses were conducted in the laboratory of hamilton health sciences and included plasma glucose , total cholesterol ( tc ) , hdl cholesterol ( hdl - c ) , and triglyceride ( tg ) ; ldl cholesterol ( ldl - c ) was calculated using the equation of friedewald ( 22 ) . \\n glucose was measured using an enzymatic reference method with hexokinase , and cholesterol levels were measured with an enzymatic colorimetric method on a roche integra analyzer . \\n mmol / l and/or hdl - c < 1.03 mmol / l and/or ldl - c > 3.3 mmol / l , according to current recommendations ( 23 ) . \\n study participants with dysglycemia were compared with those without dysglycemia using an unpaired t test for continuous variables and  test for discrete variables . \\n laboratory variables ( tc , hdl - c , ldl - c , tg , glucose , hemoglobin a1c ( hba1c ) alanine aminotransferase [ alt ] , and aspartate aminotransferase [ ast ] ) were log transformed to improve normality and are presented in table 1 as geometric means and 95% cis . \\n all other continuous variables are presented as mean  sd and discrete variables as n ( % ) . \\n the ada currently recommends criteria for screening for t2 dm in children ( table 2 ) . \\n the sensitivity and specificity of these criteria for identifying dysglycemia ( t2 dm , ifg , and igt ) and isolated igt in our population were calculated . to examine the association of risk variables with dysglycemia , \\n logistic regression analysis was used and odds ratios ( ors ) were calculated . the sensitivity and specificity of other risk strategies \\n were also evaluated including 1 ) current canadian diabetes association ( cda ) guidelines ( 24 ) , 2 ) a risk score developed by reinehr et al . \\n the cda recommends screening all subjects in puberty or aged 10 years who have two of the following : bmi > 95th centile , high - risk ethnic group or family history of t2 dm , signs or symptoms of insulin resistance , and/or use of antipsychotic medications . \\n ( 4 ) developed a simple risk score that includes parental history of t2 dm ( 2 points ) , pubertal onset ( 1 point ) , and extreme obesity defined as bmi z score > 2.58 ( 1 point ) and recommended screening children or youth with 2 points . \\n ( 3 ) recommended doing an ogtt to identify igt in children or youth if the fpg exceeded 4.8 mmol / l . as we were primarily interested in reducing the number of ogtts \\n performed , while detecting patients with isolated igt , several models for the prediction of isolated igt were developed from least invasive to most complex . \\n variables that were significant in univariate analysis were included ( age , sex , family history of t2 dm , systolic bp [ sbp ] , bmi z score , wc , hba1c , fpg , elevated alt , tc - to - hdl ratio , and tg ) . \\n model 1 included data available with history and clinical exam only ; model 2 included data from history , clinical exam , and nonfasting blood work ( hba1c ) ; model 3 included data from history , clinical exam , hba1c and fasting glucose ; and model 4 added in the influence of fasting tg . to evaluate the predictive properties of current ada and cda screening criteria and each model to identify igt , we performed receiver operating characteristic ( roc ) analysis on the entire population with complete data . to estimate the discriminative value of the predictive models \\n , we calculated the roc area under the curve ( auc ) for the outcome igt . \\n the auc for the ada and cda screening criteria and each of the models was compared using a  test . \\n although the models were developed using continuous variables , we sought to establish a user - friendly screening test using thresholds for each variable and to examine these in a logistic model . \\n the applied thresholds considered were previously recommended , including bmi z score 2.58 ( 4 ) and hba1c 5.7% , or were obtained using optimal discrimination on the roc curve ( tg > 1.17 mmol / l ) . \\n the baseline study visit occurred in the morning , after an 8- to 12-h fast ( allowing water ) , and comprised an evaluation of cardiometabolic risk factors ( including an ogtt ) , anthropometric evaluation , and completion of questionnaires as described below . \\n bmi ( kg / m ) and bmi z score were calculated based on centers for disease control and prevention normative data , using nutstat , a component of the epi info program ( 15 ) . \\n waist circumference ( wc ) was measured half - way between the iliac crest and lower rib ( 16 ) using a nonstretching tape with attached spring balance pulled to a tension of 250 g. wc z scores were calculated based on age- and sex - specific canadian normative data ( 17,18 ) . \\n blood pressure ( bp ) was measured three times on the right arm , using an oscillometric method ( omron healthcare , inc . , \\n lake forest , il ) with appropriate - sized cuff after the children had been sitting at rest for 10 min ( 19 ) . \\n age , sex , and height cutoffs for defining hypertension were based on the 95th centile using u.s . \\n parents reported the family history of premature coronary heart disease ( defined as events in first- or second - degree male relatives < 55 years old and/or female relatives < 65 years old ) , t2 dm , and obesity . \\n children aged 8 years completed a confidential questionnaire identifying their cigarette smoking history and self - assessed pubertal stage ( 20,21 ) . \\n boys and girls aged < 8 years were assumed to be prepubertal , based on normative data for pubertal onset . \\n an ogtt was conducted as follows : a baseline venous blood sample was taken and the patient consumed 1.75 g / kg glucose solution up to a maximum of 75 g orally . \\n prediabetes was defined as ifg , igt , or ifg + igt using ada criteria ( ifg : fasting glucose level 5.6 mmol / l ; igt : 2-h glucose level 7.8 \\n baseline laboratory analyses were conducted in the laboratory of hamilton health sciences and included plasma glucose , total cholesterol ( tc ) , hdl cholesterol ( hdl - c ) , and triglyceride ( tg ) ; ldl cholesterol ( ldl - c ) was calculated using the equation of friedewald ( 22 ) . \\n glucose was measured using an enzymatic reference method with hexokinase , and cholesterol levels were measured with an enzymatic colorimetric method on a roche integra analyzer . \\n dyslipidemia was defined as fasting tg > 1.7 mmol / l and/or hdl - c < 1.03 mmol / l and/or ldl - c > 3.3 mmol / l , according to current recommendations ( 23 ) . \\n study participants with dysglycemia were compared with those without dysglycemia using an unpaired t test for continuous variables and  test for discrete variables . \\n laboratory variables ( tc , hdl - c , ldl - c , tg , glucose , hemoglobin a1c ( hba1c ) alanine aminotransferase [ alt ] , and aspartate aminotransferase [ ast ] ) were log transformed to improve normality and are presented in table 1 as geometric means and 95% cis . \\n all other continuous variables are presented as mean  sd and discrete variables as n ( % ) . \\n the ada currently recommends criteria for screening for t2 dm in children ( table 2 ) . \\n the sensitivity and specificity of these criteria for identifying dysglycemia ( t2 dm , ifg , and igt ) and isolated igt in our population were calculated . to examine the association of risk variables with dysglycemia , \\n the sensitivity and specificity of other risk strategies were also evaluated including 1 ) current canadian diabetes association ( cda ) guidelines ( 24 ) , 2 ) a risk score developed by reinehr et al . \\n ( 4 ) , and 3 ) fasting glucose > 4.8 mmol / l ( 3 ) . the cda screening criteria are similar to the ada criteria but somewhat less stringent . \\n the cda recommends screening all subjects in puberty or aged 10 years who have two of the following : bmi > 95th centile , high - risk ethnic group or family history of t2 dm , signs or symptoms of insulin resistance , and/or use of antipsychotic medications . \\n ( 4 ) developed a simple risk score that includes parental history of t2 dm ( 2 points ) , pubertal onset ( 1 point ) , and extreme obesity defined as bmi z score > 2.58 ( 1 point ) and recommended screening children or youth with 2 points . \\n ( 3 ) recommended doing an ogtt to identify igt in children or youth if the fpg exceeded 4.8 mmol / l . as we were primarily interested in reducing the number of ogtts \\n performed , while detecting patients with isolated igt , several models for the prediction of isolated igt were developed from least invasive to most complex . \\n variables that were significant in univariate analysis were included ( age , sex , family history of t2 dm , systolic bp [ sbp ] , bmi z score , wc , hba1c , fpg , elevated alt , tc - to - hdl ratio , and tg ) . \\n model 1 included data available with history and clinical exam only ; model 2 included data from history , clinical exam , and nonfasting blood work ( hba1c ) ; model 3 included data from history , clinical exam , hba1c and fasting glucose ; and model 4 added in the influence of fasting tg . to evaluate the predictive properties of current ada and cda screening criteria and each model to identify igt , we performed receiver operating characteristic ( roc ) analysis on the entire population with complete data . to estimate the discriminative value of the predictive models \\n , we calculated the roc area under the curve ( auc ) for the outcome igt . \\n the auc for the ada and cda screening criteria and each of the models was compared using a  test . \\n although the models were developed using continuous variables , we sought to establish a user - friendly screening test using thresholds for each variable and to examine these in a logistic model . \\n the applied thresholds considered were previously recommended , including bmi z score 2.58 ( 4 ) and hba1c 5.7% , or were obtained using optimal discrimination on the roc curve ( tg > 1.17 mmol / l ) . \\n the descriptive characteristics and risk variables of the cohort ( n = 259 ) and of those with and without dysglycemia ( prediabetes or t2 dm ) are presented in table 1 . although the mean age was 11.8 years , participants ranged in age from 5 to 17 years . of the participants , 1 ( 0.39% ) had undiagnosed t2 dm based on a 2-h glucose > 11.1 mmol / l . \\n prediabetes was present in 20.5% of the cohort , and 4.2% had ifg , 13.9% isolated igt , and 2.3% ifg + igt . \\n thus , of the 53 participants with prediabetes identified using an ogtt , 36 ( 68.0% ) had isolated igt and would not have been identified if only fasting glucose had been measured . \\n we identified no difference in the prevalence of prediabetes in those < 10 vs. 10 years ( 17.8 vs. 22.0% ; p = 0.45 ) . \\n baseline characteristics of the study cohort the participants with dysglycemia ( prediabetes or t2 dm ) did not differ in age , self - reported pubertal stage , ethnicity , bmi z score , wc z score , or percent body fat from those without dysglycemia ( table 1 ) . \\n a family history of t2 dm was relatively common in the children in this cohort ( 50.2% ) , and the prevalence was not different in those with and without dysglycemia . diagnosed t2 dm in at least one parent was less common ( 16.2% ) but also did not differ between groups . \\n children with dysglycemia had higher sbp and diastolic bp ( dbp ) , fasting tg , hba1c , and alt . \\n the prevalence of elevated alt was also higher in the dysglycemia group ( 13.0 vs. 4.9% ; p = 0.03 ) , but no differences in the prevalence of dyslipidemia ( p = 0.07 ) or hypertension ( p = 0.14 ) were noted . \\n the prevalence of hba1c above the recommended threshold of 5.7% was not different in those with dysglycemia ( p = 0.10 ) . \\n the strongest predictor of dysglycemia in univariate analysis was hba1c ( or per 1-sd increment 3.4 [ 95% ci 1.249.35 ] ; p = 0.02 ) . \\n other cardiovascular risk factors that predicted dysglycemia included serum tg ( 1.87 [ 1.332.63 ] ; p = 0.0003 ) and sbp ( 1.04 [ 1.011.07 ] ; p = 0.01 ) . \\n the ada recommends screening children aged 10 years ( or pubertal children ) who are overweight or obese and have two associated risk factors as described in table 2 . \\n current screening criteria had a sensitivity of 38.9% ( 95% ci 25.951.9 ) and a specificity of 69.8% ( 63.576.0 ) to detect dysglycemia . in a similar manner , \\n the sensitivity to detect isolated igt was 41.7% ( 25.657.8 ) with specificity of 69.5% ( 63.575.6 ) . \\n thus , in applying the current ada screening criteria , less than half of those children with isolated igt were identified . \\n as noted in table 3 , reinehr score and fpg > 4.8 mol / l also had low sensitivity and comparable specificity to the ada criteria . \\n the cda criteria had higher sensitivity to identify a child with igt ( 81.8 vs. 43.2% using ada ) but lower specificity ( 37.7 vs. 70.2% ) . \\n ada - recommended criteria for screening children and youth for t2 dm sensitivity and specificity of current screening guidelines , published scores , and simple tg model for detecting isolated igt as described in research design and methods , we proceeded to develop the models based on increasing complexity . \\n we compared the models using the auc of the roc curves ( table 4 ) . adding hba1c or elevated alt values to data obtained from the clinical history and physical exam \\n did not improve the prediction of igt , but adding fasting blood work was beneficial . adding fasting glucose alone demonstrated no increased predictive power , but adding fasting tgs did . \\n similar conclusions were reached if the anthropometric variable included was bmi z score or wc z score . \\n roc analysis of models for prediction of isolated igt using ada criteria using thresholds for each variable in model 4 , the potential predictors age > 10 ( p = 0.49 ) , pubertal ( p = 0.52 ) , parental t2 dm ( p = 0.15 ) , hba1c > 5.7% ( p = 0.43 ) , fasting blood glucose ( p = 0.85 ) , sbp > 95th centile ( p = 0.82 ) , and bmi z score > 2.58 were not significant and were not included in the final logistical model . \\n remaining in the model was tg > 1.17 mmol / l ( or 4.3 ; p < 0.0001 ) . \\n this variable alone had clinical usefulness ( table 3 ) , and auc that exceeded the ada and cda screening criteria was somewhat lower than continuous models 4a and 4b ( table 4 ) . \\n current ada screening criteria had low discriminatory capacity for identifying dysglycemia in our cohort of overweight children presenting to a weight management program . using a specific multilevel approach to applying screening criteria , \\n we have identified a screening algorithm requiring history and physical examination only , with comparable discriminatory capacity ( auc in roc analysis ) to ada recommendations but requiring less information ( age , sex , parent history of t2 dm , sbp , and bmi z score ) . \\n the addition of a nonfasting blood test to measure hba1c did not improve the predictive properties , but adding a fasting tg improved the discriminatory capacity . \\n in fact , a fasting tg > 1.17 mmol / l had better discriminatory capacity and clinical usefulness than current ada criteria in identifying isolated igt . \\n dysglycemia was common ( 20.8% ) and igt was identified in 16.2% of the participants , comparable to the findings of several american studies ( 2,25 ) . \\n silent t2 dm was relatively rare in this population ( 1 of 259 ) but was identified on a 2-h blood glucose alone . as with previous studies , \\n the prevalence of ifg was low , and 68% of children with elevated 2-h glucose levels \\n had fasting glucose < 5.6 mmol / l ( ada cutpoint for ifg ) . among our population of obese children and adolescents , important risk predictors for \\n sbp , parental t2 dm , and higher tc - to - hdl ratio were also predictive variables . \\n important variables without evident influence include age , pubertal stage , sex , body size ( bmi ) , and wc , suggesting that among obese youth , these variables have little predictive potential for dysglycemia . \\n current ada screening criteria had low sensitivity and only moderate specificity to identify isolated igt . \\n using roc analysis , we identified a model using history , physical examination , and fasting laboratory data ( glucose and tg ) with better discrimination of igt than current ada and cda screening criteria . \\n this may enable reasonable identification of children with prediabetes while avoiding excessive use of ogtts . \\n hba1c thresholds recently have been recommended for identifying adults at high risk for t2 dm and for diagnosis of t2 dm in adults ( 26 ) . \\n this approach also has been recommended recently for adolescents , although the clinical usefulness in this age - group has since been challenged ( 27,28 ) . using national health and nutrition examination survey data , hba1c thresholds of 5.7 and 6.0% had poorer performance in identifying prediabetes in adolescents compared with adults . \\n we found no added predictive benefit of including hba1c with data from history and physical examination in identifying igt . \\n however , adding the fasting tg level improved the auc . when applying thresholds to develop a simple clinically applicable version of model 4 , only fasting tg > 1.17 mmol / l remained in the model , and this alone had sensitivity of 70% and specificity of 64% to identify igt . \\n furthermore , the auc exceeded that of current ada and cda screening methods . despite being one of very few studies to critically examine the usefulness of current screening recommendations to identify prediabetes in obese youth , our study does have some limitations . even though no influence of pubertal stage was identified on prevalence of prediabetes \\n , it is noteworthy that puberty was not assessed by a physician but was self - reported by the study participants using a validated methodology . \\n although we identified no difference in prevalence of prediabetes in those aged < 10 compared with those 10 years , only 73 participants aged < 10 were included . \\n thus , further observation of the prevalence of prediabetes and evaluation of appropriate screening criteria in this age group should occur . \\n our classification of the glycemic status of the study participants was based on a single ogtt , and given published concerns on the reliability of this measure , we may have misclassified some of the participants . \\n however , our methodology is consistent with that used in most studies examining the risk of progression to t2 dm and comparable studies identifying the prevalence of prediabetes in youth . \\n finally , our evaluation was within a select population : all children and youth were overweight , 93% were obese , and all were referred for weight management . \\n balancing the costs and the consequences of more invasive testing with the potential health advantages of screening depends on how important one considers the identification of a disorder . \\n although in adults we have interventions that prevent the progression of prediabetes to t2 dm , thus arguing for high importance of identification of prediabetes , questions remain on the natural history of prediabetes in youth . \\n 8 of 33 ( 24% ) youth with igt at baseline progressed to t2 dm during a 2-year period ( 1 ) , comparable to annual progression rates of 510% reported in adults ( 6 ) . \\n should future research support the importance of intervening in children and youth with igt , screening criteria with high sensitivity would be required . \\n although screening obese children and youth with a fasting tg provides moderate sensitivity and specificity and is better than currently recommended approaches , 30% of obese children with igt will not be identified using this screening criteria , suggesting that an ogtt be done in all obese children and youth .',\n",
       "  'output': 'objectiveto examine the performance of current screening recommendations for detecting dysglycemia in children and adolescents with obesity.research design and methodsin a cross - sectional study , an oral glucose tolerance test and demographic ( age , sex , family history of diabetes , and ethnicity ) , clinical ( bmi z score , waist circumference , and pubertal stage ) , and laboratory variables used in current pediatric screening criteria for type 2 diabetes mellitus were measured in 259 overweight or obese youth aged 517 years . \\n glycemic status was based on american diabetes association ( ada ) thresholds . the performance ( sensitivity and specificity ) of current screening criteria and newly developed models to identify isolated igt \\n were compared.resultsdysglycemia was present in 20.8% of the cohort . \\n of the 54 participants with dysglycemia , 68% had a normal fasting glucose and were identified with the 2-h glucose test . \\n current ada criteria had low sensitivity ( 41.7% [ 95% ci 25.657.8 ] ) and moderate specificity ( 69.5% [ 63.575.6 ] ) to identify igt . in receiver operating characteristic ( roc ) analysis \\n , the addition of hemoglobin a1c ( hba1c ) or fpg did not improve the roc area under the curve ( auc ) ( hba1c : 0.64 vs. 0.63 ; p = 0.54 ; hba1c + fpg : 0.66 ; p = 0.42 ) , but adding triglyceride level did ( auc 0.72 vs. 0.63 ; p = 0.03 ) . a simple model with fasting triglyceride level > 1.17 mmol / l improved auc compared with ada screening criteria ( 0.68 vs. 0.57 ; p = 0.04).conclusionsthe prevalence of igt is high among obese children and youth . \\n current screening criteria have low sensitivity to detect isolated igt . \\n although adding nonfasting laboratory values to history and physical measures does not improve diagnostic accuracy , adding fasting lipid profile improves predictive value .',\n",
       "  '__index_level_0__': 31676,\n",
       "  'model_output': 'abstract: the study population was composed of youth at the time of entry into a weight management program who enrolled in the determinants of change in childhood obesity ( decco ) study, a prospective, observational study examining determinants of health indicators at baseline and during weight management in an established weight management program. all subjects aged 517, with no untreated endocrine disorder, were eligible for study participation. participants in the decco study had four study visits  baseline ( enrollment in weight management program ), 6 months, 1 year, and 2 years ( 1 year after completion of monthly program)whereas this analysis considers only the baseline data in a cross - sectional manner. written informed consent was provided by the legal guardian and the child provided signed assent. the study was approved by the institutional review board at the hamilton health sciences corporation ( hamilton, on, canada ). the baseline study visit occurred in the morning, after an 8- to 12-h fast ( allowing water ), and comprised an evaluation of cardiometabolic risk factors ( including an ogtt ), anthropometric evaluation, and completion of questionnaires as described below. bmi ( kg / m ) and bmi z score were calculated based on centers for disease control and prevention normative data, using nutstat, a component of the epi info program ( 15 ). waist circumference ( wc ) was measured half - way between the iliac crest and lower rib ( 16 ) using a nonstretching tape with attached spring balance pulled to a tension of 250 g. wc z scores were calculated based on age- and sex - specific canadian normative data ( 17,18 ). blood pressure ( bp ) was measured three times on the right arm, using an oscillometric method ( omron healthcare, inc., lake forest, il ) with appropriate - sized cuff after the children had been sitting at rest for 10 min ( 19 ). age, sex, and height cutoffs for defining hypertension were based on the 95th centile using u.s. parents reported the family history of premature coronary heart disease ( defined as events in first- or second - degree male relatives < 55 years old and/or female relatives < 65 years old ), t2 dm, and obesity. children aged 8 years completed a confidential questionnaire identifying their cigarette smoking history and self - assessed pubertal stage ( 20,21 ). boys and girls aged < 8 years were assumed to be prepubertal, based on normative data for pubertal onset. an ogtt was conducted as follows : a baseline venous blood sample was taken and the patient consumed 1.75 g / kg glucose solution up to a maximum of 75 g orally. prediabetes was defined as ifg, igt, or ifg + igt using ada criteria ( ifg : fasting glucose level 5.6 mmol / l ; igt : 2-h glucose level 7.8 mmol / l ; ifg + igt : fasting glucose level 5.6 mmol / l and/or 2-h glucose level 7.8 mmol / l ). baseline laboratory analyses were conducted in the laboratory of hamilton health sciences and included plasma glucose, total cholesterol ( tc ), hdl cholesterol ( hdl - c ), and triglyceride ( tg ) ; ldl cholesterol ( ldl - c ) was calculated using the equation of friedewald ( 22 ). glucose was measured using an enzymatic reference method with hexokinase, and cholesterol levels were measured with an enzymatic colorimetric method on a roche integra analyzer. dyslipidemia was defined as fasting tg > 1.7 mmol / l and/or hdl - c < 1.03 mmol / l and/or ldl - c > 3.3 mmol / l, according to current recommendations ( 23 ). study participants with dysglycemia were compared with those without dysglycemia using an unpaired t test for continuous variables and  test for discrete variables. laboratory variables ( tc, hdl - c, ldl - c, tg, glucose, hemoglobin a1c ( hba1c ) alanine aminotransferase [ alt ], and aspartate aminotransferase [ ast ] ) were log transformed to improve normality and are presented in table 1 as geometric means and 95% cis. all other continuous variables are presented as mean  sd and discrete variables as n ( % ). the ada currently recommends criteria for screening for t2 dm in children ( table 2 ). the sensitivity and specificity of these criteria for identifying dysglycemia ( t2 dm, ifg, and igt ) and isolated igt in our population were calculated. to examine the association of risk variables with dysglycemia, logistic regression analysis was used and odds ratios ( ors ) were calculated. the sensitivity and specificity of other risk strategies were also evaluated including 1 ) current canadian diabetes association ( cda ) guidelines ( 24 ), 2 ) a risk score developed by reinehr et al. ( 4 ), and 3 ) fasting glucose > 4.8 mmol / l ( 3 ). the cda screening criteria are similar to the ada criteria but somewhat less stringent. the cda recommends screening all subjects in puberty or aged 10 years who have two of the following : bmi > 95th centile, high - risk ethnic group or family history of t2 dm, signs or symptoms of insulin resistance, and/or use of antipsychotic medications. ( 4 ) developed a simple risk score that includes parental history of t2 dm ( 2 points ), pubertal onset ( 1 point ), and extreme obesity defined as bmi z score > 2.58 ( 1 point ) and recommended screening children or youth with 2 points. ( 3 ) recommended doing an ogtt to identify igt in children or youth if the fpg exceeded 4.8 mmol / l. as we were primarily interested in reducing the number of ogtts performed, while detecting patients with isolated igt, several models for the prediction of isolated igt were developed from least invasive to most complex. variables that were significant in univariate analysis were included ( age, sex, family history of t2 dm, systolic bp [ sbp ], bmi z score, wc, hba1c, fpg, elevated alt, tc - to - hdl ratio, and tg ). model 1 included data available with history and clinical exam only ; model 2 included data from history, clinical exam, and nonfasting blood work ( hba1c ) ; model 3 included data from history, clinical exam, hba1c and fasting glucose ; and model 4 added in the influence of fasting tg. to evaluate the predictive properties of current ada and cda screening criteria and each model to identify igt, we performed receiver operating characteristic ( roc ) analysis on the entire population with complete data. to estimate the discriminative value of the predictive models, we calculated the roc area under the curve ( auc ) for the outcome igt. the auc for the ada and cda screening criteria and each of the models was compared using a  test. although the models were developed using continuous variables, we sought to establish a user - friendly screening test using thresholds for each variable and to examine these in a logistic model. the applied thresholds considered were previously recommended, including bmi z score 2.58 ( 4 ) and hba1c 5.7%, or were obtained using optimal discrimination on the roc curve ( tg > 1.17 mmol / l ). the descriptive characteristics and risk variables of the cohort ( n = 259 ) and of those with and without dysglycemia ( prediabetes or t2 dm ) are presented in table 1. although the mean age was 11.8 years, participants ranged in age from 5 to 17 years. of the participants, 1 ( 0.39% ) had undiagnosed t2 dm based on a 2-h glucose > 11.1 mmol / l. prediabetes was present in 20.5% of the cohort, and 4.2% had ifg, 13.9% isolated igt, and 2.3% ifg + igt. thus, of the 53 participants with prediabetes identified using an ogtt, 36 ( 68.0% ) had isolated igt and would not have been identified if only fasting glucose had been measured. we identified no difference in the prevalence of prediabetes in those < 10 vs. 10 years ( 17.8 vs. 22.0% ; p = 0.45 ). baseline characteristics of the study cohort the participants with dysglycemia ( prediabetes or t2 dm ) did not differ in age, self - reported pubertal stage, ethnicity, bmi z score, wc z score, or percent body fat from those without dysglycemia ( table 1 ). a family history of t2 dm was relatively common in the children in this cohort ( 50.2% ), and the prevalence was not different in those with and without dysglycemia. diagnosed t2 dm in at least one parent was less common ( 16.2% ) but also did not differ between groups. children with dysglycemia had higher sbp and diastolic bp ( dbp ), fasting tg, hba1c, and alt. the prevalence of elevated alt was also higher in the dysglycemia group ( 13.0 vs. 4.9% ; p = 0.03 ), but no differences in the prevalence of dyslipidemia ( p = 0.07 ) or hypertension ( p = 0.14 ) were noted. the prevalence of hba1c above the recommended threshold of 5.7% was not different in those with dysglycemia ( p = 0.10 ). the strongest predictor of dysglycemia in univariate analysis was hba1c ( or per 1-sd increment 3.4 [ 95% ci 1.249.35 ] ; p = 0.02 ). other cardiovascular risk factors that predicted dysglycemia included serum tg ( 1.87 [ 1.332.63 ] ; p = 0.0003 ) and sbp ( 1.04 [ 1.011.07 ] ; p = 0.01 ). the ada recommends screening children aged 10 years ( or pubertal children ) who are overweight or obese and have two associated risk factors as described in table 2. current screening criteria had a sensitivity of 38.9% ( 95% ci 25.951.9 ) and a specificity of 69.8% ( 63.576.0 ) to detect dysglycemia. in a similar manner, the sensitivity to detect isolated igt was 41.7% ( 25.657.8 ) with specificity of 69.5% ( 63.575.6 ). thus, in applying the current ada screening criteria, less than half of those children with isolated igt were identified. as noted in table 3, reinehr score and fpg > 4.8 mol / l also had low sensitivity and comparable specificity to the ada criteria. the cda criteria had higher sensitivity to identify a child with igt ( 81.8 vs. 43.2% using ada ) but lower specificity ( 37.7 vs. 70.2% ). ada - recommended criteria for screening children and youth for t2 dm sensitivity and specificity of current screening guidelines, published scores, and simple tg model for detecting isolated igt as described in research design and methods, we proceeded to develop the models based on increasing complexity. we compared the models using the auc of the roc curves ( table 4 ). adding hba1c or elevated alt values to data obtained from the clinical history and physical exam did not improve the prediction of igt, but adding fasting blood work was beneficial. adding fasting glucose alone demonstrated no increased predictive power, but adding fasting tgs did. similar conclusions were reached if the anthropometric variable included was bmi z score or wc z score. roc analysis of models for prediction of isolated igt using ada criteria using thresholds for each variable in model 4, the potential predictors age > 10 ( p = 0.49 ), pubertal ( p = 0.52 ), parental t2 dm ( p = 0.15 ), hba1c > 5.7% ( p = 0.43 ), fasting blood glucose ( p = 0.85 ), sbp > 95th centile ( p = 0.82 ), and bmi z score > 2.58 were not significant and were not included in the final logistical model. remaining in the model was tg > 1.17 mmol / l ( or 4.3 ; p < 0.0001 ). this variable alone had clinical usefulness ( table 3 ), and auc that exceeded the ada and cda screening criteria was somewhat lower than continuous models 4a and 4b ( table 4 ). current ada screening criteria had low discriminatory capacity for identifying dysglycemia in our cohort of overweight children presenting to a weight management program. using a specific multilevel approach to applying screening criteria, we have identified a screening algorithm requiring history and physical examination only, with comparable discriminatory capacity ( auc in roc analysis ) to ada recommendations but requiring less information ( age, sex, parent history of t2 dm, sbp, and bmi z score ). the addition of a nonfasting blood test to measure hba1c did not improve the predictive properties, but adding a fasting tg improved the discriminatory capacity. in fact, a fasting tg > 1.17 mmol / l had better discriminatory capacity and clinical usefulness than current ada criteria in identifying isolated igt. dysglycemia was common ( 20.8% ) and igt was identified in 16.2% of the participants, comparable to the findings of several american studies ( 2,25 ). silent t2 dm was relatively rare in this population ( 1 of 259 ) but was identified on a 2-h blood glucose alone. as with previous studies, the prevalence of ifg was low, and 68% of children with elevated 2-h glucose levels had fasting glucose < 5.6 mmol / l ( ada cutpoint for ifg ). among our population of obese children and adolescents, important risk predictors for sbp, parental t2 dm, and higher tc - to - hdl ratio were also predictive variables. important variables without evident influence include age, pubertal stage, sex, body size ( bmi ), and wc, suggesting that among obese youth, these variables have little predictive potential for dysglycemia. current ada screening criteria had low sensitivity and only moderate specificity to identify isolated igt. using roc analysis, we identified a model using history, physical examination, and fasting laboratory data ( glucose and tg ) with better discrimination of igt than current ada and cda screening criteria. this may enable reasonable identification of children with prediabetes while avoiding excessive use of ogtts. hba1c thresholds recently have been recommended for identifying adults at high risk for t2 dm and for diagnosis of t2 dm in adults ( 26 ). this approach also has been recommended recently for adolescents, although the clinical usefulness in this age - group has since been challenged ( 27,28 ). using national health and nutrition examination survey data, hba1c thresholds of 5.7 and 6.0% had poorer performance in identifying prediabetes in adolescents compared with adults. we found no added predictive benefit of including hba1c with data from history and physical examination in identifying igt. however, adding the fasting tg level improved the auc. when applying thresholds to develop a simple clinically applicable version of model 4, only fasting tg > 1.17 mmol / l remained in the model, and this alone had sensitivity of 70% and specificity of 64% to identify igt. furthermore, the auc exceeded that of current ada and cda screening methods. despite being one of very few studies to critically examine the usefulness of current screening recommendations to identify prediabetes in obese youth, our study does have some limitations. even though no influence of pubertal stage was identified on prevalence of prediabetes, it is noteworthy that puberty was not assessed by a physician but was self - reported by the study participants using a validated methodology. although we identified no difference in prevalence of prediabetes in those aged < 10 compared with those 10 years, only 73 participants aged < 10 were included. thus, further observation of the prevalence of prediabetes and evaluation of appropriate screening criteria in this age group should occur. our classification of the glycemic status of the study participants was based on a single ogtt, and given published concerns on the reliability of this measure, we may have misclassified some of the participants. however, our methodology is consistent with that used in most studies examining the risk of progression to t2 dm and comparable studies identifying the prevalence of prediabetes in youth. finally, our evaluation was within a select population : all children and youth were overweight, 93% were obese, and all were referred for weight management. balancing the costs and the consequences of more invasive testing with the potential health advantages of screening depends on how important one considers the identification of a disorder. although in adults we have interventions that prevent the progression of prediabetes to t2 dm, thus arguing for high importance of identification of prediabetes, questions remain on the natural history of prediabetes in youth. 8 of 33 ( 24% ) youth with igt at baseline progressed to t2 dm during a 2-year period ( 1 ), comparable to annual progression rates of 510% reported in adults ( 6 ). should future research support the importance of intervening in children and youth with igt, screening criteria with high sensitivity would be required. although screening obese children and youth with a fasting tg provides moderate sensitivity and specificity and is better than currently recommended approaches, 30% of obese children with igt will not be identified using this screening criteria, suggesting that an ogtt be done in all obese children and youth.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Summarize the given article into a concise abstract that highlights the key findings and conclusions.',\n",
       "  'input': \"Summarize the following article: alzheimer 's disease ( ad ) is a central nervous degenerative disease with memory impairment , aphasia , agnosia , and executive dysfunction , as well as personality and behavior changes . \\n pathological features of ad include  amyloid ( a ) deposition and neurofibrillary tangles , leading to progressive neuronal damage , and ultimately atrophy of the cortex and subcortical structures . magnetic resonance imaging ( mri ) \\n however , relatively few studies are available assessing changes in other brain regions in ad patients , especially the frontal lobe . interestingly , evaluating 41 patients with ad , harwood et al . found that the insight and cognitive impairment as well as functional deficits in ad are associated with the glucose metabolic rate in the frontal cortex . \\n we previously demonstrated that treatment with electroacupuncture could effectively improve the spatial learning and memory ability as well as glucose metabolism in the hippocampus of animals with ad . \\n other studies suggested that music therapy could contribute to a supplementary treatment of ad . in china , an innovative therapy combined electroacupuncture and music therapy , and the term musical electroacupuncture ( mea ) \\n addition of musical therapy helps overcome acupuncture intolerability ; therefore , the mea therapy in a way is superior to traditional electroacupuncture . in the current study \\n , we aimed to address two questions : ( 1 ) what happens in the frontal lobe during mea ? \\n do these changes differ from those observed in other brain regions ? ( 2 ) are there differences between the two therapies for ad treatment ? to this end , senescence - accelerated mouse prone 8 ( samp8 ) mice were selected as an ad animal model , and the differences between techniques were assessed . \\n first , morris ' water maze test was used to evaluate behavioral changes in the model animals . \\n then , micro - pet assessment of a region of interest ( roi ) and glucose metabolism evaluation in different brain regions were performed . \\n finally , immunohistochemistry ( ihc ) was used to assess the changes of amyloid-1 - 42 deposition in the frontal lobe after the treatments . \\n senescence - accelerated mouse prone 8 ( samp8 ) and cognate normal senescence - accelerated mouse - r1 ( samr1 ) breeding pairs were kindly provided by professor takeda at kyoto university , japan . \\n all animals were male and specific pathogen - free ( spf ) , weighing 30  2  g. they were housed in a barrier facility at the experimental animal centre of first teaching hospital of beijing university of traditional chinese medicine , under controlled temperature ( 24  2c ) and 12  h/12  h dark - light cycle , with sterile drinking water and standard pellet diet ad libitum . \\n all experiments were performed according to the national institute of health guide for the care and use of laboratory animals ( nih publications number 80 - 23 ) . \\n thirty 7.5-month - old male samp8 mice were divided into three groups ( n = 10 per group ) , including samp8 alzheimer 's disease control ( ad ) , electroacupuncture ( ea ) , and musical electroacupuncture ( mea ) groups . \\n ten 7.5-month - old male samr1 mice composed the normal control ( n ) group . \\n electroacupuncture and musical electroacupuncture treatments were performed 20 minutes per day , once daily for 15 days ( no treatment on day 8) . \\n prescription of acupuncture points included du20 baihui , du 26 shuigou , and ex - hn3 yintang ( significant extra points ) ; the locations of these points were according to the national acupuncture society for experimental research developed by the  laboratory animal acupuncture atlas . \\n the pricking method was used for du 26 shuigou and the flat thorn method for du20 baihui and ex - hn3 yintang . \\n , the needle handle was connected to the hans - lh202 electroacupuncture device ( peking university institute of science nerve and beijing hua wei industrial development company ) , with sparse wave at 2  hz , 2  v , and 0.6  ma . in the mea group \\n , the needle handle was connected to the zj-12h musical electroacupuncture device ( developed by chinese acupuncture society and manufactured by harbin zhihou medical devices co. , ltd . ) . \\n clear rhythm , moderate speed , and music prescription intensity ( curing dementia prescription ) were selected ; music intensity was adjusted so that the animals remained quiet during the treatment . in the n and ad groups , \\n no treatment was carried out , with grabbing and fixing the mice in order to ensure the same treatment conditions , once daily for 15 days . \\n morris ' water maze consisted of a circular tank ( diameter , 90  cm ; height , 50  cm ) , filled with water to a depth of 29  cm , maintained at 24  1c , and rendered opaque with blue - black ink . \\n a removable circular platform ( diameter , 9.5  cm ; height , 28  cm ) with the top surface 1  cm below the water was located inside the pool . the pool area \\n was conceptually divided into four quadrants ( ne , nw , sw , and se ) of equal size . \\n data were collected by a video camera ( tota-450d , japan ) , which was fixed to the ceiling and connected to a video recorder with an automated tracking system ( china daheng group , beijing , china ) . in the behavioral test , mice were placed in the pool of water containing a platform just below the surface of the water . \\n distal visual cues are arrayed around the room , and , in general , mice are able to find the location of the hidden platform based on these cues . \\n this test assesses the ability of mice to find the platform under conditions where they can not directly see the latter but must either remember it based on external cues or perform a search . \\n the platform was placed 1  cm under the water surface ; the water was rendered opaque by a suspension of dark blue , nontoxic tempera paint . \\n the platform was placed in a different location from that used in the visible platform testing . \\n each mouse was released from one of the 4 locations and had 60  s to search for the hidden platform . at the end of each trial , \\n the mouse was placed on the platform or allowed to stay there for 15  s. prominent spatial cues were arrayed around the room . \\n the investigator also constituted a powerful spatial cue and always sat in the same location during each trial after releasing the mouse . \\n six trials per day for 5 consecutive days were performed with the platform location kept constant . \\n the time that the mouse took to find the platform was recorded and represented escape latency . the day after completion of the hidden platform test \\n , the platform was removed ; each mouse was placed in the pool once for 60  s , starting from the same starting location used first in the hidden platform test . \\n the time spent in the platform quadrant was recorded , and the percentage of total time spent swimming to the platform quadrant was derived . \\n the f - fdg pet tracer was provided by the chinese medicine research institute pet room ; pet imaging was carried out on a siemens inveon pet / ct imaging system . before the experiments , \\n mice ( 7.5 months , 28~32  g ) were submitted to blood glucose monitoring and showed levels in the normal range ( 7.0~10.1  mmol / l ) . \\n the animals were placed in the suction chamber , inhaling oxygen mixed with 1.5% isoflurane for anesthesia . \\n after complete anesthesia , approximately 14.8~16.5  mbqf - fdg pet were injected via the tail vein . \\n after f - fdg pet tracer uptake for 60  min , the mice were placed in the prone position , parallel to the scanner long axis , with the head located within the scanner field of view . \\n the mice were anesthetized by inhalation of oxygen mixed with 1.5% isoflurane ( 1  l / min ) . filtered back projection ( fbp ) and ct photon attenuation correction were used for image reconstruction . \\n three - dimensional regions of interest were selected in the hippocampus , in transverse , coronal , and sagittal planes . \\n after the morris water maze test , the remaining six mice in each group ( four were used in micro - pet ) were anesthetized by intraperitoneal injection of 10% chloral hydrate at 0.35  ml/100  g body weight . \\n three minutes later , the chest was opened and the heart exposed ; intubation was performed from the left ventricle to the ascending aorta with quick injection of 100  ml saline \\n . then , the right atrial appendage was cut , and 4% paraformaldehyde was injected until the liver turned white with clear fluid flowing out from the right atrial appendage . after the perfusion , the mouse was decapitated and the whole brain extracted and placed on ice . \\n , paraffin embedded brain tissue sections were deparaffinized with xylene and hydrated with graded alcohol . \\n then , the sections were treated with citric acid antigen repair buffer and washed with pbs ( ph 7.4 ) every 5  min three times with shaking . \\n after incubation with 3% hydrogen peroxide for 20  min in the dark to quench endogenous peroxidase , the sections were incubated with anti - a1 - 42 antibody ( 1  :  50 , ab10148 , abcam ) overnight . then \\n , secondary antibodies were added for 30  min at room temperature , and detection was performed with dab . \\n micrographs of brain tissue samples were obtained at 400x magnification , and integral optical density ( iod ) values were calculated using image - pro plus 6.0 software . \\n data are mean  sd for each group . for the morris water maze test , the escape latency time of the hidden platform trial was analyzed by the huynh - feldt test , while one - way anova was conducted on probe trial , micro - pet test , and immunohistochemical data . \\n all statistical analyses were performed with the spss software v.17.0 ( spss , usa ) . \\n the effects of electroacupuncture and musical electroacupuncture in spatial location ability of samp8 mice in the wmw test are shown in figure 1(a ) . with training time extension , \\n the ad group showed a marked retardation in escape latency compared with the n group ( p = 0.00 ) , probably due to memory deficits resulting from the rapid aging process impairing learning and memory . compared with the ad group , \\n escape latency in the ea ( p = 0.031 ) and mea ( p = 0.023 ) groups was significantly reduced ( p < 0.05 ) . as shown in figures 1(a ) and 1(b ) , the mea group performed better than the ea group , although there was no statistically significant difference ( p = 0.895 ) . to assess therapeutic effects on spatial memory ability , performance on day 6 \\n was examined by analyzing the percentages of swimming time in the expected platform position . a higher percentage of time spent in the platform quadrant is interpreted as a higher level of memory retention . in this trial , compared with the ad group , the ea ( p = 0.045 ) and mea ( p = 0.035 ) groups showed increased time spent in the platform quadrant ( p < 0.05 ) . \\n what is more , percentages of time spent in the platform quadrant were similar between the ea and mea groups ( p = 0.907 , figure 2 ) . besides the escape time \\n , the average animal swimming speed is also associated with spatial learning and memory ability . in some cases , \\n swimming speed in the normal control group was slower , with the escape time longer than in the alzheimer 's disease group . \\n thus , escapes times can not serve as the only indicator of learning ability and memory . \\n the average swimming speed before getting on the platform is an important indicator of exercise ability and can reflect individual differences in experimental animals . compared with the n group , the swimming speed in ad group was significantly reduced ( p = 0.00 ) , indicating lower exercise ability for samp8 mice compared with samr1 animals . \\n compared with the ad group , electroacupuncture and musical electroacupuncture both increased the swimming speed of samp8 mice ( ea , p = 0.023 ; mea , p = 0.009 ) . what is more , the mea group performed better than the ea group ( figure 3 ) . \\n micro - pet images were obtained from the hippocampus , frontal lobe , and cerebral cortex of each mouse . the same color standard and code were used from top to bottom to display the metabolic rate of glucose . \\n after treatment with electroacupuncture and musical electroacupuncture , f - fdg levels in each brain region assessed were higher than values obtained for the nontherapy group ( figures 4(a ) , 4(b ) , and 4(c ) ) . to obtain acute differences in glucose metabolism among groups , the uptake rate of f \\n after treatment with electroacupuncture and musical electroacupuncture , uptake rates of f - fdg per gram in the hippocampus ( ea , p = 0.039 ; mea , p = 048 ) , cerebral cortex ( ea , p = 0.14 ; mea , p = 0.047 ) , and frontal lobe ( ea , p = 0.045 ; mea , p = 0.031 ) were higher than those obtained for the alzheimer 's disease group ( figures 5(a ) , 5(b ) , and 5(c ) ) . in the frontal lobe , the uptake rate of f \\n - fdg for the mea group was higher than that of the ea group , while , in the other two regions , the ea group showed higher values . \\n after the behavioral tests and imaging , brain tissue samples were analyzed by immunohistochemistry to assess the effects of the two therapeutic variants on amyloid-1 - 42 accumulation due to neuronal damage and memory impairment . \\n compared with the n group , iod of amyloid-1 - 42 in the frontal lobe was significantly higher in the ad group ( p = 0.00 ) , ea ( p = 0.00 ) , and mea ( p = 0.007 ) groups . \\n meanwhile , iod of amyloid-1 - 42 in frontal lobe samples from the ad group was significantly higher than those of the ea ( p = 0.00 ) and mea ( p = 0.00 ) groups . \\n interestingly , iod of amyloid-1 - 42 in frontal lobe samples from the mea group was significantly lower than that of the ea group ( p = 0.01 < 0.05 ) ( figures 6 and 7 ) . \\n the senescence - accelerated mouse ( sam ) is an accelerated aging model that was established through phenotypic selection from a common genetic pool of the akr / j mouse strain . \\n it was shown that senescence - accelerated mouse ( samp8 ) , as a model of aging , displays many features known to occur in the early stage of ad such as increased oxidative stress , amyloid - beta level alteration , and tau phosphorylation . \\n what is more , published data   and our previous research   demonstrated that samp8 could undergo acupuncture therapy to improve learning and memory ability . in this study , therefore , samp8 mice were selected as an ideal animal model for alzheimer 's disease . \\n music therapy is a nonpharmacological treatment for the behavioral and psychological symptoms of alzheimer 's disease . \\n appropriate music formulation could provide a form of relief to the ad patient and may stimulate cognitive activities so that areas subject to progressive degeneration are maintained . in the recent ten years \\n , increasing evidence suggests that proper music formulation could improve ad symptoms [ 1621 ] , especially for mild cases . besides , \\n since music therapy is nonpharmacological , it is often used in combination with other therapies . \\n musical electro - acupuncture ( mea ) combines music therapy and electro - acupuncture ; during symptomatic selection of music , the sound wave could be turned into a pulse current . \\n therefore , the effects of mea on the human auditory organ and acupoints were separately assessed . \\n specifically , the fundamental characteristics and advantages included two aspects : music therapy and irregular pulse current . \\n electroacupuncture ( ea ) is widely used in clinical practice and research and in experimental investigations into the mechanisms of acupuncture . \\n this therapy has been applied for ad treatment and could improve the cognitive function   and brain energy metabolism [ 5 , 27 ] . \\n the mechanism of ea tolerance is that the central nervous system releases analgesic substances ( including brain norepinephrine and endogenous antiopioid substances ) as well as large amounts of endogenous monoamine . among them , cholecystokinin octapeptide ( cck-8 ) is by far the most recognized antiopioid contributing to ea tolerance , which is caused by long - term use of the same frequency in ea . \\n since ad treatment requires a long - term course , it likely results in ea tolerance . \\n it transformed musical rhythms into constantly changing frequencies and waveforms to overcome the shortcomings of human body 's tolerance of general electroacupuncture . \\n meanwhile , patients were allowed to listen to relieving music , which plays a role of music therapy . \\n it was shown that such therapy performs better than traditional electroacupuncture in relieving pains , improving the symptoms of dermatosis ( urticarial disease , chloasma ) , alleviating nervous system diseases such as depression [ 3638 ] , insomnia , and anxiety [ 40 , 41 ] . however , there was seldom research on dementia . \\n studies assessing the pathogenesis of ad are currently more focused on the temporal lobe , parietal cortex , and hippocampus , with few analyzing changes in the frontal lobe . \\n recent studies found that transgenic mice with alzheimer 's disease show early cognitive decline related to frontal atrophy , with the changes taking place even earlier than in the hippocampus . \\n as shown above , although the mea therapy performed better than ea in the morris water maze test , differences were not statistically significant . in micro - pet , \\n ea therapy showed higher glucose metabolism improvement in the hippocampus and cerebral cortex compared with mea . only in the frontal lobe , \\n these findings prompted the question whether mea therapy was more inclined to play a role in the frontal lobe . to address this , \\n amyloid - beta levels were assessed in the frontal lobe of samp8 mice , and the results confirmed the above notion . comparing the different therapies in iod of amyloid - beta in the frontal lobe , mea therapy performed significantly better than ea ( p < 0.05 ) . therefore , mea indeed is inclined to play a role in the frontal lobe . \\n using behavioral tests , in vivo imaging , and protein detection , the differences between mea and ea therapy for ad treatment were assessed in samp8 mice . \\n interestingly , both ea and mea could improve spatial learning and memory ability , improving glucose metabolism in different brain regions and amyloid - beta expression in the frontal lobe . \\n what is more , the mea therapy performed better than ea in decreasing amyloid - beta amounts in the frontal lobe .\",\n",
       "  'output': \"objectives . to compare musical electroacupuncture and electroacupuncture in a mouse model of alzheimer 's disease . methods . in this study , \\n 7.5-month - old male senescence - accelerated mouse prone 8 ( samp8 ) mice were used as an alzheimer 's disease animal model . in the normal control paradigm , \\n 7.5-month - old male samr1 mice were used as the blank control group ( n group ) . \\n after 15 days of treatment , using morris water maze test , micro - pet , and immunohistochemistry , the differences among the musical electroacupuncture ( mea ) , electroacupuncture ( ea ) , alzheimer 's disease ( ad ) , and normal ( n ) groups were assessed . \\n results . \\n the morris water maze test , micro - pet , and immunohistochemistry revealed that mea and ea therapies could improve spatial learning and memory ability , glucose metabolism level in the brain , and a amyloid content in the frontal lobe , compared with the ad group ( p < 0.05 ) . \\n moreover , mea therapy performed better than ea treatment in decreasing amyloid - beta levels in the frontal lobe of mice with ad . \\n conclusion . \\n mea therapy may be superior to ea in treating alzheimer 's disease as demonstrated in samp8 mice .\",\n",
       "  '__index_level_0__': 31677,\n",
       "  'model_output': \"summarize the following article: alzheimer's disease ( ad ) is a central nervous degenerative disease with memory impairment, aphasia, agnosia, and executive dysfunction, as well as personality and behavior changes. \\n pathological features of ad include  amyloid ( a ) deposition and neurofibrillary tangles, leading to progressive neuronal damage, and ultimately atrophy of the cortex and subcortical structures. magnetic resonance imaging ( mri ) \\n however, relatively few studies are available assessing changes in other brain regions in ad patients, especially the frontal lobe. interestingly, evaluating 41 patients with ad, harwood et al. found that the insight and cognitive impairment as well as functional deficits in ad are associated with the glucose metabolic rate in the frontal cortex. \\n we previously demonstrated that treatment with electroacupuncture could effectively improve the spatial learning and memory ability as well as glucose metabolism in the hippocampus of animals with ad. \\n other studies suggested that music therapy could contribute to a supplementary treatment of ad. in china, an innovative therapy combined electroacupuncture and music therapy, and the term musical electroacupuncture ( mea ) \\n addition of musical therapy helps overcome acupuncture intolerability ; therefore, the mea therapy in a way is superior to traditional electroacupuncture. in the current study \\n, we aimed to address two questions : ( 1 ) what happens in the frontal lobe during mea? \\n do these changes differ from those observed in other brain regions? ( 2 ) are there differences between the two therapies for ad treatment? to this end, senescence - accelerated mouse prone 8 ( samp8 ) mice were selected as an ad animal model, and the differences between techniques were assessed. \\n first, morris'water maze test was used to evaluate behavioral changes in the model animals. \\n then, micro - pet assessment of a region of interest ( roi ) and glucose metabolism evaluation in different brain regions were performed. \\n finally, immunohistochemistry ( ihc ) was used to assess the changes of amyloid-1 - 42 deposition in the frontal lobe after the treatments. \\n senescence - accelerated mouse prone 8 ( samp8 ) and cognate normal senescence - accelerated mouse - r1 ( samr1 ) breeding pairs were kindly provided by professor takeda at kyoto university, japan. \\n all animals were male and specific pathogen - free ( spf ), weighing 30  2  g. they were housed in a barrier facility at the experimental animal centre of first teaching hospital of beijing university of traditional chinese medicine, under controlled temperature ( 24  2c ) and 12  h/12  h dark - light cycle, with sterile drinking water and standard pellet diet ad libitum. \\n all experiments were performed according to the national institute of health guide for the care and use of laboratory animals ( nih publications number 80 - 23 ). \\n thirty 7.5-month - old male samp8 mice were divided into three groups ( n = 10 per group ), including samp8 alzheimer's disease control ( ad ), electroacupuncture ( ea ), and musical electroacupuncture ( mea ) groups. \\n ten 7.5-month - old male samr1 mice composed the normal control ( n ) group. \\n electroacupuncture and musical electroacupuncture treatments were performed 20 minutes per day, once daily for 15 days ( no treatment on day 8). \\n prescription of acupuncture points included du20 baihui, du 26 shuigou, and ex - hn3 yintang ( significant extra points ) ; the locations of these points were according to the national acupuncture society for experimental research developed by the  laboratory animal acupuncture atlas. \\n the pricking method was used for du 26 shuigou and the flat thorn method for du20 baihui and ex - hn3 yintang. \\n, the needle handle was connected to the hans - lh202 electroacupuncture device ( peking university institute of science nerve and beijing hua wei industrial development company ), with sparse wave at 2  hz, 2  v, and 0.6  ma. in the mea group \\n, the needle handle was connected to the zj-12h musical electroacupuncture device ( developed by chinese acupuncture society and manufactured by harbin zhihou medical devices co., ltd. ). \\n clear rhythm, moderate speed, and music prescription intensity ( curing dementia prescription ) were selected ; music intensity was adjusted so that the animals remained quiet during the treatment. in the n and ad groups, \\n no treatment was carried out, with grabbing and fixing the mice in order to ensure the same treatment conditions, once daily for 15 days. \\n morris'water maze consisted of a circular tank ( diameter, 90  cm ; height, 50  cm ), filled with water to a depth of 29  cm, maintained at 24  1c, and rendered opaque with blue - black ink. \\n a removable circular platform ( diameter, 9.5  cm ; height, 28  cm ) with the top surface 1  cm below the water was located inside the pool. the pool area \\n was conceptually divided into four quadrants ( ne, nw, sw, and se ) of equal size. \\n data were collected by a video camera ( tota-450d, japan ), which was fixed to the ceiling and connected to a video recorder with an automated tracking system ( china daheng group, beijing, china ). in the behavioral test, mice were placed in the pool of water containing a platform just below the surface of the water. \\n distal visual cues are arrayed around the room, and, in general, mice are able to find the location of the hidden platform based on these cues. \\n this test assesses the ability of mice to find the platform under conditions where they can not directly see the latter but must either remember it based on external cues or perform a search. \\n the platform was placed 1  cm under the water surface ; the water was rendered opaque by a suspension of dark blue, nontoxic tempera paint. \\n the platform was placed in a different location from that used in the visible platform testing. \\n each mouse was released from one of the 4 locations and had 60  s to search for the hidden platform. at the end of each trial, \\n the mouse was placed on the platform or allowed to stay there for 15  s. prominent spatial cues were arrayed around the room. \\n the investigator also constituted a powerful spatial cue and always sat in the same location during each trial after releasing the mouse. \\n six trials per day for 5 consecutive days were performed with the platform location kept constant. \\n the time that the mouse took to find the platform was recorded and represented escape latency. the day after completion of the hidden platform test \\n, the platform was removed ; each mouse was placed in the pool once for 60  s, starting from the same starting location used first in the hidden platform test. \\n the time spent in the platform quadrant was recorded, and the percentage of total time spent swimming to the platform quadrant was derived. \\n the f - fdg pet tracer was provided by the chinese medicine research institute pet room ; pet imaging was carried out on a siemens inveon pet / ct imaging system. before the experiments, \\n mice ( 7.5 months, 28~32  g ) were submitted to blood glucose monitoring and showed levels in the normal range ( 7.0~10.1  mmol / l ). \\n the animals were placed in the suction chamber, inhaling oxygen mixed with 1.5% isoflurane for anesthesia. \\n after complete anesthesia, approximately 14.8~16.5  mbqf - fdg pet were injected via the tail vein. \\n after f - fdg pet tracer uptake for 60  min, the mice were placed in the prone position, parallel to the scanner long axis, with the head located within the scanner field of view. \\n the mice were anesthetized by inhalation of oxygen mixed with 1.5% isoflurane ( 1  l / min ). filtered back projection ( fbp ) and ct photon attenuation correction were used for image reconstruction. \\n three - dimensional regions of interest were selected in the hippocampus, in transverse, coronal, and sagittal planes. \\n after the morris water maze test, the remaining six mice in each group ( four were used in micro - pet ) were anesthetized by intraperitoneal injection of 10% chloral hydrate at 0.35  ml/100  g body weight. \\n three minutes later, the chest was opened and the heart exposed ; intubation was performed from the left ventricle to the ascending aorta with quick injection of 100  ml saline \\n. then, the right atrial appendage was cut, and 4% paraformaldehyde was injected until the liver turned white with clear fluid flowing out from the right atrial appendage. after the perfusion, the mouse was decapitated and the whole brain extracted and placed on ice. \\n, paraffin embedded brain tissue sections were deparaffinized with xylene and hydrated with graded alcohol. \\n then, the sections were treated with citric acid antigen repair buffer and washed with pbs ( ph 7.4 ) every 5  min three times with shaking. \\n after incubation with 3% hydrogen peroxide for 20  min in the dark to quench endogenous peroxidase, the sections were incubated with anti - a1 - 42 antibody ( 1  :  50, ab10148, abcam ) overnight. then \\n, secondary antibodies were added for 30  min at room temperature, and detection was performed with dab. \\n micrographs of brain tissue samples were obtained at 400x magnification, and integral optical density ( iod ) values were calculated using image - pro plus 6.0 software. \\n data are mean  sd for each group. for the morris water maze test, the escape latency time of the hidden platform trial was analyzed by the huynh - feldt test, while one - way anova was conducted on probe trial, micro - pet test, and immunohistochemical data. \\n all statistical analyses were performed with the spss software v.17.0 ( spss, usa ). \\n the effects of electroacupuncture and musical electroacupuncture in spatial location ability of samp8 mice in the wmw test are shown in figure 1(a ). with training time extension, \\n the ad group showed a marked retardation in escape latency compared with the n group ( p = 0.00 ), probably due to memory deficits resulting from the rapid aging process impairing learning and memory. compared with the ad group, \\n escape latency in the ea ( p = 0.031 ) and mea ( p = 0.023 ) groups was significantly reduced ( p < 0.05 ). as shown in figures 1(a ) and 1(b ), the mea group performed better than the ea group, although there was no statistically significant difference ( p = 0.895 ). to assess therapeutic effects on spatial memory ability, performance on day 6 \\n was examined by analyzing the percentages of swimming time in the expected platform position. a higher percentage of time spent in the platform quadrant is interpreted as a higher level of memory retention. in this trial, compared with the ad group, the ea ( p = 0.045 ) and mea ( p = 0.035 ) groups showed increased time spent in the platform quadrant ( p < 0.05 ). \\n what is more, percentages of time spent in the platform quadrant were similar between the ea and mea groups ( p = 0.907, figure 2 ). besides the escape time \\n, the average animal swimming speed is also associated with spatial learning and memory ability. in some cases, \\n swimming speed in the normal control group was slower, with the escape time longer than in the alzheimer's disease group. \\n thus, escapes times can not serve as the only indicator of learning ability and memory. \\n the average swimming speed before getting on the platform is an important indicator of exercise ability and can reflect individual differences in experimental animals. compared with the n group, the swimming speed in ad group was significantly reduced ( p = 0.00 ), indicating lower exercise ability for samp8 mice compared with samr1 animals. \\n compared with the ad group, electroacupuncture and musical electroacupuncture both increased the swimming speed of samp8 mice ( ea, p = 0.023 ; mea, p = 0.009 ). what is more, the mea group performed better than the ea group ( figure 3 ). \\n micro - pet images were obtained from the hippocampus, frontal lobe, and cerebral cortex of each mouse. the same color standard and code were used from top to bottom to display the metabolic rate of glucose. \\n after treatment with electroacupuncture and musical electroacupuncture, f - fdg levels in each brain region assessed were higher than values obtained for the nontherapy group ( figures 4(a ), 4(b ), and 4(c ) ). to obtain acute differences in glucose metabolism among groups, the uptake rate of f \\n after treatment with electroacupuncture and musical electroacupuncture, uptake rates of f - fdg per gram in the hippocampus ( ea, p = 0.039 ; mea, p = 0.048 ), cerebral cortex ( ea, p = 0.14 ; mea, p = 0.047 ), and frontal lobe ( ea, p = 0.045 ; mea, p = 0.031 ) were higher than those obtained for the alzheimer's disease group ( figures 5(a ), 5(b ), and 5(c ) ). in the frontal lobe, the uptake rate of f \\n - fdg for the mea group was higher than that of the ea group, while, in the other two regions, the ea group showed higher values. \\n after the behavioral tests and imaging, brain tissue samples were analyzed by immunohistochemistry to assess the effects of the two therapeutic variants on amyloid-1 - 42 accumulation due to neuronal damage and memory impairment. \\n compared with the n group, iod of amyloid-1 - 42 in the frontal lobe was significantly higher in the ad group ( p = 0.00 ), ea ( p = 0.00 ), and mea ( p = 0.007 ) groups. \\n meanwhile, iod of amyloid-1 - 42 in frontal lobe samples from the ad group was significantly higher than those of the ea ( p = 0.00 ) and mea ( p = 0.00 ) groups. \\n interestingly, iod of amyloid-1 - 42 in frontal lobe samples from the mea group was significantly lower than that of the ea group ( p = 0.01 < 0.05 ) ( figures 6 and 7 ). \\n the senescence - accelerated mouse ( sam ) is an accelerated aging model that was established through phenotypic selection from a common genetic pool of the akr / j mouse strain. \\n it was shown that senescence - accelerated mouse ( samp8 ), as a model of aging, displays many features known to occur in the early stage of ad such as increased oxidative stress, amyloid - beta level alteration, and tau phosphorylation. \\n what is more, published data   and our previous research   demonstrated that samp8 could undergo acupuncture therapy to improve learning and memory ability. in this study, therefore, samp8 mice were selected as an ideal animal model for alzheimer's disease. \\n music therapy is a nonpharmacological treatment for the behavioral and psychological symptoms of alzheimer's disease. \\n appropriate music formulation could provide a form of relief to the ad patient and may stimulate cognitive activities so that areas subject to progressive degeneration are maintained. in the recent ten years \\n, increasing evidence suggests that proper music formulation could improve ad symptoms [ 1621 ], especially for mild cases. besides, \\n since music therapy is nonpharmacological, it is often used in combination with other therapies. \\n musical electro - acupuncture ( mea ) combines music therapy and electro - acupuncture ; during symptomatic selection of music, the sound wave could be turned into a pulse current. \\n therefore, the effects of mea on the human auditory organ and acupoints were separately assessed. \\n specifically, the fundamental characteristics and advantages included two aspects : music therapy and irregular pulse current. \\n electroacupuncture ( ea ) is widely used in clinical practice and research and in experimental investigations into the mechanisms of acupuncture. \\n this therapy has been applied for ad treatment and could improve the cognitive function   and brain energy metabolism [ 5, 27 ]. \\n the mechanism of ea tolerance is that the central nervous system releases analgesic substances ( including brain norepinephrine and endogenous antiopioid substances ) as well as large amounts of endogenous monoamine. among them, cholecystokinin octapeptide ( cck-8 ) is by far the most recognized antiopioid contributing to ea tolerance, which is caused by long - term use of the same frequency in ea. \\n since ad treatment requires a long - term course, it likely results in ea tolerance. \\n it transformed musical rhythms into constantly changing frequencies and waveforms to overcome the shortcomings of human body's tolerance of general electroacupuncture. \\n meanwhile, patients were allowed to listen to relieving music, which plays a role of music therapy. \\n it was shown that such therapy performs better than traditional electroacupuncture in relieving pains, improving the symptoms of dermatosis ( urticarial disease, chloasma ), alleviating nervous system diseases such as depression [ 3638 ], insomnia, and anxiety [ 40, 41 ]. however, there was seldom research on dementia. \\n studies assessing the pathogenesis of ad are currently more focused on the temporal lobe, parietal cortex, and hippocampus, with few analyzing changes in the frontal lobe. \\n recent studies found that transgenic mice with alzheimer's disease show early cognitive decline related to frontal atrophy, with the changes taking place even earlier than in the hippocampus. \\n as shown above, although the mea therapy performed better than ea in the morris water maze test, differences were not statistically significant. in micro - pet, \\n ea therapy showed higher glucose metabolism improvement in the hippocampus and cerebral cortex compared with mea. only in the frontal lobe, \\n these findings prompted the question whether mea therapy was more inclined to play a role in the frontal lobe. to address this, \\n amyloid - beta levels were assessed in the frontal lobe of samp8 mice, and the results confirmed the above notion. comparing the different therapies in iod of amyloid - beta in the frontal lobe, mea therapy performed significantly better than ea ( p < 0.05 ). therefore, mea indeed is inclined to play a role in the frontal lobe. \\n using behavioral tests, in vivo imaging, and protein detection, the differences between mea and ea therapy for ad treatment were assessed in samp8 mice. \\n interestingly, both ea and mea could improve spatial learning and memory ability, improving glucose metabolism in different brain regions and amyloid - beta expression in the frontal lobe. \\n what is more, the mea therapy performed better than ea in decreasing amyloid - beta amounts in the frontal lobe.\"},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Summarize the given article into a concise abstract that highlights the key findings and conclusions.',\n",
       "  'input': \"Summarize the following article: cancer is the second leading killer in the usa , accounting for 25% of all deaths . \\n prostate cancer is the most common cancer in males , followed by lung and colorectal . for women \\n however , it should be noted that lung cancer is the number one cancer killer for both men and women ( 1 ) . \\n an abundance of evidence suggests that lifestyle factors , including exposure to chemical carcinogens ( smoking , etc . ) , \\n diet and inactivity play a major role in the development of these common cancers . in order to understand how lifestyle changes might reduce the risk for the most common cancers we must first understand how cancer develops . \\n unfortunately , many chemicals in the environment are capable of inducing free radical formation to damage dna in the body . \\n thus , at any given time most , if not all , of us might have a number of pre - neoplastic cells . if we are fortunate , the damaged dna sends a signal to genes such as p53 announcing the damage and increasing the protein products of these genes to stop the pre - neoplastic cell from dividing and hopefully repair the damaged dna . if the repair does not work , the cell should be directed to apoptosis or programmed cell death . since cancer is so common in the usa , \\n this might be the result of defects in the p53 gene or the fact that the gene is suppressed by certain factors . \\n defects in the p53 gene have been identified in about half of all cancers , but these defects are usually observed in end - stage cancer . for prostate cancer \\n all early - stage cancer has an intact p53 gene that is suppressed from acting , as we will discuss later . \\n if the p53 gene does not eliminate the defective pre - neoplastic cell , the cell is stimulated to divide ( promotion stage ) by certain co - carcinogens , leading to the formation of a tumor . \\n thus , to avoid cancer we should try to reduce the initiation stage by reducing exposure to many of the noxious chemical carcinogens present in our environment such as cigarette smoke , pesticides and many other commonly used household products . according to ames ( 2 ) \\n , the typical western diet also contains a variety of mutagens and carcinogens that may act through the generation of oxygen radicals and lead to the initiation of cancer as well as other degenerative diseases . \\n a diet high in fat and/or refined sugar has been shown to induce oxidative stress ( 35 ) . \\n consumption of red meat has been associated with cancers of the colon and rectum , breast and prostate . whether it is the meat itself or the associated fat content is not known . \\n cooking meat at moderate to high temperatures forms carcinogenic heterocyclic amines , shown in animal studies to induce colon , breast and prostate cancer ( 6 ) . \\n conversely , a diet high in whole grains , fruits and vegetables would contain large amounts of natural antioxidants that might play an important role in preventing free radical formation and cancer ( 2 ) . \\n this type of diet has been shown to reduce oxidative stress in the body ( 7 ) . a diet high in whole grains , fruits and vegetables , \\n especially if it includes an abundance of soy products would increase the intake of isoflavones , thought to reduce the risk of cancer ( 8) . \\n genistein , the most abundant isoflavone in soy , has been shown in cell culture experiments to increase p21 and caspase 3 to cause cell cycle arrest and induce apoptosis of tumor cells ( 8) . \\n consumption of soy might explain the large difference in many cancers between western and eastern cultures . \\n another factor that has been suggested to explain the difference is the consumption of green tea by eastern cultures . \\n green tea contains epigallocatechin gallate , also shown to be protective in cell culture and animal studies ( 8) . \\n attention has also been focused on the value of omega-3 fatty acids found primarily in fish and certain nuts and seeds . \\n these fatty acids block cox-2 expression and reduce inflammation that has been implicated in the early stages and/or progression of prostate , breast and colon cancers ( 911 ) . \\n conversely , omega-6 fatty acids found in meat and many vegetable oils increases cox-2 expression . \\n recent studies have shown that non - steroidal anti - inflammatory drugs ( nsaids ) that block the cox pathway reduce the development of adenomas , precursors of colon cancer , and reduce the risk for prostate cancer ( 1214 ) . \\n regular exercise has also been shown to increase the body 's antioxidant mechanisms ( 15 ) . \\n in addition to preventing the initiation of cancer , diet and exercise may play an important role in reducing the promotion of cancer and inducing apoptosis by altering hormones such as insulin , testosterone and estrogen or growth factors such as insulin - like growth factor - i ( igf - i ) . \\n the link between smoking and lung cancer was established in the first surgeon general 's report in 1964 . \\n however , a number of epidemiological studies have reported that exercise lowers the risk for lung cancer as reviewed by lee ( 16 ) . \\n the large norwegian study of 81 516 men and women followed for 19 years reported a 25% reduction in lung cancer risk for men who walked or cycled for at least 4  h per week , after controlling for smoking habits and the number of cigarettes smoked ( 17 ) . \\n the mechanism by which exercise might reduce the risk for lung cancer has not been investigated but may be related to the ability of exercise to reduce serum insulin and subsequently igf - i . \\n igf - i has been reported to be a risk factor for lung cancer ( 18 ) . \\n a high consumption of fruit and vegetables has also been associated with a reduced risk for lung cancer ( 19 ) . \\n prostate cancer is the most common male cancer in the usa , but has a very low incidence in asia . \\n however , when asian men migrate to the usa and adopt the us lifestyle the incidence of prostate cancer approaches that of us men , suggesting the involvement of lifestyle factors as opposed to a genetic difference ( 20 ) . \\n in addition , as the developing countries with a low incidence of prostate cancer become more westernized , prostate cancer increases ( 21 ) . \\n the two lifestyle factors that have received the most attention are diet , especially the fat content , and being sedentary . \\n the international data show a positive correlation between dietary fat and prostate cancer mortality with the lowest rates found in east asian men and the highest rates found in us and european men ( 22 ) . most of the prospective cohort studies within a given population , however , have failed to show a relationship between dietary fat or fatty food consumption and prostate cancer risk as discussed by moyad ( 23 ) . \\n the negative results from the cohort studies may be due to the fact that in any given population there is little variation in the dietary fat consumption , or may be due to the inability of questionnaires to accurately measure habitual fat consumption . \\n current evidence implicates omega-6 fatty acids in the promotion of cancers and omega-3 polyunsaturated fatty acids and omega-9 monounsaturated fatty acids as being protective ( 24 ) . \\n it may also be that in the international data not only do men with a low incidence of prostate cancer mortality consume much lower fat diets , they also tend to be more physically active . \\n epidemiological studies have reported that increased physical activity can reduce the risk for prostate , and other forms of cancer , in us and european men . in a recent review of the literature on physical activity and the risk for prostate cancer , thune and furberg ( 25 ) found that 14 of 28 epidemiological studies reported that increased occupational or leisure - time activity reduced the risk for prostate cancer by 1070% . in order to investigate possible mechanisms involved in the roles that diet and exercise play in the progression of prostate cancer , tymchuk et al . \\n ( 26 ) developed a bioassay using serum to stimulate prostate cancer cells in culture . by placing men on a low - fat diet consisting primarily of grains , \\n fruits and vegetables , and regular , supervised exercise they examined serum changes in vivo and their effect on prostate cancer cell growth in vitro . \\n the subjects were participants or employees from the pritikin longevity center residential program . during their stay at the center , \\n food was prepared and served buffet style to the participants and consisted of 1015% of calories from fat ( polyunsaturated / saturated fatty acid ratio = 1.24 ) , 1520% of calories from protein , and 6575% of calories from carbohydrates , primarily unrefined . \\n carbohydrates were in the form of high - fiber whole grains and other complex carbohydrates ( 5 servings / day ) , vegetables ( 4 servings / day ) , and fruits ( 3 servings / day ) . \\n protein was primarily derived from plant sources with non - fat dairy allowed for up to 2 servings / day . \\n fish or fowl was served in 3.5 ounce portions 1 day / week and in soups or casseroles 2 days / week . \\n the diet contained < 100  mg of cholesterol per day and alcohol , tobacco and caffeinated beverages were not allowed during the program . prior to starting the exercise training , subjects underwent a graded treadmill stress test . \\n based on the results , the subjects were provided with an appropriate training heart rate value and given an individualized walking program . the exercise regimen consisted of daily walking at the training heart rate for 4560  min . in the initial study tymchuk et al . \\n ( 26 ) found that just 11 days of the low - fat diet and exercise program reduced serum - stimulated lncap prostate cancer cell growth by 30% . \\n serum samples obtained from men ( employees ) who had adhered to the low - fat diet and exercise program for an average of 14 years showed an additional 15% reduction in lncap cell growth . \\n lncap is a well - established , androgen - dependent cell line , developed from a patient with prostate cancer . \\n when the serum samples from the men following the low - fat diet and exercise program were used to stimulate pc-3 cells , an androgen - independent cell line typical of advanced prostate cancer , no reduction in cell growth was found ( 26 ) . in a subsequent study ngo et al . \\n ( 27 ) confirmed the diet and exercise reduction in lncap cell growth using another androgen - dependent , patient - derived cell line , lapc-4 . \\n a control group of similar aged men without any intervention were studied over an 11-day period and no change in lncap cell growth was found . in an earlier study tymchuk et al . \\n ( 28 ) had reported that men attending the pritikin longevity center low - fat diet and exercise program had significant reductions in serum insulin and significant elevations in sex hormone - binding globulin . \\n the increase in shbg should lower the serum levels of free testosterone and estradiol , and might be a factor in the reduction in lncap cell growth observed following diet and exercise as this cell line is androgen dependent and has a mutated androgen receptor that binds both testosterone and estradiol . \\n ( 26,29 ) confirmed the reduction in serum free testosterone in the pritikin participants and subsequently reported that insulin , testosterone and estradiol could individually stimulate the growth of lncap cells . \\n however , when these hormones were added individually , or in combination , to the post diet and exercise serum they could only account for half of the reduction in lncap cell growth , indicating the involvement of other important factors . \\n ( 30 ) developed a model similar to figure 2 and started to investigate igf-1 and its binding proteins . \\n the igf axis consists of igf - i , igf - ii , six different binding proteins ( igfbp 16 ) and two receptors , igf - ir and igf - iir . \\n igf - i is a peptide growth factor produced by the liver and other tissues , and is known to play a pivotal role in regulating cell growth , differentiation and apoptosis ( programmed cell death ) ( 18,31 ) . \\n it is also a potent mitogen for most tissues including the prostate ( 18,31 ) . according to yarak et al . \\n igfbp-3 is the most abundant and binds 90% of the circulating igf - i but is not affected by different metabolic states and ngo et al . \\n ( 33 ) found that the low - fat diet and exercise program decreased not only the fasting serum level of insulin , but also igf - i while increasing igfbp-1 . \\n these changes in serum levels of igf - i and igfbp-1 are thought to be due to the changes in serum insulin and its impact on the liver . \\n ( 34 ) reported that insulin stimulated the production of igf - i by hepatocytes . \\n ( 27 ) added igf - i back to the diet and exercise serum , the reduction in lncap cell growth was completely eliminated . \\n when igfbp-1 was added to the baseline serum , they observed a significant reduction in lncap cell growth . \\n in addition to being a regulator of cell growth , igf - i has been reported to be a suppressor of apoptosis in several different studies ( 35 ) . \\n ( 27 ) studied apoptosis in their cell culture system using two different methods , annexin - v and tunel . \\n almost no apoptotic or necrotic cells were found in the fetal bovine serum ( fbs ) control or the pre diet and exercise samples . \\n however , both the annexin - v and tunel staining methods showed a significant increase in apoptosis in the post diet and exercise - serum - stimulated samples . \\n the fact that very little apoptosis was observed in the control serum - stimulated lncap cells may be the result of the high levels of igf - i and low levels of igfbp-1 in the control serum and may help to explain why prostate cancer is so prevalent in the usa . in an attempt to separate out the individual effects of diet versus \\n exercise observed in their earlier studies with the androgen - dependent prostate cancer cell lines , barnard et al . \\n ( 36 ) obtained serum samples from men who had been involved in the adult fitness program at the university of nevada , las vegas . \\n the men were matched in age with a control group of men on no diet or exercise program , and for age and duration of participation to the long - term diet and exercise subjects previously studied . \\n volunteers were requested who had participated in the program for at least 10 years ; the average was 14.7 years . \\n the program was held 5 days per week for 1  h and consisted of warm - up and flexibility activities followed by 4550  min of continuous , strenuous exercise including calisthenics and swimming laps in the pool . \\n serum insulin and igf - i were lower in the exercise and diet + exercise groups compared to controls , but were not significantly different from each other . \\n igfbp-1 was higher in both the exercise and the diet + exercise groups compared to controls and was significantly higher in the diet + exercise group compared to the exercise group . when the serum was used to stimulate the lncap cells in culture , growth was reduced in both the exercise ( 65% fbs control ) and diet + exercise ( 55% fbs control ) groups compared to the control group where the growth was 99% of the fbs . \\n the staining results from the two methods demonstrated that exercise as well as diet and exercise intervention increases apoptosis in the lncap cells . \\n when the slides from the tunel staining were quantitatively analyzed , almost twice as much apoptosis was found in the diet and exercise samples compared to the exercise - only samples . \\n the fact that apoptosis was higher in the diet + exercise subjects is in agreement with the significantly higher igfbp-1 levels compared to the exercise - only group . in an attempt to focus on the possible mechanisms involved in the reduction in lncap cell growth and increased apoptosis observed in the exercise - serum - stimulated samples , leung et al . \\n several studies have shown that igf-1 suppresses the action of p53 that is phosphorylated and stabilized when defects are found in dna . \\n the increase in p53 protein normally activates other genes or factors to cause cell cycle arrest , dna repair or to induce apoptosis ( 34 ) . \\n the serum - stimulated cell cultures were lysed , centrifuged and the supernatant analyzed for p53 protein and was found to be significantly increased in the lysates from the exercise - serum - stimulated lncap cells compared to controls . \\n these results also demonstrate that the lncap cells have an intact p53 pathway that is suppressed with serum from control subjects . according to gurumurthy et al . \\n ( 35 ) an intact p53 pathway is characteristic of all early stage prostate cancer . in end - stage prostate cancer defects \\n have been reported in the p53 gene . to further investigate the involvement of the p53 pathway in the exercise - serum - stimulated lncap cell growth reduction and induction of apoptosis , leung et al . \\n ln-56 is a lncap - derived cell line in which p53 was rendered non - functional by expression of a dominant negative fragment of p53 , known as genetic suppressor element 56 . \\n the results from the growth assay showed no significant difference between the control and exercise groups when the serum was used to stimulate the cells . \\n the exercise - serum - stimulated growth in the ln-56 cells was 91% of the fbs control compared to 65% of fbs control for the lncap cells . \\n when they examined apoptosis in the ln-56 cells , the exercise - serum - stimulated cells showed half the apoptosis observed with the control - serum - stimulated cells . \\n this was opposite to the response observed in the lncap cells where apoptosis was greatly increased in the exercise - serum - stimulated cells . \\n collectively , the results from these experiments indicate that the reduction in serum igf - i and increase in igfbp-1 resulting from adopting a very - low - fat diet and/or regular exercise allows the prostate tumor cells to stabilize the p53 protein and activate downstream effectors to reduce cell growth and induce apoptosis . \\n these data also provide a mechanism to explain the epidemiological data showing a reduction in the risk for prostate cancer in men who take part in regular exercise ( 25 ) . \\n if the observations of reduced cell growth and the induction of apoptosis reported for the cell culture studies with androgen - dependent prostate cancer cell lines also occur in the body , then a very - low - fat diet and exercise program might be of value in the treatment of prostate cancer patients , especially those with early - stage cancer . in order to investigate the possible effectiveness of a very - low - fat diet and exercise program on prostate cancer patients , ornish and colleagues ( 38,39 ) \\n randomized a group of men on  watchful waiting to control or to diet and exercise intervention . \\n the patient all had biopsy - documented prostate cancer , psa ranging from 4 to 10  ng / ml , and a gleason sum of < 7 prostate adenocarcinoma . \\n the men in the diet and exercise intervention group were prescribed a vegan diet with 10% of calories from fat supplemented with soy , 3  g / day fish oil ( omega-3 fatty acid ) and 400  iu / day vitamin e. the exercise was to be aerobic ( walking , jogging etc . ) for 3060  min 6 days / week . \\n patients were also encouraged to practice stress management techniques including yoga , breathing , imagery etc . for 1  h / day . \\n after 1 year , changes in serum psa were small but statistically significant , with the control group showing an increase and the diet and exercise group showing a drop . also , at the end of 1 year , six of 43 in the control group had gone on for conventional treatment due to rising psa while none of the 41 in the diet and exercise group had treatment . \\n there was very high adherence to the diet and exercise program and even some in the control group had made significant lifestyle changes . \\n serum samples from these patients were used in the lncap cell bioassay . compared to baseline , cell growth \\n was reduced by 9% in the control group and by 60% in the diet and exercise group . \\n the growth rate in the baseline samples was not significantly different from what had previously been observed with serum from men without prostate cancer . \\n breast cancer is the most common female cancer in the usa and , like prostate cancer , is hormone - dependent in the early stages . \\n the influence of lifestyle factors in breast cancer is supported by the large international variation and the migration studies ( 40,41 ) . even though breast cancer is initially an estrogen - dependent cancer , \\n most breast cancer occurs in postmenopausal women . with the menopause estrogen levels drop but do not completely disappear as estrogen is produced via aromatase activity , primarily in fat cells . \\n thus , it is not surprising that obesity is a risk factor for postmenopausal breast cancer \\n . elevated serum estradiol has also been shown to be a risk factor for breast cancer in postmenopausal women ( 42 ) . like prostate cancer , \\n the international data show a strong , positive correlation between per capita fat consumption and breast cancer incidence and mortality ( 40 ) . \\n epidemiological studies in countries with a high incidence of breast cancer , such as the usa , have shown that regular exercise reduces the risk for breast cancer . in their review , \\n thune and furberg ( 25 ) reported that occupational or leisure time physical activity reduced the risk for breast cancer in 26 of 41 studies by 30% in pre- , peri- and postmenopausal women . in 16 of 28 studies a graded dose \\n heber et al . ( 43 ) studied postmenopausal women attending the pritikin center and reported that the 3-week , low - fat diet and exercise program lowered serum estradiol from 18.1  3.6 to 9.4  2.4  pg / ml . in a subsequent study ( 44 ) \\n they reported serum changes in premenopausal women placed on the pritikin diet for 2 months at the ucla clinical research center . \\n however , serum estradiol was reduced by 25% during the follicular phase and by 22% during the leuteal phase while serum estrone was reduced by 19 and 18% , respectively , during the two phases . \\n shbg , produced primarily in the liver , regulates the amount of free hormone available to interact with the hormone receptors . \\n insulin suppresses the production of shbg by the liver . in a more recent study ( 45 ) with postmenopausal women attending the pritikin 3-week diet and exercise program , \\n serum insulin was reduced by 39% and shbg increased by 39% in women on hormone replacement therapy ( hrt ) . in women not on hrt , insulin was reduced by 19% and shbg increased by 42% . \\n the drop in insulin may be very important as insulin has been reported to be a risk factor for both estrogen positive and negative breast cancer ( 46 ) . \\n barnard rs , liva m , ngo tm , varr bc and hong j ( unpublished ) recently studied changes in the igf axis in postmenopausal women attending the pritikin program . in 18 women on hrt \\n , igf - i was reduced from 170  22 to 142  13  pg / ml and igfbp-1 was increased from 55  8 to 71  10  pg / ml while insulin was reduced from 14.5  2 to 9.1  1  iu / ml . \\n these changes in the igf axis are important as igf - i has been reported to be a risk factor for breast cancer and it is now well established that there is interaction between the igf and estrogen receptor pathways in breast cancer ( 18,47 ) . \\n cancer of the colon and/or rectum is the second leading cause of cancer deaths in the usa and is the third most common cancer in both men and women . over the years \\n there has been a lot of controversy regarding the involvement of lifestyle factors in intestinal cancer . \\n this may be due , in part , to different site - specific etiologies of the cancer . like the previous two cancers \\n , colorectal cancer shows a large international variation that armstrong and doll ( 40 ) attributed to the variation in dietary fat consumption . \\n prior to this , burkitt ( 48 ) suggested that other dietary factors such as fiber and refined sugar played a more important role . \\n he suggested that the removal of fiber by refining carbohydrates reduced stool bulk and increased transit time as well as adversely affecting intestional flora . \\n adenomas are precursor lesions of colorectal cancer and are informative endpoints for assessing cancer risk . \\n ( 49 ) showed inverse associations between fiber intake and colorectal adenoma . on the other hand , \\n studies in the usa , finland and sweden reported no protective effect of fiber ( 5052 ) . \\n one large cohort study in us men , the health professionals follow - up study , did find a significant inverse association of distal adenomas and soluble but not insoluble fiber intake ( 53 ) . \\n the exact reason for the inconsistency in the cohort studies is not known but may be due to the fact that the populations have been rather homogeneous with relatively low fiber intakes or may be due to the inability of food questionnaires to accurately predict habitual fiber intake . \\n the recent european prospective investigation into cancer and nutrition ( epic ) study involved 519 978 individuals with fiber intakes that ranged from 13  g / day for the lowest quintile to 34  g / day for the highest quintile ( 54 ) . comparing the highest to the lowest quintile of fiber intake they found a relative risk for large bowel cancer of 0.75 . \\n even this intake of 34  g / day was lower that the 50 +  g / day originally described by burkitt . after evaluating the scientific evidence , the european cancer prevention consensus panel concluded in 1998 that there was good evidence to support the protective effect of fiber against colon ( and breast ) cancer ( 55 ) . \\n two recent papers have suggested that hyperinsulinemia resulting from consumption of high - fat , refined - sugar diets may be an important factor in the etiology of colorectal cancer ( 56,57 ) . \\n this might be related to our proposed model for prostate cancer as igf - i has also been found to be a risk factor for colon cancer ( 18 ) . \\n a high - fat diet ( corn oil ) has also been reported to increase colon mucosa igf - i receptors in rats ( 58 ) . \\n the involvement of hyperinsulinemia and elevated igf - i might also be related to the epidemiological studies showing a reduction in intestinal cancer with increased physical activity . according to friedenreich and orenstein ( 59 ) , the most definitive evidence for an association between physical activity and cancer exists for colon cancer . of 51 studies on colon or colorectal cancer , \\n 43 demonstrated a reduction in risk in the most physically active men and women with an average reduction of 4050% and values as high as 70% for the most physically active . \\n ( 60 ) recently examined the relationship between lifestyle factors and p53 mutations in colon tumors . \\n they concluded that a western - style diet high in refined sugar and red meat was correlated with p53 mutations while no association was found with physical activity . \\n this , to our knowledge , is the first study to show a relationship between diet and p53 mutations , whether or not a western - style diet can cause p53 mutations remains to be demonstrated . \\n reddy et al . ( 61 ) studied colon cancer risk factors in eight women attending the pritikin program by collecting stool samples over 2 days and diet records over 3 days before the start and at the end of the 3-week program . \\n dietary fat intake decreased from 34 to 7% of calories and fiber increased from 17 to 37  g / day during the residential program . \\n total stool bile acid was reduced from 9.7  2 to 4.5  1  mg / g dry weight . \\n more important was the very significant reduction in the secondary bile acids , deoxycholic and lithocholic acid that suggests a change in the intestinal flora . \\n the reduction in secondary bile acids should be important as they are thought to be the most carcinogenic bile acids ( 62 ) . \\n intervention trials with bran , soluble fiber or vegetables have not reduced recurrence rates of adenomatous colorectal polyps ( 6365 ) . \\n going back to burkitt 's original work , not only did the african natives have a very low incidence of colorectal cancer with a high fiber intake , they also consumed a very - low - fat diet and were very physically active . \\n thus , it may be that total lifestyle modification is needed to reduce cancer risk , not simply modification of one aspect . \\n in his presidential address to the american cancer society in 1966 , joseph burchenal ( 66 ) suggested that the study of one form of cancer might provide guide - posts to the understanding of another related form of cancer . \\n this suggestion seems to relate to hyperinsulinemia , the igf axis and their associations with several forms of cancer . \\n however , the true unifying factor for most cancers seems to be lifestyle : smoking , a high - fat and refined - sugar diet along with a lack of physical activity . \\n these lifestyle factors can easily be changed and may prevent most types of cancer . by adopting a diet consisting primarily of whole grains , fruits and vegetables with limited amounts of meat , primarily chicken or cold - water fish , and doing 4560  min of daily exercise , one could achieve significant changes in hormones and growth factors known to be associated with cancer as shown in figure 3 . \\n primary prevention trials to test this hypothesis are difficult to conduct due to the large number of subjects , the prolonged time required and the cost . however , secondary prevention trials like the ornish study ( 38,39 ) with prostate cancer or the colorectal adenoma recurrence studies may provide important scientific evidence for the value of these lifestyle changes . \\n a model showing steps in the development of cancer . a model explaining the role of diet and a sedentary lifestyle in the development of prostate cancer [ after barnard et al . \\n a model explaining how a change in lifestyle to include a low - fat , high - fiber diet plus regular exercise might reduce the risk for cancer .\",\n",
       "  'output': 'cancer is the second leading cause of death in the usa and an abundance of evidence suggests that lifestyle factors including smoking , the typical high - fat , refined - sugar diet and physical inactivity account for the majority of cancer . \\n this review focuses on diet and inactivity as major factors for cancer promotion by inducing insulin resistance and hyperinsulinemia . \\n elevated levels of serum insulin impact on the liver primarily , increasing the production of insulin - like growth factor i ( igf - i ) while reducing the production of insulin - like growth factor binding protein 1 ( igfbp-1 ) resulting in stimulation of tumor cell growth and inhibition of apoptosis ( programmed cell death ) . adopting a diet low in fat and high in fiber - rich starch foods , which would also include an abundance of antioxidants , combined with regular aerobic exercise might control insulin resistance , reduce the resulting serum factors and thus reduce the risk for many different cancers commonly seen in the usa .',\n",
       "  '__index_level_0__': 31678,\n",
       "  'model_output': \"summarized article: cancer is the second leading killer in the usa, accounting for 25% of all deaths. \\n prostate cancer is the most common cancer in males, followed by lung and colorectal. for women \\n however, it should be noted that lung cancer is the number one cancer killer for both men and women ( 1 ). \\n an abundance of evidence suggests that lifestyle factors, including exposure to chemical carcinogens ( smoking, etc. ), \\n diet and inactivity play a major role in the development of these common cancers. in order to understand how lifestyle changes might reduce the risk for the most common cancers we must first understand how cancer develops. \\n unfortunately, many chemicals in the environment are capable of inducing free radical formation to damage dna in the body. \\n thus, at any given time most, if not all, of us might have a number of pre - neoplastic cells. if we are fortunate, the damaged dna sends a signal to genes such as p53 announcing the damage and increasing the protein products of these genes to stop the pre - neoplastic cell from dividing and hopefully repair the damaged dna. if the repair does not work, the cell should be directed to apoptosis or programmed cell death. since cancer is so common in the usa, \\n this might be the result of defects in the p53 gene or the fact that the gene is suppressed by certain factors. \\n defects in the p53 gene have been identified in about half of all cancers, but these defects are usually observed in end - stage cancer. for prostate cancer \\n all early - stage cancer has an intact p53 gene that is suppressed from acting, as we will discuss later. \\n if the p53 gene does not eliminate the defective pre - neoplastic cell, the cell is stimulated to divide ( promotion stage ) by certain co - carcinogens, leading to the formation of a tumor. \\n thus, to avoid cancer we should try to reduce the initiation stage by reducing exposure to many of the noxious chemical carcinogens present in our environment such as cigarette smoke, pesticides and many other commonly used household products. according to ames ( 2 ) \\n, the typical western diet also contains a variety of mutagens and carcinogens that may act through the generation of oxygen radicals and lead to the initiation of cancer as well as other degenerative diseases. \\n a diet high in fat and/or refined sugar has been shown to induce oxidative stress ( 35 ). \\n consumption of red meat has been associated with cancers of the colon and rectum, breast and prostate. whether it is the meat itself or the associated fat content is not known. \\n cooking meat at moderate to high temperatures forms carcinogenic heterocyclic amines, shown in animal studies to induce colon, breast and prostate cancer ( 6 ). \\n conversely, a diet high in whole grains, fruits and vegetables would contain large amounts of natural antioxidants that might play an important role in preventing free radical formation and cancer ( 2 ). \\n this type of diet has been shown to reduce oxidative stress in the body ( 7 ). a diet high in whole grains, fruits and vegetables, \\n especially if it includes an abundance of soy products would increase the intake of isoflavones, thought to reduce the risk of cancer ( 8). \\n genistein, the most abundant isoflavone in soy, has been shown in cell culture experiments to increase p21 and caspase 3 to cause cell cycle arrest and induce apoptosis of tumor cells ( 8). \\n consumption of soy might explain the large difference in many cancers between western and eastern cultures. \\n another factor that has been suggested to explain the difference is the consumption of green tea by eastern cultures. \\n green tea contains epigallocatechin gallate, also shown to be protective in cell culture and animal studies ( 8). \\n attention has also been focused on the value of omega-3 fatty acids found primarily in fish and certain nuts and seeds. \\n these fatty acids block cox-2 expression and reduce inflammation that has been implicated in the early stages and/or progression of prostate, breast and colon cancers ( 911 ). \\n conversely, omega-6 fatty acids found in meat and many vegetable oils increases cox-2 expression. \\n recent studies have shown that non - steroidal anti - inflammatory drugs ( nsaids ) that block the cox pathway reduce the development of adenomas, precursors of colon cancer, and reduce the risk for prostate cancer ( 1214 ). \\n regular exercise has also been shown to increase the body's antioxidant mechanisms ( 15 ). \\n in addition to preventing the initiation of cancer, diet and exercise may play an important role in reducing the promotion of cancer and inducing apoptosis by altering hormones such as insulin, testosterone and estrogen or growth factors such as insulin - like growth factor - i ( igf - i ). \\n the link between smoking and lung cancer was established in the first surgeon general's report in 1964. \\n however, a number of epidemiological studies have reported that exercise lowers the risk for lung cancer as reviewed by lee ( 16 ). \\n the large norwegian study of 81 516 men and women followed for 19 years reported a 25% reduction in lung cancer risk for men who walked or cycled for at least 4  h per week, after controlling for smoking habits and the number of cigarettes smoked ( 17 ). \\n the mechanism by which exercise might reduce the risk for lung cancer has not been investigated but may be related to the ability of exercise to reduce serum insulin and subsequently igf - i. \\n igf - i has been reported to be a risk factor for lung cancer ( 18 ). \\n a high consumption of fruit and vegetables has also been associated with a reduced risk for lung cancer ( 19 ). \\n prostate cancer is the most common male cancer in the usa, but has a very low incidence in asia. \\n however, when asian men migrate to the usa and adopt the us lifestyle the incidence of prostate cancer approaches that of us men, suggesting the involvement of lifestyle factors as opposed to a genetic difference ( 20 ). \\n in addition, as the developing countries with a low incidence of prostate cancer become more westernized, prostate cancer increases ( 21 ). \\n the two lifestyle factors that have received the most attention are diet, especially the fat content, and being sedentary. \\n the international data show a positive correlation between dietary fat and prostate cancer mortality with the lowest rates found in east asian men and the highest rates found in us and european men ( 22 ). most of the prospective cohort studies within a given population, however, have failed to show a relationship between dietary fat or fatty food consumption and prostate cancer risk as discussed by moyad ( 23 ). \\n the negative results from the cohort studies may be due to the fact that in any given population there is little variation in the dietary fat consumption, or may be due to the inability of questionnaires to accurately measure habitual fat consumption. \\n current evidence implicates omega-6 fatty acids in the promotion of cancers and omega-3 polyunsaturated fatty acids and omega-9 monounsaturated fatty acids as being protective ( 24 ). \\n it may also be that in the international data not only do men with a low incidence of prostate cancer mortality consume much lower fat diets, they also tend to be more physically active. \\n epidemiological studies have reported that increased physical activity can reduce the risk for prostate, and other forms of cancer, in us and european men. in a recent review of the literature on physical activity and the risk for prostate cancer, thune and furberg ( 25 ) found that 14 of 28 epidemiological studies reported that increased occupational or leisure - time activity reduced the risk for prostate cancer by 1070%. in order to investigate possible mechanisms involved in the roles that diet and exercise play in the progression of prostate cancer, tymchuk et al. \\n ( 26 ) developed a bioassay using serum to stimulate prostate cancer cells in culture. by placing men on a low - fat diet consisting primarily of grains, \\n fruits and vegetables, and regular, supervised exercise they examined serum changes in vivo and their effect on prostate cancer cell growth in vitro. \\n the subjects were participants or employees from the pritikin longevity center residential program. during their stay at the center, \\n food was prepared and served buffet style to the participants and consisted of 1015% of calories from fat ( polyunsaturated / saturated fatty acid ratio = 1.24 ), 1520% of calories from protein, and 6575% of calories from carbohydrates, primarily unrefined. \\n carbohydrates were in the form of high - fiber whole grains and other complex carbohydrates ( 5 servings / day ), vegetables ( 4 servings / day ), and fruits ( 3 servings / day ). \\n protein was primarily derived from plant sources with non - fat dairy allowed for up to 2 servings / day. \\n fish or fowl was served in 3.5 ounce portions 1 day / week and in soups or casseroles 2 days / week. \\n the diet contained < 100  mg of cholesterol per day and alcohol, tobacco and caffeinated beverages were not allowed during the program. prior to starting the exercise training, subjects underwent a graded treadmill stress test. \\n based on the results, the subjects were provided with an appropriate training heart rate value and given an individualized walking program. the exercise regimen consisted of daily walking at the training heart rate for 4560  min. in the initial study tymchuk et al. \\n ( 26 ) found that just 11 days of the low - fat diet and exercise program reduced serum - stimulated lncap prostate cancer cell growth by 30%. \\n serum samples obtained from men ( employees ) who had adhered to the low - fat diet and exercise program for an average of 14 years showed an additional 15% reduction in lncap cell growth. \\n lncap is a well - established, androgen - dependent cell line, developed from a patient with prostate cancer. \\n when the serum samples from the men following the low - fat diet and exercise program were used to stimulate pc-3 cells, an androgen - independent cell line typical of advanced prostate cancer, no reduction in cell growth was found ( 26 ). in a subsequent study ngo et al. \\n ( 27 ) confirmed the diet and exercise reduction in lncap cell growth using another androgen - dependent, patient - derived cell line, lapc-4. \\n a control group of similar aged men without any intervention were studied over an 11-day period and no change in lncap cell growth was found. in an earlier study tymchuk et al. \\n ( 28 ) had reported that men attending the pritikin longevity center low - fat diet and exercise program had significant reductions in serum insulin and significant elevations in sex hormone - binding globulin. \\n the increase in shbg should lower the serum levels of free testosterone and estradiol, and might be a factor in the reduction in lncap cell growth observed following diet and exercise as this cell line is androgen dependent and has a mutated androgen receptor that binds both testosterone and estradiol. \\n ( 26,29 ) confirmed the reduction in serum free testosterone in the pritikin participants and subsequently reported that insulin, testosterone and estradiol could individually stimulate the growth of lncap cells. \\n however, when these hormones were added individually, or in combination, to the post diet and exercise serum they could only account for half of the reduction in lncap cell growth, indicating the involvement of other important factors. \\n ( 30 ) developed a model similar to figure 2 and started to investigate igf-1 and its binding proteins. \\n the igf axis consists of igf - i, igf - ii, six different binding proteins ( igfbp 16 ) and two receptors, igf - ir and igf - iir. \\n igf - i is a peptide growth factor produced by the liver and other tissues, and is known to play a pivotal role in regulating cell growth, differentiation and apoptosis ( programmed cell death ) ( 18,31 ). \\n it is also a potent mitogen for most tissues including the prostate ( 18,31 ). according to yarak et al. \\n igfbp-3 is the most abundant and binds 90% of the circulating igf - i but is not affected by different metabolic states and ngo et al. \\n ( 33 ) found that the low - fat diet and exercise program decreased not only the fasting serum level of insulin, but also igf - i while increasing igfbp-1. \\n these changes in serum levels of igf - i and igfbp-1 are thought to be due to the changes in serum insulin and its impact on the liver. \\n ( 34 ) reported that insulin stimulated the production of igf - i by hepatocytes. \\n ( 27 ) added igf - i back to the diet and exercise serum, the reduction in lncap cell growth was completely eliminated. \\n when igfbp-1 was added to the baseline serum, they observed a significant reduction in lncap cell growth. \\n in addition to being a regulator of cell growth, igf - i has been reported to be a suppressor of apoptosis in several different studies ( 35 ). \\n ( 27 ) studied apoptosis in their cell culture system using two different methods, annexin - v and tunel. \\n almost no apoptotic or necrotic cells were found in the fetal bovine serum ( fbs ) control or the pre diet and exercise samples. \\n however, both the annexin - v and tunel staining methods showed a significant increase in apoptosis in the post diet and exercise - serum - stimulated samples. \\n the fact that very little apoptosis was observed in the control serum - stimulated lncap cells may be the result of the high levels of igf - i and low levels of igfbp-1 in the control serum and may help to explain why prostate cancer is so prevalent in the usa. in an attempt to separate out the individual effects of diet versus \\n exercise observed in their earlier studies with the androgen - dependent prostate cancer cell lines, barnard et al. \\n ( 36 ) obtained serum samples from men who had been involved in the adult fitness program at the university of nevada, las vegas. \\n the men were matched in age with a control group of men on no diet or exercise program, and for age and duration of participation to the long - term diet and exercise subjects previously studied. \\n volunteers were requested who had participated in the program for at least 10 years ; the average was 14.7 years. \\n the program was held 5 days per week for 1  h and consisted of warm - up and flexibility activities followed by 4550  min of continuous, strenuous exercise including calisthenics and swimming laps in the pool. \\n serum insulin and igf - i were lower in the exercise and diet + exercise groups compared to controls, but were not significantly different from each other. \\n igfbp-1 was higher in both the exercise and the diet + exercise groups compared to controls and was significantly higher in the diet + exercise group compared to the exercise group. when the serum was used to stimulate the lncap cells in culture, growth was reduced in both the exercise ( 65% fbs control ) and diet + exercise ( 55% fbs control ) groups compared to the control group where the growth was 99% of the fbs. \\n the staining results from the two methods demonstrated that exercise as well as diet and exercise intervention increases apoptosis in the lncap cells. \\n when the slides from the tunel staining were quantitatively analyzed, almost twice as much apoptosis was found in the diet and exercise samples compared to the exercise - only samples. \\n the fact that apoptosis was higher in the diet + exercise subjects is in agreement with the significantly higher igfbp-1 levels compared to the exercise - only group. in an attempt to focus on the possible mechanisms involved in the reduction in lncap cell growth and increased apoptosis observed in the exercise - serum - stimulated samples, leung et al. \\n several studies have shown that igf-1 suppresses the action of p53 that is phosphorylated and stabilized when defects are found in dna. \\n the increase in p53 protein normally activates other genes or factors to cause cell cycle arrest, dna repair or to induce apoptosis ( 34 ). \\n the serum - stimulated cell cultures were lysed, centrifuged and the supernatant analyzed for p53 protein and was found to be significantly increased in the lysates from the exercise - serum - stimulated lncap cells compared to controls. \\n these results also demonstrate that the lncap cells have an intact p53 pathway that is suppressed with serum from control subjects. according to gurumurthy et al. \\n ( 35 ) an intact p53 pathway is characteristic of all early stage prostate cancer. in end - stage prostate cancer defects \\n have been reported in the p53 gene. to further investigate the involvement of the p53 pathway in the exercise - serum - stimulated lncap cell growth reduction and induction of apoptosis, leung et al. \\n ln-56 is a lncap - derived cell line in which p53 was rendered non - functional by expression of a dominant negative fragment of p53, known as genetic suppressor element 56. \\n the results from the growth assay showed no significant difference between the control and exercise groups when the serum was used to stimulate the cells. \\n the exercise - serum - stimulated growth in the ln-56 cells was 91% of the fbs control compared to 65% of fbs control for the lncap cells. \\n when they examined apoptosis in the ln-56 cells, the exercise - serum - stimulated cells showed half the apoptosis observed with the control - serum - stimulated cells. \\n this was opposite to the response observed in the lncap cells where apoptosis was greatly increased in the exercise - serum - stimulated cells. \\n collectively, the results from these experiments indicate that the reduction in serum igf - i and increase in igfbp-1 resulting from adopting a very - low - fat diet and/or regular exercise allows the prostate tumor cells to stabilize the p53 protein and activate downstream effectors to reduce cell growth and induce apoptosis. \\n these data also provide a mechanism to explain the epidemiological data showing a reduction in the risk for prostate cancer in men who take part in regular exercise ( 25 ). \\n if the observations of reduced cell growth and the induction of apoptosis reported for the cell culture studies with androgen - dependent prostate cancer cell lines also occur in the body, then a very - low - fat diet and exercise program might be of value in the treatment of prostate cancer patients, especially those with early - stage cancer. in order to investigate the possible effectiveness of a very - low - fat diet and exercise program on prostate cancer patients, ornish and colleagues ( 38,39 ) \\n randomized a group of men on  watchful waiting to control or to diet and exercise intervention. \\n the patient all had biopsy - documented prostate cancer, psa ranging from 4 to 10  ng / ml, and a gleason sum of < 7 prostate adenocarcinoma. \\n the men in the diet and exercise intervention group were prescribed a vegan diet with 10% of calories from fat supplemented with soy, 3  g / day fish oil ( omega-3 fatty acid ) and 400  iu / day vitamin e. the exercise was to be aerobic ( walking, jogging etc. ) for 3060  min 6 days / week. \\n patients were also encouraged to practice stress management techniques including yoga, breathing, imagery etc. for 1  h / day. \\n after 1 year, changes in serum psa were small but statistically significant, with the control group showing an increase and the diet and exercise group showing a drop. also, at the end of 1 year, six of 43 in the control group had gone on for conventional treatment due to rising psa while none of the 41 in the diet and exercise group had treatment. \\n there was very high adherence to the diet and exercise program and even some in the control group had made significant lifestyle changes. \\n serum samples from these patients were used in the lncap cell bioassay. compared to baseline, cell growth \\n was reduced by 9% in the control group and by 60% in the diet and exercise group. \\n the growth rate in the baseline samples was not significantly different from what had previously been observed with serum from men without prostate cancer. \\n breast cancer is the most common female cancer in the usa and, like prostate cancer, is hormone - dependent in the early stages. \\n the influence of lifestyle factors in breast cancer is supported by the large international variation and the migration studies ( 40,41 ). even though breast cancer is initially an estrogen - dependent cancer, \\n most breast cancer occurs in postmenopausal women. with the menopause estrogen levels drop but do not completely disappear as estrogen is produced via aromatase activity, primarily in fat cells. \\n thus, it is not surprising that obesity is a risk factor for postmenopausal breast cancer \\n. elevated serum estradiol has also been shown to be a risk factor for breast cancer in postmenopausal women ( 42 ). like prostate cancer, \\n the international data show a strong, positive correlation between per capita fat consumption and breast cancer incidence and mortality ( 40 ). \\n epidemiological studies in countries with a high incidence of breast cancer, such as the usa, have shown that regular exercise reduces the risk for breast cancer. in their review, \\n thune and furberg ( 25 ) reported that occupational or leisure time physical activity reduced the risk for breast cancer in 26 of 41 studies by 30% in pre-, peri- and postmenopausal women. in 16 of 28 studies a graded dose \\n heber et al. ( 43 ) studied postmenopausal women attending the pritikin center and reported that the 3-week, low - fat diet and exercise program lowered serum estradiol from 18.1  3.6 to 9.4  2.4  pg / ml. in a subsequent study ( 44 ) \\n they reported serum changes in premenopausal women placed on the pritikin diet for 2 months at the ucla clinical research center. \\n however, serum estradiol was reduced by 25% during the follicular phase and by 22% during the leuteal phase while serum estrone was reduced by 19 and 18%, respectively, during the two phases. \\n shbg, produced primarily in the liver, regulates the amount of free hormone available to interact with the hormone receptors. \\n insulin suppresses the production of shbg by the liver. in a more recent study ( 45 ) with postmenopausal women attending the pritikin 3-week diet and exercise program, \\n serum insulin was reduced by 39% and shbg increased by 39% in women on hormone replacement therapy ( hrt ). in women not on hrt, insulin was reduced by 19% and shbg increased by 42%. \\n the drop in insulin may be very important as insulin has been reported to be a risk factor for both estrogen positive and negative breast cancer ( 46 ). \\n barnard rs, liva m, ngo tm, varr bc and hong j ( unpublished ) recently studied changes in the igf axis in postmenopausal women attending the pritikin program. in 18 women on hrt \\n, igf - i was reduced from 170  22 to 142  13  pg / ml and igfbp-1 was increased from 55  8 to 71  10  pg / ml while insulin was reduced from 14.5  2 to 9.1  1  iu / ml. \\n these changes in the igf axis are important as igf - i has been reported to be a risk factor for breast cancer and it is now well established that there is interaction between the igf and estrogen receptor pathways in breast cancer ( 18,47 ). \\n cancer of the colon and/or rectum is the second leading cause of cancer deaths in the usa and is the third most common cancer in both men and women. over the years \\n there has been a lot of controversy regarding the involvement of lifestyle factors in intestinal cancer. \\n this may be due, in part, to different site - specific etiologies of the cancer. like the previous two cancers \\n, colorectal cancer shows a large international variation that armstrong and doll ( 40 ) attributed to the variation in dietary fat consumption. \\n prior to this, burkitt ( 48 ) suggested that other dietary factors such as fiber and refined sugar played a more important role. \\n he suggested that the removal of fiber by refining carbohydrates reduced stool bulk and increased transit time as well as adversely affecting intestional flora. \\n adenomas are precursor lesions of colorectal cancer and are informative endpoints for assessing cancer risk. \\n ( 49 ) showed inverse associations between fiber intake and colorectal adenoma. on the other hand, \\n studies in the usa, finland and sweden reported no protective effect of fiber ( 5052 ). \\n one large cohort study in us men, the health professionals follow - up study, did find a significant inverse association of distal adenomas and soluble but not insoluble fiber intake ( 53 ). \\n the exact reason for the inconsistency in the cohort studies is not known but may be due to the fact that the populations have been rather homogeneous with relatively low fiber intakes or may be due to the inability of food questionnaires to accurately predict habitual fiber intake. \\n the recent european prospective investigation into cancer and nutrition ( epic ) study involved 519 978 individuals with fiber intakes that ranged from 13  g / day for the lowest quintile to 34  g / day for the highest quintile ( 54 ). comparing the highest to the lowest quintile of fiber intake they found a relative risk for large bowel cancer of 0.75. \\n even this intake of 34  g / day was lower that the 50 +  g / day originally described by burkitt. after evaluating the scientific evidence, the european cancer prevention consensus panel concluded in 1998 that there was good evidence to support the protective effect of fiber against colon ( and breast ) cancer ( 55 ). \\n two recent papers have suggested that hyperinsulinemia resulting from consumption of high - fat, refined - sugar diets may be an important factor in the etiology of colorectal cancer ( 56,57 ). \\n this might be related to our proposed model for prostate cancer as igf - i has also been found to be a risk factor for colon cancer ( 18 ). \\n a high - fat diet ( corn oil ) has also been reported to increase colon mucosa igf - i receptors in rats ( 58 ). \\n the involvement of hyperinsulinemia and elevated igf - i might also be related to the epidemiological studies showing a reduction in intestinal cancer with increased physical activity. according to friedenreich and orenstein ( 59 ), the most definitive evidence for an association between physical activity and cancer exists for colon cancer. of 51 studies on colon or colorectal cancer, \\n 43 demonstrated a reduction in risk in the most physically active men and women with an average reduction of 4050% and values as high as 70% for the most physically active. \\n ( 60 ) recently examined the relationship between lifestyle factors and p53 mutations in colon tumors. \\n they concluded that a western - style diet high in refined sugar and red meat was correlated with p53 mutations while no association was found with physical activity. \\n this, to our knowledge, is the first study to show a relationship between diet and p53 mutations, whether or not a western - style diet can cause p53 mutations remains to be demonstrated. \\n reddy et al. ( 61 ) studied colon cancer risk factors in eight women attending the pritikin program by collecting stool samples over 2 days and diet records over 3 days before the start and at the end of the 3-week program. \\n dietary fat intake decreased from 34 to 7% of calories and fiber increased from 17 to 37  g / day during the residential program. \\n total stool bile acid was reduced from 9.7  2 to 4.5  1  mg / g dry weight. \\n more important was the very significant reduction in the secondary bile acids, deoxycholic and lithocholic acid that suggests a change in the intestinal flora. \\n the reduction in secondary bile acids should be important as they are thought to be the most carcinogenic bile acids ( 62 ). \\n intervention trials with bran, soluble fiber or vegetables have not reduced recurrence rates of adenomatous colorectal polyps ( 6365 ). \\n going back to burkitt's original work, not only did the african natives have a very low incidence of colorectal cancer with a high fiber intake, they also consumed a very - low - fat diet and were very physically active. \\n thus, it may be that total lifestyle modification is needed to reduce cancer risk, not simply modification of one aspect. \\n in his presidential address to the american cancer society in 1966, joseph burchenal ( 66 ) suggested that the study of one form of cancer might provide guide - posts to the understanding of another related form of cancer. \\n this suggestion seems to relate to hyperinsulinemia, the igf axis and their associations with several forms of cancer. \\n however, the true unifying factor for most cancers seems to be lifestyle : smoking, a high - fat and refined - sugar diet along with a lack of physical activity. \\n these lifestyle factors can easily be changed and may prevent most types of cancer. by adopting a diet consisting primarily of whole grains, fruits and vegetables with limited amounts of meat, primarily chicken or cold - water fish, and doing 4560  min of daily exercise, one could achieve significant changes in hormones and growth factors known to be associated with cancer as shown in figure 3. \\n primary prevention trials to test this hypothesis are difficult to conduct due to the large number of subjects, the prolonged time required and the cost. however, secondary prevention trials like the ornish study ( 38,39 ) with prostate cancer or the colorectal adenoma recurrence studies may provide important scientific evidence for the value of these lifestyle changes. \\n a model showing steps in the development of cancer. a model explaining the role of diet and a sedentary lifestyle in the development of prostate cancer [ after barnard et al. \\n a model explaining how a change in lifestyle to include a low - fat, high - fiber diet plus regular exercise might reduce the risk for cancer.\"},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Condense the given article into a clear and concise abstract that represents its core content.',\n",
       "  'input': \"Summarize the following article: the clustering of cardiovascular risk factors that includes central adiposity , hypertension , hyperglycemia , and high triglycerides ( tg ) with low high density lipoprotein cholesterol ( hdl - c ) levels is termed the metabolic syndrome ( ms ) . \\n ms is known to strongly predict the long - term risk of diabetes and cardiovascular disease ( cvd ) . \\n adipose tissue products are reported to affect systemic metabolism ; among these are adiponectin , leptin , plasminogen activator inhibitor-1 ( pai-1 ) , resistin , inflammatory cytokines , and angiotensinogen . \\n adiponectin has recently attracted much attention with particular emphasis on the role of adiponectin in the regulation of insulin sensitivity and the development of insulin resistance . \\n plasma levels of adiponectin have also been reported to be significantly reduced in obese humans . \\n moreover , plasma adiponectin levels have been shown to be decreased in patients with type-2 diabetes mellitus ( t2 dm ) , cvd , hypertension , and ms.[69 ] adiponectin activates adenosine mono - phosphate activated protein kinase and peroxisome proliferator activated receptor- in the liver and skeletal muscle , thereby stimulating phosphorylation of acetyl - coa carboxylase , fatty acid oxidation , thus decreasing tissue triglyceride ( tg ) content in muscle and liver . \\n the expression levels of adipor1/r2 are also decreased in obesity , which reduces adiponectin sensitivity and finally leads to insulin resistance , the so - called  vicious cycle . \\n adiponectin was demonstrated to strongly inhibit the expression of adhesion molecules , including intracellular adhesion molecule-1 , vascular cellular adhesion molecule-1 , and e - selectin . \\n thus , various studies have highlighted the potential antidiabetic , antiatherosclerotic and anti - inflammatory properties of adiponectin . decreased levels of plasma adiponectin \\n are associated with increased body mass index ( bmi ) , decreased insulin sensitivity , less favorable plasma lipid profiles , increased levels of inflammatory markers and increased risk for the development of cvd . \\n therefore , adiponectin levels hold great promise for use in clinical application , serving as a potent indicator of underlying metabolic complications . \\n plasma pai-1 levels are elevated in obesity and insulin resistance , are positively correlated with features of the ms , and predict future risk for type 2 diabetes and cvd . \\n thus , pai-1 may contribute to the development of obesity and insulin resistance and may be a causal link between obesity and cvd.[1113 ] there are few studies which have evaluated adipokines in indian population.[1417 ] hence , we studied adiponectin and pai-1 levels and their correlation with various parameters in subjects with ms . \\n this study was carried out at the department of endocrinology of a tertiary care center and details are provided in our previous publication in this journal . subjects with age 30 years and 50 years ( to exclude all postmenopausal women ) were screened for the presence of ms according to international diabetes federation ( idf ) criteria as follows : central obesity ( waist circumference  males > 90 cm , females > 80 cm ) plus any two of the following : raised triglycerides ( > 150 mg / dl ) , reduced hdl - c ( < 40 mg / dl in men and < 50 mg / dl in women ) , raised blood pressure ( systolic 130 mm hg or diastolic 85 mm hg ) , raised fasting plasma glucose ( fpg ) ( 100 mg / dl ) . \\n age- and sex - matched healthy subjects were screened for the absence of ms . only those cases with waist circumference below the idf criteria and absence of at least three of the four parameters \\n a total of 50 drug - nave subjects with ms ( 25 males and 25 females ) and 24 controls ( 12 males and 12 females ) were included in the study . \\n subjects with hepatic disease , renal disease , other endocrine diseases , alcoholism , infectious diseases or receiving any medications were excluded from the study . \\n body fat measurement was done using inbody composition analyser - biospacer manufactured by m / s biodex medical systems inc . \\n it measured waist hip ratio ( whr ) , body fat mass ( bfm ) , percent body fat ( pbf ) and basal metabolic rate ( bmr ) . \\n fasting blood samples were drawn for the estimation of fpg , renal and hepatic parameters , a1c , lipid profile , highly sensitive c - reactive protein ( hscrp ) and fibrinogen . \\n one aliquot of the sample was frozen at 80c for the measurement of plasma insulin , adiponectin and pai-1 . \\n adiponectin was measured with avibion human adiponectin ( acrp30 ) elisa commercial kits supplied by orgenium laboratories business unit , finland , as per manufacturer 's instructions . \\n it had an assay range of 0.18515 ng / ml and a sensitivity of < 0.3 ng / ml . intra - assay precision was 10% and inter - assay precision was 12% . \\n pai-1 was measured with human pai-1 elisa ( ea-0207 ) supplied by signosis biosignal capture ( sunnyvale , ca , usa ) , as per manufacturer 's instructions . \\n it had an assay range of 0.320 ng / ml and a sensitivity of < 0.79 ng / ml . intra - assay and inter - assay precision was 15% . the homa model was used to calculate insulin resistance and insulin insensitivity . \\n the formulae are as follows : where fi = fasting insulin in iu / ml and g = fasting glucose in mmol / l . \\n the study was approved by the ethics committee of army hospital ( research and referral ) , delhi cantt , and all subjects gave written informed consent . \\n statistical analysis was carried out using epi info 3.5.3 ( cdc ; atlanta ; usa ) . \\n if barlett 's chi - square test for equality of population variances was < 0.05 , then kruskal  wallis test was applied . \\n this study was carried out in 50 cases of ms and 24 normal healthy controls . \\n basal characteristics of the cases and controls are shown in table 1 ( also given in our previous publication ) . \\n there were 37 ( 74% ) cases with t2 dm and 13 ( 26% ) cases with impaired glucose tolerance . \\n tg total cholesterol ( tc) low density lipoprotein ( ldl) and very low density lipoprotein ( vldl ) were significantly higher and hdl was significantly lower among cases than in controls . \\n most of the cases ( 28.56% ) had four features of ms , followed by cases with all features ( 16.32% ) , and 6 ( 12% ) cases had three features of ms [ table 1 ] . \\n basic characteristics of cases and controls subjects with ms had significantly lower adiponectin levels than controls ( 4.01  2.24 vs. 8.7  1.77 g / ml ; p < 0.0001 ) [ table 1 ] . \\n there was no difference in adiponectin levels between sexes ( 5.23  3.12 vs. 5.71  2.65 g / ml ; p = 0.49 ) . \\n adiponectin levels according to the number of metabolic abnormalities in univariate regression analysis , adiponectin was negatively associated with age , bmi , bfm and pbf , and positively associated with bmr . among the various parameters of ms , \\n adiponectin was negatively associated with all parameters , except hdl - c with which it was positively associated . \\n adiponectin showed strong negative association with inflammatory markers ( crp , fibrinogen ) and procoagulant marker ( pai-1 ) . \\n adiponectin was positively associated with insulin secretion ( homa - s ) and negatively associated with insulin resistance ( homa - ir ) [ table 2 ] . \\n univariate regression analysis of adipokines among all subjects multiple regression analysis showed that among the metabolic parameters , whr , fpg and tg maintained negative association with adiponectin even after adjustment for all metabolic variables . \\n however , hdl and hypertension lost significance during multiple regression analysis [ table 3 ] . \\n only bmi remained negatively associated with adiponectin when adjusted for anthropometric parameters , e.g. bmr , bfm , and percent body fat , in multiple regression analysis [ table 4 ] . \\n bmr showed positive association when adjusted with bmi , but lost significance when bfm was added . \\n similarly , pai-1 levels showed strong negative association with adiponectin [ figure 2 ] even after adjustment with other parameters like homa - ir , crp , and fibrinogen [ table 5 ] . multivariate regression analysis of adipokines with metabolic parameters among all subjects multivariate regression analysis of adipokines with anthropometric parameters among all subjects correlation between adiponectin and pai-1 among all subjects multivariate regression analysis of adipokines with other parameters among all subjects receiver operating characteristic ( roc ) curve analysis revealed best prediction value of adiponectin at 6.7 g / ml with a sensitivity of 83% , specificity of 86% , accuracy of 85% , positive predictive value of 74% , negative predictive value of 84% and positive and negative likelihood ratios of 5.95 and 0.19 , respectively ( roc 0.934 , se 0.0277 , 95% ci = 0.8790.988 ) . subjects with ms had significantly higher pai-1 levels than controls ( 53.85  16.45 vs. 17.35  4.45 ng / ml ; p < 0.0001 ) [ table 1 ] . \\n there was no difference in pai-1 levels between sexes ( 8.59  4.42 vs. 8.21  4.44 ng / ml ; p = 0.71 ) . \\n pai-1 according to the number of metabolic abnormalities in univariate regression analysis , pai-1 was positively associated with bmi , bfm and pbf , and negatively associated with bmr . among the various parameters of ms , \\n pai-1 was positively associated with all parameters of ms , except hdl with which it was negatively associated . \\n pai-1 showed strong positive association with inflammatory markers ( crp , fibrinogen ) , insulin resistance ( fasting plasma insulin and homa - ir ) and total and ldl cholesterol , but had strong negative association with adiponectin [ table 2 ] . \\n multiple regression analysis of various metabolic parameters showed that whr and tg maintained positive association with pai-1 even after adjustment for all metabolic variables . \\n however , hdl , fpg and hypertension lost significance during multiple regression analysis [ table 3 ] . \\n only pbf remained positively associated with pai-1 when adjusted for anthropometric parameters , e.g. bmr , bfm , and bmi , in multiple regression analysis [ table 4 ] . \\n similarly , pai-1 levels showed strong positive association with fibrinogen even after adjustment with other parameters like homa - ir , crp , and fibrinogen [ table 5 ] . \\n roc curve analysis revealed best prediction value of pai-1 at 25.0 ng / ml , with a sensitivity of 92% , specificity of 96% , accuracy of 95% , positive predictive value of 92% , negative predictive value of 96% and positive and negative likelihood ratios of 22.9 and 0.08 , respectively ( roc 0.975 , se 0.0178 , 95% ci = 0.9421.009 ) . \\n subjects with ms had significantly lower adiponectin levels than controls ( 4.01  2.24 vs. 8.7  1.77 g / ml ; p < 0.0001 ) [ table 1 ] . adiponectin levels decreased with increasing number of metabolic abnormalities [ figure 1 ] . \\n there was no difference in adiponectin levels between sexes ( 5.23  3.12 vs. 5.71  2.65 g / ml ; p = 0.49 ) . \\n adiponectin levels according to the number of metabolic abnormalities in univariate regression analysis , adiponectin was negatively associated with age , bmi , bfm and pbf , and positively associated with bmr . among the various parameters of ms , \\n adiponectin was negatively associated with all parameters , except hdl - c with which it was positively associated . \\n adiponectin showed strong negative association with inflammatory markers ( crp , fibrinogen ) and procoagulant marker ( pai-1 ) . \\n adiponectin was positively associated with insulin secretion ( homa - s ) and negatively associated with insulin resistance ( homa - ir ) [ table 2 ] . \\n univariate regression analysis of adipokines among all subjects multiple regression analysis showed that among the metabolic parameters , whr , fpg and tg maintained negative association with adiponectin even after adjustment for all metabolic variables . \\n however , hdl and hypertension lost significance during multiple regression analysis [ table 3 ] . \\n only bmi remained negatively associated with adiponectin when adjusted for anthropometric parameters , e.g. bmr , bfm , and percent body fat , in multiple regression analysis [ table 4 ] . \\n bmr showed positive association when adjusted with bmi , but lost significance when bfm was added . \\n similarly , pai-1 levels showed strong negative association with adiponectin [ figure 2 ] even after adjustment with other parameters like homa - ir , crp , and fibrinogen [ table 5 ] . multivariate regression analysis of adipokines with metabolic parameters among all subjects multivariate regression analysis of adipokines with anthropometric parameters among all subjects correlation between adiponectin and pai-1 among all subjects multivariate regression analysis of adipokines with other parameters among all subjects receiver operating characteristic ( roc ) curve analysis revealed best prediction value of adiponectin at 6.7 g / ml with a sensitivity of 83% , specificity of 86% , accuracy of 85% , positive predictive value of 74% , negative predictive value of 84% and positive and negative likelihood ratios of 5.95 and 0.19 , respectively ( roc 0.934 , se 0.0277 , 95% ci = 0.8790.988 ) . \\n subjects with ms had significantly higher pai-1 levels than controls ( 53.85  16.45 vs. 17.35  4.45 ng / ml ; p < 0.0001 ) [ table 1 ] . pai-1 levels increased with increasing number of metabolic abnormalities [ figure 3 ] . \\n there was no difference in pai-1 levels between sexes ( 8.59  4.42 vs. 8.21  4.44 ng / ml ; p = 0.71 ) . \\n pai-1 according to the number of metabolic abnormalities in univariate regression analysis , pai-1 was positively associated with bmi , bfm and pbf , and negatively associated with bmr . among the various parameters of ms , \\n pai-1 was positively associated with all parameters of ms , except hdl with which it was negatively associated . \\n pai-1 showed strong positive association with inflammatory markers ( crp , fibrinogen ) , insulin resistance ( fasting plasma insulin and homa - ir ) and total and ldl cholesterol , but had strong negative association with adiponectin [ table 2 ] . \\n multiple regression analysis of various metabolic parameters showed that whr and tg maintained positive association with pai-1 even after adjustment for all metabolic variables . however , hdl , fpg and hypertension lost significance during multiple regression analysis [ table 3 ] . \\n only pbf remained positively associated with pai-1 when adjusted for anthropometric parameters , e.g. bmr , bfm , and bmi , in multiple regression analysis [ table 4 ] . \\n similarly , pai-1 levels showed strong positive association with fibrinogen even after adjustment with other parameters like homa - ir , crp , and fibrinogen [ table 5 ] . \\n roc curve analysis revealed best prediction value of pai-1 at 25.0 ng / ml , with a sensitivity of 92% , specificity of 96% , accuracy of 95% , positive predictive value of 92% , negative predictive value of 96% and positive and negative likelihood ratios of 22.9 and 0.08 , respectively ( roc 0.975 , se 0.0178 , 95% ci = 0.9421.009 ) . \\n ms is known to strongly predict long - term risk of diabetes and cvd , and has also been reported to be associated with increased morbidity and mortality . \\n it is becoming increasingly common in the united states and worldwide , and is emerging as the dominant risk factor for cvd in asia . \\n the ms represents a combination of risk determinants , which include atherogenic dyslipidemia , elevated blood pressure , elevated glucose , a prothrombotic state , and a proinflammatory state . in obese persons , \\n adipose tissue products are reported to affect systemic metabolism ; among these are adiponectin , leptin , inflammatory cytokines , pai-1 , resistin , and angiotensinogen . in this study , we evaluated 50 subjects with ms ( 25 males and 25 females ) and 24 controls ( 12 males and 12 females ) . \\n we have used here idf criteria as it provides ethnic - specific criteria for central obesity . \\n all cases had significantly higher whr , bmi bfm and pbf than controls in both the sexes , which is similar to asian indian obesity phenotype . \\n low adiponectin levels have been reported in most of the studies on ms among people of various age groups , ethnicity and gender.[14152127 ] however , one study reported higher adiponectin levels in ms and another found low adiponectin level which was statistically not significant . \\n there was negative graded response of adiponectin levels with metabolic abnormalities [ figure 1 ] . \\n adiponectin was negatively related with age , bmi , bfm and pbf , whr , fpg , hypertension , tg , tc , hscrp , fibrinogen , homa - ir and pai-1 , and positively related with bmr , hdl and homa - s in the present study . \\n similar associations have been reported in the literature.[17263135 ] however , certain differences were observed between the present study and other studies . in this study , \\n adiponectin showed no relation with fasting insulin levels , as also observed by one study from south india , whereas others have reported negative correlation . \\n we have observed negative correlation of cholesterol with adiponectin , similar to that reported by bilgili et al . but others found no relation of adiponectin with tc . \\n , did not observe any relation between adiponectin and hscrp in post - pubertal asian indian adolescents , as seen by us . \\n multiple regression analysis of the metabolic parameters showed whr , fpg and tg to have an independent negative association with adiponectin even after adjustment for all metabolic variables . \\n yang et al . , observed positive association of hdl with adiponectin in multiple regression analysis . \\n however , in our study , hdl and hypertension lost significance during multiple regression analysis . \\n ku et al . , reported correlation between serum adiponectin and bmi , triglyceride , hdl - c and fasting glucose in multiple regression analysis . in the present study , \\n only bmi remained negatively associated with adiponectin when adjusted for anthropometric parameters , e.g. bmr , bfm , and pbf , in multiple regression analysis . \\n jung et al . , showed significant negative correlation of adiponectin levels with percent body fat , lipid profile and homa - ir . \\n bmr showed positive association when adjusted with bmi , but lost significance when bfm was added . \\n similarly , pai-1 levels showed strong negative association with adiponectin even after adjustment with other parameters like homa - ir , crp , and fibrinogen . \\n bilgili et al . , also found an inverse relationship between plasma adiponectin and pai-1 ( r = 0.653 , p < 0.001 ) . \\n roc curve analysis revealed best prediction value at 6.7 g / ml , with a sensitivity of 83% , specificity of 86% , and accuracy of 85% . \\n mohan et al . , also reported similar adiponectin levels ( 5.0 g / ml for males and 6.5 g / ml for females ) in a study from south india . \\n however , studies from japan have suggested lower cut - off point ( 4 g / ml ) of serum adiponectin level for the diagnosis of ms . \\n seino et al . , also suggested that measuring adiponectin may be effective for evaluating the presence of ms in nondiabetic subjects through analysis of area under the curve of roc curves . \\n subjects with ms had significantly higher pai-1 levels than controls , which is similar to that reported in many studies in the literature.[13263945 ] however , pai-1 level was higher in the present study than that reported from other ethnic populations . \\n indian population has higher pai-1 compared to african population , which is explained by the increased frequency of pai-1 4 g allele . \\n pai-1 was positively associated with bmi , bfm and pbf , and negatively associated with bmr . among the various parameters of ms , \\n pai-1 was positively associated with all parameters of ms , except hdl with which it was negatively associated . \\n pai-1 showed a strong positive association with inflammatory markers ( hscrp , fibrinogen ) , insulin resistance ( fasting plasma insulin , homa - ir ) and total and ldl cholesterol , but had strong negative association with adiponectin . \\n tg and whr were independently associated with pai-1 even after adjustment for all metabolic variables in multiple regression analysis . \\n , also found waist circumference as the strongest independent predictor of pai-1 . however , hdl , fpg and hypertension lost significance during multiple regression analysis . \\n only pbf remained positively associated with pai-1 when adjusted for anthropometric parameters , e.g. bmr , bfm , and bmi , in multiple regression analysis . \\n similarly , pai-1 levels showed a strong positive association with fibrinogen even after adjustment with other parameters like homa - ir , crp , and adiponectin . \\n roc curve analysis revealed the best prediction value at 25.0 ng / ml , with a sensitivity of 92% , specificity of 96% , accuracy of 95% , and positive predictive value of 92% . \\n other studies have also made similar observation that pai-1 is an independent determinant of ms in multivariate logistic regression analysis . \\n surprisingly , we have found higher cut - off value for adiponectin and lower cut - off value for pai-1 for diagnosis of ms . \\n the primary limitation of the present study is its cross - sectional design and the inherent possibility that genetic and/or lifestyle factors may have influenced the results of our group comparisons . \\n however , in an effort to minimize the influence of lifestyle behaviors , we studied subjects of similar age who were non - smokers , who were not currently taking medication that could influence inflammatory and oxidative markers ( i.e. statins ) , and who did not differ in habitual physical activity . \\n in addition , we used strict inclusion criteria to eliminate the confounding effects of underlying cardiovascular and metabolic disease . \\n in the present study , subjects with ms had higher bmi , bfm and percent body fat , which is reflected in lower level of adiponectin and higher level of pai-1 . also , they had increased insulin resistance and decreased insulin secretion compared to healthy controls . \\n subjects with ms were associated with higher hscrp level , emphasizing low - grade systemic inflammatory state . \\n all these factors were interdependent and associated with other cardiovascular risk factors . although the knowledge on pathogenesis and its association with metabolic risk factors such as obesity , hypertension , and cardiovascular risk is increasing day by day , the challenge is to translate research findings into substantial clinical improvements for patients . demographic and epidemiological evidence indicates that unless an effective preventive strategy is developed , there will be a sharp increase in the global prevalence of cardiometabolic risk factors including diabetes and ms . \\n lifestyle measures have been shown to improve insulin resistance , insulin secretion and various components and effects of ms,[14951 ] and hence there is an urgent need for public health measures to prevent the ongoing epidemic of diabetes and cvd .\",\n",
       "  'output': 'background : the clustering of cardiovascular risk factors is termed the metabolic syndrome ( ms ) , which strongly predicts the risk of diabetes and cardiovascular disease ( cvd ) . \\n adipokines may contribute to the development of obesity and insulin resistance and may be a causal link between ms , diabetes and cvd . \\n hence , we studied the adipokines  adiponectin and plasminogen activator inhibitor-1 ( pai-1 )  in subjects with ms.materials and methods : we studied 50 subjects with ms diagnosed by international diabetes federation ( idf ) criteria and 24 healthy age- and sex - matched controls . \\n clinical evaluation included anthropometry , body fat analysis by bioimpedance , highly sensitive c - reactive protein , insulin , adiponectin , and pai-1 measurement.results:subjects with ms had lower adiponectin ( 4.01  2.24 vs. 8.7  1.77 g / ml ; p < 0.0001 ) and higher pai-1 ( 53.85  16.45 vs. 17.35 \\n 4.45 ng / ml ; p < 0.0001 ) levels than controls . \\n both were related with the number of metabolic abnormalities . \\n adiponectin was negatively and pai-1 was positively associated with body mass index , waist hip ratio ( whr ) , body fat mass , percent body fat , and all the parameters of ms , except hdl where the pattern reversed . \\n whr and triglycerides were independent predictors of adipokines in multiple regression analysis . \\n receiver operating characteristic curve analysis showed that adiponectin ( 6.7 g / ml ) and pai-1 ( 25.0 ng / ml ) levels predicted the ms with high sensitivity , specificity and accuracy in indian population.conclusions:subjects with ms have lower adiponectin and higher pai-1 levels compared to healthy controls . \\n lifestyle measures have been shown to improve the various components of ms , and hence there is an urgent need for public health measures to prevent the ongoing epidemic of diabetes and cvd .',\n",
       "  '__index_level_0__': 31679,\n",
       "  'model_output': 'Summary of the article: \"adiponectin and plasminogen activator inhibitor-1 levels in metabolic syndrome: a case-control study\".'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Condense the given article into a clear and concise abstract that represents its core content.',\n",
       "  'input': \"Summarize the following article: therefore , the clinical difference in myocardial infarction ( mi ) between men and women could affect the diagnosis and time of decision making for treatment and hence disease outcomes . \\n knowledge of clinical symptoms and risk factors contribute to the prognosis of mi mortality in men and women differently . \\n documentation of these findings could be helpful in the management of patients treatment and/or outcomes . \\n accumulating evidence over the last several decades regarding the treatment and outcomes for coronary artery disease reveals disparities that have a clear relationship to gender and the number of people above 85 years of age is growing faster than any other age group . \\n gender differences in the clinical outcome of patients with mi may be partially explained by the women condition . \\n several conditions specific to women represent differences in the pathophysiology of coronary heart disease ( chd ) between men and women . \\n such female - specific conditions include early menopause , gestational diabetes , peripartum vascular dissection , preeclampsia and eclampsia , polycystic ovarian syndrome , low - birth - weight infants , and hypothalamic hypoestrogenemia . \\n some of these states , which occur at a younger age , lead to an increased risk for later development of chd in life . \\n the main source of estrogen before menopause is estradiol . after menopause , low level of estrogen is produced mainly from the conversion of androgens into estrone in adipose tissue . \\n these variations could be associated with the differences in ischemic and chd between men and women and are concurrent with the increased risk in women , which occurs after menopause . \\n it is confirmed by the fact that younger women with endogenous estrogen deficiency have a higher than 7-fold increase in coronary artery risk . \\n a number of studies have reported that women with mi have higher mortality rates than men . \\n however , the women with mi history have higher rates of mortality during hospitalization or the first 30 days after mi . epidemiology of mi has been well - explained and gradually updated in the developed countries . this epidemic has been reported from some asian countries , as well . \\n the prevalence of cardiovascular disease risk factors including hypertension , type 2 diabetes , smoking , and high cholesterol as well as access to therapies including percutaneous coronary intervention ( pci ) , coronary artery bypass graft ( cabg ) , and thrombolytic therapy in the patients in iran were reported differently from those in the patients in persian gulf countries . \\n for example , the prevalence of hypertension , diabetes , and high cholesterol in study of acute coronary syndrome in six arab countries ( kuwait , bahrain , the uae , yemen , oman , and qatar ) was reported as 68% , 36% , and 63% , respectively . clinical epidemiology of mi in men and women has not been yet studied in iran , one of the largest countries in middle east , and no relevant report is available . \\n this study was to determine the clinical epidemiology of mi in men and women in iran . \\n this research is a hospital - based cross - sectional study , which used the data of 20,750 mi patients in iran in 2012 . \\n the study enrolled the patients registered in iranian mi registry of iran health and medical education ministry ( department of cardiovascular disease prevention ) commissioned in the hospitals equipped with a cardiology ward across 31 provinces of iran using the date at arrival in and discharge from the hospital . \\n inclusion criteria were defined based on international classification of diseases ( the codes i22 , i21 , i24 , and i25.2 ) . \\n echocardiography ( ecg ) is used to differentiate between two types of mi , st - segment elevation mi ( stemi ) and nonstemi , by the shape of the tracing . \\n an st section of the tracing higher than the baseline is considered stemi which usually necessitates more invasive treatment . in stemi \\n , the ecg must show new st elevation in two or more adjacent ecg leads . \\n left bundle branch block ( lbbb ) and right bundle branch block were defined in accordance with recently published criteria with the exception that , for lbbb , q waves in ecg leads i , v5 , and v6 were included . \\n lbbb criteria included qrs duration of 120 ms ; rs or qs deflection in ecg leads v1 and v2 ; and slurred broad r waves in ecg leads i , avl and v6 . \\n an r wave amplitude of 1 mm in lead v1 was determined as a readily measurable standard . \\n the patients with no definite diagnosis of mi by the cardiologist were excluded from the study . \\n the demographic data of the patients including age , gender , education , place of residence , and individual , clinical , and laboratory risk factors such as the date at mi incidence , duration of hospitalization , type 2 diabetes , hypertension , smoking , dyslipidemia , type of diagnosis , treatment , the place of mi , and pain pattern were gathered . \\n the above variables were measured based on national protocol and guidelines , and world health organization ( who ) standards and registered by the cardiologist and matron of the cardiology ward in electronic medical records of the patients . \\n the registry 's data accuracy is acceptable , and several articles using these data have been so far published in authentic journals which have been referenced to in references . \\n iran 's mi registry was developed in 1389 h.s and has been being implemented in all coronary care unit ( ccu)-equipped hospitals affiliated to medical universities in iran . by this registry , \\n the data of in - patients in ccu with confirmed mi diagnosis are recorded and saved in the respected software at discharge from ccu and could be used by cardiology department of iran 's ministry of health and medical education . \\n all hospitals affiliated to medical universities and some nonaffiliated ( social insurance , humanitarian , private , and military ) hospitals have run this registry in ccus from which the data used in this study were obtained . \\n the access to these data was provided by an official permission within a letter of understanding to conduct a phd thesis of epidemiology . \\n all continuous values are expressed as mean  standard deviation ( sd ) and categorical variables are presented as a percentage . \\n univariate comparisons used chi - square tests for categorical variables and t - test for continuous variables . \\n the software used for data analysis was stata statistical software : release 12 statistical software statacorp lp , college station , tx , usa . p < 0.05 was considered as significant . \\n this research is a hospital - based cross - sectional study , which used the data of 20,750 mi patients in iran in 2012 . \\n the study enrolled the patients registered in iranian mi registry of iran health and medical education ministry ( department of cardiovascular disease prevention ) commissioned in the hospitals equipped with a cardiology ward across 31 provinces of iran using the date at arrival in and discharge from the hospital . \\n inclusion criteria were defined based on international classification of diseases ( the codes i22 , i21 , i24 , and i25.2 ) . \\n echocardiography ( ecg ) is used to differentiate between two types of mi , st - segment elevation mi ( stemi ) and nonstemi , by the shape of the tracing . \\n an st section of the tracing higher than the baseline is considered stemi which usually necessitates more invasive treatment . in stemi \\n , the ecg must show new st elevation in two or more adjacent ecg leads . \\n left bundle branch block ( lbbb ) and right bundle branch block were defined in accordance with recently published criteria with the exception that , for lbbb , q waves in ecg leads i , v5 , and v6 were included . \\n lbbb criteria included qrs duration of 120 ms ; rs or qs deflection in ecg leads v1 and v2 ; and slurred broad r waves in ecg leads i , avl and v6 . \\n an r wave amplitude of 1 mm in lead v1 was determined as a readily measurable standard . \\n the patients with no definite diagnosis of mi by the cardiologist were excluded from the study . \\n the demographic data of the patients including age , gender , education , place of residence , and individual , clinical , and laboratory risk factors such as the date at mi incidence , duration of hospitalization , type 2 diabetes , hypertension , smoking , dyslipidemia , type of diagnosis , treatment , the place of mi , and pain pattern were gathered . \\n the above variables were measured based on national protocol and guidelines , and world health organization ( who ) standards and registered by the cardiologist and matron of the cardiology ward in electronic medical records of the patients . \\n the registry 's data accuracy is acceptable , and several articles using these data have been so far published in authentic journals which have been referenced to in references . \\n iran 's mi registry was developed in 1389 h.s and has been being implemented in all coronary care unit ( ccu)-equipped hospitals affiliated to medical universities in iran . by this registry , \\n the data of in - patients in ccu with confirmed mi diagnosis are recorded and saved in the respected software at discharge from ccu and could be used by cardiology department of iran 's ministry of health and medical education . \\n all hospitals affiliated to medical universities and some nonaffiliated ( social insurance , humanitarian , private , and military ) hospitals have run this registry in ccus from which the data used in this study were obtained . \\n the access to these data was provided by an official permission within a letter of understanding to conduct a phd thesis of epidemiology . \\n all continuous values are expressed as mean  standard deviation ( sd ) and categorical variables are presented as a percentage . \\n univariate comparisons used chi - square tests for categorical variables and t - test for continuous variables . \\n the software used for data analysis was stata statistical software : release 12 statistical software statacorp lp , college station , tx , usa . p < 0.05 was considered as significant . \\n in this study , 20750 patients ( 15,033 males and 5,717 females ) with age range of 13106 ( mean : 61.2  13.4 ) years were enrolled . \\n mean  sd of age was 59.6  13.3 years in men and 65.4  12.6 in women . \\n mean age at mi incidence in men was lower than women with a significant difference ( p = 0.001 ) . by who definition \\n since the number of patients under 18 years ( nine individuals ) , as adolescent subgroup , was negligible , all patients were enrolled and studied . however , as the respectful reviewer suggested , two independent analyses were run with inclusion and exclusion of these patients . \\n then , two independent analyses were run with inclusion and exclusion of the patients under 30 years . \\n therefore , as the data were gathered from patients in all provinces across iran and the total sample size depicts mi epidemiology more soundly ; all patients were included in the analysis . the analysis results of under 18-year - old patients data have been reported , as well . only 9 ( 0.04% ) patients ( 8 men and 1 woman ) were 18 years ( mean age : 14.8  1.9 ) , of whom two men were diabetic . \\n age and risk factors of coronary artery disease in individuals with acute mi are shown in table 1 . \\n 22.2% ( 18% men and 33.4% women ) of the patients had diabetes , 26.2% ( 28.5% men and 20.1% women ) were smoker , 35.5% ( 28.6% men and 53.7% women ) had hypertension , and 17.8% ( 15%% men and 25.3% women ) had hypercholesterolemia . in - \\n age and risk factors in mi patients in - hospital status and complications of acute mi \\n in this study , epidemiologic status of mi incidence in men and women was reported for the first time in iran through a hospital - based study . \\n the findings of the present study indicated that the mi incidence pattern , mortality from mi , and risk factors prevalence were significantly different between men and women in iran . in kuwait , 87% of mi patients were male , and the mean age was reported to be 55 years , which is lower than in our study . according to registries of acute coronary events in 65 hospitals in six arab countries ( yemen , oman , bahrain , kuwait , qatar , and united arab emirates ) , \\n our study indicates that the mean age at incidence is higher in the islamic republic of iran than in these arab countries ( except for yemen with a mean age at incidence of 61 years ) . \\n the difference in mean age across different studies could be attributed to different population age distributions , differences in life expectancies and lifestyles and variations in the distribution of and coping with cardiovascular diseases risk factors . \\n there was a significant difference in chest pain between men and women . however , some studies reported no difference in this regard and some others reported a higher prevalence of chest pain in women than men . \\n our findings indicated that different factors , including chest pain , could be used as a prognosis for mi , and hence patients delayed referring to emergency centers and mortality could be partially prevented . in a similar study , \\n 73% of the patients were male , and their mean age was 61.8 years , which is similar to our study . \\n history of cabg , pci , and diabetes was reported , respectively , 4.4% , 12.5% , and 25.3% , which are higher compared to our study . in a study in india , mean age of the patients was reported 57.5 years , which is lower compared to iran . in india , 30.4% of the patients had type 2 diabetes , 37.7% had hypertension , and 40% were smoker ; the corresponding figures in our study are , respectively , 22.2 , 35.5 , and 26.2% . \\n in korea , 19.2% of mi patients had diabetes , 67.3% were smoker , and 61.2% had stemi . in our study , \\n furthermore , the prevalence of type 2 diabetes and other risk factors including hypertension and smoking in mi patients was lower in iran than in india . \\n the prevalence of type 2 diabetes in mi patients was higher in iran than in korea , and lower than in japan . in this study , men / \\n women frequency was 2.62 . in the framingham study , this ratio was 10:1 in - patients under 45 years old , declining progressively to approximately 2:1 in - patients over 75 years old . \\n finally , approximately 11.6% and 6.5% of men and women , respectively , in our study had a family history of early coronary artery disease , with a significant difference . \\n our results indicated that the familial history of early coronary artery disease was an important cardiovascular risk factor in both male and female patients . \\n our findings are consistent with several studies in other countries . however , in some studies , the prevalence of hypertension and diabetes was similar in male and female patients , which is not consistent with our study . \\n in contrast , smoking and family history of cardiovascular disease were reported higher in men than women . \\n the findings of this study confirm the higher relative risk of hypercholesterolemia , diabetes , and hypertension and mi development in women . \\n the mi incidence pattern , mortality from mi , and risk factors prevalence are significantly different between men and women in iran . \\n more emphasis on these issues in training people and healthcare professionals seems to contribute partially to patients timely referring to health care centers and preventing mi - associated mortalities . \\n the key message of the present study addresses the difference in mi incidence pattern and risk factors between men and women in iran . \\n therefore , the approach to managing , preventing , and controlling mi as the leading cause of death in iran must be different for men and women . informing patients appropriate with their risk factors and preventing delayed referral to emergency in case of mi prognosis is the first step to incorporate the findings of this study into health system . \\n further empowerment of health system staff in dealing with and triaging mi patients and adoption of appropriate care and treatment with male and female patients characteristics could be the second step .\",\n",
       "  'output': 'background : cardiovascular disease is the main reason for mortality in men and women \\n . clinical epidemiology of myocardial infarction ( mi ) in men and women has not been yet studied in iran , one of the largest middle east countries in south - western asia . \\n this study was conducted to determine the clinical epidemiology of mi in men and women in iran.methods:this hospital - based , cross - sectional study used the data of 20,750 mi patients in iran in 2012 ( the codes i22 , i21 , i24 , and i25.2 ) . \\n univariate comparisons used chi - square test for categorical variables and t - test for continuous variables . \\n p < 0.05 was considered as significant.results:totally , 20,750 mi patients ( 15,033 men and 5,717 women ) with age range of 13106 ( mean ; 61.2  13.4 ) years were enrolled . only 9 ( 0.04% ) patients ( 8 men and 1 woman ) were 18 years ( mean age \\n : 14.8  1.9 ) , out of whom only two men were diabetic . \\n 22.2% ( 18% men and 33.4% women ) of the patients had diabetes , 26.2% ( 28.5% men and 20.1% women ) were smoker and 35.5% ( 28.6% men and 53.7% women ) had hypertension . \\n st - segment elevation mi incidence was 2.8 times higher in men than women . left bundle branch block was significantly more prevalent in men than women . \\n men used percutaneous coronary intervention more frequently than women did . \\n no difference in coronary artery bypass graft was noted between men and women . \\n mortality incidence was approximately twice higher in men than women . \\n the prevalence of chest pain was higher in women than men.conclusions:the mi incidence pattern , mortality from mi , and risk factors prevalence are significantly different between men and women in iran . \\n more emphasis on these issues in training people and healthcare professionals seems to contribute partially to patients timely referring to health care centers and preventing mi - associated mortalities .',\n",
       "  '__index_level_0__': 31680,\n",
       "  'model_output': \"condense the following article into a clear and concise abstract that represents its core content: therefore, the clinical difference in myocardial infarction ( mi ) between men and women could affect the diagnosis and time of decision making for treatment and hence disease outcomes. \\n knowledge of clinical symptoms and risk factors contribute to the prognosis of mi mortality in men and women differently. \\n documentation of these findings could be helpful in the management of patients treatment and/or outcomes. \\n accumulating evidence over the last several decades regarding the treatment and outcomes for coronary artery disease reveals disparities that have a clear relationship to gender and the number of people above 85 years of age is growing faster than any other age group. \\n gender differences in the clinical outcome of patients with mi may be partially explained by the women condition. \\n several conditions specific to women represent differences in the pathophysiology of coronary heart disease ( chd ) between men and women. \\n such female - specific conditions include early menopause, gestational diabetes, peripartum vascular dissection, preeclampsia and eclampsia, polycystic ovarian syndrome, low - birth - weight infants, and hypothalamic hypoestrogenemia. \\n some of these states, which occur at a younger age, lead to an increased risk for later development of chd in life. \\n the main source of estrogen before menopause is estradiol. after menopause, low level of estrogen is produced mainly from the conversion of androgens into estrone in adipose tissue. \\n these variations could be associated with the differences in ischemic and chd between men and women and are concurrent with the increased risk in women, which occurs after menopause. \\n it is confirmed by the fact that younger women with endogenous estrogen deficiency have a higher than 7-fold increase in coronary artery risk. \\n a number of studies have reported that women with mi have higher mortality rates than men. \\n however, the women with mi history have higher rates of mortality during hospitalization or the first 30 days after mi. epidemiology of mi has been well - explained and gradually updated in the developed countries. this epidemic has been reported from some asian countries, as well. \\n the prevalence of cardiovascular disease risk factors including hypertension, type 2 diabetes, smoking, and high cholesterol as well as access to therapies including percutaneous coronary intervention ( pci ), coronary artery bypass graft ( cabg ), and thrombolytic therapy in the patients in iran were reported differently from those in the patients in persian gulf countries. \\n for example, the prevalence of hypertension, diabetes, and high cholesterol in study of acute coronary syndrome in six arab countries ( kuwait, bahrain, the uae, yemen, oman, and qatar ) was reported as 68%, 36%, and 63%, respectively. clinical epidemiology of mi in men and women has not been yet studied in iran, one of the largest countries in middle east, and no relevant report is available. \\n this study was to determine the clinical epidemiology of mi in men and women in iran. \\n this research is a hospital - based cross - sectional study, which used the data of 20,750 mi patients in iran in 2012. \\n the study enrolled the patients registered in iranian mi registry of iran health and medical education ministry ( department of cardiovascular disease prevention ) commissioned in the hospitals equipped with a cardiology ward across 31 provinces of iran using the date at arrival in and discharge from the hospital. \\n inclusion criteria were defined based on international classification of diseases ( the codes i22, i21, i24, and i25.2 ). \\n echocardiography ( ecg ) is used to differentiate between two types of mi, st - segment elevation mi ( stemi ) and nonstemi, by the shape of the tracing. \\n an st section of the tracing higher than the baseline is considered stemi which usually necessitates more invasive treatment. in stemi \\n, the ecg must show new st elevation in two or more adjacent ecg leads. \\n left bundle branch block ( lbbb ) and right bundle branch block were defined in accordance with recently published criteria with the exception that, for lbbb, q waves in ecg leads i, v5, and v6 were included. \\n lbbb criteria included qrs duration of 120 ms ; rs or qs deflection in ecg leads v1 and v2 ; and slurred broad r waves in ecg leads i, avl and v6. \\n an r wave amplitude of 1 mm in lead v1 was determined as a readily measurable standard. \\n the patients with no definite diagnosis of mi by the cardiologist were excluded from the study. \\n the demographic data of the patients including age, gender, education, place of residence, and individual, clinical, and laboratory risk factors such as the date at mi incidence, duration of hospitalization, type 2 diabetes, hypertension, smoking, dyslipidemia, type of diagnosis, treatment, the place of mi, and pain pattern were gathered. \\n the above variables were measured based on national protocol and guidelines, and world health organization ( who ) standards and registered by the cardiologist and matron of the cardiology ward in electronic medical records of the patients. \\n the registry's data accuracy is acceptable, and several articles using these data have been so far published in authentic journals which have been referenced to in references. \\n iran's mi registry was developed in 1389 h.s and has been being implemented in all coronary care unit ( ccu)-equipped hospitals affiliated to medical universities in iran. by this registry, \\n the data of in - patients in ccu with confirmed mi diagnosis are recorded and saved in the respected software at discharge from ccu and could be used by cardiology department of iran's ministry of health and medical education. \\n all hospitals affiliated to medical universities and some nonaffiliated ( social insurance, humanitarian, private, and military ) hospitals have run this registry in ccus from which the data used in this study were obtained. \\n the access to these data was provided by an official permission within a letter of understanding to conduct a phd thesis of epidemiology. \\n all continuous values are expressed as mean  standard deviation ( sd ) and categorical variables are presented as a percentage. \\n univariate comparisons used chi - square tests for categorical variables and t - test for continuous variables. \\n the software used for data analysis was stata statistical software : release 12 statistical software statacorp lp, college station, tx, usa. p < 0.05 was considered as significant. \\n this research is a hospital - based cross - sectional study, which used the data of 20,750 mi patients in iran in 2012. \\n the study enrolled the patients registered in iranian mi registry of iran health and medical education ministry ( department of cardiovascular disease prevention ) commissioned in the hospitals equipped with a cardiology ward across 31 provinces of iran using the date at arrival in and discharge from the hospital. \\n inclusion criteria were defined based on international classification of diseases ( the codes i22, i21, i24, and i25.2 ). \\n echocardiography ( ecg ) is used to differentiate between two types of mi, st - segment elevation mi ( stemi ) and nonstemi, by the shape of the tracing. \\n an st section of the tracing higher than the baseline is considered stemi which usually necessitates more invasive treatment. in stemi \\n, the ecg must show new st elevation in two or more adjacent ecg leads. \\n left bundle branch block ( lbbb ) and right bundle branch block were defined in accordance with recently published criteria with the exception that, for lbbb, q waves in ecg leads i, v5, and v6 were included. \\n lbbb criteria included qrs duration of 120 ms ; rs or qs deflection in ecg leads v1 and v2 ; and slurred broad r waves in ecg leads i, avl and v6. \\n an r wave amplitude of 1 mm in lead v1 was determined as a readily measurable standard. \\n the patients with no definite diagnosis of mi by the cardiologist were excluded from the study. \\n the demographic data of the patients including age, gender, education, place of residence, and individual, clinical, and laboratory risk factors such as the date at mi incidence, duration of hospitalization, type 2 diabetes, hypertension, smoking, dyslipidemia, type of diagnosis, treatment, the place of mi, and pain pattern were gathered. \\n the above variables were measured based on national protocol and guidelines, and world health organization ( who ) standards and registered by the cardiologist and matron of the cardiology ward in electronic medical records of the patients. \\n the registry's data accuracy is acceptable, and several articles using these data have been so far published in authentic journals which have been referenced to in references. \\n iran's mi registry was developed in 1389 h.s and has been being implemented in all coronary care unit ( ccu)-equipped hospitals affiliated to medical universities in iran. by this registry, \\n the data of in - patients in ccu with confirmed mi diagnosis are recorded and saved in the respected software at discharge from ccu and could be used by cardiology department of iran's ministry of health and medical education. \\n all hospitals affiliated to medical universities and some nonaffiliated ( social insurance, humanitarian, private, and military ) hospitals have run this registry in ccus from which the data used in this study were obtained. \\n the access to these data was provided by an official permission within a letter of understanding to conduct a phd thesis of epidemiology. \\n all continuous values are expressed as mean  standard deviation ( sd ) and categorical variables are presented as a percentage. \\n univariate comparisons used chi - square tests for categorical variables and t - test for continuous variables. \\n the software used for data analysis was stata statistical software : release 12 statistical software statacorp lp, college station, tx, usa. p < 0.05 was considered as significant. \\n in this study, 20750 patients ( 15,033 males and 5,717 females ) with age range of 13106 ( mean : 61.2  13.4 ) years were enrolled. \\n mean  sd of age was 59.6  13.3 years in men and 65.4  12.6 in women. \\n mean age at mi incidence in men was lower than women with a significant difference ( p = 0.001 ). by who definition \\n since the number of patients under 18 years ( nine individuals ), as adolescent subgroup, was negligible, all patients were enrolled and studied. however, as the respectful reviewer suggested, two independent analyses were run with inclusion and exclusion of these patients. \\n then, two independent analyses were run with inclusion and exclusion of the patients under 30 years. \\n therefore, as the data were gathered from patients in all provinces across iran and the total sample size depicts mi epidemiology more soundly ; all patients were included in the analysis. the analysis results of under 18-year - old patients data have been reported, as well. only 9 ( 0.04% ) patients ( 8 men and 1 woman ) were 18 years ( mean age : 14.8  1.9 ), of whom two men were diabetic. \\n age and risk factors of coronary artery disease in individuals with acute mi are shown in table 1. \\n 22.2% ( 18% men and 33.4% women ) of the patients had diabetes, 26.2% ( 28.5% men and 20.1% women ) were smoker, 35.5% ( 28.6% men and 53.7% women ) had hypertension, and 17.8% ( 15%% men and 25.3% women ) had hypercholesterolemia. in - \\n age and risk factors in mi patients in - hospital status and complications of acute mi \\n in this study, epidemiologic status of mi incidence in men and women was reported for the first time in iran through a hospital - based study. \\n the findings of the present study indicated that the mi incidence pattern, mortality from mi, and risk factors prevalence were significantly different between men and women in iran. in kuwait, 87% of mi patients were male, and the mean age was reported to be 55 years, which is lower than in our study. according to registries of acute coronary events in 65 hospitals in six arab countries ( yemen, oman, bahrain, kuwait, qatar, and united arab emirates ), \\n our study indicates that the mean age at incidence is higher in the islamic republic of iran than in these arab countries ( except for yemen with a mean age at incidence of 61 years ). \\n the difference in mean age across different studies could be attributed to different population age distributions, differences in life expectancies and lifestyles and variations in the distribution of and coping with cardiovascular diseases risk factors. \\n there was a significant difference in chest pain between men and women. however, some studies reported no difference in this regard and some others reported a higher prevalence of chest pain in women than men. \\n our findings indicated that different factors, including chest pain, could be used as a prognosis for mi, and hence patients delayed referring to emergency centers and mortality could be partially prevented. in a similar study, \\n 73% of the patients were male, and their mean age was 61.8 years, which is similar to our study. \\n history of cabg, pci, and diabetes was reported, respectively, 4.4%, 12.5%, and 25.3%, which are higher compared to our study. in a study in india, mean age of the patients was reported 57.5 years, which is lower compared to iran. in india, 30.4% of the patients had type 2 diabetes, 37.7% had hypertension, and 40% were smoker ; the corresponding figures in our study are, respectively, 22.2, 35.5, and 26.2%. \\n in korea, 19.2% of mi patients had diabetes, 67.3% were smoker, and 61.2% had stemi. in our study, \\n furthermore, the prevalence of type 2 diabetes and other risk factors including hypertension and smoking in mi patients was lower in iran than in india. \\n the prevalence of type 2 diabetes in mi patients was higher in iran than in korea, and lower than in japan. in this study, men / \\n women frequency was 2.62. in the framingham study, this ratio was 10:1 in - patients under 45 years old, declining progressively to approximately 2:1 in - patients over 75 years old. \\n finally, approximately 11.6% and 6.5% of men and women, respectively, in our study had a family history of early coronary artery disease, with a significant difference. \\n our results indicated that the familial history of early coronary artery disease was an important cardiovascular risk factor in both male and female patients. \\n our findings are consistent with several studies in other countries. however, in some studies, the prevalence of hypertension and diabetes was similar in male and female patients, which is not consistent with our study. \\n in contrast, smoking and family history of cardiovascular disease were reported higher in men than women. \\n the findings of this study confirm the higher relative risk of hypercholesterolemia, diabetes, and hypertension and mi development in women. \\n the mi incidence pattern, mortality from mi, and risk factors prevalence are significantly different between men and women in iran. \\n more emphasis on these issues in training people and healthcare professionals seems to contribute partially to patients timely referring to health care centers and preventing mi - associated mortalities. \\n the key message of the present study addresses the difference in mi incidence pattern and risk factors between men and women in iran. \\n therefore, the approach to managing, preventing, and controlling mi as the leading cause of death in iran must be different for men and women. informing patients appropriate with their risk factors and preventing delayed referral to emergency in case of mi prognosis is the first step to incorporate the findings of this study into health system. \\n further empowerment of health system staff in dealing with and triaging mi patients and adoption of appropriate care and treatment with male and female patients characteristics could be the second step.\"},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Summarize the given article into a concise abstract that highlights the key findings and conclusions.',\n",
       "  'input': 'Summarize the following article: the pathogenesis of gmd in pd patients is related to factors such as weight gain and insulin resistance evoked by peritoneal glucose load [ 13 ] . \\n the periodical evaluation of pd patients for gmd is of clinical relevance and should be an element of the surveillance protocol . \\n the  gold standard  method used for the diagnosis of gmd defined by the world health organization ( who ) in 1998 uses the level of 2-h post - challenge plasma glucose ( 2-hpg ) in the oral glucose tolerance test ( 75-g ogtt ) . \\n criteria for the diagnosis are the following : fasting plasma glucose ( fpg ) 100  mg / dl ( 5.6  mmol / l ) to 125  mg / dl ( 6.9  mmol / l ) ( impaired fasting glucose , ifg ) ; 2-h pg in the 75-g ogtt 140  mg / dl ( 7.8  mmol / l ) to 199  mg / dl ( 11.0  mmol / l ) ( impaired glucose tolerance , igt ) ; 2-h pg in the 75-g ogtt or random 200  mg / dl ( 11.1  mmol / l ) ( dm ) . the utility of the recently recommended use of hba1c in terms of diabetes diagnosis ( diagnostic threshold of 6.5  % ) still remains to be validated . \\n the population at a particular risk of glucose metabolism disorders includes renal transplant recipients , pregnant women , and patients treated with peritoneal dialysis . for each of these groups \\n , there is a lack of clear guidelines for the detection and diagnosis of gmd . \\n therefore , alternative methods for detecting all glucose metabolism disorders ( ifg , igt , and dm ) in the population of high risk of hyperglycemia have been investigated . \\n the issue of glucose metabolism disorders ( gmd ) in pd patients has regained interest in recent years . \\n this increase in clinical relevance was caused by new evidence that even mild hyperglycemia in the dialysis period can be harmful in the long term , being associated with worse survival and elevated risk of post - transplant diabetes mellitus [ 68 ] . \\n treatment with peritoneal dialysis is inherently associated with an additional load of glucose adsorbed from dialysis fluid . \\n the effect of glucose deriving from the peritoneal cavity on the incidence of glucose intolerance still evokes some ambiguity , and published data are equivocal [ 13 , 911 ] . \\n the recent data suggest that high glucose exposure from dialysis solution may be a risk factor for vascular calcification in non - diabetic pd patients . \\n there seem to be some analogies between the occurrence of de novo gmd in patients treated with pd and gestational diabetes ( gdm ) , in which a combination of increased maternal adiposity and naturally occurring human placental hormones produces insulin resistance [ 13 , 14 ] . in both cases , \\n gestational diabetes mellitus is defined as  any degree of glucose intolerance with onset or first recognition during pregnancy  . \\n the mechanisms that lead to chronic insulin resistance in gdm are varied as they are in the general population . \\n up to 2012 gdm was diagnosed by a two - step approach using a sequential model of universal screening with a 1-h 50-g glucose challenge test ( 50-g gct ) followed by a diagnostic 75-g oral glucose tolerance test ( 75-g ogtt ) for women with a positive screening test [ threshold value 140  mg / dl ( 7.8  mmol / l ) ] . \\n the gdm was recognized in 75-g ogtt when the plasma glucose value was 140  mg / dl . \\n ada recommendations for 2011 adopted new , stricter criteria for the diagnosis of gestational diabetes and confirmed them for 2012 . according to the current recommendations for all pregnant women between 24 and 28  weeks of pregnancy , \\n gestational diabetes is diagnosed if the fasting plasma glucose is at least 92  mg / dl ( 5.1  mmol / l ) , after 1  h 180  mg / dl ( 10.0  mmol / l ) , and after 2  h 153  mg / dl ( 8.5  mmol / l ) . \\n these criteria were based on the results of the hapo study   and recommendations of the research group of the international association of the diabetes and pregnancy study groups ( iadpsg ) . \\n there is also a critical discussion concerning the methods and criteria for the new ada 2012 diagnosis of gestational diabetes [ 2023 ] . currently , there are no clear recommendations for diagnosis and classification of glucose disturbances occurring de novo in a population of patients on pd . in our opinion , \\n the who  gold standard  is not appropriate for pd patients because gmd differ from those in the general population , and other screening strategies should be explored . \\n considering the mentioned similarities , we aimed to examine the utility of the oral glucose tolerance screening test ( 50-g gct ) for pd patients , which is used in a two - step approach to evaluate gestational diabetes . the first step \\n the 50-g gct  is performed at any time of the day ( the fasting state is not required ) , using 50  g of glucose , and the plasma glucose was measured at 1  h after administration . \\n in the current study , we aimed to evaluate the applicability of the 50-g gct for the detection of gmd in non - diabetic continuous ambulatory pd patients with normal fasting glucose levels . \\n the study was performed in 20 prevalent patients without history of diabetes before pd treatment onset who had been on a pd program at our institution as their first dialysis modality . \\n the median age of patients was 44.19  years [ interquartile range ( iqr ) 34.1556.25 ] , 9 being males and 11 being females , all caucasian with cause of end - stage renal disease ( esrd ) being glomerular disease in 12 patients ( 60  % ) , hypertensive nephropathy in four patients ( 20  % ) , interstitial nephropathy in three patients ( 15  % ) , and polycystic kidney disease in one patient ( 5  % ) . \\n the median duration of pd treatment before inclusion in the study was 15.34  months ( iqr 10.821.34 ) . \\n patients were assessed at the study onset ( on the day of the 50-g gct ) and at the end of pd treatment ( 13 patients ) or at end of the observation period ( december 2012 ) for continuing the pd program ( seven patients ) . at the study onset \\n , all patients underwent 50-g gct with a glucose dose of 50  g. the test is performed at any time of the day ( the fasting state is not required ) , using 50  g of glucose , and the glucose is measured at 1  h after the administration . \\n interpretation of our 50-g gct results was as follows : glucose < 140  mg / dl  normal value ; 140199  mg / dl  impaired glucose tolerance ( igt ) , 200  mg / dl  diabetes . \\n in case of a fasting glucose value 100125 \\n mg / dl , and normal value in 50-g gct  impaired fasting glucose ( ifg ) was diagnosed . \\n the 50-g gct was performed in patients with an empty abdomen after the night dwell draining . during the night , all patients used 1.36  % glucose containing dialysis solution . \\n the glucose was measured at 1  h after administration ; the fasting state was not required . \\n in addition , the following parameters of glucose metabolism were measured : c - peptide , fasting insulin serum concentration , and the glycated hemoglobin level ( hba1c ) . \\n the concentrations of c - peptide and insulin were evaluated in serum samples , and hba1c in whole blood using a chemiluminescent microparticle immunoassay ( cmia ) on the architect system ( abbott , usa ) . \\n based on fasting insulin and glucose values , insulin resistance ( ir ) was determined according to the homeostasis model assessment insulin resistance ( homa - ir ) . \\n they encompassed blood pressure ( bp ) , serum albumin , lipid profiles , hb , crp , liver tests , mean daily peritoneal glucose load , ultrafiltration volume , residual diuresis , weekly dialytic creatinine clearance ( ccr ) , weekly dialytic kt / v , and other laboratory parameters ( uric acid , pth , tsh , fe , tsat , and electrolytes ) . \\n systolic and diastolic bp , residual gfr , weekly dialytic ccr , and kt / v were measured by standard methods . \\n the estimated peritoneal glucose load was calculated by the product of the volume and the glucose concentration of each exchange . \\n the glucose load did not differ between the patients and was similar in all study patients during the follow - up . \\n the patients were prospectively followed for a median time of 25.8  months ( iqr 18.9933.57 ) , and 50-g gct was repeated at the end of the observation period . the statistical analysis was performed with r for windows , version 2.15.1 , and medcalc for windows , version 12.3.1.0 . \\n clinical characteristics at the study onset are shown in table  1.table  1clinical characteristics at the study onsetvariable \\n n \\n medianiqr ( interquartile range)fasting glucose level ( mg / dl)2091.583.596glucose level1  h after gct ( mg / dl)20165137.5195hba1c ( % ) 205.55.45.7c - peptide ( ng / ml)207.245.1210.95fasting insulin serum concentration ( u / ml)2010.347.7916.05homa - ir202.131.573.53systolic bp ( mmhg)20135120155.5diastolic bp ( mmhg)2087.58090serum albumin ( g / dl)203.83.653.95total cholesterol ( mg / dl)20196179231hdl cholesterol ( mg / dl)20433852ldl cholesterol ( mg / dl)20128.5105.5143triglycerides ( mg / dl)20164.5130226.5hb ( g / dl)2010.610.111.85crp ( mg / l)202.091.116.69aspat ( iu / l)2017.51421alat ( iu / l)20171225uric acid ( mg / dl)206.35.557.3pth20817490.51,221.5tsh202.191.054.11fe207451.588tsat ( % ) 2025.41933.9ca ( mmol / l)2098.259.2p ( mg / dl)206.44.857.25mean daily peritoneal glucose load ( g/24  h)20120120120ultrafiltration volume ( ml/24  h)201,3007251,500residual diuresis ( ml/24  h)201,1505001,500weekly dialytic ccr200.690.620.75weekly dialytic kt / v202.192.112.7bmi  total ( kg / m)2025.1423.8327.63 clinical characteristics at the study onset 50-g gct revealed gmd in 15 investigated patients ( 75  % ) . \\n the most frequent abnormality was igt ( plasma glucose between 140 and 199  mg / dl ) , which occurred in 11 patients ( 55  % ) . \\n however , despite normal fasting glucose , in four patients ( 20  % ) , the glucose concentrations at 1  h after oral load were above 200  mg / dl , suggesting a preliminary diabetes diagnosis . \\n the other glucose metabolism indicators exhibited little clinical utility for the detection of abnormal glucose tolerance in pd patients . \\n the median percentage of hba1c was in the normal range ( 5.5  % ) , exceeding the upper limit only in two patients ( 10  % ) . \\n median value of homa - ir was 2.13 , being above 2.6 ( the cutoff for ir ) only in seven patients ( 35  % ) . \\n c - peptide concentrations were significantly higher than in non - diabetic healthy individuals ( p  =  0.03 ) . \\n a significant correlation was found between homa - ir and c - peptide measurements ( p  =  0.001 ,  0.677 ) . \\n homa - ir and c - peptide determinations did not correlate with other investigated parameters , i.e. , serum albumin , crp , lipid profile , glucose load in the dialysis fluid , dialysis dose , ultrafiltration , and residual diuresis . \\n patients with gmd were recommended a low - carbohydrate diet , lifestyle modification to promote weight loss , and increased physical activity . \\n the adherence was checked at a monthly interval during patients visit to the pd clinic . \\n four patients , in whom diabetes was recognized after the first 50-g gct , additionally received short - acting sulphonylurea compounds ( glipizide ) for a few months ( 35 ) , and then , a diet satisfactorily corrected the glucose value . \\n the patients were prospectively observed , and after a median time of 25.8  months , the glucose metabolism evaluation was repeated . during the second 50-g gct , \\n igt persisted in eight patients ( 40  % ) , and of particular note , ifg ( 100125  mg / dl ) occurred in four patients ( 20  % ) despite 50-g gct being in the normal range . \\n all patients who exhibited the highest abnormalities suggesting diabetes in the first gct when retested at the end of the observation achieved a normal range . \\n glucose metabolism disorders at study onset and at the end of observation are shown in table  2.table  2glucose metabolism disorders at study onset and at the end of observationgct 50  ggmdstudy onsetend of observationifg0 pts4 ptsfasting glucose level ( mg / dl )  median / iqr124/112153glucose level1  h after gct ( mg / dl )  median / iqr176/152189igt11 pts8 ptsfasting glucose level ( mg / dl )  median / iqr93/839587/78.2590.25glucose level1  h after gct ( mg / dl )  median / iqr167/149184150/146167dm4 pts0 ptsfasting glucose level ( mg / dl )  median / iqr93/83.399.8glucose level1  h after gct ( mg / dl )  median / iq207/204236 glucose metabolism disorders at study onset and at the end of observation \\n the occurrence of gmd in 75  % of the study subjects representing a small single - center cohort of prevalent pd patients gives a good illustration of the epidemiological dimension of the problem . \\n after the first oral glucose load of 50  g , igt was revealed in 11 subjects ( 55  % ) , and a glucose rise suggesting diabetes appeared in four patients ( 20  % ) . \\n the 50-g gct was performed in prevalent continuous ambulatory peritoneal dialysis ( capd ) patients , who had been on dialysis for a median time of 15.34  months . \\n surprisingly , the literature on gmd in the pd population is very scanty . in two works published in the 1980s , lindholm et al . \\n [ 25 , 26 ] based on their own modification of ogtt ( using 1  g glucose per kg body weight ) carried out in 15 patients concluded that pd treatment up to 1  year does not deteriorate glucose metabolism . \\n . published results of ogtt diminished from standard 7550  g glucose load accomplished in six patients being on pd for at least 6  months . \\n the test was applied exclusively to detect insulin resistance , and the data on increased glycemic and insulinemic responses were presented . more informative and extensive \\n investigation was done by cheng et al .   in 35 nondiabetic patients treated by pd for more than 1  year . \\n they challenged patients by standard 75 ogtt and found igt in 31  % . in a larger - scale epidemiological study , \\n insulin resistance was significantly more frequent in pd patients than in hemodialysis and pre - dialysis subjects ( 47 vs. 21 and 26  % , respectively ) . in a study by tatar et al . \\n , insulin resistance was an independent risk factor for arterial stiffness in nondiabetic pd patients older than 50  years . in our present single - center study , we found homa - ir values indicating insulin resistance ( > 2.6 ) in seven patients ( 35  % ) . \\n the c - peptide levels were significantly higher in the pd group than in healthy individuals and correlated closely with homa - ir . \\n it should be mentioned that the elevated c - peptide concentrations in pd patients are mainly a consequence of the fact that 70  % of this peptide is eliminated by the kidney route . \\n however , the strong correlation with homa - ir can be treated as a sign of preserved excretory  pancreatic cells capacity . \\n commenting on the results of our study , it is worth emphasizing that the study group encompasses low - risk , middle - aged , non - obese subjects , with normal fasting glucose , normal hba1c , and slightly elevated cholesterol level . \\n the only more pronounced abnormality which is associated with glucose intolerance in epidemiological investigation was hypertriglyceridemia . \\n discovery of gmd in 75  % of patients with such clinical characteristics highlights the clinical significance of this issue . \\n we are conscious that 50-g gct was not validated in the pd population , but it seems to be well suited for a person on pd treatment due to its simplicity and convenience . \\n a plasma glucose value  140  mg / dl , we gave up on performing the second step 75-g ogtt , because the aim of our study was not to recognize diabetes by who criteria , but reveal a group with special risk of hyperglycemia . \\n we treated our test as a screening , not diagnostic method , also taking into account the cost  benefit relationship . \\n the 50-g gct allows quick verification of glucose disturbances in patients with an additional daily dose of glucose in the dialysis fluids . in contradistinction to standard 75-g ogtt , it does not require patients to keep coming to the pd clinic at different appointment hours without eating . \\n it obviously does not provide a definitive diagnosis . in the next project following these preliminary data \\n however , we believe that abnormalities revealed by 50-g gct are already of clinical value alerting the patient and physician . it provides a stimulus for preventive measures , which as shown by our experience can be effective , i.e. , the normalization of the test in four patients with the worst results at the onset . the other positive aspect of the current study is supplying evidence that gmd are not inexorably progressive under pd treatment . \\n the maintenance of normal glucose metabolism in pd patients is in the context of obtained results a feasible goal . \\n its achievement could bring benefits in terms of longer patient survival and lower risk of post - transplant diabetes development . \\n the oral glucose challenge screening gct test appears to be a sensitive instrument for the detection of glucose metabolism disorders in pd patients with normal fasting glucose .',\n",
       "  'output': 'background \\n the aim was to evaluate the clinical utility of the oral glucose tolerance screening test ( 50-g gct  glucose challenge test ) for the detection of glucose metabolism disorders ( gmd ) in peritoneal dialysis ( pd ) patients with normal fasting glucose levels . \\n methods \\n the 50-g gct was performed in 20 prevalent patients without history of diabetes before pd treatment onset , who had been on dialysis for a median time of 15.34  months . \\n in addition , other indicators of glucose metabolism were measured : c - peptide , fasting insulin serum concentration , and the glycated hemoglobin level ( hba1c ) . \\n the patients were prospectively followed for a median time of 25.8  months . \\n results50-g gct revealed gmd in 15 studied patients ( 75  % ) impaired glucose tolerance in 11 patients ( 55  % ) and diabetes mellitus in four patients ( 20  % ) . hba1c and insulin resistance , estimated by homeostasis model assessment , \\n were elevated in two ( 10  % ) and seven ( 35  % ) patients , respectively . in patients with gmd , dietetic and pharmacologic interventions were performed . \\n when the 50-g gct was repeated at the end of the observation period , 12 ( 60  % ) patients reported gmd , with no case of diabetes.conclusion50-g gct appears to be a simple and practical tool for the detection of gmd in pd patients with normal fasting glucose . \\n timely therapeutic intervention can effectively inhibit the progression of glucose intolerance during pd treatment .',\n",
       "  '__index_level_0__': 31681,\n",
       "  'model_output': 'summary: the pathogenesis of glucose metabolism disorders ( gmd ) in peritoneal dialysis ( pd ) patients is related to factors such as weight gain and insulin resistance evoked by peritoneal glucose load. the periodical evaluation of pd patients for gmd is of clinical relevance and should be an element of the surveillance protocol. the gold standard method used for the diagnosis of gmd defined by the world health organization ( who ) in 1998 uses the level of 2-h post - challenge plasma glucose ( 2-hpg ) in the oral glucose tolerance test ( 75-g ogtt ). criteria for the diagnosis are the following : fasting plasma glucose ( fpg ) 100  mg / dl ( 5.6  mmol / l ) to 125  mg / dl ( 6.9  mmol / l ) ( impaired fasting glucose, ifg ) ; 2-h pg in the 75-g ogtt 140  mg / dl ( 7.8  mmol / l ) to 199  mg / dl ( 11.0  mmol / l ) ( impaired glucose tolerance, igt ) ; 2-h pg in the 75-g ogtt or random 200  mg / dl ( 11.1  mmol / l ) ( dm ). the utility of the recently recommended use of hba1c in terms of diabetes diagnosis ( diagnostic threshold of 6.5  % ) still remains to be validated. the population at a particular risk of glucose metabolism disorders includes renal transplant recipients, pregnant women, and patients treated with peritoneal dialysis. for each of these groups, there is a lack of clear guidelines for the detection and diagnosis of gmd. therefore, alternative methods for detecting all glucose metabolism disorders ( ifg, igt, and dm ) in the population of high risk of hyperglycemia have been investigated. the issue of glucose metabolism disorders ( gmd ) in pd patients has regained interest in recent years. this increase in clinical relevance was caused by new evidence that even mild hyperglycemia in the dialysis period can be harmful in the long term, being associated with worse survival and elevated risk of post - transplant diabetes mellitus [ 68 ]. treatment with peritoneal dialysis is inherently associated with an additional load of glucose adsorbed from dialysis fluid. the effect of glucose deriving from the peritoneal cavity on the incidence of glucose intolerance still evokes some ambiguity, and published data are equivocal [ 13, 911 ]. the recent data suggest that high glucose exposure from dialysis solution may be a risk factor for vascular calcification in non - diabetic pd patients. there seem to be some analogies between the occurrence of de novo gmd in patients treated with pd and gestational diabetes ( gdm ), in which a combination of increased maternal adiposity and naturally occurring human placental hormones produces insulin resistance [ 13, 14 ]. in both cases, gestational diabetes mellitus is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. the mechanisms that lead to chronic insulin resistance in gdm are varied as they are in the general population. up to 2012 gdm was diagnosed by a two - step approach using a sequential model of universal screening with a 1-h 50-g glucose challenge test ( 50-g gct ) followed by a diagnostic 75-g oral glucose tolerance test ( 75-g ogtt ) for women with a positive screening test [ threshold value 140  mg / dl ( 7.8  mmol / l ) ]. the gdm was recognized in 75-g ogtt when the plasma glucose value was 140  mg / dl. ada recommendations for 2011 adopted new, stricter criteria for the diagnosis of gestational diabetes and confirmed them for 2012. according to the current recommendations for all pregnant women between 24 and 28  weeks of pregnancy, gestational diabetes is diagnosed if the fasting plasma glucose is at least 92  mg / dl ( 5.1  mmol / l ), after 1  h 180  mg / dl ( 10.0  mmol / l ), and after 2  h 153  mg / dl ( 8.5  mmol / l ). these criteria were based on the results of the hapo study   and recommendations of the research group of the international association of the diabetes and pregnancy study groups ( iadpsg ). there is also a critical discussion concerning the methods and criteria for the new ada 2012 diagnosis of gestational diabetes [ 2023 ]. currently, there are no clear recommendations for diagnosis and classification of glucose disturbances occurring de novo in a population of patients on pd. in our opinion, the who gold standard is not appropriate for pd patients because gmd differ from those in the general population, and other screening strategies should be explored. considering the mentioned similarities, we aimed to examine the utility of the oral glucose tolerance screening test ( 50-g gct ) for pd patients, which is used in a two - step approach to evaluate gestational diabetes. the first step the 50-g gct is performed at any time of the day ( the fasting state is not required ), using 50  g of glucose, and the plasma glucose was measured at 1  h after administration. in the current study, we aimed to evaluate the applicability of the 50-g gct for the detection of gmd in non - diabetic continuous ambulatory pd patients with normal fasting glucose levels. the study was performed in 20 prevalent patients without history of diabetes before pd treatment onset who had been on a pd program at our institution as their first dialysis modality. the median age of patients was 44.19  years [ interquartile range ( iqr ) 34.1556.25 ], 9 being males and 11 being females, all caucasian with cause of end - stage renal disease ( esrd ) being glomerular disease in 12 patients ( 60  % ), hypertensive nephropathy in four patients ( 20  % ), interstitial nephropathy in three patients ( 15  % ), and polycystic kidney disease in one patient ( 5  % ). the median duration of pd treatment before inclusion in the study was 15.34  months ( iqr 10.821.34 ). patients were assessed at the study onset ( on the day of the 50-g gct ) and at the end of pd treatment ( 13 patients ) or at end of the observation period ( december 2012 ) for continuing the pd program ( seven patients ). at the study onset, all patients underwent 50-g gct with a glucose dose of 50  g. the test is performed at any time of the day ( the fasting state is not required ), using 50  g of glucose, and the glucose is measured at 1  h after the administration. interpretation of our 50-g gct results was as follows : glucose < 140  mg / dl normal value ; 140199  mg / dl impaired glucose tolerance ( igt ), 200  mg / dl diabetes. in case of a fasting glucose value 100125  mg / dl, and normal value in 50-g gct  impaired fasting glucose ( ifg ) was diagnosed. the 50-g gct was performed in patients with an empty abdomen after the night dwell draining. during the night, all patients used 1.36  % glucose containing dialysis solution. the glucose was measured at 1  h after administration ; the fasting state was not required. in addition, the following parameters of glucose metabolism were measured : c - peptide, fasting insulin serum concentration, and the glycated hemoglobin level ( hba1c ). the concentrations of c - peptide and insulin were evaluated in serum samples, and hba1c in whole blood using a chemiluminescent microparticle immunoassay ( cmia ) on the architect system ( abbott, usa ). based on fasting insulin and glucose values, insulin resistance ( ir ) was determined according to the homeostasis model assessment insulin resistance ( homa - ir ). they encompassed blood pressure ( bp ), serum albumin, lipid profiles, hb, crp, liver tests, mean daily peritoneal glucose load, ultrafiltration volume, residual diuresis, weekly dialytic creatinine clearance ( ccr ), weekly dialytic kt / v, and other laboratory parameters ( uric acid, pth, tsh, fe, tsat, and electrolytes ). systolic and diastolic bp, residual gfr, weekly dialytic ccr, and kt / v were measured by standard methods. the estimated peritoneal glucose load was calculated by the product of the volume and the glucose concentration of each exchange. the glucose load did not differ between the patients and was similar in all study patients during the follow - up. the patients were prospectively followed for a median time of 25.8  months ( iqr 18.9933.57 ), and 50-g gct was repeated at the end of the observation period. the statistical analysis was performed with r for windows, version 2.15.1, and medcalc for windows, version 12.3.1.0. clinical characteristics at the study onset are shown in table  1.table  1clinical characteristics at the study onsetvariable \\n n \\n medianiqr ( interquartile range)fasting glucose level ( mg / dl)2091.583.596glucose level1  h after gct ( mg / dl)20165137.5195hba1c ( % ) 205.55.45.7c - peptide ( ng / ml)207.245.1210.95fasting insulin serum concentration ( u / ml)2010.347.7916.05homa - ir202.131.573.53systolic bp ( mmhg)20135120155.5diastolic bp ( mmhg)2087.58090serum albumin ( g / dl)203.83.653.95total cholesterol ( mg / dl)20196179231hdl cholesterol ( mg / dl)20433852ldl cholesterol ( mg / dl)20128.5105.5143triglycerides ( mg / dl)20164.5130226.5hb ( g / dl)2010.610.111.85crp ( mg / l)202.091.116.69aspat ( iu / l)2017.51421alat ( iu / l)20171225uric acid ( mg / dl)206.35.557.3pth20817490.51,221.5tsh202.191.054.11fe207451.588tsat ( % ) 2025.41933.9ca ( mmol / l)2098.259.2p ( mg / dl)206.44.857.25mean daily peritoneal glucose load ( g/24  h)20120120120ultrafiltration volume ( ml/24  h)201,3007251,500residual diuresis ( ml/24  h)201,1505001,500weekly dialytic ccr200.690.620.75weekly dialytic kt / v202.192.112.7bmi  total ( kg / m)2025.1423.8327.63 clinical characteristics at the study onset 50-g gct revealed gmd in 15 investigated patients ( 75  % ). the most frequent abnormality was igt ( plasma glucose between 140 and 199  mg / dl ), which occurred in 11 patients ( 55  % ). however, despite normal fasting glucose, in four patients ( 20  % ), the glucose concentrations at 1  h after oral load were above 200  mg / dl, suggesting a preliminary diabetes diagnosis. the other glucose metabolism indicators exhibited little clinical utility for the detection of abnormal glucose tolerance in pd patients. the median percentage of hba1c was in the normal range ( 5.5  % ), exceeding the upper limit only in two patients ( 10  % ). median value of homa - ir was 2.13, being above 2.6 ( the cutoff for ir ) only in seven patients ( 35  % ). c - peptide concentrations were significantly higher than in non - diabetic healthy individuals ( p  =  0.03 ). a significant correlation was found between homa - ir and c - peptide measurements ( p  =  0.001,  0.677 ). homa - ir and c - peptide determinations did not correlate with other investigated parameters, i.e., serum albumin, crp, lipid profile, glucose load in the dialysis fluid, dialysis dose, ultrafiltration, and residual diuresis. patients with gmd were recommended a low - carbohydrate diet, lifestyle modification to promote weight loss, and increased physical activity. the adherence was checked at a monthly interval during patients visit to the pd clinic. four patients, in whom diabetes was recognized after the first 50-g gct, additionally received short - acting sulphonylurea compounds ( glipizide ) for a few months ( 35 ), and then, a diet satisfactorily corrected the glucose value. the patients were prospectively observed, and after a median time of 25.8  months, the glucose metabolism evaluation was repeated. during the second 50-g gct, igt persisted in eight patients ( 40  % ), and of particular note, ifg ( 100125  mg / dl ) occurred in four patients ( 20  % ) despite 50-g gct being in the normal range. all patients who exhibited the highest abnormalities suggesting diabetes in the first gct when retested at the end of the observation achieved a normal range. glucose metabolism disorders at study onset and at the end of observation are shown in table  2.table  2glucose metabolism disorders at study onset and at the end of observationgct 50  ggmdstudy onsetend of observationifg0 pts4 ptsfasting glucose level ( mg / dl )  median / iqr124/112153glucose level1  h after gct ( mg / dl )  median / iqr176/152189igt11 pts8 ptsfasting glucose level ( mg / dl )  median / iqr93/839587/78.2590.25glucose level1  h after gct ( mg / dl )  median / iqr167/149184150/146167dm4 pts0 ptsfasting glucose level ( mg / dl )  median / iq207/204236 glucose metabolism disorders at study onset and at the end of observation \\n the occurrence of gmd in 75  % of the study subjects representing a small single - center cohort of prevalent pd patients gives a good illustration of the epidemiological dimension of the problem. after the first oral glucose load of 50  g, igt was revealed in 11 subjects ( 55  % ), and a glucose rise suggesting diabetes appeared in four patients ( 20  % ). the 50-g gct was performed in prevalent continuous ambulatory peritoneal dialysis ( capd ) patients, who had been on dialysis for a median time of 15.34  months. surprisingly, the literature on gmd in the pd population is very scanty. in two works published in the 1980s, lindholm et al. [ 25, 26 ] based on their own modification of ogtt ( using 1  g glucose per kg body weight ) carried out in 15 patients concluded that pd treatment up to 1  year does not deteriorate glucose metabolism. published results of ogtt diminished from standard 7550  g glucose load accomplished in six patients being on pd for at least 6  months. the test was applied exclusively to detect insulin resistance, and the data on increased glycemic and insulinemic responses were presented. more informative and extensive investigation was done by cheng et al.   in 35 nondiabetic patients treated by pd for more than 1  year. they challenged patients by standard 75 ogtt and found igt in 31  %. in a larger - scale epidemiological study, insulin resistance was significantly more frequent in pd patients than in hemodialysis and pre - dialysis subjects ( 47 vs. 21 and 26  %, respectively ). in a study by tatar et al., insulin resistance was an independent risk factor for arterial stiffness in nondiabetic pd patients older than 50  years. in our present single - center study, we found homa - ir values indicating insulin resistance ( > 2.6 ) in seven patients ( 35  % ). the c - peptide levels were significantly higher in the pd group than in healthy individuals and correlated closely with homa - ir. it should be mentioned that the elevated c - peptide concentrations in pd patients are mainly a consequence of the fact that 70  % of this peptide is eliminated by the kidney route. however, the strong correlation with homa - ir can be treated as a sign of preserved excretory  pancreatic cells capacity. commenting on the results of our study, it is worth emphasizing that the study group encompasses low - risk, middle - aged, non - obese subjects, with normal fasting glucose, normal hba1c, and slightly elevated cholesterol level. the only more pronounced abnormality which is associated with glucose intolerance in epidemiological investigation was hypertriglyceridemia. discovery of gmd in 75  % of patients with such clinical characteristics highlights the clinical significance of this issue. we are conscious that 50-g gct was not validated in the pd population, but it seems to be well suited for a person on pd treatment due to its simplicity and convenience. a plasma glucose value  140  mg / dl, we gave up on performing the second step 75-g ogtt, because the aim of our study was not to recognize diabetes by who criteria, but reveal a group with special risk of hyperglycemia. we treated our test as a screening, not diagnostic method, also taking into account the cost  benefit relationship. the 50-g gct allows quick verification of glucose disturbances in patients with an additional daily dose of glucose in the dialysis fluids. in contradistinction to standard 75-g ogtt, it does not require patients to keep coming to the pd clinic at different appointment hours without eating. it obviously does not provide a definitive diagnosis. in the next project following these preliminary data however, we believe that abnormalities revealed by 50-g gct are already of clinical value alerting the patient and physician. it provides a stimulus for preventive measures, which as shown by our experience can be effective, i.e., the normalization of the test in four patients with the worst results at the onset. the other positive aspect of the current study is supplying evidence that gmd are not inexorably progressive under pd treatment. the maintenance of normal glucose metabolism in pd patients is in the context of obtained results a feasible goal. its achievement could bring benefits in terms of longer patient survival and lower risk of post - transplant diabetes development. the oral glucose challenge screening gct test appears to be a sensitive instrument for the detection of glucose metabolism disorders in pd patients with normal fasting glucose.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Write a summary of the article that captures the main ideas and significant details.',\n",
       "  'input': 'Summarize the following article: renal dysfunction is a strong risk factor for cardiovascular disease in the general population,1 ) and it is associated with an increased risk of death and cardiovascular events in patients with a broad range of cardiovascular diseases , including heart failure,2 ) stable coronary artery disease undergoing percutaneous coronary intervention ( pci)3)4 ) and acute coronary syndromes.5)6 ) in the setting of acute myocardial infarction ( ami ) , mortality risk is increased in patients with renal dysfunction ( rd ) of any degree of severity.7 - 9 ) primary pci is the best reperfusion strategy for ami patients and its mortality benefit has been shown in randomized trials.10 - 12 ) however , most of these trials frequently excluded patients with rd , and few studies examining the outcomes of ami patients with rd undergoing primary pci have been reported . to date \\n , several studies evaluating the in - hospital prognostic significance of rd in patients undergoing primary pci for ami have reported that rd is an independent predictor of in - hospital mortality,13 - 15 ) even in the case of a successful pci.13)14 ) however , one of these studies13 ) used serum creatinine level to determine rd despite the fact that serum creatinine level can be unreliable as an estimate of renal function ( rf ) , while the other studies14)15 ) included a small number of patients and divided patients according to their rf into merely 2 groups which is insufficient for rd risk stratification . \\n the aim of the present study was to investigate the impact of admission estimated glomerular filtration rate ( gfr ) on in - hospital outcomes in patients with st - segment elevation myocardial infarction ( stemi ) undergoing primary pci using data from the korea acute myocardial infarction registry ( kamir ) . \\n kamir is a korean prospective multicenter online registry designed to reflect \" real - world \" practice trends for patients presenting with ami in the recent reperfusion era ; the registry has been supported by the korean circulation society since november 2005 . \\n online registry of ami cases ( www.kamir.or.kr ) has been performed at 41 universities or community hospitals that are high - volume centers with facilities for primary pci and onsite cardiac surgery . \\n data were collected at each site by a trained study coordinator using a standardized case report form , and registered and submitted from individual institutions via password - protected internet - based electronic case report forms . \\n the study protocol was approved by the ethics committee at each participating institution . from january 2006 to december 2007 , \\n , 864 patients were excluded from this study because they had received fibrinolytic therapy and 2,407 patients were excluded because they did not undergo pci as the primary treatment strategy ; an additional 82 patients were excluded due to missing data needed to calculate estimated gfr . \\n 1 ) . data on clinical , angiographic and in - hospital outcomes were collected . \\n the mean age of the study patients was 62.212.8 years , and 3,355 ( 73.8% ) patients were males . the mean estimated gfr was 78.3 ml / min/1.73 m. the angiographic success rate was 91.8% , and the overall in - hospital mortality rate was 5.3% . \\n stemi was defined by the presence of new st - segment elevation of at least 1 mm ( 0.1 mv ) in 2 contiguous leads or new left bundle - branch block on the index or subsequent electrocardiogram with at least 1 positive cardiac biochemical marker of necrosis . \\n primary pci was defined as percutaneous coronary revascularization within 24 hours of symptom onset without antecedent treatment with a fibrinolytic agent as the initial therapy . \\n successful pci was defined as thrombolysis in myocardial infarction 3 flow with residual stenosis 50% in the infarct - related artery . \\n major bleeding was defined as intracranial bleeding , bleeding associated with the need for blood transfusion , or any other clinically relevant bleeding as judged by the investigator . \\n rf was defined by estimated gfr , which was calculated by the modification of diet in renal disease equation ( mdrd)16 ) from the serum creatinine level measured on admission . \\n normal rf , moderate and severe rd were defined as estimated gfr 60 ml / min/1.73 m , between 30 to 59 ml / min/1.73 m and < 30 ml / min/1.73 m , respectively . \\n all analyses were performed using statistical package for the social sciences ( spss ) software version 17.0 ( spss inc , chicago , il , usa ) . \\n data are presented as meanstandard deviation or median with interquartiles for continuous variables , and as frequency for categorical variables . \\n comparisons between continuous variables were done using one - way analysis of variance or the kruskal - wallis test , while the pearson \\'s chi - square test was used for categorical variables . \\n kamir is a korean prospective multicenter online registry designed to reflect \" real - world \" practice trends for patients presenting with ami in the recent reperfusion era ; the registry has been supported by the korean circulation society since november 2005 . \\n online registry of ami cases ( www.kamir.or.kr ) has been performed at 41 universities or community hospitals that are high - volume centers with facilities for primary pci and onsite cardiac surgery . \\n data were collected at each site by a trained study coordinator using a standardized case report form , and registered and submitted from individual institutions via password - protected internet - based electronic case report forms . \\n from january 2006 to december 2007 , a total of 7,895 stemi patients were registered in kamir . of these , 864 patients were excluded from this study because they had received fibrinolytic therapy and 2,407 patients were excluded because they did not undergo pci as the primary treatment strategy ; an additional 82 patients were excluded due to missing data needed to calculate estimated gfr . \\n 1 ) . data on clinical , angiographic and in - hospital outcomes were collected . \\n the mean age of the study patients was 62.212.8 years , and 3,355 ( 73.8% ) patients were males . \\n the mean estimated gfr was 78.3 ml / min/1.73 m. the angiographic success rate was 91.8% , and the overall in - hospital mortality rate was 5.3% . \\n stemi was defined by the presence of new st - segment elevation of at least 1 mm ( 0.1 mv ) in 2 contiguous leads or new left bundle - branch block on the index or subsequent electrocardiogram with at least 1 positive cardiac biochemical marker of necrosis . \\n primary pci was defined as percutaneous coronary revascularization within 24 hours of symptom onset without antecedent treatment with a fibrinolytic agent as the initial therapy . \\n successful pci was defined as thrombolysis in myocardial infarction 3 flow with residual stenosis 50% in the infarct - related artery . \\n major bleeding was defined as intracranial bleeding , bleeding associated with the need for blood transfusion , or any other clinically relevant bleeding as judged by the investigator . \\n rf was defined by estimated gfr , which was calculated by the modification of diet in renal disease equation ( mdrd)16 ) from the serum creatinine level measured on admission . \\n normal rf , moderate and severe rd were defined as estimated gfr 60 ml / min/1.73 m , between 30 to 59 ml / min/1.73 m and < 30 ml / min/1.73 m , respectively . \\n all analyses were performed using statistical package for the social sciences ( spss ) software version 17.0 ( spss inc , chicago , il , usa ) . \\n data are presented as meanstandard deviation or median with interquartiles for continuous variables , and as frequency for categorical variables . \\n comparisons between continuous variables were done using one - way analysis of variance or the kruskal - wallis test , while the pearson \\'s chi - square test was used for categorical variables . \\n patients with rd were older , were more often females and had lower bmi values . also , they were more likely to have lower systolic blood pressure , increased heart rate and higher killip class at presentation . \\n pre - hospital delay time was similar in the rd group and the normal rf group , but door - to - balloon time was longer in the rd group as compared to the normal rf group . on medical history , \\n with respect to laboratory findings , high sensitivity c - reactive protein and b - type natriuretic peptide levels were higher in the rd group , but peak creatine kinase - mb level and left ventricular ejection fraction were lower in the rd group as compared to the normal rf group . \\n use of both heparin and gp iib / iiia inhibitor was lower in the rd group as compared to the normal rf group ( table 1 ) . \\n patients with rd were more likely to have multivessel disease and left main coronary artery stenosis . \\n the location of infarct - related artery was significantly different in the three groups , according to their rf . while involvement of the left anterior descending coronary artery was less frequent , involvement of the right coronary artery was more frequent in the severe rd group . \\n also , rate of successful pci decreased significantly as rf declined ; however , rate of stent insertion remained similar in all the three groups ( table 2 ) . in - \\n hospital complications , including arrhythmia , cardiogenic shock , ischemic events , acute renal failure and major bleeding , developed more frequently in patients with rd ( table 3 ) . \\n in - hospital mortality rates increased significantly as estimated gfr decreased ( p<0.001 ) , and approximately one - fourth of the patients ( 25.6% ) in the severe rd group died ( fig . \\n 2 ) . although the main cause of in - hospital mortality was pump failure ( p<0.001 ) , frequencies of the causes of mortality were not significantly different between the three groups ( p=0.165 ) ( table 4 ) . \\n on multivariate logistic regression analysis , age , diabetes , killip class 3 , successful pci and left ventricular ejection fraction were identified as independent predictors of in - hospital mortality . \\n in addition , decreased estimated gfr was also identified as a powerful independent predictor of in - hospital mortality . when compared with the normal rf group , adjusted or was 2.67 { 95% confidence interval ( ci ) : 1.44 to 4.93 ; p=0.002 } in the moderate rd group and 4.09 ( 95% ci : 1.48 to 11.28 ; p=0.006 ) in the severe rd group ( table 5 ) . \\n patients with rd were older , were more often females and had lower bmi values . also , they were more likely to have lower systolic blood pressure , increased heart rate and higher killip class at presentation . \\n pre - hospital delay time was similar in the rd group and the normal rf group , but door - to - balloon time was longer in the rd group as compared to the normal rf group . on medical history , \\n with respect to laboratory findings , high sensitivity c - reactive protein and b - type natriuretic peptide levels were higher in the rd group , but peak creatine kinase - mb level and left ventricular ejection fraction were lower in the rd group as compared to the normal rf group . \\n use of both heparin and gp iib / iiia inhibitor was lower in the rd group as compared to the normal rf group ( table 1 ) . \\n patients with rd were more likely to have multivessel disease and left main coronary artery stenosis . \\n the location of infarct - related artery was significantly different in the three groups , according to their rf . while involvement of the left anterior descending coronary artery was less frequent , involvement of the right coronary artery was more frequent in the severe rd group . \\n also , rate of successful pci decreased significantly as rf declined ; however , rate of stent insertion remained similar in all the three groups ( table 2 ) . \\n in - hospital complications , including arrhythmia , cardiogenic shock , ischemic events , acute renal failure and major bleeding , developed more frequently in patients with rd ( table 3 ) . \\n in - hospital mortality rates increased significantly as estimated gfr decreased ( p<0.001 ) , and approximately one - fourth of the patients ( 25.6% ) in the severe rd group died ( fig . \\n 2 ) . although the main cause of in - hospital mortality was pump failure ( p<0.001 ) , frequencies of the causes of mortality were not significantly different between the three groups ( p=0.165 ) ( table 4 ) . \\n on multivariate logistic regression analysis , age , diabetes , killip class 3 , successful pci and left ventricular ejection fraction were identified as independent predictors of in - hospital mortality . \\n in addition , decreased estimated gfr was also identified as a powerful independent predictor of in - hospital mortality . when compared with the normal rf group , adjusted or was 2.67 { 95% confidence interval ( ci ) : 1.44 to 4.93 ; p=0.002 } in the moderate rd group and 4.09 ( 95% ci : 1.48 to 11.28 ; p=0.006 ) in the severe rd group ( table 5 ) . \\n the main finding of the present study is that rd defined by estimated gfr at admission is an independent predictor of in - hospital mortality in patients with stemi undergoing primary pci ; this increased mortality risk was observed not only in the patients with severe rd but also in the patients with moderate rd . in the present study , \\n rd was defined by estimated gfr calculated using the mdrd equation , which is currently recommended in clinical practice,17 ) and patients were divided into three groups . although rd , as defined by either serum creatinine level or estimated gfr , has been associated with increased mortality in patients with ami,13 - 15)18)19)21 ) serum creatinine level is insensitive for an early detection of rd and could underestimate the incidence of moderate or severe rd concealed behind the near - normal creatinine levels,9)22)23 ) thereby underscoring the risk of rd in ami patients . \\n furthermore , a graded risk of rd clearly exists , rf should be classified into at least 3 groups using estimated gfr for appropriate rd risk stratification in clinical practice . \\n our study on the basis of estimated gfr , showed that patients with moderate rd had a six - fold higher in - hospital mortality rate , while patients with severe rd had a eleven - fold higher in - hospital mortality rate as compared to the patients with normal rf . in our study , patients with rd were older , and were more often women . \\n although rf decreases with age and women tend to be older than men at the time of ami presentation,24 ) it may also be an inherent influence of the variables used in the mdrd equation . \\n in addition to older age and female gender , rd was more frequently associated with hypertension , diabetes , higher killip class , multivessel disease and low left ventricular ejection fraction . \\n these findings which have been described by other authors13)19)21 ) predispose to worse clinical outcomes after ami . \\n however , after adjustment for baseline differences , increased in - hospital mortality persisted in the patients with rd , suggesting that an increased mortality in patients with rd was not fully explained by these associated conditions , and that rd is a strong independent predictor of in - hospital mortality . the rate of in - hospital complications was higher in the patients with rd as compared to the patients with normal rf . \\n cardiogenic shock , the most common cause of death in this study regardless of rf , developed with a three - fold higher frequency . \\n it may be possible that the high incidence of unsuccessful pci , recurrent ischemia or re - infarction and bleeding may potentiate the already existing weakened ischemic resistance reflected by high prevalence of diabetes and multivessel disease in the rd group . \\n after ami , acute renal failure more commonly developed among those patients with low left ventricular ejection fraction , higher killip class , anterior wall infarction , a hematocrit < 30% , congestive heart failure , cardiogenic shock or stroke during admission.25 ) the rd group in our study shared many of these features , and although this study did not assess contrast - induced nephropathy ( cin ) it may also contribute to it . usually , the clinical benefit of primary pci is accompanied by an increased risk of bleeding in ami patients with rd , and a previous study has reported that rd is independently associated with bleeding after primary pci.19 ) as expected , despite the less frequent use of heparin and glycoprotein iib / iiia inhibitors in the rd group as compared to the normal rf group , which have a proven efficacy in the setting of ami , major bleeding increased significantly in the rd group as compared to the normal rf group . despite the fact that primary pci is the most effective ami treatment in terms of improvement in survival , this mortality benefit is attenuated in some patient subgroups , including the elderly , women , patients with renal insufficiency , heart failure , diabetes , anaemia , acute hyperglycemia , cardiogenic shock , and those developing cin.15 ) because the patients with rd frequently have more than one of these conditions , they might be at a very high risk of mortality after ami . \\n a recent study by medi et al.26 ) which investigated the benefit of reperfusion strategies in stemi patients in the presence of rd , reported that mortality rates remain high ; they also found that primary pci was associated with a lower adjusted in - hospital mortality than fibrinolytic therapy in the patients with normal rf and moderate rd . \\n however , in the patients with severe rd , primary pci was not associated with reduced mortality . in conclusion , we have limited knowledge on the optimal reperfusion strategy for the severe rd group . to improve the survival in ami patients with rd undergoing primary pci , more aggressive treatment and meticulous care are needed . \\n firstly , the success of primary pci has special importance because a successful pci is an independent predictor of in - hospital mortality as shown in our study and rd was shown to be associated with the risk of unsuccessful pci results . \\n secondly , medications such as aspirin , beta - blockers , and ace inhibitors should be administered early after ami , so that the patients with rd could gain a similar mortality benefit as their normal rf counterparts.27)28 ) thirdly , reducing bleeding complications29 ) by using the radial artery approach and direct thrombin inhibitor during pci is needed.30 ) fourthly , an effort should be made to prevent cin , including adequate hydration , reducing contrast use , use of low - osmolarity contrast and administration of n - acetylcysteine.19)20 ) because kamir is a large multicenter population - based prospectively - designed study including unselected patients with ami , it provides comprehensive information on treatments and outcomes among patients with ami and rd in the contemporary pci era . \\n because this study included stemi patients only , the median pre - hospital delay time in the rd group was relatively short as compared to that in the previous studies13)19 ) ; this feature could minimize the hemodynamic compromising effect of ami on baseline serum creatinine level . \\n similar to a previous study , because the patients with rd underwent pci less often as compared to those with normal rf , there might be a selection bias and unidentified confounders , which might limit the generalizability of the data . \\n secondly , we did not collect information on medications relevant for prognostication , and therefore analyses in this study was not controlled for the impact of these drugs . \\n thirdly , there are inherent limitations of the estimated gfr calculation.17 ) decreased estimated gfr on admission is a strong risk factor for increased in - hospital complications and mortality in stemi patients undergoing primary pci . \\n these risks increased in a stepwise fashion according to the degree of decreased estimated gfr . \\n clinicians should be alert to the increased mortality in patients with rd and make all the attempts to reduce complications of primary pci and stress intensive medical management of these high - risk patients . \\n similar to a previous study , because the patients with rd underwent pci less often as compared to those with normal rf , there might be a selection bias and unidentified confounders , which might limit the generalizability of the data . secondly , we did not collect information on medications relevant for prognostication , and therefore analyses in this study was not controlled for the impact of these drugs . \\n decreased estimated gfr on admission is a strong risk factor for increased in - hospital complications and mortality in stemi patients undergoing primary pci . \\n these risks increased in a stepwise fashion according to the degree of decreased estimated gfr . \\n clinicians should be alert to the increased mortality in patients with rd and make all the attempts to reduce complications of primary pci and stress intensive medical management of these high - risk patients .',\n",
       "  'output': 'background and objectivespatients with renal dysfunction ( rd ) experience worse prognosis after myocardial infarction ( mi ) . \\n the aim of the present study was to investigate the impact of admission estimated glomerular filtration rate ( egfr ) on clinical outcomes of patients undergoing primary percutaneous coronary intervention ( pci ) for st - segment elevation mi ( stemi).subjects and methodswe retrospectively evaluated 4,542 eligible patients from the korea acute myocardial infarction registry ( kamir ) . \\n patients were divided into three groups according to egfr ( ml / min/1.73 m2 ) : normal renal function ( rf ) group ( egfr 60 , n=3,515 ) , moderate rd group ( egfr between 30 to 59 , n=894 ) and severe rd group ( egfr < 30 , n=133 ) . baseline characteristics , angiographic and procedural results , and in - hospital outcomes between the three groups were compared.resultsage , gender , killip class 3 , hypertension , diabetes , congestive heart failure , peak creatine kinase - mb , high sensitivity c - reactive protein , b - type natriuretic peptide , left ventricle ejection fraction , multivessel disease , infarct - related artery and rate of successful pci were significantly different between the 3 groups ( p<0.05 ) . \\n with decline in rf , in - hospital complications developed with an increasing frequency ( 14.1% vs. 31.8% vs. 45.5% , p<0.0001 ) . in - hospital \\n mortality rate was significantly higher in the moderate and severe rd groups as compared to the normal rf group ( 2.3% vs. 13.9% vs. 25.6% , p<0.0001 ) . \\n using multivariate logistic regression analysis , adjusted odds ratio for in - hospital mortality was 2.67 { 95% confidence interval ( ci ) 1.44 - 4.93 , p=0.002 } in the moderate rd group , and 4.09 ( 95% ci 1.48 - 11.28 , p=0.006 ) in the severe rd group as compared to the normal rf group.conclusiondecreased admission egfr was associated with worse clinical courses and it was an independent predictor of in - hospital mortality in stemi patients undergoing primary pci .',\n",
       "  '__index_level_0__': 31682,\n",
       "  'model_output': 'summarize the following article: renal dysfunction is a strong risk factor for cardiovascular disease in the general population,1 ) and it is associated with an increased risk of death and cardiovascular events in patients with a broad range of cardiovascular diseases, including heart failure,2 ) stable coronary artery disease undergoing percutaneous coronary intervention ( pci)3)4 ) and acute coronary syndromes.5)6 ) in the setting of acute myocardial infarction ( ami ), mortality risk is increased in patients with renal dysfunction ( rd ) of any degree of severity.7 - 9 ) primary pci is the best reperfusion strategy for ami patients and its mortality benefit has been shown in randomized trials.10 - 12 ) however, most of these trials frequently excluded patients with rd, and few studies examining the outcomes of ami patients with rd undergoing primary pci have been reported. to date \\n, several studies evaluating the in - hospital prognostic significance of rd in patients undergoing primary pci for ami have reported that rd is an independent predictor of in - hospital mortality,13 - 15 ) even in the case of a successful pci.13)14 ) however, one of these studies13 ) used serum creatinine level to determine rd despite the fact that serum creatinine level can be unreliable as an estimate of renal function ( rf ), while the other studies14)15 ) included a small number of patients and divided patients according to their rf into merely 2 groups which is insufficient for rd risk stratification. \\n the aim of the present study was to investigate the impact of admission estimated glomerular filtration rate ( gfr ) on in - hospital outcomes in patients with st - segment elevation myocardial infarction ( stemi ) undergoing primary pci using data from the korea acute myocardial infarction registry ( kamir ). \\n kamir is a korean prospective multicenter online registry designed to reflect \" real - world \" practice trends for patients presenting with ami in the recent reperfusion era ; the registry has been supported by the korean circulation society since november 2005. \\n online registry of ami cases ( www.kamir.or.kr ) has been performed at 41 universities or community hospitals that are high - volume centers with facilities for primary pci and onsite cardiac surgery. \\n data were collected at each site by a trained study coordinator using a standardized case report form, and registered and submitted from individual institutions via password - protected internet - based electronic case report forms. \\n the study protocol was approved by the ethics committee at each participating institution. from january 2006 to december 2007, \\n, 864 patients were excluded from this study because they had received fibrinolytic therapy and 2,407 patients were excluded because they did not undergo pci as the primary treatment strategy ; an additional 82 patients were excluded due to missing data needed to calculate estimated gfr. \\n 1 ). data on clinical, angiographic and in - hospital outcomes were collected. \\n the mean age of the study patients was 62.212.8 years, and 3,355 ( 73.8% ) patients were males. the mean estimated gfr was 78.3 ml / min/1.73 m. the angiographic success rate was 91.8%, and the overall in - hospital mortality rate was 5.3%. \\n stemi was defined by the presence of new st - segment elevation of at least 1 mm ( 0.1 mv ) in 2 contiguous leads or new left bundle - branch block on the index or subsequent electrocardiogram with at least 1 positive cardiac biochemical marker of necrosis. \\n primary pci was defined as percutaneous coronary revascularization within 24 hours of symptom onset without antecedent treatment with a fibrinolytic agent as the initial therapy. \\n successful pci was defined as thrombolysis in myocardial infarction 3 flow with residual stenosis 50% in the infarct - related artery. \\n major bleeding was defined as intracranial bleeding, bleeding associated with the need for blood transfusion, or any other clinically relevant bleeding as judged by the investigator. \\n rf was defined by estimated gfr, which was calculated by the modification of diet in renal disease equation ( mdrd)16 ) from the serum creatinine level measured on admission. \\n normal rf, moderate and severe rd were defined as estimated gfr 60 ml / min/1.73 m, between 30 to 59 ml / min/1.73 m and < 30 ml / min/1.73 m, respectively. \\n all analyses were performed using statistical package for the social sciences ( spss ) software version 17.0 ( spss inc, chicago, il, usa ). \\n data are presented as meanstandard deviation or median with interquartiles for continuous variables, and as frequency for categorical variables. \\n comparisons between continuous variables were done using one - way analysis of variance or the kruskal - wallis test, while the pearson\\'s chi - square test was used for categorical variables. \\n kamir is a korean prospective multicenter online registry designed to reflect \" real - world \" practice trends for patients presenting with ami in the recent reperfusion era ; the registry has been supported by the korean circulation society since november 2005. \\n online registry of ami cases ( www.kamir.or.kr ) has been performed at 41 universities or community hospitals that are high - volume centers with facilities for primary pci and onsite cardiac surgery. \\n data were collected at each site by a trained study coordinator using a standardized case report form, and registered and submitted from individual institutions via password - protected internet - based electronic case report forms. \\n from january 2006 to december 2007, a total of 7,895 stemi patients were registered in kamir. of these, 864 patients were excluded from this study because they had received fibrinolytic therapy and 2,407 patients were excluded because they did not undergo pci as the primary treatment strategy ; an additional 82 patients were excluded due to missing data needed to calculate estimated gfr. \\n 1 ). data on clinical, angiographic and in - hospital outcomes were collected. \\n the mean age of the study patients was 62.212.8 years, and 3,355 ( 73.8% ) patients were males. \\n the mean estimated gfr was 78.3 ml / min/1.73 m. the angiographic success rate was 91.8%, and the overall in - hospital mortality rate was 5.3%. \\n stemi was defined by the presence of new st - segment elevation of at least 1 mm ( 0.1 mv ) in 2 contiguous leads or new left bundle - branch block on the index or subsequent electrocardiogram with at least 1 positive cardiac biochemical marker of necrosis. \\n primary pci was defined as percutaneous coronary revascularization within 24 hours of symptom onset without antecedent treatment with a fibrinolytic agent as the initial therapy. \\n successful pci was defined as thrombolysis in myocardial infarction 3 flow with residual stenosis 50% in the infarct - related artery. \\n major bleeding was defined as intracranial bleeding, bleeding associated with the need for blood transfusion, or any other clinically relevant bleeding as judged by the investigator. \\n rf was defined by estimated gfr, which was calculated by the modification of diet in renal disease equation ( mdrd)16 ) from the serum creatinine level measured on admission. \\n normal rf, moderate and severe rd were defined as estimated gfr 60 ml / min/1.73 m, between 30 to 59 ml / min/1.73 m and < 30 ml / min/1.73 m, respectively. \\n all analyses were performed using statistical package for the social sciences ( spss ) software version 17.0 ( spss inc, chicago, il, usa ). \\n data are presented as meanstandard deviation or median with interquartiles for continuous variables, and as frequency for categorical variables. \\n comparisons between continuous variables were done using one - way analysis of variance or the kruskal - wallis test, while the pearson\\'s chi - square test was used for categorical variables. \\n patients with rd were older, were more often females and had lower bmi values. also, they were more likely to have lower systolic blood pressure, increased heart rate and higher killip class at presentation. \\n pre - hospital delay time was similar in the rd group and the normal rf group, but door - to - balloon time was longer in the rd group as compared to the normal rf group. on medical history, \\n with respect to laboratory findings, high sensitivity c - reactive protein and b - type natriuretic peptide levels were higher in the rd group, but peak creatine kinase - mb level and left ventricular ejection fraction were lower in the rd group as compared to the normal rf group. \\n use of both heparin and gp iib / iiia inhibitor was lower in the rd group as compared to the normal rf group ( table 1 ). \\n patients with rd were more likely to have multivessel disease and left main coronary artery stenosis. \\n the location of infarct - related artery was significantly different in the three groups, according to their rf. while involvement of the left anterior descending coronary artery was less frequent, involvement of the right coronary artery was more frequent in the severe rd group. \\n also, rate of successful pci decreased significantly as rf declined ; however, rate of stent insertion remained similar in all the three groups ( table 2 ). in - \\n hospital complications, including arrhythmia, cardiogenic shock, ischemic events, acute renal failure and major bleeding, developed more frequently in patients with rd ( table 3 ). \\n in - hospital mortality rates increased significantly as estimated gfr decreased ( p<0.001 ), and approximately one - fourth of the patients ( 25.6% ) in the severe rd group died ( fig. \\n 2 ). although the main cause of in - hospital mortality was pump failure ( p<0.001 ), frequencies of the causes of mortality were not significantly different between the three groups ( p=0.165 ) ( table 4 ). \\n on multivariate logistic regression analysis, age, diabetes, killip class 3, successful pci and left ventricular ejection fraction were identified as independent predictors of in - hospital mortality. \\n in addition, decreased estimated gfr was also identified as a powerful independent predictor of in - hospital mortality. when compared with the normal rf group, adjusted or was 2.67 { 95% confidence interval ( ci ) : 1.44 to 4.93 ; p=0.002 } in the moderate rd group and 4.09 ( 95% ci : 1.48 to 11.28 ; p=0.006 ) in the severe rd group ( table 5 ). \\n patients with rd were older, were more often females and had lower bmi values. also, they were more likely to have lower systolic blood pressure, increased heart rate and higher killip class at presentation. \\n pre - hospital delay time was similar in the rd group and the normal rf group, but door - to - balloon time was longer in the rd group as compared to the normal rf group. on medical history, \\n with respect to laboratory findings, high sensitivity c - reactive protein and b - type natriuretic peptide levels were higher in the rd group, but peak creatine kinase - mb level and left ventricular ejection fraction were lower in the rd group as compared to the normal rf group. \\n use of both heparin and gp iib / iiia inhibitor was lower in the rd group as compared to the normal rf group ( table 1 ). \\n patients with rd were more likely to have multivessel disease and left main coronary artery stenosis. \\n the location of infarct - related artery was significantly different in the three groups, according to their rf. while involvement of the left anterior descending coronary artery was less frequent, involvement of the right coronary artery was more frequent in the severe rd group. \\n also, rate of successful pci decreased significantly as rf declined ; however, rate of stent insertion remained similar in all the three groups ( table 2 ). \\n in - hospital complications, including arrhythmia, cardiogenic shock, ischemic events, acute renal failure and major bleeding, developed more frequently in patients with rd ( table 3 ). \\n in - hospital mortality rates increased significantly as estimated gfr decreased ( p<0.001 ), and approximately one - fourth of the patients ( 25.6% ) in the severe rd group died ( fig. \\n 2 ). although the main cause of in - hospital mortality was pump failure ( p<0.001 ), frequencies of the causes of mortality were not significantly different between the three groups ( p=0.165 ) ( table 4 ). \\n on multivariate logistic regression analysis, age, diabetes, killip class 3, successful pci and left ventricular ejection fraction were identified as independent predictors of in - hospital mortality. \\n in addition, decreased estimated gfr was also identified as a powerful independent predictor of in - hospital mortality. when compared with the normal rf group, adjusted or was 2.67 { 95% confidence interval ( ci ) : 1.44 to 4.93 ; p=0.002 } in the moderate rd group and 4.09 ( 95% ci : 1.48 to 11.28 ; p=0.006 ) in the severe rd group ( table 5 ). \\n the main finding of the present study is that rd defined by estimated gfr at admission is an independent predictor of in - hospital mortality in patients with stemi undergoing primary pci ; this increased mortality risk was observed not only in the patients with severe rd but also in the patients with moderate rd. in the present study, \\n rd was defined by estimated gfr calculated using the mdrd equation, which is currently recommended in clinical practice,17 ) and patients were divided into three groups. although rd, as defined by either serum creatinine level or estimated gfr, has been associated with increased mortality in patients with ami,13 - 15)18)19)21 ) serum creatinine level is insensitive for an early detection of rd and could underestimate the incidence of moderate or severe rd concealed behind the near - normal creatinine levels,9)22)23 ) thereby underscoring the risk of rd in ami patients. \\n furthermore, a graded risk of rd clearly exists, rf should be classified into at least 3 groups using estimated gfr for appropriate rd risk stratification in clinical practice. \\n our study on the basis of estimated gfr, showed that patients with moderate rd had a six - fold higher in - hospital mortality rate, while patients with severe rd had a eleven - fold higher in - hospital mortality rate as compared to the patients with normal rf. in our study, patients with rd were older, and were more often women. \\n although rf decreases with age and women tend to be older than men at the time of ami presentation,24 ) it may also be an inherent influence of the variables used in the mdrd equation. \\n in addition to older age and female gender, rd was more frequently associated with hypertension, diabetes, higher killip class, multivessel disease and low left ventricular ejection fraction. \\n these findings which have been described by other authors13)19)21 ) predispose to worse clinical outcomes after ami. \\n however, after adjustment for baseline differences, increased in - hospital mortality persisted in the patients with rd, suggesting that an increased mortality in patients with rd was not fully explained by these associated conditions, and that rd is a strong independent predictor of in - hospital mortality. the rate of in - hospital complications was higher in the patients with rd as compared to the patients with normal rf. \\n cardiogenic shock, the most common cause of death in this study regardless of rf, developed with a three - fold higher frequency. \\n it may be possible that the high incidence of unsuccessful pci, recurrent ischemia or re - infarction and bleeding may potentiate the already existing weakened ischemic resistance reflected by high prevalence of diabetes and multivessel disease in the rd group. \\n after ami, acute renal failure more commonly developed among those patients with low left ventricular ejection fraction, higher killip class, anterior wall infarction, a hematocrit < 30%, congestive heart failure, cardiogenic shock or stroke during admission.25 ) the rd group in our study shared many of these features, and although this study did not assess contrast - induced nephropathy ( cin ) it may also contribute to it. usually, the clinical benefit of primary pci is accompanied by an increased risk of bleeding in ami patients with rd, and a previous study has reported that rd is independently associated with bleeding after primary pci.19 ) as expected, despite the less frequent use of heparin and glycoprotein iib / iiia inhibitors in the rd group as compared to the normal rf group, which have a proven efficacy in the setting of ami, major bleeding increased significantly in the rd group as compared to the normal rf group. despite the fact that primary pci is the most effective ami treatment in terms of improvement in survival, this mortality benefit is attenuated in some patient subgroups, including the elderly, women, patients with renal insufficiency, heart failure, diabetes, anaemia, acute hyperglycemia, cardiogenic shock, and those developing cin.15 ) because the patients with rd frequently have more than one of these conditions, they might be at a very high risk of mortality after ami. \\n a recent study by medi et al.26 ) which investigated the benefit of reperfusion strategies in stemi patients in the presence of rd, reported that mortality rates remain high ; they also found that primary pci was associated with a lower adjusted in - hospital mortality than fibrinolytic therapy in the patients with normal rf and moderate rd. \\n however, in the patients with severe rd, primary pci was not associated with reduced mortality. in conclusion, we have limited knowledge on the optimal reperfusion strategy for the severe rd group. to improve the survival in ami patients with rd undergoing primary pci, more aggressive treatment and meticulous care are needed. \\n firstly, the success of primary pci has special importance because a successful pci is an independent predictor of in - hospital mortality as shown in our study and rd was shown to be associated with the risk of unsuccessful pci results. \\n secondly, medications such as aspirin, beta - blockers, and ace inhibitors should be administered early after ami, so that the patients with rd could gain a similar mortality benefit as their normal rf counterparts.27)28 ) thirdly, reducing bleeding complications29 ) by using the radial artery approach and direct thrombin inhibitor during pci is needed.30 ) fourthly, an effort should be made to prevent cin, including adequate hydration, reducing contrast use, use of low - osmolarity contrast and administration of n - acetylcysteine.19)20 ) because kamir is a large multicenter population - based prospectively - designed study including unselected patients with ami, it provides comprehensive information on treatments and outcomes among patients with ami and rd in the contemporary pci era. \\n because this study included stemi patients only, the median pre - hospital delay time in the rd group was relatively short as compared to that in the previous studies13)19 ) ; this feature could minimize the hemodynamic compromising effect of ami on baseline serum creatinine level. \\n similar to a previous study, because the patients with rd underwent pci less often as compared to those with normal rf, there might be a selection bias and unidentified confounders, which might limit the generalizability of the data. \\n secondly, we did not collect information on medications relevant for prognostication, and therefore analyses in this study was not controlled for the impact of these drugs. \\n thirdly, there are inherent limitations of the estimated gfr calculation.17 ) decreased estimated gfr on admission is a strong risk factor for increased in - hospital complications and mortality in stemi patients undergoing primary pci. \\n these risks increased in a stepwise fashion according to the degree of decreased estimated gfr. \\n clinicians should be alert to the increased mortality in patients with rd and make all the attempts to reduce complications of primary pci and stress intensive medical management of these high - risk patients. \\n similar to a previous study, because the patients with rd underwent pci less often as compared to those with normal rf, there might be a selection bias and unidentified confounders, which might limit the generalizability of the data. secondly, we did not collect information on medications relevant for prognostication, and therefore analyses in this study was not controlled for the impact of these drugs. \\n decreased estimated gfr on admission is a strong risk factor for increased in - hospital complications and mortality in stemi patients undergoing primary pci. \\n these risks increased in a stepwise fashion according to the degree of decreased estimated gfr. \\n clinicians should be alert to the increased mortality in patients with rd and make all the attempts to reduce complications of primary pci and stress intensive medical management of these high - risk patients.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': 'Summarize the following article: the term  metabolic syndrome  refers to the simultaneous onset and progression of factors \\n known to trigger atherosclerosis , such as obesity , dyslipidemia , hypertension , impaired \\n fasting glucose , and impaired glucose tolerance1 , \\n 2 . \\n for example , it has been shown that the risks \\n of cardiac disease and type 2 diabetes and their mortality rates increase when metabolic \\n syndrome is present3,4,5 . physical inactivity and sedentary behavior as daily habits \\n are considered major causes of \\n metabolic syndrome6 , and it has been \\n reported that the lack of physical activity itself can be a risk factor for early death from \\n atherosclerotic cardiovascular disease7 , 8 . \\n therefore , increasing physical activity in \\n daily life is considered important for preventing metabolic syndrome9 , 10 . \\n studies on \\n physical activity and metabolic syndrome reported that the prevalence of metabolic syndrome \\n was lower in groups with high levels of physical activity than in inactive groups , showing \\n an inverse correlation11 , 12 \\n . meanwhile , physical activity level is also influenced by sociodemographic \\n characteristics13 . according to a study \\n comparing occupation and physical activity , \\n physical activity level was low among office \\n workers with primarily sedentary tasks and little physical activity at work14 , 15 . \\n furthermore , office workers were reported to have inactive leisure \\n activities after work in addition to sedentary behaviors in the workplace16 , 17 . \\n bauman et al.18 \\n analyzed the sedentary time at work and at home in 20 countries using the international \\n physical activity questionnaire ( ipaq ) and showed that the probability of sitting down for \\n more than 9 hours per day was more than three times greater with low physical activity than \\n it was with high physical activity . \\n the association of physical inactivity at work and in \\n daily life with the prevalence of metabolic syndrome has been shown in various studies . \\n moreover , a study by mndez - hernndez et al.19 showed that the risk of metabolic syndrome decreased by 0.75-fold \\n in a group with more than 3 hours of physical activity at work compared with those in a \\n group that did not . \\n choi et al.20 also \\n reported that those with sedentary tasks and low physical activity levels among 1,001 u.s . \\n workers had a higher risk of abdominal obesity , which is the essential identifying factor of \\n metabolic syndrome . \\n in addition , a study by kim et al.21 , which analyzed the risk of metabolic syndrome for each \\n occupational group in south korea , revealed that the relative risk for metabolic syndrome \\n was 1.25-fold higher among office workers than it was among non - office workers , and that \\n their physical activity level was low . \\n in other words , the risk of metabolic syndrome can be \\n associated with physical activity levels according to a person s occupation . however , although sociodemographic characteristics , such as occupation type of task , and \\n work environment , affect cardiovascular disease and diabetes are important factors in \\n metabolic syndrome22,23,24 , studies elucidating the \\n effect of preventing metabolic syndrome by taking into account the physical activity level \\n of white - collar workers with primarily sedentary tasks are lacking . \\n therefore , the present \\n study examined the relationship between physical activity level and metabolic syndrome by \\n considering the daily physical activity level of white - collar workers . \\n general characteristics , physical activity levels , and metabolic syndrome factors were \\n assessed in 385 male white - collar workers who participated in the 2013 seoul metabolic \\n syndrome . \\n management campaign ( may , 2013 ) . after excluding those who did not participate in \\n the survey for measuring physical activity or blood testing , 331 male white - collar workers \\n were selected as study subjects . \\n the study was approved by the ethics and research committee \\n for research involving human beings of the institution in which the study was performed . \\n height and weight were measured using an electronic scale ( inbody4.0 , biospace , seoul , \\n south korea ) . for waist circumference \\n , the midpoint of the subcostal region and the upper \\n iliac crest on both sides was measured to the nearest 0.1  cm in the standing position using \\n a measuring tape . \\n blood pressure was measured once in the right arm using an electronic hematomanometer \\n ( ft-700r , jawon medical , gyeongsan , south korea ) in a sitting position after 10 minutes of \\n rest . when the reading was abnormal , \\n blood pressure was remeasured after another 10 minutes \\n of rest . for blood testing , \\n venous blood was collected on an empty stomach after the patient had \\n fasted for more than 10 hours , after which fasting glucose , high - density lipoprotein ( hdl ) \\n cholesterol and triglycerides were measured . \\n physical activity levels of the study subjects were measured by a long - form , \\n self - administered version of the ipaq questionnaire25 . \\n the level of physical activity was calculated from the data \\n obtained in the present study based on the score conversion system of the ipaq . \\n the activity \\n level measured with the ipaq was divided into low , moderate , and high physical activity , as \\n follows : 1 . \\n low physical activity : no activity was reported or some activity was reported but not \\n enough to meet categories 2 or 3 . 2 . \\n a. 3 or more days of vigorous - intensity activity of at least 20 minutes per day . \\n b. 5 or more days of moderate - intensity activity and/or walking for at least 30 minutes per \\n day . c. 5 or more days of any combination of walking , moderate - intensity , or vigorous - intensity \\n activities achieving a minimum of at least 600 met - min / week . 3 . \\n a. vigorous - intensity activity of at least 3 days per week and accumulation of at least \\n 1,500 met - min / week . \\n b. 7 or more days of any combination of walking or moderate- or vigorous - intensity activity \\n accumulation of at least 3,000 met - min / week . \\n metabolic syndrome diagnostic criteria consisted of the 5 components suggested by national \\n cholesterol education program treatment panel iii ( ncep - atp)26 . \\n the waist circumference classifications for asian populations \\n suggested by the who were consulted27 . \\n subjects were diagnosed with metabolic syndrome if three or more of the following conditions \\n were met : hdl 40  mg / dl , triglycerides 150  mg / dl , sbp and dbp at rest 130 or 85 mmhg , \\n fasting glucose 100  mg / dl , or waist circumference 90  cm . to examine the general characteristics of the study subjects , means and standard deviations \\n were calculated from their body measurements , and metabolic syndrome factors ( continuous \\n variables ) and engaging in drinking and smoking ( categorical variables ) were expressed as \\n frequencies and percentages . to observe the differences between metabolic syndrome - related \\n factors according to physical activity level , one - way analysis of variance was performed . to \\n verify the associations between metabolic syndrome variables and physical activity level , \\n odds ratios was calculated using logistic regression analysis . the level of statistical \\n significance (  ) \\n the comparison of groups according to physical activity level did not show differences in \\n age , weight , and height among groups . regarding metabolic syndrome factors , \\n waist \\n circumference and triglycerides were significantly lower in the moderate and high physical \\n activity groups than in the low activity group ( p<0.05 and p<0.05 , respectively ) . \\n hdl \\n cholesterol was significantly higher in the moderate and high physical activity groups than \\n in the low activity group ( p<0.05 ) . \\n although there were differences in systolic and \\n diastolic blood pressure and fasting glucose level between the physical activity levels , \\n they were not significant ( table 1table 1.general characteristics of the participants and their metabolic syndrome \\n variables according to level of physical activityphysical activitylowmoderatehigh(n=111)(n=115)(n=105)age ( years)48.1  7.347.8  7.248.8  6.0weight ( kg)169.9  6.4170.6  5.6170.2  5.4height ( cm)71.0  9.070.2  9.469.9  7.7physical activity***1,367.6 \\n 960.83,604.2  1,579.1 7,219.9  3,296.8 smokes , n ( % ) 60 ( 54.1)61 ( 53.0)46 ( 43.8)drinks , n ( % ) 54 ( 48.8)63 ( 54.8)48 ( 45.7)ms factorwc ( cm)*82.8  7.180.5  7.8 80.7  6.6 tg ( mg / dl)*163.1  124.0127.2  69.8 132.6  113.2 hdl ( mg / dl)**49.3  12.753.3  12.8 54.2  12.5 sbp ( mmhg)134.5  13.7 132.3  15.7 132.4  14.9 dbp ( mmhg)84.1  9.0 82.4  10.3 81.9  10.4 fg \\n ( mg / dl)97.1  22.8 92.6  12.1 91.9  14.9 data are shown as mean  standard deviation values unless otherwise indicated . \\n a : low \\n physical activity ; b : moderate physical activity ; c : high physical activity ; dbp : \\n diastolic blood pressure ; fg : fasting glucose ; hdl : high - density lipoprotein \\n cholesterol ; ms : metabolic syndrome ; sbp : systolic blood pressure ; tg : triglycerides ; \\n wc : waist circumference . * p<0.05 , * * p<0.01 , * * * p<0.001 ) . data are shown as mean  standard deviation values unless otherwise indicated . \\n a : low \\n physical activity ; b : moderate physical activity ; c : high physical activity ; dbp : \\n diastolic blood pressure ; fg : fasting glucose ; hdl : high - density lipoprotein \\n cholesterol ; ms : metabolic syndrome ; sbp : systolic blood pressure ; tg : triglycerides ; \\n wc : waist circumference . \\n * p<0.05 , * * p<0.01 , * * * p<0.001 in the relationship between physical activity and metabolic syndrome factors , waist \\n circumference and fasting glucose showed negative correlations ( p<0.001 and p<0.05 , \\n respectively ) , whereas hdl cholesterol showed a positive correlation ( p<0.05 ) \\n . however , \\n triglycerides , systolic blood pressure , and diastolic blood pressure did not show \\n significant relationships ( table 2table 2.association between physical activity and metabolic syndrome factorswctghdlsbpdbpfgphysical activity 0.176***0.0500.113 * 0.0000.0650.135*dbp : diastolic blood pressure ; fg : fasting glucose ; hdl : high - density lipoprotein \\n cholesterol ; sbp : systolic blood pressure ; tg : triglycerides ; wc : waist circumference . \\n * p<0.05 , * * * p<0.001 ) . \\n dbp : diastolic blood pressure ; fg : fasting glucose ; hdl : high - density lipoprotein \\n cholesterol ; sbp : systolic blood pressure ; tg : triglycerides ; wc : waist circumference \\n . \\n * p<0.05 , * * * p<0.001 the prevalence of metabolic syndrome according to the level of physical activity was 25.2% \\n for the low physical activity group , 13% for the moderate physical group , and 14.3% for the \\n high physical group ; it was significantly lower in the moderate and high physical activity \\n groups ( p<0.05 ) . \\n the prevalence of metabolic syndrome according to an hdl cholesterol \\n level 40  mg / dl was 27.0% in the low physical activity group , 13.9% in the moderate physical \\n activity group , and 9.5% in the high physical activity group ( p<0.001 ) . \\n fasting glucose \\n also showed significant differences , with the prevalences of metabolic syndrome being 29.7% \\n in the low physical activity group , 20.0% in the moderate physical activity group , and 16.2% \\n in the high physical activity group ( p<0.05 ) . \\n however , waist circumference , \\n triglycerides , blood pressure , and other variables did not show differences ( table 3table 3.prevalence of metabolic syndrome according to level of physical activityphysical activitymetabolic syndrome*wctghdl***bpfg*90  cm 150  mg / dl40  mg / dl130 or 85 mmhg \\n 100  mg / dllow ( n=111)28 ( 25.2)21 ( 18.9)36 ( 32.4)30 ( 27.0)78 ( 70.3)33 ( 29.7)moderate ( n=115)15 ( 13.0)16 ( 13.9)31 ( 27.0)16 ( 13.9)65 ( 56.5)23 ( 20.0)high ( n=105)15 ( 14.3)12 ( 11.4)23 ( 21.9)10 ( 9.5)61 ( 58.1)17 ( 16.2)total ( n=331)58 ( 17.5)49 ( 14.8)90 ( 27.2)56 ( 16.9)204 ( 61.6)73 ( 22.1)data are shown as numbers ( % ) . \\n bp : blood pressure ; fg : fasting glucose ; hdl : \\n high - density lipoprotein cholesterol ; tg : triglycerides ; wc : waist circumference . \\n bp : blood pressure ; fg : fasting glucose ; hdl : \\n high - density lipoprotein cholesterol ; tg : triglycerides ; wc : waist circumference . \\n * p<0.05 , * * * p<0.001 the odds ratio for metabolic syndrome according to the level of physical activity was 2.03 \\n ( 95% ci , 1.014.09 ) in the low physical activity group . \\n this group had a greater risk of \\n developing metabolic syndrome than the group with a high level of physical activity ( table 4table 4.odds ratio of having metabolic syndrome according to level of physical \\n activityadjustedor(95% ci)high physical activity1.00moderate physical activity0.85(0.391.85)low physical activity2.03(1.014.09)ci : confidence interval ; or : odds ratio ) . \\n ci : confidence interval ; or : odds ratio with respect to metabolic syndrome factors according to the level of physical activity , the \\n odds ratio for hdl cholesterol level 40  mg / dl was 3.52 ( 95% ci , 1.627.67 ) , with the low \\n physical activity group having an increased risk compared with the high physical activity \\n group , and the odds ratio for fasting glucose 100  mg / dl increased to 2.36 ( 95% ci , \\n 1.194.66 ) \\n . however , waist circumference , triglycerides , and blood pressure factors did not \\n show significant associations ( table \\n 5table 5.odds ratio of having metabolic syndrome variables according to level of physical \\n activityphysical activitywc90  cm tg150  mg / dlhdl40  mg / dlbp130 or 85 mmhgfg100  mg / dlor ( 95% ci)or ( 95% ci)or ( 95% ci)or ( 95% ci)or ( 95% ci)high1.001.001.001.001.00moderate1.24 ( 0.552.80)1.18 ( 0.622.24)1.55 ( 0.663.61)1.76 ( 0.993.13)1.23 ( 0.602.53)low1.86 ( 0.864.02)1.73 ( 0.923.25)3.52 ( 1.627.67)0.89 ( 0.511.54)2.36 ( 1.194.66)bp : blood pressure ; \\n fg : fasting glucose ; hdl : high - density lipoprotein cholesterol ; \\n or : odds ratio ; tg : triglycerides ; wc : waist circumference ) . bp : blood pressure ; fg : fasting glucose ; hdl : high - density lipoprotein cholesterol ; \\n or : odds ratio ; tg : triglycerides ; wc : waist circumference \\n the present study examined the relationship between physical activity level and metabolic \\n syndrome in male white - collar workers by dividing the workers into low , moderate , and high \\n physical activity groups according to ipaq classification . \\n the study results showed that the \\n moderate and highly active groups showed significant differences compared with the low \\n activity group in waist circumference , triglycerides , and hdl cholesterol , which are the \\n risk factors for metabolic syndrome . \\n the study also showed that the level of physical \\n activity was associated with waist circumference , fasting glucose , and hdl cholesterol . \\n furthermore , the prevalence of metabolic syndrome was low for workers with moderate and high \\n physical activities compared with those with low physical activity . \\n previous studies have already proven that physical activity and exercise play a crucial \\n role in preventing metabolic syndrome , a complex cardiovascular disease28 , 29 , and moderate \\n or vigorous physical activity is recommended for health promotion and prevention of chronic \\n disease30 . \\n however , adults generally do \\n not engage in physical activity or exercise of moderate intensity or higher , and a lifestyle \\n with primarily sedentary behavior is prevalent31 . a study on the prevalence of metabolic syndrome showed that the \\n risk of metabolic syndrome decreased as the level of physical activity increased32 . \\n moreover , decreased physical activity has \\n been shown to be associated with metabolic syndrome factors such as obesity , hypertension , \\n diabetes , and dyslipidemia33,34,35 , and a group \\n with high levels of physical activity had a lower incidence of metabolic syndrome compared \\n with those in an inactive group , showing a negative correlation11 . \\n similar to previous studies , the present study showed \\n that for metabolic syndrome factors according to the level of physical activity in male \\n white - collar workers , waist circumference and triglycerides were significantly higher in the \\n group with low physical activity than they were in the moderate or high physical activity \\n groups , while hdl cholesterol was significantly lower in the low physical activity group \\n than it was in the moderate or high activity group . \\n in addition , with respect to the \\n association between physical activity level and metabolic syndrome , waist circumference and \\n fasting glucose showed a negative correlation , whereas hdl cholesterol showed a positive \\n correlation . \\n these results indicate that although not all of the factors of metabolic \\n syndrome showed clear differences according to the level of physical activity in public \\n office workers , moderate and high levels of physical activity are effective in decreasing \\n risk factors for metabolic syndrome in white - collar workers compared with low levels of \\n physical activity . \\n this suggests that reducing sedentary lifestyles and inactivity and \\n increasing the level of physical activity in daily life an important for white - collar \\n workers who are at risk of metabolic syndrome due to a sedentary work environment . \\n a previous investigation of 7,432 adults using the ipaq showed that a group that exercised \\n more than 3 times per week ( 20.3% ) had a lower prevalence of metabolic syndrome than a the \\n group without physical activity ( 36.2%)36 . a prospective cohort study of 874 middle - aged men and women showed a \\n lower prevalence of metabolic syndrome in a group with high physical activity levels12 , and the odds ratio for metabolic syndrome \\n prevalence tended to decrease as the level of physical activity increased37 . in a study by zhu et al.38 of 11,239 adults examined as part of the \\n third national health and nutrition examination survey ( nhanes iii ) in the u.s . , when a \\n group without physical activity was given a value of 1 , the odds ratio for the prevalence of \\n metabolic syndrome in a group with high physical activity was 0.41 times ( 95% ci , 0.310.54 ) \\n greater in males . in a study by chung39 , \\n when a group that engaged in regular exercise more than 5 times per week was given a value \\n of 1 , the odds ratio a group without any exercise increased by 1.7 times ( 95% ci , 1.02.8 ) . \\n in the present study , the overall prevalence of metabolic syndrome was 17.5% in male public \\n office workers ; according to the physical activity level , the prevalence of metabolic \\n syndrome was higher in those with low physical activity ( 25.2% ) than in those with moderate \\n ( 13.0% ) or high ( 14.3% ) activity . \\n the odds ratio for metabolic syndrome was 2.03-fold higher \\n in the group with low physical activity ( 95% ci , 1.014.09 ) compared with the high physical \\n activity group . \\n as the physical activity level decreased in public office workers whose work \\n mainly involved sedentary tasks , the risk of metabolic syndrome incidence also tended to \\n decrease . \\n this indicates that the level of physical activity is important for decreasing the \\n risk of metabolic syndrome . \\n however , because the study was a cross - sectional study on white - collar workers within a \\n certain region , it is limited in terms of predicting the incidence of metabolic syndrome \\n according to physical activity level . \\n furthermore , we did not analyze any job - related \\n factors , such as employment history , position , and work stress , which is another limitation \\n of the present study . \\n further analysis of such factors may reveal further indicators of \\n being at risk for metabolic syndrome and other health conditions . in conclusion \\n , the present study showed that low physical activity is associated with a \\n higher prevalence of metabolic syndrome in white - collar workers whose work primarily \\n involves sedentary tasks . \\n therefore , this suggests that increasing the level of physical \\n activity is important for preventing metabolic syndrome in office workers with relatively \\n low physical activity .',\n",
       "  'output': '[ purpose ] physical activity is important for preventing and managing metabolic syndrome . \\n white - collar workers can be inherently predisposed to chronic diseases , as their jobs are \\n primarily sedentary . \\n the purpose of this study was to examine the relationship between \\n physical activity and metabolic syndrome in male white - collar workers . \\n [ subjects and \\n methods ] physical activity and metabolic syndrome factors were measured in 331 male public \\n office workers . \\n physical activity was classified as high ( n=101 ) , moderate ( n=115 ) , or low \\n ( n=111 ) using the international physical activity questionnaire . to diagnose metabolic \\n syndrome , the u.s . \\n national cholesterol education program s standard was used . \\n [ results ] \\n waist circumference and triglyceride levels , factors of metabolic syndrome , were \\n significantly higher in the low physical activity group than in the moderate or high \\n activity group . \\n high - density lipoprotein cholesterol was significantly lower in the low \\n physical activity group than in the moderate or high activity group . \\n waist circumference \\n and fasting glucose were negatively correlated with physical activity level , and hdl \\n cholesterol showed a positive correlation with waist circumference . \\n the odds ratios for \\n metabolic syndrome were 2.03 times higher ( 95% confidence interval , 1.014.09 ) in the low \\n physical activity group than in the high physical activity group . \\n [ conclusion ] low \\n physical activity was a risk factor for metabolic syndrome in white - collar workers . \\n therefore , increasing physical activity in daily life may prevent metabolic syndrome in \\n white - collar workers .',\n",
       "  '__index_level_0__': 31683,\n",
       "  'model_output': 'Summarized article is below.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': 'Summarize the following article: written informed consent was obtained from 18 healthy , nonsmoking subjects ( men / women 5/13 , mean  sd age 27.2  9.4 years , mean bmi 23.6  2.8 kg / m , mean fasting plasma glucose level 5.09  0.35 \\n none of the participants were on chronic medication ( with the exception of oral contraceptives ) , reported type 2 diabetes among first - degree relatives , or had a history of cardiovascular events . \\n a pregnancy test was performed in female subjects at the screening visit to exclude pregnancy . \\n the study was approved by the institutional review board of the radboud university nijmegen medical centre . \\n all participants underwent two euglycemic glucose clamp experiments ( 13,16 ) to investigate the pharmacokinetics and pharmacodynamics of rapid - acting insulin delivered by jet injection or conventional pen injection , using a double - blind , double - dummy , randomized cross over study design . \\n there was a washout period of at least 1 week between the two clamps , whereas female subjects were tested at 4- or 8-week intervals to ensure that experiments took place during corresponding periods of the menstrual cycle . \\n participants were admitted to the research unit at 0830 h after an overnight fast and having abstained from smoking , alcohol use , and caffeine use for at least 24 h. the experiments were performed in supine position in a temperature controlled room ( 2224c ) . \\n one catheter was inserted in retrograde fashion in a dorsal hand vein for blood sampling . \\n this hand was placed in a heated box , kept at 55c to arterialize venous blood ( 17,18 ) . \\n the other catheter was placed in an antecubital vein of the contralateral arm for administration of 20% dextrose . after instrumentation , a 30-min equilibration period was included before blood was sampled for baseline values of plasma glucose and plasma insulin . \\n subsequently , all participants received both insulin ( aspart , novo nordisk , bagsvaerd , denmark ) in a dose of 0.2 units / kg body wt and a comparable volume of placebo solution ( test medium penfill , novo nordisk , bagsvaerd , denmark ) simultaneously injected subcutaneously in the abdomen . on one occasion , \\n insulin was administered by jet injection ( insujet , european pharma group bv , schiphol - rijk , the netherlands ) and placebo by conventional pen ( novopen iii , novo nordisk ) ; on the other occasion , insulin was injected by the conventional pen and placebo by the jet injector . \\n two - by - two block randomization was used to randomize the sequence by which the two devices were used for insulin and placebo injections . \\n the jet injector device used in this study was equipped with a loaded spring mechanism , kept in place by a counterpressure lock / release system . after pressing the nozzle perpendicular to the skin , the jet injector releases insulin with sufficient force to enter the subcutaneous tissue to a depth equivalent to standard needle syringe . to avoid premature insulin release , \\n both the jet injector and the conventional pen were operated by trained personnel only and were prepared by a nurse who was not involved in the trial . \\n after administration of insulin and placebo solution , plasma glucose was maintained at euglycemic levels ( 5.0 \\n mmol / l ) for 8 h by a variable infusion of 20% dextrose , the rate of which was determined by plasma glucose measurements at 5-min intervals during the first 4 h and at 10-min intervals thereafter . \\n blood for plasma insulin levels was sampled every 10 min during the 1st hour and every 30 min for the remainder of the study . \\n all pharmacodynamic and pharmacokinetic study end points were derived from the exogenous glucose infusion rate ( gir ) and insulin concentration profiles . \\n the primary study end point was the time to maximal gir ( t - girmax ) , corresponding to the time until the maximal glucose - lowering effect of insulin was obtained . \\n secondary pharmacodynamic end points were the maximal gir ( c - girmax ) , the time to 50% of glucose disposal ( t - gir50% ) , and the total amount of glucose administered calculated from the area under the curve ( auc ) ( girtot ) . \\n secondary pharmacokinetic end points included the time to maximal insulin concentration ( t - insmax ) , the maximal insulin concentration ( c - insmax ) , the area under the insulin concentration curve ( insauc ) , and the time until 50% of insulin absorption , calculated as 50% of the area under the insulin concentration curve ( t - insauc50% ) . \\n plasma glucose levels were determined in duplicate , immediately after blood sampling by the glucose oxidase method ( beckman glucose analyzer ii , beckman instruments , fullerton , ca ) . \\n blood sampled for plasma insulin measurements was collected in lithium - heparin tubes and placed on ice . \\n assuming a t - girmax of 94 min with a sd of 46 min for aspart insulin administered subcutaneously in the abdomen by conventional pen injection ( 10 ) , we calculated that a total of 18 subjects would be needed to find a 20% reduction in the primary end point with 80% statistical power at the conventional p value of 0.05 , after correction for small sample sizes . \\n all statistical analyses were performed by spss 16.0 ( statistical package for social sciences , chicago , il ) . a p value of < 0.05 was considered statistically significant . \\n all participants underwent two euglycemic glucose clamp experiments ( 13,16 ) to investigate the pharmacokinetics and pharmacodynamics of rapid - acting insulin delivered by jet injection or conventional pen injection , using a double - blind , double - dummy , randomized cross over study design . \\n there was a washout period of at least 1 week between the two clamps , whereas female subjects were tested at 4- or 8-week intervals to ensure that experiments took place during corresponding periods of the menstrual cycle . \\n participants were admitted to the research unit at 0830 h after an overnight fast and having abstained from smoking , alcohol use , and caffeine use for at least 24 h. the experiments were performed in supine position in a temperature controlled room ( 2224c ) . \\n one catheter was inserted in retrograde fashion in a dorsal hand vein for blood sampling . \\n this hand was placed in a heated box , kept at 55c to arterialize venous blood ( 17,18 ) . \\n the other catheter was placed in an antecubital vein of the contralateral arm for administration of 20% dextrose . \\n after instrumentation , a 30-min equilibration period was included before blood was sampled for baseline values of plasma glucose and plasma insulin . \\n subsequently , all participants received both insulin ( aspart , novo nordisk , bagsvaerd , denmark ) in a dose of 0.2 units / kg body wt and a comparable volume of placebo solution ( test medium penfill , novo nordisk , bagsvaerd , denmark ) simultaneously injected subcutaneously in the abdomen . on one occasion , \\n insulin was administered by jet injection ( insujet , european pharma group bv , schiphol - rijk , the netherlands ) and placebo by conventional pen ( novopen iii , novo nordisk ) ; on the other occasion , insulin was injected by the conventional pen and placebo by the jet injector . \\n two - by - two block randomization was used to randomize the sequence by which the two devices were used for insulin and placebo injections . the jet injector device used in this study \\n was equipped with a loaded spring mechanism , kept in place by a counterpressure lock / release system . after pressing the nozzle perpendicular to the skin , the jet injector releases insulin with sufficient force to enter the subcutaneous tissue to a depth equivalent to standard needle syringe . to avoid premature insulin release , the system unlocks only when sufficient pressure has been applied to the nozzle . \\n both the jet injector and the conventional pen were operated by trained personnel only and were prepared by a nurse who was not involved in the trial . \\n after administration of insulin and placebo solution , plasma glucose was maintained at euglycemic levels ( 5.0 \\n mmol / l ) for 8 h by a variable infusion of 20% dextrose , the rate of which was determined by plasma glucose measurements at 5-min intervals during the first 4 h and at 10-min intervals thereafter . \\n blood for plasma insulin levels was sampled every 10 min during the 1st hour and every 30 min for the remainder of the study . \\n all pharmacodynamic and pharmacokinetic study end points were derived from the exogenous glucose infusion rate ( gir ) and insulin concentration profiles . \\n the primary study end point was the time to maximal gir ( t - girmax ) , corresponding to the time until the maximal glucose - lowering effect of insulin was obtained . \\n secondary pharmacodynamic end points were the maximal gir ( c - girmax ) , the time to 50% of glucose disposal ( t - gir50% ) , and the total amount of glucose administered calculated from the area under the curve ( auc ) ( girtot ) . \\n secondary pharmacokinetic end points included the time to maximal insulin concentration ( t - insmax ) , the maximal insulin concentration ( c - insmax ) , the area under the insulin concentration curve ( insauc ) , and the time until 50% of insulin absorption , calculated as 50% of the area under the insulin concentration curve ( t - insauc50% ) . \\n plasma glucose levels were determined in duplicate , immediately after blood sampling by the glucose oxidase method ( beckman glucose analyzer ii , beckman instruments , fullerton , ca ) . \\n blood sampled for plasma insulin measurements was collected in lithium - heparin tubes and placed on ice . \\n assuming a t - girmax of 94 min with a sd of 46 min for aspart insulin administered subcutaneously in the abdomen by conventional pen injection ( 10 ) , we calculated that a total of 18 subjects would be needed to find a 20% reduction in the primary end point with 80% statistical power at the conventional p value of 0.05 , after correction for small sample sizes . \\n all statistical analyses were performed by spss 16.0 ( statistical package for social sciences , chicago , il ) . a p value of < 0.05 was considered statistically significant . \\n all 18 subjects completed the study . in two subjects , one of the clamp experiments had to be rescheduled because insulin levels failed to increase , with both incidents occurring when the jet injector contained insulin . \\n in one instance , the jet injector was incompletely checked for air bubbles in the system . in the other instance , the spring was released before proper contact could be made with the skin , after which the jet injector was returned to the manufacturer and replaced . \\n injections were well tolerated by the participants , although some participants regarded the firm pressure required for injection with the jet injector as unpleasant . \\n mean plasma glucose levels during the clamps were 5.0  0.1 mmol / l with both devices . \\n the corresponding coefficients of variation were 8.0  0.8% and 7.3  0.5% for the jet injector and conventional insulin pen , respectively . \\n all results of pharmacodynamic end points are shown in fig . 1 and listed in table 1 . \\n the time to maximal glucose - lowering effect , as represented by t - girmax , was reduced by > 50% when insulin was administered with the jet injector as compared with conventional insulin administration . \\n there were no differences in maximal glucose - lowering effect ( c - girmax ) or the total amount of glucose administered ( girtot ) between the two devices . \\n however , the time to 50% of glucose disposal ( t - gir50% ) , representing the total duration of insulin action , was approximately 40 min shorter for insulin administration by jet injector than that by conventional insulin pen . \\n mean gir after administration of rapid - acting insulin by the jet injector ( closed symbols , black line ) or the conventional insulin pen ( open symbols , dashed line ) during the euglycemic glucose clamp . \\n pharmacokinetic and pharmacodynamic parameters for insulin administration with the jet injector and the conventional insulin pen the results of pharmacokinetic end points are also listed in table 1 . in analogy with the pharmacodynamic results , the time to reach peak insulin levels \\n was reduced by more than 50% after jet injector insulin administration as compared with insulin administration with the conventional pen . \\n insulin administered with the jet injector also resulted in higher peak insulin levels ( c - insmax ) than insulin administered with the conventional insulin pen ( fig . \\n 2 ) . the insauc did not differ between the jet injector and the conventional insulin pen , but t - insauc50% was significantly shorter for the jet injector , indicating faster insulin absorption from the subcutaneous tissue into the circulation . \\n mean plasma insulin levels after administration of rapid - acting insulin by the jet injector ( closed symbols , black line ) or the conventional insulin pen ( open symbols , dashed line ) during the euglycemic glucose clamp . \\n there was no indication that sex modified the pharmacodynamic or pharmacokinetic differences between the jet injector and conventional pen for insulin administration . \\n in fact , the jet injector performed significantly better than the conventional pen in both groups , when analyzed separately ( data not shown but available upon request ) . \\n all results of pharmacodynamic end points are shown in fig . 1 and listed in table 1 . \\n the time to maximal glucose - lowering effect , as represented by t - girmax , was reduced by > 50% when insulin was administered with the jet injector as compared with conventional insulin administration . \\n there were no differences in maximal glucose - lowering effect ( c - girmax ) or the total amount of glucose administered ( girtot ) between the two devices . \\n however , the time to 50% of glucose disposal ( t - gir50% ) , representing the total duration of insulin action , was approximately 40 min shorter for insulin administration by jet injector than that by conventional insulin pen . \\n mean gir after administration of rapid - acting insulin by the jet injector ( closed symbols , black line ) or the conventional insulin pen ( open symbols , dashed line ) during the euglycemic glucose clamp . \\n pharmacokinetic and pharmacodynamic parameters for insulin administration with the jet injector and the conventional insulin pen \\n the results of pharmacokinetic end points are also listed in table 1 . in analogy with the pharmacodynamic results , the time to reach peak insulin levels \\n was reduced by more than 50% after jet injector insulin administration as compared with insulin administration with the conventional pen . \\n insulin administered with the jet injector also resulted in higher peak insulin levels ( c - insmax ) than insulin administered with the conventional insulin pen ( fig . \\n 2 ) . the insauc did not differ between the jet injector and the conventional insulin pen , but t - insauc50% was significantly shorter for the jet injector , indicating faster insulin absorption from the subcutaneous tissue into the circulation . \\n mean plasma insulin levels after administration of rapid - acting insulin by the jet injector ( closed symbols , black line ) or the conventional insulin pen ( open symbols , dashed line ) during the euglycemic glucose clamp . \\n there was no indication that sex modified the pharmacodynamic or pharmacokinetic differences between the jet injector and conventional pen for insulin administration . \\n in fact , the jet injector performed significantly better than the conventional pen in both groups , when analyzed separately ( data not shown but available upon request ) . \\n in this study , the pharmacodynamic and pharmacokinetic profiles of the rapid - acting insulin analog aspart , injected by either jet injection technique or by conventional insulin pen , were compared . \\n we found that the jet injector greatly enhanced the rate of insulin absorption , resulting in a truly immediate onset of action and approximately halving of the time to reach maximal glucose - lowering effect in comparison with conventional insulin administration . \\n in addition , insulin administration by jet injection reduced the total duration of hyperinsulinemia and insulin action by 3040 min when compared with conventional insulin administration . \\n there were no indications that these benefits of the jet injector over the conventional pen differed between women and men . \\n our data are in line with previous studies that have shown a more rapid increase in insulin levels and shorter duration of hyperinsulinemia after administration of regular insulin by jet injection compared with administration by needle syringe ( 38 ) . \\n the results of the current study also extend those of a recent study performed by sarno et al . \\n ( 9 ) , who compared administration of various insulins ( including lispro insulin ) with jet injection to that with needle syringes . in that study , time \\n to peak insulin levels after lispro insulin administration was shorter for the jet injector than for needle syringe injection , but a statistically significant pharmacodynamic effect could not be established . also , the number of volunteers examined was small ( n = 4 ) and the dose of insulin used was fixed at a relatively high level ( 30 units for all ) . \\n our study convincingly shows the pharmacokinetic and pharmacodynamic superiority of jet injection over conventional needle pens for administration of rapid - acting insulin at a dose that is realistic for many people with type 1 or type 2 diabetes . \\n it is also the first time that jet injection technology was compared with an insulin pen , which most patients prefer over syringes for their ease of use and high level of accuracy ( 20 ) . \\n insulin injected by jet injection displays a specific cone - like dispersion pattern in the subcutaneous tissue with a relatively large surface area ( 1,2 ) . \\n it seems plausible that this dispersion pattern enhances absorption of insulin into the circulation , thus explaining a more immediate glucose - lowering effect . \\n the current jet injector uses a high - velocity jet that ensures > 90% delivery of injected insulin into the subcutaneous tissue , without risking penetration of the underlying muscle , at a jet stream diameter of 0.15 mm . \\n these device characteristics compare favorably to the length and diameter of pen needles that typically measure 68 mm and 0.5 mm , respectively . a limitation to the use of jet injectors in comparison with insulin pens \\n is that sufficient training is required with both air - free filling of the injection chamber and the injection procedure itself . \\n we had to reschedule the first experiment , probably because of an air bubble in the system , and another experiment because of early discharge of the spring system , possibly related to failure of the lock / release system . however , after proper training , administration of the entire dose of insulin can be achieved in almost all instances ( 21 ) . \\n the pharmacokinetic and pharmacodynamic profile of rapid - acting insulin administered by the jet injector approached the physiological pattern of endogenous insulin secretion and subsequent glucose - lowering response more closely than insulin administered by a conventional insulin pen . \\n consequently , a more physiological meal insulin substitution may decrease immediate postprandial hyperglycemia , whereas the more rapid tapering of hyperinsulinemia may reduce the risk of late postprandial hypoglycemia . \\n however , postprandial glucose may contribute less to overall glycemic control than preprandial glucose in patients with diabetes , and the role of postprandial hyperglycemia as an independent cardiovascular risk factor is still uncertain ( 22 ) . \\n therefore , appropriately designed studies are needed to determine whether and to what extent the favorable pharmacological properties of insulin administration by jet injection found in this study translate into clinical benefit in the longer term for patients with diabetes . a strength of our study is the use of a double - dummy cross over study design , ensuring that both participants and investigators were truly blinded during the execution of the experiments . \\n moreover , because we used a placebo solution that contained the same ingredients as the insulin solution ( except for insulin ) , the smell and viscosity of the two liquids were indistinguishable . \\n a limitation of this study is that the euglycemic clamps were performed in healthy individuals rather than in patients with diabetes , the target population for such a device . \\n in addition , only one insulin dose was investigated ; it can not be determined with certainty whether the current differences in time - action profiles can be extrapolated to other insulin doses . \\n finally , the ease of use of the jet injector was not tested , which is important for a device that is aimed at being used on a daily basis . in conclusion \\n , the current study shows that when insulin is administered with a jet injector instead of a conventional insulin pen , a more rapid onset of insulin action can be achieved . \\n insulin administered by the jet injector resembles the pattern of endogenous insulin secretion more closely and could therefore be useful in providing a more physiologic postprandial insulin profile . \\n future research will need to investigate whether these results can be replicated in patients with diabetes and what the clinical implications are .',\n",
       "  'output': 'objectiveinsulin administered by jet injectors is dispensed over a larger subcutaneous area than insulin injected with a syringe , which may facilitate a more rapid absorption . \\n this study compared the pharmacologic profile of administration of insulin aspart by jet injection to that by conventional insulin pen.research design and methodseuglycemic glucose clamp tests were performed in 18 healthy volunteers after subcutaneous administration of 0.2 units / kg body wt of aspart , either administered by jet injection or by conventional pen , using a randomized , double - blind , double - dummy , cross over study design . \\n pharmacodynamic and pharmacokinetic profiles were derived from the glucose infusion rate ( gir ) needed to maintain euglycemia and from plasma insulin levels , respectively.resultsthe time to maximal gir was significantly shorter when insulin was injected with the jet injector compared with conventional pen administration ( 51  3 vs. 105  11 min , p < 0.0001 ) . the time to peak insulin concentration \\n was similarly reduced ( 31  3 vs. 64  6 min , p < 0.0001 ) and peak insulin concentrations were increased ( 108  13 vs. 79  7 mu / l , p = 0.01 ) when insulin was injected by jet injection compared with conventional pen injection . \\n jet injector insulin administration reduced the time to 50% glucose disposal by 40 min ( p < 0.0001 ) . \\n there were no differences in maximal gir , total insulin absorption , or total insulin action between the two devices.conclusionsadministration of insulin aspart by jet injection enhances insulin absorption and reduces the duration of glucose - lowering action . \\n this profile resembles more closely the pattern of endogenous insulin secretion and may help to achieve better meal insulin coverage and correction of postprandial glucose excursions .',\n",
       "  '__index_level_0__': 31684,\n",
       "  'model_output': 'Summarize the following article: written informed consent was obtained from 18 healthy, nonsmoking subjects ( men / women 5/13, mean  sd age 27.2  9.4 years, mean bmi 23.6  2.8 kg / m, mean fasting plasma glucose level 5.09  0.35 \\n none of the participants were on chronic medication ( with the exception of oral contraceptives ), reported type 2 diabetes among first - degree relatives, or had a history of cardiovascular events. \\n a pregnancy test was performed in female subjects at the screening visit to exclude pregnancy. \\n the study was approved by the institutional review board of the radboud university nijmegen medical centre. \\n all participants underwent two euglycemic glucose clamp experiments ( 13,16 ) to investigate the pharmacokinetics and pharmacodynamics of rapid - acting insulin delivered by jet injection or conventional pen injection, using a double - blind, double - dummy, randomized cross over study design. \\n there was a washout period of at least 1 week between the two clamps, whereas female subjects were tested at 4- or 8-week intervals to ensure that experiments took place during corresponding periods of the menstrual cycle. \\n participants were admitted to the research unit at 0830 h after an overnight fast and having abstained from smoking, alcohol use, and caffeine use for at least 24 h. the experiments were performed in supine position in a temperature controlled room ( 2224c ). \\n one catheter was inserted in retrograde fashion in a dorsal hand vein for blood sampling. \\n this hand was placed in a heated box, kept at 55c to arterialize venous blood ( 17,18 ). \\n the other catheter was placed in an antecubital vein of the contralateral arm for administration of 20% dextrose. after instrumentation, a 30-min equilibration period was included before blood was sampled for baseline values of plasma glucose and plasma insulin. \\n subsequently, all participants received both insulin ( aspart, novo nordisk, bagsvaerd, denmark ) in a dose of 0.2 units / kg body wt and a comparable volume of placebo solution ( test medium penfill, novo nordisk, bagsvaerd, denmark ) simultaneously injected subcutaneously in the abdomen. on one occasion, insulin was administered by jet injection ( insujet, european pharma group bv, schiphol - rijk, the netherlands ) and placebo by conventional pen ( novopen iii, novo nordisk ) ; on the other occasion, insulin was injected by the conventional pen and placebo by the jet injector. \\n two - by - two block randomization was used to randomize the sequence by which the two devices were used for insulin and placebo injections. \\n the jet injector device used in this study was equipped with a loaded spring mechanism, kept in place by a counterpressure lock / release system. after pressing the nozzle perpendicular to the skin, the jet injector releases insulin with sufficient force to enter the subcutaneous tissue to a depth equivalent to standard needle syringe. to avoid premature insulin release, both the jet injector and the conventional pen were operated by trained personnel only and were prepared by a nurse who was not involved in the trial. \\n after administration of insulin and placebo solution, plasma glucose was maintained at euglycemic levels ( 5.0 \\n mmol / l ) for 8 h by a variable infusion of 20% dextrose, the rate of which was determined by plasma glucose measurements at 5-min intervals during the first 4 h and at 10-min intervals thereafter. \\n blood for plasma insulin levels was sampled every 10 min during the 1st hour and every 30 min for the remainder of the study. \\n all pharmacodynamic and pharmacokinetic study end points were derived from the exogenous glucose infusion rate ( gir ) and insulin concentration profiles. \\n the primary study end point was the time to maximal gir ( t - girmax ), corresponding to the time until the maximal glucose - lowering effect of insulin was obtained. \\n secondary pharmacodynamic end points were the maximal gir ( c - girmax ), the time to 50% of glucose disposal ( t - gir50% ), and the total amount of glucose administered calculated from the area under the curve ( auc ) ( girtot ). \\n secondary pharmacokinetic end points included the time to maximal insulin concentration ( t - insmax ), the maximal insulin concentration ( c - insmax ), the area under the insulin concentration curve ( insauc ), and the time until 50% of insulin absorption, calculated as 50% of the area under the insulin concentration curve ( t - insauc50% ). \\n plasma glucose levels were determined in duplicate, immediately after blood sampling by the glucose oxidase method ( beckman glucose analyzer ii, beckman instruments, fullerton, ca ). \\n blood sampled for plasma insulin measurements was collected in lithium - heparin tubes and placed on ice. \\n assuming a t - girmax of 94 min with a sd of 46 min for aspart insulin administered subcutaneously in the abdomen by conventional pen injection ( 10 ), we calculated that a total of 18 subjects would be needed to find a 20% reduction in the primary end point with 80% statistical power at the conventional p value of 0.05, after correction for small sample sizes. \\n all statistical analyses were performed by spss 16.0 ( statistical package for social sciences, chicago, il ). a p value of < 0.05 was considered statistically significant. \\n all participants underwent two euglycemic glucose clamp experiments ( 13,16 ) to investigate the pharmacokinetics and pharmacodynamics of rapid - acting insulin delivered by jet injection or conventional pen injection, using a double - blind, double - dummy, randomized cross over study design. \\n there was a washout period of at least 1 week between the two clamps, whereas female subjects were tested at 4- or 8-week intervals to ensure that experiments took place during corresponding periods of the menstrual cycle. \\n participants were admitted to the research unit at 0830 h after an overnight fast and having abstained from smoking, alcohol use, and caffeine use for at least 24 h. the experiments were performed in supine position in a temperature controlled room ( 2224c ). \\n one catheter was inserted in retrograde fashion in a dorsal hand vein for blood sampling. \\n this hand was placed in a heated box, kept at 55c to arterialize venous blood ( 17,18 ). \\n the other catheter was placed in an antecubital vein of the contralateral arm for administration of 20% dextrose. \\n after instrumentation, a 30-min equilibration period was included before blood was sampled for baseline values of plasma glucose and plasma insulin. \\n subsequently, all participants received both insulin ( aspart, novo nordisk, bagsvaerd, denmark ) in a dose of 0.2 units / kg body wt and a comparable volume of placebo solution ( test medium penfill, novo nordisk, bagsvaerd, denmark ) simultaneously injected subcutaneously in the abdomen. on one occasion, insulin was administered by jet injection ( insujet, european pharma group bv, schiphol - rijk, the netherlands ) and placebo by conventional pen ( novopen iii, novo nordisk ) ; on the other occasion, insulin was injected by the conventional pen and placebo by the jet injector. \\n two - by - two block randomization was used to randomize the sequence by which the two devices were used for insulin and placebo injections. \\n the jet injector device used in this study was equipped with a loaded spring mechanism, kept in place by a counterpressure lock / release system. after pressing the nozzle perpendicular to the skin, the jet injector releases insulin with sufficient force to enter the subcutaneous tissue to a depth equivalent to standard needle syringe. to avoid premature insulin release, both the jet injector and the conventional pen were operated by trained personnel only and were prepared by a nurse who was not involved in the trial. \\n after administration of insulin and placebo solution, plasma glucose was maintained at euglycemic levels ( 5.0 \\n mmol / l ) for 8 h by a variable infusion of 20% dextrose, the rate of which was determined by plasma glucose measurements at 5-min intervals during the first 4 h and at 10-min intervals thereafter. \\n blood for plasma insulin levels was sampled every 10 min during the 1st hour and every 30 min for the remainder of the study. \\n all pharmacodynamic and pharmacokinetic study end points were derived from the exogenous glucose infusion rate ( gir ) and insulin concentration profiles. \\n the primary study end point was the time to maximal gir ( t - girmax ), corresponding to the time until the maximal glucose - lowering effect of insulin was obtained. \\n secondary pharmacodynamic end points were the maximal gir ( c - girmax ), the time to 50% of glucose disposal ( t - gir50% ), and the total amount of glucose administered calculated from the area under the curve ( auc ) ( girtot ). \\n secondary pharmacokinetic end points included the time to maximal insulin concentration ( t - insmax ), the maximal insulin concentration ( c - insmax ), the area under the insulin concentration curve ( insauc ), and the time until 50% of insulin absorption, calculated as 50% of the area under the insulin concentration curve ( t - insauc50% ). \\n plasma glucose levels were determined in duplicate, immediately after blood sampling by the glucose oxidase method ( beckman glucose analyzer ii, beckman instruments, fullerton, ca ). \\n blood sampled for plasma insulin measurements was collected in lithium - heparin tubes and placed on ice. \\n assuming a t - girmax of 94 min with a sd of 46 min for aspart insulin administered subcutaneously in the abdomen by conventional pen injection ( 10 ), we calculated that a total of 18 subjects would be needed to find a 20% reduction in the primary end point with 80% statistical power at the conventional p value of 0.05, after correction for small sample sizes. \\n all statistical analyses were performed by spss 16.0 ( statistical package for social sciences, chicago, il ). a p value of < 0.05 was considered statistically significant. \\n all 18 subjects completed the study. in two subjects, one of the clamp experiments had to be rescheduled because insulin levels failed to increase, with both incidents occurring when the jet injector contained insulin. \\n in one instance, the jet injector was incompletely checked for air bubbles in the system. in the other instance, the spring was released before proper contact could be made with the skin, after which the jet injector was returned to the manufacturer and replaced. \\n injections were well tolerated by the participants, although some participants regarded the firm pressure required for injection with the jet injector as unpleasant. \\n mean plasma glucose levels during the clamps were 5.0  0.1 mmol / l with both devices. \\n the corresponding coefficients of variation were 8.0  0.8% and 7.3  0.5% for the jet injector and conventional insulin pen, respectively. \\n all results of pharmacodynamic end points are shown in fig. 1 and listed in table 1. \\n the time to maximal glucose - lowering effect, as represented by t - girmax, was reduced by > 50% when insulin was administered with the jet injector as compared with conventional insulin administration. \\n there were no differences in maximal glucose - lowering effect ( c - girmax ) or the total amount of glucose administered ( girtot ) between the two devices. \\n however, the time to 50% of glucose disposal ( t - gir50% ), representing the total duration of insulin action, was approximately 40 min shorter for insulin administration by jet injector than that by conventional insulin pen. \\n mean gir after administration of rapid - acting insulin by the jet injector ( closed symbols, black line ) or the conventional insulin pen ( open symbols, dashed line ) during the euglycemic glucose clamp. \\n pharmacokinetic and pharmacodynamic parameters for insulin administration with the jet injector and the conventional insulin pen the results of pharmacokinetic end points are also listed in table 1. in analogy with the pharmacodynamic results, the time to reach peak insulin levels \\n was reduced by more than 50% after jet injector insulin administration as compared with insulin administration with the conventional pen. \\n insulin administered with the jet injector also resulted in higher peak insulin levels ( c - insmax ) than insulin administered with the conventional insulin pen ( fig. \\n 2 ). the insauc did not differ between the jet injector and the conventional insulin pen, but t - insauc50% was significantly shorter for the jet injector, indicating faster insulin absorption from the subcutaneous tissue into the circulation. \\n mean plasma insulin levels after administration of rapid - acting insulin by the jet injector ( closed symbols, black line ) or the conventional insulin pen ( open symbols, dashed line ) during the euglycemic glucose clamp. \\n there was no indication that sex modified the pharmacodynamic or pharmacokinetic differences between the jet injector and conventional pen for insulin administration. \\n in fact, the jet injector performed significantly better than the conventional pen in both groups, when analyzed separately ( data not shown but available upon request ). \\n all results of pharmacodynamic end points are shown in fig. 1 and listed in table 1. \\n the time to maximal glucose - lowering effect, as represented by t - girmax, was reduced by > 50% when insulin was administered with the jet injector as compared with conventional insulin administration. \\n there were no differences in maximal glucose - lowering effect ( c - girmax ) or the total amount of glucose administered ( girtot ) between the two devices. \\n however, the time to 50% of glucose disposal ( t - gir50% ), representing the total duration of insulin action, was approximately 40 min shorter for insulin administration by jet injector than that by conventional insulin pen. \\n mean gir after administration of rapid - acting insulin by the jet injector ( closed symbols, black line ) or the conventional insulin pen ( open symbols, dashed line ) during the euglycemic glucose clamp. \\n pharmacokinetic and pharmacodynamic parameters for insulin administration with the jet injector and the conventional insulin pen \\n the results of pharmacokinetic end points are also listed in table 1. in analogy with the pharmacodynamic results, the time to reach peak insulin levels \\n was reduced by more than 50% after jet injector insulin administration as compared with insulin administration with the conventional pen. \\n insulin administered with the jet injector also resulted in higher peak insulin levels ( c - insmax ) than insulin administered with the conventional insulin pen ( fig. \\n 2 ). the insauc did not differ between the jet injector and the conventional insulin pen, but t - insauc50% was significantly shorter for the jet injector, indicating faster insulin absorption from the subcutaneous tissue into the circulation. \\n mean plasma insulin levels after administration of rapid - acting insulin by the jet injector ( closed symbols, black line ) or the conventional insulin pen ( open symbols, dashed line ) during the euglycemic glucose clamp. \\n there was no indication that sex modified the pharmacodynamic or pharmacokinetic differences between the jet injector and conventional pen for insulin administration. \\n in fact, the jet injector performed significantly better than the conventional pen in both groups, when analyzed separately ( data not shown but available upon request ). \\n in this study, the pharmacodynamic and pharmacokinetic profiles of the rapid - acting insulin analog aspart, injected by either jet injection technique or by conventional insulin pen, were compared. \\n we found that the jet injector greatly enhanced the rate of insulin absorption, resulting in a truly immediate onset of action and approximately halving of the time to reach maximal glucose - lowering effect in comparison with conventional insulin administration. \\n in addition, insulin administration by jet injection reduced the total duration of hyperinsulinemia and insulin action by 3040 min when compared with conventional insulin administration. \\n there were no indications that these benefits of the jet injector over the conventional pen differed between women and men. \\n our data are in line with previous studies that have shown a more rapid increase in insulin levels and shorter duration of hyperinsulinemia after administration of regular insulin by jet injection compared with administration by needle syringe ( 38 ). \\n the results of the current study also extend those of a recent study performed by sarno et al. \\n ( 9 ), who compared administration of various insulins ( including lispro insulin ) with jet injection to that with needle syringes. in that study, time \\n to peak insulin levels after lispro insulin administration was shorter for the jet injector than for needle syringe injection, but a statistically significant pharmacodynamic effect could not be established. also, the number of volunteers examined was small ( n = 4 ) and the dose of insulin used was fixed at a relatively high level ( 30 units for all ). \\n our study convincingly shows the pharmacokinetic and pharmacodynamic superiority of jet injection over conventional needle pens for administration of rapid - acting insulin at a dose that is realistic for many people with type 1 or type 2 diabetes. \\n it is also the first time that jet injection technology was compared with an insulin pen, which most patients prefer over syringes for their ease of use and high level of accuracy ( 20 ). \\n insulin injected by jet injection displays a specific cone - like dispersion pattern in the subcutaneous tissue with a relatively large surface area ( 1,2 ). \\n it seems plausible that this dispersion pattern enhances absorption of insulin into the circulation, thus explaining a more immediate glucose - lowering effect. \\n the current jet injector uses a high - velocity jet that ensures > 90% delivery of injected insulin into the subcutaneous tissue, without risking penetration of the underlying muscle, at a jet stream diameter of 0.15 mm. \\n these device characteristics compare favorably to the length and diameter of pen needles that typically measure 68 mm and 0.5 mm, respectively. a limitation to the use of jet injectors in comparison with insulin pens \\n is that sufficient training is required with both air - free filling of the injection chamber and the injection procedure itself. \\n we had to reschedule the first experiment, probably because of an air bubble in the system, and another experiment because of early discharge of the spring system, possibly related to failure of the lock / release system. however, after proper training, administration of the entire dose of insulin can be achieved in almost all instances ( 21 ). \\n the pharmacokinetic and pharmacodynamic profile of rapid - acting insulin administered by the jet injector approached the physiological pattern of endogenous insulin secretion and subsequent glucose - lowering response more closely than insulin administered by a conventional insulin pen. \\n consequently, a more physiological meal insulin substitution may decrease immediate postprandial hyperglycemia, whereas the more rapid tapering of hyperinsulinemia may reduce the risk of late postprandial hypoglycemia. \\n however, postprandial glucose may contribute less to overall glycemic control than preprandial glucose in patients with diabetes, and the role of postprandial hyperglycemia as an independent cardiovascular risk factor is still uncertain ( 22 ). \\n therefore, appropriately designed studies are needed to determine whether and to what extent the favorable pharmacological properties of insulin administration by jet injection found in this study translate into clinical benefit in the longer term for patients with diabetes. a strength of our study is the use of a double - dummy cross over study design, ensuring that both participants and investigators were truly blinded during the execution of the experiments. \\n moreover, because we used a placebo solution that contained the same ingredients as the insulin solution ( except for insulin ), the smell and viscosity of the two liquids were indistinguishable. \\n a limitation of this study is that the euglycemic clamps were performed in healthy individuals rather than in patients with diabetes, the target population for such a device. \\n in addition, only one insulin dose was investigated ; it can not be determined with certainty whether the current differences in time - action profiles can be extrapolated to other insulin doses. \\n finally, the ease of use of the jet injector was not tested, which is important for a device that is aimed at being used on a daily basis. in conclusion \\n, the current study shows that when insulin is administered with a jet injector instead of a conventional insulin pen, a more rapid onset of insulin action can be achieved. \\n insulin administered by the jet injector resembles the pattern of endogenous insulin secretion more closely and could therefore be useful in providing a more physiologic postprandial insulin profile. \\n future research will need to investigate whether these results can be replicated in patients with diabetes and what the clinical implications are.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': \"Summarize the following article: metformin is widely used to improve insulin resistance ( ir ) , but the mechanism is not fully understood . \\n although liver is the primary target , metformin acts on a variety of tissues , including adipose tissue , skeletal muscles , endothelium , and ovary [ 1 , 2 ] . \\n previous studies have demonstrated metformin exerts the metabolic actions , especially the glucoregulatory action , mainly through amp activated protein kinase ( ampk ) [ 3 , 4 ] . in recent years , metformin has been reported to have an impact on the production of adipokines ( e.g. , adiponectin , leptin ) , which might be associated with the insulin - sensitizing effect of this agent [ 5 , 6 ] . \\n pigment epithelium - derived factor ( pedf ) , an adipokine discovered in recent years , plays an important role in obesity - induced ir . \\n it is one of the most abundant proteins secreted by human adipocytes with the property to induce ir and inflammatory signaling in adipocytes and skeletal cells . \\n serum pedf levels elevate in obese mice and reduce upon weight loss ; prolonged pedf administration stimulates adipose tissue lipolysis , results in ectopic lipid deposition , and reduces insulin sensitivity , whereas neutralizing pedf with pedf antibody in obese mice enhances insulin sensitivity [ 7 , 9 ] . \\n clinical researches have revealed that serum pedf level is an independent determinant of ir in patients with essential hypertension . in our previous work , \\n increased serum pedf levels , which are closely associated with ir and chronic inflammation , are observed in patients with polycystic ovary syndrome . \\n additionally , pedf is also found to be an important determinant of oxidative stress , inflammation , and angiogenesis [ 12 , 13 ] . \\n it is presently unclear whether metformin could influence pedf production in adipose tissue and liver . \\n a study showed that the improvement of ir , following diet and/or surgery - induced weight loss , was associated with the magnitude of decrease in serum pedf levels and pedf expression of adipose tissue . in this context , the present study was undertaken to get insights into the effect of metformin on the expression and secretion of pedf in adipocyte and hepatocyte and whether this effect is associated with the ir - improving action of the agent , which may help to clarify pharmacological action of metformin . \\n our data showed metformin inhibits pedf production and release , and ampk plays a key role in this process , which is closely associated with the improvement of ir . \\n animal care and experimental procedures were performed with the approval from the animal care committees of chongqing medical university . after two weeks of adaptive feeding , \\n the seven - week - old sd rats were randomly assigned to receive a normal chow diet ( 15% fat ) ( nc group , n = 6 ) or a high fat diet ( 45% fat ) ( n = 12 ) for 15 weeks ; then the high - fat - diet rats were gavaged saline ( hf group , n = 6 ) or metformin ( glucophage , sanofi , france ) 400  mg / kg / d ( met group , \\n n = 6 ) for 4 weeks . at the end of the 19th week , \\n insulin sensitivity was assessed by the hyperinsulinemic - euglycemic clamp , and then the rats were culled with cervical dislocation . when sacrificed , blood and tissue samples were collected for further assessments . \\n mouse embryo fibroblast 3t3-l1 cells were obtained from american type culture collection ( manassas , va ) and grown in dulbecco 's modified eagle 's medium ( dmem ) containing 1% antibiotics ( life technologies , maryland , us ) as described previously . human hepatoma cells ( hepg2 cells ) \\n ( obtained from american type culture collection ) were grown in 1640 medium supplemented with 10% calf serum and 1% antibiotics . \\n hepg2 cells and differentiated 3t3-l1 cells seeded on 96-well plates were treated with 0 , 0.05 , 0.5 , 5 , and 50  nm insulin for 24  h , and the insulin ( 100  nm ) mediated glucose uptake was examined to validate the establishment of the cell models . \\n the ir cell models were treated with or without 0.1  mm metformin ( sigma , us ) for 24  h , and the 40  m compound c ( sigma , us ) was added 1  h before metformin addition . \\n the tracer used to monitor glucose uptake in cells was 6-[n-(7-nitrobenz-2-oxa-1 , 3-diazol-4-yl ) amino]-6-deoxyglucose ( 2-nbdg ; sigma , us ) , with the method described previously , with some modification [ 19 , 20 ] . \\n after treatment , the cell medium was removed , and the cells were washed twice with krebs'-ringer's - hepes ( krh ) buffer ( 136  mm nacl , 20  mm hepes , 4.7  mm kcl , 1.25  mm mgso4 , and 1.25  mm cacl2 , ph 7.4 ) and the plate was measured by a fluorescence microplate reader ( spectramaxm2 multimode plate readers , molecular devices , usa ) set at an excitation wavelength of 488  nm and an emission wavelength of 520  nm , and the results were expressed as fa . treated with 2-nbdg ( 50 \\n m ) for 15  min and washed twice with krh buffer , the cells were measured by the fluorescence microplate reader again and the results were expressed as fb . later on , treated with 2-nbdg combined with insulin ( 100  nm ) for 15  min and washed twice with krh buffer , the cells were measured by the fluorescence microplate reader for the third time and the results were expressed as fc . \\n finally , the cell viability was measured by 4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method and the results were expressed as od . \\n pedf concentration in the serum and the supernatants of 3t3-l1 and hepg2 cells was analyzed by the elisa kits ( uscn life science inc , china ) according to the manufacturer 's instruction . \\n serum insulin was determined by the elisa kits ( uscn life science inc , china ) . \\n serum lipids were measured as follows : total cholesterol ( tc ) using the cholesterol oxidase - hdaos method ( wako , osaka , japan ) ; triglycerides ( tg ) using the gpo - hdaos glycerol blanking method ( wako ) ; high - density lipoprotein cholesterol ( hdl - c ) using the immunoinhibition ( direct ) method ( wako ) ; and low - density lipoprotein cholesterol ( ldl - c ) using the selective protection enzymatic ( direct ) method ( wako ) . \\n clamp was performed as described previously , with some modifications [ 21 , 22 ] . in brief , after rats were anesthetized with 10% chloral hydrate ( 0.4  ml/100 g body weight ) , two polyethylene catheters were inserted into the right jugular vein and left carotid artery . \\n patency was maintained by 0.5% heparin ( 1  ml / kg body weight ) administration , and the vein catheter was connected with two digital syringe pumps ( medtronic , inc , usa ) by a y connector . \\n blood samples of 600  l were obtained for the measurement of serum insulin , lipids , and pedf before the infusion of insulin . \\n the infusion rate of insulin ( humulin regular insulin , eli lilly , usa ) , mixed with a variable volume of 0.1% bsa , was set at ( 10  mu / kg / min ) , and when the plasma glucose was lower than 5.0 \\n mmol / l ) was maintained by a variable infusion rate that was adjusted according to the plasma glucose level at 5  min intervals . during the last 60 min of the clamp when the plasma glucose level became steady , \\n the glucose infusion rate was calculated as the average results of the last thirteen times of plasma glucose levels . \\n total rna was extracted using the trizol reagent ( life technologies , maryland , usa ) according to the manufacturer 's instruction . \\n the rna purity was assessed by measuring od at 260 and 280  nm with the standard of a260/a280  1.8 . \\n rna was treated with 1 unit of dnase i ( life technologies , maryland , usa ) for 15  min at room temperature . cdna synthesis was performed with 0.5  mg total rna treated with dnase i in a 10  l reaction system using the first strand synthesis for rt - pcr kit ( takara ) . \\n real - time reverse transcription polymerase chain reaction ( rt - pcr ) was performed in the applied biosystems 7500 real - time pcr system , using sybr green dye ( qiagen , german ) according to the manufacturer 's protocol . \\n all the primers were designed by beacon designer software and synthesized by life technologies corporation . \\n proteins were extracted from tissues and cells using cell lysis buffer for western blotting ( beyotime , jiangsu , china ) , and protein concentration was determined using the bca protein assay kit ( beyotime ) . \\n sample proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis in a bio - rad mini - protean apparatus . \\n membranes were blocked with blocking buffer and incubated with primary antibodies ( goat polyclonal anti - pedf , rabbit polyclonal anti - pampk , rabbit polyclonal anti - beta actin , santa cruz biotechnology , usa ) overnight at 4c , followed by horseradish peroxidase - labeled secondary antibodies ( santa cruz biotechnology , usa ) for one hour at room temperature . \\n immunoreactive proteins were visualized using enhanced chemiluminescence ( ecl , beyotime , china ) , and the band intensities were quantified using quantity one software ( bio - rad , usa ) . \\n data involving more than two groups were assessed by one - way anova   ( with games howell test for post hoc analysis ) . \\n compared with the nc group , rats in the hf group showed higher levels of body weight , fasting plasma glucose , fasting serum insulin , ldl - c , and a lower level of glucose infusion rate ( table 2 ) . \\n in addition , the mrna expression levels of phosphoenolpyruvate carboxykinase ( pepck ) and glucose 6-phosphatase ( g-6-pase ) , in the liver were also significantly upregulated in the high - fat diet induced obese rats ( figure 1 ) . with metformin treatment for 4 weeks , the ir of the high - fat diet induced obese rats was obviously improved , manifested as enhanced glucose infusion rate , reduced serum tg and serum insulin levels , and down - regulated mrna expression of pepck , g-6-pase ( table 2 , figure 1 ) . \\n the high - fat diet induced obese rats showed higher levels of serum pedf as compared with the nc group ( 2.16  0.09 versus 1.77  0.14  g / ml , p < 0.05 , figure 2(a ) ) , and a negative association was found between the serum pedf concentration and glucose infusion rate ( r =  0.67 , p < 0.05 , figure 2(b ) ) . \\n the mrna and protein expression of pedf in the epididymal adipose tissue and liver were significantly up - regulated in the hf group as compared to the nc group . \\n however , the metformin group exhibited decreased serum pedf levels ( 2.16  0.09 versus 1.69    0.24  g / ml , p < 0.05 , figure 2(a ) ) and down - regulated pedf expression when compared with the hf group ( figures 2(c ) and 2(d ) ) . to be in accordance with the ir condition in vivo , ir models of adipocytes and hepatocytes \\n were established by the hyperinsulinemic method [ 1618 ] . with a low or moderate concentration of insulin ( 0.05  nm5  nm ) treatment for 24  h , \\n the glucose uptake in the adipocytes and hepatocytes showed no significant changes ; however , when the insulin concentration was as high as 50  nm , an obvious decreased glucose uptake was observed , indicating an ir status in the cell models ( figure 3 ) . \\n similar to the results in vivo , increased pedf expression and secretion were found in the ir adipocytes and hepatocytes . \\n while with 0.1  mm metformin treatment , the pedf expression was down - regulated and the pedf secretion was lowered , accompanied with increased glucose uptake in the ir adipocytes and hepatocytes ( figure 4 ) . since metformin exerts its metabolic action mainly through ampk [ 3 , 4 ] , the phosphorylation at threonine 172 of the  subunit of ampk was examined , and the results showed metformin treatment stimulated ampk phosphorylation in adipose tissue and liver of the obese rats , which was accompanied with the profound reduction in pedf protein content ( figure 2 ) . in vitro , when the ir adipocytes and hepatocytes were treated with metformin combined with an ampk inhibitor compound c , the inhibitive effects of metformin on pedf expression or secretion were abrogated ( figure 4 ) . \\n first identified in retinal pigment epithelium cells , pedf is expressed in various tissues throughout the body such as the eye , adipose tissue , liver , and muscle [ 79 , 13 ] . \\n it is reported as a multifunctional , pleiotropic protein with antiangiogenic , antioxidant , neurotrophic , and both pro- and anti - inflammatory properties [ 12 , 13 ] . in the previous work , we found the serum pedf level is elevated in women with polycystic ovary syndrome and is associated with ir , indicating pedf may play a role in the pathogenesis of ir in patients with polycystic ovary syndrome . \\n metformin , a widely prescribed agent to improve ir , has been reported to have an impact on the production of adipokines ( e.g , adiponectin , leptin ) , which might be associated with the ir - improving effect of the agent [ 5 , 6 ] . while pedf has been reported to play an important role in the development of ir [ 79 ] \\n for the first time , our study reports that metformin inhibits the expression and secretion of pedf in adipocyte and hepatocyte via stimulating ampk phosphorylation , and this effect is associated with the ir - improving action of metformin . to get insights into the effect of metformin on pedf when metformin exerts its ir - improving action , \\n high - fat diet induced obese rats were used for the in vivo experiment and validated as being insulin resistant by the hyperinsulinemic - euglycemic clamp . in vitro \\n , the ir models of 3t3-l1 and hepg2 cells were established by the hyperinsulinemic method and validated through glucose uptake test . \\n it is generally accepted that ir is the most common cause of hyperinsulinemia ; however , recent studies have revealed that ir might also be a result of prolonged exposure of high concentrations of insulin [ 2426 ] . \\n liu et al .   found that exposure of cultured hepatocytes to 10100  nm insulin for 24  h induces significant ir , which might be associated with disturbed insulin signal transduction and oxidative stress . \\n another study reported that exposure to 1  m insulin for 6  h , 3t3-l1 cell showed down - regulated mrna expression of glucose transporter 4 and lost their capacity for acute stimulation of glucose uptake by insulin . \\n similar to these studies , our data revealed that , incubated with 50  nm insulin for 24  h , the adipocytes and hepatocytes were markedly insensitive to insulin as shown by the decreased glucose uptake when stimulated by 100  nm insulin . \\n it is noteworthy that although the high concentration of 50  nm insulin induced ir in vitro , this might not be duplicated in vivo since the serum insulin level as high as 50  nm has rarely been reported in human . both in vivo and in vitro , increased pedf secretion as well as expression were found in tissues and cells with ir . \\n furthermore , we found the serum pedf levels were negatively correlated with the insulin sensitivity . in the study of crowe et al . \\n , an elevated serum pedf and expression in adipose tissue were also observed in high - fat diet induced mice , which are in line with our in vivo findings . with metformin intervention for 4 weeks , high - fat diet induced obese rats exhibited obvious improvement of ir , manifested as enhanced glucose infusion rate , reduced serum tg and fasting serum insulin levels , and down - regulated mrna expression of key enzymes which promote gluconeogenesis and fatty acid synthesis . \\n in addition , serum pedf levels as well as expression of pedf in the adipose tissue and liver decreased significantly during ir improvement caused by metformin . in accordance with the in vivo findings , insulin resistant adipocytes and \\n hepatocytes also showed decreased secretion and expression of pedf with metformin treatment , accompanied with enhanced glucose uptake .   to further investigate the role played by the target molecule of metformin , the phosphorylation at threonine 172 of the  subunit of ampk was measured in the rats , and we found the impact of metformin on pedf expression in adipose tissue and liver was associated with stimulation of ampk phosphorylation . when combined with compound c , the suppressive effect of metformin on pedf \\n those results suggest that metformin exerts the effect on pedf via stimulation of ampk phosphorylation . \\n additionally , our study indicates ampk might be a potential regulator of pedf production , on transcriptional or posttranscriptional level , although the detailed mechanism needs further study . \\n the study conducted by akin et al .   on 36 turkish type 2 diabetic patients showed that , after metformin treatment for 6 months , the serum pedf levels increased . \\n the different subjects in akin 's study ( type 2 diabetic patients ) and ours ( high - fat diet induced obese rats ) might partially explain the discrepancy in the results of the two studies . \\n besides , metformin exerts complex effect in vivo , whether the increase of serum pedf in type 2 diabetic patients is a direct effect of metformin is still unclear . \\n although different from metformin in mechanism , troglitazone was an insulin sensitizer which was once used to improve ir . \\n , our study reveals that metformin inhibits expression and secretion of pedf in adipocytes and hepatocytes via the stimulation of ampk phosphorylation . \\n in addition , our study indicates ampk might be a potential regulator of pedf . although we found the effect of metformin on pedf \\n is closely associated with the ir - improving action of the agent , whether the action is mainly mediated through an inhibition in pedf still needs further study .\",\n",
       "  'output': 'objective . \\n pigment epithelium - derived factor ( pedf ) plays an important role in obesity - induced insulin resistance ( ir ) . \\n the study aims to investigate the effect of metformin , a widely used agent to improve ir , on pedf production both in vivo and in vitro \\n . methods . \\n sd rats were divided into normal control group , high fat group ( hf group ) , and metformin group ( met group ) . \\n hyperinsulinemic euglycemic clamp was performed to evaluate insulin sensitivity . \\n ir models of 3t3-l1 and hepg2 cells were established and then treated with metformin and inhibitor of amp activated protein kinase ( ampk ) . \\n results . in vivo , \\n the hf group showed increased serum pedf which is negatively correlated with insulin sensitivity , while the met group revealed decreased serum pedf and downregulated pedf expression in fat and liver , concomitant with significantly improved ir . in vitro , the ir cells showed enhanced pedf secretion and expression , whereas metformin lowered pedf secretion and expression , accompanied with increased glucose uptake . \\n metformin stimulated ampk phosphorylation in fat and liver of the obese rats , while in vitro , when combined with ampk inhibitor , the effect of metformin on pedf was abrogated . \\n conclusions . \\n metformin inhibits the expression and secretion of pedf in fat and liver via promoting ampk phosphorylation , which is closely associated with ir improvement .',\n",
       "  '__index_level_0__': 31685,\n",
       "  'model_output': '\"Metformin Inhibits the Expression and Secretion of Pigment Epithelium-Derived Factor in Adipocyte and Hepatocyte via AMP-Activated Protein Kinase Phosphorylation\".'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': \"Summarize the following article: the global prevalence of diabetes mellitus has been remarkably increased during the last two decades and has reached from almost 30 million cases in 1985 to 285 million cases in 2010 ( 1 ) . \\n the prevalence of diabetes in iran was about 7.7% in 2005 ( 2 ) , and this amount reached 8.7% in 2007 ( 2 ) . \\n obviously , many factors are required to meet the needs of the patients with diabetes . \\n although , complete treatment of diabetes is a long way ahead , medical care and sociopsychological support have great effects on its acute and chronic outcomes ( 3 ) . in light of high prevalence of this disease , it has become the subject of significant research in different clinical areas . because of the increased prevalence of diabetes and its complex etiology , \\n adaptation mechanisms are needed to make a change in the concepts of diabetes management and the treatment programs that have been considered so far . \\n this change should be from the physical variables to sociopsychological factors which may be effective on the disease management and its outcomes ( 4 ) . \\n in addition , the new treatment recommendations have specifically confirmed the importance of the integration of sociopsychological concepts with the usual care of patients with diabetes . \\n this new approach helps them achieve suitable control over their glucose level and leads to the person 's high compatibility ( 5 ) . \\n marital satisfaction is a situation in which husband and wife have a sense of happiness and are satisfied from each other most of the times . \\n satisfactory relationships between couples can be measured by mutual love , the amount of caring from each other , and understanding of each other ( 6 ) . according to winch ( as cited in olia ) , marital satisfaction is the adaptation between the individual 's present situation in marital relationships and his or her expected situation . \\n marital satisfaction does not appear from thin air and its development needs the effort of the couple . \\n the study results show that the outcome of marital satisfaction ( supporting each other ) can affect people s health ( 7 ) . \\n furthermore , a positive correlation has been found between marital conflict , anxiety , depression , and the low level of physical health ( 8) . \\n literature review in iran and other countries revealed that there has been no study about the relationship between marital satisfaction and compatibility with diabetes in patients with type 2 diabetes . despite benefiting from multiple therapeutic interventions like diets , regular exercise , weight control , chemotherapies , and epidemiologic investigations \\n the aim of the present study was to investigate the relationship between marital satisfactions with compatibility with type 2 diabetes . \\n this study method was descriptive - correlative . the sample consisted of patients ( 20 - 60 years old ) with diabetes who refereed to diabetes clinic in meybod , iran . \\n the patients with the following criteria were enrolled in the study : being 20 to 60 years old , having diagnosed their disease at least one year before the study , visiting one of the physicians in the diabetes clinic , and having medical case with the physician . \\n the people who had the following exclusion criteria were omitted from the study : having history of other physical diseases except the ones related to diabetes symptoms , and having mental retardation or other psychological disorders before diabetes diagnosis . according to the mentioned criteria , 160 patients from the clinic members ( 103 females and 57 males ) were randomly selected . \\n the sample size was determined based on random sample size formula of krejcie ( 9 ) which estimated to be 160 out of community of 280 patients . at first the list of the names of all people who were at that age range \\n they were called and those who had the criteria for entering into the study were chosen and invited for participating in the study . the questionnaires that were used in this study \\n they believed that this scale is related to the changes that happen during the individual 's life ( 10 ) . \\n this questionnaire included 47 questions rated in a 5-point scale from  completely agree  to  completely disagree . \\n the validity of the instruments was also calculated by content validity method and its reliability was calculated by retest method ( 0.82 ) that was significant ( 11 ) . \\n the factors are family relationships , relationship with friends , dependency and independency conflicts , physical image , and the attitude toward the disease . \\n these factors show how diabetes affects the individual 's way of living and his or her compatibility . \\n those responses that show positive compatibility with diabetes were given the score of 1 and those which show negative compatibility were given 0 . \\n the reliability of this questionnaire with retest method on 15 patients with diabetes was found 0.73 after 5 weeks , and its content validity was confirmed by 3 psychologists and endocrinologists and psychiatric nursing . \\n they believed that this scale is related to the changes that happen during the individual 's life ( 10 ) . \\n this questionnaire included 47 questions rated in a 5-point scale from  completely agree  to  completely disagree . \\n the validity of the instruments was also calculated by content validity method and its reliability was calculated by retest method ( 0.82 ) that was significant ( 11 ) . \\n the factors are family relationships , relationship with friends , dependency and independency conflicts , physical image , and the attitude toward the disease . \\n these factors show how diabetes affects the individual 's way of living and his or her compatibility . \\n those responses that show positive compatibility with diabetes were given the score of 1 and those which show negative compatibility were given 0 . \\n the reliability of this questionnaire with retest method on 15 patients with diabetes was found 0.73 after 5 weeks , and its content validity was confirmed by 3 psychologists and endocrinologists and psychiatric nursing . \\n most of the study samples were in the age range of 41 - 50 with the frequency of 50 which involves 31.2% of the participants and the least frequency was in the age range of 21 - 30 with 11 ( 6.8% ) participants . also , most of the participants were women 103 ( 64.4% ) . \\n table 1 shows the mean and standard deviation of marital satisfaction and the aspects of compatibility with diabetes in the sample group . \\n table 1 shows that the mean and standard deviation of marital satisfaction in the sample group are respectively 136.9 and 14.07 , and the mean and standard deviation of compatibility with diabetes are respectively 40.12 and 3.33 . \\n table 2 shows the result of anova ( analysis of variance ) on the mean of marital satisfaction score in two groups ( men and women with diabetes ) . \\n table 2 shows that , there is no significant difference between women and men with diabetes regarding marital satisfaction ( p = 0.3 ) . \\n table 3 shows the correlation between marital satisfaction and aspects of compatibility with diabetes in women and men with diabetes . \\n table 3 shows that a positive , significant relationship exists between marital satisfaction and compatibility with diabetes in women ( p = 0.006 ; r = 0.26 ) . \\n it means that as marital satisfaction increases in women with diabetes , compatibility with diabetes will also increase . \\n however , there is no significant relationship between marital satisfaction and compatibility with diabetes in men with diabetes ( p = 0.87 ; r = 0.02 ) . \\n also , there is no significant relationship between aspects of compatibility with diabetes and marital satisfaction in women and men . \\n as it was mentioned , the present study was carried out to investigate the relationship between marital satisfaction and compatibility with diabetes in patients with type 2 diabetes . \\n the results revealed that a positive significant relationship exists between marital satisfaction and compatibility with diabetes in women . \\n it means that by increasing marital satisfaction , compatibility with diabetes increases and vice versa . \\n in fact , marital satisfaction affects people 's mental health and these result are in consistent with the results of other studies ( 12 , 13 ) in which the relationship between mental health and marital satisfaction were investigated in people with chronic diseases . \\n the results of the other studies ( 14 , 15 ) in which the relationship between family support and blood glucose control was investigated in elderly with type 2 diabetes revealed that family support increases marital satisfaction which is in line with increasing the elderly mental health . \\n elder and george ( 16 ) also cited in their study that close relationships are the main source of pleasure and support during life . \\n people who have closer relationships are in better physical and mental health condition ( 16 , 17 ) which is consistent with the results of this study . \\n lal and bartle - haring ( 18 ) investigated marital satisfaction in patients with chronic lung diseases and their results also revealed that marital satisfaction was related to psychological improvement which could affect and alleviate their chronic pains . \\n whitsitt ( 19 ) investigated coping strategies and compatibility with coronary artery diseases in couples and the results showed that marital quality can affect better compatibility with the disease . \\n 20 ) revealed in their studies that the relationship between the couples can reinforce the behaviors related to health and lead to people 's improvement . \\n therefore , this issue destroys the balance of suitable behaviors and leads to loss of intimacy . \\n marital satisfaction is considered as a continuum and an evolutionary process between husband and wife . \\n marital satisfaction includes some elements such as self - esteem , self - effectiveness , domination , and control over life . \\n the weakness in any of these factors leads to the reduction in individual 's health and ability for dealing with his or her present conditions . \\n in fact , marital satisfaction acts as a protective and reinforcing factor for the patient . \\n when marital satisfaction is high , domination , control , and life expectancy will increase in the person and he or she tries more to improve himself or herself . \\n when marital satisfaction is high , the person also benefits from the advantages of this relationship which occurs in a substitutive way and he or she can adopt his or her condition . in this study the interaction of variables like occupation , education , duration of marriage , number of children , personality , place of living , and other effective social and cultural variables were not examined with the test variables . \\n therefore , it is suggested that the relationship of test variables with other variables such as age , gender , education , duration of marriage , and personality be investigated in different cities . \\n in addition , this study has its own limitations like the small number of the subjects who were a group of patients referred to the hospitals in meybod . \\n so , further studies should be done , in different cities and on other age groups with other instruments and the results should be compared . in the future studies it is important to consider other psychological factors too , since investigating possible interactive effects of some personal issues in predicting compatibility with type 2 diabetes can help us in explaining problems regarding diabetes management in a more suitable way .\",\n",
       "  'output': 'background : marriage is a legal pact between a man and a woman for participating in a social life together which can play an important role in dealing with difficulties.objectives:this study was carried out to investigate the relationship between marital satisfaction and compatibility with diabetes in patients with type 2 diabetes.patients and methods : the study method was descriptive - correctional . \\n the study sample included 160 diabetic patients ( 103 females and 57 males ) who were randomly selected . \\n the instruments used were enrich marital satisfaction questionnaire and the questionnaire of compatibility with diabetes . \\n in addition , the data were analyzed through descriptive statistics and analysis of variance by spss.results:the result of the study revealed a significant correlation ( p = 0.006 ) between marital satisfaction and compatibility with diabetes in women with type 2 diabetes ( r = 0.26 ) . \\n however , this correlation was not significant in men with diabetes . also , a significant relationship existed between the dimensions of compatibility with diabetes and marital satisfaction in both men and women with diabetes.conclusions:marital satisfaction affects compatibility with diabetes in women . \\n therefore , it might be possible to increase compatibility with diabetes in them by offering specialized interventions as family and couples therapies and giving consultations .',\n",
       "  '__index_level_0__': 31686,\n",
       "  'model_output': \"summarize the following article: the global prevalence of diabetes mellitus has been remarkably increased during the last two decades and has reached from almost 30 million cases in 1985 to 285 million cases in 2010 ( 1 ). the prevalence of diabetes in iran was about 7.7% in 2005 ( 2 ), and this amount reached 8.7% in 2007 ( 2 ). obviously, many factors are required to meet the needs of the patients with diabetes. although, complete treatment of diabetes is a long way ahead, medical care and sociopsychological support have great effects on its acute and chronic outcomes ( 3 ). in light of high prevalence of this disease, it has become the subject of significant research in different clinical areas. because of the increased prevalence of diabetes and its complex etiology, adaptation mechanisms are needed to make a change in the concepts of diabetes management and the treatment programs that have been considered so far. this change should be from the physical variables to sociopsychological factors which may be effective on the disease management and its outcomes ( 4 ). in addition, the new treatment recommendations have specifically confirmed the importance of the integration of sociopsychological concepts with the usual care of patients with diabetes. this new approach helps them achieve suitable control over their glucose level and leads to the person's high compatibility ( 5 ). marital satisfaction is a situation in which husband and wife have a sense of happiness and are satisfied from each other most of the times. satisfactory relationships between couples can be measured by mutual love, the amount of caring from each other, and understanding of each other ( 6 ). according to winch ( as cited in olia ), marital satisfaction is the adaptation between the individual's present situation in marital relationships and his or her expected situation. marital satisfaction does not appear from thin air and its development needs the effort of the couple. the study results show that the outcome of marital satisfaction ( supporting each other ) can affect people s health ( 7 ). furthermore, a positive correlation has been found between marital conflict, anxiety, depression, and the low level of physical health ( 8). literature review in iran and other countries revealed that there has been no study about the relationship between marital satisfaction and compatibility with diabetes in patients with type 2 diabetes. despite benefiting from multiple therapeutic interventions like diets, regular exercise, weight control, chemotherapies, and epidemiologic investigations the aim of the present study was to investigate the relationship between marital satisfactions with compatibility with type 2 diabetes. this study method was descriptive - correlative. the sample consisted of patients ( 20 - 60 years old ) with diabetes who refereed to diabetes clinic in meybod, iran. the patients with the following criteria were enrolled in the study : being 20 to 60 years old, having diagnosed their disease at least one year before the study, visiting one of the physicians in the diabetes clinic, and having medical case with the physician. the people who had the following exclusion criteria were omitted from the study : having history of other physical diseases except the ones related to diabetes symptoms, and having mental retardation or other psychological disorders before diabetes diagnosis. according to the mentioned criteria, 160 patients from the clinic members ( 103 females and 57 males ) were randomly selected. the sample size was determined based on random sample size formula of krejcie ( 9 ) which estimated to be 160 out of community of 280 patients. at first the list of the names of all people who were at that age range they were called and those who had the criteria for entering into the study were chosen and invited for participating in the study. the questionnaires that were used in this study they believed that this scale is related to the changes that happen during the individual's life ( 10 ). this questionnaire included 47 questions rated in a 5-point scale from completely agree to completely disagree. the validity of the instruments was also calculated by content validity method and its reliability was calculated by retest method ( 0.82 ) that was significant ( 11 ). the factors are family relationships, relationship with friends, dependency and independency conflicts, physical image, and the attitude toward the disease. these factors show how diabetes affects the individual's way of living and his or her compatibility. those responses that show positive compatibility with diabetes were given the score of 1 and those which show negative compatibility were given 0. the reliability of this questionnaire with retest method on 15 patients with diabetes was found 0.73 after 5 weeks, and its content validity was confirmed by 3 psychologists and endocrinologists and psychiatric nursing. they believed that this scale is related to the changes that happen during the individual's life ( 10 ). this questionnaire included 47 questions rated in a 5-point scale from completely agree to completely disagree. the validity of the instruments was also calculated by content validity method and its reliability was calculated by retest method ( 0.82 ) that was significant ( 11 ). the factors are family relationships, relationship with friends, dependency and independency conflicts, physical image, and the attitude toward the disease. these factors show how diabetes affects the individual's way of living and his or her compatibility. those responses that show positive compatibility with diabetes were given the score of 1 and those which show negative compatibility were given 0. the reliability of this questionnaire with retest method on 15 patients with diabetes was found 0.73 after 5 weeks, and its content validity was confirmed by 3 psychologists and endocrinologists and psychiatric nursing. most of the study samples were in the age range of 41 - 50 with the frequency of 50 which involves 31.2% of the participants and the least frequency was in the age range of 21 - 30 with 11 ( 6.8% ) participants. also, most of the participants were women 103 ( 64.4% ). table 1 shows the mean and standard deviation of marital satisfaction and the aspects of compatibility with diabetes in the sample group. table 1 shows that the mean and standard deviation of marital satisfaction in the sample group are respectively 136.9 and 14.07, and the mean and standard deviation of compatibility with diabetes are respectively 40.12 and 3.33. table 1 shows the result of anova ( analysis of variance ) on the mean of marital satisfaction score in two groups ( men and women with diabetes ). table 2 shows that, there is no significant difference between women and men with diabetes regarding marital satisfaction ( p = 0.3 ). table 3 shows the correlation between marital satisfaction and aspects of compatibility with diabetes in women and men with diabetes. table 3 shows that a positive, significant relationship exists between marital satisfaction and compatibility with diabetes in women ( p = 0.006 ; r = 0.26 ). it means that as marital satisfaction increases in women with diabetes, compatibility with diabetes will also increase. however, there is no significant relationship between marital satisfaction and compatibility with diabetes in men with diabetes ( p = 0.87 ; r = 0.02 ). also, there is no significant relationship between aspects of compatibility with diabetes and marital satisfaction in women and men. as it was mentioned, the present study was carried out to investigate the relationship between marital satisfaction and compatibility with diabetes in patients with type 2 diabetes. the results revealed that a positive significant relationship exists between marital satisfaction and compatibility with diabetes in women. it means that by increasing marital satisfaction, compatibility with diabetes increases and vice versa. in fact, marital satisfaction affects people's mental health and these result are in consistent with the results of other studies ( 12, 13 ) in which the relationship between mental health and marital satisfaction were investigated in people with chronic diseases. the results of the other studies ( 14, 15 ) in which the relationship between family support and blood glucose control was investigated in elderly with type 2 diabetes revealed that family support increases marital satisfaction which is in line with increasing the elderly mental health. elder and george ( 16 ) also cited in their study that close relationships are the main source of pleasure and support during life. people who have closer relationships are in better physical and mental health condition ( 16, 17 ) which is consistent with the results of this study. lal and bartle - haring ( 18 ) investigated marital satisfaction in patients with chronic lung diseases and their results also revealed that marital satisfaction was related to psychological improvement which could affect and alleviate their chronic pains. whitsitt ( 19 ) investigated coping strategies and compatibility with coronary artery diseases in couples and the results showed that marital quality can affect better compatibility with the disease. 20 ) revealed in their studies that the relationship between the couples can reinforce the behaviors related to health and lead to people's improvement. therefore, this issue destroys the balance of suitable behaviors and leads to loss of intimacy. marital satisfaction is considered as a continuum and an evolutionary process between husband and wife. marital satisfaction includes some elements such as self - esteem, self - effectiveness, domination, and control over life. the weakness in any of these factors leads to the reduction in individual's health and ability for dealing with his or her present conditions. in fact, marital satisfaction acts as a protective and reinforcing factor for the patient. when marital satisfaction is high, domination, control, and life expectancy will increase in the person and he or she tries more to improve himself or herself. when marital satisfaction is high, the person also benefits from the advantages of this relationship which occurs in a substitutive way and he or she can adopt his or her condition. in this study the interaction of variables like occupation, education, duration of marriage, number of children, personality, place of living, and other effective social and cultural variables were not examined with the test variables. therefore, it is suggested that the relationship of test variables with other variables such as age, gender, education, duration of marriage, and personality be investigated in different cities. in addition, this study has its own limitations like the small number of the subjects who were a group of patients referred to the hospitals in meybod. so, further studies should be done, in different cities and on other age groups with other instruments and the results should be compared. in the future studies it is important to consider other psychological factors too, since investigating possible interactive effects of some personal issues in predicting compatibility with type 2 diabetes can help us in explaining problems regarding diabetes management in a more suitable way.\"},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': \"Summarize the following article: elevated serum uric acid levels are associated with a variety of adverse health outcomes , including gout , hypertension , diabetes mellitus , metabolic syndrome , and cardiovascular diseases . \\n several genome - wide association studies ( gwass ) have identified genes that may be causally associated with uric acid levels , including the atp - binding cassette , subfamily g , member 2 ( abcg2 ) gene ( mim 603756 ) [ 2 , 3 , 4 , 5 , 6 , 7 ] . \\n replication studies of abcg2 variants have been performed in western and asian countries [ 8 , 9 ] . \\n identified a significant association between the rs2725220 single - nucleotide polymorphism ( snp ) on chromosome 4q22 and uric acid levels . \\n the abcg2 protein is a high - capacity transporter for uric acid excretion in the kidney , liver , and gut [ 10 , 11 ] . in this study \\n , we analyzed the relationship between uric acid levels and the abcg2 snp rs2725220 using a group of volunteers from the korean metabolic syndrome research initiative study in seoul . \\n we also analyzed the association of the abcg2 snp with body mass index and waist circumference levels . \\n subjects for the gwas were recruited from the korean metabolic syndrome research initiative study in seoul city , which was initiated in december 2005 . \\n a total of 9,128 individuals were recruited in 2006 , and an additional 17,569 individuals were recruited in 2007 [ 12 , 13 , 14 ] . \\n volunteers from the first round underwent routine health examinations at the health promotion centers in university hospitals between january 2006 and december 2007 . from this \\n the subject characteristics were described in a previous study . in brief , of the 6,563 individuals whose adiponectin was measured , 1,004 individuals were genotyped . \\n the 1,004 subjects were all healthy individuals and were not undergoing any treatment for hyperuricemia . \\n the institutional review board of human research of yonsei university approved the protocols of this study , and written informed consent was obtained from all subjects prior to enrollment . \\n participants were interviewed using a structured questionnaire to collect a personal history of cigarette smoking ( never smoked , ex - smoker , or current smoker ) and demographic characteristics ( age , gender , etc . ) . \\n waist circumference was measured midway between the lower rib and iliac crest . for measurements of weight and height , \\n body mass indices were calculated as the subject 's weight ( kg ) divided by the square of the subject 's height ( m ) . for clinical chemistry assays , \\n serum was separated from peripheral venous blood samples obtained from each participant after a 12-hour fast and stored at -70. biomarkers of metabolic syndrome , including fasting blood glucose , total cholesterol , triglycerides , and high - density lipoprotein cholesterol , and uric acid levels were measured . \\n quality control of the data was conducted in accordance with the procedures recommended by the korean association of laboratory quality control . \\n samples from the seoul city cohort were genotyped on the affymetrix genome - wide human snp array 5.0 ( affymetrix inc . , \\n santa clara , ca , usa ) at dnalink . for the data obtained from this chip , internal quality control ( qc ) measures \\n were used : the qc call rate ( dynamic model algorithm ) always exceeded 86% . \\n ten of the 1,004 individuals were removed due to low genotyping call rates ( < 95% ) . \\n three individuals were excluded due to failed genotyping of rs2725220 , leaving a total of 991 individuals for the study . \\n most statistical analyses were performed using plink and sas ( version 9.2 ; sas institute , cary , nc , usa ) . \\n the abcg2 gene snp rs2725220 was selected using the affymetrix genomewide human snp array 5.0 . \\n each snp was tested for possible effects on uric acid levels under an additive model . \\n the multivariate linear regression models used in the study incorporated covariates ( age and sex ) . \\n odds ratios ( ors ) with 95% confidence intervals ( cis ) were calculated to examine the association of the abcg2 snp with abnormal uric acid levels ( 7 mg / dl for men and 6 mg / dl for women ) . \\n all statistical tests were two - sided , and the statistical significance was determined as p < 0.05 . \\n subjects for the gwas were recruited from the korean metabolic syndrome research initiative study in seoul city , which was initiated in december 2005 . \\n a total of 9,128 individuals were recruited in 2006 , and an additional 17,569 individuals were recruited in 2007 [ 12 , 13 , 14 ] . \\n volunteers from the first round underwent routine health examinations at the health promotion centers in university hospitals between january 2006 and december 2007 . from this \\n the subject characteristics were described in a previous study . in brief , of the 6,563 individuals whose adiponectin was measured , 1,004 individuals were genotyped . \\n the 1,004 subjects were all healthy individuals and were not undergoing any treatment for hyperuricemia . \\n the institutional review board of human research of yonsei university approved the protocols of this study , and written informed consent was obtained from all subjects prior to enrollment . \\n participants were interviewed using a structured questionnaire to collect a personal history of cigarette smoking ( never smoked , ex - smoker , or current smoker ) and demographic characteristics ( age , gender , etc . ) . \\n waist circumference was measured midway between the lower rib and iliac crest . for measurements of weight and height , \\n body mass indices were calculated as the subject 's weight ( kg ) divided by the square of the subject 's height ( m ) . for clinical chemistry assays , serum was separated from peripheral venous blood samples obtained from each participant after a 12-hour fast and stored at -70. biomarkers of metabolic syndrome , including fasting blood glucose , total cholesterol , triglycerides , and high - density lipoprotein cholesterol , and uric acid levels were measured . \\n quality control of the data was conducted in accordance with the procedures recommended by the korean association of laboratory quality control . \\n samples from the seoul city cohort were genotyped on the affymetrix genome - wide human snp array 5.0 ( affymetrix inc . , santa clara , ca , usa ) at dnalink . for \\n the data obtained from this chip , internal quality control ( qc ) measures were used : the qc call rate ( dynamic model algorithm ) always exceeded 86% . \\n ten of the 1,004 individuals were removed due to low genotyping call rates ( < 95% ) . \\n three individuals were excluded due to failed genotyping of rs2725220 , leaving a total of 991 individuals for the study . \\n most statistical analyses were performed using plink and sas ( version 9.2 ; sas institute , cary , nc , usa ) . \\n the abcg2 gene snp rs2725220 was selected using the affymetrix genomewide human snp array 5.0 . \\n each snp was tested for possible effects on uric acid levels under an additive model . \\n the multivariate linear regression models used in the study incorporated covariates ( age and sex ) . \\n odds ratios ( ors ) with 95% confidence intervals ( cis ) were calculated to examine the association of the abcg2 snp with abnormal uric acid levels ( 7 mg / dl for men and 6 mg / dl for women ) . \\n all statistical tests were two - sided , and the statistical significance was determined as p < 0.05 . \\n the majority of individuals in this study was middle - aged ( table 1 ) . \\n mean levels of uric acid in the dataset were higher in males ( 6.23 mg / dl ) than in females ( 4.21 mg / dl ) . \\n the percentage of individuals with abnormal uric acid levels ( 7.0 mg / dl ) was 14.7% for the seoul city sample . \\n the percentage of current smokers in the seoul city dataset was 46.4% among male subjects and 3.9% among female subjects . \\n table 2 shows the p - values from a linear regression model for uric acid levels in the cohort sample , with age and sex included as covariates in the model . \\n the rs2725220 snp in the abcg2 gene was found to be associated with mean uric acid levels ( effect per allele 0.25 mg / dl , p < 0.0001 ) , which was significant after bonferroni correction ( p = 0.00025 ) . \\n the minor allele frequency of rs2725220 was 0.222 , and hardy - weinberg equilibrium was satisfied ( p = 0.7079 ) . \\n we also analyzed the association of rs2725220 with abnormal uric acid levels ( table 3 ) . \\n subjects with the gc / cc genotype had a 1.78-fold ( range , 1.22- to 2.62-fold ) higher risk of having abnormal uric acid levels ( 7.0 mg / dl ) than subjects with the gg genotype . when analyzed by gender , the association with abcg2 was stronger in men than in women . in table 4 , we analyzed the association of abcg2 by body mass index ( bmi ) quartile levels and waist circumference quartile levels in male subjects . \\n the association with abcg2 was much stronger in male subjects with bmi  26.4 ( or , 5.09 ; 95% ci , 2.41 to 10.8 ) than in male subjects with bmi < 26.4 . \\n the association with abcg2 was also a little bit stronger in male subjects with waist circumference ( wc )  91 ( or , 2.10 ; 95% ci , 1.08 to 4.10 ) than in male subjects with wc < 91 . \\n in a cohort study of 991 subjects , an abcg2 gene snp was associated with increased uric acid , consistent with previous studies . \\n several gwass have reported that abcg2 exerts a major influence on uric acid levels [ 2 , 3 , 6 , 7 ] . \\n conducted a genomewide study in which an snp in the abcg2 gene , rs2231142 , displayed strong evidence of an association with uric acid levels ( p < 10 ) . \\n another gwas also reported that rs2231142 showed a strong association with uric acid levels ( p = 5.1  10 ) . \\n more recently , a gwas in european - american obesity cases and controls reported significant genome - wide association of two snps with uric acid levels : rs2622605 and rs1481017 . \\n another recent gwas also reported a strong association between rs2231142 and uric acid levels ( p = 3.34.1  10 ) . in the present study , rs2725220 was found to have a strong association with uric acid levels . in agreement with these findings \\n , a recent study reported that rs2725220 was strongly associated with uric acid levels ( effect per allele -0.135 mg / dl , p = 4.2  10 ) . \\n several recent studies reported that the association between serum uric acid and the allelic effects of snps in abcg2 was sex - specific [ 8 , 9 ] . in a recent study of 4 us populations , \\n the association between rs2231142 and serum uric acid was significantly stronger in men and postmenopausal women compared to their premenopausal counterparts . in the present study , the association of the abcg2 gene snp with uric acid was stronger in men than in women . \\n a modification of the effect of the associations between abcg2 snps and serum uric acid concentrations by interactions with obesity has been reported [ 3 , 9 ] . in a recent study of 4 us populations , \\n the association between rs2231142 and serum uric acid was stronger in normal - weight subjects than in obese subjects . \\n in the present study , we also examined the association of the abcg2 snp with uric acid levels according to bmi level and waist circumference . \\n the association was stronger in subjects with a high bmi and high wc levels than in subjects with a low bmi and low wc levels . \\n the abcg2 gene encodes a membrane transporter belonging to the atp - binding cassette superfamily of membrane transporters , a group involved in the trafficking of biological molecules across cell membranes . \\n . allikmets et al .   mapped the abcg2 gene to human chromosome 4q22 using radiation hybrid analysis . \\n we estimated the identity by state over all snps , and only four individuals were shown to be biological relatives . \\n genetic studies in asian populations may not identify the same set of genes as those in european populations . \\n nevertheless , the seoul city cohort study in korean populations indicates that the abcg2 gene on chromosome 4 is associated with serum uric acid levels , as is the case in several other populations .\",\n",
       "  'output': 'elevated serum uric acid levels are associated with a variety of adverse health outcomes , including gout , hypertension , diabetes mellitus , metabolic syndrome , and cardiovascular diseases . \\n several genome - wide association studies on uric acid levels have implicated the atp - binding cassette , subfamily g , member 2 ( abcg2 ) gene as being possibly causal . \\n we investigated an association between the single - nucleotide polymorphism ( snp ) rs2725220 in the abcg2 gene and uric acid levels in the korean population . \\n a total of 991 subjects in seoul city were used for a replication study with abcg2 snp rs2725220 . \\n the rs2725220 snp in the abcg2 gene was associated with mean uric acid levels ( effect per allele 0.25 mg / dl , p < 0.0001 ) . \\n subjects with the gc / cc genotype had a 1.78-fold ( range , 1.22- to 2.62-fold ) higher risk of having abnormal uric acid levels ( 7.0 mg / dl ) than subjects with the gg genotype . when analyzed by gender , the association with abcg2 was stronger in men than in women . \\n the association with abcg2 was much stronger in male subjects with body mass index ( bmi )  26.4 ( odds ratio , 5.09 ; 95% confidence interval , 2.41 to 10.8 ) than in male subjects with bmi < 26.4 . \\n this study clearly demonstrates that genetic variations in abcg2 influence uric acid levels in korean adults .',\n",
       "  '__index_level_0__': 31687,\n",
       "  'model_output': \"summarize the following article: elevated serum uric acid levels are associated with a variety of adverse health outcomes, including gout, hypertension, diabetes mellitus, metabolic syndrome, and cardiovascular diseases. \\n several genome - wide association studies ( gwass ) have identified genes that may be causally associated with uric acid levels, including the atp - binding cassette, subfamily g, member 2 ( abcg2 ) gene ( mim 603756 ) [ 2, 3, 4, 5, 6, 7 ]. \\n replication studies of abcg2 variants have been performed in western and asian countries [ 8, 9 ]. \\n identified a significant association between the rs2725220 single - nucleotide polymorphism ( snp ) on chromosome 4q22 and uric acid levels. \\n the abcg2 protein is a high - capacity transporter for uric acid excretion in the kidney, liver, and gut [ 10, 11 ]. in this study \\n, we analyzed the relationship between uric acid levels and the abcg2 snp rs2725220 using a group of volunteers from the korean metabolic syndrome research initiative study in seoul. \\n we also analyzed the association of the abcg2 snp with body mass index and waist circumference levels. \\n subjects for the gwas were recruited from the korean metabolic syndrome research initiative study in seoul city, which was initiated in december 2005. \\n a total of 9,128 individuals were recruited in 2006, and an additional 17,569 individuals were recruited in 2007 [ 12, 13, 14 ]. \\n volunteers from the first round underwent routine health examinations at the health promotion centers in university hospitals between january 2006 and december 2007. from this \\n the subject characteristics were described in a previous study. in brief, of the 6,563 individuals whose adiponectin was measured, 1,004 individuals were genotyped. \\n the 1,004 subjects were all healthy individuals and were not undergoing any treatment for hyperuricemia. \\n the institutional review board of human research of yonsei university approved the protocols of this study, and written informed consent was obtained from all subjects prior to enrollment. \\n participants were interviewed using a structured questionnaire to collect a personal history of cigarette smoking ( never smoked, ex - smoker, or current smoker ) and demographic characteristics ( age, gender, etc. ). \\n waist circumference was measured midway between the lower rib and iliac crest. for measurements of weight and height, \\n body mass indices were calculated as the subject's weight ( kg ) divided by the square of the subject's height ( m ). for clinical chemistry assays, \\n serum was separated from peripheral venous blood samples obtained from each participant after a 12-hour fast and stored at -70. biomarkers of metabolic syndrome, including fasting blood glucose, total cholesterol, triglycerides, and high - density lipoprotein cholesterol, and uric acid levels were measured. \\n quality control of the data was conducted in accordance with the procedures recommended by the korean association of laboratory quality control. \\n samples from the seoul city cohort were genotyped on the affymetrix genome - wide human snp array 5.0 ( affymetrix inc., \\n santa clara, ca, usa ) at dnalink. for the data obtained from this chip, internal quality control ( qc ) measures \\n were used : the qc call rate ( dynamic model algorithm ) always exceeded 86%. \\n ten of the 1,004 individuals were removed due to low genotyping call rates ( < 95% ). \\n three individuals were excluded due to failed genotyping of rs2725220, leaving a total of 991 individuals for the study. \\n most statistical analyses were performed using plink and sas ( version 9.2 ; sas institute, cary, nc, usa ). \\n the abcg2 gene snp rs2725220 was selected using the affymetrix genomewide human snp array 5.0. \\n each snp was tested for possible effects on uric acid levels under an additive model. \\n the multivariate linear regression models used in the study incorporated covariates ( age and sex ). \\n odds ratios ( ors ) with 95% confidence intervals ( cis ) were calculated to examine the association of the abcg2 snp with abnormal uric acid levels ( 7 mg / dl for men and 6 mg / dl for women ). \\n all statistical tests were two - sided, and the statistical significance was determined as p < 0.05. \\n subjects for the gwas were recruited from the korean metabolic syndrome research initiative study in seoul city, which was initiated in december 2005. \\n a total of 9,128 individuals were recruited in 2006, and an additional 17,569 individuals were recruited in 2007 [ 12, 13, 14 ]. \\n volunteers from the first round underwent routine health examinations at the health promotion centers in university hospitals between january 2006 and december 2007. from this \\n the subject characteristics were described in a previous study. in brief, of the 6,563 individuals whose adiponectin was measured, 1,004 individuals were genotyped. \\n the 1,004 subjects were all healthy individuals and were not undergoing any treatment for hyperuricemia. \\n the institutional review board of human research of yonsei university approved the protocols of this study, and written informed consent was obtained from all subjects prior to enrollment. \\n participants were interviewed using a structured questionnaire to collect a personal history of cigarette smoking ( never smoked, ex - smoker, or current smoker ) and demographic characteristics ( age, gender, etc. ). \\n waist circumference was measured midway between the lower rib and iliac crest. for measurements of weight and height, \\n body mass indices were calculated as the subject's weight ( kg ) divided by the square of the subject's height ( m ). for clinical chemistry assays, serum was separated from peripheral venous blood samples obtained from each participant after a 12-hour fast and stored at -70. biomarkers of metabolic syndrome, including fasting blood glucose, total cholesterol, triglycerides, and high - density lipoprotein cholesterol, and uric acid levels were measured. \\n quality control of the data was conducted in accordance with the procedures recommended by the korean association of laboratory quality control. \\n samples from the seoul city cohort were genotyped on the affymetrix genome - wide human snp array 5.0 ( affymetrix inc., santa clara, ca, usa ) at dnalink. for \\n the data obtained from this chip, internal quality control ( qc ) measures were used : the qc call rate ( dynamic model algorithm ) always exceeded 86%. \\n ten of the 1,004 individuals were removed due to low genotyping call rates ( < 95% ). \\n three individuals were excluded due to failed genotyping of rs2725220, leaving a total of 991 individuals for the study. \\n most statistical analyses were performed using plink and sas ( version 9.2 ; sas institute, cary, nc, usa ). \\n the abcg2 gene snp rs2725220 was selected using the affymetrix genomewide human snp array 5.0. \\n each snp was tested for possible effects on uric acid levels under an additive model. \\n the multivariate linear regression models used in the study incorporated covariates ( age and sex ). \\n odds ratios ( ors ) with 95% confidence intervals ( cis ) were calculated to examine the association of the abcg2 snp with abnormal uric acid levels ( 7 mg / dl for men and 6 mg / dl for women ). \\n all statistical tests were two - sided, and the statistical significance was determined as p < 0.05. \\n the majority of individuals in this study was middle - aged ( table 1 ). \\n mean levels of uric acid in the dataset were higher in males ( 6.23 mg / dl ) than in females ( 4.21 mg / dl ). \\n the percentage of individuals with abnormal uric acid levels ( 7.0 mg / dl ) was 14.7% for the seoul city sample. \\n the percentage of current smokers in the seoul city dataset was 46.4% among male subjects and 3.9% among female subjects. \\n table 2 shows the p - values from a linear regression model for uric acid levels in the cohort sample, with age and sex included as covariates in the model. \\n the rs2725220 snp in the abcg2 gene was found to be associated with mean uric acid levels ( effect per allele 0.25 mg / dl, p < 0.0001 ), which was significant after bonferroni correction ( p = 0.00025 ). \\n the minor allele frequency of rs2725220 was 0.222, and hardy - weinberg equilibrium was satisfied ( p = 0.7079 ). \\n we also analyzed the association of rs2725220 with abnormal uric acid levels ( table 3 ). \\n subjects with the gc / cc genotype had a 1.78-fold ( range, 1.22- to 2.62-fold ) higher risk of having abnormal uric acid levels ( 7.0 mg / dl ) than subjects with the gg genotype. when analyzed by gender, the association with abcg2 was stronger in men than in women. in table 4, we analyzed the association of abcg2 by body mass index ( bmi ) quartile levels and waist circumference quartile levels in male subjects. \\n the association with abcg2 was much stronger in male subjects with bmi  26.4 ( or, 5.09 ; 95% ci, 2.41 to 10.8 ) than in male subjects with bmi < 26.4. \\n the association with abcg2 was also a little bit stronger in male subjects with waist circumference ( wc )  91 ( or, 2.10 ; 95% ci, 1.08 to 4.10 ) than in male subjects with wc < 91. \\n in a cohort study of 991 subjects, an abcg2 gene snp was associated with increased uric acid, consistent with previous studies. \\n several gwass have reported that abcg2 exerts a major influence on uric acid levels [ 2, 3, 6, 7 ]. \\n conducted a genomewide study in which an snp in the abcg2 gene, rs2231142, displayed strong evidence of an association with uric acid levels ( p < 10 ). \\n another gwas also reported that rs2231142 showed a strong association with uric acid levels ( p = 5.1  10 ). \\n more recently, a gwas in european - american obesity cases and controls reported significant genome - wide association of two snps with uric acid levels : rs2622605 and rs1481017. \\n another recent gwas also reported a strong association between rs2231142 and uric acid levels ( p = 3.34.1  10 ). in the present study, rs2725220 was found to have a strong association with uric acid levels. in agreement with these findings \\n, a recent study reported that rs2725220 was strongly associated with uric acid levels ( effect per allele -0.135 mg / dl, p = 4.2  10 ). \\n several recent studies reported that the association between serum uric acid and the allelic effects of snps in abcg2 was sex - specific [ 8, 9 ]. in a recent study of 4 us populations, \\n the association between rs2231142 and serum uric acid was significantly stronger in men and postmenopausal women compared to their premenopausal counterparts. in the present study, the association of the abcg2 gene snp with uric acid was stronger in men than in women. \\n a modification of the effect of the associations between abcg2 snps and serum uric acid concentrations by interactions with obesity has been reported [ 3, 9 ]. in a recent study of 4 us populations, \\n the association between rs2231142 and serum uric acid was stronger in normal - weight subjects than in obese subjects. \\n in the present study, we also examined the association of the abcg2 snp with uric acid levels according to bmi level and waist circumference. \\n the association was stronger in subjects with a high bmi and high wc levels than in subjects with a low bmi and low wc levels. \\n the abcg2 gene encodes a membrane transporter belonging to the atp - binding cassette superfamily of membrane transporters, a group involved in the trafficking of biological molecules across cell membranes. \\n. allikmets et al.   mapped the abcg2 gene to human chromosome 4q22 using radiation hybrid analysis. \\n we estimated the identity by state over all snps, and only four individuals were shown to be biological relatives. \\n genetic studies in asian populations may not identify the same set of genes as those in european populations. \\n nevertheless, the seoul city cohort study in korean populations indicates that the abcg2 gene on chromosome 4 is associated with serum uric acid levels, as is the case in several other populations.\"},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Write a summary of the article that captures the main ideas and significant details.',\n",
       "  'input': 'Summarize the following article: patients hospitalized in the cardiovascular surgery department of carlos haya hospital ( mlaga , spain ) were recruited between february 2007 and june 2008 ( n = 15 ) . \\n all patients had an advanced atherosclerotic process and type 2 diabetes for a mean  sd of 12  7 years . \\n from patients with clinical stage iv peripheral arterial occlusive disease ( paod ) and amputation of inferior limbs , two types of vascular biopsy specimens were collected : occlusive popliteal artery ( opa ) with atherosclerotic plaque and femoral vein ( fv ) . as much of the opa as the fv was obtained from the vascular bundle of each patient . \\n the inclusion criteria were age 1880 years ( all patients were > 60 and written informed consent ) . \\n the presence of atherosclerotic risk factors was evaluated using the european society of cardiology and hypertension definition for hypertension ( systolic blood pressure 140 mmhg and/or diastolic blood pressure 90 mmhg ) , the american diabetes association 2010 definition for type 2 diabetes ( repeated fasting glucose levels 126 mg / dl if being treated with oral antidiabetic agents or insulin at the time of the study or if hba1c > 6.5% ) , the national cholesterol education program - adult treatment panel iii criteria for triglyceride ( 150 mg / dl ) and hdl cholesterol ( men < 40 mg / dl , women < 50 mg / dl ) levels , a bmi > 30 kg / m for obesity , and a smoking habit up to 6 months before the hospital admission . \\n anthropometric and biochemical parameters were sex , age , waist circumference , systolic and diastolic blood pressure , glucose , hba1c , total cholesterol , hdl cholesterol , ldl cholesterol , and triglycerides . additionally , we measured the homeostasis model assessment index , which is used to quantify insulin resistance and -cell function . \\n the approximating equation for insulin resistance used a fasting blood sample and was derived by ( glucose  insulin)/405 , where glucose is given in milligrams per deciliter and insulin is given in microunits per milliliter . \\n the patients were admitted to the hospital 72 h before surgery , and their treatment often was modified to prepare them for surgery . for all patients , there was a drug washout period of 12 h before blood collection . \\n the therapeutic characteristics of the patients were oral antidiabetic drugs ( 20.0% ) , including metformin , gliclazide , or repaglinide ( 6.7% each ) ; insulin ( 86.7% ) ; antihypertensive drugs ( 80.0% ) , including ace inhibitors ( 26.7% ) , angiotensin receptor blockers ( 20% ) , calcium channel blockers ( 20% ) , -blockers ( 20.0% ) , and diuretics ( 46.7% ) ; hypolipemiant drugs , including statins ( 26.7% ) ; antiaggregant drugs ( 80.0% ) ; and anticoagulant drugs ( 53.3% ) . \\n each patient had a stable treatment regimen in the 6 months before the study , which also was an inclusion criterion for this study . \\n the study was approved by the hospital ethics committee , and all patients gave written informed consent . the study protocol complied with the principles of the helsinki declaration . \\n the vascular biopsy specimens , removed immediately after surgery , were immersed in 2-methylbutane and then in liquid nitrogen . \\n histological studies were performed on 4-mm - thick sections of the vessels , and atheromatous plaque cut in a cryostat at 20c was thaw mounted onto poly - l - lysine  treated slides . \\n tissues were then stained with masson trichrome and photographed under routine light microscopy ( leica microsystems ltd . ) . \\n igg and igm antioxldl abs were measured in duplicate as previously described ( 9,10 ) . in brief , the ldl was isolated from fasting plasma from human blood donors by density gradient ultracentrifugation . \\n microtiter plates for determination of igg and igm anti - mda - ldl antibodies were coated with either native ldl or mda - ldl and the serum of each patient . \\n the absorbance was read , and the binding of antibodies to mda - ldl ( antioxldl abs ) was calculated by subtracting the binding of native ldl from the binding of mda - ldl . \\n pieces of opa and fv vessels were homogenized using the tripure isolation reagent ( roche molecular biochemicals , barcelona , spain ) according to the manufacturer s instructions in ice and a laboratory batch mixer ( t25-ultra3-turrax basic ; ika equipment laboratory ) . \\n cdna was obtained from 1 g rna using the high capacity cdna reverse transcription kit ( formerly the high capacity cdna archive kit ; applied biosystems , foster city , ca ) . \\n rnas with ratios between 1.7 and 2 were considered adequate for quantification of mrna expression . \\n recombinant rnasin ribonuclease inhibitor ( applied biosystems ) was added to prevent rnase - mediated degradation . \\n gene expression analyses were performed at the mrna level by taqman low density array ( tlda ) . \\n predesigned taqman probe and primer sets for target genes were chosen from an online catalog ( applied biosystems ) . \\n these were factory - loaded into the 384 wells of the tlda card , which was configured into 8 identical 24-gene sets in duplicate . \\n twenty - two genes were chosen based on literature reviews of key molecules in inflammation and immunology . \\n studied genes classified by metabolic pathway involved five microliters of single - stranded cdna ( equivalent to 100 ng total rna ) were mixed with 45 l nuclease - free water and 50 l taqman universal pcr master mix . \\n after gentle mixing and centrifugation , the 100-l mixture was transferred into a loading port on a tlda card . \\n the card was centrifuged twice for 1 min at 1,100 rpm to distribute the samples from the loading port into each well . \\n it was then sealed and placed in the micro fluidic card sample block of an applied biosystems 7900ht pcr system . \\n the thermal cycling condition was 2 min at 50c and 10 min at 95c followed by 40 cycles of 30 s at 97c and 1 min at 59.7c . \\n expression levels were measured in duplicate . only the genes with reproducible amplification curves of both duplicates were analyzed and presented . \\n tlda cards were analyzed with relative quantitation ( rq ) documents and the rq manager software for automated data analysis . \\n gene expression values ( rq ) were calculated based on the  cycle threshold method . \\n cycle threshold values , defined as the point at which the fluorescence rises above the background fluorescence , were calculated with sds 2.3 software ( applied biosystems ) . \\n a mixture of dna from opa was used as a calibrator , and 18s rrna was the reference for normalization . \\n results are expressed as mean  sd . relationships between cellular biomarkers and antioxldl ab ( plasma igg / igm antioxldl ab levels ) were examined by means of the pearson correlation test . \\n statistical analyses were performed with spss for windows version 17.0 ( ibm corporation inc . , somers , ny ) . \\n the aim of this study was to assess the correlation between plasma igg / igm antioxldl ab levels with specific inflammatory , apoptotic , and lipid metabolism biomarkers in both opa with atheromatous plaque and fv without plaque . \\n the sample size calculation was realized , considering that a correlation coefficient < 0.65 could lead to a type 1 error or a false - positive correlation . \\n thus , based on this aim , the sample size was calculated to have > 70% power (  = 0.05 ) and an expected correlation coefficient of 0.65 . following this statistical approach , \\n the vascular biopsy specimens , removed immediately after surgery , were immersed in 2-methylbutane and then in liquid nitrogen . \\n histological studies were performed on 4-mm - thick sections of the vessels , and atheromatous plaque cut in a cryostat at 20c was thaw mounted onto poly - l - lysine  treated slides . \\n tissues were then stained with masson trichrome and photographed under routine light microscopy ( leica microsystems ltd . ) . \\n igg and igm antioxldl abs were measured in duplicate as previously described ( 9,10 ) . in brief , the ldl was isolated from fasting plasma from human blood donors by density gradient ultracentrifugation . \\n microtiter plates for determination of igg and igm anti - mda - ldl antibodies were coated with either native ldl or mda - ldl and the serum of each patient . \\n the absorbance was read , and the binding of antibodies to mda - ldl ( antioxldl abs ) was calculated by subtracting the binding of native ldl from the binding of mda - ldl . \\n pieces of opa and fv vessels were homogenized using the tripure isolation reagent ( roche molecular biochemicals , barcelona , spain ) according to the manufacturer s instructions in ice and a laboratory batch mixer ( t25-ultra3-turrax basic ; ika equipment laboratory ) . \\n cdna was obtained from 1 g rna using the high capacity cdna reverse transcription kit ( formerly the high capacity cdna archive kit ; applied biosystems , foster city , ca ) . \\n rnas with ratios between 1.7 and 2 were considered adequate for quantification of mrna expression . \\n recombinant rnasin ribonuclease inhibitor ( applied biosystems ) was added to prevent rnase - mediated degradation . \\n gene expression analyses were performed at the mrna level by taqman low density array ( tlda ) . \\n predesigned taqman probe and primer sets for target genes were chosen from an online catalog ( applied biosystems ) . \\n these were factory - loaded into the 384 wells of the tlda card , which was configured into 8 identical 24-gene sets in duplicate . \\n twenty - two genes were chosen based on literature reviews of key molecules in inflammation and immunology . \\n studied genes classified by metabolic pathway involved five microliters of single - stranded cdna ( equivalent to 100 ng total rna ) were mixed with 45 l nuclease - free water and 50 l taqman universal pcr master mix . after gentle mixing and centrifugation , the 100-l mixture was transferred into a loading port on a tlda card . \\n the card was centrifuged twice for 1 min at 1,100 rpm to distribute the samples from the loading port into each well . \\n it was then sealed and placed in the micro fluidic card sample block of an applied biosystems 7900ht pcr system . \\n the thermal cycling condition was 2 min at 50c and 10 min at 95c followed by 40 cycles of 30 s at 97c and 1 min at 59.7c . \\n tlda cards were analyzed with relative quantitation ( rq ) documents and the rq manager software for automated data analysis . \\n gene expression values ( rq ) were calculated based on the  cycle threshold method . \\n cycle threshold values , defined as the point at which the fluorescence rises above the background fluorescence , were calculated with sds 2.3 software ( applied biosystems ) . \\n a mixture of dna from opa was used as a calibrator , and 18s rrna was the reference for normalization . \\n results are expressed as mean  sd . relationships between cellular biomarkers and antioxldl ab ( plasma igg / igm antioxldl ab levels ) were examined by means of the pearson correlation test . \\n statistical analyses were performed with spss for windows version 17.0 ( ibm corporation inc . , somers , ny ) . \\n the aim of this study was to assess the correlation between plasma igg / igm antioxldl ab levels with specific inflammatory , apoptotic , and lipid metabolism biomarkers in both opa with atheromatous plaque and fv without plaque . \\n the sample size calculation was realized , considering that a correlation coefficient < 0.65 could lead to a type 1 error or a false - positive correlation . \\n thus , based on this aim , the sample size was calculated to have > 70% power (  = 0.05 ) and an expected correlation coefficient of 0.65 . following this statistical approach , \\n to characterize histologically the vascular biopsy specimens from patients with atherosclerosis , sections from the vessels were stained with masson trichrome and photographed under light microscopy ( fig . \\n the sections corresponding to the opa had soft plaques with a lipid nucleus and calcium deposits . \\n the capsule had few collagen fibers and vascular smooth muscle cells , although with an excess of macrophages and lymphocytes ( fig . \\n 1a ) . in the fv biopsy specimens , we found a normal histology , with the adventitial layer comprising connective tissue as well as collagen and elastic fibers , the media layer comprising smooth muscle and elastic fibers , and the inner layer comprising an elastic membrane lining and smooth endothelium where endothelial cells were located ( fig . \\n ( a high - quality digital representation of this figure is available in the online issue . ) on the other hand , in the patients with paod , different anthropometric parameters ( sex , age , bmi , and blood pressure ) were not correlated with igg and igm antioxldl abs ( table 2 ) . \\n biochemical parameters showed a negative correlation between igm antioxldl ab and c - ldl plasma levels ( r = 0.562 , p = 0.05 ) in opa , but this significance disappeared in fv . \\n clinical and biochemical variables from patients with paod in addition , we investigated the possible correlation of plasma igg and igm antioxldl ab levels with gene expression of different biomarkers ( mrna levels ) in patients with paod . \\n the expression was obtained from 46 genes that have an important relevance in all the studied metabolic pathways , and their expression in vessels with a highly atherogenic environment ( i.e. , opa , fv ) were analyzed . \\n only 11 genes were significantly correlated with antioxldl abs in the biopsy specimens ( table 3 ) . \\n the genes altered were those involved in inflammation , apoptosis , cell cycle , cell turnover , transcription factor , and lipid metabolism compared with the housekeeping genes 18s rrna and gapdh . in fv , igg antioxldl ab showed a negative correlation with mmp10 and a positive correlation with mmp2 . on the other hand \\n , there was a positive correlation between igm antioxldl ab and akt1 , casp3 , pparg , tfpi , nfkb , and vegfa ( table 4 ) . \\n in opa , igm antioxldl ab showed a positive correlation with mmp10 , akt1 , bax , cdkn1a , scarb1 , and vegfa , and igg antioxldl ab had no correlation with the studied genes ( table 5 ) . \\n genes with significant correlation with antioxldl abs in the opa and fv biopsy specimens simple linear correlations between different biomarkers and antioxldl abs from fv biopsy specimens simple linear correlations between different biomarkers and antioxldl abs from opa biopsy specimens to assess the association between igg and igm antioxldl abs and drugs , multiple regression models were used to correct for confounding factors . the association analysis did not fall within any of the proposed models ( data not shown ) . \\n the most relevant finding in this study is that igm antioxldl ab showed a significant correlation with different signaling pathways ( inflammation , apoptosis , and lipid metabolism ) in a highly atherosclerotic environment . to study signaling pathways , there are some important points to consider . \\n the atherosclerotic process is the lipid accumulation in blood vessels , which triggers different responses leading to the plaque development . \\n it has been demonstrated that the atherosclerotic process is accentuated in large arteries where hemodynamic forces are exerted ( 20 ) . \\n we demonstrate that in both a vein and an artery , plasma levels of igm antioxldl ab correlate with these signaling pathways , indicating that this antibody was expressed in a determined environment ( atherosclerotic medium ) independently of the analyzed vessel \\n . this event does not occur with igg antioxldl ab . of all biochemical and anthropometric characteristics of these patients with diabetes , in accord with other studies ( 9,11 ) , only plasma c - ldl levels showed a negative correlation with igm antioxldl ab . \\n numerous studies have linked both igg and igm antioxldl abs with atherosclerosis , although it seems that there are more consistent data about the negative association of igm levels with the atherosclerotic process ( 21 ) . in occluded arteries , only igm levels are positively correlated with the signaling pathways , as argued by many authors ( 22 ) . in the present study , we analyzed the biomarkers of the different metabolic pathways that have significant correlation with antioxldl ab . \\n with respect to inflammatory biomarkers , it is known that during plaque formation , muscle cells migrate from the media to the intimal layer , where they proliferate and generate growth factors , such as vegfa . in the past decade , vegfa was believed to be a proinflammatory biomarker in endothelial cells involved in the atherosclerotic process ( 23 ) . in the present study , \\n expression of vegfa is associated with igm antioxldl abs in both fv and opa , demonstrating this relationship . \\n another inflammatory biomarker , tissue factor pathway inhibitor ( tfpi ) , is a potent regulator of the tissue factor pathway that together with ldl modulates tissue factor function ( 24 ) . \\n other proinflammatory biomarkers are the metalloproteinases , which are a family of zinc - dependent endopeptidases , and they are a major contributor to plaque rupture ( 25 ) . \\n mmp10 is a key link between inflammation and thrombosis , particularly in situations of increased thrombotic risk ( 26 ) . in the present study \\n all these findings suggest that igm antioxldl ab is related to the inflammatory process inside an atherosclerotic environment . in relation to lipid metabolism pathway , two biomarkers correlated with antioxldl abs . on the one hand , \\n as such , it depends on the amount of cholesterol in lipid - laden macrophages ( 27 ) inside atheroma plaque . in peripheral cells , \\n the lipid uptake by scavenger receptor initiates chronic proinflammatory cascades linked to atherosclerosis . in this sense \\n , the present study demonstrates that scarb1 is positively correlated with igm antioxldl ab levels in opa . \\n in addition , another lipid biomarker is a nuclear hormone receptor , pparg , which also is positively correlated with igm antioxldl ab levels in fv . \\n pparg agonist - mediated inhibition of the renin - angiotensin - aldosterone system and the thromboxane a2 system as well as endothelial protection may possibly be involved in the inhibitory effects on blood pressure and atherosclerosis ( 28 ) in this vessel ; thus , the atherosclerotic process is not developed in this environment . \\n activation of pparg by its ligands could modulate gene transcription , such as nfkb , thereby leading to multiple antiatherogenic and fibrinolytic effects ( 29 ) . \\n in fact , nfkb also shows a positive correlation with igm antioxldl ab levels in fv . \\n when igm antioxldl ab levels were analyzed in relation with some biomarkers of the apoptosis pathway , we found that akt1 , casp3 , and bax in fv and only akt1 and bax in opa showed a positive correlation with igm antioxldl ab . \\n recently , it was demonstrated that in human umbilical vein endothelial cells , oxldl - induced apoptosis was associated with upregulation of proapoptotic bax and casp3 and inhibition of antiapoptotic akt1 accompanied by reciprocal changes in the methylation of promoter regions of these genes ( 30 ) . in this sense , it could be hypothesized that because of this correlation between these biomarkers and igm antioxldl ab , this antibody has a protective function in atheroma plaque . \\n on the other hand , it was demonstrated that casp3 cleaves specifically with cdkn1a and may trigger the apoptosis pathway ( 31 ) . \\n the expression of this gene is modulated by the tumor suppressor protein p53 ( 33 ) . in this study , a positive correlation between cdkn1a and igm antioxldl ab was found in opa . in conclusion , the results of this study show that the gene expression of the apoptosis , lipid metabolism , and inflammation metabolic pathways in the fv and opa vessels is directly related to the levels of igm antioxldl ab . because this is a cross - sectional study , we could not determine whether igm antioxldl ab has a proinstability effect in plaques , whether it exerts a protective compensatory response , or whether it is merely a correlative marker for the presence of inflammatory cells in patients with diabetes .',\n",
       "  'output': 'objectiveoxidized lipoproteins and antioxidized ldl antibodies ( antioxldl abs ) have been detected in human plasma and atherosclerotic lesions . \\n the principle aim of this study was to analyze the possible relationship between igg and igm antioxldl abs and factors involved in different metabolic pathways ( inflammation , lipid metabolism , apoptosis , and cell cycle arrest profile ) in the occluded popliteal artery ( opa ) compared with the femoral vein ( fv).research design and methodsfifteen patients with advanced atherosclerosis and type 2 diabetes undergoing lower limb amputation participated in this study . \\n each patient had opa and fv biopsy specimens and peripheral arterial occlusive disease . by real - time pcr \\n , gene expression was analyzed from the opa and fv specimens , and antioxldl ab levels were measured by specific enzyme - linked immunosorbent assay .resultsthe opa and fv showed a positive correlation between only igm antioxldl ab levels and the expression of genes involved in different metabolic pathways , including inflammation ( tfpi ) , apoptosis ( bax , caspase 3 , akt1 ) , plaque disruption ( mmp2 and mmp10 ) , lipid metabolism ( scarb1 , pparg ) , and cell turnover ( cdkn1a ) , and genes for transcription and growth factors ( nfkb and vegfa , respectively).conclusionsthe results show that gene expression in the metabolic pathways ( apoptosis , lipid metabolism , and inflammation ) in the opa and fv are directly related to the levels of igm antioxldl abs .',\n",
       "  '__index_level_0__': 31688,\n",
       "  'model_output': 'the study by alonso et al. ( 1 ) investigated the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in atheromatous plaque ( opa ) and in a vein ( fv ). the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the results showed that the expression of biomarkers of inflammation, apoptosis, and lipid metabolism in fv and opa vessels was directly related to the levels of igm antioxldl ab. \\n the authors concluded that the results of this study show that the gene expression of the apoptosis, lipid metabolism, and inflammation metabolic pathways in the fv and opa vessels is directly related to the levels of igm antioxldl ab. \\n however, the study has several important limitations. \\n first, the study design was a cross - sectional study, and the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers was not investigated longitudinally. \\n second, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n third, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fourth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n tenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eleventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twelfth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirteenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fourteenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifteenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixteenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventeenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighteenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n nineteenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twentieth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twenty - first, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twenty - second, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twenty - third, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twenty - fourth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twenty - fifth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twenty - sixth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twenty - seventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twenty - eighth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n twenty - ninth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirtieth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirty - first, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirty - second, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirty - third, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirty - fourth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirty - fifth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirty - sixth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirty - seventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirty - eighth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n thirty - ninth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fortieth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n forty - first, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n forty - second, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n forty - third, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n forty - fourth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n forty - fifth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n forty - sixth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n forty - seventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n forty - eighth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n forty - ninth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fiftieth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifty - first, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifty - second, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifty - third, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifty - fourth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifty - fifth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifty - sixth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifty - seventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifty - eighth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n fifty - ninth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixtieth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixty - first, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixty - second, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixty - third, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixty - fourth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixty - fifth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixty - sixth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixty - seventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixty - eighth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n sixty - ninth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventieth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventy - first, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventy - second, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventy - third, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventy - fourth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventy - fifth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventy - sixth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventy - seventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventy - eighth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n seventy - ninth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eightieth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighty - first, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighty - second, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighty - third, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighty - fourth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighty - fifth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighty - sixth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighty - seventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighty - eighth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n eighty - ninth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninetieth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninety - first, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninety - second, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninety - third, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninety - fourth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninety - fifth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninety - sixth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninety - seventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninety - eighth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n ninety - ninth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundredth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - first, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - second, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - third, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - fourth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - fifth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - sixth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - seventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - eighth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - ninth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - tenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - eleventh, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - twelfth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - thirteenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - fourteenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - fifteenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease. \\n the relationship between antioxldl abs and inflammatory, apoptotic, and lipid metabolism biomarkers in patients with type 2 diabetes and advanced atherosclerotic disease is not necessarily applicable to the general population. \\n hundred - sixteenth, the study population was composed of patients with type 2 diabetes and advanced atherosclerotic disease.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': \"Summarize the following article: metabolic data from 330 whites from the southern part of germany were included in the analyses . \\n they participated in an ongoing study on the pathophysiology of type 2 diabetes ( 23 ) . \\n individuals were included into the study when they fulfilled at least one of the following criteria : a family history of type 2 diabetes , a bmi > 27 kg / m , previous diagnosis of impaired glucose tolerance , or gestational diabetes . \\n they were considered healthy according to a physical examination and routine laboratory tests . as assessed by means of a standard questionnaire , the participants had no history of liver disease such as hepatitis and did not consume more than two alcoholic drinks per day . \\n data from 16 individuals ( 6 women , 10 men , age 66  9 years , bmi 24  4 kg / m ) undergoing liver surgery because of hepatic carcinoma or liver metastasis were also included in the present study . \\n they tested negative for viral hepatitis and had no liver cirrhosis . informed written consent was obtained from all participants , and the local medical ethics committee had approved the protocol . \\n waist circumference was measured at the midpoint between the lateral iliac crest and lowest rib . \\n furthermore , we measured total and visceral fat with an axial t1-weighed fast spin echo technique with a 1.5 t whole - body imager ( magnetom sonata , siemens healthcare ) ( 24 ) . \\n volunteers were in prone position and images were recorded from fingers to toes with a slice thickness of 10 mm and a gap between slices of 10 mm \\n . segmentation of images was performed by semiautomatic thresholding based on a matlab routine ( mathworks ) . \\n visceral fat was quantified in 16 to 21 slices ( depending on the size of the volunteer ) between femoral heads and diaphragm , not differentiating between intra- and retroperitoneal fat , by manual delineation of the visceral compartment . \\n fat volume from images was calculated by multiplying the in - plane pixel dimensions with the slice thickness and the number of pixels classified as fat . \\n volumes between contiguous slices are calculated by simply doubling the volume of the adjacent slice . \\n liver fat was measured as previously described ( 23 ) by localized hmr spectroscopy , applying a single - voxel steam technique with a short echo time ( te = 10 ms ) and a long repetition time ( tr = 4 s ) avoiding t2-related signal losses . \\n volunteers were in supine position , and a single element of the spine array coil was used for acquisition of spectroscopic data . \\n spectra were recorded in posterior part of segment seven from a volume of interest of 3  3  2 cm in an acquisition time of 2:08 min ( 32 acquisitions ) . \\n volunteers were asked to be in respiration during data acquisition to minimize movement artifacts and resulting line broadening . \\n postprocessing of spectra was performed by manual integration of water signal ( h2o at 4.7 ppm ) and sum of methylene ( ch2 at 1.3 ppm ) and methyl signals ( ch3 at 0.95 ppm ) . \\n liver fat is given by si((ch2)n + ch3)/si(h2o )  100 , where si is the corresponding signal integral in arbitrary units . \\n we obtained venous plasma samples at 0 , 30 , 60 , 90 , and 120 min for determination of plasma glucose and insulin . \\n glucose tolerance was determined according to the 1997 world health organization diagnostic criteria ( 25 ) . \\n insulin sensitivity was determined with a primed insulin infusion at a rate of 40 mu / m per min for 2 h as previously described ( 23 ) . \\n blood glucose was determined using a bedside glucose analyzer ( glucose - oxidase method ; ysi , yellow springs instruments , yellow springs , co ) . \\n plasma insulin was determined by microparticle enzyme immunoassay ( advia siemens healthcare diagnostics , eschborn , germany ) . \\n plasma fetuin - a was determined by an immunoturbidimetric method as previously described ( 18,20 ) . \\n the insulin sensitivity index ( in micromole per kilogram per minute per picomole per liter ) for systemic glucose uptake was calculated as the mean infusion rate of glucose ( in micromole per kilogram per minute ) necessary to maintain euglycemia during the last 40 min of the euglycemic - hyperinsulinemic clamp divided by the steady - state plasma insulin concentration . \\n the latter was the mean insulin concentration at minute 100 , 110 , and 120 of the clamp ( mean for all control subjects : 532  15 \\n insulin sensitivity from the ogtt was estimated as proposed by matsuda and defronzo ( 26 ) . \\n liver samples were taken from normal , nondiseased tissue during surgery , immediately frozen in liquid nitrogen , and stored at 80c . \\n tissue samples were homogenized in pbs containing 1% triton x-100 using a tissuelyser ( qiagen , hilden , germany ) and triglyceride content was quantified using the advia 1650 clinical chemistry analyzer ( siemens healthcare diagnostics , eschborn , germany ) . \\n frozen tissue was homogenized in a tissuelyser ( qiagen ) , and rna was extracted with the rneasy tissue kit ( qiagen ) according to the manufacturer 's instructions . \\n reverse transcription of total rna quantitative pcr of tnf- and -actin was performed on the light cycler system ( roche , mannheim , germany ) using sybr green . \\n pnpla3 mrna expression was quantified using the quantitect sybr green pcr kit and quantitect primer assay qt00055419 ( qiagen ) on a roche lightcycler 480 ( mannheim , germany ) . for genotyping , \\n dna was isolated from whole blood using a commercial dna isolation kit ( nucleospin , macherey & nagel , dren , germany ) . \\n the snp rs738409 in pnpla3 was genotyped using taqman assays ( applied biosystems , foster city , ca ) . \\n we also genotyped the snp rs6006460 , although it has a very low allelic frequency in european americans and was found to be associated with liver fat only in blacks ( 21 ) . \\n the taqman genotyping reaction was amplified on a geneamp pcr system 7000 ( 50c for 2 min , 95c for 10 min , followed by 40 cycles of 95c for 15 s and 60c for 1 min ) , and fluorescence was detected on an abi prism sequence detector ( applied biosystems ) . \\n the taqman assay was validated by direct sequencing of the snps in 50 control subjects , and both methods gave identical results . \\n the genotyping success rate for the snp rs738409 was 99.9% , and rescreening of 3.3% of the control subjects with the taqman assay gave 100% identical results . \\n data that were not normally distributed ( e.g. , liver fat , insulin sensitivity , body fat distribution ; shapiro - wilk w test ) were logarithmically transformed . to adjust the effects of covariates and identify independent relationships , we first performed forward stepwise regression analyses to identify the variables to be included into a multiple regression model . \\n next , we performed multivariate linear regression analyses with these variables as independent parameters . to test the effect of the genotype on the metabolically relevant parameters , the parameter to be considered \\n for each dependent variable , two models were applied . in the additive model , the effects of all possible genotypes on the dependent variable were compared ; in the dominant model homozygotes for the major c allele were compared with heterozygotes and homozygotes for the minor g allele . \\n the relationship of the snps with insulin sensitivity was also investigated in more lean and more obese control subjects . \\n men and women were separately divided by the median total body fat content into two groups . \\n the lean men and lean women , as well as the obese men and women , were combined thereafter . \\n logistic regression with adjustment for covariates was applied to determine the odds ratio of the genotypes for being diagnosed with fatty liver . \\n the statistical software package jmp 4.0 ( sas institute , cary , nc ) was used . \\n waist circumference was measured at the midpoint between the lateral iliac crest and lowest rib . \\n furthermore , we measured total and visceral fat with an axial t1-weighed fast spin echo technique with a 1.5 t whole - body imager ( magnetom sonata , siemens healthcare ) ( 24 ) . \\n volunteers were in prone position and images were recorded from fingers to toes with a slice thickness of 10 mm and a gap between slices of 10 mm . \\n segmentation of images was performed by semiautomatic thresholding based on a matlab routine ( mathworks ) . \\n visceral fat was quantified in 16 to 21 slices ( depending on the size of the volunteer ) between femoral heads and diaphragm , not differentiating between intra- and retroperitoneal fat , by manual delineation of the visceral compartment . \\n fat volume from images was calculated by multiplying the in - plane pixel dimensions with the slice thickness and the number of pixels classified as fat . \\n volumes between contiguous slices are calculated by simply doubling the volume of the adjacent slice . \\n liver fat was measured as previously described ( 23 ) by localized hmr spectroscopy , applying a single - voxel steam technique with a short echo time ( te = 10 ms ) and a long repetition time ( tr = 4 s ) avoiding t2-related signal losses . \\n volunteers were in supine position , and a single element of the spine array coil was used for acquisition of spectroscopic data . \\n spectra were recorded in posterior part of segment seven from a volume of interest of 3  3  2 cm in an acquisition time of 2:08 min ( 32 acquisitions ) . \\n volunteers were asked to be in respiration during data acquisition to minimize movement artifacts and resulting line broadening . \\n postprocessing of spectra was performed by manual integration of water signal ( h2o at 4.7 ppm ) and sum of methylene ( ch2 at 1.3 ppm ) and methyl signals ( ch3 at 0.95 ppm ) . \\n liver fat is given by si((ch2)n + ch3)/si(h2o )  100 , where si is the corresponding signal integral in arbitrary units . \\n we obtained venous plasma samples at 0 , 30 , 60 , 90 , and 120 min for determination of plasma glucose and insulin . \\n glucose tolerance was determined according to the 1997 world health organization diagnostic criteria ( 25 ) . \\n insulin sensitivity was determined with a primed insulin infusion at a rate of 40 mu / m per min for 2 h as previously described ( 23 ) . \\n blood glucose was determined using a bedside glucose analyzer ( glucose - oxidase method ; ysi , yellow springs instruments , yellow springs , co ) . \\n plasma insulin was determined by microparticle enzyme immunoassay ( advia siemens healthcare diagnostics , eschborn , germany ) . \\n plasma fetuin - a was determined by an immunoturbidimetric method as previously described ( 18,20 ) . \\n the insulin sensitivity index ( in micromole per kilogram per minute per picomole per liter ) for systemic glucose uptake was calculated as the mean infusion rate of glucose ( in micromole per kilogram per minute ) necessary to maintain euglycemia during the last 40 min of the euglycemic - hyperinsulinemic clamp divided by the steady - state plasma insulin concentration . \\n the latter was the mean insulin concentration at minute 100 , 110 , and 120 of the clamp ( mean for all control subjects : 532  15 \\n insulin sensitivity from the ogtt was estimated as proposed by matsuda and defronzo ( 26 ) . \\n liver samples were taken from normal , nondiseased tissue during surgery , immediately frozen in liquid nitrogen , and stored at 80c . \\n tissue samples were homogenized in pbs containing 1% triton x-100 using a tissuelyser ( qiagen , hilden , germany ) and triglyceride content was quantified using the advia 1650 clinical chemistry analyzer ( siemens healthcare diagnostics , eschborn , germany ) . \\n frozen tissue was homogenized in a tissuelyser ( qiagen ) , and rna was extracted with the rneasy tissue kit ( qiagen ) according to the manufacturer 's instructions . \\n reverse transcription of total rna quantitative pcr of tnf- and -actin was performed on the light cycler system ( roche , mannheim , germany ) using sybr green . \\n pnpla3 mrna expression was quantified using the quantitect sybr green pcr kit and quantitect primer assay qt00055419 ( qiagen ) on a roche lightcycler 480 ( mannheim , germany ) . \\n for genotyping , dna was isolated from whole blood using a commercial dna isolation kit ( nucleospin , macherey & nagel , dren , germany ) . \\n the snp rs738409 in pnpla3 was genotyped using taqman assays ( applied biosystems , foster city , ca ) . \\n we also genotyped the snp rs6006460 , although it has a very low allelic frequency in european americans and was found to be associated with liver fat only in blacks ( 21 ) . \\n the taqman genotyping reaction was amplified on a geneamp pcr system 7000 ( 50c for 2 min , 95c for 10 min , followed by 40 cycles of 95c for 15 s and 60c for 1 min ) , and fluorescence was detected on an abi prism sequence detector ( applied biosystems ) . \\n the taqman assay was validated by direct sequencing of the snps in 50 control subjects , and both methods gave identical results . \\n the genotyping success rate for the snp rs738409 was 99.9% , and rescreening of 3.3% of the control subjects with the taqman assay gave 100% identical results . \\n data that were not normally distributed ( e.g. , liver fat , insulin sensitivity , body fat distribution ; shapiro - wilk w test ) were logarithmically transformed . to adjust the effects of covariates and identify independent relationships , we first performed forward stepwise regression analyses to identify the variables to be included into a multiple regression model . \\n next , we performed multivariate linear regression analyses with these variables as independent parameters . to test the effect of the genotype on the metabolically relevant parameters , the parameter to be considered was set as the dependent variable . \\n the effects of all possible genotypes on the dependent variable were compared ; in the dominant model homozygotes for the major c allele were compared with heterozygotes and homozygotes for the minor g allele . \\n the relationship of the snps with insulin sensitivity was also investigated in more lean and more obese control subjects . \\n men and women were separately divided by the median total body fat content into two groups . \\n the lean men and lean women , as well as the obese men and women , were combined thereafter . logistic regression with adjustment for covariates was applied to determine the odds ratio of the genotypes for being diagnosed with fatty liver . \\n the statistical software package jmp 4.0 ( sas institute , cary , nc ) was used . \\n the 330 subjects ( 130 men and 200 women ) had a mean age of 45 ( range 1869 ) years . \\n anthropometrics and metabolic characteristics of the subjects covered a wide range that was particularly large for total body fat ( 470 kg ) , visceral fat ( 0.210.1 kg ) , liver fat ( 0.230.0% ) , and insulin sensitivity ( ogtt : 1.633.4 arbitrary units ; clamp : 0.0080.347 mol  kg  min  pm ) . \\n a total of 105 control subjects had fatty liver ( liver fat > 5.56% ) ( 27 ) . \\n liver fat was higher in males than females ( 7.3  0.5 vs. 4.8  0.4% , p < 0.0001 ) and correlated positively with age ( r = 0.18 , p = 0.001 ) , total body fat ( r = 0.30 , p < 0.0001 ) , visceral fat ( r = 0.59 , p < 0.0001 ) , and inversely with insulin sensitivity ( ogtt : r = 0.53 , p < 0.0001 ; clamp : r = 0.56 , p < 0.0001 ) . in forward stepwise linear regression analyses including age , sex , liver fat , total fat , and visceral fat , liver fat was the strongest determinant of insulin sensitivity estimated from the ogtt ( f ratio : 56 ) followed by age ( f ratio : 9 ) , total fat ( f ratio : 9 ) , and visceral fat ( f ratio : 5 ) . \\n similar results were found for insulin sensitivity measured by the clamp ( f ratios ; liver fat : 39 ; visceral fat : 12 ; total fat : 10 ; and age : 9 ) . in our population , the frequency of the minor g allele of the snp rs738409 in pnpla3 was 0.26 , similar to findings in european americans ( 0.23 ) ( 21 ) , and the snp was in hardy - weinberg equilibrium (  test ; p > 0.05 ) . \\n the snp rs738409 was strongly associated with liver fat content depicting an allele - dose effect . \\n carriers of the g allele had significantly higher liver fat compared to c allele homozygotes , independently of age , sex , and adiposity ( table 1 ) and even of visceral adiposity ( p < 0.0001 , fig . 1a ) . furthermore , g allele carriers had higher odds ratios ( cg : 2.15 [ 95% ci 1.193.91 ] ; gg : 3.71 [ 95% ci 1.3710.53 ] ) for being diagnosed with fatty liver compared to c allele homozygotes ( table 1 , fig . \\n 2 ) . however , the predictive effect of the snp for diagnosing control subjects with fatty liver was only moderate ( dominant model : positive predictive value of the snp : 0.51 ; negative predictive value of the snp : 0.61 ) . \\n associations of the snp rs738409 in pnpla3 with demographic and metabolic characteristics values represent means  se . for statistical analyses , nonnormally distributed parameters \\n body weight , bmi , waist circumference , and total body fat were adjusted for age and sex . \\n isi , insulin sensitivity index , available in 222 control subjects ( c / c n = 124 ; c / g n = 72 ; t / t n = 26 ) . relationships of the snp rs738409 c > g ( ile148met ) in pnpla3 with liver fat ( a ) and insulin sensitivity ( b ) in all 330 subjects ( tat , total adipose tissue ; vat , visceral adipose tissue ) . \\n liver fat content in subjects without and with fatty liver and the relationship of the snp rs738409 with liver fat content in subjects having fatty liver ( c ) . \\n insulin sensitivity in subjects without and with fatty liver and the relationship of the snp rs738409 with insulin sensitivity in subjects having fatty liver ( d ) . \\n interestingly , the snp was not associated with insulin sensitivity estimated from the ogtt ( table 1 , fig . \\n 1b ) or measured by the clamp ( table 1 , p = 0.32 after adjustment for age , sex , total fat , and visceral fat ) . \\n power analyses revealed that at the -level of 0.05 and at a power of 80% the minimum detectable effect sizes among all three genotypes ( genotypes cc , cg , and gg ) were 8.5% for insulin sensitivity estimated from the ogtt and 9% for insulin sensitivity measured by the clamp . in a dominant model ( genotype cc vs. cg + gg ) the effect sizes were 8% for insulin sensitivity estimated from the ogtt and 8.3% for insulin sensitivity measured by the clamp . \\n furthermore , the snp was not associated with total fat and visceral fat , liver enzymes , high - sensitivity ( hs)-crp , or fetuin - a levels ( table 1 ) . for the liver enzymes , at the -level of 0.05 and at a power of 80% the minimum detectable effect sizes among all three genotypes were 7.5% for alanine aminotransferase ( alt ) and 5.5% for aspartate \\n for hs - crp levels , the effect sizes were much larger ( all three genotypes : 21% and dominant model : 19% ) . to address in more detail the relationships of the snp rs738409 in pnpla3 with liver fat and insulin sensitivity , we first divided subjects in those with and without fatty liver . as expected upon definition liver fat was much higher in control subjects with fatty liver ( fig . \\n the first noteworthy finding was that the snp was no longer associated with liver fat content , adjusted for age , sex , total fat , and visceral fat , once subjects already displayed fatty liver , possibly because of a ceiling effect . \\n the second interesting finding was that in control subjects with fatty liver , for a very similar liver fat content , carriers of the g allele appeared to be not just equally but actually more insulin sensitive than cc homozygotes , and insulin sensitivity in gg homozygotes was statistically not different compared to control subjects without fatty liver ( fig . \\n 1d ) . upon this finding , based on the data in the literature showing that pnpla3 is becoming increasingly expressed under energy excess ( 2831 ) and because there is an interaction of the snp rs738409 with obesity on insulin sensitivity ( 32 ) , we next divided the control subjects in more lean and more obese by the median total adipose tissue mass . \\n while in the lean group insulin sensitivity estimated by the ogtt and adjusted for age , sex , total fat , visceral fat , and liver fat was not associated with the genotype ( fig . \\n 3a ) , it significantly increased with increasing copy numbers of the g allele in the obese group ( fig . \\n relationships of the snp rs738409 c > g ( ile148met ) in pnpla3 with insulin sensitivity in all 330 subjects separated by the median total body fat mass into more lean ( a ) and more obese ( b ) control subjects . because steatosis - induced inflammation is accompanied by insulin resistance , we further investigated in human liver biopsies the relationships of expression of the proinflammatory gene tnf- and of pnpla3 with the triglyceride content according to the genotype . \\n the snp was not associated with tnf- expression ( p = 0.64 ) . however , liver triglyceride content correlated positively with the expression of the proinflammatory cytokine tnf- in homozygote carriers of the c allele ( n = 6 ) but not in carriers of the g allele ( n = 10 , fig . \\n relationships of hepatic triglyceride content with mrna expression of pnpla3 ( a ) and tnf- ( b ) in human liver tissue . \\n relationships between hepatic triglyceride content and mrna expression of tnf- in c allele homozygotes ( c ) and g allele carriers ( d ) of the snp rs738409 c > g ( ile148met ) in pnpla3 . \\n the 330 subjects ( 130 men and 200 women ) had a mean age of 45 ( range 1869 ) years . \\n anthropometrics and metabolic characteristics of the subjects covered a wide range that was particularly large for total body fat ( 470 kg ) , visceral fat ( 0.210.1 kg ) , liver fat ( 0.230.0% ) , and insulin sensitivity ( ogtt : 1.633.4 arbitrary units ; clamp : 0.0080.347 mol  kg  min  pm ) . \\n a total of 105 control subjects had fatty liver ( liver fat > 5.56% ) ( 27 ) . \\n liver fat was higher in males than females ( 7.3  0.5 vs. 4.8  0.4% , p < 0.0001 ) and correlated positively with age ( r = 0.18 , p = 0.001 ) , total body fat ( r = 0.30 , p < 0.0001 ) , visceral fat ( r = 0.59 , p < 0.0001 ) , and inversely with insulin sensitivity ( ogtt : r = 0.53 , p < 0.0001 ; clamp : r = 0.56 , p < 0.0001 ) . in forward stepwise linear regression analyses including age , sex , liver fat , total fat , and visceral fat , liver fat was the strongest determinant of insulin sensitivity estimated from the ogtt ( f ratio : 56 ) followed by age ( f ratio : 9 ) , total fat ( f ratio : 9 ) , and visceral fat ( f ratio : 5 ) . \\n similar results were found for insulin sensitivity measured by the clamp ( f ratios ; liver fat : 39 ; visceral fat : 12 ; total fat : 10 ; and age : 9 ) . \\n in our population , the frequency of the minor g allele of the snp rs738409 in pnpla3 was 0.26 , similar to findings in european americans ( 0.23 ) ( 21 ) , and the snp was in hardy - weinberg equilibrium (  test ; p > 0.05 ) . \\n the snp rs738409 was strongly associated with liver fat content depicting an allele - dose effect . \\n carriers of the g allele had significantly higher liver fat compared to c allele homozygotes , independently of age , sex , and adiposity ( table 1 ) and even of visceral adiposity ( p < 0.0001 , fig . 1a ) . furthermore , g allele carriers had higher odds ratios ( cg : 2.15 [ 95% ci 1.193.91 ] ; gg : 3.71 [ 95% ci 1.3710.53 ] ) for being diagnosed with fatty liver compared to c allele homozygotes ( table 1 , fig . \\n 2 ) . however , the predictive effect of the snp for diagnosing control subjects with fatty liver was only moderate ( dominant model : positive predictive value of the snp : 0.51 ; negative predictive value of the snp : 0.61 ) . \\n associations of the snp rs738409 in pnpla3 with demographic and metabolic characteristics values represent means  se . for statistical analyses , nonnormally distributed parameters \\n body weight , bmi , waist circumference , and total body fat were adjusted for age and sex . \\n isi , insulin sensitivity index , available in 222 control subjects ( c / c n = 124 ; c / g n = 72 ; t / t n = 26 ) . relationships of the snp rs738409 c > g ( ile148met ) in pnpla3 with liver fat ( a ) and insulin sensitivity ( b ) in all 330 subjects ( tat , total adipose tissue ; vat , visceral adipose tissue ) . \\n liver fat content in subjects without and with fatty liver and the relationship of the snp rs738409 with liver fat content in subjects having fatty liver ( c ) . \\n insulin sensitivity in subjects without and with fatty liver and the relationship of the snp rs738409 with insulin sensitivity in subjects having fatty liver ( d ) . \\n odds ratios of the genotypes of the snp rs738409 c > g ( ile148met ) in pnpla3 for predicting fatty liver . \\n interestingly , the snp was not associated with insulin sensitivity estimated from the ogtt ( table 1 , fig . \\n 1b ) or measured by the clamp ( table 1 , p = 0.32 after adjustment for age , sex , total fat , and visceral fat ) . \\n power analyses revealed that at the -level of 0.05 and at a power of 80% the minimum detectable effect sizes among all three genotypes ( genotypes cc , cg , and gg ) were 8.5% for insulin sensitivity estimated from the ogtt and 9% for insulin sensitivity measured by the clamp . in a dominant model ( genotype cc vs. cg + gg ) the effect sizes were 8% for insulin sensitivity estimated from the ogtt and 8.3% for insulin sensitivity measured by the clamp . \\n furthermore , the snp was not associated with total fat and visceral fat , liver enzymes , high - sensitivity ( hs)-crp , or fetuin - a levels ( table 1 ) . for the liver enzymes , at the -level of 0.05 and at a power of 80% the minimum detectable effect sizes among all three genotypes were 7.5% for alanine aminotransferase ( alt ) and 5.5% for aspartate aminotransferase ( ast ) . in a dominant model , the effect sizes were 7% for alt and 5% for ast . for hs - crp levels , \\n the effect sizes were much larger ( all three genotypes : 21% and dominant model : 19% ) . to address in more detail the relationships of the snp rs738409 in pnpla3 with liver fat and insulin sensitivity , we first divided subjects in those with and without fatty liver . as expected upon definition liver fat was much higher in control subjects with fatty liver ( fig . \\n the first noteworthy finding was that the snp was no longer associated with liver fat content , adjusted for age , sex , total fat , and visceral fat , once subjects already displayed fatty liver , possibly because of a ceiling effect . \\n the second interesting finding was that in control subjects with fatty liver , for a very similar liver fat content , carriers of the g allele appeared to be not just equally but actually more insulin sensitive than cc homozygotes , and insulin sensitivity in gg homozygotes was statistically not different compared to control subjects without fatty liver ( fig . \\n 1d ) . upon this finding , based on the data in the literature showing that pnpla3 is becoming increasingly expressed under energy excess ( 2831 ) and because there is an interaction of the snp rs738409 with obesity on insulin sensitivity ( 32 ) , we next divided the control subjects in more lean and more obese by the median total adipose tissue mass . \\n while in the lean group insulin sensitivity estimated by the ogtt and adjusted for age , sex , total fat , visceral fat , and liver fat was not associated with the genotype ( fig . \\n 3a ) , it significantly increased with increasing copy numbers of the g allele in the obese group ( fig . \\n relationships of the snp rs738409 c > g ( ile148met ) in pnpla3 with insulin sensitivity in all 330 subjects separated by the median total body fat mass into more lean ( a ) and more obese ( b ) control subjects . because steatosis - induced inflammation is accompanied by insulin resistance , we further investigated in human liver biopsies the relationships of expression of the proinflammatory gene tnf- and of pnpla3 with the triglyceride content according to the genotype . \\n the snp was not associated with tnf- expression ( p = 0.64 ) . however , liver triglyceride content correlated positively with the expression of the proinflammatory cytokine tnf- in homozygote carriers of the c allele ( n = 6 ) but not in carriers of the g allele ( n = 10 , fig . \\n relationships of hepatic triglyceride content with mrna expression of pnpla3 ( a ) and tnf- ( b ) in human liver tissue . \\n relationships between hepatic triglyceride content and mrna expression of tnf- in c allele homozygotes ( c ) and g allele carriers ( d ) of the snp rs738409 c > g ( ile148met ) in pnpla3 . \\n recently , the first gwa approach searching for genetic variants associated with liver fat identified the rs738409 snp in pnpla3 , encoding patatin - like phospholipase 3 , also known as adiponutrin , as the variant that was by far most strongly associated with liver fat content in three populations ( 21 ) . in the present study , using precise measurements of liver fat and body fat distribution we confirmed the strong relationship of the snp with liver fat . \\n ( 21 ) we provide novel data that this relationship was independent of total and visceral adiposity , which are important determinants of hepatic steatosis ( 36,33 ) . \\n thus , hepatic pnpla3 activity most probably directly affects fat accumulation in the liver , a hypothesis that is supported by our finding of a strong positive correlation of hepatic pnpla3 mrna expression with liver triglyceride content in liver tissue samples . of note , in the study by romeo \\n this variant was not associated with estimates of insulin resistance in any of the three populations or in more than 14,000 control subjects of the atherosclerosis risk in communities study ( 21 ) . considering the strong relationship of liver fat with insulin resistance ( 36,34 ) , \\n therefore , we further investigated whether the snp rs738409 in pnpla3 was associated with insulin sensitivity estimated from the ogtt and measured by the euglycemic - hyperinsulinemic clamp . \\n the advantage of these techniques for estimating insulin sensitivity compared to the use of fasting values , as done in the study of romeo et al . , is that they provide a more dynamic and precise measurement of this phenotype . \\n furthermore , the snp was not associated with liver enzymes or hs - crp levels , markers of hepatic and systemic inflammation , which are commonly elevated in insulin resistance ( 6,14 ) . because fetuin - a may be involved in fatty liver  induced insulin resistance and strongly determines the incidence of diabetes and cardiovascular disease ( 1620 ) , we further investigated the relationship of the snp with circulating fetuin - a . \\n although liver fat correlated with circulating fetuin - a ( p = 0.01 ) , the snp was not associated with fetuin - a levels . in the study by romeo et al . \\n ( 21 ) , the snp rs738409 was not associated with alt or ast levels in more than 1,800 blacks or more than 1,000 european americans . only in 597 hispanics , \\n a significant relationship with alt and ast levels was found . in a recent gwa approach aiming at identifying genes influencing liver enzymes , another snp in pnpla3 ( rs2281135 ) , but not the snp rs738409 , \\n our finding of no significant association of the snp with liver enzymes is in agreement with the findings of romeo et al . in blacks and european americans \\n nevertheless , we can not exclude that we may have missed small differences because of the relatively small sample size . in the study by romeo et al . \\n , the relationship of the snp rs738409 with hs - crp levels was not investigated . \\n we did not find a significant relationship of the snp rs738409 with hs - crp levels . \\n for this analysis we had a low power ; therefore , we can not exclude a relationship of the snp with this parameter . \\n because there was a clear - cut higher liver fat content , but no increase in insulin resistance in carriers of the minor g allele compared to c allele homozygotes , we hypothesized that specifically pnpla3-mediated accumulation of liver fat appears to be metabolically benign . \\n if this was the case , then for a similar amount of liver fat g allele carriers must be more insulin sensitive than c allele homozygotes . \\n indeed , in more obese control subjects , insulin sensitivity , adjusted for age , sex , total fat , visceral fat , and liver fat , was higher in carriers of the minor g allele . \\n furthermore , in homozygous g allele carriers with fatty liver , insulin sensitivity was no more significantly different from control subjects without fatty liver , despite the large difference in liver fat . \\n these data support the hypothesis that pnpla3 is involved in the generation of a metabolically benign fatty liver . \\n because these findings are derived from a more obese smaller subsample of the study population , the effects of pnpla3 may be important particularly in obesity . \\n one of them is the acyl : coa : diacylglycerol acyltransferase 2 ( dgat2 ) gene that encodes the protein dgat2 that catalyzes the final step of triacylglycerol biosynthesis ( 36 ) . \\n liver - specific dgat2-overexpressing mice developed hepatic steatosis with a fivefold increase in liver triglyceride content compared to control subjects , but not whole - body or hepatic insulin resistance ( 37 ) . \\n conversely , antisense oligonucleotide treatment targeting the dgat2 reduced liver triglycerides in mice fed a high - fat diet , without improving insulin sensitivity or glucose tolerance ( 38 ) . in agreement with these data we found that a snp in dgat2 was associated with liver fat but not with insulin resistance in humans ( 39 ) . \\n another candidate is the elongation of long - chain fatty acids ( elovl ) gene ( elovl6 ) . \\n elovl catalyzes the conversion of palmitate to stearate as well as palmitoleate to vaccinate , thus regulating the hepatic fatty acid composition ( 40 ) . \\n mice deficient for elovl6 developed obesity and hepatic steatosis , but not insulin resistance , hyperinsulinemia , or hyperglycemia under a high - fat diet ( 41 ) . \\n the paradox of this finding may be because of lipotoxicity ( 42 ) . according to this concept , triglycerides are probably the least toxic form in which the lipid excess can be stored in ectopic tissues , at least in the short - term . \\n the incorporation of fatty acids into triglycerides , as well as their oxidative degradation , thus represents protection from lipotoxicity . \\n however , when these compensatory mechanisms are overwhelmed , fatty acids induce damage to cells resulting in impaired metabolism ( 43,44 ) . \\n several pathways are thought to be operative in this process . among them , activation of nuclear factor-b and c - jun nh2-terminal kinase , which are involved in insulin resistance ( 14,45,46 ) , are critical . besides these proinflammatory pathways fatty acid and diacylglycerol ( dag ) directly activate protein kinase c- , thus inhibiting hepatic insulin signaling ( 41,47,48 ) . what is the putative role of pnpla3/adiponutrin in these pathways ? \\n data in the literature strongly support that it probably has no lipase activity ( 49,50 ) but rather lipogenic functions in adipose tissue under feeding conditions , particularly under carbohydrate intake ( 30,31 ) . \\n it was further hypothesized that if this protein has similar functions in the liver , then increased hepatic expression or activity may result in increased triglyceride synthesis ( 31,49 ) . \\n pnpla3/adiponutrin was found to have transacetylase functions and uses dag as an acyl acceptor ( 31,32,49 ) . \\n therefore , increased activity of the protein may also result in depletion in the hepatic dag and fatty acid content , both of which are involved in lipotoxicity ( 47,48 ) . \\n thus , this protective mechanism may result in a metabolically benign phenotype under increased lipid load by partitioning excess hepatic fatty acids to triglycerides that may protect against lipotoxicity . in support of this hypothesis \\n , we found that in carriers of the minor rs738409 g allele , the mrna expression of the proinflammatory gene tnf- in the liver was less strongly associated with triglyceride content compared to c allele homozygotes . \\n what may be the clinical implication of these findings ? because fatty liver is becoming a worldwide epidemic , it is necessary not only to screen for its presence but also for control subjects at the highest risk for fatty liver  induced complications . \\n if further studies confirm the role of pnpla3/adiponutrin in the generation of steatosis without complications , then screening for genetic variation in pnpla3 may help to stratify this risk . in conclusion , \\n the snp rs738409 in pnpla3 is strongly , and independently of total and visceral adiposity , associated with fatty liver but not with insulin resistance or estimates of liver injury . \\n therefore , pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences and may serve as a useful tool for estimating the risk of fatty liver  induced complications .\",\n",
       "  'output': 'objectivein a genome - wide association scan , the rs738409 c > g single nucleotide polymorphism ( snp ) in the patatin - like phospholipase 3 gene ( pnpla3 ) was strongly associated with increased liver fat but not with insulin resistance estimated from fasting values . \\n we investigated whether the snp determines liver fat independently of visceral adiposity and whether it may even play a role in protecting from insulin resistance.research design and methodsliver fat was measured by 1h magnetic resonance spectroscopy and total and visceral fat by magnetic resonance tomography in 330 subjects . \\n insulin sensitivity was estimated during an oral glucose tolerance test and the euglycemic - hyperinsulinemic clamp ( n = 222 ) . \\n pnpla3 and tumor necrosis factor- mrna and triglyceride content were measured in liver biopsies from 16 subjects.resultsliver fat correlated strongly with insulin sensitivity ( p < 0.0001 ) independently of age , sex , total fat , and visceral fat . \\n g allele carriers of the snp rs738409 had higher liver fat ( p < 0.0001 ) and an odds ratio of 2.38 ( 95% ci 1.374.20 ) for having fatty liver compared to c allele homozygotes . \\n interestingly , insulin sensitivity ( oral glucose tolerance test : p = 0.99 ; clamp : p = 0.32 ) , serum c - reactive protein levels , lipids , or liver enzymes ( all p > 0.14 ) were not different among the genotypes . additional adjustment for liver fat actually revealed increased insulin sensitivity in more obese carriers of the g allele ( p = 0.01 ) . in liver biopsies \\n triglyceride content correlated positively with expression of the proinflammatory gene tumor necrosis factor- in c allele homozygotes ( n = 6 , \\n p = 0.027 ) but not in g allele carriers ( n = 10 , p = 0.149).conclusionspnpla3 may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences .',\n",
       "  '__index_level_0__': 31689,\n",
       "  'model_output': 'thank you for your interest in our article. \\n we would like to clarify that the results of the present study are not in conflict with those of romeo et al. \\n in the present study, we confirm the association of the snp rs738409 with liver fat in our population. \\n the study by romeo et al. \\n was the first to show a strong relationship of the snp rs738409 in pnpla3 with liver fat. \\n furthermore, we confirm that the snp rs738409 is not associated with insulin sensitivity, liver enzymes, or hs - crp. \\n the study by romeo et al. \\n did not investigate the relationship of the snp rs738409 with insulin sensitivity. \\n we found that the snp rs738409 in pnpla3 is not associated with insulin resistance in our population. \\n however, we show that the snp rs738409 is associated with insulin sensitivity in more obese subjects. \\n these findings suggest that the effects of pnpla3/adiponutrin may be important particularly in obesity. \\n we further show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences. \\n furthermore, we show that in homozygous g allele carriers with fatty liver, insulin sensitivity is not different from control subjects without fatty liver, despite the large difference in liver fat. \\n these data suggest that pnpla3/adiponutrin may be an important key to understand the mechanisms discriminating fatty liver with and'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Write a summary of the article that captures the main ideas and significant details.',\n",
       "  'input': 'Summarize the following article: with the development of enhanced radiation technology and interventional techniques , effective diagnosis and treatment are possible for patients with coronary and other peripheral vascular diseases . \\n however , therapeutic effects always come with complications , including vascular perforation , dissection , and contrast - induced nephropathy ( cin ) . among these complications \\n , cin has been demonstrated to be associated with irreversible renal insufficiency , prolonged hospitalization , and high cost . additionally , cin has unfavorable early and late prognosis . \\n therefore , it is important to diagnose cin and provide treatment as soon as possible , which depends on the early diagnosis . \\n contrast - induced nephropathy , also referred to as contrast - induced acute kidney injury , has become the third leading cause of hospital - acquired acute kidney injury . \\n half of these cases are caused by repeated exposure to contrast media during cardiac catheterization and coronary angiography ( cag ) . \\n contrast - induced nephropathy is defined as an increase in serum creatinine ( scr ) concentration > 0.5 mg / dl or a minimum of 25% increase from baseline within 72 h after contrast administration , without evidence of other causes . \\n detection of serum creatinine is the foundation for the diagnosis of cin ; however , the scr level may not be determined quickly enough to reflect decreased renal function , and scr level is affected by factors such as age , sex , and muscle mass . in conclusion , scr is not a perfect glomerular filtration rate ( gfr ) biomarker and is not sensitive enough to detect early changes in gfr . \\n thus , there is great need for a more sensitive and reliable biomarker for predicting the occurrence of acute kidney injury ( aki ) or cin . \\n numerous clinical trials have been sought to find discover an appropriate biomarker for early and precise assessment of renal function [ 68 ] . \\n disappointingly , many biomarkers have been confirmed to be useless , including neutrophil gelatinase - associated lipocalin , urinary liver type fatty acid - binding protein ( l - fabp ) , and urinary kidney injury molecule 1 . \\n serum cystatin c ( cys c ) is a non - glycosylated protein with low molecular mass ( 13 kda ) . \\n it is a cysteine protease inhibitor synthesized by all nucleated cells and released into the blood by glomerular filtration . \\n most importantly , external factors have little effect on the serum level of cys c. previous studies have demonstrated its utility in detection of diabetic mellitus and hypertensive nephropathy . in the present study we sought to determine the ability of cys c to predict the occurrence of cin in patients who underwent cag and intervention , and we compared the sensitivity and specificity of cystatin c and serum creatinine in the diagnosis of cin . \\n from january 2015 to may 2015 , a total of 300 consecutive patients who underwent only diagnostic coronary angiography for suspected coronary heart disease were enrolled in the study . \\n it was funded by the national natural science foundation of china ( no . 81200153 ) , the science foundation of health department , sichuan province ( no . 20120213 ) , the science foundation of science and technology department , sichuan province ( no . \\n 2015sz0180 ) , and the science foundation of the science and technology department , sichuan province ( no . \\n the exclusion criteria included : 1 ) patients with chronic nephropathy ( ckd stage 2 to 4 ) ; 2 ) patients with other contrast exposure within 1 week , or exposure to nephrotoxic drugs ; 3 ) patients with previous kidney transplantation , cardiac dysfunction , thyroid disorder , or cancer ; 4 ) patients who were unable to understand the study content or provide consent ; 5 ) patients younger than 18 or older than 80 years old ; and 6 ) patients simultaneously participating in other studies . \\n patient data were recorded for feasibility analysis at admission , including sex , age , body mass index ( bmi ) , left ventricular ejection fraction ( lvef ) , hypertension , and diabetes mellitus , as well as use of oral medicines , especially angiotensin - converting enzyme inhibitors / angiotensin receptor blockers ( acei / arb ) , and statins . \\n fasting baseline renal function and serum level of cys c were measured as basal indicators 24 h before cag . as another important evaluation indicator , estimated gfr ( egfr ) \\n was calculated by the levey modification of the modification of diet in renal disease ( mdrd ) formula . \\n a standard dose ( 35 ml / kg ) of iodinated contrast medium ( iohexol , ge pharmaceutical , shanghai ) was used . in the process of angiography , we recorded the operation time and the infusion dose of contrast medium . \\n serum samples were collected at 12 , 24 , and 48 h after cag for measuring postoperative levels of cys c and creatinine . \\n all blood samples were analyzed by the clinical laboratory in our hospital . according to the definition of cin , we calculated the change in creatinine and confirmed the occurrence of cin . \\n then , all the patients were assigned into 2 groups based on whether cin occurred . after grouping , we compared the collected demographics , medication usage , exposure to contrast medium , and serum levels of cys c and creatinine at different time points . \\n results are expressed as mean  standard deviation ( sd ) for continuous variables and frequencies for categorical variables . \\n differences between groups were examined by nonparametric test and chi - square test for continuous and categorical variables , respectively . \\n other variables that were significantly associated with outcome were fed into the model in a stepwise procedure . \\n an alpha value of 0.05 , corresponding to a p value < 0.05 , served as the criterion for establishing statistical significance . the diagnostic sensitivity and specificity for the early diagnosis of cin based on the serum level of cys c and scr at 24 h \\n from january 2015 to may 2015 , a total of 300 consecutive patients who underwent only diagnostic coronary angiography for suspected coronary heart disease were enrolled in the study . \\n it was funded by the national natural science foundation of china ( no . 81200153 ) , the science foundation of health department , sichuan province ( no . 20120213 ) , the science foundation of science and technology department , sichuan province ( no . \\n 2015sz0180 ) , and the science foundation of the science and technology department , sichuan province ( no . \\n the exclusion criteria included : 1 ) patients with chronic nephropathy ( ckd stage 2 to 4 ) ; 2 ) patients with other contrast exposure within 1 week , or exposure to nephrotoxic drugs ; 3 ) patients with previous kidney transplantation , cardiac dysfunction , thyroid disorder , or cancer ; 4 ) patients who were unable to understand the study content or provide consent ; 5 ) patients younger than 18 or older than 80 years old ; and 6 ) patients simultaneously participating in other studies . \\n patient data were recorded for feasibility analysis at admission , including sex , age , body mass index ( bmi ) , left ventricular ejection fraction ( lvef ) , hypertension , and diabetes mellitus , as well as use of oral medicines , especially angiotensin - converting enzyme inhibitors / angiotensin receptor blockers ( acei / arb ) , and statins . \\n fasting baseline renal function and serum level of cys c were measured as basal indicators 24 h before cag . as another important evaluation indicator , estimated gfr ( egfr ) \\n was calculated by the levey modification of the modification of diet in renal disease ( mdrd ) formula . \\n a standard dose ( 35 ml / kg ) of iodinated contrast medium ( iohexol , ge pharmaceutical , shanghai ) was used . in the process of angiography , we recorded the operation time and the infusion dose of contrast medium . \\n serum samples were collected at 12 , 24 , and 48 h after cag for measuring postoperative levels of cys c and creatinine . \\n all blood samples were analyzed by the clinical laboratory in our hospital . according to the definition of cin , we calculated the change in creatinine and confirmed the occurrence of cin . \\n then , all the patients were assigned into 2 groups based on whether cin occurred . after grouping , \\n we compared the collected demographics , medication usage , exposure to contrast medium , and serum levels of cys c and creatinine at different time points . \\n results are expressed as mean  standard deviation ( sd ) for continuous variables and frequencies for categorical variables . \\n differences between groups were examined by nonparametric test and chi - square test for continuous and categorical variables , respectively . \\n other variables that were significantly associated with outcome were fed into the model in a stepwise procedure . \\n an alpha value of 0.05 , corresponding to a p value < 0.05 , served as the criterion for establishing statistical significance . the diagnostic sensitivity and specificity for the early diagnosis of cin based on the serum level of cys c and scr at 24 h were calculated by use of roc curve analysis and auc assessment . \\n a total of 300 patients ( 179 males , 121 females ) with a mean age of 63.479.92 were included in the final study . according to the definition of cin , patients with a > 25% relative increase of serum creatinine , or an increase in concentration of serum creatinine of at least by 44 mmol / l from the baseline 48 h after cag , \\n we analyzed and compared the demographics of the 2 groups . as is shown in table 1 , \\n patients in the cin group were significantly older than those in the non - cin group ( p=0.048 ) , and the cin group had a higher proportion of females than the non - cin group ( p=0.037 ) . \\n however , the differences in the ratio of hypertension , diabetes mellitus , smoking , and cardiac dysfunction were not statistically significant . medication history was also recorded to analyze the effect on renal function , though there were no obvious distinctions between the 2 groups ( all p>0.05 ) . \\n previous researchers have used infusion dose of contrast medium and the exposure time as important indicators of cin , and we demonstrated the importance of these 2 indicators in our study . \\n patients in the cin group received significantly larger doses of contrast medium ( p=0.040 ) and the operation time was longer compared to the non - cin group . \\n comparison of basal renal function and serum level of cys c showed no significant differences between the 2 groups . \\n as an important procedure in our study , we measured the serum levels of creatinine and cystatin c at various time points . compared vertically , \\n the rise in serum cys c was the maximum at 24 h , which was significantly higher than baseline ( p<0.001 ) . \\n then , the level declined , but still remained higher at 48 h ( p<0.01 ) . \\n the serum level of creatinine in the cin group peaked at 48 h ( p<0.001 ) and was not significantly different at 24 h. egfr had decreased at 24 h and had even more obviously decreased at 48 h ( p<0.001 ) . \\n it is obvious that the change in serum level of cys c occurred prior to the change in serum level of creatinine . in the non - cin group , \\n the differences in scr and cys c before and after the procedure were both non - significant . compared horizontally , \\n the difference in cys c level between the 2 groups became apparent at 24 h ( p<0.001 ) and lasted until 48 h. the serum level of scr in the cin group was significantly higher than that in the non - cin group only at 48 h , and the difference was not obvious at 24 h. moreover , compared with non - cin group , egfr decreased from 24 h to 48 h in the cin group , and both differences were significant ( p<0.001 ) . \\n table 2 shows that the change in serum level of cys c became significantly different before that of scr . to study the significance of cys c and scr in cin \\n the area under the curve ( auc ) of cys c at 12 h and 24 h was 0.735 ( 95% ci : 0.6480.823 , p=0.000 ) and 0.928 ( 95% ci : 0.8700.987 , p=0.000 ) , respectively , and the optimum cut - off level was 1.315 mg / l ( sensitivity=79.3% and specificity=55.4% ) and 1.55 mg / l ( sensitivity=82.8% and specificity=97.8% ) , respectively . the auc of changes in cys c between baseline and 12 h and 24 h were 0.758 ( 95% ci : 0.6680.847 , p=0.001 ) and 0.936 ( 95% ci : 0.8790.992 , p=0.000 ) , respectively , and the optimum cut - off level was 0.185 mg / \\n l ( sensitivity=79.3% and specificity=95.3% ) and 0.26 mg / l ( sensitivity=89.7% and specificity=95.6% ) , respectively . \\n the auc was 0.923 ( 95% ci : 0.8750.972 , p=0.000 ) and the optimum cut - off level was 17.15% ( sensitivity=79.3% and specificity=87.8% ) . \\n when we chose the serum level of creatinine at 24 h for roc analysis , the auc was 0.733 ( 95% ci : 0.6400.825 , p<0.001 ) and the optimum cut - off level was 73.55 \\n mol / l ( sensitivity=89.7% and specificity=43.5% ) . according to the results in table 3 \\n , although the aucs of cys c at 24 h and cys c changes at 24 h were similar , serum cys c with concentration changes > 0.26 mg / l had higher sensitivity ( 89.7% vs. 82.8% ) but lower specificity ( 95.6% vs. 97.8% ) for differentiating cin and non - cin . \\n a total of 300 patients ( 179 males , 121 females ) with a mean age of 63.479.92 were included in the final study . according to the definition of cin , patients with a > 25% relative increase of serum creatinine , or an increase in concentration of serum creatinine of at least by 44 mmol / l from the baseline 48 h after cag , \\n we analyzed and compared the demographics of the 2 groups . as is shown in table 1 , \\n patients in the cin group were significantly older than those in the non - cin group ( p=0.048 ) , and the cin group had a higher proportion of females than the non - cin group ( p=0.037 ) . \\n however , the differences in the ratio of hypertension , diabetes mellitus , smoking , and cardiac dysfunction were not statistically significant . medication history was also recorded to analyze the effect on renal function , though there were no obvious distinctions between the 2 groups ( all p>0.05 ) . \\n previous researchers have used infusion dose of contrast medium and the exposure time as important indicators of cin , and we demonstrated the importance of these 2 indicators in our study . \\n patients in the cin group received significantly larger doses of contrast medium ( p=0.040 ) and the operation time was longer compared to the non - cin group . \\n comparison of basal renal function and serum level of cys c showed no significant differences between the 2 groups . \\n as an important procedure in our study , we measured the serum levels of creatinine and cystatin c at various time points . compared vertically , \\n the rise in serum cys c was the maximum at 24 h , which was significantly higher than baseline ( p<0.001 ) . \\n then , the level declined , but still remained higher at 48 h ( p<0.01 ) . \\n the serum level of creatinine in the cin group peaked at 48 h ( p<0.001 ) and was not significantly different at 24 h. egfr had decreased at 24 h and had even more obviously decreased at 48 h ( p<0.001 ) . \\n it is obvious that the change in serum level of cys c occurred prior to the change in serum level of creatinine . in the non - cin group , \\n the differences in scr and cys c before and after the procedure were both non - significant . compared horizontally , \\n the difference in cys c level between the 2 groups became apparent at 24 h ( p<0.001 ) and lasted until 48 h. the serum level of scr in the cin group was significantly higher than that in the non - cin group only at 48 h , and the difference was not obvious at 24 h. moreover , compared with non - cin group , egfr decreased from 24 h to 48 h in the cin group , and both differences were significant ( p<0.001 ) . \\n table 2 shows that the change in serum level of cys c became significantly different before that of scr . \\n to study the significance of cys c and scr in cin , we chose the serum levels at different time points for roc analysis . \\n the area under the curve ( auc ) of cys c at 12 h and 24 h was 0.735 ( 95% ci : 0.6480.823 , p=0.000 ) and 0.928 ( 95% ci : 0.8700.987 , p=0.000 ) , respectively , and the optimum cut - off level was 1.315 mg / l ( sensitivity=79.3% and specificity=55.4% ) and 1.55 mg / \\n the auc of changes in cys c between baseline and 12 h and 24 h were 0.758 ( 95% ci : 0.6680.847 , p=0.001 ) and 0.936 ( 95% ci : 0.8790.992 , p=0.000 ) , respectively , and the optimum cut - off level was 0.185 mg / l ( sensitivity=79.3% and specificity=95.3% ) and 0.26 mg / l ( sensitivity=89.7% and specificity=95.6% ) , respectively . \\n the auc was 0.923 ( 95% ci : 0.8750.972 , p=0.000 ) and the optimum cut - off level was 17.15% ( sensitivity=79.3% and specificity=87.8% ) . \\n when we chose the serum level of creatinine at 24 h for roc analysis , the auc was 0.733 ( 95% ci : 0.6400.825 , p<0.001 ) and the optimum cut - off level was 73.55 \\n mol / l ( sensitivity=89.7% and specificity=43.5% ) . according to the results in table 3 , although the aucs of cys c at 24 h and cys c changes at 24 h were similar , serum cys c with concentration changes > 0.26 mg / l had higher sensitivity ( 89.7% vs. 82.8% ) but lower specificity ( 95.6% vs. 97.8% ) for differentiating cin and non - cin . \\n contrast - induced nephropathy is a well - known complication that can be observed after some enhanced radiologic and angiographic examinations and treatments . \\n the injury is generally mild and transient but can result in lasting renal dysfunction and it is associated with increased morbidity and mortality . \\n one is the influence of renal hemodynamics caused by contrast medium exposure and the other is the direct cytotoxicity of contrast medium to renal tubular epithelial cells . in addition , there are no effective therapies for the acute kidney injury caused by contrast medium , so the only option is to prevent it from happening . \\n nowadays , serum level of creatinine is widely used and recognized as a diagnostic clinical indicator of cin . \\n however , scr could be affected by numerous factors like age , sex , and muscle mass . \\n because of the reserve capacity of the kidneys , concentrations of scr can be within the reference range with a certain degree of impaired renal function . in our study , the level of scr increased significantly 48 h after exposure and was obviously higher than in the non - cin group ( p<0.001 ) . \\n therefore , scr is not efficient and accurate enough as a diagnostic indicator of cin . \\n these limitations prompted us to look for another indicator that can reflect damaged renal function in early stages . \\n the results showed that the serum level of cys c significantly increased at 24 h in cin patients , which was before the increase in scr . \\n the variation tendency of cys c in the non - cin group was not obvious , as opposed to the increase in the cin group ( p=0.121 vs. p<0.001 ) . \\n cys c is a 13-kda non - glycosylated protein that is a cysteine protease inhibitor . \\n it is produced by almost all nucleated cells at a constant rate and removed from the blood by glomerular filtration . \\n the kidneys are the only organs that clear cys c , and the serum level of cys c only depends on gfr . \\n therefore , in theory , the concentration change of cys c can reflect the change of gfr more sensitively than scr . \\n bachorzewska - gajewska et al . found the same variation tendency of cys c after contrast medium exposure . \\n their study including 410 patients with chronic kidney disease indicated that cys c is a reliable biomarker and predictor for the early diagnosis of cin . \\n however , the form of cys c used for cin diagnosis is still in dispute . \\n our study again verified the significant predictors of cin , including age , female sex , the dose of contrast medium , and the exposure time . \\n most importantly , we revealed the potential association between the increase of cys c and the occurrence of cin . \\n a certain increase of the concentration of cys c is sensitive and specific for the prediction of cin after contrast medium exposure . despite of the achievements of our study \\n firstly , we only included patients with normal renal function at baseline , which limited the observations of the significance of cys c in patients with chronic kidney disease . \\n then , we excluded patients who underwent pci from our study , leading to insufficient contrast medium exposure . \\n in addition , we analyzed the different forms of cys c for the early diagnosis of cin and results showed similar significance among these indicators . \\n therefore , the best form of cys c for the diagnosis of cin still remains uncertain . \\n in conclusion , our study demonstrated that the change in concentration of cys c is superior to scr as a biomarker in the early detection of cin . \\n we found that the changed concentration of cys c is superior to scr as a biomarker in the early detection of cin .',\n",
       "  'output': 'backgroundcontrast - induced nephropathy is acute kidney injury caused by contrast medium exposure . \\n serum creatinine is the clinical diagnostic standard , but it does not yield quick results . the serum level of cystatin c is stable and it can reflect renal function sensitively . the study aimed to assess the usefulness of cystatin c for early diagnosis of contrast - induced nephropathy in patients undergoing coronary angiography.material/methodswe included 300 patients who underwent cag . according to the scr at 48 h , patients were divided into 2 groups : cin group and non - cin group . \\n their demographics and basal renal function were recorded . \\n changes in scr , cys c , and e gfr were compared at the same time . \\n roc analysis was used to assess the sensitivity and specificity of cys c in the early diagnosis of cin.resultscomparison of basal renal function and serum level of cys c showed no significant differences between the 2 groups . \\n serum level of cys c increased significantly at 24 h ( p<0.001 ) , and scr increased significantly at 48 h. roc analysis showed that the auc of the change in cys c between baseline and 24 h was 0.936 ( 95% ci : 0.8790.992 , p=0.000 ) and the optimum cut - off level was 0.26 mg / l ( sensitivity=89.7% and specificity=95.6%).conclusionsthe concentration change of cys c is better than scr as a biomarker in the early detection of cin .',\n",
       "  '__index_level_0__': 31690,\n",
       "  'model_output': 'summary: with the development of enhanced radiation technology and interventional techniques, effective diagnosis and treatment are possible for patients with coronary and other peripheral vascular diseases. however, therapeutic effects always come with complications, including vascular perforation, dissection, and contrast - induced nephropathy ( cin ). among these complications, cin has been demonstrated to be associated with irreversible renal insufficiency, prolonged hospitalization, and high cost. additionally, cin has unfavorable early and late prognosis. therefore, it is important to diagnose cin and provide treatment as soon as possible, which depends on the early diagnosis. contrast - induced nephropathy, also referred to as contrast - induced acute kidney injury, has become the third leading cause of hospital - acquired acute kidney injury. half of these cases are caused by repeated exposure to contrast media during cardiac catheterization and coronary angiography ( cag ). contrast - induced nephropathy is defined as an increase in serum creatinine ( scr ) concentration > 0.5 mg / dl or a minimum of 25% increase from baseline within 72 h after contrast administration, without evidence of other causes. detection of serum creatinine is the foundation for the diagnosis of cin ; however, the scr level may not be determined quickly enough to reflect decreased renal function, and scr level is affected by factors such as age, sex, and muscle mass. in conclusion, scr is not a perfect glomerular filtration rate ( gfr ) biomarker and is not sensitive enough to detect early changes in gfr. thus, there is great need for a more sensitive and reliable biomarker for predicting the occurrence of acute kidney injury ( aki ) or cin. numerous clinical trials have been sought to find discover an appropriate biomarker for early and precise assessment of renal function [ 68 ]. disappointingly, many biomarkers have been confirmed to be useless, including neutrophil gelatinase - associated lipocalin, urinary liver type fatty acid - binding protein ( l - fabp ), and urinary kidney injury molecule 1. serum cystatin c ( cys c ) is a non - glycosylated protein with low molecular mass ( 13 kda ). it is a cysteine protease inhibitor synthesized by all nucleated cells and released into the blood by glomerular filtration. most importantly, external factors have little effect on the serum level of cys c. previous studies have demonstrated its utility in detection of diabetic mellitus and hypertensive nephropathy. in the present study we sought to determine the ability of cys c to predict the occurrence of cin in patients who underwent cag and intervention, and we compared the sensitivity and specificity of cystatin c and serum creatinine in the diagnosis of cin. from january 2015 to may 2015, a total of 300 consecutive patients who underwent only diagnostic coronary angiography for suspected coronary heart disease were enrolled in the study. it was funded by the national natural science foundation of china ( no. 81200153 ), the science foundation of health department, sichuan province ( no. 20120213 ), the science foundation of science and technology department, sichuan province ( no. 2015sz0180 ), and the science foundation of the science and technology department, sichuan province ( no. the exclusion criteria included : 1 ) patients with chronic nephropathy ( ckd stage 2 to 4 ) ; 2 ) patients with other contrast exposure within 1 week, or exposure to nephrotoxic drugs ; 3 ) patients with previous kidney transplantation, cardiac dysfunction, thyroid disorder, or cancer ; 4 ) patients who were unable to understand the study content or provide consent ; 5 ) patients younger than 18 or older than 80 years old ; and 6 ) patients simultaneously participating in other studies. patient data were recorded for feasibility analysis at admission, including sex, age, body mass index ( bmi ), left ventricular ejection fraction ( lvef ), hypertension, and diabetes mellitus, as well as use of oral medicines, especially angiotensin - converting enzyme inhibitors / angiotensin receptor blockers ( acei / arb ), and statins. fasting baseline renal function and serum level of cys c were measured as basal indicators 24 h before cag. as another important evaluation indicator, estimated gfr ( egfr ) was calculated by the levey modification of the modification of diet in renal disease ( mdrd ) formula. a standard dose ( 35 ml / kg ) of iodinated contrast medium ( iohexol, ge pharmaceutical, shanghai ) was used. in the process of angiography, we recorded the operation time and the infusion dose of contrast medium. serum samples were collected at 12, 24, and 48 h after cag for measuring postoperative levels of cys c and creatinine. all blood samples were analyzed by the clinical laboratory in our hospital. according to the definition of cin, we calculated the change in creatinine and confirmed the occurrence of cin. then, all the patients were assigned into 2 groups based on whether cin occurred. after grouping, we compared the collected demographics, medication usage, exposure to contrast medium, and serum levels of cys c and creatinine at different time points. results are expressed as mean  standard deviation ( sd ) for continuous variables and frequencies for categorical variables. differences between groups were examined by nonparametric test and chi - square test for continuous and categorical variables, respectively. other variables that were significantly associated with outcome were fed into the model in a stepwise procedure. an alpha value of 0.05, corresponding to a p value < 0.05, served as the criterion for establishing statistical significance. the diagnostic sensitivity and specificity for the early diagnosis of cin based on the serum level of cys c and scr at 24 h were calculated by use of roc curve analysis and auc assessment. a total of 300 patients ( 179 males, 121 females ) with a mean age of 63.479.92 were included in the final study. according to the definition of cin, patients with a > 25% relative increase of serum creatinine, or an increase in concentration of serum creatinine of at least by 44 mmol / l from the baseline 48 h after cag, we analyzed and compared the demographics of the 2 groups. as is shown in table 1, patients in the cin group were significantly older than those in the non - cin group ( p=0.048 ), and the cin group had a higher proportion of females than the non - cin group ( p=0.037 ). however, the differences in the ratio of hypertension, diabetes mellitus, smoking, and cardiac dysfunction were not statistically significant. medication history was also recorded to analyze the effect on renal function, though there were no obvious distinctions between the 2 groups ( all p>0.05 ). previous researchers have used infusion dose of contrast medium and the exposure time as important indicators of cin, and we demonstrated the importance of these 2 indicators in our study. patients in the cin group received significantly larger doses of contrast medium ( p=0.040 ) and the operation time was longer compared to the non - cin group. comparison of basal renal function and serum level of cys c showed no significant differences between the 2 groups. as an important procedure in our study, we measured the serum levels of creatinine and cystatin c at various time points. compared vertically, the rise in serum cys c was the maximum at 24 h, which was significantly higher than baseline ( p<0.001 ). then, the level declined, but still remained higher at 48 h ( p<0.01 ). the serum level of creatinine in the cin group peaked at 48 h ( p<0.001 ) and was not significantly different at 24 h. egfr had decreased at 24 h and had even more obviously decreased at 48 h ( p<0.001 ). it is obvious that the change in serum level of cys c occurred prior to the change in serum level of creatinine. in the non - cin group, the differences in scr and cys c before and after the procedure were both non - significant. compared horizontally, the difference in cys c level between the 2 groups became apparent at 24 h ( p<0.001 ) and lasted until 48 h. the serum level of scr in the cin group was significantly higher than that in the non - cin group only at 48 h, and the difference was not obvious at 24 h. moreover, compared with non - cin group, egfr decreased from 24 h to 48 h in the cin group, and both differences were significant ( p<0.001 ). table 2 shows that the change in serum level of cys c became significantly different before that of scr. to study the significance of cys c and scr in cin the area under the curve ( auc ) of cys c at 12 h and 24 h was 0.735 ( 95% ci : 0.6480.823, p=0.000 ) and 0.928 ( 95% ci : 0.8700.987, p=0.000 ), respectively, and the optimum cut - off level was 1.315 mg / l ( sensitivity=79.3% and specificity=55.4% ) and 1.55 mg / l ( sensitivity=82.8% and specificity=97.8% ), respectively. the auc of changes in cys c between baseline and 12 h and 24 h were 0.758 ( 95% ci : 0.6680.847, p=0.001 ) and 0.936 ( 95% ci : 0.8790.992, p=0.000 ), respectively, and the optimum cut - off level was 0.185 mg / l ( sensitivity=79.3% and specificity=95.3% ) and 0.26 mg / l ( sensitivity=89.7% and specificity=95.6% ), respectively. the auc was 0.923 ( 95% ci : 0.8750.972, p=0.000 ) and the optimum cut - off level was 17.15% ( sensitivity=79.3% and specificity=87.8% ). when we chose the serum level of creatinine at 24 h for roc analysis, the auc was 0.733 ( 95% ci : 0.6400.825, p<0.001 ) and the optimum cut - off level was 73.55 mol / l ( sensitivity=89.7% and specificity=43.5% ). according to the results in table 3, although the aucs of cys c at 24 h and cys c changes at 24 h were similar, serum cys c with concentration changes > 0.26 mg / l had higher sensitivity ( 89.7% vs. 82.8% ) but lower specificity ( 95.6% vs. 97.8% ) for differentiating cin and non - cin. a total of 300 patients ( 179 males, 121 females ) with a mean age of 63.479.92 were included in the final study. according to the definition of cin, patients with a > 25% relative increase of serum creatinine, or an increase in concentration of serum creatinine of at least by 44 mmol / l from the baseline 48 h after cag, we analyzed and compared the demographics of the 2 groups. as is shown in table 1, patients in the cin group were significantly older than those in the non - cin group ( p=0.048 ), and the cin group had a higher proportion of females than the non - cin group ( p=0.037 ). however, the differences in the ratio of hypertension, diabetes mellitus, smoking, and cardiac dysfunction were not statistically significant. medication history was also recorded to analyze the effect on renal function, though there were no obvious distinctions between the 2 groups ( all p>0.05 ). previous researchers have used infusion dose of contrast medium and the exposure time as important indicators of cin, and we demonstrated the importance of these 2 indicators in our study. patients in the cin group received significantly larger doses of contrast medium ( p=0.040 ) and the operation time was longer compared to the non - cin group. comparison of basal renal function and serum level of cys c showed no significant differences between the 2 groups. as an important procedure in our study, we measured the serum levels of creatinine and cystatin c at various time points. compared vertically, the rise in serum cys c was the maximum at 24 h, which was significantly higher than baseline ( p<0.001 ). then, the level declined, but still remained higher at 48 h ( p<0.01 ). the serum level of creatinine in the cin group peaked at 48 h ( p<0.001 ) and was not significantly different at 24 h. egfr had decreased at 24 h and had even more obviously decreased at 48 h ( p<0.001 ). it is obvious that the change in serum level of cys c occurred prior to the change in serum level of creatinine. in the non - cin group, the differences in scr and cys c before and after the procedure were both non - significant. compared horizontally, the difference in cys c level between the 2 groups became apparent at 24 h ( p<0.001 ) and lasted until 48 h. the serum level of scr in the cin group was significantly higher than that in the non - cin group only at 48 h, and the difference was not obvious at 24 h. moreover, compared with non - cin group, egfr decreased from 24 h to 48 h in the cin group, and both differences were significant ( p<0.001 ). table 2 shows that the change in serum level of cys c became significantly different before that of scr. to study the significance of cys c and scr in cin we chose the serum levels at different time points for roc analysis. the area under the curve ( auc ) of cys c at 12 h and 24 h was 0.735 ( 95% ci : 0.6480.823, p=0.000 ) and 0.928 ( 95% ci : 0.8700.987, p=0.000 ), respectively, and the optimum cut - off level was 1.315 mg / l ( sensitivity=79.3% and specificity=55.4% ) and 1.55 mg / l ( sensitivity=82.8% and specificity=97.8% ), respectively. the auc of changes in cys c between baseline and 12 h and 24 h were 0.758 ( 95% ci : 0.6680.847, p=0.001 ) and 0.936 ( 95% ci : 0.8790.992, p=0.000 ), respectively, and the optimum cut - off level was 0.185 mg / l ( sensitivity=79.3% and specificity=95.3% ) and 0.26 mg / l ( sensitivity=89.7% and specificity=95.6% ), respectively. the auc was 0.923 ( 95% ci : 0.8750.972, p=0.000 ) and the optimum cut - off level was 17.15% ( sensitivity=79.3% and specificity=87.8% ). when we chose the serum level of creatinine at 24 h for roc analysis, the auc was 0.733 ( 95% ci : 0.6400.825, p<0.001 ) and the optimum cut - off level was 73.55 mol / l ( sensitivity=89.7% and specificity=43.5% ). according to the results in table 3, although the aucs of cys c at 24 h and cys c changes at 24 h were similar, serum cys c with concentration changes > 0.26 mg / l had higher sensitivity ( 89.7% vs. 82.8% ) but lower specificity ( 95.6% vs. 97.8% ) for differentiating cin and non - cin. contrast - induced nephropathy is a well - known complication that can be observed after some enhanced radiologic and angiographic examinations and treatments. the injury is generally mild and transient but can result in lasting renal dysfunction and it is associated with increased morbidity and mortality. one is the influence of renal hemodynamics caused by contrast medium exposure and the other is the direct cytotoxicity of contrast medium to renal tubular epithelial cells. in addition, there are no effective therapies for the acute kidney injury caused by contrast medium, so the only option is to prevent it from happening. nowadays, serum level of creatinine is widely used and recognized as a diagnostic clinical indicator of cin. however, scr could be affected by numerous factors like age, sex, and muscle mass. because of the reserve capacity of the kidneys, concentrations of scr can be within the reference range with a certain degree of impaired renal function. in our study, the level of scr increased significantly 48 h after exposure and was obviously higher than in the non - cin group ( p<0.001 ). therefore, scr is not efficient and accurate enough as a diagnostic indicator of cin. these limitations prompted us to look for another indicator that can reflect damaged renal function in early stages. the results showed that the serum level of cys c significantly increased at 24 h in cin patients, which was before the increase in scr. the variation tendency of cys c in the non - cin group was not obvious, as opposed to the increase in the cin group ( p=0.121 vs. p<0.001 ). cys c is a 13-kda non - glycosylated protein that is a cysteine protease inhibitor. it is produced by almost all nucleated cells at a constant rate and removed from the blood by glomerular filtration. the kidneys are the only organs that clear cys c, and the serum level of cys c only depends on gfr. therefore, in theory, the concentration change of cys c can reflect the change of gfr more sensitively than scr. bachorzewska - gajewska et al. found the same variation tendency of cys c after contrast medium exposure. their study including 410 patients with chronic kidney disease indicated that cys c is a reliable biomarker and predictor for the early diagnosis of cin. however, the form of cys c used for cin diagnosis is still in dispute. our study again verified the significant predictors of cin, including age, female sex, the dose of contrast medium, and the exposure time. most importantly, we revealed the potential association between the increase of cys c and the occurrence of cin. a certain increase of the concentration of cys c is sensitive and specific for the prediction of cin after contrast medium exposure. despite of the achievements of our study firstly, we only included patients with normal renal function at baseline, which limited the observations of the significance of cys c in patients with chronic kidney disease. then, we excluded patients who underwent pci from our study, leading to insufficient contrast medium exposure. in addition, we analyzed the different forms of cys c for the early diagnosis of cin and results showed similar significance among these indicators. therefore, the best form of cys c for the diagnosis of cin still remains uncertain. in conclusion, our study demonstrated that the change in concentration of cys c is superior to scr as a biomarker in the early detection of cin. we found that the changed concentration of cys c is superior to scr as a biomarker in the early detection of cin.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': \"Summarize the following article: pulmonary mucoepidermoid carcinoma ( pmec ) is a rare cancer that comprises only 0.1 to 0.2% of all primary lung malignancies ( 1,2,3,4 ) . \\n pmec is classified as a salivary gland type lung carcinoma , which originates from the submucosal glands of the trachea and bronchus ( 5,6 ) . \\n histologic grade , cancer stage and lymph node metastasis are reported independent factors for long - term prognosis in patients with pmec ( 5 ) . \\n it is now generally accepted that low - grade pmec behaves like a benign or low - grade malignant tumor , while high - grade pmec shows virulent characteristics like any other non - small cell lung cancer and has occasional lymph node metastasis . \\n therefore , if tumor grade could be predicted before surgery , it might reduce unnecessary lymph node dissection and even preserve lung function with limited pulmonary resection in patients with low - grade pmec . \\n on the other hand , in cases expected to have high - grade tumor , extended pulmonary resection with more radical lymph node dissection or neoadjuvant treatments could be performed \\n . however , there is no diagnostic tool to predict tumor grade prior to surgery for pmec . \\n this study evaluated whether the maximum standardized uptake value ( suvmax ) of fluorine-18 fluorodeoxyglucose positron emission tomography / computed tomography ( f - fdg pet / ct ) is a significant predictor for pathologic grade and postsurgical outcomes in patients following surgery for pmec . \\n this retrospective study was approved by our hospital 's institutional review board . from 2005 to 2013 , 27 patients ( 0.5% of all primary lung cancer patients ) underwent complete resection with curative intent for pmec . \\n four patients with pet / cts taken at other hospitals or without studies prior to surgery were excluded from enrollment . \\n patients were instructed to fast for six hours prior to receiving 370 mbq ( 10 mci ) of f - fdg by intravenous injection . \\n forty - five minutes after the injection , pet / ct scans ( ge healthcare ; milwaukee , wi , usa ) were performed . from 2005 to 2008 , a discovery ls scanner was used for pet / ct in eight patients . \\n ct was performed at 140 kev , 40 - 120 ma , tube rotation time of 0.5 seconds per rotation , pitch of 6 , and section thickness of 5 mm . from 2008 to 2013 , a discovery ste scanner was used for the other 15 patients , with ct performed at 140 kev , 30 - 170 ma , tube rotation time of 0.5 seconds per rotation , pitch of 6 , and section thickness of 3.75 mm . \\n pet data sets were reconstructed iteratively with an ordered subsets expectation - maximization algorithm and a segmented attenuation correction ( two iterations , 28 subsets ) , and also with the ct data . \\n commercial software ( advantage workstation version 4.4 ; ge healthcare ) was used to accurately co - register the separate ct and pet scan data . \\n the suvmax of the primary tumor was measured by the software . in brief , a volume - of - interest encircling the whole primary tumor was manually drawn , taking into account the ct , pet and fused pet / ct images , which allowed the software to automatically show the suvmax of primary tumor . \\n tumors were located in the segmental bronchi or lobar bronchus in 17 patients , main bronchus in five patients and trachea in one patient . \\n complete resection of the tumor ( r0 ) was histologically confirmed in all subjects , and every operation also included mediastinal lymph node dissection . \\n there were nine lobectomies , seven sleeve lobectomies , one bilobectomy , one sleeve bilobectomy , three pneumonectomies , one bronchial wedge resection , and one tracheal resection and anastomosis . \\n eighteen patients underwent pulmonary resection via open thoracotomy , and five patients underwent video - assisted thoracoscopic surgery ( vats ) . \\n the patients visited the outpatient clinic and had ct or pet / ct scans every three months for two years after surgery and then every six months for three more years . \\n patient survival was reviewed , and the end date was defined as the latest follow - up date or the date of patient death . \\n disease - free survival was defined as the time between diagnosis and the first clinical or pathologic evidence of loco - regional or distant recurrent disease . \\n histopathologic tumor grade was defined according to the grading system of the armed forces institute of pathology ( 15,16 ) . \\n tumors that met the criteria for grade 1 were classified as low - grade tumors in our study . \\n similarly , tumors that met the grade 2 and 3 criteria were classified as high - grade tumors . \\n overall , there were 16 patients with low - grade tumors and seven patients with high - grade tumors ( one patient with grade 2 , six patients with grade 3 ) . \\n pathologic staging was classified according to the 7th american joint committee on cancer staging criteria . \\n all data were statistically analyzed using stata statistical software 2007 , version 10 ( statacorp lp , college station , tx , usa ) . \\n suvmax of the main tumor in pet / ct images was correlated with tumor grade . \\n the optimal cutoff value was calculated as 6.5 by receiver operating characteristic ( roc ) curve and area under curve was 0.92 . \\n patients with a suvmax of 6.5 or higher were assigned to the high suv group ( n = 7 ) and the rest were assigned to the low suv group ( n = 16 ) . \\n we compared tumor grade , pathologic stage , and long - term outcomes between the low suv group and the high suv group . \\n tests were performed for categorical variables , and unpaired t tests were performed for continuous variables . overall survival was analyzed with kaplan - meier curves and the log - rank test . \\n this retrospective study was approved by our hospital 's institutional review board . from 2005 to 2013 , 27 patients ( 0.5% of all primary lung cancer patients ) underwent complete resection with curative intent for pmec . \\n four patients with pet / cts taken at other hospitals or without studies prior to surgery were excluded from enrollment . \\n patients were instructed to fast for six hours prior to receiving 370 mbq ( 10 mci ) of f - fdg by intravenous injection . \\n forty - five minutes after the injection , pet / ct scans ( ge healthcare ; milwaukee , wi , usa ) were performed . from 2005 to 2008 , a discovery ls scanner was used for pet / ct in eight patients . \\n ct was performed at 140 kev , 40 - 120 ma , tube rotation time of 0.5 seconds per rotation , pitch of 6 , and section thickness of 5 mm . from 2008 to 2013 , a discovery ste scanner was used for the other 15 patients , with ct performed at 140 kev , 30 - 170 ma , tube rotation time of 0.5 seconds per rotation , pitch of 6 , and section thickness of 3.75 mm . \\n pet data sets were reconstructed iteratively with an ordered subsets expectation - maximization algorithm and a segmented attenuation correction ( two iterations , 28 subsets ) , and also with the ct data . \\n commercial software ( advantage workstation version 4.4 ; ge healthcare ) was used to accurately co - register the separate ct and pet scan data . \\n the suvmax of the primary tumor was measured by the software . in brief , a volume - of - interest encircling the whole primary tumor was manually drawn , taking into account the ct , pet and fused pet / ct images , which allowed the software to automatically show the suvmax of primary tumor . \\n tumors were located in the segmental bronchi or lobar bronchus in 17 patients , main bronchus in five patients and trachea in one patient . \\n complete resection of the tumor ( r0 ) was histologically confirmed in all subjects , and every operation also included mediastinal lymph node dissection . \\n there were nine lobectomies , seven sleeve lobectomies , one bilobectomy , one sleeve bilobectomy , three pneumonectomies , one bronchial wedge resection , and one tracheal resection and anastomosis . \\n eighteen patients underwent pulmonary resection via open thoracotomy , and five patients underwent video - assisted thoracoscopic surgery ( vats ) . \\n the patients visited the outpatient clinic and had ct or pet / ct scans every three months for two years after surgery and then every six months for three more years . \\n patient survival was reviewed , and the end date was defined as the latest follow - up date or the date of patient death . \\n disease - free survival was defined as the time between diagnosis and the first clinical or pathologic evidence of loco - regional or distant recurrent disease . \\n histopathologic tumor grade was defined according to the grading system of the armed forces institute of pathology ( 15,16 ) . \\n tumors that met the criteria for grade 1 were classified as low - grade tumors in our study . \\n similarly , tumors that met the grade 2 and 3 criteria were classified as high - grade tumors . \\n overall , there were 16 patients with low - grade tumors and seven patients with high - grade tumors ( one patient with grade 2 , six patients with grade 3 ) . \\n pathologic staging was classified according to the 7th american joint committee on cancer staging criteria . \\n all data were statistically analyzed using stata statistical software 2007 , version 10 ( statacorp lp , college station , tx , usa ) . \\n suvmax of the main tumor in pet / ct images was correlated with tumor grade . \\n the optimal cutoff value was calculated as 6.5 by receiver operating characteristic ( roc ) curve and area under curve was 0.92 . \\n patients with a suvmax of 6.5 or higher were assigned to the high suv group ( n = 7 ) and the rest were assigned to the low suv group ( n = 16 ) . \\n we compared tumor grade , pathologic stage , and long - term outcomes between the low suv group and the high suv group . \\n tests were performed for categorical variables , and unpaired t tests were performed for continuous variables . overall survival was analyzed with kaplan - meier curves and the log - rank test . \\n the mean age was significantly higher in the high suv group than the low suv group ( 57.6  11.7 years vs. 39.6  17.2 years respectively , p = 0.010 ) . \\n notably , all three patients under age 20 were included in the low suv group and had a low grade tumor . \\n most of the patients ( 87.0% ) showed an eastern cooperative oncology group performance score of 0 or 1 and only three patients had a performance score of 2 ( two patients from high suv group and one patient from low suv group ) . \\n the mean suvmax was 15.4  11.5 in the high suv group and 3.9  1.3 in the low suv group . \\n 0.001 ) and larger tumor sizes ( 43.6  9.0 mm vs. 21.4  3.0 mm , p = 0.003 ) . typical enhanced ct and pet / ct images of low suv group are presented in figure 2 and images of high suv group in figure 3 . \\n the high suv group also had more frequent t3/4 stage ( 72.4% vs. 6.3% , p = 0.006 ) , more frequent lymph node metastases ( 57.1% vs. 0% , p = 0.001 ) , and consequently , higher cancer stages ( stage i / ii vs. iii , p = 0.001 ) than the low suv group . \\n enhanced ct and pet / ct images of the patient with regional lymph node metastasis are presented in figure 4 . \\n the low suv group had low grade tumors , except for one patient , and no lymph node metastasis . the sensitivity and specificity of pet / ct for predicting tumor grade were 85.7% and 93.8% , respectively . \\n accuracy was 91.3% and the positive and negative predictive value was 85.7% and 93.8% , respectively . \\n length of follow - up was similar between the two groups ( mean 48.6  38.7 months ; p = 0.660 ) . \\n in the high suv group , four patients ( 57.1% ) suffered cancer recurrence during follow - up , and one died of cancer 5 months after surgery . \\n another patient from high suv group showed no evidence of cancer recurrence , but died of brain infarct during the follow - up . \\n in contrast , none of the patients in the low suv group experienced recurrence or mortality . as a result , \\n the 5-year overall survival rate was significantly higher in the low suv group than the high suv group ( 100% vs. 71.4% respectively , p = 0.031 ) . \\n three - year disease - free survival was also significantly higher in the low suv group ( 100% vs. 17.9% respectively , p < 0.001 ) . high grade tumor ( p < 0.001 ) , pathologic stage iii ( p \\n multivariate analysis for long - term survival was unavailable , because there was no mortality or recurrence in patients with the low suv group . \\n kaplan - meier curves of overall and disease - free survival rates according to suv group are diagrammed in figure 5 . \\n since fdg - pet uptake in pmec was first reported in a 5-year - old girl ( 17 ) , several studies have addressed the subject . \\n case of low - grade pmec without nodal metastasis and reported a suvmax of 3.63 ( 18 ) and 6.2 ( 19 ) . a case report involving high - grade pmec with \\n the suvmax data from these studies precisely matches our results , further suggesting that a suvmax higher than 6.5 indicates a possible high - grade tumor . \\n suvmax in salivary gland type carcinoma ( including seven cases of pmec ) reportedly tends to be greater in high - grade tumors ( 21 ) . additionally , a recent study concerning surgical outcomes in 14 patients with pmec , the median suvmax increased significantly along with tumor grade ( p = 0.041 ) ( 14 ) . presently , pet revealed significant differences ( p < 0.001 ) in tumor grade according to suv group . \\n high fdg uptake has been associated with more frequent nodal or distant metastases , but failed to predict long - term survival ( 22 ) . \\n however in this study , pet / ct data was available in 11 patients ( 36.7% ) and other subtypes of salivary gland type lung cancer were included . \\n presently , nodal metastasis was significantly associated with the high suv group ( p = 0.001 ) . \\n furthermore , overall and disease - free survivals were significantly better in the low suv group . to our knowledge , this is the first study to report the prognostic value of fdg - pet / ct for long - term outcomes in pmec patients . \\n the low suv group had good long - term prognosis without recurrence after complete resection of tumor . \\n in contrast , despite complete resection , the high suv group suffered from local or distant recurrence . in the high suv group , \\n these results are similar to the prior conclusion that adjuvant chemotherapy does not seem to be effective in high grade pmec ( 23 ) . \\n the most common site of pmec in the tracheobronchial tree is the segmental bronchi , which are located within the lung parenchyma . in the present study , nine patients ( 56.3% ) in the low suv group underwent simple lobectomies , and five of these simple lobectomies \\n were performed by vats . even in patients who required sleeve resection of the bronchus , vats could be attempted . \\n use of vats sleeve lobectomy in low - grade pmec in the left main bronchus has been described ( 24 ) . \\n therefore , in selected patients with low pet / ct uptake , vats represents a feasible and effective surgical option . \\n considering the rarity of pmec , multi - center studies with large number of cases are needed to reconfirm and support the results of this study . \\n another limitation is that the change in pet / ct device once during follow - up might have caused alteration of suvmax , although the differences were likely minimal . in conclusion , f - fdg pet / ct appears to be a useful preoperative imaging modality for predicting tumor grade , nodal stage and postsurgical prognosis . \\n patients with a suvmax greater than 6.5 were more likely to have a high - grade tumor , lymph node metastasis and cancer recurrence . \\n therefore , pmec patients with high uptake on pet / ct imaging might require aggressive mediastinal lymph node dissection and adjuvant therapies . \\n further studies with more cases of pmec are necessary to verify the validity of pet / ct for prediction of long - term prognosis .\",\n",
       "  'output': 'objectivethe maximum standardized uptake value ( suvmax ) of pulmonary mucoepidermoid carcinoma ( pmec ) in fluorine-18fluorodeoxyglucose positron emission tomography / computed tomography ( 18f - fdg pet / ct ) was evaluated as a preoperative predictor of pathologic grade and survival rate.materials and methodstwenty - three patients who underwent preoperative pet / ct and complete resection for pmec were enrolled . \\n the optimal cut - off suvmax for tumor grade was calculated as 6.5 by receiver operating characteristic curve . \\n the patients were divided into a high suv group ( n = 7 ) and a low suv group ( n = 16 ) . \\n clinicopathologic features were compared between the groups by 2 test and overall survival was determined by kaplan - meier analysis.resultsthe mean suvmax was 15.4  11.5 in the high suv group and 3.9  1.3 in the low suv group . \\n all patients except one from the low suv group had low grade tumors and all had no nodal metastasis . the sensitivity and specificity of suvmax from pet / ct for predicting tumor grade was 85.7% and 93.8% , respectively . during the follow - up period ( mean , 48.6  38.7 months ) , four patients from the high suv group experienced cancer recurrence , and one died of cancer . in contrast , none of the low suv group had recurrence or mortality . \\n five - year overall survival rate was significantly higher in the low suv group ( 100% vs. 71.4% , p = 0.031).conclusionpulmonary mucoepidermoid carcinoma patients with high suvmax in pet / ct had higher tumor grade , more frequent lymph node metastasis and worse long - term outcome . \\n therefore , pmec patients with high uptake on pet / ct imaging might require aggressive mediastinal lymph node dissection and adjuvant therapies .',\n",
       "  '__index_level_0__': 31691,\n",
       "  'model_output': 'below is the generated abstract. it may need to be edited for accuracy and coherence.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Write a summary of the article that captures the main ideas and significant details.',\n",
       "  'input': \"Summarize the following article: diabetes is a major public health concern in the united states because of its prevalence , considerable morbidity and mortality , and economic burden with total medical costs of 245 billion dollars in 2012 alone [ 1 , 2 ] . in 2010 , \\n the prevalence rate of diabetes in the us was 9.3% , affecting older population ( 65 years or older ) even more dramatically with the rate of 25.9% . \\n diabetes is associated with serious complications , including coronary heart disease , stroke , kidney failure , neuropathy , blindness , and amputation , and was the seventh leading cause of death in 2010 [ 1 , 2 ] . \\n obesity is a major risk factor for t2d [ 2 , 3 ] , and the risk of diabetes increases directly with bmi [ 2 , 4 , 5 ] . \\n according to national center for health statistics ( nchs ) more than one - third of us adults ( 34.9 percent ) were obese in 2011 - 2012 . \\n the medical care costs of obesity in the united states are staggering , totaling about $ 147 billion dollars in 2008 alone . \\n weight loss is important therapeutic goal in obese patients with t2d , because even moderate weight loss ( 5% ) improves insulin sensitivity [ 2 , 8 ] . \\n bariatric surgery is the most effective weight - loss therapy and has considerable beneficial effects on diabetes and other obesity - related comorbidities [ 2 , 911 ] . \\n weight - loss surgery by laparoscopic sleeve gastrectomy ( sg ) leads to a 4065% reduction in excess weight and , amazingly , 56% of patients achieve resolution in their type 2 diabetes and 37% see improvement in their t2d symptoms . \\n laparoscopic gastric bypass ( gb ) is a more intense surgery that typically results in a 6070% loss of excess weight and is also characterized by improvement or resolution of diabetes [ 9 , 12 , 13 ] . \\n the objective of this study was to provide insight into the mechanism by which gut / stomach rerouting leads to weight loss and the improvement or resolution of diabetes . in metabolomics , \\n an individual 's metabolic state is profiled by multiplexed measurement of many low - molecular - weight metabolites . \\n discrete groups of chemically related metabolites ( e.g. , amino acids ) are quantified in a biological sample . \\n in contrast , nontargeted analysis is a more qualitative approach that surveys as many different metabolites as possible . \\n using primarily targeted approaches , multiple studies have identified higher levels of branched - chain and aromatic amino acids in insulin - resistant , obese , and t2d individuals . \\n more recent studies demonstrated that higher levels of these amino acids are predictive of progression to t2d as well as future insulin resistance and hyperglycemia [ 14 , 1822 ] . \\n recently , gall and colleagues   used nontargeted approach to identify plasma metabolites associated with development of insulin resistance and/or glucose intolerance . \\n two top - ranked metabolites were an organic acid , -hydroxybutyrate ( -hb ) , and a lipid , 1-linoleoyl - glycerophosphocholine ( l - gpc ) . \\n proposed fasting -hb and l - gpc levels as new biomarkers to help predict dysglycemia and t2d [ 14 , 24 ] . \\n this nontargeted global metabolomic profiling represents new tool that allows the comprehensive survey of metabolism and metabolic networks to gain insight into phenotype and identify biomarker candidates . \\n so far this approach was used to find a way to predict the progression to t2d as well as future insulin resistance and impaired glucose tolerance by serum analysis of insulin - resistant , obese individuals who progressed to t2d . \\n we took an opposite approach utilizing bariatric surgery tool as the most promising way to affect weight loss and to rectify t2d symptoms in morbidly obese patients . \\n it is not known whether metabolic response is the same for all bariatric procedures , nor is it known whether there are any differences between nondiabetic and t2d patients . \\n 15 patients represented three disease - surgery groups : nondiabetic ( non - t2d ) receiving sg and t2d receiving either sg or gb surgery ( table 1 ) . \\n blood samples were collected over the course of treatment for each patient at the following times : at baseline ( bl ) prior to dieting / surgery , 14 days after baseline with adherence to strict preoperation weight - loss liquid diet ( preop diet ) , and 28 days after surgery recovery after bariatric surgery ( postop ) . \\n blood samples were collected in serum separator tubes , allowed to stand at room temperature for 1520 minutes , centrifuged at 2500  rpm for 10 minutes at 4c , aliquoted , snap frozen in liquid nitrogen , and stored at 80c until analysis . \\n ( durham , nc ) , using two independent platforms : ultrahigh performance liquid chromatography / tandem mass spectrometry ( uhplc - ms / ms ) optimized for basic species or acidic species , and gas chromatography / mass spectrometry ( gc / ms ) . \\n general platform methods are described in details in online supplemental data section ( see supplementary methods and materials available online at http://dx.doi.org/10.1155/2016/3467403 ) . \\n following log transformation and imputation with minimum observed values for each compound , repeated measures 2-way anova with posttest contrasts was used to identify biochemicals that differed significantly between experimental groups and across study time points with statistical cut - offs for p value ( p < 0.05 ) . \\n multiple comparisons were accounted for by estimating the false discovery rate using q - values of less than 5% ( q < 0.05 ) . \\n genome - wide association studies have identified many t2d susceptibility genes [ 14 , 26 ] but generally failed to improve risk prediction over that provided by routine clinical measures [ 14 , 27 ] . \\n global nontargeted analysis performed in this study is the first study to provide the insight into mechanism by which bariatric surgery leads to weight loss and resolution or improvement of t2d . \\n this approach might also be used to identify t2d biomarker candidates and find new , cost effective treatments that can replace surgery itself . since metabolomic profiling generates a wealth of data that must be parsed to extract information , we chose statistical cut - offs at both the level of individual metabolites  p values  and the level of multiple testing across the 476 metabolites detected in the serum samples  q - values . by narrowing in on metabolites meeting the conservative criteria of p < 0.05 and an estimated false discovery rate of less than 5% ( q < 0.05 ) \\n , we were able to reduce the complexity of the dataset and observed a number of statistically significant changes that occurred in common in nondiabetic and t2d patients with sg or gb . \\n furthermore , we were able to identify concerted changes of related metabolites that pointed to areas of metabolism that were affected by standard preop diet as well as by bariatric surgery itself . \\n a list of all 476 metabolites detected and heat map of the statistical comparisons across time and patient groups are presented in online supplemental tables a1 and a2 . \\n comparison of serum profiles at baseline , following a preop weight reduction diet , and after weight - loss surgery revealed several key metabolic differences as highlighted below . \\n fat mobilization and oxidation were the key signatures associated with preop diet . prior to surgery \\n , patients were subjected to 2-week clear liquid diet that promoted weight loss on the order of 35% of body weight . \\n the preoperative liquid diet is a 14-day high protein , very low calorie diet ( vlcd ) designed to deplete glycogen and fat stores in the liver or  shrink the liver  which is lifted to access the stomach during surgery . \\n this vlcd includes 800  kcal with 80  g protein and typically produces a 1020-pound weight loss . \\n high protein drinks with less than 200 calories and at least 20  g protein are consumed 3 - 4x daily ; no solid food is allowed on this diet . \\n in addition , at least 64 ounces of sugar - free decaffeinated clear liquids a day are recommended along with a multivitamin and a calcium + vitamin d supplement . \\n medications , such as antihyperglycemics , are adjusted during this preoperative weight - loss phase to account for decreased calorie and carbohydrate intake . \\n the study found that patients who follow a preoperative liquid diet effectively reduced visceral fat and achieve greater weight loss . \\n examination of preop metabolic profiles , serum samples taken immediately before surgery , showed a profound mobilization of fat as attested by statistically significant elevations of ketones , monoacylglycerols , oleate , and an acyl - carnitine ( online supplemental table a3 , figure 1 ) . \\n these are compounds associated with lipolysis and fatty acid oxidation which suggested that a major metabolic effect of the preop diet was to stimulate fat tissue triglyceride hydrolysis , transport of fatty acids to the liver , and subsequent liver fatty acid oxidation and ketogenesis to supply energy substrates for peripheral tissues . \\n the elevation of the markers associated with lipolysis and ketone production was transient and , in most cases , returned to near baseline levels by day 28 postsurgery time point . \\n these results suggest that 35% weight loss experienced by patients during preop diet is largely due to the consumption of adipose reserves for energy production . \\n another interesting observation is that preop diet led to a transient elevation of alpha - hydroxybutyrate ( -hb ) and its precursor alpha - ketobutyrate ( online supplemental table a3 , figure 1 ) . \\n -hb is a sensitive biomarker of insulin resistance [ 23 , 24 ] which suggests that both nondiabetic and t2d patients experienced a temporary relative increase in insulin resistance during preop diet . \\n compounds that changed in a statistically significant manner after 28 days of recovery from bariatric surgery , relative to baseline , were more numerous and diverse than observed in response to the preoperation diet . \\n 62 compounds in the postsurgery to baseline comparison represented p < 0.05 and showed q < 0.05 in at least one of the disease - surgery groups ( online supplemental table a4 ) . \\n 28 compounds showed p and q - value cut - offs across all three disease - surgery groups at the 28-day postsurgery sample collection time point relative to baseline . \\n 13 of the compounds that changed across all three groups had fold - change increases  including 100-fold + increases for trans - urocanate , cis - urocanate , pyroglutamylvaline , and heme in most or all of the groups . \\n the remaining fifteen compounds that changed across all three groups were reduced at the postsurgery time point compared to baseline . \\n levels of ascorbate and various tocopherols were substantially reduced with ascorbate showing a 12.5-fold or greater decrease in each of the groups ( online supplemental table a4 , figure 2 ) . \\n difficulty in absorbing micronutrients , such as vitamin c , following bariatric surgery has been reported previously [ 29 , 30 ] and appeared to be confirmed at a shorter follow - up time point in this study . \\n weight - loss surgery led to concerted changes in compounds related to sulfur - containing amino acid metabolism that were largely shared across the groups . \\n glutathione ( gsh ) is a tripeptide comprised of glutamate , cysteine , and glycine . \\n these amino acids along with the recycling intermediates cys - gly and 5-oxoproline were increased in all groups following surgery ( online supplemental table a4 ) , suggesting a greater potential availability of substrates for gsh production . oxidized forms of glutathione and cysteine , such as the mixed heterodimer cysteine - glutathione and glutathione homodimer gssg , \\n were elevated following surgery ( online supplemental table a4 , figure 2 ) and could be a sign of increased oxidative stress following surgery . however , an alternate interpretation is that a greater availability of glutathione and sulfur - containing amino acids following weight - loss surgery led to the greater formation of these oxidized compounds . \\n pyruvate  the terminal product of glucose metabolism via the glycolysis pathway  dropped sharply after bariatric surgery ( online supplemental table a4 , figure 3 ) , likely indicating its more efficient mitochondrial utilization . \\n the reduction of pyruvate was matched by increases in fumarate , in all t2d patients , and malate perhaps indicating an inadequate supply of acetyl - coa , which is derived from pyruvate , relative to the level of tca cycle components . \\n however , levels of the glycolytic intermediate 3-phosphoglycerate ( 3-pg ) increased after surgery as did nonglycolytic products  glycerol and serine  potentially derived from 3-pg . \\n in addition to changes in pyruvate production , glucose usage via the pentose phosphate pathway ( ppp ) was also shifted following bariatric surgery . \\n the ppp is a key source of pentose sugars used for nucleotide synthesis as well as nadph which is used for reductive synthesis reactions and regeneration of reduced glutathione . \\n ppp intermediates and derivative pentose sugars , including ribulose-5-phosphate and xylulose-5-phosphate that are isobars that can not be differentiated by our platform , and their nonphosphorylated products , such as xylulose , were significantly increased in all groups following surgery ( online supplemental table a4 , figure 3 ) . \\n glucose carbons , via glucose-6-phosphate , may have been directed toward the pentose phosphate pathway in the face of the proposed decrease in glycolysis pathway activity . \\n for example , at baseline , metformin was detected in 100% of the t2d sg patient samples , 60% of the t2d gb samples , and none of the nondiabetic sg samples . \\n after bariatric surgery , metformin was only detected in 20% of the t2d sg and gb serum samples . \\n postsurgery serum glucose levels decreased relative to baseline but this change only reached statistical significance ( p < 0.05 ) in the t2d sg group ( online supplemental table a4 , figure 3 ) . in total , the results suggest that bariatric surgery affected glucose metabolism through glycolytic and nonglycolytic pathways similarly for all three of the disease - surgery groups . \\n each of the patient groups experienced an increase in serum heme levels around 100-fold compared to their respective baseline levels following surgery ( online supplemental table a4 ) . \\n a couple of interesting possibilities , such as a reduced level of heme breakdown by heme oxygenase ( ho ) or an increased level of synthesis by 5-aminolevulinate synthase ( ala synthase ) , could explain these changes . \\n the understanding of ho-1 function has evolved beyond a simple disposal of heme to include cytoprotective , anti - inflammatory , and antioxidant functions . \\n for instance , endogenous carbon monoxide produced by ho-1 engages multiple signal transduction pathways to confer antiapoptotic and anti - inflammatory effects and biliverdin and bilirubin are potent antioxidants . \\n ho activation has been shown to have insulin sensitizing and anti - inflammation effects in t2d . \\n so the increase in heme and biliverdin following surgery could represent an increase in heme oxidation by ho leading to greater antioxidant protection and insulin sensitivity . on the other hand \\n , the greater availability of glycine , which shows a relative deficiency in t2d [ 23 , 32 ] , could also serve as the basis for greater heme production by ala synthase \\n the rate - limiting enzyme of heme formation whose expression is repressed by glucose . on the other hand , biliverdin catabolism  which can reflect red blood cell turnover and heme disposal  was less evident following surgery as indicated by reductions in bilirubin zz and its ee photoisomer ( online supplemental table a4 ) . \\n together , these exciting results suggest that bariatric surgery may promote antioxidant defense and insulin sensitivity through both increased heme synthesis and ho activity or expression . \\n diabetes and obesity are chronic conditions associated with elevated oxidative / inflammatory activities with a continuum of tissue insults leading to more severe cardiometabolic and renal complications including myocardial infarction and end - stage - renal damage . \\n a common denominator of these chronic conditions is the enhanced levels of cytokines like tumour necrosis factor - alpha ( tnf- ) , interleukin ( il-6 ) , il-1beta , and resistin , which in turn activates the c - jun - n - terminal kinase ( jnk ) and nf-b , pathways , creating a vicious cycle that exacerbates insulin resistance , type-2 diabetes , and related complications . \\n emerging evidence indicates that heme oxygenase ( ho ) inducers are endowed with potent antidiabetic and insulin sensitizing effects besides their ability to suppress immune / inflammatory response . \\n importantly , the ho system abates inflammation through several mechanisms including the suppression of macrophage - infiltration and abrogation of oxidative / inflammatory transcription factors like nf-b , jnk , and activating protein-1 . \\n thus , ho system could be explored in the search for novel remedies against t2d and its complications . \\n proposed using fasting -hb and l - gpc levels as new biomarkers to help predict dysglycemia and t2d [ 14 , 24 ] . both were detected in this study but postsurgery results do not bear out an improvement in insulin resistance based on these markers . \\n -hb is positively but l - gpc is negatively correlated with insulin resistance , so a postsurgery signature of improved insulin sensitivity would be expected to show a decrease of -hb and an increase of l - gpc . \\n our findings showed an opposite pattern : -hb was increased during the liquid weight - loss diet and then returned to near baseline levels after the surgery , while l - gpc levels showed significant postsurgery decrease across all three disease - surgery groups ( online supplemental table a4 , figure 1 ) . \\n there could be several reasons for this to occur , including the assumption that -hb will drop after bariatric surgery is incorrect , or the 28-day time point is too soon to register a change . \\n for the t2d subjects , there is the potential that metformin therapy also altered the baseline levels of -hb and l - gpc . \\n large increases in histidine derivatives were possibly due to altered gut microbiome composition or increased liver histidine - ammonia lyase activity . \\n histidine and several catabolites , such as imidazole propionate and urocanate isomers , both trans- and cis - urocanate , were significantly elevated ( p < 0.05 , q < 0.00001 , including 100-fold + increases for trans - urocanate and cis - urocanate ) in all three groups ( online supplemental table a4 , figure 4 ) . \\n histidine is classified as an essential amino acid but gut bacteria can synthesize it , perhaps using precursors supplied by the human host . \\n these markers may be an indication of changes in gut microbiome as the direct participation of the rat intestinal flora in the degradation of urocanate to imidazole propionate has been demonstrated previously . \\n although the sample size was very small , these results suggested that histidine metabolites could also be important marker candidates to monitor metabolic changes associated with weight - loss surgery . \\n recently , ryan and colleagues   found that vertical sleeve gastrectomy that led to weight loss and improvement of diabetes also resulted in changes in the gut bacteria . \\n the researchers observed changes in several key bacterial groups that have been previously linked to the risk of t2d , and these changes were related to increase in circulating of bile acids that are known to bind to the nuclear receptor fxr . \\n interesting is the researches proposal that manipulating the gut bacteria might be another way to mimic the surgery . on the other hand , \\n urocanate is also formed in the liver by histidine - ammonia lyase ( hal ) which converts histidine into urocanate and ammonia . \\n interestingly , hal gene expression in hepatocytes can be stimulated by glucagon , so it is also possible that the increase of urocanate following surgery reflects a change in circulating glucagon levels . \\n cis - urocanate has interesting immunosuppressive properties that are believed to help protect the skin during sun exposure and perhaps sites distal from the skin . \\n little is known about imidazole propionate but it is a reported constituent of urine and has been proposed as a marker of intestinal dysfunction . \\n it may be useful to validate the ability of trans - urocanate , cis - urocanate , and imidazole propionate to serve as markers to monitor bariatric surgery in a larger independent cohort of patients and targeted quantitative assay . \\n it will also be interesting to determine what , if any , utility such markers have for predicting long - term patient outcomes following surgery . comparing the postsurgery to the preoperation diet time point revealed 18 compounds that met the p and q - value cut - off criteria across all three disease - surgery groups ( online supplemental table a5 ) . \\n thirteen were increased postsurgery samples relative to the samples collected at the preoperation diet time point and trans - urocanate , cis - urocanate , and pyroglutamylvaline displayed 100-fold or greater increases in nearly all of the groups . \\n ascorbate and 1-linolenoylglycerol showed the greatest reductions among the 5 compounds that decreased in postsurgery samples relative to preoperation diet samples following surgery , but these reductions could also reflect altered gut absorption of these vitamins in addition to their consumption via the quenching of reactive oxygen species . \\n there were 29 additional compounds that represented p < 0.05 in all groups but did not reach q < 0.05 for all of the disease - surgery combinations . \\n histidine and several catabolites , such as imidazole propionate and urocanate isomers , were increased in t2d patients and the urocanate isomers were also likewise increased in nondiabetic patients after surgery ( online supplemental tables a4 and a5 ) . \\n again , these results suggest that histidine metabolites could be important markers to monitor metabolic changes associated with weight - loss surgery . \\n global metabolomic analysis was used to evaluate the changes occurring in nondiabetic and t2d patients experiencing either less extreme sleeve gastrectomy or a full gastric bypass . \\n this study allowed gaining insights into the metabolic changes during both the preoperation weight - loss diet and early postsurgery recovery that accompany bariatric surgery . to identify metabolic changes that were conserved across nondiabetic and t2d patients and different bariatric surgery procedures \\n sleeve gastrectomy ( sg ) versus gastric bypass ( gb)the metabolomic data collected for each disease - surgery combination were filtered according to statistical cut - offs for p value ( p < 0.05 ) and to establish an estimated false discovery rate of less than 5% ( q < 0.05 ) . \\n it is important to point out that , despite age and sex difference , t2d status or bariatric surgery procedure , and coexistence of other associated diseases , all patients demonstrated striking similarity in major metabolome changes associated with preoperation weight - loss diet and bariatric surgery itself . \\n the preoperation weight - loss diet was associated with a strong lipid metabolism signature related to triglyceride hydrolysis , fatty acid oxidation , and ketone formation . \\n glucose metabolism via glycolytic and nonglycolytic pathways appeared to share a similar response across all patients regardless of baseline t2d status or the bariatric surgery procedure . \\n glycolysis pathway appeared to be suppressed and perhaps led to an accumulation of the tca cycle components : malate and fumarate . \\n such increases might indicate a greater demand for pentose sugars and nadph and the redirection of glucose-6-phosphate away from glycolysis . \\n increased heme levels were a likely sign of improved antioxidant defense via the action of heme oxygenase and liver function through increased heme biosynthesis in the liver . \\n the simultaneous postsurgery disappearance of vitamin c and surge in oxidative stress markers such as allantoin and cysteine - glutathione disulfide suggest that micronutrient status should be monitored and supported by nutritional supplementation . \\n this initial study provided a broad understanding of how metabolism changed globally in morbidly obese subjects following weight - loss surgery . \\n future serum metabolomic profiling studies focusing on baseline and 28 days ( or other ) after surgery with a greater number of patients in each group might help to further resolve differences between diabetic and nondiabetic patients . \\n additionally , profiling of baseline and postsurgery fecal samples might provide a more focused manner to interrogate changes associated with gut and microbiome function . \\n finally , the significance of this study lays in the exploration of future treatments for obesity and t2d that can mimic bariatric surgery weight loss and improvement and resolution of t2d .\",\n",
       "  'output': 'the goal of this study was to provide insight into the mechanism by which bariatric surgical procedures led to weight loss and improvement or resolution of diabetes . \\n global biochemical profiling was used to evaluate changes occurring in nondiabetic and type 2 diabetic ( t2d ) patients experiencing either less extreme sleeve gastrectomy or a full gastric bypass . \\n we were able to identify changes in metabolism that were affected by standard preoperation liquid weight loss diet as well as by bariatric surgery itself . \\n preoperation weight - loss diet was associated with a strong lipid metabolism signature largely related to the consumption of adipose reserves for energy production . \\n glucose usage shift away from glycolytic pyruvate production toward pentose phosphate pathway , via glucose-6-phosphate , appeared to be shared across all patients regardless of t2d status or bariatric surgery procedure . \\n our results suggested that bariatric surgery might promote antioxidant defense and insulin sensitivity through both increased heme synthesis and ho activity or expression . \\n changes in histidine and its metabolites following surgery might be an indication of altered gut microbiome ecology or liver function . \\n this initial study provided broad understanding of how metabolism changed globally in morbidly obese nondiabetic and t2d patients following weight - loss surgery .',\n",
       "  '__index_level_0__': 31692,\n",
       "  'model_output': 'Summarization of the article was difficult due to the complex nature of the study.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Summarize the given article into a concise abstract that highlights the key findings and conclusions.',\n",
       "  'input': 'Summarize the following article: fungi have been extensively isolated and investigated from skin in various parts of the world . \\n fungal diseases have markedly increased during the recent years ( 1 ) ; although more increase is observed in opportunistic mycoses . \\n determining the mycoflora of normal people is important when the role of skin is considered as a reservoir for microorganisms . \\n infectious diseases , mostly the ones that affect the epidermal or mucous membrane , are serious troubles all over the world because of hygiene and education deficiency . \\n microbiome of human skin refers to complete collection of microorganisms comprising bacteria , fungi and virus . \\n the kind and quantity of skin microbes are different from one individual to another depending on the location of the body . \\n fungi are among the most significant groups of these skin pathogens ( 2 ) . \\n cutaneous mycoses refer to skin infection and its appendages are involved in yeasts and filamentous fungi . \\n they have the affinity to parasitized tissues with rich keratin and create the skin inflammatory responses and cause severe itching , burning and redness . moreover , these diseases cause cosmetic outcomes . \\n candidiasis includes the infections that vary from superficial ; for example , oral thrush and vulvovaginitis , to visceral and potentially life - threatening diseases \\n . superficial infections of dermal inflammation and discomfort are frequent in numerous human societies . \\n toe webs harbor fungi more than the less occluded parts such as trunk , legs , and arms ( 2 ) . at present a normal healthy skin in adults \\n is expected to transmit a number of representatives of the genera candida , malassezia and geotrichum as well as few anthropophilic dermatophytes as inhabitants of the normal skin . \\n direct examination , and culture and molecular analyses are employed to recognize the skin microbial inhabitants . \\n direct examination is based on finding the microbial elements such as unicellular yeast , mycelium and pseudohyphae . \\n the presence of malassezia spp . in healthy human skin was identified in previous investigation in the nineteenth century . \\n the incidence and density of colonization depended on the activity of sebaceous gland and age . \\n the species most commonly associated with this disease are , malassezia \\n globosa , m. \\n furfur and m. \\n sympodialis ( 3 - 5 ) . this disorder could be observed in temperate climates , particularly during summer in humid months . \\n the malassezia yeast form generates dicarboxylic acids similar to azelaic acid which prohibit tyrosine kinase that consequences in hypopigmentation of skin ( 4 ) \\n diagnosis of this disease is clinically easy and it is confirmed by microscopic examination of skin scraping on potassium hydroxide or using scotch tape . \\n conversion from yeast form of malassezia to mycelia form was promoted with warm and humid weather . \\n immunodeficiency , poor hygiene , diabetes and poor nutrition are other factors related to pityriasis versicolor . \\n the seborrheic areas are chest , back , abdomen , neck , and proximal arms . \\n the lesions possess different colors such as yellow , brown , pink , red or hypo pigmented . \\n keratinophilic fungi are the groups which could infect the skin , hair and nail in human ( 6 , 7 ) . \\n anthropophilic type of theses fungi can apparently live in healthy human skin which may contribute to transmission of the fungi ( 8 , 9 ) . \\n the current study aimed to investigate the incidence of fungal flora on interdigital spaces of the human foot . \\n samples were collected from toe webs of 865 girl students who lived in the dormitories of ahvaz jundishapur university of medical sciences in autumn 2008 . \\n the tested web spaces did not show any signs of infection such as erythema , scaling , blistering and itching . \\n the samples were collected into sterilized clean pockets and transferred immediately to the mycology medical laboratory . \\n a part of the samples were digested with 20% koh and screened by a light microscope for fungal elements . \\n another part of the samples were cultured on sabouraud glucose agar ( sga ) and sga containing 0.05 mg / ml chloramphenicol and 0.5 mg/ ml cyclohexmide . \\n the filamentous fungi were identified after slide culturing according to their gross and morphological features . \\n yeasts were identified on the bases of germ tube formation , morphology on the corn meal agar medium , and assay of unease activity . \\n out of the 865 samples , 616 ( 71.2% ) were positive in direct examination or culture . \\n the culture was positive in 349 ( 40.3% ) specimens ; and 22 ( % 2.5% ) samples were also positive for both direct examination and culture . \\n the most common fungal isolates in direct test were yeast ( 29.4% ) , followed by conidia ( 0 . \\n 92% ) , melanised hypha ( 0.35% ) and non - septated hypha ( 0.23% ) . \\n skin surface is moderately dry , fairly acidic and dead cells are the prime source of nutrition . \\n skin has an environment which inhibits the growth of numerous microorganisms , however , some have adapted to living on the skin . \\n candida and malassezia species are two good examples that inhabit on the skin ( 3 , 4 , 10 , 11 ) . \\n the current study performed a comprehensive and quantitative analysis of the mycoflora on the surface of interdigital skin of girl students . \\n overall fungal structure was found on the skin of 30.9% of the students in the direct examination with koh . \\n the rates of the total yeast counts were much higher than those of molds in samples of skin in the direct examination . \\n the species of candida live on skin and cause the frequent skin infection named candidiasis . \\n candida species were isolated from 1.2% of interdigital spaces of people in the current study . \\n although skin candidiasis is not life threatening , it can affect the emotional and physical status of the patients . \\n malassezia species is considered as an opportunistic fungus , since it stays benign until the conditions that convey it to cause infection are provided .   in the current study , \\n various fungi which can be considered as possible agents for skin diseases were isolated . in the present study , \\n various fungi were isolated from the skin which could be considered as possible causes of skin diseases . compared to many fungal diseases , \\n host - fungus association in dermatophytosis was significant because dermatophytes affect immunocompetent persons ; however they usually invade just superficial keratinized tissues . \\n currently , not much has been recognized from the relevant factors which mediate adherence of these fungi to host . \\n the capability of t. \\n rubrum to adhere to epithelial cells is a trait to carbohydrate - specific adhesin on microconidia ( 12 ) . \\n morphological observation detected the fibrillar projections in t. \\n mentagrophytes through the adherence stage ( 13 , 14 ) . in the current research various saprophytic fungi \\n actually , many of the fungal spores recovered from the skin can be found in the atmosphere . \\n the present study demonstrated the incidence of fungal flora on interdigital spaces of human foot . \\n the obtained results showed that fungi can survive on the surfaces of skin without showing the sign of infection .',\n",
       "  'output': 'background : fungi have been extensively isolated and investigated from skin in various parts of the world . determining the mycoflora of normal people is important when the role of skin is considered as a reservoir for microorganisms.objectives:the current study aimed to investigate the incidence of fungal flora on interdigital spaces of the human foot.patients and methods : samples were collected from interdigital spaces of 865 girl students who lived in the dormitories of ahvaz jundishapur university of medical sciences . \\n a part of the sample was digested with 20% koh and screened by a light microscope for fungal elements . \\n another part of the sample was cultured on sabouraud glucose agar ( sga ) and sga containing 0.05 mg / ml chloramphenicol and 0.5 mg / ml cycloheximide . \\n the fungal colonies were identified based on morphological and microscopic characteristics and biochemical tests.results:in the current study , out of the 865 samples , 616 ( 71 . \\n 2% ) were positive in direct examination or culture . \\n of these , 267 samples ( 30 . \\n 9% ) were positive in direct examination . \\n the most common fungal isolates in direct test were yeast ( 29 . \\n 4% ) , followed by conidia ( 0 . \\n 92% ) , melanised hypha ( 0 . \\n 35% ) and non - septated hyphae ( 0 . \\n 23% ) . \\n trichophyton mentagrophytes was isolated in one of the specimens.conclusionsthe present study demonstrated the incidence of fungal flora on interdigital spaces of human foot . \\n the current study results showed that fungi can survive on surfaces of skin without showing the sign of infection .',\n",
       "  '__index_level_0__': 31693,\n",
       "  'model_output': '\"summarize the following article: fungi have been extensively isolated and investigated from skin in various parts of the world. \\n fungal diseases have markedly increased during the recent years ( 1 ) ; although more increase is observed in opportunistic mycoses. \\n determining the mycoflora of normal people is important when the role of skin is considered as a reservoir for microorganisms. \\n infectious diseases, mostly the ones that affect the epidermal or mucous membrane, are serious troubles all over the world because of hygiene and education deficiency. \\n microbiome of human skin refers to complete collection of microorganisms comprising bacteria, fungi and virus. \\n the kind and quantity of skin microbes are different from one individual to another depending on the location of the body. \\n fungi are among the most significant groups of these skin pathogens ( 2 ). \\n cutaneous mycoses refer to skin infection and its appendages are involved in yeasts and filamentous fungi. \\n they have the affinity to parasitized tissues with rich keratin and create the skin inflammatory responses and cause severe itching, burning and redness. moreover, these diseases cause cosmetic outcomes. \\n candidiasis includes the infections that vary from superficial ; for example, oral thrush and vulvovaginitis, to visceral and potentially life - threatening diseases \\n. superficial infections of dermal inflammation and discomfort are frequent in numerous human societies. \\n toe webs harbor fungi more than the less occluded parts such as trunk, legs, and arms ( 2 ). at present a normal healthy skin in adults \\n is expected to transmit a number of representatives of the genera candida, malassezia and geotrichum as well as few anthropophilic dermatophytes as inhabitants of the normal skin. \\n direct examination, and culture and molecular analyses are employed to recognize the skin microbial inhabitants. \\n direct examination is based on finding the microbial elements such as unicellular yeast, mycelium and pseudohyphae. \\n the presence of malassezia spp. in healthy human skin was identified in previous investigation in the nineteenth century. \\n the incidence and density of colonization depended on the activity of sebaceous gland and age. \\n the species most commonly associated with this disease are, malassezia \\n globosa, m. \\n furfur and m. \\n sympodialis ( 3 - 5 ). this disorder could be observed in temperate climates, particularly during summer in humid months. \\n the malassezia yeast form generates dicarboxylic acids similar to azelaic acid which prohibit tyrosine kinase that consequences in hypopigmentation of skin ( 4 ) \\n diagnosis of this disease is clinically easy and it is confirmed by microscopic examination of skin scraping on potassium hydroxide or using scotch tape. \\n conversion from yeast form of malassezia to mycelia form was promoted with warm and humid weather. \\n immunodeficiency, poor hygiene, diabetes and poor nutrition are other factors related to pityriasis versicolor. \\n the seborrheic areas are chest, back, abdomen, neck, and proximal arms. \\n the lesions possess different colors such as yellow, brown, pink, red or hypo pigmented. \\n keratinophilic fungi are the groups which could infect the skin, hair and nail in human ( 6, 7 ). \\n anthropophilic type of theses fungi can apparently live in healthy human skin which may contribute to transmission of the fungi ( 8, 9 ). \\n the current study aimed to investigate the incidence of fungal flora on interdigital spaces of the human foot. \\n samples were collected from toe webs of 865 girl students who lived in the dormitories of ahvaz jundishapur university of medical sciences in autumn 2008. \\n the tested web spaces did not show any signs of infection such as erythema, scaling, blistering and itching. \\n the samples were collected into sterilized clean pockets and transferred immediately to the mycology medical laboratory. \\n a part of the samples were digested with 20% koh and screened by a light microscope for fungal elements. \\n another part of the samples were cultured on sabouraud glucose agar ( sga ) and sga containing 0.05 mg / ml chloramphenicol and 0.5 mg/ ml cyclohexmide. \\n the filamentous fungi were identified after slide culturing according to their gross and morphological features. \\n yeasts were identified on the bases of germ tube formation, morphology on the corn meal agar medium, and assay of unease activity. \\n out of the 865 samples, 616 ( 71.2% ) were positive in direct examination or culture. \\n the culture was positive in 349 ( 40.3% ) specimens ; and 22 ( % 2.5% ) samples were also positive for both direct examination and culture. \\n the most common fungal isolates in direct test were yeast ( 29.4% ), followed by conidia ( 0. \\n 92% ), melanised hypha ( 0.35% ) and non - septated hypha ( 0.23% ). \\n skin surface is moderately dry, fairly acidic and dead cells are the prime source of nutrition. \\n skin has an environment which inhibits the growth of numerous microorganisms, however, some have adapted to living on the skin. \\n candida and malassezia species are two good examples that inhabit on the skin ( 3, 4, 10, 11 ). \\n the current study performed a comprehensive and quantitative analysis of the mycoflora on the surface of interdigital skin of girl students. \\n overall fungal structure was found on the skin of 30.9% of the students in the direct examination with koh. \\n the rates of the total yeast counts were much higher than those of molds in samples of skin in the direct examination. \\n the species of candida live on skin and cause the frequent skin infection named candidiasis. \\n candida species were isolated from 1.2% of interdigital spaces of people in the current study. \\n although skin candidiasis is not life threatening, it can affect the emotional and physical status of the patients. \\n malassezia species is considered as an opportunistic fungus, since it stays benign until the conditions that convey it to cause infection are provided.   in the current study, \\n various fungi which can be considered as possible agents for skin diseases were isolated. in the present study, \\n various fungi were isolated from the skin which could be considered as possible causes of skin diseases. compared to many fungal diseases, \\n host - fungus association in dermatophytosis was significant because dermatophytes affect immunocompetent persons ; however they usually invade just superficial keratinized tissues. \\n currently, not much has been recognized from the relevant factors which mediate adherence of these fungi to host. \\n the capability of t. \\n rubrum to adhere to epithelial cells is a trait to carbohydrate - specific adhesin on microconidia ( 12 ). \\n morphological observation detected the fibrillar projections in t. \\n mentagrophytes through the adherence stage ( 13, 14 ). in the current research various saprophytic fungi \\n actually, many of the fungal spores recovered from the skin can be found in the atmosphere. \\n the present study demonstrated the incidence of fungal flora on interdigital spaces of human foot. \\n the obtained results showed that fungi can survive on the surfaces of skin without showing the sign of infection.\"'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Summarize the given article into a concise abstract that highlights the key findings and conclusions.',\n",
       "  'input': 'Summarize the following article: oral glucose administration leads to greater insulin release from pancreatic islets than intravenous glucose loading that yields equivalent glucose levels . \\n gut hormonal substances released in response to glucose include the incretins , gastric inhibitory polypeptide ( gip ) and glucagonlike peptide1 ( glp1 ) , which are responsible for 5060% of postprandial insulin secretion . \\n gip is secreted on meal ingestion from kcells in the proximal small intestine , whereas glp1 is secreted from lcells in the distal small intestine and colon , and binds to their respective receptors ( gip receptor [ gipr ] and glp1 receptor ) on the surface of pancreatic cells to stimulate insulin secretion by increasing the intracellular adenosine 3,5monophosphate ( camp ) concentration . \\n the incretin effect has been shown to be reduced in type 2 diabetic subjects compared with those with normal glucose tolerance ( ngt ) in previous studies , suggesting that a reduced incretin effect might be associated with hyperglycemia after food intake and glucose loading in type 2 diabetes . when intravenous infusion of gip or glp1 was carried out in type 2 diabetic subjects , glp1 potentiated insulin secretion from pancreatic cells , but gip did not , showing that the gipr signal is downregulated in cells in type 2 diabetes . in studies using rodent models , it was reported that gipr mrna and protein expression levels in islets are decreased in the diabetic state . in contrast , in the nondiabetic obese state \\n the gip signal might be enhanced as a result of increased gipr sensitivity of cells to gip or increased gip secretion from kcells in the nondiabetic obese state . \\n indeed , gip concentrations are reported to be increased in obese rodent models and human subjects compared with those in lean rodents and human subjects , respectively . \\n furthermore , we have previously shown the hypersensitivity of gipr to gip in cells of high fatinduced obese mice . \\n plasma glp1 concentrations in type 2 diabetic patients are reported to be reduced after meal ingestion and glucose loading . however , in other studies it was reported that glp1 concentrations did not differ in ngt and type 2 diabetic subjects . \\n thus , the measurement of gip and glp1 concentrations in various metabolic states is important to evaluate the effects of incretin on insulin secretion . \\n insulin sensitivity in asian subjects has been shown to be higher than in mexican americans and caucasians in previous reports , which is partly as a result of the fact that asians , including japanese , are generally less obese . \\n furthermore , insulin secretion rather than insulin sensitivity is the more important factor in progression from ngt to diabetes in japanese subjects . \\n we have reported that earlyphase insulin secretion is considerably decreased , even in japanese ngt subjects with 1h plasma glucose ( pg ) levels during oral glucose tolerance test ( ogtt ) of more than 180  mg / dl . \\n thus , it is especially important to evaluate incretin secretion and determine the factors associated with incretin secretion in japanese ngt subjects , because gip and incretin is responsible for more than 50% of postprandial insulin secretion after glucose ingestion . \\n the factors responsible for incretin secretion have been reported in caucasian subjects , but have not been thoroughly elucidated in japanese subjects . in the present study , we evaluated gip and glp1 levels during ogtt and determined the factors involved in gip and glp1 secretion ( area under the curve [ auc ] of gip and glp1 during ogtt ) in japanese ngt subjects . \\n the subjects had no history of hypertension , hyperlipidemia or kidney and liver diseases , and did not take any drugs 2  weeks before the study . \\n the study was designed in compliance with the ethics regulations of the helsinki declaration and kyoto university . \\n blood samples for the measurement of liver and kidney function , hba1c , serum triglyceride ( tg ) , total cholesterol and highdensity lipoprotein ( hdl)cholesterol levels were drawn after an overnight fast . \\n all subjects received ogtt . after the subjects fasted overnight for 1016  h , standard ogtt with 75  g glucose was given according to the national diabetes data group recommendations . \\n blood samples were collected at 15 , 0 , 10 , 20 , 30 , 60 , 90 , 120 , 150 and 180  min after glucose loading and were centrifuged at 1800  g at 4c for 10  min . after collecting supernatant of the samples , plasma and serum \\n plasma gip , glp1 levels and the various parameters ( pg , serum immunoreactive insulin [ iri ] , serum cpeptide reactivity [ cpr ] , tg , serum free fatty acid [ ffa ] and plasma glucagon ) were measured at the indicated times ( plasma gip and glp1 levels were measured at 15 , 0 , 10 , 30 , 60 , 90 , 120 and 180  min after glucose loading , and plasma glucagon levels were measured at 15 , 0 , 30 , 60 , 90 , 120 and 180  min after glucose loading ) . the pg levels were measured by glucose oxidase method . \\n total gip and total glp1 levels were measured using human gip elisa kit ( linco research , st charles , mo , usa ; range of detection from 8.2  pg / ml to 2000  pg / dl ) and human glp1 elisa kit ( meso scale discovery , gaithersburg , md , usa ; range of detection from 2.4  pg / ml to 1,000,000  pg / dl ) , respectively , as previously described . \\n the auc of pg , iri , cpr , tg , ffa , glucagon , total gip ( aucgip ) and total glp1 ( aucglp1 ) were calculated . \\n we then analyzed the relationship between the auc of gip ( gip secretion ) and glp1 ( glp1 secretion ) and age , body mass index ( bmi ) and the parameters during ogtt . \\n basal insulin secretion and sensitivity were evaluated by homeostasis model assessment ( homa ) cell function and homeostasis model assessment of insulin resistance ( homair ) , respectively . \\n earlyphase insulin secretion and systemic insulin sensitivity during ogtt were evaluated by insulinogenic index and insulin sensitivity index ( isi ) composite . \\n the calculations of the four indices were as follows : equation \\n equation \\n equation \\n equation \\n  all analyses were carried out using statistical analysis software ( spss version 17.0 , ibm , somers , ny , usa ) system . \\n statistical analysis was carried out by anova with fisher s plsd test for changing levels of gip , glp1 , and the parameters during ogtt and differences between the two groups were assessed by unpaired ttest . \\n we used simple regression analysis to determine the relationship between aucgip or aucglp1 and the age , bmi and the parameters during ogtt , and we carried out multiple regression analysis to determine the factors most strongly associated with aucgip and aucglp1 , and the indices of insulin secretion and sensitivity . \\n the subjects had no history of hypertension , hyperlipidemia or kidney and liver diseases , and did not take any drugs 2  weeks before the study . \\n the study was designed in compliance with the ethics regulations of the helsinki declaration and kyoto university . \\n blood samples for the measurement of liver and kidney function , hba1c , serum triglyceride ( tg ) , total cholesterol and highdensity lipoprotein ( hdl)cholesterol levels were drawn after an overnight fast . \\n all subjects received ogtt . after the subjects fasted overnight for 1016  h , standard ogtt with 75  g glucose was given according to the national diabetes data group recommendations . \\n blood samples were collected at 15 , 0 , 10 , 20 , 30 , 60 , 90 , 120 , 150 and 180  min after glucose loading and were centrifuged at 1800  g at 4c for 10  min . after collecting supernatant of the samples , plasma and serum \\n plasma gip , glp1 levels and the various parameters ( pg , serum immunoreactive insulin [ iri ] , serum cpeptide reactivity [ cpr ] , tg , serum free fatty acid [ ffa ] and plasma glucagon ) were measured at the indicated times ( plasma gip and glp1 levels were measured at 15 , 0 , 10 , 30 , 60 , 90 , 120 and 180  min after glucose loading , and plasma glucagon levels were measured at 15 , 0 , 30 , 60 , 90 , 120 and 180  min after glucose loading ) . \\n total gip and total glp1 levels were measured using human gip elisa kit ( linco research , st charles , mo , usa ; range of detection from 8.2  pg / ml to 2000  pg / dl ) and human glp1 elisa kit ( meso scale discovery , gaithersburg , md , usa ; range of detection from 2.4  pg / ml to 1,000,000 \\n the auc of pg , iri , cpr , tg , ffa , glucagon , total gip ( aucgip ) and total glp1 ( aucglp1 ) were calculated . \\n we then analyzed the relationship between the auc of gip ( gip secretion ) and glp1 ( glp1 secretion ) and age , body mass index ( bmi ) and the parameters during ogtt . \\n basal insulin secretion and sensitivity were evaluated by homeostasis model assessment ( homa ) cell function and homeostasis model assessment of insulin resistance ( homair ) , respectively . \\n earlyphase insulin secretion and systemic insulin sensitivity during ogtt were evaluated by insulinogenic index and insulin sensitivity index ( isi ) composite . \\n the calculations of the four indices were as follows : equation \\n equation \\n equation \\n equation \\n  all analyses were carried out using statistical analysis software ( spss version 17.0 , ibm , somers , ny , usa ) system . \\n statistical analysis was carried out by anova with fisher s plsd test for changing levels of gip , glp1 , and the parameters during ogtt and differences between the two groups were assessed by unpaired ttest . \\n we used simple regression analysis to determine the relationship between aucgip or aucglp1 and the age , bmi and the parameters during ogtt , and we carried out multiple regression analysis to determine the factors most strongly associated with aucgip and aucglp1 , and the indices of insulin secretion and sensitivity . \\n mean age was 31.7    1.3  years and mean bmi was 23.1    0.9  kg / m . \\n hdl , highdensity lipoprotein ; homa , homeostasis model assessment ; homair , homeostasis model assessment of insulin resistance ; isi , insulin sensitivity index . \\n the levels of gip , glp1 , pg , iri , cpr , tg , ffa and glucagon after glucose loading were measured ( figure  1 ) . \\n the subjects were diagnosed ngt according to who criteria with fasting plasma glucose and 2h glucose levels below 6.1 and 7.8  mmol / l , respectively . \\n levels of pg , iri and cpr were significantly increased from 10  min after glucose loading compared with fasting level ( figure  1a  c ) . \\n ffa levels were significantly decreased from 10  min after glucose loading ( figure  1d ) . \\n glucagon levels were significantly decreased from 30  min after glucose loading ( figure  1f ) . \\n total gip levels were significantly increased from 10  min during ogtt ( figure  1 g ) . \\n total glp1 levels were significantly increased from 10  min during ogtt with peaks at 30 and 120  min ( figure  1h ) . \\n concentrations of ( a ) plasma glucose , ( b ) serum immunoreactive insulin , ( c ) serum cpeptide reactivity ( cpr ) , ( d ) serum free fatty acid ( ffa ) , ( e ) serum triglyceride ( tg ) , ( f ) glucagon , ( g ) total gastric inhibitory polypeptide ( gip ) and ( h ) total glucagonlike peptide1 ( glp1 ) during oral glucose tolerance test in 17 japanese subjects . \\n mean    se , * p  <  0.05 , * * p  <  0.01 , * * \\n we analyzed the relationship between aucgip or aucglp1 and age , bmi and the several parameters ( auc of pg , iri , cpr , tg , ffa and glucagon ) . \\n aucgip were positively related to bmi and auc of cpr , iri and glucagon , but aucglp1 was not related to these factors ( figure  2a  c ; auc data of iri during ogtt are not shown ; p  <  0.05 ) . \\n in contrast , aucglp1 was inversely related to auc of pg ( figure  2d ) , but aucgip was not . \\n simple regression analysis of gastric inhibitory polypeptide secretion ( aucgip ) and ( a ) body mass index ( bmi ) , ( b ) auc of serum cpeptide reactivity ( cpr ) and ( c ) glucagon . \\n ( d ) simple regression analysis of glucagonlike peptide1 secretion ( aucglp1 ) and auc of plasma glucose ( pg ) . \\n we then analyzed the relationship between aucgip or aucglp1 and indices of insulin secretion and insulin sensitivity . \\n aucgip was positively related to insulinogenic index and homair , whereas aucglp1 was positively related to homa cell function ( figure  3a  c ) . \\n isi composite was not related to either aucgip or aucglp1 ( figure  3d ) . \\n in addition , multiple regression analysis was carried out to determine the factors strongly associated with aucgip and aucglp . \\n the insulinogenic index was the most strongly associated factor in aucgip ( correlation coefficients 0.56 , standardized  0.56 , p  <  0.05 ) of the four indices ; homa cell function was the strongest factor in aucglp1 ( homa cell function : correlation coefficients 0.524 , standardized  0.870 , p  <  0.01 , isi composite : correlation coefficients 0.063 , standardized  0.581 , p  <  0.05 ) \\n .  relationship between gastric inhibitory polypeptide secretion ( aucgip ) and glucagonlike peptide1 secretion ( aucglp1 ) and the indices of insulin secretion and insulin sensitivity . \\n ( a ) insulinogenic index , ( b ) homeostasis model assessment ( homa ) cell function , ( c ) homeostasis model assessment of insulin resistance ( homair ) and ( d ) insulin sensitivity index ( isi ) composite . \\n in the present study , we estimated the incretin level after glucose loading in japanese ngt subjects and found that plasma gip and glp1 levels during ogtt are related to different factors . \\n incretin action of gip is reduced in the diabetic state as a result of decreased gip receptor expression on pancreatic cells , whereas gip signaling is enhanced and maintains glucose homeostasis by compensatory increased insulin secretion in the obese state . in some human studies in caucasians , plasma gip levels \\n are increased in obese subjects and there is a positive relationship between aucgip and auc of ffa during ogtt . in the present study , aucgip after glucose loading \\n was not associated with auc of ffa , but was positively associated with bmi , homair , and auc of iri and cpr after glucose loading . \\n in fact , obese subjects are known to have hyperinsulinemia and insulin resistance , and bmi was strongly associated with auc of iri and cpr . \\n thus , gip secretion from kcells may well be associated with insulin resistance to maintain postprandial hyperinsulinemia in japanese ngt subjects . \\n it might be explained by the fact that gip secretion is associated with the amount of glucose loading , whereas blood glucose levels are maintained within normal levels by gipinduced compensatory insulin secretion in ngt subjects . \\n glp1 secretions of type 2 diabetes subjects after glucose or meal ingestion are diverse in human studies . \\n recently , it is reported that glp1 levels after ingestion of glucose and mix meal in japanese type 2 diabetic subjects were not decreased compared with those in ngt subjects , suggesting that glp1 secretion is not decreased in japanese type 2 diabetes . \\n two studies of caucasian subjects found that aucglp1 during ogtt is positively associated with age and auc of glucagon , whereas auc of glp1 is negatively associated with bmi or bodyweight and auc of ffa . in the present study , aucglp1 was negatively related to auc of pg during ogtt , showing that the increase in glp1 secretion after glucose loading is associated with a decrease in postprandial glucose levels in japanese ngt subjects . \\n it has been reported that glp1 levels after glucose loading are positively related to gastric empting in caucasian subjects . \\n although we did not measure gastric empting of the subjects in the present study , increasing glp1 secretion after glucose loading might decrease postprandial glucose levels through gastric emptying . in the present study , \\n however , because japanese subjects are less obese than caucasian subjects , the difference observed in the relationship between aucgip and glp1 , and auc of ffa might reflect this ethnic difference in caucasians and japanese . \\n insulin secretion , rather than insulin sensitivity , is the more important factor in the progression from ngt to type 2 diabetes in japanese patients . because incretin is an intestinal hormone that induces postprandial insulin secretion \\n , we hypothesize that gip and glp1 secretion is more crucial in japanese subjects than in caucasian subjects . \\n indeed , glp1 mimetics and dpp4 inhibitors improve glycemic control better in japanese type 2 diabetic patients than in caucasian type 2 diabetic patients in clinical trials . \\n we therefore evaluated the correlation between gip secretion ( aucgip ) and glp1 secretion ( aucglp1 ) , and the indices of insulin secretion and insulin sensitivity in japanese ngt subjects during ogtt . \\n the values of homa cell , insulinogenic index , homair and isi composite were similar to those in previous studies of japanese subjects . \\n aucgip was positively associated with the insulinogenic index and homair , and the insulinogenic index was strongly associated with aucgip , whereas aucglp1 was associated only with homa cell among the four indices . \\n it has been reported that earlyphase insulin secretion is an important factor in the progression from ngt through impaired glucose tolerance ( igt ) to type 2 diabetes , and that basal insulin secretion ( homa cell ) and insulin resistance are important factors in the progression from ngt through impaired fasting glucose ( ifg ) to type 2 diabetes in japanese patients . \\n thus , enhancing the gip and glp1 signals might be particularly useful in inhibiting the progression of type 2 diabetes in japanese patients . \\n recently , variants at the gip receptor gene locus associated with 2h glucose levels during ogtt were identified by metaanalysis of genomewide association studies . in subjects who carry this gip receptor risk allele , \\n these data seem to support our results that gip secretion is associated with insulinogenic index in japanese ngt subjects . in conclusion , we evaluated plasma gip and glp1 levels during ogtt in japanese ngt subjects . \\n glp1 secretion was associated with pg during ogtt , and basal insulin secretion ( homa cell ) and gip secretion was associated with bmi and earlyphase insulin secretion ( insulinogenic index ) . \\n thus , there might be different factors associated with gip and glp1 secretion during ogtt in japanese subjects .',\n",
       "  'output': 'abstractaims / introduction :   gastric inhibitory polypeptide ( gip ) and glucagonlike peptide1 ( glp1 ) are major incretins that potentiate insulin secretion from pancreatic cells . \\n the factors responsible for incretin secretion have been reported in caucasian subjects , but have not been thoroughly evaluated in japanese subjects . \\n we evaluated the factors associated with incretin secretion during oral glucose tolerance test ( ogtt ) in japanese subjects with normal glucose tolerance ( ngt).materials and methods :   we measured plasma gip and glp1 levels during ogtt in 17 japanese ngt subjects and evaluated the factors associated with gip and glp1 secretion using simple and multiple regression analyses.results :   gip secretion ( aucgip ) was positively associated with body mass index ( p  <  0.05 ) , and area under the curve ( auc ) of cpeptide ( p  <  0.05 ) and glucagon ( p  <  0.01 ) , whereas glp1 secretion ( aucglp1 ) was negatively associated with auc of plasma glucose ( p  <  0.05 ) . \\n the insulinogenic index was most strongly associated with gip secretion ( p  <  0.05 ) ; homeostasis model assessment cell was the most the strongly associated factor in glp1 secretion ( p  <  0.05 ) among the four indices of insulin secretion and insulin sensitivity.conclusions :   several distinct factors might be associated with gip and glp1 secretion during ogtt in japanese subjects . \\n ( j diabetes invest , doi : 10.1111/j.20401124.2010.00078.x , 2011 )',\n",
       "  '__index_level_0__': 31694,\n",
       "  'model_output': 'summary : oral glucose administration leads to greater insulin release from pancreatic islets than intravenous glucose loading that yields equivalent glucose levels. \\n gut hormonal substances released in response to glucose include the incretins, gastric inhibitory polypeptide ( gip ) and glucagonlike peptide1 ( glp1 ), which are responsible for 5060% of postprandial insulin secretion. \\n gip is secreted on meal ingestion from kcells in the proximal small intestine, whereas glp1 is secreted from lcells in the distal small intestine and colon, and binds to their respective receptors ( gip receptor [ gipr ] and glp1 receptor ) on the surface of pancreatic cells to stimulate insulin secretion by increasing the intracellular adenosine 3,5monophosphate ( camp ) concentration. \\n the incretin effect has been shown to be reduced in type 2 diabetic subjects compared with those with normal glucose tolerance ( ngt ) in previous studies, suggesting that a reduced incretin effect might be associated with hyperglycemia after food intake and glucose loading in type 2 diabetes. when intravenous infusion of gip or glp1 was carried out in type 2 diabetic subjects, glp1 potentiated insulin secretion from pancreatic cells, but gip did not, showing that the gipr signal is downregulated in cells in type 2 diabetes. in studies using rodent models, it was reported that gipr mrna and protein expression levels in islets are decreased in the diabetic state. in contrast, in the nondiabetic obese state \\n the gip signal might be enhanced as a result of increased gipr sensitivity of cells to gip or increased gip secretion from kcells in the nondiabetic obese state. \\n indeed, gip concentrations are reported to be increased in obese rodent models and human subjects compared with those in lean rodents and human subjects, respectively. \\n furthermore, we have previously shown the hypersensitivity of gipr to gip in cells of high fatinduced obese mice. \\n plasma glp1 concentrations in type 2 diabetic patients are reported to be reduced after meal ingestion and glucose loading. however, in other studies it was reported that glp1 concentrations did not differ in ngt and type 2 diabetic subjects. \\n thus, the measurement of gip and glp1 concentrations in various metabolic states is important to evaluate the effects of incretin on insulin secretion. \\n insulin sensitivity in asian subjects has been shown to be higher than in mexican americans and caucasians in previous reports, which is partly as a result of the fact that asians, including japanese, are generally less obese. \\n furthermore, insulin secretion rather than insulin sensitivity is the more important factor in progression from ngt to diabetes in japanese subjects. \\n we have reported that earlyphase insulin secretion is considerably decreased, even in japanese ngt subjects with 1h plasma glucose ( pg ) levels during oral glucose tolerance test ( ogtt ) of more than 180  mg / dl. \\n thus, it is especially important to evaluate incretin secretion and determine the factors associated with incretin secretion in japanese ngt subjects, because gip and incretin is responsible for more than 50% of postprandial insulin secretion after glucose ingestion. \\n the factors responsible for incretin secretion have been reported in caucasian subjects, but have not been thoroughly elucidated in japanese subjects. in the present study, we evaluated gip and glp1 levels during ogtt and determined the factors involved in gip and glp1 secretion ( area under the curve [ auc ] of gip and glp1 during ogtt ) in japanese ngt subjects. \\n the subjects had no history of hypertension, hyperlipidemia or kidney and liver diseases, and did not take any drugs 2  weeks before the study. \\n the study was designed in compliance with the ethics regulations of the helsinki declaration and kyoto university. \\n blood samples for the measurement of liver and kidney function, hba1c, serum triglyceride ( tg ), total cholesterol and highdensity lipoprotein ( hdl)cholesterol levels were drawn after an overnight fast. \\n all subjects received ogtt. after the subjects fasted overnight for 1016  h, standard ogtt with 75  g glucose was given according to the national diabetes data group recommendations. \\n blood samples were collected at 15, 0, 10, 20, 30, 60, 90, 120, 150 and 180  min after glucose loading and were centrifuged at 1800  g at 4c for 10  min. after collecting supernatant of the samples, plasma and serum \\n plasma gip, glp1 levels and the various parameters ( pg, serum immunoreactive insulin [ iri ], serum cpeptide reactivity [ cpr ], tg, serum free fatty acid [ ffa ] and plasma glucagon ) were measured at the indicated times ( plasma gip and glp1 levels were measured at 15, 0, 10, 30, 60, 90, 120 and 180  min after glucose loading, and plasma glucagon levels were measured at 15, 0, 30, 60, 90, 120 and 180  min after glucose loading ). the pg levels were measured by glucose oxidase method. \\n total gip and total glp1 levels were measured using human gip elisa kit ( linco research, st charles, mo, usa ; range of detection from 8.2  pg / ml to 2000  pg / dl ) and human glp1 elisa kit ( meso scale discovery, gaithersburg, md, usa ; range of detection from 2.4  pg / ml to 1,000,000  pg / dl ), respectively, as previously described. \\n the auc of pg, iri, cpr, tg, ffa, glucagon, total gip ( aucgip ) and total glp1 ( aucglp1 ) were calculated. \\n we then analyzed the relationship between the auc of gip ( gip secretion ) and glp1 ( glp1 secretion ) and age, body mass index ( bmi ) and the parameters during ogtt. \\n basal insulin secretion and sensitivity were evaluated by homeostasis model assessment ( homa ) cell function and homeostasis model assessment of insulin resistance ( homair ), respectively. \\n earlyphase insulin secretion and systemic insulin sensitivity during ogtt were evaluated by insulinogenic index and insulin sensitivity index ( isi ) composite. \\n the calculations of the four indices were as follows : equation \\n equation \\n equation \\n equation \\n  all analyses were carried out using statistical analysis software ( spss version 17.0, ibm, somers, ny, usa ) system. \\n statistical analysis was carried out by anova with fisher s plsd test for changing levels of gip, glp1, and the parameters during ogtt and differences between the two groups were assessed by unpaired ttest. \\n we used simple regression analysis to determine the relationship between aucgip or aucglp1 and the age, bmi and the parameters during ogtt, and we carried out multiple regression analysis to determine the factors most strongly associated with aucgip and aucglp1, and the indices of insulin secretion and sensitivity. \\n the subjects had no history of hypertension, hyperlipidemia or kidney and liver diseases, and did not take any drugs 2  weeks before the study. \\n the study was designed in compliance with the ethics regulations of the helsinki declaration and kyoto university. \\n blood samples for the measurement of liver and kidney function, hba1c, serum triglyceride ( tg ), total cholesterol and highdensity lipoprotein ( hdl)cholesterol levels were drawn after an overnight fast. \\n all subjects received ogtt. after the subjects fasted overnight for 1016  h, standard ogtt with 75  g glucose was given according to the national diabetes data group recommendations. \\n blood samples were collected at 15, 0, 10, 20, 30, 60, 90, 120, 150 and 180  min after glucose loading and were centrifuged at 1800  g at 4c for 10  min. after collecting supernatant of the samples, plasma and serum \\n plasma gip, glp1 levels and the various parameters ( pg, serum immunoreactive insulin [ iri ], serum cpeptide reactivity [ cpr ], tg, serum free fatty acid [ ffa ] and plasma glucagon ) were measured at the indicated times ( plasma gip and glp1 levels were measured at 15, 0, 10, 30, 60, 90, 120 and 180  min after glucose loading, and plasma glucagon levels were measured at 15, 0, 30, 60, 90, 120 and 180  min after glucose loading ). \\n total gip and total glp1 levels were measured using human gip elisa kit ( linco research, st charles, mo, usa ; range of detection from 8.2  pg / ml to 2000  pg / dl ) and human glp1 elisa kit ( meso scale discovery, gaithersburg, md, usa ; range of detection from 2.4  pg / ml to 1,000,000 \\n the auc of pg, iri, cpr, tg, ffa, glucagon, total gip ( aucgip ) and total glp1 ( aucglp1 ) were calculated. \\n we then analyzed the relationship between the auc of gip ( gip secretion ) and glp1 ( glp1 secretion ) and age, body mass index ( bmi ) and the parameters during ogtt. \\n basal insulin secretion and sensitivity were evaluated by homeostasis model assessment ( homa ) cell function and homeostasis model assessment of insulin resistance ( homair ), respectively. \\n earlyphase insulin secretion and systemic insulin sensitivity during ogtt were evaluated by insulinogenic index and insulin sensitivity index ( isi ) composite. \\n the calculations of the four indices were as follows : equation \\n equation \\n equation \\n equation \\n  all analyses were carried out using statistical analysis software ( spss version 17.0, ibm, somers, ny, usa ) system. \\n statistical analysis was carried out by anova with fisher s plsd test for changing levels of gip, glp1, and the parameters during ogtt and differences between the two groups were assessed by unpaired ttest. \\n we used simple regression analysis to determine the relationship between aucgip or aucglp1 and the age, bmi and the parameters during ogtt, and we carried out multiple regression analysis to determine the factors most strongly associated with aucgip and aucglp1, and the indices of insulin secretion and sensitivity. \\n mean age was 31.7    1.3  years and mean bmi was 23.1    0.9  kg / m. \\n hdl, highdensity lipoprotein ; homa, homeostasis model assessment ; homair, homeostasis model assessment of insulin resistance ; isi, insulin sensitivity index. \\n the levels of gip, glp1, pg, iri, cpr, tg, ffa and glucagon after glucose loading were measured ( figure  1 ). \\n the subjects were diagnosed ngt according to who criteria with fasting plasma glucose and 2h glucose levels below 6.1 and 7.8  mmol / l, respectively. \\n levels of pg, iri and cpr were significantly increased from 10  min after glucose loading compared with fasting level ( figure  1a  c ). \\n ffa levels were significantly decreased from 10  min after glucose loading ( figure  1d ). \\n glucagon levels were significantly decreased from 30  min after glucose loading ( figure  1f ). \\n total gip levels were significantly increased from 10  min during ogtt ( figure  1 g ). \\n total glp1 levels were significantly increased from 10  min during ogtt with peaks at 30 and 120  min ( figure  1h ). \\n concentrations of ( a ) plasma glucose, ( b ) serum immunoreactive insulin, ( c ) serum cpeptide reactivity ( cpr ), ( d ) serum free fatty acid ( ffa ), ( e ) serum triglyceride ( tg ), ( f ) glucagon, ( g ) total gastric inhibitory polypeptide ( gip ) and ( h ) total glucagonlike peptide1 ( glp1 ) during oral glucose tolerance test in 17 japanese subjects. \\n mean    se, * p  <  0.05, * * p  <  0.01, * * \\n we analyzed the relationship between aucgip or aucglp1 and age, bmi and the several parameters ( auc of pg, iri, cpr, tg, ffa and glucagon ). \\n aucgip were positively related to bmi and auc of cpr, iri and glucagon, but aucglp1 was not related to these factors ( figure  2a  c ; auc data of iri during ogtt are not shown ; p  <  0.05 ). \\n in contrast, aucglp1 was inversely related to auc of pg ( figure  2d ), but aucgip was not. \\n simple regression analysis of gastric inhibitory polypeptide secretion ( aucgip ) and ( a ) body mass index ( bmi ), ( b ) auc of serum cpeptide reactivity ( cpr ) and ( c ) glucagon. \\n ( d ) simple regression analysis of glucagonlike peptide1 secretion ( aucglp1 ) and auc of plasma glucose ( pg ). \\n we then analyzed the relationship between aucgip or aucglp1 and indices of insulin secretion and insulin sensitivity. \\n aucgip was positively related to insulinogenic index and homair, whereas aucglp1 was positively related to homa cell function ( figure  3a  c ). \\n isi composite was not related to either aucgip or aucglp1 ( figure  3d ). \\n in addition, multiple regression analysis was carried out to determine the factors strongly associated with aucgip and aucglp. \\n the insulinogenic index was the most strongly associated factor in aucgip ( correlation coefficients 0.56, standardized  0.56, p  <  0.05 ) of the four indices ; homa cell function was the strongest factor in aucglp1 ( homa cell function : correlation coefficients 0.524, standardized  0.870, p  <  0.01, isi composite : correlation coefficients 0.063, standardized  0.581, p  <  0.05 ) \\n.  relationship between gastric inhibitory polypeptide secretion ( aucgip ) and glucagonlike peptide1 secretion ( aucglp1 ) and the indices of insulin secretion and insulin sensitivity. \\n ( a ) insulinogenic index, ( b ) homeostasis model assessment ( homa ) cell function, ( c ) homeostasis model assessment of insulin resistance ( homair ) and ( d ) insulin sensitivity index ( isi ) composite. \\n in the present study, we estimated the incretin level after glucose loading in japanese ngt subjects and found that plasma gip and glp1 levels during ogtt are related to different factors. \\n incretin action of gip is reduced in the diabetic state as a result of decreased gip receptor expression on pancreatic cells, whereas gip signaling is enhanced and maintains glucose homeostasis by compensatory increased insulin secretion in the obese state. in some human studies in caucasians, plasma gip levels \\n are increased in obese subjects and there is a positive relationship between aucgip and auc of ffa during ogtt. in the present study, aucgip after glucose loading \\n was not associated with auc of ffa, but was positively associated with bmi, homair, and auc of iri and cpr after glucose loading. \\n in fact, obese subjects are known to have hyperinsulinemia and insulin resistance, and bmi was strongly associated with auc of iri and cpr. \\n thus, gip secretion from kcells may well be associated with insulin resistance to maintain postprandial hyperinsulinemia in japanese ngt subjects. \\n it might be explained by the fact that gip secretion is associated with the amount of glucose loading, whereas blood glucose levels are maintained within normal levels by gipinduced compensatory insulin secretion in ngt subjects. \\n glp1 secretions of type 2 diabetes subjects after glucose or meal ingestion are diverse in human studies. \\n recently, it is reported that glp1 levels after ingestion of glucose and mix meal in japanese type 2 diabetic subjects were not decreased compared with those in ngt subjects, suggesting that glp1 secretion is not decreased in japanese type 2 diabetes. \\n two studies of caucasian subjects found that aucglp1 during ogtt is positively associated with age and auc of glucagon, whereas auc of glp1 is negatively associated with bmi or bodyweight and auc of ffa. in the present study, aucglp1 was negatively related to auc of pg during ogtt, showing that the increase in glp1 secretion after glucose loading is associated with a decrease in postprandial glucose levels in japanese ngt subjects. \\n it has been reported that glp1 levels after glucose loading are positively related to gastric empting in caucasian subjects. \\n although we did not measure gastric empting of the subjects in the present study, increasing glp1 secretion after glucose loading might decrease postprandial glucose levels through gastric emptying. in the present study, \\n however, because japanese subjects are less obese than caucasians, the difference observed in the relationship between aucgip and glp1, and auc of ffa might reflect this ethnic difference in caucasians and japanese. \\n insulin secretion, rather than insulin sensitivity, is the more important factor in the progression from ngt to type 2 diabetes in japanese patients. because incretin is an intestinal hormone that induces postprandial insulin secretion \\n, we hypothesize that gip and glp1 secretion is more crucial in japanese subjects than in caucasian subjects. \\n indeed, glp1 mimetics and dpp4 inhibitors improve glycemic control better in japanese type 2 diabetic patients than in caucasian type 2 diabetic patients in clinical trials. \\n we therefore evaluated the correlation between gip secretion ( aucgip ) and glp1 secretion ( aucglp1 ), and the indices of insulin secretion and insulin sensitivity in japanese ngt subjects during ogtt. \\n the values of homa cell, insulinogenic index, homair and isi composite were similar to those in previous studies of japanese subjects. \\n aucgip was positively associated with the insulinogenic index and homair, and the insulinogenic index was strongly associated with aucgip, whereas aucglp1 was associated only with homa cell among the four indices. \\n it has been reported that earlyphase insulin secretion is an important factor in the progression from ngt through impaired glucose tolerance ( igt ) to type 2 diabetes, and that basal insulin secretion ( homa cell ) and insulin resistance are important factors in the progression from ngt through impaired fasting glucose ( ifg ) to type 2 diabetes in japanese patients. \\n thus, enhancing the gip and glp1 signals might be particularly useful in inhibiting the progression of type 2 diabetes in japanese patients. \\n recently, variants at the gip receptor gene locus associated with 2h glucose levels during ogtt were identified by metaanalysis of genomewide association studies. in subjects who carry this gip receptor risk allele, \\n these data seem to support our results that gip secretion is associated with insulinogenic index in japanese ngt subjects. in conclusion, we evaluated plasma gip and glp1 levels during ogtt in japanese ngt subjects. \\n glp1 secretion was associated with pg during ogtt, and basal insulin secretion ( homa cell ) and gip secretion was associated with bmi and earlyphase insulin secretion ( insulinogenic index ). \\n thus, there might be different factors associated with gip and glp1 secretion during ogtt in japanese subjects.'},\n",
       " {'dataset': 'pubmed',\n",
       "  'split_data': 'test',\n",
       "  'task': 'summarization',\n",
       "  'instruction': 'Generate a brief and coherent abstract from the provided article text.',\n",
       "  'input': \"Summarize the following article: there are similarities between children and adults suffering from heart failure ( hf ) , such as the preferred pharmacological treatment ( 1 ) , the use of pace - makers and heart transplants ( 2,3 ) , the inability of the patient to reach the predicted heart rate for the patient 's age during cardiopulmonary exercise testing ( 4,5 ) , and the ergoespirometric response under similar clinical conditions ( 5 ) . in adults , \\n endothelial dysfunction is related to the development of diastolic dysfunction ( 6,7 ) , chagas disease , left ventricular hypertrophy ( 8) , ischemic cardiomyopathy , hf ( 8,9 ) , obesity , type 1 diabetes , hyperlipidemia , arterial hypertension ( 10 ) , peripheral arterial disease , chronic kidney disease ( 11 ) and atherosclerosis ( 12 ) because the dysfunction predisposes the vasculature to vasoconstriction , leukocyte adherence , platelet activation , and vascular inflammation ( 13 ) . \\n nevertheless , there is a lack of data regarding endothelial function in children with cardiomyopathy . \\n the severity of endothelial dysfunction is related to the cardiovascular risk ( 14 ) , the severity of cardiovascular symptoms ( 15 ) , and the inability to exercise ( 11 ) and represents a predictor for cardiac transplant and death ( 16 ) . \\n it is known that diseases , such as kawasaki 's disease ( 8) , hyperlipidemia ( 10 ) , obesity , and type 1 diabetes , play important roles in systemic inflammation and endothelial dysfunction ( 17 ) . \\n these diseases may increase the likelihood of cardiovascular events ( 18 ) and may predispose children to the development of cardiomyopathy . based on these considerations , we reviewed the published literature on endothelial function in pre - pubertal children to evaluate the endothelial function in pre - pubertal children with cardiomyopathy or children at risk of developing cardiomyopathy , and we conducted an analysis of the data from the relevant studies . \\n this analysis was undertaken to help clarify the role of endothelial impairment in children at risk of suffering from cardiomyopathy . \\n endothelial function can be analyzed by noninvasive methods , including ultrasonography ( us ) ( 19 ) and peripheral artery tonometry ( pat ) ( 20 ) . during a us examination , the baseline rest image of the subject 's brachial artery \\n is acquired , and a 5-min arterial occlusion is performed using cuff inflation to at least 50 mm hg suprasystolic pressure . \\n the subsequent cuff deflation induces reactive hyperemia that results in an increase in flow or , more precisely , shear stress by dilating the brachial artery ; this phenomenon is designated flow - mediated dilatation ( fmd ) . after returning to the baseline , a second brachial artery image is recorded after the administration of nitroglycerine ( ntg ) ; this image corresponds to the contribution of the intima muscle relaxation to the dilation and is known as the endothelium - independent vasodilatation ( 19 ) . \\n in contrast to us , the pat evaluation is a method that does not require the administration of drugs , and it combines the assessment of the flow - mediated dilatation after the same 5-min arterial cuff occlusion , with the arterial pulse wave amplitude measurement taken using a pneumatic fingertip probe ( 20 ) . \\n a search of the pubmed , bireme , and scielo databases was conducted to perform a systematic review , according to the recommendations of prisma ( 21 ) . \\n the search was performed using the following keywords : endothelial , child , pediatrics , and infant . \\n the results were limited to human studies published in english , spanish , and portuguese . \\n the initial selection was based on the title and abstract , and those deemed relevant were retained for further analysis . \\n the exclusion criteria included the following : analyses of the endothelial function in animals , cadavers , adolescents or adults ; reviews ; analyses of either the coronary or pulmonary arteries or the neurological or osteomuscular systems ; if the patients had rheumatic , oncohematological , splenic or hepatic diseases ; or if the studies were trials related to markers , genetics and interventions . \\n the list of potential trials to include was verified by the authors of the present study . \\n we note that there may be a risk of bias across the studies because not all of the trials published have been indexed in the selected databases . \\n the following data were collected for analysis : the number of patients enrolled in the study ; the patient 's age ; whether sexual maturity had been reached ; any diseases involved ; the protocol used for the endothelial function evaluation and the fmd , ntg , and pat values . collected data in all tables were expressed following disease order , in order to better clarify data presentation and analysis . \\n the values of endothelial function were expressed as the mean  standard deviation ( sd ) , as collected from the original trials . \\n the data from healthy children were compared with the data for unhealthy children , and the differences were analyzed using the student t - test . \\n a total of 559 articles were retrieved after the preliminary search , and 21 articles were considered potentially relevant based on the title and abstract . \\n a careful analysis of these articles was performed , and ten trials were excluded for several reasons . \\n table 1 presents the general descriptions of the included studies and provides information regarding the participants , their ages , their diseases , the endothelial evaluation method used and whether there were differences between genders ( table 1 ) . \\n all eleven of the selected studies provided data for healthy children for comparison , and , with the exception of one study ( 22 ) , all of the studies compared healthy children to ill children . \\n four of the studies evaluated obese children ( 23 - 26 ) , one evaluated children with obesity and type 1 diabetes ( 27 ) , three studied children with type 1 diabetes ( 28 - 30 ) , and two evaluated children with kawasaki 's disease ( 31 - 32 ) . \\n these reviewed studies reported a mean age of 9.81.8 years old , and only four articles investigated the sexual maturation of the group of pre - pubertal children ( 23,25,26,29 ) . \\n forty - five percent of all of the studies found no difference in the endothelial function between genders , and 55% of the reports did not provide these data ( table 1 ) . \\n most of the studies used ultrasound to determine the percent diameter changes for the fmd and ntg assessments ( 22 - 29,31,32 ) . \\n only one study used reactive hyperemia  peripheral artery tonometry ( rh - pat ) for the same purpose ( 30 ) , showing that the endothelial function was impaired in diabetic children relative to that in healthy children ( 1.630.5 vs. 1.950.3 for diabetic children vs. healthy children ) ( 30 ) . \\n the fmd response values from all of the other articles for obese and diabetic children were significantly lower than those for healthy children ( 5.91.29% for obese children , 4.50.7% for diabetic children , and 9.81.8% for healthy children ; p<0.0008 ) . \\n the obese children had a 39% lower fmd response than the healthy children , and the diabetic children had a decrease in their fmd of 25% ( table 2 ) . \\n the children with kawasaki 's disease had 27% lower fmd responses than the healthy children ( 7.11.27% vs. 9.81.8% , respectively ) , but this difference was not statistically significant ( p  =  0.26 ) . \\n the fmd data for the obese children , diabetic children , and children with kawasaki 's disease exhibited no statistically significant differences ( p<0.38 ) ( table 2 ) . \\n the ntg response ( table 2 ) also showed no significant difference among the groups ( 22.77.1% for healthy children , 19.62.0% for obese children and \\n 16.65.9% for diabetic children ; p<0.19 ) . among the excluded studies , one contained no data on endothelial function ( 33 ) , and most of the excluded studies did not list the data for pre - pubertal children , post - pubertal children ( 34 - 39 ) and adults ( 40,41 ) separately . \\n another study ( 42 ) published data for the same patients as used in a previously published study ( 32 ) . \\n ultrasound is the most frequently used method to evaluate endothelial function because it has a low cost , is safe and is sufficiently reproducible . however , some limitations of this method are that the fmd response can be influenced by both temperature and age , and ultrasound requires drug administration and the recording of images for posterior analysis ( 19 ) . \\n another technique for the assessment of endothelial function is the pat method , which has been proposed to be more practical and precise ( 20 ) , and pat results are moderately significantly correlated with us results ( 43 ) . \\n the pat method combines the traditional flow - mediated dilatation measurement with pneumatic fingertip probes to measure the arterial pulse wave amplitude ( 20 ) . \\n one study ( 31 ) chose pat over us and confirmed that diabetic children have endothelial dysfunction , as do adults ( 44,45 ) . in five studies ( 22,24,25,28,32 ) , the gender of the individual did not correlate with the endothelial function , as has been found for adults ( 60 ) and adolescents ( 61 ) . \\n pre - pubertal children show lower responses to beta - adrenergic receptors and have lower levels of circulating catecholamines ( adrenaline and noradrenaline ) than adolescents and adults ( 46 ) . \\n the obese children exhibit accelerated growth and , therefore , earlier puberty ( 47 ) , which is evidenced by an advancement of menarche by 2.2 years ( 11.2 vs. 13.4 years , respectively ) ( 48 ) because fat mass influences the levels of hormones ( 49,50 ) . \\n these data reinforce the need for the evaluation of sexual maturation in studies involving children . the extent of sexual maturation is widely accessed using the tanner - whitehouse scale , which is based on secondary sexual characteristics , such as breast development and menarche in girls , standards for penis development in boys , and pubic hair development in both sexes ( 51 ) . \\n this lack of sexual maturity assessment explains why those trials that combined information for children , adolescents ( 33 - 39 ) , and adults ( 40,41 ) were excluded in the present study and explains the elevated fmd data from one study ( 24 ) , which included a higher mean age of obese children of 124 years old . \\n the evaluation of sexual maturity also explains why three of the included studies ( 23,25,26 ) that assessed the pubertal stage by clinical examination yielded similar fmd data . \\n diabetic and obese individuals have hyperinsulinemia , and both diabetes and obesity are related to the higher hormone ( 50 ) and inflammation levels ( 52 ) that contribute to increased arterial stiffness and vascular lesions , which are related to both endothelial function and structural arterial changes ( 53 ) and may explain the endothelial dysfunction results for these groups ( 23 - 30 ) . \\n in addition to some methodological disparities , all of the studies showed significantly impaired endothelial function ( fmd response ) in the obese and diabetic children despite the lack of a difference in the ntg response , a result that was reported for adults ( 54 ) when compared with healthy subjects ( 55 ) . however , fmd impairment seems to be greater in adults than in children ( 44% in obese adults and 55% in diabetic adults ) ; similarly , adults show no difference in ntg responses ( 54,56 ) . \\n the collected fmd values in children with kawasaki 's disease are lower than those in healthy children ( 31,32 ) , which can indicate a low , but persistent , level of inflammation ( 57 ) , as evidenced by higher c - reactive protein ( crp ) levels ( 52,53,58 ) . \\n only one study ( 32 ) included ntg data , and this lack of data limits the discussion of the information provided . \\n the fmd values suggest that the major dysfunctions in these children occur as a result of the local nitric oxide ( no ) bioavailability in the endothelium ( no production ) because the shear stress induced by reactive hyperemia activates endothelial no production ( 59 ) . \\n the ntg response also suggests that the vascular smooth muscle cell function is preserved ( 19 ) . yet , one study showed significantly lower gt values in obese children than in healthy children ( 27 ) , and two other studies did not publish values for the ntg response ( 22,24 ) . some reports ( 20,25,28 ) \\n did not describe how long the subjects were at rest , according to corretti et al . \\n ( 22 ) , > 10 min is recommended , between the collections of the fmd and ntg response images , which might have contributed to the reported outcomes . \\n it is also worth noting that three of the trials ( 24,27,29 ) allowed the arteries to return to the basal condition and that two of these studies ( 24,29 ) did not yield statistically significant data . in spite of the statistically significant differences in some of the endothelial function responses , the number of trials regarding this subject remains limited . \\n another limitation of the data search for pre - pubertal children is that the studies list the results for adults , teenagers , and children together , and do not divide the data by group according to the puberty state and age . \\n the small number of studies in children may also be due to the use of the us method because drug administration is required . however , the new method of endothelial function evaluation , the pat method , might help increase the number of trials using this population . \\n although endothelial dysfunction has been identified in adults as a predictor of cardiac transplant and death , the clinical implications of endothelial dysfunction were not presented in the selected trials , nor were they the focus of the current study ; however , this correlation should be further evaluated in children . \\n lastly , even though the number of pre - pubertal children with endothelial dysfunction is unknown , there is a great number of children who suffer from this condition . \\n thus , the barriers in the pediatric field must be broken , and more studies on this topic should be performed to understand this population better . in conclusion , \\n endothelial function is an important clinical feature because it may indicate the severity of cardiovascular symptoms , prognosis , and mortality . \\n children at risk of developing cardiomyopathy exhibit endothelial dysfunction ; however , the prevalence of endothelial dysfunction in cardiomyopathic children remains unknown because of the lack of data . \\n we suggest that attention should be paid to the consequences of endothelial function in this group . \\n a search of the pubmed , bireme , and scielo databases was conducted to perform a systematic review , according to the recommendations of prisma ( 21 ) . \\n the search was performed using the following keywords : endothelial , child , pediatrics , and infant . \\n the results were limited to human studies published in english , spanish , and portuguese . \\n the initial selection was based on the title and abstract , and those deemed relevant were retained for further analysis . \\n the exclusion criteria included the following : analyses of the endothelial function in animals , cadavers , adolescents or adults ; reviews ; analyses of either the coronary or pulmonary arteries or the neurological or osteomuscular systems ; if the patients had rheumatic , oncohematological , splenic or hepatic diseases ; or if the studies were trials related to markers , genetics and interventions . \\n the list of potential trials to include was verified by the authors of the present study . \\n we note that there may be a risk of bias across the studies because not all of the trials published have been indexed in the selected databases . \\n the following data were collected for analysis : the number of patients enrolled in the study ; the patient 's age ; whether sexual maturity had been reached ; any diseases involved ; the protocol used for the endothelial function evaluation and the fmd , ntg , and pat values . collected data in all tables were expressed following disease order , in order to better clarify data presentation and analysis . \\n the values of endothelial function were expressed as the mean  standard deviation ( sd ) , as collected from the original trials . \\n the data from healthy children were compared with the data for unhealthy children , and the differences were analyzed using the student t - test . \\n a total of 559 articles were retrieved after the preliminary search , and 21 articles were considered potentially relevant based on the title and abstract . \\n a careful analysis of these articles was performed , and ten trials were excluded for several reasons . \\n table 1 presents the general descriptions of the included studies and provides information regarding the participants , their ages , their diseases , the endothelial evaluation method used and whether there were differences between genders ( table 1 ) . \\n all eleven of the selected studies provided data for healthy children for comparison , and , with the exception of one study ( 22 ) , all of the studies compared healthy children to ill children . \\n four of the studies evaluated obese children ( 23 - 26 ) , one evaluated children with obesity and type 1 diabetes ( 27 ) , three studied children with type 1 diabetes ( 28 - 30 ) , and two evaluated children with kawasaki 's disease ( 31 - 32 ) . \\n these reviewed studies reported a mean age of 9.81.8 years old , and only four articles investigated the sexual maturation of the group of pre - pubertal children ( 23,25,26,29 ) . \\n forty - five percent of all of the studies found no difference in the endothelial function between genders , and 55% of the reports did not provide these data ( table 1 ) . \\n most of the studies used ultrasound to determine the percent diameter changes for the fmd and ntg assessments ( 22 - 29,31,32 ) . \\n only one study used reactive hyperemia  peripheral artery tonometry ( rh - pat ) for the same purpose ( 30 ) , showing that the endothelial function was impaired in diabetic children relative to that in healthy children ( 1.630.5 vs. 1.950.3 for diabetic children vs. healthy children ) ( 30 ) . \\n the fmd response values from all of the other articles for obese and diabetic children were significantly lower than those for healthy children ( 5.91.29% for obese children , 4.50.7% for diabetic children , and 9.81.8% for healthy children ; p<0.0008 ) . \\n the obese children had a 39% lower fmd response than the healthy children , and the diabetic children had a decrease in their fmd of 25% ( table 2 ) . \\n the children with kawasaki 's disease had 27% lower fmd responses than the healthy children ( 7.11.27% vs. 9.81.8% , respectively ) , but this difference was not statistically significant ( p  =  0.26 ) . \\n the fmd data for the obese children , diabetic children , and children with kawasaki 's disease exhibited no statistically significant differences ( p<0.38 ) ( table 2 ) . \\n the ntg response ( table 2 ) also showed no significant difference among the groups ( 22.77.1% for healthy children , 19.62.0% for obese children and \\n 16.65.9% for diabetic children ; p<0.19 ) . among the excluded studies , one contained no data on endothelial function ( 33 ) , and most of the excluded studies did not list the data for pre - pubertal children , post - pubertal children ( 34 - 39 ) and adults ( 40,41 ) separately . \\n another study ( 42 ) published data for the same patients as used in a previously published study ( 32 ) . \\n ultrasound is the most frequently used method to evaluate endothelial function because it has a low cost , is safe and is sufficiently reproducible . \\n however , some limitations of this method are that the fmd response can be influenced by both temperature and age , and ultrasound requires drug administration and the recording of images for posterior analysis ( 19 ) . \\n another technique for the assessment of endothelial function is the pat method , which has been proposed to be more practical and precise ( 20 ) , and pat results are moderately significantly correlated with us results ( 43 ) . \\n the pat method combines the traditional flow - mediated dilatation measurement with pneumatic fingertip probes to measure the arterial pulse wave amplitude ( 20 ) . \\n one study ( 31 ) chose pat over us and confirmed that diabetic children have endothelial dysfunction , as do adults ( 44,45 ) . in five studies ( 22,24,25,28,32 ) \\n , the gender of the individual did not correlate with the endothelial function , as has been found for adults ( 60 ) and adolescents ( 61 ) . \\n pre - pubertal children show lower responses to beta - adrenergic receptors and have lower levels of circulating catecholamines ( adrenaline and noradrenaline ) than adolescents and adults ( 46 ) . \\n the obese children exhibit accelerated growth and , therefore , earlier puberty ( 47 ) , which is evidenced by an advancement of menarche by 2.2 years ( 11.2 vs. 13.4 years , respectively ) ( 48 ) because fat mass influences the levels of hormones ( 49,50 ) . \\n these data reinforce the need for the evaluation of sexual maturation in studies involving children . the extent of sexual maturation is widely accessed using the tanner - whitehouse scale , which is based on secondary sexual characteristics , such as breast development and menarche in girls , standards for penis development in boys , and pubic hair development in both sexes ( 51 ) . \\n this lack of sexual maturity assessment explains why those trials that combined information for children , adolescents ( 33 - 39 ) , and adults ( 40,41 ) were excluded in the present study and explains the elevated fmd data from one study ( 24 ) , which included a higher mean age of obese children of 124 years old . \\n the evaluation of sexual maturity also explains why three of the included studies ( 23,25,26 ) that assessed the pubertal stage by clinical examination yielded similar fmd data . \\n diabetic and obese individuals have hyperinsulinemia , and both diabetes and obesity are related to the higher hormone ( 50 ) and inflammation levels ( 52 ) that contribute to increased arterial stiffness and vascular lesions , which are related to both endothelial function and structural arterial changes ( 53 ) and may explain the endothelial dysfunction results for these groups ( 23 - 30 ) . \\n in addition to some methodological disparities , all of the studies showed significantly impaired endothelial function ( fmd response ) in the obese and diabetic children despite the lack of a difference in the ntg response , a result that was reported for adults ( 54 ) when compared with healthy subjects ( 55 ) . however , fmd impairment seems to be greater in adults than in children ( 44% in obese adults and 55% in diabetic adults ) ; similarly , adults show no difference in ntg responses ( 54,56 ) . \\n the collected fmd values in children with kawasaki 's disease are lower than those in healthy children ( 31,32 ) , which can indicate a low , but persistent , level of inflammation ( 57 ) , as evidenced by higher c - reactive protein ( crp ) levels ( 52,53,58 ) . \\n only one study ( 32 ) included ntg data , and this lack of data limits the discussion of the information provided . \\n the fmd values suggest that the major dysfunctions in these children occur as a result of the local nitric oxide ( no ) bioavailability in the endothelium ( no production ) because the shear stress induced by reactive hyperemia activates endothelial no production ( 59 ) . \\n the ntg response also suggests that the vascular smooth muscle cell function is preserved ( 19 ) . yet , one study showed significantly lower gt values in obese children than in healthy children ( 27 ) , and two other studies did not publish values for the ntg response ( 22,24 ) . some reports ( 20,25,28 ) \\n did not describe how long the subjects were at rest , according to corretti et al . \\n ( 22 ) , > 10 min is recommended , between the collections of the fmd and ntg response images , which might have contributed to the reported outcomes . \\n it is also worth noting that three of the trials ( 24,27,29 ) allowed the arteries to return to the basal condition and that two of these studies ( 24,29 ) did not yield statistically significant data . \\n in spite of the statistically significant differences in some of the endothelial function responses , the number of trials regarding this subject remains limited . \\n another limitation of the data search for pre - pubertal children is that the studies list the results for adults , teenagers , and children together , and do not divide the data by group according to the puberty state and age . \\n the small number of studies in children may also be due to the use of the us method because drug administration is required . \\n however , the new method of endothelial function evaluation , the pat method , might help increase the number of trials using this population . \\n although endothelial dysfunction has been identified in adults as a predictor of cardiac transplant and death , the clinical implications of endothelial dysfunction were not presented in the selected trials , nor were they the focus of the current study ; however , this correlation should be further evaluated in children . \\n lastly , even though the number of pre - pubertal children with endothelial dysfunction is unknown , there is a great number of children who suffer from this condition . \\n thus , the barriers in the pediatric field must be broken , and more studies on this topic should be performed to understand this population better . in conclusion , \\n endothelial function is an important clinical feature because it may indicate the severity of cardiovascular symptoms , prognosis , and mortality . \\n children at risk of developing cardiomyopathy exhibit endothelial dysfunction ; however , the prevalence of endothelial dysfunction in cardiomyopathic children remains unknown because of the lack of data . \\n we suggest that attention should be paid to the consequences of endothelial function in this group . \\n guilherme v guimares ( cnpq # 304733/2008 - 3 ) was supported by conselho nacional de pesquisa .\",\n",
       "  'output': \"although it is known that obesity , diabetes , and kawasaki 's disease play important roles in systemic inflammation and in the development of both endothelial dysfunction and cardiomyopathy , there is a lack of data regarding the endothelial function of pre - pubertal children suffering from cardiomyopathy . in this study \\n , we performed a systematic review of the literature on pre - pubertal children at risk of developing cardiomyopathy to assess the endothelial function of pre - pubertal children at risk of developing cardiomyopathy . \\n we searched the published literature indexed in pubmed , bireme and scielo using the keywords  endothelial ' ,  children ' ,  pediatric ' and  infant ' and then compiled a systematic review . \\n the end points were age , the pubertal stage , sex differences , the method used for the endothelial evaluation and the endothelial values themselves . \\n no studies on children with cardiomyopathy were found . \\n only 11 papers were selected for our complete analysis , where these included reports on the flow - mediated percentage dilatation , the values of which were 9.801.80 , 5.901.29 , 4.500.70 , and 7.101.27 for healthy , obese , diabetic and pre - pubertal children with kawasaki 's disease , respectively . \\n there was no significant difference in the dilatation , independent of the endothelium , either among the groups or between the genders for both of the measurements in children ; similar results have been found in adolescents and adults . \\n the endothelial function in cardiomyopathic children remains unclear because of the lack of data ; nevertheless , the known dysfunctions in children with obesity , type 1 diabetes and kawasaki 's disease may influence the severity of the cardiovascular symptoms , the prognosis , and the mortality rate . the results of this study encourage future research into the consequences of endothelial dysfunction in pre - pubertal children .\",\n",
       "  '__index_level_0__': 31695,\n",
       "  'model_output': 'Thank you for submitting this article for consideration in our journal. We regret to inform you that we have decided not to move forward with your article at this time. Although we appreciate the effort you put into preparing your submission, our reviewers determined that the content does not meet our publication standards. We wish you the best in your future writing endeavors.'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet based on the given nutritional goals.',\n",
       "  'input': 'Ensure the daily carbohydrate intake does not exceed 71g, protein intake is at least 58g, and fat intake does not exceed 44g.',\n",
       "  'output': '{\"Breakfast\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Lunch\": \"Curried Chickpea Stew with Roasted Vegetables\", \"Dinner\": \"Parmesan Tofu with Butternut Squash Noodles\"}',\n",
       "  '__index_level_0__': 32166,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Sausage and Egg Casserole\", \"Lunch\": \"Curried Chickpea Stew with Roasted Vegetables\", \"Dinner\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes Parmesan cheese(grated, for the topping).',\n",
       "  'output': '{\"Breakfast\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Lunch\": \"Curried Chickpea Stew with Roasted Vegetables\", \"Dinner\": \"Parmesan Tofu with Butternut Squash Noodles\"}',\n",
       "  '__index_level_0__': 32167,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Peach & Cream Smoothie\", \"Dinner\": \"Curried Chickpea Stew with Roasted Vegetables\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes olive oil.',\n",
       "  'output': '{\"Breakfast\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Lunch\": \"Curried Chickpea Stew with Roasted Vegetables\", \"Dinner\": \"Parmesan Tofu with Butternut Squash Noodles\"}',\n",
       "  '__index_level_0__': 32168,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Watermelon Quinoa Salad\", \"Dinner\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes butternut squash(for the noodles).',\n",
       "  'output': '{\"Breakfast\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Lunch\": \"Curried Chickpea Stew with Roasted Vegetables\", \"Dinner\": \"Parmesan Tofu with Butternut Squash Noodles\"}',\n",
       "  '__index_level_0__': 32169,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\", \"Dinner\": \"Curried Chickpea Stew with Roasted Vegetables\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Analyze and summarize the nutritional content of a daily diet.',\n",
       "  'input': '{\"Breakfast\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Lunch\": \"Curried Chickpea Stew with Roasted Vegetables\", \"Dinner\": \"Parmesan Tofu with Butternut Squash Noodles\"}',\n",
       "  'output': '{\"Daily Total\": {\"Carbohydrate (g)\": 71, \"Protein (g)\": 58, \"Fat (g)\": 44, \"Sodium (mg)\": 1440, \"Cholesterol (mg)\": 60}}',\n",
       "  '__index_level_0__': 32170,\n",
       "  'model_output': '{\"Daily Total\": {\"Carbohydrate (g)\": 60, \"Protein (g)\": 43, \"Fat (g)\": 29, \"Sodium (mg)\": 1025, \"Cholesterol (mg)\": 70}}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet based on the given nutritional goals.',\n",
       "  'input': 'Ensure the daily carbohydrate intake does not exceed 59g, protein intake is at least 63g, and fat intake does not exceed 45g.',\n",
       "  'output': '{\"Breakfast\": \"Eggs Drowned in Salsa Verde\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Steak Salad with Orange\"}',\n",
       "  '__index_level_0__': 32171,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Peach & Cream Smoothie\", \"Dinner\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes garlic(minced).',\n",
       "  'output': '{\"Breakfast\": \"Eggs Drowned in Salsa Verde\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Steak Salad with Orange\"}',\n",
       "  '__index_level_0__': 32172,\n",
       "  'model_output': '{\"Breakfast\": \"Peach & Cream Smoothie\", \"Lunch\": \"Chicken Nuggets with Honey Mustard Dipping Sauce\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes Kosher Salt.',\n",
       "  'output': '{\"Breakfast\": \"Eggs Drowned in Salsa Verde\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Steak Salad with Orange\"}',\n",
       "  '__index_level_0__': 32173,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Easy Garlic Bok Choy\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes Extra Virgin Olive Oil(for the dressing).',\n",
       "  'output': '{\"Breakfast\": \"Eggs Drowned in Salsa Verde\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Steak Salad with Orange\"}',\n",
       "  '__index_level_0__': 32174,\n",
       "  'model_output': '{\"Breakfast\": \"Sugar Free Yogurt Parfait with Fresh Berries\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Analyze and summarize the nutritional content of a daily diet.',\n",
       "  'input': '{\"Breakfast\": \"Eggs Drowned in Salsa Verde\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Steak Salad with Orange\"}',\n",
       "  'output': '{\"Daily Total\": {\"Carbohydrate (g)\": 59, \"Protein (g)\": 63, \"Fat (g)\": 45, \"Sodium (mg)\": 1420, \"Cholesterol (mg)\": 370}}',\n",
       "  '__index_level_0__': 32175,\n",
       "  'model_output': '{\"Daily Total\": {\"Carbohydrate (g)\": 35, \"Protein (g)\": 61, \"Fat (g)\": 33, \"Sodium (mg)\": 1070, \"Cholesterol (mg)\": 220}}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet based on the given nutritional goals.',\n",
       "  'input': 'Ensure the daily carbohydrate intake does not exceed 47g, protein intake is at least 48g, and fat intake does not exceed 18.5g.',\n",
       "  'output': '{\"Breakfast\": \"Peach & Cream Smoothie\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Sausage and Egg Casserole\"}',\n",
       "  '__index_level_0__': 32176,\n",
       "  'model_output': '{\"Breakfast\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Watermelon Quinoa Salad\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes lower sodium soy sauce.',\n",
       "  'output': '{\"Breakfast\": \"Peach & Cream Smoothie\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Sausage and Egg Casserole\"}',\n",
       "  '__index_level_0__': 32177,\n",
       "  'model_output': '{\"Breakfast\": \"Maple-Pumpkin Spice Oatmeal Cookies\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes black pepper.',\n",
       "  'output': '{\"Breakfast\": \"Peach & Cream Smoothie\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Sausage and Egg Casserole\"}',\n",
       "  '__index_level_0__': 32178,\n",
       "  'model_output': '{\"Breakfast\": \"Peach & Cream Smoothie\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes carrots(shredded).',\n",
       "  'output': '{\"Breakfast\": \"Peach & Cream Smoothie\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Sausage and Egg Casserole\"}',\n",
       "  '__index_level_0__': 32179,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Peach & Cream Smoothie\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Analyze and summarize the nutritional content of a daily diet.',\n",
       "  'input': '{\"Breakfast\": \"Peach & Cream Smoothie\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Sausage and Egg Casserole\"}',\n",
       "  'output': '{\"Daily Total\": {\"Carbohydrate (g)\": 47, \"Protein (g)\": 48, \"Fat (g)\": 18.5, \"Sodium (mg)\": 1060, \"Cholesterol (mg)\": 145}}',\n",
       "  '__index_level_0__': 32180,\n",
       "  'model_output': '{\"Daily Total\": {\"Carbohydrate (g)\": 39, \"Protein (g)\": 43, \"Fat (g)\": 19.5, \"Sodium (mg)\": 790, \"Cholesterol (mg)\": 130}}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet based on the given nutritional goals.',\n",
       "  'input': 'Ensure the daily carbohydrate intake does not exceed 43g, protein intake is at least 72g, and fat intake does not exceed 31g.',\n",
       "  'output': '{\"Breakfast\": \"Smoked-Paprika Salmon\", \"Lunch\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}',\n",
       "  '__index_level_0__': 32181,\n",
       "  'model_output': '{\"Breakfast\": \"Green Bean and Chicken Sausage Skillet\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes Chinese five-spice powder.',\n",
       "  'output': '{\"Breakfast\": \"Smoked-Paprika Salmon\", \"Lunch\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}',\n",
       "  '__index_level_0__': 32182,\n",
       "  'model_output': '{\"Breakfast\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes lower sodium soy sauce.',\n",
       "  'output': '{\"Breakfast\": \"Smoked-Paprika Salmon\", \"Lunch\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}',\n",
       "  '__index_level_0__': 32183,\n",
       "  'model_output': '{\"Breakfast\": \"Mint Chocolate Chip Cookies\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes carrots(julienned).',\n",
       "  'output': '{\"Breakfast\": \"Smoked-Paprika Salmon\", \"Lunch\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}',\n",
       "  '__index_level_0__': 32184,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\", \"Dinner\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Analyze and summarize the nutritional content of a daily diet.',\n",
       "  'input': '{\"Breakfast\": \"Smoked-Paprika Salmon\", \"Lunch\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}',\n",
       "  'output': '{\"Daily Total\": {\"Carbohydrate (g)\": 43, \"Protein (g)\": 72, \"Fat (g)\": 31, \"Sodium (mg)\": 1535, \"Cholesterol (mg)\": 235}}',\n",
       "  '__index_level_0__': 32185,\n",
       "  'model_output': '{\"Daily Total\": {\"Carbohydrate (g)\": 54, \"Protein (g)\": 74, \"Fat (g)\": 33, \"Sodium (mg)\": 1450, \"Cholesterol (mg)\": 185}}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet based on the given nutritional goals.',\n",
       "  'input': 'Ensure the daily carbohydrate intake does not exceed 56g, protein intake is at least 12g, and fat intake does not exceed 17g.',\n",
       "  'output': '{\"Breakfast\": \"High-Fiber Zucchini Muffins\", \"Lunch\": \"Colorful Pasta Salad\", \"Dinner\": \"Easy Garlic Bok Choy\"}',\n",
       "  '__index_level_0__': 32186,\n",
       "  'model_output': '{\"Breakfast\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Curried Chickpea Stew with Roasted Vegetables\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes Bow-tie pasta.',\n",
       "  'output': '{\"Breakfast\": \"High-Fiber Zucchini Muffins\", \"Lunch\": \"Colorful Pasta Salad\", \"Dinner\": \"Easy Garlic Bok Choy\"}',\n",
       "  '__index_level_0__': 32187,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Turkey Chili Stuffed Sweet Potatoes\", \"Dinner\": \"Grilled Chicken with Plums and Zucchini Skewers\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes black pepper.',\n",
       "  'output': '{\"Breakfast\": \"High-Fiber Zucchini Muffins\", \"Lunch\": \"Colorful Pasta Salad\", \"Dinner\": \"Easy Garlic Bok Choy\"}',\n",
       "  '__index_level_0__': 32188,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Roasted Cabbage Steaks\", \"Dinner\": \"Pumpkin Spice Oatmeal Cookies\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes baby bok choy(roots trimmed).',\n",
       "  'output': '{\"Breakfast\": \"High-Fiber Zucchini Muffins\", \"Lunch\": \"Colorful Pasta Salad\", \"Dinner\": \"Easy Garlic Bok Choy\"}',\n",
       "  '__index_level_0__': 32189,\n",
       "  'model_output': '{\"Breakfast\": \"Easy Garlic Bok Choy\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Grilled Chicken with Plums and Zucchini Skewers\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Analyze and summarize the nutritional content of a daily diet.',\n",
       "  'input': '{\"Breakfast\": \"High-Fiber Zucchini Muffins\", \"Lunch\": \"Colorful Pasta Salad\", \"Dinner\": \"Easy Garlic Bok Choy\"}',\n",
       "  'output': '{\"Daily Total\": {\"Carbohydrate (g)\": 56, \"Protein (g)\": 12, \"Fat (g)\": 17, \"Sodium (mg)\": 675, \"Cholesterol (mg)\": 26}}',\n",
       "  '__index_level_0__': 32190,\n",
       "  'model_output': '{\"Daily Total\": {\"Carbohydrate (g)\": 70, \"Protein (g)\": 27, \"Fat (g)\": 31, \"Sodium (mg)\": 1050, \"Cholesterol (mg)\": 60}}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet based on the given nutritional goals.',\n",
       "  'input': 'Ensure the daily carbohydrate intake does not exceed 60g, protein intake is at least 34g, and fat intake does not exceed 24g.',\n",
       "  'output': '{\"Breakfast\": \"Rigatoni With Sun-Dried Tomatoes, Pesto, And Olives\", \"Lunch\": \"Simple Summer Cucumber and Tomato Salad\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}',\n",
       "  '__index_level_0__': 32191,\n",
       "  'model_output': '{\"Breakfast\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes black pepper.',\n",
       "  'output': '{\"Breakfast\": \"Rigatoni With Sun-Dried Tomatoes, Pesto, And Olives\", \"Lunch\": \"Simple Summer Cucumber and Tomato Salad\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}',\n",
       "  '__index_level_0__': 32192,\n",
       "  'model_output': '{\"Breakfast\": \"Easy Garlic Bok Choy\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Cauliflower Steaks\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes Chinese five-spice powder.',\n",
       "  'output': '{\"Breakfast\": \"Rigatoni With Sun-Dried Tomatoes, Pesto, And Olives\", \"Lunch\": \"Simple Summer Cucumber and Tomato Salad\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}',\n",
       "  '__index_level_0__': 32193,\n",
       "  'model_output': '{\"Breakfast\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Grilled Chicken with Plums and Zucchini Skewers\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes Kalamata olives(pitted, coarsely chopped).',\n",
       "  'output': '{\"Breakfast\": \"Rigatoni With Sun-Dried Tomatoes, Pesto, And Olives\", \"Lunch\": \"Simple Summer Cucumber and Tomato Salad\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}',\n",
       "  '__index_level_0__': 32194,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Curried Chickpea Stew with Roasted Vegetables\", \"Dinner\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Analyze and summarize the nutritional content of a daily diet.',\n",
       "  'input': '{\"Breakfast\": \"Rigatoni With Sun-Dried Tomatoes, Pesto, And Olives\", \"Lunch\": \"Simple Summer Cucumber and Tomato Salad\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}',\n",
       "  'output': '{\"Daily Total\": {\"Carbohydrate (g)\": 60, \"Protein (g)\": 34, \"Fat (g)\": 24, \"Sodium (mg)\": 910, \"Cholesterol (mg)\": 120}}',\n",
       "  '__index_level_0__': 32195,\n",
       "  'model_output': '{\"Daily Total\": {\"Carbohydrate (g)\": 61, \"Protein (g)\": 47, \"Fat (g)\": 26, \"Sodium (mg)\": 1250, \"Cholesterol (mg)\": 135}}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet based on the given nutritional goals.',\n",
       "  'input': 'Ensure the daily carbohydrate intake does not exceed 42g, protein intake is at least 40g, and fat intake does not exceed 25g.',\n",
       "  'output': '{\"Breakfast\": \"Maple-Pumpkin Spice Oatmeal Cookies\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Air Fryer Crisp Egg Cups\"}',\n",
       "  '__index_level_0__': 32196,\n",
       "  'model_output': '{\"Breakfast\": \"Watermelon Quinoa Salad\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Grilled Chicken with Plums and Zucchini Skewers\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes carrots(shredded).',\n",
       "  'output': '{\"Breakfast\": \"Maple-Pumpkin Spice Oatmeal Cookies\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Air Fryer Crisp Egg Cups\"}',\n",
       "  '__index_level_0__': 32197,\n",
       "  'model_output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes Thai style chili garlic sauce.',\n",
       "  'output': '{\"Breakfast\": \"Maple-Pumpkin Spice Oatmeal Cookies\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Air Fryer Crisp Egg Cups\"}',\n",
       "  '__index_level_0__': 32198,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Peach & Cream Smoothie\", \"Dinner\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes Chinese five-spice powder.',\n",
       "  'output': '{\"Breakfast\": \"Maple-Pumpkin Spice Oatmeal Cookies\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Air Fryer Crisp Egg Cups\"}',\n",
       "  '__index_level_0__': 32199,\n",
       "  'model_output': '{\"Breakfast\": \"Cilantro Lime Rice\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Easy Garlic Bok Choy\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Analyze and summarize the nutritional content of a daily diet.',\n",
       "  'input': '{\"Breakfast\": \"Maple-Pumpkin Spice Oatmeal Cookies\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Air Fryer Crisp Egg Cups\"}',\n",
       "  'output': '{\"Daily Total\": {\"Carbohydrate (g)\": 42, \"Protein (g)\": 40, \"Fat (g)\": 25, \"Sodium (mg)\": 1230, \"Cholesterol (mg)\": 335}}',\n",
       "  '__index_level_0__': 32200,\n",
       "  'model_output': '{\"Daily Total\": {\"Carbohydrate (g)\": 64, \"Protein (g)\": 36, \"Fat (g)\": 22, \"Sodium (mg)\": 1060, \"Cholesterol (mg)\": 200}}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet based on the given nutritional goals.',\n",
       "  'input': 'Ensure the daily carbohydrate intake does not exceed 69g, protein intake is at least 46g, and fat intake does not exceed 29g.',\n",
       "  'output': '{\"Breakfast\": \"Smoothie Breakfast Bowl\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Grilled Strawberries on \\\\u201cCr\\\\u00e8me\\\\u201d with Balsamic Glaze\"}',\n",
       "  '__index_level_0__': 32201,\n",
       "  'model_output': '{\"Breakfast\": \"Strawberry Cream Cheese French Toast Casserole\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Watermelon Quinoa Salad\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes Chinese five-spice powder.',\n",
       "  'output': '{\"Breakfast\": \"Smoothie Breakfast Bowl\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Grilled Strawberries on \\\\u201cCr\\\\u00e8me\\\\u201d with Balsamic Glaze\"}',\n",
       "  '__index_level_0__': 32202,\n",
       "  'model_output': '{\"Breakfast\": \"Easy Garlic Bok Choy\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes balsamic glaze or balsamic reduction sauce*.',\n",
       "  'output': '{\"Breakfast\": \"Smoothie Breakfast Bowl\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Grilled Strawberries on \\\\u201cCr\\\\u00e8me\\\\u201d with Balsamic Glaze\"}',\n",
       "  '__index_level_0__': 32203,\n",
       "  'model_output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes KIND Maple Glazed Pecan & Sea Salt bar OR 1/2 cup low sugar granola(crumbled).',\n",
       "  'output': '{\"Breakfast\": \"Smoothie Breakfast Bowl\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Grilled Strawberries on \\\\u201cCr\\\\u00e8me\\\\u201d with Balsamic Glaze\"}',\n",
       "  '__index_level_0__': 32204,\n",
       "  'model_output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Cauliflower Tostadas with Avocado Salsa\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Analyze and summarize the nutritional content of a daily diet.',\n",
       "  'input': '{\"Breakfast\": \"Smoothie Breakfast Bowl\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Grilled Strawberries on \\\\u201cCr\\\\u00e8me\\\\u201d with Balsamic Glaze\"}',\n",
       "  'output': '{\"Daily Total\": {\"Carbohydrate (g)\": 69, \"Protein (g)\": 46, \"Fat (g)\": 29, \"Sodium (mg)\": 910, \"Cholesterol (mg)\": 140}}',\n",
       "  '__index_level_0__': 32205,\n",
       "  'model_output': '{\"Daily Total\": {\"Carbohydrate (g)\": 49, \"Protein (g)\": 41, \"Fat (g)\": 17.5, \"Sodium (mg)\": 1090, \"Cholesterol (mg)\": 125}}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet based on the given nutritional goals.',\n",
       "  'input': 'Ensure the daily carbohydrate intake does not exceed 118g, protein intake is at least 69g, and fat intake does not exceed 36g.',\n",
       "  'output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Chili Stuffed Sweet Potatoes\"}',\n",
       "  '__index_level_0__': 32206,\n",
       "  'model_output': '{\"Breakfast\": \"Watermelon Quinoa Salad\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Curried Chickpea Stew with Roasted Vegetables\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes lower sodium soy sauce.',\n",
       "  'output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Chili Stuffed Sweet Potatoes\"}',\n",
       "  '__index_level_0__': 32207,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Lunch\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\", \"Dinner\": \"Easy Garlic Bok Choy\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes carrots(shredded).',\n",
       "  'output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Chili Stuffed Sweet Potatoes\"}',\n",
       "  '__index_level_0__': 32208,\n",
       "  'model_output': '{\"Breakfast\": \"Easy Garlic Bok Choy\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Cherry Tomatoes with Rosemary & Garlic\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes celery(small diced).',\n",
       "  'output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Chili Stuffed Sweet Potatoes\"}',\n",
       "  '__index_level_0__': 32209,\n",
       "  'model_output': '{\"Breakfast\": \"Greek Vegetable Pita Pizzas\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Easy Garlic Bok Choy\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Analyze and summarize the nutritional content of a daily diet.',\n",
       "  'input': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Turkey Chili Stuffed Sweet Potatoes\"}',\n",
       "  'output': '{\"Daily Total\": {\"Carbohydrate (g)\": 118, \"Protein (g)\": 69, \"Fat (g)\": 36, \"Sodium (mg)\": 1260, \"Cholesterol (mg)\": 180}}',\n",
       "  '__index_level_0__': 32210,\n",
       "  'model_output': '{\"Daily Total\": {\"Carbohydrate (g)\": 71, \"Protein (g)\": 53, \"Fat (g)\": 21, \"Sodium (mg)\": 1050, \"Cholesterol (mg)\": 165}}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet based on the given nutritional goals.',\n",
       "  'input': 'Ensure the daily carbohydrate intake does not exceed 102g, protein intake is at least 47g, and fat intake does not exceed 29.5g.',\n",
       "  'output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Beef & Broccoli Stir Fry\", \"Dinner\": \"Turkey Sausage and Egg Casserole\"}',\n",
       "  '__index_level_0__': 32211,\n",
       "  'model_output': '{\"Breakfast\": \"Curried Chickpea Stew with Roasted Vegetables\", \"Lunch\": \"Easy Garlic Bok Choy\", \"Dinner\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes chia seeds.',\n",
       "  'output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Beef & Broccoli Stir Fry\", \"Dinner\": \"Turkey Sausage and Egg Casserole\"}',\n",
       "  '__index_level_0__': 32212,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Sausage and Egg Casserole\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Watermelon Quinoa Salad\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes egg substitute.',\n",
       "  'output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Beef & Broccoli Stir Fry\", \"Dinner\": \"Turkey Sausage and Egg Casserole\"}',\n",
       "  '__index_level_0__': 32213,\n",
       "  'model_output': '{\"Breakfast\": \"Turkey Sausage and Egg Casserole\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Curried Chickpea Stew with Roasted Vegetables\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Recommend a daily diet that includes a specific ingredient.',\n",
       "  'input': 'Create a diet that includes frozen broccoli stir fry vegetable blend.',\n",
       "  'output': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Beef & Broccoli Stir Fry\", \"Dinner\": \"Turkey Sausage and Egg Casserole\"}',\n",
       "  '__index_level_0__': 32214,\n",
       "  'model_output': '{\"Breakfast\": \"Peach & Cream Smoothie\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\"}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'daily_diets',\n",
       "  'instruction': 'Analyze and summarize the nutritional content of a daily diet.',\n",
       "  'input': '{\"Breakfast\": \"Ginger Infused Oatmeal\", \"Lunch\": \"Beef & Broccoli Stir Fry\", \"Dinner\": \"Turkey Sausage and Egg Casserole\"}',\n",
       "  'output': '{\"Daily Total\": {\"Carbohydrate (g)\": 102, \"Protein (g)\": 47, \"Fat (g)\": 29.5, \"Sodium (mg)\": 755, \"Cholesterol (mg)\": 67}}',\n",
       "  '__index_level_0__': 32215,\n",
       "  'model_output': '{\"Daily Total\": {\"Carbohydrate (g)\": 65, \"Protein (g)\": 44, \"Fat (g)\": 20.5, \"Sodium (mg)\": 870, \"Cholesterol (mg)\": 115}}'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Flax seeds',\n",
       "  'output': \"Orange, Asparagus, and Avocado Salad is recommended. The reason is 'Orange, Asparagus, and Avocado Salad' complements 'Flax seeds' as it provides a good source of healthy fats, fiber, and vitamins, which can help address the deficiencies in the consumed food. However, caution should be taken with the fat content in the salad, as it may be higher than desired for some individuals.\",\n",
       "  '__index_level_0__': 35166,\n",
       "  'model_output': \"Greek Bean Salad is recommended. The reason is 'Greek Bean Salad' complements 'Flax seeds' because it provides a good source of protein, fiber, and other essential nutrients that are lacking in flax seeds. However, caution should be taken with the dressing, as it may contain added sugars or unhealthy fats.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Lettuce, arugula, raw',\n",
       "  'output': 'Budget-Friendly Vegetable Stew with Whole Wheat Dumplings is recommended. The reason is The Budget-Friendly Vegetable Stew with Whole Wheat Dumplings complements Lettuce, arugula, raw by providing a good source of protein, fat, and carbohydrates that are lacking in the consumed food. However, caution should be taken as the stew may contain higher levels of sodium and cholesterol compared to the raw greens.',\n",
       "  '__index_level_0__': 35167,\n",
       "  'model_output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Lettuce, arugula, raw' as it provides a good source of protein, healthy fats, and essential vitamins and minerals that are lacking in the lettuce. However, caution should be taken with the sodium content in the sausage, as it may be high for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Salmon, baked or broiled, made with oil',\n",
       "  'output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Salmon, baked or broiled, made with oil' as it provides a balanced combination of protein, healthy fats, and vegetables. However, caution should be taken to choose sausages with low fat and sodium content to avoid potential health risks.\",\n",
       "  '__index_level_0__': 35168,\n",
       "  'model_output': \"Balsamic Chicken & Peppers is recommended. The reason is 'Balsamic Chicken & Peppers' complements 'Salmon, baked or broiled, made with oil' as it provides a different protein source, additional vitamins, and lower fat content. However, caution should be taken with the sodium content in the dish.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Chicken, NS as to part and cooking method, skin not eaten',\n",
       "  'output': \"Herbed Soft Scrambled Eggs on Toast is recommended. The reason is 'Herbed Soft Scrambled Eggs on Toast' complements 'Chicken, NS as to part and cooking method, skin not eaten' as it provides a good source of protein and healthy fats, which are lacking in the consumed food. However, caution should be taken with the amount of cholesterol in the dish, especially for individuals with specific dietary restrictions\",\n",
       "  '__index_level_0__': 35169,\n",
       "  'model_output': \"Greek Bean Salad is recommended. The reason is 'Greek Bean Salad' complements 'Chicken, NS as to part and cooking method, skin not eaten' as it provides a good source of protein, fiber, and essential vitamins and minerals that are lacking in the consumed food. However, caution should be taken as the salad may contain added fats and sodium, which should be considered if the individual has specific dietary restrictions or health concerns.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Peanut butter',\n",
       "  'output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Peanut butter' as it provides a good source of protein, healthy fats, and essential vitamins and minerals. However, caution should be taken with the sodium content in pre-cooked sausages, as they may contribute to high blood pressure or other health issues\",\n",
       "  '__index_level_0__': 35170,\n",
       "  'model_output': \"Baked Salmon with Fresh Tomato Salsa is recommended. The reason is 'Baked Salmon with Fresh Tomato Salsa' complements 'Peanut butter' as it provides a good source of protein, healthy fats, and essential nutrients that are lacking in peanut butter. However, caution should be taken with the sodium content in the salmon dish, as it may be high for individuals on a low-sodium diet.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Fruit juice blend, 100% juice',\n",
       "  'output': \"Grilled Chicken Sausage with Zucchini and Peppers. is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers.' can complement 'Fruit juice blend, 100% juice' by providing a good source of protein, fiber, vitamins, and minerals that are lacking in the juice. However, caution should be taken with the sodium content of the sausage, as it may be high.\",\n",
       "  '__index_level_0__': 35171,\n",
       "  'model_output': 'Mediterranean Chicken Pita is recommended. The reason is The Mediterranean Chicken Pita complements the Fruit juice blend by providing a balanced combination of protein, carbohydrates, and fats, which are lacking in the juice. However, caution should be taken with the sodium content in the pita, as it may be higher than desired for some individuals.'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Egg omelet or scrambled egg, made with oil',\n",
       "  'output': \"Grilled Lime Chicken Fajitas is recommended. The reason is 'Grilled Lime Chicken Fajitas' complements 'Egg omelet or scrambled egg, made with oil' because it provides a lean protein source with lower fat content and includes healthy vegetables. However, caution should be taken with the sodium content in the fajitas, as excessive sodium intake can be harmful to health.\",\n",
       "  '__index_level_0__': 35172,\n",
       "  'model_output': 'Mediterranean Bean Salad is recommended. The reason is Mediterranean Bean Salad complements Egg omelet or scrambled egg as it provides a good source of protein, healthy fats, and carbohydrates, which are lacking in the egg dish. However, caution should be taken with the sodium content in the salad, as it may be high for some individuals.'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Soft drink, fruit flavored, caffeine containing',\n",
       "  'output': \"Crispy Baked Broccoli is recommended. The reason is 'Crispy Baked Broccoli' complements 'Soft drink, fruit flavored, caffeine containing' as it provides essential nutrients like protein, fiber, and vitamins that are lacking in the soft drink. However, caution should be taken as the broccoli dish contains some fat, which may not be suitable for individuals following a low-fat diet.\",\n",
       "  '__index_level_0__': 35173,\n",
       "  'model_output': 'Greek Bean Salad is recommended. The reason is The Greek Bean Salad complements Soft drink, fruit flavored, caffeine containing because it provides a good source of protein and fiber, which can help address the deficiencies in the consumed food. However, caution should be taken with the sodium content in the salad, as it may be high for some individuals.'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Pasta, cooked',\n",
       "  'output': 'Red Onion Green Beans is recommended. The reason is Red Onion Green Beans can complement Pasta, cooked by providing additional nutrients such as vitamins and minerals that are lacking in pasta. However, caution should be taken as Red Onion Green Beans may contain higher levels of fat and cholesterol compared to pasta.',\n",
       "  '__index_level_0__': 35174,\n",
       "  'model_output': \"Mediterranean Chicken Pita is recommended. The reason is 'Mediterranean Chicken Pita' complements 'Pasta, cooked' as it provides a good source of protein, healthy fats, and additional vitamins and minerals that are lacking in the consumed food. However, caution should be taken with the portion size and added ingredients in the pita to avoid excessive sodium and fat intake.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Soybean curd',\n",
       "  'output': \"Mediterranean Lentil Soup is recommended. The reason is 'Mediterranean Lentil Soup' complements 'Soybean curd' as it provides a good source of fiber, protein, and carbohydrates, which are lacking in soybean curd. However, individuals should be cautious of the sodium content in the soup, especially if they are watching their sodium intake.\",\n",
       "  '__index_level_0__': 35175,\n",
       "  'model_output': 'Mediterranean Chicken Pita is recommended. The reason is Mediterranean Chicken Pita complements Soybean curd as it provides a good source of protein and fiber, which are lacking in Soybean curd. However, caution should be taken with the sodium content in Mediterranean Chicken Pita, as it may be high for individuals watching their sodium intake.'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Squash, winter type, mashed, fat added in cooking, no sugar added in cooking',\n",
       "  'output': \"Greek Bean Salad is recommended. The reason is 'Greek Bean Salad' complements 'Squash, winter type, mashed, fat added in cooking, no sugar added in cooking' because beans are a good source of protein, fiber, and other nutrients that are lacking in the consumed food. However, caution should be taken with the total fat content of the salad, as it may contribute to\",\n",
       "  '__index_level_0__': 35176,\n",
       "  'model_output': \"Grilled Lime Chicken Fajitas is recommended. The reason is 'Grilled Lime Chicken Fajitas' complements 'Squash, winter type, mashed, fat added in cooking, no sugar added in cooking' by providing a good source of protein and healthy fats that are lacking in the squash dish. However, caution should be taken with the sodium content in the fajitas, as it may be high for\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Flax seeds',\n",
       "  'output': 'Bountiful Harvest Vegetable Salad is recommended. The reason is The Bountiful Harvest Vegetable Salad complements Flax seeds because it provides a good balance of protein, healthy fats, and carbohydrates, which can help address the nutritional deficiencies found in Flax seeds. However, individuals should be cautious of the sodium content in the salad, as excessive sodium intake can be harmful to health.',\n",
       "  '__index_level_0__': 35177,\n",
       "  'model_output': \"Greek Chicken and Potatoes with Sautéed Kale, Raisins, and Feta Cheese is recommended. The reason is 'Greek Chicken and Potatoes with Sautéed Kale, Raisins, and Feta Cheese' complements 'Flax seeds' as it provides a balanced combination of protein, carbohydrates, and fats, along with essential vitamins and minerals. However, caution should be taken with the sodium content in the dish, as it may be higher than\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Gnocchi, potato',\n",
       "  'output': 'Mediterranean Chicken Pita is recommended. The reason is The Mediterranean Chicken Pita complements Gnocchi, potato by providing a balanced combination of protein, carbohydrates, and fats. It also offers a different flavor profile and texture, which can add variety to the diet. However, caution should be taken with the sodium content in the Mediterranean Chicken Pita, as it may be high for individuals watching their sodium',\n",
       "  '__index_level_0__': 35178,\n",
       "  'model_output': \"Grilled Lime Chicken Fajitas is recommended. The reason is 'Grilled Lime Chicken Fajitas' complements 'Gnocchi, potato' as it provides a lean protein source, low-carb veggies, and a flavorful sauce that can be used as a topping for the gnocchi. However, caution should be taken with the sodium content in the fajita sauce, as it may be high for individuals watching their sodium intake.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Wine, table, red',\n",
       "  'output': \"Chopped Veggie Salad with Feta is recommended. The reason is 'Chopped Veggie Salad with Feta' complements 'Wine, table, red' by providing essential nutrients such as protein, fiber, and vitamins that are lacking in the consumed food. However, caution should be taken with the sodium content in the salad, as excessive intake of sodium may have negative health effects.\",\n",
       "  '__index_level_0__': 35179,\n",
       "  'model_output': \"Greek Chicken Pita with Hummus, Tomato, and Cucumber Salad is recommended. The reason is 'Greek Chicken Pita with Hummus, Tomato, and Cucumber Salad' complements 'Wine, table, red' as it provides a good source of protein, healthy fats, and carbohydrates, which are lacking in red wine. However, caution should be taken with the sodium content in the dish, as it may be high for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Rice, white, with soy-based sauce, fat not added in cooking',\n",
       "  'output': \"Greek Chicken & Potatoes with Sautéed Kale, Raisins & Feta Cheese is recommended. The reason is 'Greek Chicken & Potatoes with Sautéed Kale, Raisins & Feta Cheese' complements 'Rice, white, with soy-based sauce, fat not added in cooking' as it provides a diverse range of nutrients and flavors that can help address the deficiencies in the consumed food. However, caution should be taken with the added fats\",\n",
       "  '__index_level_0__': 35180,\n",
       "  'model_output': \"Grilled Lime Chicken Fajitas is recommended. The reason is 'Grilled Lime Chicken Fajitas' complements 'Rice, white, with soy-based sauce, fat not added in cooking' as it provides a good source of protein, healthy fats, and essential vitamins and minerals that are lacking in the rice dish. However, caution should be taken with the sodium content in the fajitas, as it may be high for\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Vegetable soup, home recipe',\n",
       "  'output': \"Chicken–White Bean Soup With Fresh Veggie Topper is recommended. The reason is 'Chicken–White Bean Soup With Fresh Veggie Topper' complements 'Vegetable soup, home recipe' because it provides a good balance of protein, carbohydrates, and fats, which can help address the nutritional deficiencies in the vegetable soup. One cautionary point is that the chicken soup may contain higher sodium content compared to the vegetable soup,\",\n",
       "  '__index_level_0__': 35181,\n",
       "  'model_output': \"Grilled Lime Chicken Fajitas is recommended. The reason is 'Grilled Lime Chicken Fajitas' complements 'Vegetable soup, home recipe' as it provides a good source of protein and healthy fats, which are lacking in the soup. However, caution should be taken with the sodium content in the fajitas, as it may be higher than desired for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Spaghetti sauce',\n",
       "  'output': \"Rustic Red Potatoes and Green Beans is recommended. The reason is 'Rustic Red Potatoes and Green Beans' complements 'Spaghetti sauce' because it provides a good balance of carbohydrates, proteins, and fats that are lacking in the sauce. However, it may be high in sodium, so individuals watching their sodium intake should consume it in moderation.\",\n",
       "  '__index_level_0__': 35182,\n",
       "  'model_output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Spaghetti sauce' as it provides a good source of protein, healthy fats, and essential vitamins and minerals. However, caution should be taken with the sodium content in the sausage, as it may be high for individuals with specific dietary restrictions.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Pepper, sweet, green, raw',\n",
       "  'output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Pepper, sweet, green, raw' as it provides a good source of protein, healthy fats, and additional vitamins and minerals. However, caution should be taken to select sausages with low fat and sodium content to avoid potential drawbacks related to health concerns.\",\n",
       "  '__index_level_0__': 35183,\n",
       "  'model_output': \"Bountiful Blueberry Quinoa Salad is recommended. The reason is 'Bountiful Blueberry Quinoa Salad' complements 'Pepper, sweet, green, raw' because it provides a good source of protein and healthy fats, which are lacking in the consumed food. However, caution should be taken with the added sugar content in the salad, as it may not be suitable for individuals watching their sugar intake.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Licorice',\n",
       "  'output': 'Mini Vegetable Frittata is recommended. The reason is Mini Vegetable Frittata complements Licorice because it is a low carb option with vegetables that can help balance out the high sugar content of Licorice. However, caution should be taken with portion sizes and additional ingredients, as the frittata does contain some fat and cholesterol.',\n",
       "  '__index_level_0__': 35184,\n",
       "  'model_output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Licorice' as it provides a good source of protein, healthy fats, and essential vitamins and minerals. However, caution should be taken with the sodium content in the sausage, which may be higher than desired for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'BaNonea, raw',\n",
       "  'output': \"Grilled Peaches with Fresh Blueberry Compote is recommended. The reason is 'Grilled Peaches with Fresh Blueberry Compote' complements 'BaNonea, raw' as it provides a balance of protein, fats, and carbohydrates that are lacking in the consumed food. However, caution should be taken with the potential added sugars in the compote, which may contribute to excess sugar intake.\",\n",
       "  '__index_level_0__': 35185,\n",
       "  'model_output': \"Greek Salmon and Veggie Packets is recommended. The reason is 'Greek Salmon and Veggie Packets' complements 'BaNonea, raw' by providing a good source of protein and essential fatty acids, which are lacking in the consumed food. However, caution should be taken with the sodium content in the dish, as it may be higher than desired for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'BaNonea, raw',\n",
       "  'output': \"Rustic Red Potatoes and Green Beans is recommended. The reason is 'Rustic Red Potatoes and Green Beans' complements 'BaNonea, raw' by providing a good source of protein, healthy fats, and essential vitamins and minerals that are lacking in the consumed food. However, caution should be taken with the total carbohydrate content of the dish, as it may not be suitable for individuals following a low-car\",\n",
       "  '__index_level_0__': 35186,\n",
       "  'model_output': \"Mediterranean Chicken Pita is recommended. The reason is 'Mediterranean Chicken Pita' complements 'BaNonea, raw' by providing a good source of protein and healthy fats, which are lacking in the raw beans. However, caution should be taken with the portion size and added toppings, such as high-fat dressings, to avoid excessive calorie and fat intake.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Chocolate, semi-sweet morsel',\n",
       "  'output': 'Fresh Vegetable Summer Rolls is recommended. The reason is Fresh Vegetable Summer Rolls complement Chocolate, semi-sweet morsels because they are low in total fat and contain protein, which can help balance out the high fat and low protein content of the chocolate. However, caution should be taken as summer rolls may not provide as much fiber or certain vitamins and minerals that are present in chocolate.',\n",
       "  '__index_level_0__': 35187,\n",
       "  'model_output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Chocolate, semi-sweet morsel' as it provides lean protein, fiber, and essential vitamins and minerals that are lacking in the chocolate morsels. However, caution should be taken with the sodium content in the sausage, as it may be high for individuals\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Cookie, molasses',\n",
       "  'output': \"Crispy Baked Broccoli is recommended. The reason is 'Crispy Baked Broccoli' complements 'Cookie, molasses' because it is a nonstarchy vegetable dish that can help balance out the high carbohydrate and sugar content of the cookie. However, be cautious of the potential drawbacks of 'Crispy Baked Broccoli' such as sodium content if you are watching your sodium intake.\",\n",
       "  '__index_level_0__': 35188,\n",
       "  'model_output': 'Mediterranean Chickpea Salad is recommended. The reason is The Mediterranean Chickpea Salad complements Cookie, molasses as it provides a good source of protein, healthy fats, and carbohydrates, which are lacking in the cookie. However, caution should be taken with the sodium content in the salad, as it may be high for some individuals.'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Soy sauce',\n",
       "  'output': \"Grilled Peaches with Fresh Blueberry Compote is recommended. The reason is 'Grilled Peaches with Fresh Blueberry Compote' complements 'Soy sauce' as it provides a balanced mix of macronutrients and essential vitamins and minerals. However, caution should be taken with the added sugars in the compote, which may not be suitable for individuals looking to limit their sugar intake.\",\n",
       "  '__index_level_0__': 35189,\n",
       "  'model_output': \"Mediterranean Chicken Pita is recommended. The reason is 'Mediterranean Chicken Pita' complements 'Soy sauce' as it provides a good source of protein, healthy fats, and carbohydrates, which are lacking in soy sauce. However, caution should be taken with the sodium content in 'Mediterranean Chicken Pita', as it may be high for individuals watching their salt intake.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Milk, reduced fat (2%)',\n",
       "  'output': 'Greek Bean Salad is recommended. The reason is Greek Bean Salad complements Milk, reduced fat (2%) as it provides additional protein, fiber, and essential nutrients that are lacking in the milk. However, individuals should be cautious of the fat content in the salad, as it is higher compared to the milk.',\n",
       "  '__index_level_0__': 35190,\n",
       "  'model_output': \"Greek Bean Salad with Lemon and Oregano is recommended. The reason is 'Greek Bean Salad with Lemon and Oregano' complements 'Milk, reduced fat (2%)' as it provides a good source of protein, healthy fats, and carbohydrates, which are lacking in the consumed food. However, caution should be taken as the salad may contain higher amounts of sodium and cholesterol compared to the consumed food.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Coffee, brewed',\n",
       "  'output': \"Grilled Lime Chicken Fajitas is recommended. The reason is 'Grilled Lime Chicken Fajitas' complements 'Coffee, brewed' by providing a good source of protein, healthy fats, and carbohydrates, which are lacking in coffee. However, caution should be taken with the sodium content in fajitas, as excessive sodium intake can lead to health issues like high blood pressure.\",\n",
       "  '__index_level_0__': 35191,\n",
       "  'model_output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Coffee, brewed' as it provides a good source of protein, healthy fats, and essential vitamins and minerals that are lacking in coffee. However, caution should be taken with the sodium content in the sausage, as it may be high for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Sesame oil',\n",
       "  'output': 'Mediterranean Chicken Pita is recommended. The reason is Mediterranean Chicken Pita complements Sesame oil as it provides a source of protein and carbohydrates, which are lacking in Sesame oil. However, caution should be taken with the amount of total fat in the Mediterranean Chicken Pita, as it may contribute to exceeding daily fat intake goals.',\n",
       "  '__index_level_0__': 35192,\n",
       "  'model_output': \"Turkey and Bean Chili is recommended. The reason is 'Turkey and Bean Chili' complements 'Sesame oil' as it provides a good source of protein, fiber, and other essential nutrients that are lacking in sesame oil. However, caution should be taken with the sodium content in the chili, as it may be high for individuals watching their salt intake.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Soy sauce, reduced sodium',\n",
       "  'output': \"Chopped Black Bean Chicken Salad is recommended. The reason is 'Chopped Black Bean Chicken Salad' complements 'Soy sauce, reduced sodium' as it provides protein and fiber from the chicken and black beans, which are lacking in soy sauce. However, caution should be taken with the sodium content in the salad, as it may be higher than desired for individuals watching their sodium intake.\",\n",
       "  '__index_level_0__': 35193,\n",
       "  'model_output': 'Mediterranean Chicken Pita is recommended. The reason is The Mediterranean Chicken Pita complements Soy sauce, reduced sodium by providing a good source of protein, healthy fats, and carbohydrates. However, caution should be taken with the sodium content in the Mediterranean Chicken Pita, as it may be higher than desired for some individuals.'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Lentil soup, home recipe, canned, or ready-to-serve',\n",
       "  'output': \"Mediterranean Lentil Soup is recommended. The reason is 'Mediterranean Lentil Soup' complements 'Lentil soup, home recipe, canned, or ready-to-serve' by providing a lower total fat content, lower cholesterol, and lower sodium levels. However, it may lack some of the essential vitamins and minerals found in the homemade or ready-to-serve version.\",\n",
       "  '__index_level_0__': 35194,\n",
       "  'model_output': 'Greek Bean Salad is recommended. The reason is Greek Bean Salad complements Lentil soup by providing a good source of protein, fiber, and vitamins. However, caution should be taken with the dressing, as it may contain added sugars or unhealthy fats.'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Blackberries, frozen',\n",
       "  'output': \"Winter Salad with Citrus is recommended. The reason is 'Winter Salad with Citrus' complements 'Blackberries, frozen' as it provides a good source of protein, healthy fats, and fiber, which are lacking in the blackberries. However, caution should be taken with the amount of added dressing or toppings, as they could potentially increase the sugar and saturated fat content.\",\n",
       "  '__index_level_0__': 35195,\n",
       "  'model_output': \"Turkey and Egg Breakfast Bowl is recommended. The reason is 'Turkey and Egg Breakfast Bowl' complements 'Blackberries, frozen' as it provides a good source of protein, healthy fats, and carbohydrates, which are lacking in blackberries. However, caution should be taken with the fat content in the breakfast bowl, as excessive consumption of fats can be detrimental to one's health.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Peppers, green, cooked, made with oil',\n",
       "  'output': \"Greek Chicken & Potatoes with Sautéed Kale, Raisins & Feta Cheese is recommended. The reason is 'Greek Chicken & Potatoes with Sautéed Kale, Raisins & Feta Cheese' complements 'Peppers, green, cooked, made with oil' as it provides a balanced combination of protein, carbohydrates, and fats along with a variety of vitamins and minerals. However, caution should be taken with the sodium content in the dish,\",\n",
       "  '__index_level_0__': 35196,\n",
       "  'model_output': \"Turkey Meatball and Sausage Egg Casserole is recommended. The reason is 'Turkey Meatball and Sausage Egg Casserole' complements 'Peppers, green, cooked, made with oil' as it provides a good source of protein, healthy fats, and carbohydrates to balance out the nutrients lacking in the consumed food. However, caution should be taken with the sodium content in the casserole, as it may be\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Chard, raw',\n",
       "  'output': \"The recommended meal is Mediterranean Chicken Pita. is recommended. The reason is The recommended meal, Mediterranean Chicken Pita, can complement the deficiencies in 'Chard, raw' by providing a balanced combination of protein, carbohydrates, fiber, and essential vitamins and minerals. However, caution should be exercised in the portion size and ingredients used to avoid excess saturated fat and sodium content.\",\n",
       "  '__index_level_0__': 35197,\n",
       "  'model_output': \"Grilled Lime Chicken Fajitas is recommended. The reason is 'Grilled Lime Chicken Fajitas' complements 'Chard, raw' as it provides a good source of protein, healthy fats, and essential vitamins and minerals that are lacking in the raw chard. However, caution should be taken with the sodium content in the fajitas, as it may be high for individuals watching their sodium intake.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Coffee, brewed',\n",
       "  'output': \"Mediterranean Farro Bowls with Lemon Yogurt and Chili Oil is recommended. The reason is 'Mediterranean Farro Bowls with Lemon Yogurt and Chili Oil' complements 'Coffee, brewed' by providing a balanced mix of macronutrients and essential vitamins and minerals. However, caution should be taken as the dish may contain higher levels of fat and cholesterol compared to the coffee, which could be a drawback for individuals looking to\",\n",
       "  '__index_level_0__': 35198,\n",
       "  'model_output': 'Mediterranean Chicken Pita is recommended. The reason is The Mediterranean Chicken Pita complements Coffee, brewed by providing a balanced protein and carbohydrate content, as well as essential vitamins and minerals that are lacking in the consumed food. However, caution should be taken with the sodium content in the Mediterranean Chicken Pita, as it may be higher than desired for individuals with specific dietary restrictions.'},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Turnip greens, cooked, from fresh, fat not added in cooking',\n",
       "  'output': \"Grilled Peaches with Fresh Blueberry Compote is recommended. The reason is 'Grilled Peaches with Fresh Blueberry Compote' complements 'Turnip greens, cooked, from fresh, fat not added in cooking' because it offers a different set of nutrients that can help address the deficiencies in the turnip greens. However, caution should be taken with the potential added sugars in the blueberry compote.\",\n",
       "  '__index_level_0__': 35199,\n",
       "  'model_output': \"Greek Orzo Salad with Peas, Artichoke Hearts, and Feta is recommended. The reason is 'Greek Orzo Salad with Peas, Artichoke Hearts, and Feta' complements 'Turnip greens, cooked, from fresh, fat not added in cooking' as it provides a good source of protein, healthy fats, and additional vitamins and minerals. However, caution should be taken with the sodium content in the salad,\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Rice, white, cooked, fat not added in cooking',\n",
       "  'output': \"Cilantro Lime Quinoa is recommended. The reason is 'Cilantro Lime Quinoa' complements 'Rice, white, cooked, fat not added in cooking' as it provides more protein, fiber, and certain essential nutrients that are lacking in white rice. However, it is important to note that quinoa may be higher in calories and carbohydrates compared to white rice, so portion control is necessary for\",\n",
       "  '__index_level_0__': 35200,\n",
       "  'model_output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Rice, white, cooked, fat not added in cooking' as it provides a good source of protein and lower carbohydrates. However, caution should be taken with the sodium content in the sausage, as it may be high for individuals\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Peanut butter',\n",
       "  'output': \"Chopped Black Bean Chicken Salad is recommended. The reason is 'Chopped Black Bean Chicken Salad' complements 'Peanut butter' as it provides a good source of protein, healthy fats, and fiber, which are lacking in peanut butter. However, caution should be taken with the sodium content of the salad, as it may be high for individuals with certain dietary restrictions.\",\n",
       "  '__index_level_0__': 35201,\n",
       "  'model_output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Peanut butter' as it provides a good source of protein, healthy fats, and essential vitamins and minerals. However, caution should be taken with the sodium content in the sausage, which may be higher than desired for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Beets, pickled',\n",
       "  'output': \"Kale Apple Slaw is recommended. The reason is 'Kale Apple Slaw' complements 'Beets, pickled' because it provides a good source of protein and fiber, which are lacking in pickled beets. However, individuals should be cautious of the total fat content in 'Kale Apple Slaw' as it may be higher compared to pickled beets.\",\n",
       "  '__index_level_0__': 35202,\n",
       "  'model_output': \"Grilled Lime Chicken Fajitas is recommended. The reason is 'Grilled Lime Chicken Fajitas' complements 'Beets, pickled' as it provides a good source of protein and healthy fats, which are lacking in the pickled beets. However, caution should be taken with the sodium content in the fajitas, as it may be higher than desired for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Egg omelet or scrambled egg, made with oil',\n",
       "  'output': \"Good Morning Power Parfait is recommended. The reason is 'Good Morning Power Parfait' complements 'Egg omelet or scrambled egg, made with oil' as it provides a good balance of protein, carbohydrates, and fat, along with additional nutrients like calcium and vitamins from yogurt and fruits. However, individuals should be cautious of added sugars or high-calorie toppings that may negate the health benefits\",\n",
       "  '__index_level_0__': 35203,\n",
       "  'model_output': \"Greek Bean Salad is recommended. The reason is 'Greek Bean Salad' complements 'Egg omelet or scrambled egg, made with oil' as it provides a good source of protein, fiber, and essential vitamins and minerals that are lacking in the omelet. However, caution should be taken with the fat content in the salad, as it may be higher than desired for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Carrots, raw',\n",
       "  'output': 'Mediterranean Lentil Soup is recommended. The reason is Mediterranean Lentil Soup complements Carrots, raw because it provides a good source of protein, fiber, and carbohydrates that are lacking in raw carrots. However, individuals should be cautious of the sodium content in the soup, as it may be higher than desired for some dietary needs.',\n",
       "  '__index_level_0__': 35204,\n",
       "  'model_output': \"Grilled Lime Chicken Fajitas is recommended. The reason is 'Grilled Lime Chicken Fajitas' complements 'Carrots, raw' as it provides a good source of protein, healthy fats, and essential vitamins and minerals that are lacking in carrots. However, caution should be taken with the sodium content in the fajitas, as it may be higher than desired for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Tomatoes, raw',\n",
       "  'output': \"Greek Orzo Salad with Peas, Lemon and Kalamata Olives is recommended. The reason is 'Greek Orzo Salad with Peas, Lemon and Kalamata Olives' complements 'Tomatoes, raw' as it provides a balance of proteins, fats, and carbohydrates, along with additional flavors and textures. A cautionary point is that the salad may contain higher sodium content, so individuals watching their sodium intake should be mindful when consuming\",\n",
       "  '__index_level_0__': 35205,\n",
       "  'model_output': \"Grilled Peaches with Fresh Berry Compote is recommended. The reason is 'Grilled Peaches with Fresh Berry Compote' complements 'Tomatoes, raw' as it provides a good source of protein, healthy fats, and additional vitamins and minerals that are lacking in tomatoes. However, caution should be taken with the added sugars and fats in the recipe, as they may contribute to overall calorie intake and should be consumed in moderation.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Butter, stick, salted',\n",
       "  'output': 'Broccoli Amandine is recommended. The reason is Broccoli Amandine complements Butter, stick, salted as it provides heart-healthy fats, protein, and fiber which are lacking in the consumed food. However, caution should be taken with portion sizes of Broccoli Amandine as it contains fats that may contribute to higher calorie intake if consumed in excess.',\n",
       "  '__index_level_0__': 35206,\n",
       "  'model_output': \"Mediterranean Chicken Pita is recommended. The reason is 'Mediterranean Chicken Pita' complements 'Butter, stick, salted' as it provides a balanced combination of protein, carbohydrates, and fats, along with essential vitamins and minerals. However, caution should be taken with the sodium content in the pita, as it may be high for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Coffee, brewed',\n",
       "  'output': \"Bountiful Harvest Vegetable Salad is recommended. The reason is The 'Bountiful Harvest Vegetable Salad' complements 'Coffee, brewed' because it provides a balance of nutrients including protein, fat, and carbohydrates that are lacking in coffee. However, if the salad dressing is high in unhealthy fats or added sugars, it could potentially negate the nutritional benefits of the salad.\",\n",
       "  '__index_level_0__': 35207,\n",
       "  'model_output': \"Greek Bean Salad is recommended. The reason is 'Greek Bean Salad' complements 'Coffee, brewed' as it provides a good source of protein, fiber, and healthy fats which are lacking in coffee. However, caution should be taken with the sodium content in the salad, as it may be high for individuals on a low-sodium diet.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Tomatoes, raw',\n",
       "  'output': \"Grilled Lime Chicken Fajitas is recommended. The reason is 'Grilled Lime Chicken Fajitas' complements 'Tomatoes, raw' because it provides lean protein and low-carb vegetables, addressing the deficiencies in protein, fiber, and certain vitamins and minerals found in tomatoes. One cautionary point is that fajitas may contain high levels of sodium depending on the seasoning and marinade used.\",\n",
       "  '__index_level_0__': 35208,\n",
       "  'model_output': \"Greek Bean Salad is recommended. The reason is 'Greek Bean Salad' complements 'Tomatoes, raw' as it provides a good source of protein, fiber, and essential vitamins and minerals that are lacking in tomatoes. However, caution should be taken with the fat content in the salad, as it may be higher than desired for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Peanut butter',\n",
       "  'output': 'Greek Bean Salad is recommended. The reason is Greek Bean Salad complements Peanut butter as it provides a good source of protein, fiber, and other essential nutrients that are lacking in Peanut butter. However, individuals with certain dietary restrictions or allergies to beans should exercise caution when consuming Greek Bean Salad.',\n",
       "  '__index_level_0__': 35209,\n",
       "  'model_output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Peanut butter' as it provides a good source of protein, healthy fats, and essential vitamins and minerals. However, caution should be taken with the sodium content in the sausage, as it may be higher compared to the peanut butter.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Flour, white, all-purpose',\n",
       "  'output': \"Mediterranean Chicken Pita is recommended. The reason is 'Mediterranean Chicken Pita' complements 'Flour, white, all-purpose' by providing a good source of protein and fiber, which are lacking in the consumed food. However, caution should be taken with the amount of total fat and cholesterol in the pita, as they may not be suitable for individuals on a low-fat diet.\",\n",
       "  '__index_level_0__': 35210,\n",
       "  'model_output': \"Grilled Romaine Hearts With Lemon-Rosemary Crust is recommended. The reason is 'Grilled Romaine Hearts With Lemon-Rosemary Crust' complements 'Flour, white, all-purpose' as it provides a good source of protein, healthy fats, and essential vitamins and minerals that are lacking in the consumed food. However, caution should be taken with the added fats and calories in the crust, which may be a concern for individuals\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Milk, reduced fat (2%)',\n",
       "  'output': \"Cauliflower Tabbouleh is recommended. The reason is 'Cauliflower Tabbouleh' complements 'Milk, reduced fat (2%)' as it provides a good source of protein and healthy fats while being low in carbohydrates. However, it may not provide as much calcium and certain vitamins found in milk, so it's important to incorporate other calcium-rich foods into the diet.\",\n",
       "  '__index_level_0__': 35211,\n",
       "  'model_output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Milk, reduced fat (2%)' as it provides a good source of protein, healthy fats, and essential vitamins and minerals that are lacking in milk. However, caution should be taken with the sodium content in the sausage, as it may be higher than desired for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Cheese, cream',\n",
       "  'output': \"Bountiful Harvest Vegetable Salad is recommended. The reason is The 'Bountiful Harvest Vegetable Salad' complements 'Cheese, cream' as it provides a balance of nutrients such as protein, carbohydrates, and fats, which are lacking in the consumed food. However, caution should be taken with the salad dressing and toppings to avoid adding excess unhealthy fats and calories.\",\n",
       "  '__index_level_0__': 35212,\n",
       "  'model_output': \"Greek Bean Salad is recommended. The reason is 'Greek Bean Salad' complements 'Cheese, cream' as it provides a good source of protein, fiber, and essential vitamins and minerals. However, caution should be taken with the sodium content in the salad, as it may be high for individuals with certain dietary restrictions.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Carbonated water, unsweetened',\n",
       "  'output': 'Crispy Baked Broccoli is recommended. The reason is Crispy Baked Broccoli complements Carbonated water, unsweetened as it provides essential nutrients such as protein, fat, and carbohydrates that are lacking in the consumed food. However, caution should be taken as the baked broccoli may contain added fats or seasonings that could increase the overall calorie and sodium content.',\n",
       "  '__index_level_0__': 35213,\n",
       "  'model_output': \"Grilled Chicken Sausage with Zucchini and Peppers is recommended. The reason is 'Grilled Chicken Sausage with Zucchini and Peppers' complements 'Carbonated water, unsweetened' as it provides a good source of protein and essential nutrients such as vitamins and minerals that are lacking in carbonated water. However, caution should be taken with the sodium content in the sausage, as it may be high for some individuals.\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Potato, boiled, from fresh, peel eaten, fat added in cooking, NS as to type of fat',\n",
       "  'output': 'Roasted Cauliflower is recommended. The reason is Roasted Cauliflower complements Potato by providing a different set of nutrients and flavors, helping to balance out the deficiencies in the consumed food. One drawback of Roasted Cauliflower is that it may contain higher levels of sodium if seasoning is added excessively during the roasting process.',\n",
       "  '__index_level_0__': 35214,\n",
       "  'model_output': \"Greek Veggie Pita is recommended. The reason is 'Greek Veggie Pita' complements 'Potato, boiled, from fresh, peel eaten, fat added in cooking, NS as to type of fat' because it provides a good balance of protein, carbohydrates, and fats, as well as essential vitamins and minerals. However, caution should be taken with the sodium content in the pita, especially for individuals\"},\n",
       " {'dataset': 'diabetes_food_hub',\n",
       "  'split_data': 'test',\n",
       "  'task': 'alternative_diet',\n",
       "  'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.',\n",
       "  'input': 'Sweet potato, casserole or mashed',\n",
       "  'output': 'Broccoli, Frozen & Cooked is recommended. The reason is Broccoli, frozen & cooked complements sweet potato, casserole or mashed by providing a good source of protein and essential nutrients while being low in fat. However, it is important to note that broccoli may not provide the same level of certain vitamins and minerals found in sweet potatoes, such as vitamin B6 and potassium.',\n",
       "  '__index_level_0__': 35215,\n",
       "  'model_output': 'Mini Veggie Frittatas is recommended. The reason is Mini Veggie Frittatas complement Sweet potato casserole or mashed by providing a good source of protein and additional vegetables, which are lacking in the sweet potato dish. However, caution should be taken with the portion size of the frittatas to avoid consuming excessive calories and fat.'}]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "df = pd.DataFrame(data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>dataset</th>\n",
       "      <th>split_data</th>\n",
       "      <th>task</th>\n",
       "      <th>instruction</th>\n",
       "      <th>input</th>\n",
       "      <th>output</th>\n",
       "      <th>__index_level_0__</th>\n",
       "      <th>model_output</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>bionli</td>\n",
       "      <td>test</td>\n",
       "      <td>nli</td>\n",
       "      <td>Evaluate if the hypothesis can be inferred fro...</td>\n",
       "      <td>[PRE] To investigate the mechanism of thyroid ...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>29785</td>\n",
       "      <td>entailment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>bionli</td>\n",
       "      <td>test</td>\n",
       "      <td>nli</td>\n",
       "      <td>Classify the relationship between the premise ...</td>\n",
       "      <td>[PRE] Cold exposure reverses the diabetogenic ...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>29786</td>\n",
       "      <td>contradiction</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  dataset split_data task                                        instruction  \\\n",
       "0  bionli       test  nli  Evaluate if the hypothesis can be inferred fro...   \n",
       "1  bionli       test  nli  Classify the relationship between the premise ...   \n",
       "\n",
       "                                               input         output  \\\n",
       "0  [PRE] To investigate the mechanism of thyroid ...  contradiction   \n",
       "1  [PRE] Cold exposure reverses the diabetogenic ...  contradiction   \n",
       "\n",
       "   __index_level_0__   model_output  \n",
       "0              29785     entailment  \n",
       "1              29786  contradiction  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['nli', 'ie_extract_relation', 'qa_subjective', 'qa_objective',\n",
       "       'summarization', 'daily_diets', 'alternative_diet'], dtype=object)"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['task'].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.6\n"
     ]
    }
   ],
   "source": [
    "# nli\n",
    "\n",
    "nli_df = df[df['task'] == 'nli']\n",
    "\n",
    "correct_predictions = (nli_df['output'] == nli_df['model_output']).sum()\n",
    "total_predictions = len(nli_df) \n",
    "\n",
    "nli_acc = correct_predictions / total_predictions\n",
    "\n",
    "print(nli_acc)  # bioinstruct - 0.33 "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "precision: 0.1259782608695652\n",
      "recall: 0.18\n",
      "f1: 0.1424948024948025\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/data/jaesung/anaconda3/envs/meal/lib/python3.12/site-packages/sklearn/metrics/_classification.py:1531: UndefinedMetricWarning: Precision is ill-defined and being set to 0.0 in labels with no predicted samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, f\"{metric.capitalize()} is\", len(result))\n",
      "/data/jaesung/anaconda3/envs/meal/lib/python3.12/site-packages/sklearn/metrics/_classification.py:1531: UndefinedMetricWarning: Recall is ill-defined and being set to 0.0 in labels with no true samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, f\"{metric.capitalize()} is\", len(result))\n"
     ]
    }
   ],
   "source": [
    "# ie - ie_extract_relation\n",
    "from sklearn.metrics import precision_score, recall_score, f1_score\n",
    "\n",
    "\n",
    "ie_extract_relation = df[df['task'] == 'ie_extract_relation']\n",
    "\n",
    "y_true = ie_extract_relation['output']\n",
    "y_pred = ie_extract_relation['model_output']\n",
    "\n",
    "precision = precision_score(y_true, y_pred, average='weighted')\n",
    "recall = recall_score(y_true, y_pred, average='weighted')\n",
    "f1 = f1_score(y_true, y_pred, average='weighted')\n",
    "\n",
    "print(f\"precision: {precision}\") \n",
    "print(f\"recall: {recall}\")\n",
    "print(f\"f1: {f1}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 4.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 2.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 4.5\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "**Evaluation of Model's Response:**\n",
      "\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 3.0\n",
      "\n",
      "Overall, the model's response is coherent with the input article, providing a detailed summary of the content. However, the response lacks completeness as it does not cover all key points and findings from the original text. Additionally, the naturalness of the response could be improved for better readability and fluency.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 2.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 2.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "Based on the provided inputs, here is the evaluation of the QA model's response:\n",
      "\n",
      "- Coherence: 4.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 4.0\n",
      "\n",
      "Overall, the model's response is coherent and natural, but it lacks completeness as it focuses more on lifestyle factors and less on insulin resistance and hyperinsulinemia, which are crucial aspects of cancer development as highlighted in the true answer.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4.5\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.0\n",
      "- Completeness: 2.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 4.5\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 2.5\n",
      "- Completeness: 2.0\n",
      "- Naturalness: 2.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 5.0\n",
      "- Completeness: 5.0\n",
      "- Naturalness: 5.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4.5\n",
      "- Naturalness: 4.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 2.0\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 1.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 2.0\n",
      "- Completeness: 1.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4\n",
      "- Naturalness: 4.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.0\n",
      "  - The model's response does not provide a clear summary of the article, as it mentions the difficulty of summarizing without delving into the key findings or insights provided in the original text.\n",
      "\n",
      "- Completeness: 2.5\n",
      "  - The model's response lacks key details and important findings from the original article, such as the specific metabolic changes observed in patients undergoing bariatric surgery and the implications for weight loss and diabetes improvement.\n",
      "\n",
      "- Naturalness: 3.0\n",
      "  - The response is somewhat disjointed and lacks the flow expected in a human-like summary. It reads more like a vague comment rather than a coherent summary of the article.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "평균 점수:\n",
      "Coherence       3.850000\n",
      "Completeness    3.433333\n",
      "Naturalness     3.483333\n",
      "Concept_F1      0.000000\n",
      "BLEURT          0.539845\n",
      "BERTScore_F1    0.603795\n",
      "dtype: float64\n"
     ]
    }
   ],
   "source": [
    "# summarization\n",
    "\n",
    "import openai\n",
    "import pandas as pd\n",
    "import re\n",
    "from sklearn.metrics import f1_score\n",
    "from bert_score import score as bert_score\n",
    "from transformers import AutoTokenizer, AutoModelForSequenceClassification\n",
    "import torch\n",
    "\n",
    "import os\n",
    "from dotenv import load_dotenv\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "openai.api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "\n",
    "bleurt_model_name = \"Elron/bleurt-large-512\"\n",
    "tokenizer = AutoTokenizer.from_pretrained(bleurt_model_name)\n",
    "bleurt_model = AutoModelForSequenceClassification.from_pretrained(bleurt_model_name)\n",
    "bleurt_model.eval()\n",
    "\n",
    "device = torch.device(\"cuda\" if torch.cuda.is_available() else \"cpu\")\n",
    "bleurt_model = bleurt_model.to(device)\n",
    "\n",
    "MAX_CONTEXT_LENGTH = 8192\n",
    "\n",
    "def evaluate_with_gpt4(input_text, model_output, true_output):\n",
    "\n",
    "    input_text = input_text[:MAX_CONTEXT_LENGTH]\n",
    "    model_output = model_output[:MAX_CONTEXT_LENGTH]\n",
    "    true_output = true_output[:MAX_CONTEXT_LENGTH]\n",
    "\n",
    "    prompt = f\"\"\"\n",
    "    You are tasked with evaluating the quality of a QA model's responses based on the following metrics:\n",
    "    1. **Coherence**: Does the model's response logically align with the context provided in the input?\n",
    "    2. **Completeness**: Does the model's response sufficiently answer the question in the input?\n",
    "    3. **Naturalness**: Does the model's response sound fluent and human-like?\n",
    "\n",
    "    **Input**:\n",
    "    {input_text}\n",
    "\n",
    "    **Model's Response**:\n",
    "    {model_output}\n",
    "\n",
    "    **True Answer**:\n",
    "    {true_output}\n",
    "\n",
    "    Please rate each metric on a scale from 1 to 5. \n",
    "    Example response format:\n",
    "    - Coherence: X.X\n",
    "    - Completeness: X.X\n",
    "    - Naturalness: X.X\n",
    "    \"\"\"\n",
    "    try:\n",
    "        response = openai.ChatCompletion.create(\n",
    "            model=\"gpt-3.5-turbo-0125\",\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": \"You are an expert evaluator for Summarization models.\"},\n",
    "                {\"role\": \"user\", \"content\": prompt}\n",
    "            ]\n",
    "        )\n",
    "        return response[\"choices\"][0][\"message\"][\"content\"]\n",
    "    except Exception as e:\n",
    "        print(\"Error with GPT-4 API:\", e)\n",
    "        return None\n",
    "\n",
    "def extract_scores(evaluation):\n",
    "\n",
    "    if evaluation is None:\n",
    "        return {\n",
    "            \"Coherence\": 0.0,\n",
    "            \"Completeness\": 0.0,\n",
    "            \"Naturalness\": 0.0\n",
    "        }\n",
    "    coherence = re.search(r\"Coherence: (\\d\\.\\d)\", evaluation)\n",
    "    completeness = re.search(r\"Completeness: (\\d\\.\\d)\", evaluation)\n",
    "    naturalness = re.search(r\"Naturalness: (\\d\\.\\d)\", evaluation)\n",
    "    \n",
    "    return {\n",
    "        \"Coherence\": float(coherence.group(1)) if coherence else 0.0,\n",
    "        \"Completeness\": float(completeness.group(1)) if completeness else 0.0,\n",
    "        \"Naturalness\": float(naturalness.group(1)) if naturalness else 0.0\n",
    "    }\n",
    "\n",
    "def calculate_concept_f1(y_true, y_pred):\n",
    "    return f1_score(y_true, y_pred, average=\"micro\")\n",
    "\n",
    "def calculate_bleurt(y_true, y_pred):\n",
    "\n",
    "    inputs = tokenizer(y_pred, y_true, return_tensors=\"pt\", padding=True, truncation=True, max_length=512)\n",
    "    inputs = {key: value.to(device) for key, value in inputs.items()}\n",
    "    \n",
    "    with torch.no_grad():\n",
    "        scores = bleurt_model(**inputs).logits\n",
    "\n",
    "    if scores.numel() == 1:\n",
    "        return float(scores.squeeze().item())  \n",
    "    return [float(score) for score in scores.squeeze().tolist()]  \n",
    "\n",
    "def calculate_bleurt_and_bertscore(y_true, y_pred):\n",
    "\n",
    "    bleurt_score_value = calculate_bleurt(y_true, y_pred)\n",
    "\n",
    "    _, _, bert_f1 = bert_score(y_pred, y_true, lang=\"en\", rescale_with_baseline=True)\n",
    "\n",
    "    bert_f1 = [float(score) for score in bert_f1]\n",
    "\n",
    "    return {\n",
    "        \"BLEURT\": bleurt_score_value if isinstance(bleurt_score_value, float) else sum(bleurt_score_value) / len(bleurt_score_value),\n",
    "        \"BERTScore_F1\": sum(bert_f1) / len(bert_f1)\n",
    "    }\n",
    "\n",
    "def normalize_scores(df, column):\n",
    "    df[column] = df[column].apply(\n",
    "        lambda x: float(x) if isinstance(x, torch.Tensor) else x\n",
    "    )\n",
    "    min_val = df[column].min()\n",
    "    max_val = df[column].max()\n",
    "    df[column] = df[column].apply(\n",
    "        lambda x: (x - min_val) / (max_val - min_val) if max_val > min_val else 0.5\n",
    "    )\n",
    "    return df\n",
    "\n",
    "qa_df = df[df['task'] == 'summarization']\n",
    "\n",
    "results = []\n",
    "\n",
    "for _, row in qa_df.iterrows():\n",
    "    input_text = row['input']\n",
    "    model_output = row['model_output']\n",
    "    true_output = row['output']\n",
    "    \n",
    "    evaluation = evaluate_with_gpt4(input_text, model_output, true_output)\n",
    "    print(f\"Evaluation result:\\n{evaluation}\")\n",
    "    \n",
    "    scores = extract_scores(evaluation)\n",
    "    \n",
    "    concept_f1 = calculate_concept_f1([true_output], [model_output])\n",
    "    \n",
    "    metric_scores = calculate_bleurt_and_bertscore([true_output], [model_output])\n",
    "\n",
    "    results.append({\n",
    "        \"input\": input_text,\n",
    "        \"model_output\": model_output,\n",
    "        \"true_output\": true_output,\n",
    "        \"evaluation\": evaluation,\n",
    "        \"Coherence\": scores[\"Coherence\"],\n",
    "        \"Completeness\": scores[\"Completeness\"],\n",
    "        \"Naturalness\": scores[\"Naturalness\"],\n",
    "        \"Concept_F1\": concept_f1,\n",
    "        \"BLEURT\": metric_scores[\"BLEURT\"],\n",
    "        \"BERTScore_F1\": metric_scores[\"BERTScore_F1\"]\n",
    "    })\n",
    "\n",
    "evaluation_df = pd.DataFrame(results)\n",
    "\n",
    "evaluation_df = normalize_scores(evaluation_df, \"BLEURT\")\n",
    "evaluation_df = normalize_scores(evaluation_df, \"BERTScore_F1\")\n",
    "\n",
    "average_scores = evaluation_df[[\"Coherence\", \"Completeness\", \"Naturalness\", \"Concept_F1\", \"BLEURT\", \"BERTScore_F1\"]].mean()\n",
    "\n",
    "print(\"평균 점수:\")\n",
    "print(average_scores)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Accuracy: 0.4100\n"
     ]
    }
   ],
   "source": [
    "import re\n",
    "from sklearn.metrics import accuracy_score\n",
    "\n",
    "def extract_choice(text):\n",
    "    match = re.search(r'\\b([A-D])\\b', text)\n",
    "    return match.group(1) if match else None\n",
    "\n",
    "df['output_parsed'] = df['output'].apply(extract_choice)\n",
    "df['model_output_parsed'] = df['model_output'].apply(extract_choice)\n",
    "\n",
    "filtered_df = df.dropna(subset=['output_parsed', 'model_output_parsed'])\n",
    "\n",
    "accuracy = accuracy_score(filtered_df['output_parsed'], filtered_df['model_output_parsed'])\n",
    "\n",
    "print(f\"Accuracy: {accuracy:.4f}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Evaluating daily diets: 100%|██████████| 40/40 [00:34<00:00,  1.17it/s]\n",
      "Evaluating alternative diets: 0it [00:00, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Daily Diets Average Scores:\n",
      "Coherence               3.5750\n",
      "Completeness            3.3250\n",
      "Naturalness             3.9625\n",
      "Nutritional Adequacy    3.0000\n",
      "Caloric Balance         3.2250\n",
      "dtype: float64\n",
      "\n",
      "Alternative Diets scores not available:\n",
      "Missing columns: ['Improvement', 'Suitability']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "# daily diets\n",
    "\n",
    "import openai\n",
    "import pandas as pd\n",
    "import re\n",
    "from tqdm import tqdm\n",
    "\n",
    "from dotenv import load_dotenv\n",
    "import os\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "openai.api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "\n",
    "MAX_CONTEXT_LENGTH = 8192\n",
    "\n",
    "def evaluate_with_gpt4(input_text, model_output, true_output, task_type):\n",
    "    input_text = input_text[:MAX_CONTEXT_LENGTH]\n",
    "    model_output = model_output[:MAX_CONTEXT_LENGTH]\n",
    "    true_output = true_output[:MAX_CONTEXT_LENGTH]\n",
    "\n",
    "    if task_type == \"daily_diets\":\n",
    "        prompt = f\"\"\"\n",
    "        You are tasked with evaluating the quality of a meal recommendation model's responses based on the following metrics:\n",
    "        1. **Coherence**: Does the model's response logically align with the context provided in the input?\n",
    "        2. **Completeness**: Does the model's response sufficiently answer the input request?\n",
    "        3. **Naturalness**: Does the model's response sound fluent and human-like?\n",
    "        4. **Nutritional Adequacy**: Does the meal align with the nutritional goals in the input, considering reasonable flexibility and practical applicability in real-life scenarios?\n",
    "        5. **Caloric Balance**: Are the recommended meals well-balanced in terms of calories?\n",
    "\n",
    "        **Input**:\n",
    "        {input_text}\n",
    "\n",
    "        **Model's Response**:\n",
    "        {model_output}\n",
    "\n",
    "        **True Answer**:\n",
    "        {true_output}\n",
    "\n",
    "        Please rate each metric on a scale from 1 to 5. \n",
    "        Example response format:\n",
    "        - Coherence: X.X\n",
    "        - Completeness: X.X\n",
    "        - Naturalness: X.X\n",
    "        - Nutritional Adequacy: X.X\n",
    "        - Caloric Balance: X.X\n",
    "        \"\"\"\n",
    "    elif task_type == \"alternative_diets\":\n",
    "        prompt = f\"\"\"\n",
    "        You are tasked with evaluating the quality of a meal recommendation model's responses based on the following metrics:\n",
    "        1. **Coherence**: Does the model's response logically align with the context provided in the input?\n",
    "        2. **Completeness**: Does the model's response sufficiently answer the input request?\n",
    "        3. **Naturalness**: Does the model's response sound fluent and human-like?\n",
    "        4. **Improvement**: Does the recommended meal address the shortcomings of the previous meal?\n",
    "        5. **Suitability**: Is the recommended meal suitable for a diabetes patient?\n",
    "\n",
    "        **Input**:\n",
    "        {input_text}\n",
    "\n",
    "        **Model's Response**:\n",
    "        {model_output}\n",
    "\n",
    "        **True Answer**:\n",
    "        {true_output}\n",
    "\n",
    "        Please rate each metric on a scale from 1 to 5. \n",
    "        Example response format:\n",
    "        - Coherence: X.X\n",
    "        - Completeness: X.X\n",
    "        - Naturalness: X.X\n",
    "        - Improvement: X.X\n",
    "        - Suitability: X.X\n",
    "        \"\"\"\n",
    "    try:\n",
    "        response = openai.ChatCompletion.create(\n",
    "            model=\"gpt-3.5-turbo-0125\",\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": \"You are an expert evaluator for meal recommendation models.\"},\n",
    "                {\"role\": \"user\", \"content\": prompt}\n",
    "            ]\n",
    "        )\n",
    "        return response[\"choices\"][0][\"message\"][\"content\"]\n",
    "    except Exception as e:\n",
    "        print(\"Error with GPT-4 API:\", e)\n",
    "        return None\n",
    "\n",
    "# 점수 추출 함수\n",
    "def extract_scores(evaluation, task_type):\n",
    "    if evaluation is None:\n",
    "        if task_type == \"daily_diets\":\n",
    "            return {\n",
    "                \"Coherence\": 0.0,\n",
    "                \"Completeness\": 0.0,\n",
    "                \"Naturalness\": 0.0,\n",
    "                \"Nutritional Adequacy\": 0.0,\n",
    "                \"Caloric Balance\": 0.0\n",
    "            }\n",
    "        elif task_type == \"alternative_diets\":\n",
    "            return {\n",
    "                \"Coherence\": 0.0,\n",
    "                \"Completeness\": 0.0,\n",
    "                \"Naturalness\": 0.0,\n",
    "                \"Improvement\": 0.0,\n",
    "                \"Suitability\": 0.0\n",
    "            }\n",
    "\n",
    "    scores = {}\n",
    "    if task_type == \"daily_diets\":\n",
    "        metrics = [\"Coherence\", \"Completeness\", \"Naturalness\", \"Nutritional Adequacy\", \"Caloric Balance\"]\n",
    "    elif task_type == \"alternative_diets\":\n",
    "        metrics = [\"Coherence\", \"Completeness\", \"Naturalness\", \"Improvement\", \"Suitability\"]\n",
    "\n",
    "    for metric in metrics:\n",
    "        match = re.search(fr\"{metric}: (\\d\\.\\d)\", evaluation)\n",
    "        scores[metric] = float(match.group(1)) if match else 0.0\n",
    "\n",
    "    return scores\n",
    "\n",
    "results = []\n",
    "\n",
    "daily_df = df[(df['task'] == 'daily_diets') & (df['output'].str.contains('\"Breakfast\"'))]\n",
    "\n",
    "for _, row in tqdm(daily_df.iterrows(), total=len(daily_df), desc=\"Evaluating daily diets\"):\n",
    "    evaluation = evaluate_with_gpt4(row['input'], row['model_output'], row['output'], \"daily_diets\")\n",
    "    scores = extract_scores(evaluation, \"daily_diets\")\n",
    "    results.append({**row.to_dict(), **scores})\n",
    "\n",
    "alternative_df = df[df['task'] == 'alternative_diets']\n",
    "\n",
    "for _, row in tqdm(alternative_df.iterrows(), total=len(alternative_df), desc=\"Evaluating alternative diets\"):\n",
    "    evaluation = evaluate_with_gpt4(row['input'], row['model_output'], row['output'], \"alternative_diets\")\n",
    "    scores = extract_scores(evaluation, \"alternative_diets\")\n",
    "    results.append({**row.to_dict(), **scores})\n",
    "\n",
    "evaluation_df = pd.DataFrame(results)\n",
    "\n",
    "if \"Nutritional Adequacy\" in evaluation_df.columns and \"Caloric Balance\" in evaluation_df.columns:\n",
    "    daily_avg = evaluation_df[evaluation_df['task'] == 'daily_diets'][[\n",
    "        \"Coherence\", \"Completeness\", \"Naturalness\", \n",
    "        \"Nutritional Adequacy\", \"Caloric Balance\"\n",
    "    ]].mean()\n",
    "    print(\"Daily Diets Average Scores:\")\n",
    "    print(daily_avg)\n",
    "\n",
    "if \"Improvement\" in evaluation_df.columns and \"Suitability\" in evaluation_df.columns:\n",
    "    alternative_avg = evaluation_df[evaluation_df['task'] == 'alternative_diets'][[\n",
    "        \"Coherence\", \"Completeness\", \"Naturalness\", \n",
    "        \"Improvement\", \"Suitability\"\n",
    "    ]].mean()\n",
    "    print(\"\\nAlternative Diets Average Scores:\")\n",
    "    print(alternative_avg)\n",
    "else:\n",
    "    missing_columns = [col for col in [\"Improvement\", \"Suitability\"] if col not in evaluation_df.columns]\n",
    "    print(\"\\nAlternative Diets scores not available:\")\n",
    "    print(f\"Missing columns: {missing_columns}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Evaluating alternative diets:   0%|          | 0/50 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Evaluating alternative diets: 100%|██████████| 50/50 [00:43<00:00,  1.16it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Alternative Diets Average Scores:\n",
      "Coherence       4.32\n",
      "Completeness    3.85\n",
      "Naturalness     4.02\n",
      "Improvement     3.27\n",
      "Suitability     3.90\n",
      "dtype: float64\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "# alternative diets\n",
    "\n",
    "import openai\n",
    "import pandas as pd\n",
    "import re\n",
    "from tqdm import tqdm\n",
    "\n",
    "from dotenv import load_dotenv\n",
    "import os\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "\n",
    "openai.api_key = os.getenv(\"OPNEAI_API_KEY\")\n",
    "\n",
    "MAX_CONTEXT_LENGTH = 8192\n",
    "\n",
    "def evaluate_with_gpt4(input_text, model_output, true_output, task_type):\n",
    "\n",
    "    input_text = input_text[:MAX_CONTEXT_LENGTH]\n",
    "    model_output = model_output[:MAX_CONTEXT_LENGTH]\n",
    "    true_output = true_output[:MAX_CONTEXT_LENGTH]\n",
    "\n",
    "    if task_type == \"daily_diets\":\n",
    "        prompt = f\"\"\"\n",
    "        You are tasked with evaluating the quality of a meal recommendation model's responses based on the following metrics:\n",
    "        1. **Coherence**: Does the model's response logically align with the context provided in the input?\n",
    "        2. **Completeness**: Does the model's response sufficiently answer the input request?\n",
    "        3. **Naturalness**: Does the model's response sound fluent and human-like?\n",
    "        4. **Nutritional Adequacy**: Does the meal response meet the nutritional goals mentioned in the input?\n",
    "        5. **Caloric Balance**: Are the recommended meals well-balanced in terms of calories?\n",
    "\n",
    "        **Input**:\n",
    "        {input_text}\n",
    "\n",
    "        **Model's Response**:\n",
    "        {model_output}\n",
    "\n",
    "        **True Answer**:\n",
    "        {true_output}\n",
    "\n",
    "        Please rate each metric on a scale from 1 to 5. \n",
    "        Example response format:\n",
    "        - Coherence: X.X\n",
    "        - Completeness: X.X\n",
    "        - Naturalness: X.X\n",
    "        - Nutritional Adequacy: X.X\n",
    "        - Caloric Balance: X.X\n",
    "        \"\"\"\n",
    "    elif task_type == \"alternative_diet\":\n",
    "        prompt = f\"\"\"\n",
    "        You are tasked with evaluating the quality of a meal recommendation model's responses based on the following metrics:\n",
    "\n",
    "        1. **Coherence**: Does the model's response logically align with the context provided in the input?\n",
    "        2. **Completeness**: Does the model's response sufficiently answer the input request?\n",
    "        3. **Naturalness**: Does the model's response sound fluent and human-like?\n",
    "        4. **Improvement**: Assume that the recommended alternative meal is an improvement over the previous meal. Evaluate how effectively it builds upon and enhances the previous meal, even if the changes are small or subtle.\n",
    "        5. **Suitability**: Is the recommended meal suitable for a diabetes patient?\n",
    "\n",
    "        **Input**:\n",
    "        {input_text}\n",
    "\n",
    "        **Model's Response**:\n",
    "        {model_output}\n",
    "\n",
    "        **True Answer**:\n",
    "        {true_output}\n",
    "\n",
    "        Please rate each metric on a scale from 1 to 5. \n",
    "        Example response format:\n",
    "        - Coherence: X.X\n",
    "        - Completeness: X.X\n",
    "        - Naturalness: X.X\n",
    "        - Improvement: X.X\n",
    "        - Suitability: X.X\n",
    "        \"\"\"\n",
    "    try:\n",
    "        response = openai.ChatCompletion.create(\n",
    "            model=\"gpt-3.5-turbo-0125\",\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": \"You are an expert evaluator for meal recommendation models.\"},\n",
    "                {\"role\": \"user\", \"content\": prompt}\n",
    "            ]\n",
    "        )\n",
    "        return response[\"choices\"][0][\"message\"][\"content\"]\n",
    "    except Exception as e:\n",
    "        print(\"Error with GPT-4 API:\", e)\n",
    "        return None\n",
    "\n",
    "def extract_scores(evaluation, task_type):\n",
    "    if evaluation is None:\n",
    "        if task_type == \"daily_diets\":\n",
    "            return {\n",
    "                \"Coherence\": 0.0,\n",
    "                \"Completeness\": 0.0,\n",
    "                \"Naturalness\": 0.0,\n",
    "                \"Nutritional Adequacy\": 0.0,\n",
    "                \"Caloric Balance\": 0.0\n",
    "            }\n",
    "        elif task_type == \"alternative_diet\":\n",
    "            return {\n",
    "                \"Coherence\": 0.0,\n",
    "                \"Completeness\": 0.0,\n",
    "                \"Naturalness\": 0.0,\n",
    "                \"Improvement\": 0.0,\n",
    "                \"Suitability\": 0.0\n",
    "            }\n",
    "\n",
    "    scores = {}\n",
    "    if task_type == \"daily_diets\":\n",
    "        metrics = [\"Coherence\", \"Completeness\", \"Naturalness\", \"Nutritional Adequacy\", \"Caloric Balance\"]\n",
    "    elif task_type == \"alternative_diet\":\n",
    "        metrics = [\"Coherence\", \"Completeness\", \"Naturalness\", \"Improvement\", \"Suitability\"]\n",
    "\n",
    "    for metric in metrics:\n",
    "        match = re.search(fr\"{metric}: (\\d\\.\\d)\", evaluation)\n",
    "        scores[metric] = float(match.group(1)) if match else 0.0\n",
    "\n",
    "    return scores\n",
    "\n",
    "results = []\n",
    "\n",
    "alternative_df = df[df['task'] == 'alternative_diet']\n",
    "\n",
    "for _, row in tqdm(alternative_df.iterrows(), total=len(alternative_df), desc=\"Evaluating alternative diets\"):\n",
    "    evaluation = evaluate_with_gpt4(row['input'], row['model_output'], row['output'], \"alternative_diet\")\n",
    "    scores = extract_scores(evaluation, \"alternative_diet\")\n",
    "    results.append({**row.to_dict(), **scores})\n",
    "\n",
    "evaluation_df = pd.DataFrame(results)\n",
    "\n",
    "if all(col in evaluation_df.columns for col in [\"Improvement\", \"Suitability\"]):\n",
    "    alternative_avg = evaluation_df[[\n",
    "        \"Coherence\", \"Completeness\", \"Naturalness\", \n",
    "        \"Improvement\", \"Suitability\"\n",
    "    ]].mean()\n",
    "    print(\"\\nAlternative Diets Average Scores:\")\n",
    "    print(alternative_avg)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 2.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 1.0\n",
      "- Completeness: 1.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 4.5\n",
      "- Naturalness: 4.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 1.0\n",
      "- Completeness: 1.0\n",
      "- Naturalness: 1.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 4.5\n",
      "- Naturalness: 4.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 2.5\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 2.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 2.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 2.0\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.0\n",
      "- Completeness: 2.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 2.0\n",
      "- Completeness: 1.0\n",
      "- Naturalness: 1.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.0\n",
      "- Completeness: 2.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 4.5\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 2.0\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.0\n",
      "- Completeness: 1.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.0\n",
      "- Completeness: 1.0\n",
      "- Naturalness: 2.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "Based on the provided scenario, here is the evaluation of the QA model's response:\n",
      "\n",
      "- **Coherence**: 1.0  \n",
      "The model's response lacks coherence with the context provided in the input. While the input detailed a specific case of an individual experiencing erectile dysfunction and seeking guidance, the model's response lists a plethora of potential causes without addressing the individual's specific situation.\n",
      "\n",
      "- **Completeness**: 1.0  \n",
      "The model's response is not complete as it fails to sufficiently answer the specific questions and concerns raised in the input. It provides a broad list of potential causes without addressing the individual's medical history, symptoms, or the effects of the medication they are currently taking.\n",
      "\n",
      "- **Naturalness**: 1.0  \n",
      "The response lacks naturalness as it repeats a long list of potential causes in a repetitive and unnatural manner. The response sounds robotic, lacks empathy, and does not engage with the individual seeking help.\n",
      "\n",
      "Overall, the QA model's response falls short in coherence, completeness, and naturalness, scoring low on all metrics.\n",
      "\n",
      "If you have any more questions or need further assistance, feel free to ask!\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 2.5\n",
      "- Naturalness: 2.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 4.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 1.0\n",
      "- Completeness: 2.0\n",
      "- Naturalness: 2.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.0\n",
      "- Completeness: 3.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 2.0\n",
      "- Completeness: 4.5\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 2.5\n",
      "- Completeness: 4.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 2.0\n",
      "- Completeness: 2.0\n",
      "- Naturalness: 1.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 2.5\n",
      "- Naturalness: 3.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 4.5\n",
      "- Completeness: 3.0\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 3.5\n",
      "- Completeness: 4.0\n",
      "- Naturalness: 3.5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation result:\n",
      "- Coherence: 1.0\n",
      "- Completeness: 2.0\n",
      "- Naturalness: 4.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of RobertaModel were not initialized from the model checkpoint at roberta-large and are newly initialized: ['roberta.pooler.dense.bias', 'roberta.pooler.dense.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "평균 점수:\n",
      "Coherence       3.310000\n",
      "Completeness    2.920000\n",
      "Naturalness     3.180000\n",
      "Concept_F1      0.000000\n",
      "BLEURT          0.515577\n",
      "BERTScore_F1    0.639133\n",
      "dtype: float64\n"
     ]
    }
   ],
   "source": [
    "# qa_subjective\n",
    "\n",
    "import openai\n",
    "import pandas as pd\n",
    "import re\n",
    "from sklearn.metrics import f1_score\n",
    "from bert_score import score as bert_score\n",
    "from transformers import AutoTokenizer, AutoModelForSequenceClassification\n",
    "import torch\n",
    "\n",
    "from dotenv import load_dotenv\n",
    "import os\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "openai.api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "\n",
    "bleurt_model_name = \"Elron/bleurt-large-512\"\n",
    "tokenizer = AutoTokenizer.from_pretrained(bleurt_model_name)\n",
    "bleurt_model = AutoModelForSequenceClassification.from_pretrained(bleurt_model_name)\n",
    "bleurt_model.eval()\n",
    "\n",
    "device = torch.device(\"cuda\" if torch.cuda.is_available() else \"cpu\")\n",
    "bleurt_model = bleurt_model.to(device)\n",
    "\n",
    "MAX_CONTEXT_LENGTH = 8192\n",
    "\n",
    "def evaluate_with_gpt4(input_text, model_output, true_output):\n",
    "    input_text = input_text[:MAX_CONTEXT_LENGTH]\n",
    "    model_output = model_output[:MAX_CONTEXT_LENGTH]\n",
    "    true_output = true_output[:MAX_CONTEXT_LENGTH]\n",
    "\n",
    "    prompt = f\"\"\"\n",
    "    You are tasked with evaluating the quality of a QA model's responses based on the following metrics:\n",
    "    1. **Coherence**: Does the model's response logically align with the context provided in the input?\n",
    "    2. **Completeness**: Does the model's response sufficiently answer the question in the input?\n",
    "    3. **Naturalness**: Does the model's response sound fluent and human-like?\n",
    "\n",
    "    **Input**:\n",
    "    {input_text}\n",
    "\n",
    "    **Model's Response**:\n",
    "    {model_output}\n",
    "\n",
    "    **True Answer**:\n",
    "    {true_output}\n",
    "\n",
    "    Please rate each metric on a scale from 1 to 5. \n",
    "    Example response format:\n",
    "    - Coherence: X.X\n",
    "    - Completeness: X.X\n",
    "    - Naturalness: X.X\n",
    "    \"\"\"\n",
    "    try:\n",
    "        response = openai.ChatCompletion.create(\n",
    "            model=\"gpt-3.5-turbo-0125\",\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": \"You are an expert evaluator for QA models.\"},\n",
    "                {\"role\": \"user\", \"content\": prompt}\n",
    "            ]\n",
    "        )\n",
    "        return response[\"choices\"][0][\"message\"][\"content\"]\n",
    "    except Exception as e:\n",
    "        print(\"Error with GPT-4 API:\", e)\n",
    "        return None\n",
    "\n",
    "def extract_scores(evaluation):\n",
    "    if evaluation is None:\n",
    "        return {\n",
    "            \"Coherence\": 0.0,\n",
    "            \"Completeness\": 0.0,\n",
    "            \"Naturalness\": 0.0\n",
    "        }\n",
    "    coherence = re.search(r\"Coherence: (\\d\\.\\d)\", evaluation)\n",
    "    completeness = re.search(r\"Completeness: (\\d\\.\\d)\", evaluation)\n",
    "    naturalness = re.search(r\"Naturalness: (\\d\\.\\d)\", evaluation)\n",
    "    \n",
    "    return {\n",
    "        \"Coherence\": float(coherence.group(1)) if coherence else 0.0,\n",
    "        \"Completeness\": float(completeness.group(1)) if completeness else 0.0,\n",
    "        \"Naturalness\": float(naturalness.group(1)) if naturalness else 0.0\n",
    "    }\n",
    "\n",
    "def calculate_concept_f1(y_true, y_pred):\n",
    "    return f1_score(y_true, y_pred, average=\"macro\")\n",
    "\n",
    "\n",
    "def calculate_bleurt(y_true, y_pred):\n",
    "    inputs = tokenizer(y_pred, y_true, return_tensors=\"pt\", padding=True, truncation=True, max_length=512)\n",
    "    inputs = {key: value.to(device) for key, value in inputs.items()}\n",
    "    \n",
    "    with torch.no_grad():\n",
    "        scores = bleurt_model(**inputs).logits\n",
    "\n",
    "    if scores.numel() == 1:\n",
    "        return float(scores.squeeze().item()) \n",
    "    return [float(score) for score in scores.squeeze().tolist()] \n",
    "\n",
    "def calculate_bleurt_and_bertscore(y_true, y_pred):\n",
    "    bleurt_score_value = calculate_bleurt(y_true, y_pred)\n",
    "\n",
    "    _, _, bert_f1 = bert_score(y_pred, y_true, lang=\"en\", rescale_with_baseline=True)\n",
    "\n",
    "    bert_f1 = [float(score) for score in bert_f1]\n",
    "\n",
    "    return {\n",
    "        \"BLEURT\": bleurt_score_value if isinstance(bleurt_score_value, float) else sum(bleurt_score_value) / len(bleurt_score_value),\n",
    "        \"BERTScore_F1\": sum(bert_f1) / len(bert_f1)\n",
    "    }\n",
    "\n",
    "def normalize_scores(df, column):\n",
    "\n",
    "    df[column] = df[column].apply(\n",
    "        lambda x: float(x) if isinstance(x, torch.Tensor) else x\n",
    "    )\n",
    "    min_val = df[column].min()\n",
    "    max_val = df[column].max()\n",
    "\n",
    "    df[column] = df[column].apply(\n",
    "        lambda x: (x - min_val) / (max_val - min_val) if max_val > min_val else 0.5\n",
    "    )\n",
    "    return df\n",
    "\n",
    "qa_df = df[df['task'] == 'qa_subjective']\n",
    "\n",
    "results = []\n",
    "\n",
    "for _, row in qa_df.iterrows():\n",
    "    input_text = row['input']\n",
    "    model_output = row['model_output']\n",
    "    true_output = row['output']\n",
    "    \n",
    "    evaluation = evaluate_with_gpt4(input_text, model_output, true_output)\n",
    "    print(f\"Evaluation result:\\n{evaluation}\")\n",
    "    \n",
    "    scores = extract_scores(evaluation)\n",
    "    \n",
    "    concept_f1 = calculate_concept_f1([true_output], [model_output])\n",
    "    \n",
    "    metric_scores = calculate_bleurt_and_bertscore([true_output], [model_output])\n",
    "\n",
    "    results.append({\n",
    "        \"input\": input_text,\n",
    "        \"model_output\": model_output,\n",
    "        \"true_output\": true_output,\n",
    "        \"evaluation\": evaluation,\n",
    "        \"Coherence\": scores[\"Coherence\"],\n",
    "        \"Completeness\": scores[\"Completeness\"],\n",
    "        \"Naturalness\": scores[\"Naturalness\"],\n",
    "        \"Concept_F1\": concept_f1,\n",
    "        \"BLEURT\": metric_scores[\"BLEURT\"],\n",
    "        \"BERTScore_F1\": metric_scores[\"BERTScore_F1\"]\n",
    "    })\n",
    "\n",
    "evaluation_df = pd.DataFrame(results)\n",
    "\n",
    "evaluation_df = normalize_scores(evaluation_df, \"BLEURT\")\n",
    "evaluation_df = normalize_scores(evaluation_df, \"BERTScore_F1\")\n",
    "\n",
    "average_scores = evaluation_df[[\"Coherence\", \"Completeness\", \"Naturalness\", \"Concept_F1\", \"BLEURT\", \"BERTScore_F1\"]].mean()\n",
    "\n",
    "print(\"평균 점수:\")\n",
    "print(average_scores)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>dataset</th>\n",
       "      <th>split_data</th>\n",
       "      <th>task</th>\n",
       "      <th>instruction</th>\n",
       "      <th>input</th>\n",
       "      <th>output</th>\n",
       "      <th>__index_level_0__</th>\n",
       "      <th>model_output</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>430</th>\n",
       "      <td>diabetes_food_hub</td>\n",
       "      <td>test</td>\n",
       "      <td>daily_diets</td>\n",
       "      <td>Recommend a daily diet based on the given nutr...</td>\n",
       "      <td>Ensure the daily carbohydrate intake does not ...</td>\n",
       "      <td>{\"Breakfast\": \"Chicken and Cucumber Lettuce Wr...</td>\n",
       "      <td>32166</td>\n",
       "      <td>{\"Breakfast\": \"Turkey Sausage and Egg Casserol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>431</th>\n",
       "      <td>diabetes_food_hub</td>\n",
       "      <td>test</td>\n",
       "      <td>daily_diets</td>\n",
       "      <td>Recommend a daily diet that includes a specifi...</td>\n",
       "      <td>Create a diet that includes Parmesan cheese(gr...</td>\n",
       "      <td>{\"Breakfast\": \"Chicken and Cucumber Lettuce Wr...</td>\n",
       "      <td>32167</td>\n",
       "      <td>{\"Breakfast\": \"Turkey Meatball \\u201cWonton\\u2...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "               dataset split_data         task  \\\n",
       "430  diabetes_food_hub       test  daily_diets   \n",
       "431  diabetes_food_hub       test  daily_diets   \n",
       "\n",
       "                                           instruction  \\\n",
       "430  Recommend a daily diet based on the given nutr...   \n",
       "431  Recommend a daily diet that includes a specifi...   \n",
       "\n",
       "                                                 input  \\\n",
       "430  Ensure the daily carbohydrate intake does not ...   \n",
       "431  Create a diet that includes Parmesan cheese(gr...   \n",
       "\n",
       "                                                output  __index_level_0__  \\\n",
       "430  {\"Breakfast\": \"Chicken and Cucumber Lettuce Wr...              32166   \n",
       "431  {\"Breakfast\": \"Chicken and Cucumber Lettuce Wr...              32167   \n",
       "\n",
       "                                          model_output  \n",
       "430  {\"Breakfast\": \"Turkey Sausage and Egg Casserol...  \n",
       "431  {\"Breakfast\": \"Turkey Meatball \\u201cWonton\\u2...  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## nutri score, HEI\n",
    "\n",
    "df[df['task']=='daily_diets'].head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'{\"Breakfast\": \"Turkey Sausage and Egg Casserole\", \"Lunch\": \"Curried Chickpea Stew with Roasted Vegetables\", \"Dinner\": \"Chicken and Cucumber Lettuce Wraps with Peanut Sauce\"}'"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['task']=='daily_diets'].iloc[0]['model_output']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>title</th>\n",
       "      <th>description</th>\n",
       "      <th>prep_time</th>\n",
       "      <th>cook_time</th>\n",
       "      <th>servings</th>\n",
       "      <th>steps</th>\n",
       "      <th>tags</th>\n",
       "      <th>ingredients</th>\n",
       "      <th>nutrition_facts.Amount per serving</th>\n",
       "      <th>nutrition_facts.Total Fat</th>\n",
       "      <th>nutrition_facts.Cholesterol</th>\n",
       "      <th>nutrition_facts.Sodium</th>\n",
       "      <th>nutrition_facts.Total Carbohydrate</th>\n",
       "      <th>nutrition_facts.Protein</th>\n",
       "      <th>file_name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>Chicken Apple Crunch Salad</td>\n",
       "      <td>This savory and sweet chicken apple crunch sal...</td>\n",
       "      <td>5 min</td>\n",
       "      <td>1 hr</td>\n",
       "      <td>5</td>\n",
       "      <td>['Cube cooked chicken. Dice apple and celery. ...</td>\n",
       "      <td>['CKD Non-Dialysis', 'CKD Dialysis', 'Kidney-F...</td>\n",
       "      <td>[{'label': 'cooked chicken', 'us_measure': '2 ...</td>\n",
       "      <td>230</td>\n",
       "      <td>10g</td>\n",
       "      <td>65mg</td>\n",
       "      <td>210mg</td>\n",
       "      <td>15g</td>\n",
       "      <td>21g</td>\n",
       "      <td>kidney-friendly</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Broccoli and Apple Salad</td>\n",
       "      <td>This kidney-friendly recipe is a kid favorite....</td>\n",
       "      <td>10 min</td>\n",
       "      <td>1 hr</td>\n",
       "      <td>8</td>\n",
       "      <td>['Add the remaining ingredients and coat with ...</td>\n",
       "      <td>['CKD Non-Dialysis', 'CKD Dialysis', 'Kidney-F...</td>\n",
       "      <td>[{'label': 'Plain Nonfat Greek yogurt', 'us_me...</td>\n",
       "      <td>130</td>\n",
       "      <td>9g</td>\n",
       "      <td>9mg</td>\n",
       "      <td>70mg</td>\n",
       "      <td>12g</td>\n",
       "      <td>4g</td>\n",
       "      <td>kidney-friendly</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0                       title  \\\n",
       "0           0  Chicken Apple Crunch Salad   \n",
       "1           1    Broccoli and Apple Salad   \n",
       "\n",
       "                                         description prep_time cook_time  \\\n",
       "0  This savory and sweet chicken apple crunch sal...     5 min      1 hr   \n",
       "1  This kidney-friendly recipe is a kid favorite....    10 min      1 hr   \n",
       "\n",
       "   servings                                              steps  \\\n",
       "0         5  ['Cube cooked chicken. Dice apple and celery. ...   \n",
       "1         8  ['Add the remaining ingredients and coat with ...   \n",
       "\n",
       "                                                tags  \\\n",
       "0  ['CKD Non-Dialysis', 'CKD Dialysis', 'Kidney-F...   \n",
       "1  ['CKD Non-Dialysis', 'CKD Dialysis', 'Kidney-F...   \n",
       "\n",
       "                                         ingredients  \\\n",
       "0  [{'label': 'cooked chicken', 'us_measure': '2 ...   \n",
       "1  [{'label': 'Plain Nonfat Greek yogurt', 'us_me...   \n",
       "\n",
       "   nutrition_facts.Amount per serving nutrition_facts.Total Fat  \\\n",
       "0                                 230                       10g   \n",
       "1                                 130                        9g   \n",
       "\n",
       "  nutrition_facts.Cholesterol nutrition_facts.Sodium  \\\n",
       "0                        65mg                  210mg   \n",
       "1                         9mg                   70mg   \n",
       "\n",
       "  nutrition_facts.Total Carbohydrate nutrition_facts.Protein        file_name  \n",
       "0                                15g                     21g  kidney-friendly  \n",
       "1                                12g                      4g  kidney-friendly  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "dfh = pd.read_csv(\"/data/jaesung/llm_for_diabetes/src/data/data2_daily_diets/diabetes_food_hub.csv\")\n",
    "dfh.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"[{'label': 'cooked chicken', 'us_measure': '2 cup', 'metric_measure': '473 ml'}, {'label': 'Gala apples', 'us_measure': '1 cup', 'metric_measure': '237 ml'}, {'label': 'celery', 'us_measure': '1/2 cup', 'metric_measure': '118 ml'}, {'label': 'scallions', 'us_measure': '2 tbsp', 'metric_measure': '30 ml'}, {'label': 'raisins', 'us_measure': '1/4 cup', 'metric_measure': '59 ml'}, {'label': 'light mayonnaise', 'us_measure': '1/3 cup', 'metric_measure': '78 ml'}, {'label': 'light sour cream', 'us_measure': '1 tbsp', 'metric_measure': '15 ml'}, {'label': 'lemon juice', 'us_measure': '1 tbsp', 'metric_measure': '15 ml'}, {'label': 'ground cinnamon', 'us_measure': '1/4 tsp', 'metric_measure': '1 g'}, {'label': 'black pepper', 'us_measure': '1/4 tsp', 'metric_measure': '1 g'}]\""
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfh['ingredients'].iloc[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Unnamed: 0', 'title', 'description', 'prep_time', 'cook_time',\n",
       "       'servings', 'steps', 'tags', 'ingredients',\n",
       "       'nutrition_facts.Amount per serving', 'nutrition_facts.Total Fat',\n",
       "       'nutrition_facts.Cholesterol', 'nutrition_facts.Sodium',\n",
       "       'nutrition_facts.Total Carbohydrate', 'nutrition_facts.Protein',\n",
       "       'file_name'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfh.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Skipping row 434: Invalid meal structure\n",
      "Skipping row 439: Invalid meal structure\n",
      "Skipping row 444: Invalid meal structure\n",
      "Skipping row 449: Invalid meal structure\n",
      "Skipping row 454: Invalid meal structure\n",
      "Skipping row 459: Invalid meal structure\n",
      "Skipping row 464: Invalid meal structure\n",
      "Skipping row 469: Invalid meal structure\n",
      "Skipping row 474: Invalid meal structure\n",
      "Skipping row 479: Invalid meal structure\n",
      "{'row_index': 430, 'output_scores': {'Breakfast': {'score': 8.777777777777779, 'grade': 'C'}, 'Lunch': {'score': 12.555555555555557, 'grade': 'D'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': -0.7222222222222223, 'grade': 'B'}, 'Lunch': {'score': 12.555555555555557, 'grade': 'D'}, 'Dinner': {'score': 8.777777777777779, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 431, 'output_scores': {'Breakfast': {'score': 8.777777777777779, 'grade': 'C'}, 'Lunch': {'score': 12.555555555555557, 'grade': 'D'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 4.222222222222221, 'grade': 'C'}, 'Dinner': {'score': 12.555555555555557, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 432, 'output_scores': {'Breakfast': {'score': 8.777777777777779, 'grade': 'C'}, 'Lunch': {'score': 12.555555555555557, 'grade': 'D'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 11.666666666666668, 'grade': 'D'}, 'Dinner': {'score': 8.777777777777779, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 433, 'output_scores': {'Breakfast': {'score': 8.777777777777779, 'grade': 'C'}, 'Lunch': {'score': 12.555555555555557, 'grade': 'D'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 10.61111111111111, 'grade': 'D'}, 'Dinner': {'score': 12.555555555555557, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 435, 'output_scores': {'Breakfast': {'score': 11.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 7.666666666666666, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 4.222222222222221, 'grade': 'C'}, 'Dinner': {'score': 8.777777777777779, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 436, 'output_scores': {'Breakfast': {'score': 11.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 7.666666666666666, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 4.222222222222221, 'grade': 'C'}, 'Lunch': {'score': 6.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 437, 'output_scores': {'Breakfast': {'score': 11.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 7.666666666666666, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 4.5, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 438, 'output_scores': {'Breakfast': {'score': 11.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 7.666666666666666, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 0.22222222222222232, 'grade': 'B'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 10.61111111111111, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 440, 'output_scores': {'Breakfast': {'score': 4.222222222222221, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': -0.7222222222222223, 'grade': 'B'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 6.152777777777779, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 11.666666666666668, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 441, 'output_scores': {'Breakfast': {'score': 4.222222222222221, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': -0.7222222222222223, 'grade': 'B'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 8.305555555555555, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 8.777777777777779, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 442, 'output_scores': {'Breakfast': {'score': 4.222222222222221, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': -0.7222222222222223, 'grade': 'B'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 4.222222222222221, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 6.152777777777779, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 443, 'output_scores': {'Breakfast': {'score': 4.222222222222221, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': -0.7222222222222223, 'grade': 'B'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 4.222222222222221, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 445, 'output_scores': {'Breakfast': {'score': 5.333333333333334, 'grade': 'C'}, 'Lunch': {'score': 8.777777777777779, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 14.555555555555557, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 8.0, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 10.61111111111111, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 446, 'output_scores': {'Breakfast': {'score': 5.333333333333334, 'grade': 'C'}, 'Lunch': {'score': 8.777777777777779, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 14.555555555555557, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 8.777777777777779, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 10.61111111111111, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 447, 'output_scores': {'Breakfast': {'score': 5.333333333333334, 'grade': 'C'}, 'Lunch': {'score': 8.777777777777779, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 14.555555555555557, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 3.0972222222222223, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 448, 'output_scores': {'Breakfast': {'score': 5.333333333333334, 'grade': 'C'}, 'Lunch': {'score': 8.777777777777779, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 14.555555555555557, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 10.61111111111111, 'grade': 'D'}, 'Dinner': {'score': 10.61111111111111, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 450, 'output_scores': {'Breakfast': {'score': 9.097222222222221, 'grade': 'C'}, 'Lunch': {'score': 8.347222222222221, 'grade': 'C'}, 'Dinner': {'score': 4.5, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 8.777777777777779, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 12.555555555555557, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 451, 'output_scores': {'Breakfast': {'score': 9.097222222222221, 'grade': 'C'}, 'Lunch': {'score': 8.347222222222221, 'grade': 'C'}, 'Dinner': {'score': 4.5, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 14.11111111111111, 'grade': 'D'}, 'Dinner': {'score': 6.111111111111111, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 452, 'output_scores': {'Breakfast': {'score': 9.097222222222221, 'grade': 'C'}, 'Lunch': {'score': 8.347222222222221, 'grade': 'C'}, 'Dinner': {'score': 4.5, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 5.75, 'grade': 'C'}, 'Dinner': {'score': 8.305555555555555, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 453, 'output_scores': {'Breakfast': {'score': 9.097222222222221, 'grade': 'C'}, 'Lunch': {'score': 8.347222222222221, 'grade': 'C'}, 'Dinner': {'score': 4.5, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 4.5, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 6.111111111111111, 'grade': 'C'}}, 'model_daily_score': {'score': 14.555555555555557, 'grade': 'D'}}\n",
      "{'row_index': 455, 'output_scores': {'Breakfast': {'score': 11.625, 'grade': 'D'}, 'Lunch': {'score': 5.263888888888889, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 6.152777777777779, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 10.61111111111111, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 456, 'output_scores': {'Breakfast': {'score': 11.625, 'grade': 'D'}, 'Lunch': {'score': 5.263888888888889, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 4.5, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 4.680555555555555, 'grade': 'C'}}, 'model_daily_score': {'score': 13.0, 'grade': 'D'}}\n",
      "{'row_index': 457, 'output_scores': {'Breakfast': {'score': 11.625, 'grade': 'D'}, 'Lunch': {'score': 5.263888888888889, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 6.152777777777779, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 6.111111111111111, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 458, 'output_scores': {'Breakfast': {'score': 11.625, 'grade': 'D'}, 'Lunch': {'score': 5.263888888888889, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 12.555555555555557, 'grade': 'D'}, 'Dinner': {'score': 6.152777777777779, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 460, 'output_scores': {'Breakfast': {'score': 8.305555555555555, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 4.333333333333334, 'grade': 'C'}}, 'output_daily_score': {'score': 14.333333333333336, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 11.666666666666668, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 6.111111111111111, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 461, 'output_scores': {'Breakfast': {'score': 8.305555555555555, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 4.333333333333334, 'grade': 'C'}}, 'output_daily_score': {'score': 14.333333333333336, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 10.61111111111111, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 462, 'output_scores': {'Breakfast': {'score': 8.305555555555555, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 4.333333333333334, 'grade': 'C'}}, 'output_daily_score': {'score': 14.333333333333336, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 4.222222222222221, 'grade': 'C'}, 'Dinner': {'score': 10.61111111111111, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 463, 'output_scores': {'Breakfast': {'score': 8.305555555555555, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 4.333333333333334, 'grade': 'C'}}, 'output_daily_score': {'score': 14.333333333333336, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 1.7638888888888893, 'grade': 'B'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 4.5, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 465, 'output_scores': {'Breakfast': {'score': 12.555555555555557, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 6.333333333333334, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 11.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 11.666666666666668, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 466, 'output_scores': {'Breakfast': {'score': 12.555555555555557, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 6.333333333333334, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 4.5, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 6.152777777777779, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 467, 'output_scores': {'Breakfast': {'score': 12.555555555555557, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 6.333333333333334, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 10.61111111111111, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 468, 'output_scores': {'Breakfast': {'score': 12.555555555555557, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 6.333333333333334, 'grade': 'C'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 9.88888888888889, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 470, 'output_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 14.11111111111111, 'grade': 'D'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 11.666666666666668, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 12.555555555555557, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 471, 'output_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 14.11111111111111, 'grade': 'D'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 9.444444444444445, 'grade': 'C'}, 'Lunch': {'score': 10.61111111111111, 'grade': 'D'}, 'Dinner': {'score': 4.5, 'grade': 'C'}}, 'model_daily_score': {'score': 14.555555555555557, 'grade': 'D'}}\n",
      "{'row_index': 472, 'output_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 14.11111111111111, 'grade': 'D'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 4.5, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 10.61111111111111, 'grade': 'D'}}, 'model_daily_score': {'score': 14.555555555555557, 'grade': 'D'}}\n",
      "{'row_index': 473, 'output_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 14.11111111111111, 'grade': 'D'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 11.11111111111111, 'grade': 'D'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 4.5, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 475, 'output_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 13.222222222222221, 'grade': 'D'}, 'Dinner': {'score': -0.7222222222222223, 'grade': 'B'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 12.555555555555557, 'grade': 'D'}, 'Lunch': {'score': 4.5, 'grade': 'C'}, 'Dinner': {'score': 9.444444444444445, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 476, 'output_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 13.222222222222221, 'grade': 'D'}, 'Dinner': {'score': -0.7222222222222223, 'grade': 'B'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': -0.7222222222222223, 'grade': 'B'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 11.666666666666668, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 477, 'output_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 13.222222222222221, 'grade': 'D'}, 'Dinner': {'score': -0.7222222222222223, 'grade': 'B'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': -0.7222222222222223, 'grade': 'B'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 12.555555555555557, 'grade': 'D'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n",
      "{'row_index': 478, 'output_scores': {'Breakfast': {'score': 15.0, 'grade': 'D'}, 'Lunch': {'score': 13.222222222222221, 'grade': 'D'}, 'Dinner': {'score': -0.7222222222222223, 'grade': 'B'}}, 'output_daily_score': {'score': 15.0, 'grade': 'D'}, 'model_scores': {'Breakfast': {'score': 4.222222222222221, 'grade': 'C'}, 'Lunch': {'score': 9.444444444444445, 'grade': 'C'}, 'Dinner': {'score': 8.777777777777779, 'grade': 'C'}}, 'model_daily_score': {'score': 15.0, 'grade': 'D'}}\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import json\n",
    "import re\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "\n",
    "# 데이터 유효성 검사 함수\n",
    "# meal_data(JSON 문자열)에서 반드시 Breakfast, Lunch, Dinner 키가 존재해야 함\n",
    "def is_valid_meal_structure(json_string):\n",
    "    try:\n",
    "        data = json.loads(json_string)\n",
    "        return all(key in data for key in ['Breakfast', 'Lunch', 'Dinner'])\n",
    "    except (json.JSONDecodeError, TypeError):\n",
    "        return False\n",
    "\n",
    "# 텍스트 유사도 기반으로 가장 유사한 행 찾기\n",
    "# TF-IDF를 사용하여 dfh의 제목과 입력된 title 간 유사도를 계산\n",
    "def find_most_similar_row(title, dfh):\n",
    "    vectorizer = TfidfVectorizer()\n",
    "    tfidf_matrix = vectorizer.fit_transform(dfh['title'])\n",
    "    input_vector = vectorizer.transform([title])\n",
    "    similarities = cosine_similarity(input_vector, tfidf_matrix)\n",
    "    most_similar_idx = similarities.argmax()\n",
    "    return dfh.iloc[most_similar_idx]\n",
    "\n",
    "# Nutri-Score를 계산하는 함수\n",
    "def calculate_nutri_score(nutrition):\n",
    "    try:\n",
    "        # 에너지 점수 계산\n",
    "        energy = nutrition.get('nutrition_facts.Energy (kJ)', 0)\n",
    "        energy_points = min(energy / 335, 10)\n",
    "\n",
    "        # 기타 불리한 점수 계산\n",
    "        saturated_fat_points = min(nutrition.get('nutrition_facts.Total Fat', 0) / 1, 10)\n",
    "        sugar_points = min(nutrition.get('nutrition_facts.Total Carbohydrate', 0) / 4.5, 10)\n",
    "        sodium_points = min(nutrition.get('nutrition_facts.Sodium', 0) / 90, 10)\n",
    "\n",
    "        unfavorable_points = energy_points + saturated_fat_points + sugar_points + sodium_points\n",
    "\n",
    "        # 유리한 점수 계산\n",
    "        fiber_points = 0  # 데이터에 섬유질 정보가 없을 경우 기본값 0\n",
    "        protein_points = min(nutrition.get('nutrition_facts.Protein', 0) / 1.6, 5)\n",
    "        fruit_veg_points = 0  # 과일/야채 정보가 없을 경우 기본값 0\n",
    "\n",
    "        favorable_points = fiber_points + protein_points + fruit_veg_points\n",
    "\n",
    "        # 최종 Nutri-Score 계산\n",
    "        total_score = unfavorable_points - favorable_points\n",
    "        return total_score\n",
    "    except Exception as e:\n",
    "        print(f\"Error in calculate_nutri_score: {e}, nutrition: {nutrition}\")\n",
    "        return None\n",
    "\n",
    "# Nutri-Score 등급 계산\n",
    "def get_nutri_score_grade(score):\n",
    "    if score <= -1:\n",
    "        return \"A\"\n",
    "    elif score <= 2:\n",
    "        return \"B\"\n",
    "    elif score <= 10:\n",
    "        return \"C\"\n",
    "    elif score <= 18:\n",
    "        return \"D\"\n",
    "    else:\n",
    "        return \"E\"\n",
    "\n",
    "# 영양 데이터 정리 함수\n",
    "def clean_nutrition_data(title, dfh):\n",
    "    try:\n",
    "        matched_row = find_most_similar_row(title, dfh)\n",
    "        nutrition = {\n",
    "            'nutrition_facts.Amount per serving': extract_numeric_value(matched_row.get('nutrition_facts.Amount per serving', 0)),\n",
    "            'nutrition_facts.Total Fat': extract_numeric_value(matched_row.get('nutrition_facts.Total Fat', 0)),\n",
    "            'nutrition_facts.Sodium': extract_numeric_value(matched_row.get('nutrition_facts.Sodium', 0)),\n",
    "            'nutrition_facts.Total Carbohydrate': extract_numeric_value(matched_row.get('nutrition_facts.Total Carbohydrate', 0)),\n",
    "            'nutrition_facts.Protein': extract_numeric_value(matched_row.get('nutrition_facts.Protein', 0)),\n",
    "        }\n",
    "        return nutrition\n",
    "    except Exception as e:\n",
    "        print(f\"Error in clean_nutrition_data: {e}, title: {title}\")\n",
    "        return None\n",
    "\n",
    "# 단위 제거 및 숫자 변환 함수\n",
    "def extract_numeric_value(value):\n",
    "    try:\n",
    "        if isinstance(value, str):\n",
    "            match = re.search(r\"(\\d+(\\.\\d+)?)\", value)\n",
    "            if match:\n",
    "                return float(match.group(1))\n",
    "        elif isinstance(value, (int, float)):\n",
    "            return float(value)\n",
    "    except Exception as e:\n",
    "        print(f\"Error in extract_numeric_value: {e}, value: {value}\")\n",
    "    return 0.0\n",
    "\n",
    "# 각 식사의 Nutri-Score 계산 함수\n",
    "def calculate_meal_nutri_score(meal_data, dfh):\n",
    "    meal_scores = {}\n",
    "    total_nutrition = {\n",
    "        'nutrition_facts.Energy (kJ)': 0,\n",
    "        'nutrition_facts.Total Fat': 0,\n",
    "        'nutrition_facts.Sodium': 0,\n",
    "        'nutrition_facts.Total Carbohydrate': 0,\n",
    "        'nutrition_facts.Protein': 0\n",
    "    }\n",
    "\n",
    "    for meal, title in meal_data.items():\n",
    "        matched_row = find_most_similar_row(title, dfh)\n",
    "        nutrition = {\n",
    "            'nutrition_facts.Energy (kJ)': extract_numeric_value(matched_row.get('nutrition_facts.Energy (kJ)', 0)),\n",
    "            'nutrition_facts.Total Fat': extract_numeric_value(matched_row.get('nutrition_facts.Total Fat', 0)),\n",
    "            'nutrition_facts.Sodium': extract_numeric_value(matched_row.get('nutrition_facts.Sodium', 0)),\n",
    "            'nutrition_facts.Total Carbohydrate': extract_numeric_value(matched_row.get('nutrition_facts.Total Carbohydrate', 0)),\n",
    "            'nutrition_facts.Protein': extract_numeric_value(matched_row.get('nutrition_facts.Protein', 0))\n",
    "        }\n",
    "\n",
    "        score = calculate_nutri_score(nutrition)\n",
    "        meal_scores[meal] = {\n",
    "            'score': score,\n",
    "            'grade': get_nutri_score_grade(score)\n",
    "        }\n",
    "\n",
    "        for key in total_nutrition:\n",
    "            total_nutrition[key] += nutrition[key]\n",
    "\n",
    "    daily_score = calculate_nutri_score(total_nutrition)\n",
    "    daily_grade = get_nutri_score_grade(daily_score)\n",
    "\n",
    "    return meal_scores, {'score': daily_score, 'grade': daily_grade}\n",
    "\n",
    "# 전체 Nutri-Score 계산 및 결과 저장 함수\n",
    "def calculate_scores(df, dfh):\n",
    "    results = []\n",
    "\n",
    "    for idx, row in df.iterrows():\n",
    "        try:\n",
    "            if not is_valid_meal_structure(row.get('output', '')) or not is_valid_meal_structure(row.get('model_output', '')):\n",
    "                print(f\"Skipping row {idx}: Invalid meal structure\")\n",
    "                continue\n",
    "\n",
    "            output_data = json.loads(row['output'])\n",
    "            model_output_data = json.loads(row['model_output'])\n",
    "\n",
    "            output_scores, output_daily_score = calculate_meal_nutri_score(output_data, dfh)\n",
    "            model_scores, model_daily_score = calculate_meal_nutri_score(model_output_data, dfh)\n",
    "\n",
    "            results.append({\n",
    "                'row_index': idx,\n",
    "                'output_scores': output_scores,\n",
    "                'output_daily_score': output_daily_score,\n",
    "                'model_scores': model_scores,\n",
    "                'model_daily_score': model_daily_score\n",
    "            })\n",
    "        except Exception as e:\n",
    "            print(f\"Error processing row {idx}: {e}\")\n",
    "            results.append({\n",
    "                'row_index': idx,\n",
    "                'output_scores': None,\n",
    "                'output_daily_score': None,\n",
    "                'model_scores': None,\n",
    "                'model_daily_score': None\n",
    "            })\n",
    "\n",
    "    return results\n",
    "\n",
    "# 실행 및 결과 출력\n",
    "results = calculate_scores(df, dfh)\n",
    "for result in results:\n",
    "    print(result)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "tmp = pd.DataFrame(results)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>row_index</th>\n",
       "      <th>output_scores</th>\n",
       "      <th>output_daily_score</th>\n",
       "      <th>model_scores</th>\n",
       "      <th>model_daily_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>430</td>\n",
       "      <td>{'Breakfast': {'score': 8.777777777777779, 'gr...</td>\n",
       "      <td>{'score': 15.0, 'grade': 'D'}</td>\n",
       "      <td>{'Breakfast': {'score': -0.7222222222222223, '...</td>\n",
       "      <td>{'score': 15.0, 'grade': 'D'}</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>431</td>\n",
       "      <td>{'Breakfast': {'score': 8.777777777777779, 'gr...</td>\n",
       "      <td>{'score': 15.0, 'grade': 'D'}</td>\n",
       "      <td>{'Breakfast': {'score': 9.444444444444445, 'gr...</td>\n",
       "      <td>{'score': 15.0, 'grade': 'D'}</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   row_index                                      output_scores  \\\n",
       "0        430  {'Breakfast': {'score': 8.777777777777779, 'gr...   \n",
       "1        431  {'Breakfast': {'score': 8.777777777777779, 'gr...   \n",
       "\n",
       "              output_daily_score  \\\n",
       "0  {'score': 15.0, 'grade': 'D'}   \n",
       "1  {'score': 15.0, 'grade': 'D'}   \n",
       "\n",
       "                                        model_scores  \\\n",
       "0  {'Breakfast': {'score': -0.7222222222222223, '...   \n",
       "1  {'Breakfast': {'score': 9.444444444444445, 'gr...   \n",
       "\n",
       "               model_daily_score  \n",
       "0  {'score': 15.0, 'grade': 'D'}  \n",
       "1  {'score': 15.0, 'grade': 'D'}  "
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tmp.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Output Daily Score 평균: 14.888888888888891\n",
      "Output Daily Grade 최빈값: D\n",
      "Model Daily Score 평균: 14.916666666666666\n",
      "Model Daily Grade 최빈값: D\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from statistics import mode\n",
    "\n",
    "# 'score' 평균 계산\n",
    "output_score_mean = tmp['output_daily_score'].apply(lambda x: x['score']).mean()\n",
    "model_score_mean = tmp['model_daily_score'].apply(lambda x: x['score']).mean()\n",
    "\n",
    "# 'grade' 최빈값 계산\n",
    "output_grade_mode = tmp['output_daily_score'].apply(lambda x: x['grade']).mode()[0]\n",
    "model_grade_mode = tmp['model_daily_score'].apply(lambda x: x['grade']).mode()[0]\n",
    "\n",
    "# 결과 출력\n",
    "print(f\"Output Daily Score 평균: {output_score_mean}\")\n",
    "print(f\"Output Daily Grade 최빈값: {output_grade_mode}\")\n",
    "print(f\"Model Daily Score 평균: {model_score_mean}\")\n",
    "print(f\"Model Daily Grade 최빈값: {model_grade_mode}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "meal_kernel",
   "language": "python",
   "name": "meal"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
